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Symposium Session 1 Symposium Session 2 Symposium Session 3
Therapeutic Applications of EVs
Platelets, Coagulation, and 
Inflammation
EVs in Neurologic Diseases
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chairs: Peter Quesenberry and 
Jan Lotvall
Chairs: Eric Boilard and Pia Sijander
Chairs:  Lynn Pulliam and Laura 
Vella
Symposium Session 4 Symposium Session 5 Symposium Session 6
EV Biogenesis EVs in Tumor Biology EVs in Inflammatory Diseases
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chairs: Matias Ostrowski and 
Crisslyn D'Souza
Chairs: Michael Freeman and Carolina 
Soekmadji
Chairs: Edit Buzas and Rienk 
Nieuwland 
11:00 – 12:30pm
12:30 – 1:30pm Lunch
1:30 – 2:15pm
8:00 – 9:00am Registration
Wednesday, 17 May 2017 - Pre-Meeting Education Day
8:30 - 5:30pm The Pre-meeting Education Day is a successful tradition of the annual ISEV meetings. Focusing on 
particular topics within the extracellular vesicle field, select experts provide deep insight into certain 
basic aspects of extracellular vesicles. These educational presentations collectively illuminate burning 
questions and provide a comprehensive insight into the topic.
Parallel Sessions
*Education Day First Sessions: Biology and Technology
*Education Day Second Sessions: Extracellular Vesicles in Health and Disease
Thursday, 18 May 2017
8:30 – 9:00am Welcome Coffee
9:00 – 9:20am
Opening Sessions (Room 1 Metropolitan Ballroom - West and Centre)
 Speaker: Philip Stahl, PhD 
9:30 – 10:30am
Plenary Session 1 –Extracellular Vesicles in Pathology of Complex Tissues
Chairs: Andrew Hill, PhD; Susmita Sahoo, PhD
10:30 – 11:00am Networking Coffee
Oral with Poster Session 1 Oral with Poster Session 2 Oral with Poster Session 3
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chair: Thomas Kislinger Chair: Uta Erdbruegger Chair: Eric Boilard 
Symposium Session 7 Symposium Session 8 Symposium Session 9
Emerging Technologies in EV 
CharacterizationRoom: 
Metropolitan Ballroom - West 
and Centre
Chairs: Hubert Yin and John 
Nolan
EV Interactions with Cellular Targets




Biotech Sponsored Session 
3:30 - 3:45pm
Chairs: Dolores Di Vizio and TBD
Chairs: Peter Kurre and Olga 
Volpert
2:20-3:00pm






























Meet the Experts Session 1 Meet the Experts Session 2 Meet the Experts Session 3
EV-Mediated Functional 
Delivery of Protein and Nucleic 
Acids
EV Lipids and Lipidomics
Rigor and Reproducibility in 
EV Analysis
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Moderator: Lucia Languino  Moderator: Yong Song Gho Moderator: Chris Gardiner 
Speakers: Janusz Rak and 
Raghu Kalluri
Speakers: Hang Hubert Yin and Alicia 
Llorente
Speakers: An Hendrix and 
Andreas Moller
Symposium Session 10 Symposium Session 11 Symposium Session 12
Novel Developments in EV 
Isolation
EVs in Tumor Metastasis EVs in Viral Infections
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chairs: Alain Brisson and Dylan 
Burger
Chairs: Lei Zheng and Yves DeClerck
Chairs: Marc-Andre Langlois 
and Caroline Gilbert
9:00 – 10:00am
Friday, 19 May 2017
7:45 – 8:30am
5:15 – 6:30pm
Poster Session T01 - From Biogenesis to Targeting
Poster Session T02 - EV Isolation
Poster Session T03 - EVs in Tissue Protection and Repair
Poster Session T04 - EVs in Cancer Therapy and Drug Resistance
Poster Session T05 - Novel Developments in EV Characterization
Poster Session T06 - Non-Cancer EV Biomarkers
Poster Session T07 - EV Proteomics and Lipidomics
Poster Session T08 - EVs in Viral and Bacterial Infections
Poster Session T09 - EVs in Diseases of the Central Nervous System
Poster Session T10 - EVs in Tumor Metastasis and Angiogenesis
Poster Session T11 - EVs and the Immune System
6:30 - 8:00pm
Satellite Event (Room: Metropolitan Ballroom - West and Centre)
Meet the National and International Societies: This event will provide an opportunity for scientific 
Room: Metropolitan Ballroom - 
West and Centre
Symposium Session 13 Symposium Session 14 Symposium Session 15
Novel Technologies in EV 
Characterization
EVs in Cardiovascular Disorders
EV RNAs as Cancer 
Biomarkers
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chairs: Joanne Lannigan and 
Rienk Nieuwland
Chairs: Chantal Boulanger and Mike 
Davis
Chairs: Andrew Hill and 
Kendall Jensen
Symposium Session 16 Symposium Session 17 Symposium Session 18
EV Omics
EVs in Tissue Repair and 
Inflammation
Biogenesis: EVs and Viruses
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chairs: Juan Falcon-Perez and 
Suresh Mathivanan
Chairs: Chris Gardiner and Shilpa 
Buch
Chairs: Leonid Margolis and 
Jennifer Jones
3:30 - 5:15 pm
10:00 – 10:30am Networking Coffee
10:30 – 11:30am
Plenary Session 2 – Plasma Membrane and Cellular Vesicles (Room: Metropolitan Ballroom - West 
and Centre)
Chairs: Xandra Breakefield; Alissa Weaver
Featured Abstracts
11:30 – 12:30pm 
Chairs: Xandra Breakefield and Alissa Weaver
12:30 – 1:30pm Lunch
1:30 – 3:00pm





























Meet the Experts Session 4 Meet the Experts Session 5 Meet the Experts Session 6
In Vivo Imaging-based Analysis 
of EV-biological Activity
Vesicular and Non-vesicular 




Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chair: TBD Chair: Esther Nolte-t Hoen Chair: Ana Claudia Torrecilhas
Speakers: Takahiro Ochiya and 
Charles Lai
Speakers: Alissa Weaver and 
Muneesh Tewari
Speakers: Rodrigo Soares and 
Martin Olivier
5:15 – 6:30pm
Poster Session F01 - EV-Based Cancer Biomarkers
Poster Session F02 - EV Isolation: Developments
Poster Session F03 - Bodyfluid Biomarkers of Cancer
Poster Session F04 - EVs in the Tumor Microenvironment
Poster Session F05 - Inflammatory Disorders, Tissue Injury, and Coagulation
Poster Session F06 - EVs and Stem Cells I
Poster Session F07 - EVs in the Central Nervous System
Poster Session F08 - Intercellular and Inter-Organismal Crosstalk
Poster Session F09 - EVs in Parasitic Diseases
Poster Session F10 - EVs as Mediators of Cancer Cell Signaling
Poster Session F11 - Cell and Tissue Remodeling and Repair
Satellite Event (Room: Metropolitan Ballroom - West and Centre)
6:30 – 8:00pm ISEV-ISAC-ISTH Workshop: This satellite event will provide insight into the scientific interaction of 
Saturday, 20 May 2017
7:45 – 8:30am
Symposium Session 19 Symposium Session 20 Symposium Session 21
EVs in Tumor Immunity and 
Angiogenesis
EVs in Stem Cell and Cardiovascular 
Biology
Milk EVs
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chairs:  Carol Parent and 
Janusz Rak
Chairs: Costanza Emanueli and Uta 
Erdbruegger
Chairs: Martinjn van 
Herwijnen and Patrick Provost
JEV Editorial Board Meeting
Symposium Session 22 Symposium Session 23 Symposium Session 24
EV-Mediated Communication 
Between Host and 
Microorganisms
EV-Based Cancer Biomarkers EV Functions in Inflammation
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chairs: Patricia Xander and 
Ana Claudia Torrecilhas
Chairs: Aled Clayton and Lorraine 
O'Driscoll
Chairs: Saara Laitinen and 
Takahiro Ochiya
Symposium Session 25 Symposium Session 26 Symposium Session 27
EV-Mediated Communication 
in Cancer II
EVs as Epigenetic Regulators
EVs in Cancer Progression 
and Therapy
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chairs: Louise Laurent and 
Dave Carter
Chairs: Hidetoshi Tahara and TBD
Chairs: Andries Zijlstra and 
Peter Quesenberry
11:30 – 12:30pm ISEV General Assembly (Room: Metropolitan Ballroom - West and Centre)
12:30 – 1:30pm Lunch
1:30 – 3:00pm
3:00 – 3:30pm Networking Coffee
3:30-5:15
10:30 – 11:30am
Plenary Session 3 – From Extracellular Vesicles to Coordinated Behaviour of Cellular Populations 
(Room: Metropolitan Ballroom - West and Centre)
Moderators: Marca Wauben; Ken Witwer
9:00 – 10:00am





























Symposium Session 28 Symposium Session 29 Symposium Session 30
EVs in Cardiovascular 
Diseases and Vascular 
Disorders
Evs in Immune System and 
Inflammation
Novel Developments in EV 
Biogensis and 
Characterization
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom
Chairs: TBD and Jason Fish Chairs: TBD and Eric Boilard
Chairs: An Hendrix and Jeff 
Franklin
Room: Metropolitan Ballroom - 
West and Centre
Chairs: Andrew Hill, PhD; 
Susmita Sahoo, PhD
11:20 – 11:50am
Wrap Up Sessions – Clinical (Room: Metropolitan Ballroom - West and Centre)
Speaker: Uta Erdbrugger
Wrap Up Sessions – Basic Science
Speaker: Eric Boilard
11:50-12:15pm Special Achievement Award and Closing Remarks (Room: Metropolitan Ballroom - West and Centre)




Experts Workshop Session 1 Experts Workshop Session 2 Experts Workshop Session 3
Workshop on exRNA biology and 
the analytical methods organized 
by the ERCC, NIH
EV-TRACK Demonstration Workshop Data 
Analysis with FunRich
Room: Metropolitan Ballroom - 
West and Centre
Room: Metropolitan Ballroom - East Room: Harbour Ballroom




Sunday, 21 May 2017
Dave Carter
5:15 – 6:30pm
Poster Session S1 - EVs and Stem Cells II
Poster Session S2 - EVs for Therapeutic Applications
Poster Session S3 - EVs in Biofluids
Poster Session S4 - Isolation, Characterization, and Detection of EVs
Poster Session S5 - EVs in Cardiovascular Disease
Poster Session S6 - EVs in Cancer Biology and Progression
Poster Session S7 - Cancer
Poster Session S8 - Viruses, Bacteria, Fungi, and Parasites






























Thursday May 18, 2017
Room: Metropolitan Ballroom West and Centre
Opening Plenary Session 9:00–9:20 a.m.
Chairs: Andrew Hill, PhD; Susmita Sahoo, PhD
Speaker:
Philip Stahl, PhD (Washington University, St. Louis, MO,
United States)
The Exosome Paradigm of Intercellular Communication
Room:
Plenary Session-1: Extracellular Vesicles in Pathology of
Complex Tissues
Chairs: Andrew Hill, PhD; Susmita Sahoo, PhD 9:30–10:30 a.m.
Speakers:
Thomas Thum, PhD, MD (Hannover Medical School,
Germany)
Non-coding RNA and Microvesicles in Cardiovascular
Homeostasis and Disease
Jeffrey Wrana, PhD (Mt. Sinai Hospital, Toronto,
Ontario, Canada)
The Role of Exosomes in Planar Cell Polarity in
Pathological Cell Migration
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Room: Metropolitan Ballroom West and Centre
Symposium Session 1 – Therapeutic Applications of EVs
Chairs: Peter Quesenberry and Jan Lotvall 11:00–12:30 p.m.
OT1.01
Therapeutic potential for Spodoptera-derived microvesicle delivery of
the membrane transport proteins cystinosin, sialin and CFTR
Jodi Mullet and Jess Thoene
University of Michigan, MI, United States
Introduction: Therapeutic use of transmembrane proteins is limited because
they irreversibly denature when away from their native lipid membrane.
Mutations in such proteins cause many lethal disorders including two lyso-
somal transport disorders, cystinosis and infantile sialic acid storage disease
due to defective cystinosin and sialin. Cystic fibrosis is due tomutations in the
plasma membrane anion transporter CFTR. Cystinosin and sialin-deficient
fibroblasts accumulate lysosomal cystine or sialic acid. Cystinosis patients
develop highly painful corneal cystine crystals, currently treated hourly with
cysteamine eye drops. We here show delivery of functional membrane
transport proteins to fibroblasts and cornea via microvesicles.c
Methods: Transport proteins were cloned in Baculovirus and expressed
in Sf9 cells at an MOI of 1.0. Microvesicles ~90 nm dia were purified
from 3 d post lytic infection Sf9 supernatant, dialysed into Ham’s F12
media, sterilised via 0.22 µm filters and 1011 microvesicles/ml
(NanoSight quantitation) placed on cultured fibroblasts or ex vivo wt
NZW rabbit ocular globes. Cystine and sialic acid were quantified by
LC/MS and colorimetric assay, respectively. Cystinosin and sialin in the
microvesicles was confirmed by protein LC/MS/MS (1). Delivery of
cystinosin-GFP and GFP-CFTR to target tissue was determined by
confocal immunofluorescence microscopy.
Results: We have previously shown that addition of cystinosin or sialin-
containing microvesicles decreases stored lysosomal cystine or sialic acid
by ~50% at 96 h and persists to 196 h after a single administration. No
effect was seen on cells pre-loaded with 3[H] mannitol, precluding
increased exocytosis (1). GFP-tagged transport proteins added to cul-
tured normal or cystinotic fibroblasts or rabbit ocular globes displayed
punctate perinuclear green fluorescence with time dependence and
penetration of cystinosin-GFP into the cornea of ~50% after 96 h.
Summary: Use of microvesicles to deliver transmembrane proteins has
significant potential to treat lethal inborn errors of transport at the
lysosomal and plasma membrane. Cystinosin-containing microvesicle
eye drops may be a significant advance by permitting weekly adminis-
tration. Kickstart Award from the University of Michigan.
Reference
1. Thoene et al., Mol. Gen. Metab. 2013; 109: 77–85.
OT1.02
Exosome-mediated delivery of CFTR protein to human bronchial
epithelia as a novel therapeutic strategy to treat Cystic Fibrosis
Inna Uliyakina1, Justin Hean1, Andreas Koschinski1, Miguel Lobo1, Samir El
Andaloussi1, Alison Mahoney2, Ray Jupp2 and Matthew J. Wood3
1University of Oxford, Oxford, United Kingdom; 2UCB Pharma;
3Department of Physiology, Anatomy and Genetics, University of Oxford,
Oxford, United Kingdom
Introduction: Cystic fibrosis (CF), the most common life-shortening
genetic disorder among Caucasians, affects over 70,000 patients worldwide.
CF is caused by mutations in the gene encoding the CF transmembrane
conductance regulator (CFTR) protein, an anion (chloride/bicarbonate)
channel that is expressed at the apical membrane of epithelial cells to
control salt and water transport. To date more than 2000 mutations have
been reported in the gene. For the majority of CF patients, successful
therapy requires the replacement of the mutated gene or protein by a
functional entity. As with many clinical trials for CF, gene therapies have
been unsuccessful mainly due to the low uptake of CFTR cDNA through
the thick mucus obstructing the airways and to the deleterious immune
response of the host organism. Recently, exosomes have been demonstrated
to efficiently and specifically deliver proteins, mRNA and si/miRNAs with
little or no toxicity or immunogenicity in vivo. Here, we propose to use
exosome-mediated delivery of CFTR protein to CF respiratory epithelia in
order to restore the deficient chloride transport.
Methods: Exosomes were isolated by size-exclusion liquid chromatography
andwere analysedNTA, µBCA andwestern blot. Localisation and the plasma
membrane (PM) stability of CFTR was monitored by live-cell confocal
microscopy and cell-surface biotinylation, respectively. Functional activity
of CFTR channel was measured by whole-cell patch clamp technique.
Results: In order to improve the trafficking of CFTR into exosomes,
several fusion constructs containing CFTR and exosomal proteins were
generated. For instance, CFTR was fused to exosomal membrane proteins
such as tetraspanins, endosome- and exosome biogenesis-associated pro-
teins. Fusion constructs were fully processed, expressed at the PM of the
epithelial cells and functionally active as a chloride transporter. CF human
bronchial epithelial cells depleted for CFTR protein were incubated with
exosomes containing CFTR protein and the localisation of the exosome-
delivered CFTR protein was monitored by confocal microscopy showing
the successful uptake of the engineered exosomes.
Conclusions: Exosome-mediated delivery of CFTR is thus a promising solu-
tion to treat/alleviate CF pathology independently from the type of mutation.
OT1.03
Bio-inspired synthetic exosomes carrying microRNA let-7b for post-
ischemic vascular regeneration
Sezin Aday1, Inbal Halevy2, Maryam Anwar3, Marie Besnier1, Cristina
Beltrami1, Andrew Herman1, Susmita Sahoo4, Enrico Petretto5, Gianni
Angelini1, Dan Peer2 and Costanza Emanueli6
1University of Bristol, Bristol, United Kingdom; 2Tel Aviv University, Tel
Aviv, Israel; 3Imperial College London, London, UK; 4Cardiovascular
Research Center, Icahn School of Medicine at Mount Sinai, New York,
USA; 5Duke-NUS Medical School, NC, USA; 6Bristol Heart Institute,
University of Bristol, Bristol, United Kingdom
Ischemic diseases are the leading cause of illness and death around the world.
Localised therapeutic angiogenesis able to improve themicrovascular network
could help the suffering patients by providing additional blood flow to
inadequately perfused areas. Exosomes with variable microRNA cargos are
released from different progenitor cell types and stimulate angiogenesis in
animal models. We recently showed that human pericardial fluid (PF) sur-
rounding the heart also contains exosomes able to promote angiogenesis via
the delivery of the microRNA let-7b-5p to recipient hypoxic endothelial cells
(ECs). Here, we aimed to: (1) characterise the common microRNA cargo of
endogenous angiogenic exosomes using bioinformatics, (2) exploit this
knowledge to develop off-the-shelf artificial exosomes (AEs) with superior
proangiogenic capacities, (3) validate the angiogenic potential of the bioin-
spiredAEs. Pilot bioinformatics analyses integrating data ofmiRNAarrays on
proangiogenic exosomes (from PF and bone marrow-derived CD34+ cells)
confirmed the enrichment of let-7b-5p in these exosomes. Next, we produced
AEs containing either let-7b-5p or fluorescent cy5-cel-miR-39, as control. The
AEs were uptaken by human ECs and pericytes cultured under hypoxic
conditions, without causing toxicity. let-7b-AEs transferred functional let-
7b, thus decreased the expression of TGFBR1 andCASP3 (validated targets of





























let-7b-5p) in recipient cells. let-7b-AEs improved EC survival and angiogen-
esis in vitro. In vivo, cel-miR-39-AEs injection in ischemic murine muscles
resulted in their uptake by 12% and 11% of the local microvascular ECs and
pericytes, respectively. Overall, our preliminary results suggest the therapeutic
potential of bioinspiredAEs containing let-7b,whichwill be further developed
by: (1) employing clustering techniques to find candidate miRNAs grouping
with let-7b; (2) functionalising AEs to preferentially target ischemic ECs.
OT1.04
Scalable, cGMP-compatible purification of EV enriched with
heterodimeric interleukin-15
Dionysios C. Watson1, Bryant Yung2, Aizea Morales-Kastresana1, Cristina
Bergamaschi1, Bhabadeb Chowdhury1, Jennifer C. Jones3, Barbara Felber1,
Xiaoyuan Chen2 and George Pavlakis1
1National Cancer Institute, National Institutes of Health, NY, USA; 2National
Institute of Biomedical Imaging and Bioengineering, National Institutes of
Health, NY, USA; 3National Cancer Institute, Vaccine Branch, MD, USA
Introduction: We previously showed that hollow-fibre bioreactors are a
rich source of extracellular vesicles (EVs). These EVs were purified by
ultracentrifugation; however, purification by ultracentrifugation was not
easily scalable and preparations contained macromolecular contami-
nants. In this study, we tested scalable, cGMP-compatible purification
methods to obtain highly purified preparations of EVs carrying hetero-
dimeric interleukin-15 (hetIL-15), a cytokine tested in clinical trials for
treatment of cancer.
Methods: We constructed a HEK293 cell line stably expressing a hetero-
dimeric IL-15 /Lactadherin fusion protein. Cells were grown in a hollow-
fibre bioreactor with serum-free media; conditioned media were clarified
by centrifugation and filtration, and subsequently concentrated by tan-
gential flow filtration (TFF). EVs were then purified by size-exclusion
chromatography (SEC). EV preparations were characterised by nano-
particle tracking analysis (NTA), ELISA, flow cytometry, transmission
electron microscopy (TEM) and mass spectrometry. Bioactivity of IL-15
was measured through the dose-dependent proliferation of the human
NK-92 cell line upon exposure to the cytokine.
Results: Concentration by TFF (750kDa MWCO) removed many of the
contaminating vesicle-free proteins. By monitoring 260/280 light absorp-
tion during SEC, the EV-containing fraction could be reliably collected,
as confirmed by NTA. Particle yield of SEC was similar to that of
ultracentrifugation, while purity (particle:protein ratio) was 8-fold
higher. The major contaminant of ultracentrifugation, ferritin, was
decreased by 26-fold by SEC. EV from cells expressing the hetIL-15/
Lactadherin fusion protein contained 100-fold more cytokine compared
to EV from cells expressing the natural cytokine, while both forms
retained bioactivity.
Conclusion: Lactadherin fusion constructs remain EV-associated after
SEC, and retain their bioactivity. Processing of bioreactor conditioned
media by TFF ultrafiltration/concentration followed by SEC results in
highly purified EV preparations. Given the scalability and cGMP com-
patibility of these methods, they could be useful in large-scale prepara-
tion of clinical grade EV.
OT1.05
Exosome-SIRPalpha, a CD47 blockade increases cancer cell
phagocytosis
Eunee Koh1, Yoosoo Yang2 and In-San Kim2
1KU-KIST Graduate School of Converging Science and Technology, Seoul,
Republic of Korea; 2Korea Institute of Science and Technology, Seoul,
Republic of Korea
CD47, a “don’t eat me” signal, is over-expressed on the surface of most
tumours that interacts with signal regulatory protein α (SIRPα) on
phagocytic cells. By engaging SIRPα, CD47 limits the ability of
macrophages to engulf tumour cells, which acts as a major phagocytic
barrier. In this study, we developed an exosome-based immune check-
point blockade that antagonises the interaction between CD47 and
SIRPα. These exosomes harbouring SIRPα variants (SIRPα-exosomes)
were sufficient to induce remarkably augmented tumour phagocytosis,
lead to prime effective anti-tumour T cell response. Given that clustering
of native CD47 provides a high binding avidity to ligate dimerised SIRPα
on macrophage, nature-derived exosomes could be appreciable platform
to antagonise CD47. Disruption of CD47-SIRPα interaction by SIRPα-
exosomes leads to an increase in cells being engulfed by macrophages
and a concomitant inhibition of tumour growth in tumour-bearing
mice. Moreover, SIRPα-exosomes therapy promotes an intensive T cell
infiltration in syngeneic mouse models of cancer, raising the possibility
of CD47-targeted therapies to unleash both an innate and adaptive anti-
tumour response. Note that very small amount of exosomal SIRPα
proteins could effectively lead to phagocytic elimination of tumour
cells both in vitro and in vivo. Our results suggest that superlative
exosome-based platform has broad potential to maximise the therapeutic
efficacy of membrane-associated protein therapeutics (1).
Reference
1. Koh et al., Biomaterials 2017; 121: 121–129.
OT1.06
Novel therapeutic strategies against cancer metastasis by targeting
extracellular vesicles by specific antibodies
Nao Nishida-Aoki1, Naoomi Tominaga1, Fumitaka Takeshita2, Hikaru
Sonoda1, Yusuke Yoshioka1 and Takahiro Ochiya1
1Division of Molecular and Cellular Medicine, National Cancer Centre
Research Institute, Japan; 2Department of Functional Analysis, FIOC,
National Cancer Centre Research Institute, Japan
Introduction: Cancer-derived extracellular vesicles (EVs) promote
metastasis by forming cancer microenvironment and pre-metastatic
niche. Therefore, inhibiting the pro-metastatic function of cancer-
derived EVs is expected to suppress metastasis. We demonstrated the
therapeutic concept of targeting EVs using an experimental model.
Methods: The antibodies specific to human CD9 and human CD63 were
injected intravenously for every 3 days for a total of 3 times to an
orthotropic mice model of highly-metastatic human breast cancer.
After 35 days, the metastasis levels were evaluated by ex vivo imaging
and immunohistochemistry. The EVs collected by ultracentrifugation
from filtrated culture media were stained by a lipophilic dye PKH67 or
DiR. To transiently remove mouse innate macrophages, clodronate
liposomes were injected intravenously 5 days before the administration
of the EVs.
Results: The species-specificity and the binding ability on the surface of
the EVs from the human breast cancer cells of the antibodies were
confirmed. Antibody treatment significantly reduced lung metastasis
compared to the control IgG treatment. The antibodies did not decrease
the size of the primary tumours, cell proliferation and invasion abilities,
but decreased the amount of circulating cancer-derived EVs. These
observations suggested that the antibodies suppressed metastasis by
disrupting the EVs but not primary tumours. Indeed, the antibodies
stimulated removal of EVs by macrophages both in vitro and in vivo.
The stimulation of EV removal disappeared by depletion of innate
macrophages of mice, indicating that the stimulation of removal of the
EVs was macrophage-dependent.
Conclusion: Recognition of the cancer-derived EVs by antibodies sup-
pressed lung metastasis, by stimulating the removal of the EVs by
macrophages. Identifying the specific targets at the surface of the can-
cer-derived EVs is required for practical use.
Reference
1. Nishida-Aoki et al., Mol. Ther. 2017; 25: 181–191.





























Room: Metropolitan Ballroom East
Symposium Session 2 – Platelets, Coagulation, and Inflammation
Chairs: Eric Boilard and Pia Sijander 11:00–12:30 p.m.
OT2.01
Extracellular vesicles from activated platelets: a quantitative cryo-
electron microscopy and immuno-gold labelling study
Alain R. Brisson1, Sisareuth Tan1, Celine Gounou1, Romain Linares1, Nicolas
Arraud1 and Stephane Mornet2
1UMR-5248 CNRS – University of Bordeaux, Bordeaux, France; 2UPR-
ICMCB CNRS
Introduction: Upon activation, blood platelets release two types of extra-
cellular vesicles (EV), namely microparticles characterised by the pre-
sence at their surface of phosphatidylserine (PS), which supports their
role in haemostasis and in thrombosis (1), and exosomes characterised
by their small size (50–100 nm) and the presence of CD63 on their
surface (2). However, a clear distinction between microparticles and
exosomes is hampered by the difficulty of EV characterisation, which
results from their heterogeneity and from the lack of reliable methods
allowing their isolation and quantification. Using cryo-electron micro-
scopy (EM) and immuno-gold labelling (3), we have revisited the ques-
tion of EVs released by activated platelets with the objective to provide a
quantitative description of the size, phenotype and relative amounts of
the main EV populations, focusing mainly on PS+ EVs CD41+ EVs and
CD63+ EVs (4).
Methods: Peripheral blood was collected over citrate from four healthy
adult donors after informed consent. Platelets from platelet rich plasma
(PRP) samples were activated with thrombin, TRAP or CRP-XL. Gold
nanoparticles conjugated with annexin-5, anti-CD41- or anti-CD63-
mAbs were synthesised to label PS+ EVs, platelet-derived EVs and
CD63+ EVs, respectively (3). Cryo-EM was performed as described
in (3).
Results: We found that EVs activated by the three agonists presented a
similar size distribution, about 50% of them ranging from 50 to 400 nm.
About 60% EVs were found to expose CD41, a majority of them expos-
ing also PS. Several mechanisms of EV formation are proposed to
explain the presence of large amounts (40%) of CD41-negative or PS-
negative EVs of large size, as well as large EVs containing organelles,
principally mitochondria or granules.
We found also that the majority of EVs in activated platelets expose
CD63. Two populations of CD63+ EVs were distinguished, namely large
EVs with low labelling density and small EVs, likely the exosomes, with
high labelling density.
Conclusion: This study provides a quantitative description of EVs from
activated platelets and opens new insight on EV formation mechanisms.
References
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OT2.02
Morphological pathways involved in the release of extracellular
vesicles from TRAP-activated platelets
Oumsalama K. Elhelu, Silvia De Paoli, Tseday Tegegn, Michael Strader, Ivan
Tarandovskiy, Abdu Alayash, Mikhail Ovanesov and Jan Simak
FDA
Platelet-derived extracellular vesicles (PEVs), released upon platelet
(PLT) activation play significant roles in inflammation, thrombosis,
and other pathologies. Here we investigate PEV release from thrombin
receptor-activating peptide-6 (TRAP-6)-activated washed PLTs. Two
major PEV populations were isolated by a two-step centrifugation:
20,000g to collect the large and dense PEVs (L-PEVs), followed by
100,000g spin to obtain the small exosome size PEVs (S-PEVs).
Orthogonal analysis of S-PEVs and L-PEVs by MS-proteomics, MS-
lipid panel, electron microscopy (EM), laser-scanning confocal micro-
scopy (LSCM), nanoparticle tracking analysis (NTA) and flow cytometry
(FC) were used. Results indicate that about 90% of PEVs are in the size
range 40–350 nm. S-PEVs compose the majority of the PLT vesiculome
and have different proteomic and lipidomic profiles, compared to
L-PEVs. Interestingly, S-PEVs have 2-fold higher phosphatidylserine
content and corresponding 5.7-fold higher thrombin generation procoa-
gulant activity per 1 nm2 of the PEV surface area, compared to L-PEVs.
FC analysis using MitoTracker and Tom20 Mab indicates that about
50% of FC-detectable PEVs contain mitochondria from which 10% refer
to “free” mitochondria and 90% to mitochondria enclosed in vesicles.
Based on MS-proteomics and extensive EM analysis, we propose four
plausible mechanisms for PEV release: (1) plasma membrane budding,
(2) extrusion of multi-vesicular bodies and cytoplasmic vacuoles, (3)
plasma membrane blistering induced by PLT cytoskeleton contraction,
and (4) we demonstrate a previously undescribed type of PEV – the
“podiasomes” which originate from “pearling” of PLT pseudopodia. We
show that the PLT vesiculome encompasses ectosomes, exosomes, free
mitochondria, mitochondria-containing vesicles and exhausted PLT
ghosts. The findings and conclusions in this article have not been
formally disseminated by the Food and Drug Administration and should
not be construed to represent any agency determination or policy.
OT2.03
Salivary EV: a new link between platelets and coagulation
Yuanjie Yu1, Elmar Gool2, René Berckmans1, Auguste Sturk1, Arjan
Barendrecht3, Coen Maas3 and Rienk Nieuwland1
1Clinical Chemistry Department, Academisch Medisch Centrum;
2Biomedical Engineering & Physics, Academisch Medisch Centrum; 3UMC
Utrecht
Human saliva contains extracellular vesicles (EV) exposing tissue factor
(TF; (1)). This TF triggers coagulation in plasma, but whether salivary
EV interact with platelets to promote coagulation is hitherto unexplored.
We hypothesised that the TF-exposing EV from saliva interact with
platelets exposing P-selectin, as described earlier for TF-exposing EV
from tumour cells in a mouse model of vascular injury (2), making the
platelets procoagulant. To test this hypothesis, we investigated the pre-
sence of P-selectin glycoprotein ligand-1 (PSGL-1) and CD24, two
ligands of P-selectin, on salivary EV. PSGL-1 presence was below the
detection limit when analysed by high-resolution flow cytometry. In
contrast, the salivary EV abundantly expose CD24. Immune depletion
of CD24-exposing EV completely removed the TF coagulant activity as
measured by fibrin generation, and co-localisation of CD24 and TF on
EV was confirmed by immunogold labelling transmission electron
microscopy. In a whole blood flow model, salivary EV accumulated on
the surface of aggregated platelets and the deposited EV promoted fibrin
generation . Whether the deposition of EV is indeed mediated by the
interaction between CD24 and P-selectin, is currently being studied.
Collectively, we demonstrate that CD24+/TF+ EV may be a novel link
between platelets and coagulation at a site of vascular injury.
References
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Pregnancy-associated circulating extracellular vesicles induce
different phenotype changes in monocyte and trophoblast cell lines
Árpád Ferenc Kovács1, Nóra Fekete1, Orsolya Láng1, László Kőhidai1, Lilla
Turiák2, Rigó János3, Edit Buzás1 and Éva Pállinger1
1Department of Genetics, Cell- and Immunobiology, Semmelweis University,
Budapest, Hungary; 2Research Centre for Natural Sciences, Hungarian
Academy of Sciences, Budapest, Hungary; 31st Department of Obstetrics
and Gynecology, Semmelweis University, Budapest, Hungary
Introduction: Extracellular vesicles (EVs) represent a critically impor-
tant, directed intercellular communication pathway during pregnancy.
Circulating EVs in different microenvironments may exert divergent
effects on the potential target cells. The aim of our study was to assess
the effects of preeclampsia-associated circulating EVs (PE-EV) on
monocytes and trophoblast cells.
Methods: BeWo trophoblast and THP-1 monocyte cell lines were used
as model systems. EV-enriched preparations from blood plasma of
healthy and preeclamptic third trimester pregnant women were isolated
by differential centrifugation and were characterised by flow cytometry,
DLS, TEM. The protein and miRNA cargos of EVs were assessed by
mass spectrometry and a PCR Array, respectively. We evaluated the
binding of EVs and the EV-induced cellular changes by flow cytometry.
Changes in the expression of genes encoding for inflammatory and
adhesion molecules were quantified by RT-PCR. Time dependent, EV-
induced cytokine production was evaluated by a cytometric bead assay
and a protein array. We used healthy pregnant-derived EVs (HP-EV) as
biological controls.
Results: Circulating EVs bound onto both cell lines, however, they
induced differential phenotypic changes. THP-1 cells produced signifi-
cantly more inflammatory cytokines (TNF, IL-6 and IFN gamma) upon
PE-EV treatment than upon treatment with HP-EVs. Analysis of pro-
teins showed that preeclamptic EVs carried more proteins involved in
biological processes related to inflammation, cell migration and adhesion
as compared to HP-EVs.
Conclusion: The possible systemic effects of EVs exerted on monocytes
and locally, on pregnancy-specific trophoblast cells were reflected by the
high number of differential changes induced by the circulating EVs in
these cell types. Gene expression, cell surface protein- and secreted
cytokine patterns were all differentially influenced by PE-EVs.
Circulating PE-EVs modified monocyte and trophoblast functions in a
complex manner, suggesting that they might participate in the patho-
genesis of preeclampsia.
OT2.05
Interaction of microvesicles with immune cells in lipopolysaccharide-
stimulated whole blood
Rene Weiss1, Marion Gröger2, Sabine Rauscher2, Birgit Fendl1, Michael B.
Fischer3, Viktoria Weber1 and Andreas Spittler4
1CD-Laboratory for Innovative Therapy Approaches in Sepsis; 2Core Facility
Imaging; 3Department for Health Science and Biomedicine; 4Core Facility
Flow Cytometry & Surgical Research Laboratories
Introduction: Cells stimulated with lipopolysaccharide (LPS) produce
extracellular vesicles. Here, we aimed to study the release of microvesi-
cles (MVs) in LPS-stimulated whole blood and their interaction with
immune cells.
Methods: Freshly drawn whole blood anticoagulated with heparin was
stimulated with LPS from E. coli (0.1 µg/ml; 3 h; gentle rolling; 37°C) or
left untreated. Cell-MV interaction was characterised and visualised
using imaging flow cytometry (ImageStreamx MkII, Millipore).
Leukocyte populations, free MVs, and cell-bound MVs were determined
after incubation of whole blood with antibodies against CD45, CD14,
CD16, CD15, CD3, CD56, CD235a and CD41, as well as with lactad-
herin (LA) as marker for phosphatidylserine-exposing MVs. Whole
blood was diluted 1:10 with phosphate buffered saline prior to analysis.
Cell populations were additionally sorted (Moflo Astrios EQ, Beckman
Coulter) and subsequently visualised using confocal microscopy
(LSM780 Airyscan, Zeiss). Whole blood was centrifuged two times
(2500 g, 10 min; 13,000 g, 15 min, both at room temperature), and
free MVs were characterised in platelet free plasma (PFP) using flow
cytometry (CytoFLEX, Beckman Coulter). Triggering signal for MVs
analysis was set to FITC conjugated lactadherin.
Results: In LPS-stimulated whole blood, a higher percentage of monocyte-
MV aggregates (CD14++LA+CD41+, 99% vs. 88%), granulocyte-MV aggre-
gates (CD15lowLA+CD41+, 60% vs. 24%), NK cell-MV aggregates (7% vs.
0%) as well as T-cell-MV aggregates (4% vs. 1%) were present as com-
pared to the unstimulated control. No MVs double positive for LA and
antigens other than CD41 were detected on leukocytes. There was no
substantial difference in counts of free MVs in LPS-stimulated and unsti-
mulated samples (18,876 ± 6,125 MVs/µl vs. 17,191 ± 3,618 MVs/µl).
Conclusion: Imaging flow cytometry is a suitable method to study the
interaction of extracellular vesicles with their target cells in whole blood.
Platelet derived vesicles adhere preferentially to monocytes and granu-
locytes, while almost no MVs are bound to T-cells and NK cells.
OT2.06
Lymph as a vector of microparticles during rheumatoid arthritis
Nicolas Tessandier1, Imene Melki1, Nathalie Cloutier1, Andreea Milasan2,
Catherine Martel2, Paul R. Fortin1 and Eric Boilard3
1CRCHU de Québec – Université Laval, Ville de Quebec, Canada; 2Montreal
Heart Institute – Department of Medicine, Faculty of Medicine, Université de
Montreal, Montreal, Canada; 3Department of Microbiology-Infectious
Disease and Immunity and Faculty of Medicine, Université Laval, Ville de
Quebec, Canada
Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune inflam-
matory disease leading to progressive damage of bone and cartilage. Different
players are implicated in the pathogenesis, but the role of immune complexes
(ICs) is recognised as critical. While the joint represents the major site of the
inflammatory process, extra-articular manifestations are also involved.
During RA, the synovial fluid is enriched in leukocytes inflammatory mole-
cules, and platelet-derived microparticles (PMP), which are suggested to
amplify inflammation. Lymphatic circulation drains plasma ultrafiltrate of
the interstitial medium through lymphatic capillaries and vessels to the heart.
We hypothesise that in RA, lymph draining the inflamed joints could
propagate PMP to extra-articular sites.
Methods: We used the K/BxN serum transfer murine model of RA. As
FcγRIIA is the sole receptor for IC on human platelets, and mouse
platelets are devoid of any receptor for immunoglobulin G IC, we
further considered the contribution of IC in the process using transgenic
mice expressing FcγRIIA on all myeloid cells, including platelets. We
collected lymph from control and RA mice and ensured limited blood
contamination along the process by quantifying erythrocytes and plate-
lets. We analysed MP composition by cryo-electro-microscopy, dynamic
light scattering and flow cytometry.
Results: We reveal the presence of MPs (average diameter 150 nm) in
lymph, the majority of them not exposing phosphatidylserine. Among
identifiable MPs, PMPs dominantly accumulate in lymph. Of interest,
concentrations of PMPs increase significantly during RA, dependently of
FcγRIIA signalling, specifically in the lymph draining the inflamed
articulation and not in lymph draining another anatomical site.
Conclusion: Since PMPs are known to participate in cellular commu-
nication, their increased concentrations during RA open up new hor-
izons to understand the consequences of extravasated MPs during a
sustained inflammation.
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OT3.01
Microglia release distinct extracellular vesicle populations in
response to different pathological stimuli
Pia Pužar Dominkuš1, Matjaž Stenovec2, Jure Loboda1, Simona Sitar3, Nataša
Resnik4, Saša Trkov Bobnar2, Eva Lasič2, Ana Plemenitaš5, B. Matija
Peterlin6, Peter Veranič4, Marko Kreft2, Ema Žagar3 and Metka Lenassi1
1Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana,
Slovenia; 2Laboratory of Neuroendocrinology-Molecular Cell Physiology, Institute
of Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana,
Slovenia; 3Department of Polymer Chemistry and Technology, National
Institute of Chemistry, Ljubljana, Slovenia; 4Institute of Cellular Biology, Faculty
of Medicine, University of Ljubljana, Ljubljana, Slovenia; 5Institute of
Biochemistry, Faculty of Medicine, University of Ljubljana, Slovenia;
6Department of Medicine, University of California San Francisco, USA
Introduction: Microglia protect the central nervous system against injury
or infection, but also promote neurodegeneration when activated impro-
perly. Activated microglia may communicate with the environment by the
release of extracellular vesicles (EVs). We here examined whether different
pathological stimuli (ATP – a signal for brain lesion, Ca2+ ionophore
ionomycin and expression of HIV-1 protein Nef) evoke release of distinct
EVs compared to resting immortalised human microglia.
Methods: We analysed morphology and molecular composition of EVs
by transmission electron microscopy, asymmetric-flow field-flow frac-
tionation connected to various detectors (optimised for detection of the
entire range of EV sizes), flow cytometry, nanoparticle tracking analysis
and immunoblotting; and examined the properties of punctuated Nef.
GFP in live cells by confocal microscopy.
Results: The average radius (Rrms) of EVs constitutively released from non-
stimulated microglia (~5 × 107 EVs/106 cells) increased from 191 nm (after
24 h incubation) to 365 nm (48 h) and 445 nm (72 h). After pulse (30 min)
increase in intracellular Ca2+ concentration ([Ca2+]i), bigger (Rrms 338 nm
(ATP), 422 nm (ionomycin)), but not more numerous EVs with specific
protein composition, were released (24 h). Conversely, EVs released from
Nef.GFP-expressing cells (48 h) were more concentrated (up to 30×),
smaller (Rrms 172 nm), floated on sucrose gradient in exosome fractions
(immuno-positive for flotillin, Tsg101, annexin) and contained Nef.GFP to
a small extent. Nef was also released with flotillin-positive EVs from HIV-1
infected microglia. In live cells, punctuated Nef.GFP comprised large, [Ca2
+]i independent, non-directional population that differed from the dextran-
and LysoTracker-labelled vesicles; mobility of later was diminished in Nef.
GFP-expressing cells in comparison to controls.
Conclusion: Microglia respond to diverse pathological stimuli by releas-
ing specific (but still heterogeneous) EV populations, which could
explain diverse functions of microglial EVs.
OT3.02
Serum miRNA exosomal biomarkers associated with Alzheimer’s
disease are also detected in brain derived exosomes from Alzheimer’s
human post-mortem tissue
Lesley Cheng1, Laura J. Vella2, Benjamin J. Scicluna1, Colin L. Masters2,
Malcolm Horne2, Kevin J. Barnham2 and Andrew F. Hill1
1Department of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Victoria, Australia; 2The Florey Institute of
Neuroscience and Mental Health, The University of Melbourne, Parkville,
Victoria, Australia
Introduction: Alzheimer’s disease (AD) affects more than 55million people
worldwide and is expected to double every 20 years in the absence of
disease-modifying drugs. Therapeutic strategies aimed at limiting
neurodegeneration require methods to diagnose the disease in preclinical
patients. Several blood-based tests have been explored to detect AD how-
ever, evidence is required to determine whether blood sampling is an
appropriate specimen to diagnose brain diseases. Previously we isolated
serum exosomes from AD patients which displayed an abnormal composi-
tion of 16 specific microRNA (miRNA) biomarkers compared to controls.
Methods: To provide evidence that our serum exosomal miRNA bio-
markers are suitable for the detection of a brain condition, we also
profiled exosomes isolated from post-mortem human AD (n = 8) and
control (n = 8) brain tissues. Exosomes were extensively characterised to
meet the minimal experimental requirements set out by The
International Society for Extracellular Vesicles to be defined as exosomes
and small RNA profiling was performed by next-generation sequencing.
Results: Brain derived exosomes (BDEs) were found to contain a unique
profile of small RNA, including miRNA, compared to whole tissue.
Furthermore, all 16 AD serum exosomal biomarkers, identified in our
previous study, were detected in BDEs including a panel of BDE specific
miRNA that target genes involved in AD pathology. These genes were
then validated by qRT-PCR in human tissues and translated to AD cell
models with the aim to use mimetic exosomes loaded with miRNA to
counteract imbalances of mRNA transcription.
Conclusion: This work has identified a highly specific panel of miRNA
that is both present in the brain and blood of AD patients. The miRNA
candidates can be used to develop a blood-based diagnostic test highly
relevant to a brain disease, equivalent to non-invasive brain biopsy, and
further studied to understand AD pathology and other neurodegenera-
tive diseases to identify therapeutic targets.
OT3.03
Neurons export extracellular vesicles enriched in molecular
chaperones and misfolded proteins
Jingti Deng and Janice E. A. Braun
University of Calgary, Calgary, Canada
Aims: The transmission of misfolded/toxic proteins, such as tau, superoxide
dismutase 1, α-synuclein or huntingtin from affected to unaffected areas of
the brain is a hallmark of many neurodegenerative diseases. The differences
between the pathogenic transmission of toxic proteins and the routine export
of extracellular vesicles thatmediate the transfer of hydrophobic and cytosolic
proteins, lipid and RNA between cells is not clearly defined. To address this
knowledge gap, we have chosen to investigate the impact of molecular
chaperones on the export of cellular proteins. Many molecular chaperones
contribute to proteostasis, andwe have focused on the J protein co-chaperone
family that is known to selectively target client proteins. Cysteine string
protein (CSPα) is a critical neural J protein and we have recently demon-
strated that it is exported from neurons in extracellular vesicles.
Methods: Extracellular vesicles were isolated from mouse brain slices as
well as CAD cells transiently expressing either the polyglutamine
expanded protein 72Q huntingtinexon1 or superoxide dismutase-1
(SOD-1G93A), along with select J proteins. The protein content of extra-
cellular vesicles was determined by western blot analysis.
Results: Here we show that exported vesicles from native mouse neurons
contain J protein co-chaperones, in particular, CSPα. In CAD cells
expressing disease-associated proteins, such as 72Q huntingtinexon1 or
SOD-1G93A but not CSPα, these toxic proteins are retained by the cell.
However, in the presence of wild-type CSPα, but not the CSPa mutant
HPD/AAA, both 72Q huntingtinexon1 and SOD-1G93A are transported out
of the cells via extracellular vesicles. The vesicle-based export of various
other proteins (e.g. Gas) is unaffected by WT CSPa.
Conclusions: Our results indicate that J proteins export specific proteins
via extracellular vesicles. These findings suggest a link between the
CSPα-mediated removal of toxic proteins and the transmission of mis-
folded/toxic proteins from affected to unaffected areas of the brain.
Funding: This work was funded by the Alberta Prion Research Institute.






























Exosomal microRNAs in cerebrospinal fluid of patients with genetic
frontotemporal dementia in the genetic frontotemporal dementia
initiative – a biomarker study
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Toronto, Canada; 2Department of Computer Science, University of Toronto,
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Donnelly Centre for Cellular and Biomolecular Research, University of
Toronto, Toronto, Canada; 10Tanz Centre for Research in Neurodegenerative
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Introduction: The lack of biomarkers for frontotemporal dementia (FTD)
results in diagnostic delays and hinders drug development. Hence, there is
an urgent need for diagnostic biomarkers. Investigating genetic FTD
provides the opportunity to study pre-symptomatic individuals who are
at increased risk of developing the disease. MicroRNAs can regulate
mRNAs in disease pathways and have remarkable potential as biomarkers.
Due to vesicular protection in exosomes, microRNAs are relatively stable
in body fluids. To determine whether exosomal microRNAs in cerebrosp-
inal fluid of patients with FTD can serve as diagnostic biomarkers, we
characterised exosomal microRNA expression in pre-symptomatic and
symptomatic individuals carrying a pathogenic mutation.
Methods: We recruited participants to this multicentre study who either
were known carriers of a pathogenic mutation or were at risk of carrying
a mutation because a first-degree relative was a known symptomatic
mutation carrier. We isolated exosomes from cerebrospinal fluid using a
commercially available kit. MicroRNA extraction was followed by real-
time polymerase chain reaction in 384-well plates containing a total of
752 human microRNA primers. Exosomal microRNA expression was
assessed in 23 pre-symptomatic and 17 symptomatic mutation carriers.
Results: MiR-204-5p and miR-632 were significantly decreased in sympto-
matic compared to pre-symptomatic mutation carriers (p < 0.005).
Decrease of miR-204-5p and miR-632 revealed receiver operator charac-
teristics with an area of 0.89 [confidence interval of 0.80–0.99] (p < 0.05)
with potential for a diagnostic biomarker. Let-7a-5p, miR-23b-3p, miR-
29a-3p, miR-30b-5p, miR-605-5p, and miR-892a were found less com-
monly in symptomatic compared to pre-symptomatic mutation carriers
and healthy non-mutation carriers (p < 0.05). MRNAs targeted by these
microRNAs were found in pathways of neurodegeneration.
Conclusion: Decrease of certain exosomal miRNAs has potential as
diagnostic biomarker for FTD. Validation of our results in independent
patient cohorts including sporadic cases will be necessary before this test
can be applied in clinical practice.
This work was submitted by MC Tartaglia, on behalf of the Genetic FTD
Initiative, GENFI
OT3.05
The novel long non-coding RNA TALNEC2 regulates the stemness and
mesenchymal transformation of glioma stem cells and their exosome-
mediated interaction with microglia cells
Shlomit Brodie1, Simona Cazacu2, Laila Poisson2, Steve Kalkanis2, Doron
Ginsburg3 and Chaya Brodie4
1Bar-Ilan University, Israel; 2Henry Ford Health Systems, Detroit, MI,
USA; 3Faculty of Life Sciences, Bar-Ilan University, Israel; 4Faculty of
Life Sciences Bar-Ilan University, Israel and Neurosurgery Department,
Henry Ford Health Systems, Detroit, MI, USA
Glioblastoma (GBM) are characterised by an infiltrative nature and high
resistance to radio- and chemotherapy. GBM contain a subpopulation of
glioma stem cells (GSCs) that is implicated in therapy resistance and tumour
recurrence. Long non-coding RNAs (lncRNAs) play major roles in various
processes associated with tumorigenesis and stemness. Here, we report the
expression and functions of a novel lncRNA, TALNEC2 that was identified
using RNA seq of E2F1-regulated lncRNAs. TALNEC2 expression was
increased in astrocytic tumours in a grade-dependent manner and in
mesenchymal GBM compared with the proneural and G-CIMP subtypes.
Moreover, TLANEC2 was more significantly expressed in GBM specimens
derived from short-term (<9 months) compared to long-term (>3 years)
survivors. TALNEC2 was not expressed in normal brain tissues, astrocytes or
neural stem cells, but its expression was high in GSCs and glioma cell lines.
Silencing of TALNEC2 resulted in a decrease in the self-renewal of GSCs,
expression of stemness and mesenchymal markers and in increased sensitiv-
ity of GSCs to radiation (3 Gy). Moreover, silencing of TALNEC2 resulted in
inhibition of xenograft growth and prolonged animal survival. UsingmiRNA
sequencing we identified specific miRNAs that were altered in the silenced
cells and that mediated TALNEC2 effects via targeting of NF-kB, SOX2 and
Dicer pathways. TALNEC2 was highly enriched in exosomes secreted from
GSCs and played a role in the interaction of GSCs withmicroglia and in their
polarisation by altering the delivery of miR-21 and miR-195 to these cells.
Moreover, TALNEC2was detected in serum exosomes ofmice bearing GSC-
derived xenografts. In conclusion, we identified a novel E2F1-regulated
lncRNA that induced mesenchymal transformation and stemness of GSCs.
The expression of TALNEC2 is associated with the increased tumorigenic
potential of GSCs, their resistance to radiation andwith the cross talk of GSCs
andmicroglia.We conclude that TALNEC2 is an attractive therapeutic target
for the targeting of GSCs and the treatment of GBM.
OT3.06
Neuronal exophers: a novel large vesicle that functions in the
removal of neurotoxic cytoplasm components
Ilija Melentijevic1, Marton Toth1, Meghan Arnold1, Ryan Guasp1, Girish
Harinath1, Ken Nguyen2, Daniel Taub3, Alex Parker4, Christian Neri5,
Christopher Gabel3, David Hall2 and Monica Driscoll1
1Rutgers, The State University of New Jersey, USA; 2Albert Einstein College
of Medicine; 3Boston University Medical Campus, MA, USA; 4Université de
Montreal, Montreal, Canada; 5Institut de Biologie Paris-Seine (IBPS), CNRS
UMR 8256, Paris, France
Combating late-onset neurodegenerative disease and age associated
functional decline in brain are major health challenges of our time.
For the effective design of interventions that protect the nervous system
from disease-induced and/or age-associated deterioration, we must fully
understand endogenous mechanisms for neuronal protection and how
they might fail to enable disease promotion. Recently, it has come to be
appreciated that neurodegenerative disease proteins/aggregates can be
found outside of mammalian neurons, and when outside can actually be
taken up by neighbouring cells. Transfer of offending molecules has
been suggested to be a mechanism of pathogenesis spread for multiple
neurodegenerative diseases, including the prevalent Alzheimer’s and
Parkinson diseases. We discovered a novel capacity of young adult C.
elegans neurons – neurons can extrude large (~4 µM) vesicles, which can
include aggregated human neurodegenerative disease proteins, mito-
chondria or lysosomes, but no nuclear DNA. We call these extrusions
“exophers”. The ability to jettison cell contents is first evident about day
2–3 of adult life, coincident with the documented changes to adult
proteostasis, and is then minimal until 9–10 days of adult life.
Extrusion is increased when protein turnover or autophagy is inhibited.
Moreover, exophers can selectively incorporate aggregation-prone pro-
teins and oxidised mitochondria. Exopher contents can appear later in
remote cells. Neurons that have made exophers appear to maintain
functionality longer than non-exopher producing neurons. Thus, this
pathway may constitute a novel neuronal protection mechanism that
serves to maintain protein/organelle homeostasis when other systems are
compromised. We propose that the neuronal extrusion phenomenon
constitutes a significant but currently unknown conserved pathway by
which healthy neurons maintain their functions, and speculate that, in
diseases, this pathway may malfunction to promote spread of pathology.
We will present the basic characterisation of neuronal exopher produc-
tion and our latest data on genetic influences on exopher generation.
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Terminal complement components are critical in the release of
cellular RNA in circulation
Virginia Camacho1,2, John Tigges1, Shulin Lu1, Thomas Thomou1, Vasilis
Toxavidis1, Horea Rus3 and Ionita C. Ghiran1,2
1Beth Israel Deaconess Medical Center; 2Harvard Medical School, MA, USA;
3University of Maryland, MD, USA
Introduction: Despite of over 10 years of intense research, the intimate
mechanisms responsible for extracellular vesicles (EVs) formation (exo-
somes and microvesicles), and the release of cellular RNA species
(exRNAs) in circulation are currently unknown. The complement sys-
tem is comprised of over 20 soluble and membrane bound proteins with
critical roles in recognising, binding, and removal of foreign particles as
well as initiating and regulating innate and acquired immune responses.
Activation of the complement system occurs during both, normal (cir-
cadian variation), and pathological conditions through either classical,
alternative, or lectine pathways leading to the formation and transient
insertion of C5b-9/Mac pore complex into cellular plasma membrane.
We hypothesise that MAC-insertion promotes a sudden, significant and
transient water and Ca2+ influx, leading to: (i) endocytosis of the affected
area, followed by delivery of C5b-9/MAC-containing plasma membrane
into the multi vesicular body (MVB), and its incorporation into exo-
somes, or (ii) exocytosis of the C9 channle/MAC-affected plasma mem-
brane patch followed by microvesicles (MVs) formation. In addition, the
size of the MAC/C5b-9 pore, 12 nm, is large enough to: (i) allow
cytoplasmic RNA species to be transferred into the MVB following
endocytosis of C5b-9/MAC-containing plasma membrane, and (ii)
RNA species located near the plasma membrane to be released in the
extracellular space upon C5b-9/MAC insertion.
Methods: Freshly isolated human red blood cells or HUVEC cells were
incubated with low concentrations of purified complement components
C5-C9 for 20 minutes in the presence of calcium and magnesium. The
EV and EV-free fractions were collected and analysed for protein and
RNA composition, and the presence of C9 channel in the EV fraction
and cellular localisation and organelle distribution of C5b-9 in HUVEC
cells analysed by fluorescence and electron microscopy.
Results: Our results showed that when purified human red blood cells
(RBCs) undergo sub-lytic complement activation (no haemoglobin
release), there is an increase in the numbers extracellular RBC-derived
vesicles, as well as the in concentration RBC-derived exRNAs, especially
miR451, miR92a, and miR7b in the supernatant. The exRNAs species are
found both in the EV as well as in the EV-free factions. Proteomic
analysis of RBC-derived EVs identified, in addition to MAC/5b-9 pore
complex, increased amounts of GPI-anchored complement regulatory
proteins, CD55 and CD59, confirming our previous data showing that
the insertion of MAC/C5b-9 channel takes place in cholesterol-rich
domains. Co-localisation studies using vascular endothelial cells and
molecular beacons, place MAC/C5b-9, and specific miRNAs into the
MVB, suggesting a possible role for MAC/C5b-9 in miRNAs loading
into exosome. Moreover, time-lapse qPCR experiments using cell super-
natants also indicated a gradual “unloading” of exRNAs from the EV-
into the EV-free faction, suggesting that the extracellular vesicles could
“leak” through C5b-9/MAC-pore, long after EVs are released from the
parent cells, thus explaining several new and unexpected published
findings describing high concentrations of blood exRNAs outside of
EV fractions.
Conclusion: Our results, for the first time implicate MAC/C5b-9 as: (i) a
channel responsible for exosomes and microparticle biogenesis, and (ii)
loading of cytosolic RNAs into the exosomes, and (iii) the direct release
of cytoplasmic RNA species into the circulation (exRNAs).
OT4.02
Physical coherence and network analysis reveals NEDD4 as novel
regulator of exosomal biogenesis
Sushma Anand1, David Chisanga2, Shivakumar Keerthikumar3, Natalie J
Foot4, Sharad Kumar4 and Suresh Mathivanan3
1Department of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Melbourne, Australia; 2La Trobe University,
Melbourne, Australia; 3La Trobe Institute for Molecular University,
Melbourne, Australia; 4Centre for Cancer Biology, University of South
Australia, Adelaide, Australia
Introduction: Exosomes are small membrane extracellular vesicles that
are secreted under physiological and pathological conditions. However,
very little is known about the biogenesis of exosomes. Here, we studied
ESCRT dependent mechanism of exosomal biogenesis using physical
coherence and network based analysis.
Methods: Using a conserved interaction network and physical coherence
model, we indented to identify novel regulators of exosome secretion. To
remove literature bias on the protein-protein interaction models, we per-
formed physical interaction enrichment analysis and identified ESCRT pro-
tein neighbours that could regulate exosomal biogenesis. Next, we evaluated
the role of novel regulators, NEDD4 and STAMBP in exosomal secretion by
molecular biology and biochemical experiments.
Results: A total of more than 50 proteins including NEDD4, SDCBP and
STAMBP with significant p-values were identified. SDCBP has already been
implicated in exosomal biogenesis in previous studies and hence validates our
approach. In this study, we investigated the role of the E3 ligase NEDD4 in
the biogenesis of exosomes. To address this, we generated CRISPR based
NEDD4 knockout (KO) in LIM1215 colorectal cancer cells. In addition, we
utilised MEFs from Nedd4 KO mice. Exosome were isolated from wild type
(WT) and KO cells using differential centrifugation coupled with ultracen-
trifugation. The isolated exosomes were quantified based on nanoparticle
tracking analysis (NTA) and total protein amount. The analysis revealed
significant reduction in exosome secretion in NEDD4 KO cells compared
to WT cells suggesting that NEDD4 is a novel regulator of exosomal biogen-
esis. Furthermore, immunoblotting was performed to confirm the reduced
levels of exosomal enriched markers such as Alix and TSG101. Follow-up
quantitative proteomic analysis of exosomes derived from WT/KO cells
revealed protein cargo dependent on NEDD4. Hence, the results validate
the predictions based on physical coherence and network models.
Summary: Overall, in this study we have identified novel regulators of
exosomal biogenesis using an integrated bioinformatics and experimental
approach.
OT4.03
The EBV LMP1 interactome contains ESCRT-dependent and
independent extracellular vesicle sorting proteins
Mark A. Rider, Mujeeb Cheerathodi, Stephanie N. Hurwitz, Lauren A.
Howell, Xia Liu and David G. Meckes
Florida State University College of Medicine, FL, USA
Introduction: The Epstein-Barr virus (EBV) latent membrane pro-
tein 1 (LMP1) is an oncogene required for immortalising resting B
lymphocytes and also plays a key role in the transformation of non-
lymphoid tissue. The discovery and characterisation of LMP1 pro-
tein-protein interactions will likely generate new targets to treat
EBV-associated cancers. Unfortunately, classical molecular tools for





























identifying protein associations are restrictive. Immunoaffinity pur-
ification techniques, for example, rely on harvesting stable protein
complexes that are frequently difficult to isolate, and often overlook
proteins with transient or weak interactions.
Methods: In this study, we define the broader LMP1 interactome using
the recently developed BioID method. We fused the bacterial biotin
protein ligase (BirA) to LMP1 and harvested biotinylated target proteins;
the biotin ‘tag’ indicated proteins with vicinal, transient, or stable asso-
ciations with LMP1.
Results: Using mass spectrometry, we identified over 1000 proteins
across seven independent experiments with direct or indirect relation-
ships to LMP1. Additional Significance Analysis of INTeractome
(SAINT) analysis assigned confidence scores to potential LMP1
protein-protein interactions. Over 400 proteins had a high SAINT
score of greater than or equal to 0.8. Pathway analysis suggested that
a significant number of the proteins identified are involved in signal
transduction and endosome trafficking. Interestingly, a large number of
proteins thought to be important in exosome formation and protein
targeting were recognised as probable LMP1 interacting partners,
including CD63, syntenin-1, ALIX, TSG101, Hrs, CHMPs, and sorting
nexins.
Summary: It is likely that LMP1, which signals from endosomal mem-
branes and is secreted from cells in exosomes, modifies protein traffick-
ing throughout the cell. By way of manipulating the endosomal
pathways, LMP1 may exert its oncogenic effects on the surrounding
microenvironment.





























Room: Metropolitan Ballroom East
Symposium Session 5 – EVs in Tumour Biology
Chairs: Michael Freeman and Carolina Soekmadji 1:30–2:15 p.m.
OT5.01
NAPG can regulate tumour-specific EV secretion
Yusuke Yoshioka1, Nobuyoshi Kosaka2 and Takahiro Ochiya1
1Division of Molecular and Cellular Medicine, National Cancer Centre
Research Institute, Japan; 2National Cancer Centre Research Institute
Introduction: Extracellular vesicle (EV) transfer of cancer pathogenic
components enables long-distance crosstalk between cancer cells and
distant organs, resulting in the promotion of the initial steps for pre-
metastatic niche formation. Therefore, understanding the critical mole-
cular mechanisms underlying the secretion of EVs in cancer cells is an
important issue for developing novel therapeutic strategies. The aim of
this study is to identify EV secretion-suppressive miRNAs (ESS-
miRNAs) and its target genes.
Methods: We used an original screening system based on ExoScreen
assay for monitoring CD9 or CD63 positive EV secretion (1). In this
assay system, EVs are captured by two types of antibodies, which are
detected by photosensitiser beads. One is a biotinylated antibody and the
other is an antibody conjugated to AlphaLISA acceptor beads. Using this
screening system and a miRNA mimic library containing 2042 miRNAs,
ESS-miRNAs were identified in the breast cancer cell line MDA-MB-
231D3H2LN, and the prostate cancer cell line PC-3ML. The particle
number of EVs was determined using a NanoSight.
Results: Based on the screening result, 4 miRNAs were selected as
putative ESS-miRNAs. These miRNAs were further validated by
ExoScreen and NanoSight. As a result of the validation, miR-194 was
found to inhibit EV secretion in cancer cells. Moreover, NSF attachment
protein gamma (NAPG) which appear to be a general component of the
intracellular membrane fusion apparatus, was identified as a target gene
for miR-194. The knockdown of NAPG also inhibited EV secretion in
cancer cells. The suppression of NAPG decreased lung dissemination of
breast cancer cells in an orthotopic mouse model.
Conclusion: Here we identify EV secretion-suppressive miRNA and its
target gene, and find that the knockdown of NAPG suppresses lung
metastasis. These results pave the way towards identifying new thera-
peutic targets for preventing metastatic spread.
Reference
1. Yoshioka Y., et al., Nat. Commun., 2014.
OT5.02
Intercellular communication between melanoma and stroma cells
induce PD-1 overexpression and tumour progression
Edina Gyukity-Sebestyen1, Mária Harmati1, Gabriella Dobra1, Istan B.
Nemeth2, Johanna Mihály3, Agnes Zvara1, Eva Hunyadi Gulyas1, Robert
Katona1, Istvan Nagy1, Peter Horvath1, Tibor Pankotai4, Miklós Erdélyi4,
Zoltan Janos Vereb5, Tamas Biro3, Lajos Kemeny2 and Krisztina Buzas1
1Biological Research Centre, Hungarian Academy of Sciences, Budapest,
Hungary; 2Department of Dermatology and Allergology, University of
Szeged, Szeged, Hungary; 3Departments of Immunology and Physiology,
University of Debrecen, Debrecen, Hungary; 4Faculty of Science and
Informatics, University of Szeged, Szeged, Hungary; 5Department of
Ophthalmology, University of Szeged, Szeged, Hungary
Introduction: PD-1 is a member of the T cell regulator membrane
protein family and one of the most promising therapeutic targets in
metastatic melanoma. It has been described that highly invasive mela-
noma subpopulation overexpress PD-1 and the increased PD-1:PD-L1
interaction can promote tumour growth via the mTOR pathway.
However, the background of the elevated PD-1 production is not
known. To clarify this, we investigated the intercellular exosomal com-
munication between cancer cells and tumour matrix.
Methods: In vitro, we modelled the tumour stroma with adipose-derived
mesenchymal stem cells (MSCs) and investigated their interaction with
melanoma exosomes. In vivo, the classical B16F1-C57BL/6 mice model was
used. To follow PD-1 expression, Western blot, immunocytochemistry and
STORM were used. To describe changes in oncogenes and tumour suppres-
sor genes, we used a customised Life Technologies qPCR panel with 44 genes.
The potential interactions between genes were analysed by ingenuity pathway
analysis.
Results: We demonstrated that melanoma exosomes upregulate PD-1 and
induce a genetic reprogramming in MSCs in vitro. The qPCR panel showed
clear oncogenic dominance in exosome-exposed MSCs. These cells showed
delayed apoptotic response and started to express melanoma specific mar-
kers, such as MLANA andMITF. In our in vivomodel, tumour bearing mice
injected with re-educated MSCs i.v. suffered from very fast progression of
metastatic disease and the oncogenic dominance of gene expression profile
was detected in the lung of the animals also.
Conclusion: These results suggest that melanoma exosomes re-educate
MSCs, which show a skewed balance towards a melanoma stem cell-like
phenotype. Elevated PD-1 expression and melanoma specific markers
also indicate a cancerous transformation of stem cells. Taken together,
communication by cancer exosomes enhances the cancerous microen-
vironment via re-education of stem cells in the tumour matrix.
Funding: This research was funded by OTKA K 112493, GINOP-2.3.2-
15-2016-00001.
OT5.03
Zebrafish: a new animal model to study tumour EVs in vivo
Vincent Hyenne1, Shima Ghoroghi2, Jack Bauer2, François Delalande3,
Christine Carapito3, Mayeul Collot4, Andrey Klymchenko4, Sebastien
Harlepp5, Lefebvre Olivier2 and Jacky G. Goetz2
1INSERM U1109 /CNRS; 2INSERM U1109; 3IPHC UMR7178 CNRS/
Unistra; 4UMR7213 CNRS; 5IPCMS/INSERM U1109
Tumour extracellular vesicles (EVs) are key mediators of the intercellu-
lar communication between tumour and stromal cells. This communica-
tion can occur locally or at distance and fosters metastatic progression.
However, local or distant dissemination of tumour EVs has only been
poorly characterised in living organisms. In particular, how EVs circu-
late in the blood flow, how they cross the endothelial barrier or how
specifically they are uptaken by stromal cells is not known. EVs are
hundreds of nanometres sized objects and are thus difficult to track in
vivo. Moreover, adapted model organisms are lacking. We decided to use
exploit the multiple advantages of the zebrafish (ZF) embryo to study
tumour EVs in vivo. The ZF embryo is perfectly suited for intravital
imaging with high spatial and temporal resolution and recently emerged
as a valid model in cancer biology. We labelled EVs purified from
different cancer cell types using our newly developed and highly specific
lipid binding Membright dye. Upon injection in the blood circulation,
we successfully tracked individual flowing EVs using high-speed con-
focal imaging. We could determine their average speed in the blood
flow, their dependence on hemodynamic profiles as well as their pre-
ferential sites of arrest in the vasculature. Furthermore, we identified the
main cell types targeted by the injected EVs: endothelial cells and
macrophages. Using a correlated light and electron microscopy
approach, we described the compartments storing the uptaken EVs.
Besides, we demonstrated that ZF melanoma cells secrete EVs contain-
ing some recognised exosomal markers, as identified by mass spectro-
metry. Using these cells, we generated tumours in the ZF embryos and
developed tools to follow EVs naturally released by these tumour cells.
Therefore, our works establishes the ZF embryo as new model to study
tumour EVs in vivo and will allow to tackle essential aspects of the
biology of tumour EVs in the future.
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OT6.01
Annexin-A5 is targeted by heme during haemolysis and fails to block
externalised phosphatidylserine in extracellular vesicles during Sickle
cell disease
Sihem Sadoudi1, Sylvain Le Jeune2, Dominique Charue1, Laurent Kiger3,
Lubka Roumenina4, Chantal M Boulanger1 and Olivier P. Blanc-Brude1
1INSERM UMR970 – Paris Cardiovascular Research Centre (ParCC);
2Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Sickle Cell
Disease Expertise Centre; 3INSERM UMR955, Etablissement Francais du
Sang, IMRB, Hôpital Henri Mondor; 4INSERM UMR1138, Centre de
recherche des Cordeliers
Intravascular haemolysis, such as in sickle cell disease (SCD), is char-
acterised by red blood cell damage, high levels of cell-free heme and
extracellular vesicles in plasma, along with inflammation and tissue
injury. Stressed leukocytes, platelets, endothelial and red blood cells
shed microparticles (MP) that bear externalised phosphatidylserine
(PS) at their surface and promote tissue injury. Conversely, intracellular
annexin-A5 acts as an inhibitor of externalised PS at the surface of cells
and MP. Annexin-A5 is thought to orchestrate vesicle trafficking, pro-
mote cell membrane repair, protect against PS-mediated effects and
enforce anti-inflammatory and anti-thrombotic control. We investigated
a possible functional relationship between intravascular haemolysis and
annexins. We hypothesised that annexin-A5 activity is blocked by extra-
cellular heme as it comes into contact with plasma during intravascular
haemolysis. In order to test this, we measured PS-, PS+, CD235a+ and
annexin-A5+ MP in adult SCD patient and matched control plasmas.
We explored annexin-A5 expression in plasma and blood cells by
Western blots and ELISA, and also quantified the PS-binding function-
ality of plasma annexin-A5. Immunocapture of plasma annexin-A5
revealed a strong association with heme (Abs398 nm signature) during
SCD, especially during acute haemolytic events. In SCD plasma, we
found increased total annexin-A5, but virtually undetectable levels of
functional annexin-A5, contrary to controls. This implied a greatly
reduced ratio of functional annexin-A5/circulating PS+ MP. Moreover,
purified heme bound to annexin-A5 with relatively high affinity in vitro,
as demonstrated using absorbance shift, autofluorescence quenching and
plasmon surface resonance assays, with human serum albumin and
hemopexin in competition tests. Haemoglobin and heme also triggered
annexin-A5 aggregation in vitro, producing high molecular weight and
heat-resistant multimers, observed by western blot. Finally, heme com-
pletely prevented the binding of exogenous annexin-A5 to plasma and
purified PS+ MP, as well as their subsequent detection by flow cytome-
try. Together, our data suggest that PS-neutralising annexin-A5 is inhib-
ited by cell-free heme, contributing to the accumulation of PS+ MP in
plasma during intravascular haemolysis.
OT6.02
Impact of ageing on plasma extracellular vesicle concentration,
protein profile and internalisation by leukocytes
Nicole Noren Hooten1, Erez Eitan1, Jamal Green1, Monica Bodogai1, Nicolle
Mode1, Rikke Baek2, Malene M Jorgensen2, Kenneth Witwer3, Alan
Zonderman1, Arya Biragyn1, Mark Mattson1 and Michele Evans1
1National Institute on Aging, National Institutes of Health; 2Department of
Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark; 3The
Johns Hopkins University School of Medicine, MD, USA
Introduction: Extracellular vesicles (EVs), including exosomes, micro-
vesicles and apoptotic bodies, are released by cells into the circulation.
EVs mediate intercellular communication between both neighbouring
and distant cells and have biological and physiological roles in both
homeostatic and pathological conditions. Emerging roles for EVs in
age-related diseases, including cancer, neurodegenerative, metabolic,
and cardiovascular disease, suggest that EVs have the potential to be
useful for diagnostics as well as for therapeutics. However, the majority
of research thus far has focused on identifying differences in EVs when
comparing disease states and matched controls.
Methods: We wanted to examine age-related changes in circulating
plasma EVs. We isolated plasma EVs from a sub-cohort of the Healthy
Aging in Neighborhoods of Diversity across the Life Span (HANDLS)
study, which is a longitudinal, epidemiologic study of ageing. This sub-
cohort consisted of young, middle-aged and old individuals (n = 74),
who had contributed plasma at two different time points to allow both
cross-sectional and longitudinal analyses.
Results: Importantly, we found that EV concentration decreases sig-
nificantly with human age both in our cross-sectional and longitudinal
analyses. We also report that lifestyle factors including body-mass
index and smoking also affect EV concentration. To examine whether
decreased concentration with age is due to an increase in internalisa-
tion by circulating cells, we established a FACS-based assay to measure
the internalisation of EVs by PBMCs. EVs from older individuals /were
more readily internalised by B cells and increased the expression of the
activation marker MHC-II on monocytes compared with EVs from
younger individuals, indicating that the decreased concentration of
EVs with age may be due in part to increased internalisation. In
addition, we identified EV proteins that were significantly changed
with age. Interestingly, we also report a significant similarity of both
EV concentration and protein amount in individuals over time.
Conclusions: This study provides important insight into establishing an
EV profile with human age, which will further aid in the development of
EV-based technologies for diagnostics and therapies for ageing and age-
related diseases.
OT6.03
Age-related changes in miRNA expression profiles in extracellular
vesicles in the murine post traumatic OA model
Ok Hee Jeon1, David Wilson2, Bonita Powell3, Jordan Green2, Kenneth
Witwer3 and Jennifer Elisseeff2
1Johns Hopkins University, MD, USA; 2Johns Hopkins University,
Department of Biomedical Engineering, MD, USA; 3The Johns Hopkins
University School of Medicine, MD, USA
Introduction: Ageing and trauma are risk factors for the development of
osteoarthritis (OA), a degenerative joint disease with accompanying
cartilage degradation, persistent pain and impairment of mobility.
However, the underlying mechanisms remain unclear, impeding the
development of therapeutic interventions that might prevent or treat
the disease. Recently, it has been reported that extracellular vesicles
(EVs) play a role in ageing. The expression of their miRNAs changes
during ageing and may alter the environment of joint tissue by mod-
ulating extracellular matrix degradation and inflammation. In this study,
our objective is to examine EV-derived miRNA expression in synovial
fluid, where main place for the joint inflammation, from young and old
mice using a post-traumatic OA model created by anterior cruciate
ligament transection (ACLT).
Methods: We performed the ACLT surgery on mice aged 10 weeks and
19months and collected the synovial fluid by injecting and aspirating saline
on 4 weeks post surgery. EVs were purified by differential ultracentrifuga-
tion of the synovial fluid and the morphology and size of EVs were
characterised with transmission electron microscopy and nanoparticle
tracking analysis. RNA was isolated using Exiqon biofluids kits and miR-
34, -146a and -128a were quantified by real-time quantitative PCR before
performing the profiling assays to measure all miRNAs simultaneously.





























Results: miR-34, which is known to be downregulated cartilage-related
extracellular matrix synthesis and upregulated during ageing, -146a and
-128a, which is known to be controller of inflammation and reactive
oxygen species production in the joint, were enhanced in the aged mice
with ACLT surgery compared to young mice with and without surgery
and aged mice without the surgery as well.
Conclusion: EV from synovial fluid-derived miRNAs contribute to the
development of post-traumatic OA during ageing by transferring
miRNA-34, -146a and -128a. These results suggest that EV-derived
miRNAs may be biomarker of ageing and could be potential therapeu-
tic targets for treating trauma and age-related degenerative joint
disease.
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OPT01.01 = PT01.04
Amoeboid cancer cells shed extracellular vesicles enriched with
nuclear derived material
Mariana Reis Sobreiro1, Jie-Fu Chen1, Samantha Morley1, Sungyong You1,
Kenneth Steadman1, Navjot Kaur Gill2, Gina C-Y Chu1, Leland W.K. Chung1,
Hisashi Tanaka1, Wei Yang1, Amy C. Rowat2, Hsian-Rong Tseng2, Edwin M.
Posadas1, Dolores Di Vizio1 and Michael R. Freeman1
1Cedars Sinai Medical Center; 2University of California, CA, USA
Introduction: Deformation of the nucleus is required for migrating cells
to pass through interstitial tissue spaces. However, it remains unexplored
how cells modify nuclear stiffness during metastasis. Cancer cells exhi-
biting an “amoeboid” phenotype migrate in a manner that resembles
neutrophil movement, in which nuclear deformation plays a critical role.
Amoeboid tumour cells are characterised by their plasticity, ability to
rapidly move through extracellular matrixes and high rates of shedding
of extracellular vesicles (EVs).
Methods: Mass spectrometry, flow cytometry, differential centrifugation,
iodixanol gradient, confocal 3D imaging, time lapse video microscopy,
western blot, NanoVelcro Chip.
Results: Here we demonstrate that stable disruption of nuclear structure
by silencing DIAPH3, emerin, or lamin A/C promotes conversion to the
highly metastatic amoeboid phenotype in prostate and breast cancer cells.
These amoeboid cells produced vesicles from nuclear blebs, underwent
shedding of non-apoptotic EVs containing DNA, and exhibited increased
sensitivity to inhibitors of DNA damage repair. Amoeboid features were
detected in high grade prostate cancer, and capture of circulating tumour
cells in mice and patients with metastatic prostate cancer.
Conclusion: These findings suggest the potential of incorporating the use
of biomarkers of amoeboid tumour cells into clinical strategies for
precision medicine.
OPT01.02 = PF04.01
Extracellular vesicles derived from cancer-associated fibroblasts may
have a role in oral cancer invasion
Mauricio R. Dourado1, Johanna Korvala2, Raija Sormunen3, Ilkka
Miinalainen4, Sami Yokoo5, Pirjo Åström2, Adriana Franco Paes Leme5,
RIcardo Della Coletta1 and Tuula Salo6
1Department of Oral Diagnosis, Piracicaba Dental School, Unicamp,
Piracicaba, Brazil; 2Cancer and Translational Medicine Research Centre,
University of Oulu, Oulu, Finland; 3Biocenter Oulu, University of Oulu,
Oulu, Finland; 4Biocenter Microscopy Service, University of Oulu, Oulu,
Finland; 5Mass Spectrometry Facility, LNBio-CNPEM; 6Medical Research
Centre, University of Oulu, Oulu, Finland
Introduction: A major constituent of the tumour microenvironment are the
cancer-associated fibroblasts (CAFs), known to participate in tumour initia-
tion and progression. The communication between stroma cells and tumour
is essential for cancer progression, therefore we aim to study extracellular
vesicles (EVs) as mediators for the interplay between CAFs and tumour cells.
Methods: Following the ethical guidelines, five CAF and five oral normal
fibroblasts (ONF) cell lines were isolated from tumour surrounding and
healthy tissue, respectively, and tested for CAF markers (e.g. α-SMA) using
qPCR. EVs were isolated using differential ultracentrifugation, and DC
protein assay (BioRad®) was used for protein quantification. EV character-
isation was accessed by nanoparticle tracking analysis, immunoelectron
microscopy (IEM) and Exo-check antibody array (System Biosciences®).
Scratch wound healing assay was used to access migration of cancer cells
and the invasion assays were carried out using an organotypic model based
in leyomioma tissue. Proliferation (BrdU®), viability (MTT®) and apoptosis
(FACScan™) of treated cells were also evaluated. To access the EVs proteo-
mic cargo we used mass spectometry (Orbitrap, Thermo Scientific™) and
cDNA microarray (Affymetrix®) to analyse the changes at RNA level in
HSC3 cells treated with EVs from CAF/ONF.
Results: Nanosight NS300 showed most of the vesicles between
100–200 nm and variable concentration. CAFs EVs had stronger signal
against Flotilin, CD81 and Alix in the antibody array when compared to
ONF EVs. CAFs EVs increased HSC3 and SAS cells invasion and HSC3
migration. In myoma tissue, CAFs EVs induced deeper invasion with
increased spreading of HSC3 cells. Proliferation was not affected by EVs
treatment, but the viability decreased and apoptosis rate increased. Using
bioinformatic tools, proteomic and cDNA microarray data were com-
bined for possible targets selection.
Conclusion: CAF EVs treatment increased cancer invasion, tumour
spreading and migration of aggressive oral cancer cell lines. It also
seems to reduce cell viability and induce apoptosis. The selected targets
will help to elucidate the mechanisms behind that phenotype.
OPT01.03 = PF03.01
Identification of non-invasive prostate cancer biomarkers by miRNA
deep sequencing analysis of urinary extracellular vesicles
Marta Rodriguez-Moreno1, Cristina Bajo-Santos2, Viktor Berge3, Aija Linē4
and Alicia Llorente1
1Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway;
2Latvian Biomedical Research and Study Centre /University of Latvia, Riga,
Latvia; 3Department of Urology, Oslo University Hospital, Oslo, Norway;
4Latvian Biomedical Research and Study Centre, Riga, Latvia
Introduction: Prostate cancer (PCa) is the most commonly diagnosed
male malignancy and the second leading cause of cancer-related death in
males in the Western world. Suspected PCa patients usually undergo
prostate biopsy, but this is an invasive procedure that may over- or
underestimate the grade or extent of pathology. To improve the diag-
nosis of PCa novel biomarkers are therefore needed. Cancer-derived
extracellular vesicles (EVs) contain specific mRNAs and microRNAs
(miRNAs) that can be analysed in biological fluids in a non-invasive
way, and these molecules are being investigated as potential cancer
biomarkers with diagnostic and prognostic potential. The aim of this
study was to identify miRNAs in urinay EVs that can distinguish
prostate cancer patients from healthy donors.
Methods: For this purpose, urinary EVs from 30 individuals (10 healthy
controls and 20 PCa patients at different stages of the disease) were isolated
by sequential centrifugation. Then, RNA was isolated from the samples and
the miRNAs cargo was determined by next generation sequencing.
Results: Comparative analysis of the approx. 254 microRNAs identified
in EVs isolated from cancer patients and controls revealed 7 miRNAs
differentially downregulated in exosomes of PCa patients. Interestingly,
several of these small RNAs have previously been associated with PCa in
tissue samples.
Conclusion: Our data suggest that detection of specific EVs miRNAs in urine
samples may serve as a liquid biopsy enabling patient stratification and
monitoring of treatment response. The expression of the deregulated
miRNAs is currently being validated by qRT-PCR in an independent cohort.
OPT01.04 = PF06.08
Pancreatic cancer ExoNet
Carolina de Freitas Ruivo1, Tiago Gama2, Carlos Melo3, José Machado4 and
Sónia Melo4
1i3S – Instituto de Investigação e Inovação em Saúde; 2i3S; 3The Gurdon Institute,
University of Cambridge, Cambridge, United Kingdom; 4i3S – Ipatimup





























Intra-tumour heterogeneity represents a major challenge for cancer
treatment. The different clones and cancer cell subpopulations in a
tumour present distinct tumorigenic capabilities and therapy resistance.
Intercellular communication is a key mechanism used by cancer cells to
communicate amongst them, with microenviroment and other cells of
the body. Communication between subpopulations of cancer cells sup-
ports their cooperation to drive tumour progression and to potentiate
tumour’s response to therapy. Exosomes are extracellular vesicles which
play a central part in cell–cell communication. Exosomes are capable of
horizontal reprogramming and re-education through the delivery of
their cargo to recipient cells.
We have identified five subpopulations of pancreatic cancer cells based on
cell surface markers (EpCAM, CD24, CD44 and CD133) which discrimi-
nate cells with different tumorigenic and self-renewal capacity. Using
stable clones of cancer cells that express exosomes markers fused with
fluorescent reporter proteins and secrete colour-coded exosomes, we have
studied the flow of exosomes between distinct subpopulations of cancer
cells in co-culture. The flow of exosomes was studied in the absence and
presence of a standard care chemotherapy agent used for pancreatic
cancer, and evaluated by confocal microscopy and flow cytometry.
Here we show that subpopulations of cancer cells communicate with
each other via exosomes through an organised dynamic communication
network (ExoNet). The ExoNet reshapes in the presence of therapy to
allow the tumour to respond and overcome the challenge. The presence
of multicolor positive cells showed that exosomes are exchanged
between different cancer cell subpopulations forming distinct routes of
communication. The flow of exosomes is not a random process and
occurs more frequently between specific subpopulations of cancer cells
forming an organised network, which supports tumour growth. The
established ExoNet is dynamic and reshapes in the presence of gemci-
tabine and cancer associated fibroblasts. Therefore, we have demon-
strated that subpopulations of cancer cells communicate between them
in an organised way using exosomes and form a dynamic network of
communication, which conveys the tumour with plastic properties that
allows it to adapt in face of therapy.
OPT01.05 = PS02.02
Enzymatic exosomes with GPI-anchored hyaluronidase for enhanced
tumour penetration and anti-tumour efficacy
Yeon-Sun Hong1, Yoosoo Yang2 and In-San Kim2
1KU-KIST Graduate School of Converging Science and Technology, Seoul,
Republic of Korea, Korea University, Seoul, Republic of Korea; 2Korea
Institute of Science and Technology, Seoul, Republic of Korea
Given the physiological abnormalities in tumours, multiple biological bar-
riers need to be overcome before nanomedicines are delivered to the target
site. Here we report an exosome-based strategy that overcomes the
immunosuppressive and anti-cancer therapy resistant tumour microenvir-
onment with overly accumulated extracellular matrix. This enzymatic exo-
some harbouring native PH20 hyaluronidase (Exo-PH20) could penetrate
deeply into tumour foci via hyaluronan degradation, allowing tumour
growth inhibition and increased T cell infiltration into tumour. In addition,
exosome-mediated simultaneous delivery of PH20 hyaluronidase and che-
motherapeutics (Doxorubicin) triggers synergistic effect on the tumour
growth inhibition with a low dose of drug. This exosome is designed to
degrade hyaluronan on its moving paths, thereby augmenting nanoparticle
penetration and drug diffusion. Note that, engineered exosome with native
GPI anchored form of hyaluronidase has higher enzymatic activity than
truncated form of recombinant protein. Our results provide the promising
exosome-based platform harbouring membrane-associated enzyme with
increased activity. We expect that the enzymatic exosome has potential
for use as a biologically active drug delivery vehicle in treating cancers.
OPT01.06 = LBO.01
Mesenchymal stem cell derived exosomes mediate neurovascular
protection
Johnathon D. Anderson, Jan Nolta, Peter Belafsky, Maggie Kuhn and Greg
Farwell
University of California Davis Medical Center, CA, USA
Introduction: Mesenchymal stem cells (MSCs) facilitate functional
recovery in numerous animal models of inflammatory and ischemic
tissue related diseases with a growing body of research suggesting that
exosomes mediate many of these therapeutic effects. However, it
remains unclear which types of proteins are packaged into exosomes
as compared to the cells from which they are derived.
Methods: Using high-resolution isoelectric focusing coupled liquid chro-
matography tandem mass spectrometry, we have previously reported
that MSC derived exosomes are packaged with angiogenic proteins and
functionally induce angiogenesis under ischemic conditions. Here, using
comprehensive proteomic analysis, we demonstrated that exosomes are
packaged with a markedly higher fraction of specific protein subclasses
as compared to their cells of origin, indicating regulation of their con-
tents. We also demonstrated the therapeutics effects of MSC exosomes in
two animal models, ischemic stroke and diabetic retinopathy. We also
characterized the metabolomic and lipidomic composition of MSC exo-
somes using mass spectrometry.
Results: We find that MSC exosomes are packaged with distinct classes
of proteins, metabolites and lipid membrane components. We demon-
strate that MSC exosomes improve outcomes in two models of ischemic
tissue diseases, ischemic stroke and diabetic retinopathy.
Summary/Conclusion: MSC exosomes hold the potential to be used as a
novel therapeutic platform which holds several advantages over the use
of MSCs.
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Protective role of extracellular vesicles in diabetic microangiopathy
Chiara Gai, Tatiana Lopatina, Yonathan Gomez, Maria Felice Brizzi and
Giovanni Camussi
Department of Medical Science, University of Turin, Torino, Italy
Introduction: Diabetic microangiopathy is a pathological process ending
in endothelial dysfunction and vascular lesions. Adipose mesenchymal
stem cells (ASCs) are a population of multipotent adult stem cells with
immunosuppressive, anti-inflammatory, and regenerative properties. It
has been previously described that extracellular vesicles (EVs) derived
from ASCs (ASC-EVs) possess pro-angiogenic abilities. The aim of the
present study was to evaluate whether ASC-EVs may inhibit endothelial
cells dysfunction induced by intermittent hyperglycaemia mimicking
human microangiopathy condition.
Methods: We set up an in vitro intermittent hyperglycemic model by
culturing Human Microvascular Endothelial Cells (HMEC) for 7 days
with 48 h cycles of high glucose (HG – 25 mM) – normal glucose (NG –
5 mM) exposure. At day 5 HMEC were incubated with a dose of
10 × 103 EV/cell of ASC-EVs or vehicle alone for 48 h. At day 7 we
evaluated apoptosis (Annexin V), proliferation (BrdU incorporation),
oxidative stress (DNPH), and tube formation ability (Matrigel).
Results: Intermittent high-low glucose (INT HG) induced the onset of a
significant decrease of HMEC proliferation, an increased number of
apoptotic cells, oxidation of intercellular proteins, and a reduction in
the formation of capillary-like structures in Matrigel. Treatment with
ASC-EVs significantly restored proliferation, inhibited apoptosis and
oxidation, and restored capillary-like formation ability.
Furthermore, to evaluate ASC-EVs mechanism of action, their mRNA
cargo was analysed. We observed that ASC-EVs contain high HGF
mRNA levels. Therefore, tube formation assay on Matrigel in the pre-
sence of ASC-EVs, with or without HGF-receptor inhibitor (crizotinib)
was performed. We observed that crizotinib significantly reduced the
ASC-EVs-induced capillary-like formation. Microarray analysis of cells
treated in different experimental conditions were also performed.
Conclusions: Results of the present study demonstrate that ASC-EVs
may inhibit the endothelial dysfunction induced by INT HG, which
mimic diabetic microvascular injury. ASC-EVs may, at least in part,
exert pro-angiogenic effects by delivering HGF mRNA to recipient
endothelial cells and by activating HGF signalling pathway.
OPT02.02 = PT03.02
Significant improvement of survival of rats with acute liver failure by
high concentration exosome of human adipose-derived stem cells
Yinpeng Jin, Hongchao Li, Junyi Wang, Lingyu Meng, Li Li, Xiaojin Wang,
Chengwei Chen and Qingchun Fu
Shanghai Liver Disease Research Centre, The 85th Hospital of PLA
Introduction: To collect the conditioned medium (CM) of human adi-
pose-derived stem cells (ADSC), obtain exosome through isolation, treat
D-gal induced rat model of acute liver failure with ADSC, ADSC exo-
some and ADSC lysate, respectively, and compare their efficacy and
analyse the potential effective elements of ADSC exosome and the
underlying mechanisms.
Methods: 1. To obtain ADSC from healthy human abdominal subcuta-
neous fat tissues through collagenase I digestion and purify the cells
through adherent culture, 2. Collect exosome by ultra filtration concen-
tration centrifugation, and evaluate ingredients including proteins and
RNAs in the exosome via protein mass spectrometry and gene sequen-
cing, 3. Assess the influence of CM and ADSC co-culture on the pro-
liferation of ADSC through in vitro assay, 4. Smash ADSC with
ultrasound, and obtain the corresponding cell lysis solution, 5.
Construct SD rat model of acute liver failure with biphasic injection of
D-gal into the rat abdominal cavity, and treat the acute liver failure rats
with ADSC, low concentration lysate solution, high concentration lysate
solution, low concentration exosome and high concentration exosome
through vena femoralis injection. Observe the survival of the rats, and
evaluate the rats and human RNA expression differentiations in the rats’
liver tissues in high concentration exosome group and PBS controlled
group, 6. Analyse the key genes that function in the treatment proce-
dures of acute liver failure with ADSC exosome by bioinformatics
methods.
Results: 1. Highly purified adipose derived stem cells could be obtained
through adherent culture. 2. The exosome collected through ultrafiltra-
tion concentration centrifugation could be observed and presented as
30–100 nm-size circular goblet membrane vesicle under electron micro-
scope; the protein mass spectrometry identified 1466 kinds of peptides
for the exosome and RNA-sequencing identified more than 100 kinds of
miRNA for the exosome. 3. In the in vitro co-culture experiment, the
proliferation rates of ADSC were positively correlated with the concen-
trations of exosome within a certain concentration ranges. 4. Cell lysis
solutions with rich proteins could be obtained by smashing the ADSC
through ultrasound. 5. In animal experiment, the survival of the rats in
ADSC group, low concentration lysis solution group, high concentration
lysis solution group, low concentration exosome group and high con-
centration exosome group were 37.5%, 25%, 50%, 62.5% and 100%,
respectively, whereas in PBS controlled group, the survival of the rats
was only 27.3%, therefore, it was speculated that the efficacies of exo-
some in treating acute liver failure rats were positively correlated with its
concentrations. 6. Bioinformatics methods have identified that the
lncRNA GADD45AP1 and H19 regulate the phenotype changes of the
rat livers in the exosome group through influencing MAPK pathway.
Conclusion: High concentration ADSC exosome has good curative effect
for acute liver failure rats, and could improve their survival. lncRNA
GADD45AP1and H19 are probably the key genes that function in the
treatment procedures for acute liver failure.
OPT02.03 = PT11.01
In vivo analysis of the potential of exosomes isolated from menstrual
blood-derived mesenchymal stem cells in regeneration of insulin-
producing cells in diabetic type 1 animal model
Elahe Mahdipour
Department of Medical Biotechnology, School of Medicine, Mashhad
University of Medical Sciences, Mashhad, Iran
Introduction: Diabetes type 1 is characterised by the lack of insulin
production as a result of degeneration of insulin-producing beta cells
in the pancreas. The autoimmune response against beta cells is the main
reason for this disease; therefore any strategies that help immune
response regulation can be beneficial. Studies have shown the effective-
ness of mesenchymal stem cells in regulation of T cell response and
pancreatic islet repair. However, application of MSCs accompanies the
cell therapy safety issue. The unknown fate of injected stem cells is one
of the major safety concerns regarding stem cell therapies; therefore, in
this study we have used the exosomal secretome of MSCs to regenerate
insulin-producing cells.
Methods: Mesenchymal stem cells were isolated from menstrual blood as
a rich and non-invasive source of MSCs. Exosomes were isolated and
characterised using western blot and AFM, TEM techniques. Exosomes
were injected intravenously at different time points after induction of





























diabetes using STZ. Blood glucose and insulin levels were measured at
pre-determined time points and animals were sacrificed at day 60 and
regeneration of beta cells and insulin production at pancreas were
analysed using immunohistochemistry.
Results: Flow cytometric and differentiation assays confirmed the char-
acters of MSCs derived from menstrual blood. The presence of CD81,
CD63, Tsg-101, Calnexin markers on exosomes was confirmed using
western blotting and AFM and TEM analysis verified the presence of
purified exosomes. Altogether, the blood levels of glucose and insulin
and the histochemistry analyses represented the regenerative potential of
exosomes isolated from menstrual blood-derived mesenchymal stem
cells in the restoration of insulin-producing cells.
Conclusion: Although very successful in preclinical studies, mesenchy-
mal stem cells have still very limited therapeutic applications in clinic
mainly because of their safety concerns. Secreted exosome from these
cells exerts most beneficial properties of stem cells; however, they follow
fewer safety issues as they are not active agents as cells are. This work
represents the effectiveness of mesenchymal stem cell-derived exosomes
in the regeneration of pancreatic beta cells.
OPT02.04 = PF07.01
Stroke extracellular vesicles express inflammatory markers and
induce macrophage activation
Yvonne Couch1, Naveed Akbar1, Simon Davis1, Roman Fischer1, Kim Wals1,
Alex Dickens2, Ain Neuhaus1, Annette Burgess1, Peter Rothwell1 and Alastair
Buchan1
1University of Oxford, Oxford, UK; 2University of Turku, Turku, Finland
Extracellular vesicles (EVs) are lipid complexes shed from the mem-
brane of cells, as well as actively exocytosed, as part of normal physiol-
ogy, but also during pathological processes such as those occurring
during a stroke. Here, EVs were quantified and analysed in the sera of
patients after an acute stroke (<24 h, Oxford Vascular Study). EV
number, but not size, is significantly increased in stroke patients
when compared to age-matched controls. The number of EVs does
not correlate with NIHSS score, age or levels of circulating TNFr1, but
does positively correlate with circulating levels of C-reactive protein
and neuron specific enolase. Isolated EV fractions were subjected to
untargeted MS/MS followed by principle components and pathway
analyses, revealing an overall increase in acute phase response proteins,
including active C-reactive protein. Finally, EV fractions were applied
to monocyte/macrophage cultures and were found to induce inflam-
matory gene expression. This data demonstrates for the first time that
the EV fraction produced in the acute phase after a stroke is pro-
inflammatory in nature and is capable of inducing inflammation in
immune cells.
OPT02.05 = PS05.01
Proteomic profiling reveal Src as a novel microvesicle-associated
biomarker for myocardial infarction
Olof Gidlöf1, Mikael Evander2, Thomas Laurell1 and David Erlinge3
1Lund University, Sweden; 2Department of Biomedical Engineering, Lund
University, Sweden; 3Department of Cardiology, Clinical Sciences, Lund
University, Sweden
Introduction: Extracellular vesicles (EVs) are a promising source of plasma
biomarkers for a wide array of disease states, including cardiovascular disease.
The principal method for isolating EVs from blood is differential centrifuga-
tion, but this technique is time consuming andmay compromise the integrity
of the vesicles. Acoustic seed trapping is a rapid, non-contact alternative to
centrifugation for isolation of EVs from plasma. The aim of this study was to
compare the proteomic profiles of EVs from patients with myocardial infarc-
tion (MI) and healthy controls isolated with acoustic seed trapping or
differential centrifugation using a proximity extension based assay to identify
novel EV-associated biomarkers for MI.
Method: Plasma EVs were isolated from 10 patients with myocardial
infarction and 10 healthy controls, using acoustic seed trapping or
differential centrifugation (20,000g for 1 h). Protein was extracted from
isolated EVs and EV-depleted supernatant and subjected to proteomic
profiling using the Proseek Multiplex CVD and Inflammation Panels
(Olink Bioscience). EV-associated proteins of interest were confirmed
with transmission electron microscopy (TEM), flow cytometry and
nanoparticle tracking analysis (NTA).
Results: 90 proteins were detected in EVs or EV-depleted supernatant.
40% of detected proteins were enriched in either of the EV fractions,
whereas only 6% were enriched in the EV-depleted supernatant. The
protein profile of EVs isolated with acoustic trapping and differential
centrifugation was highly similar, as analysed by hierarchical cluster-
ing and principal component analysis. 10 proteins were differentially
expressed in both EV fractions, and one notable EV-associated pro-
tein with significantly higher levels in MI patients was Proto-onco-
gene tyrosine-kinase Src. The presence of Src on EVs of all sizes (50–
800 nm) was confirmed with flow cytometry, TEM and NTA. Src was
present on EVs of platelet, endothelial cell and leucocyte origin, as
determined by flow cytometry.
Conclusion: There is considerable overlap in the proteomic profiles of
EVs isolated with acoustic trapping and differential centrifugation. Src is
associated with EVs of different sizes and origins and is a potentially
novel biomarker for MI.
OPT02.06 = LBO.02
Cross-talk between monocyte and endothelial cells via Inflammatory
Extracellular Vesicles in cardiovascular disease
Baharak Hosseinkhani1, Nynke Van den Akker2, Mick Gagliardi2, Sören
Kuypers1, Daniel G. M. Molin2 and Luc Michiels1
1Hasselt University, Biomedical research institute, Martelarenlaan 42, 3500
Hasselt, Belgium; 2Maastricht University, dept. Of Physiology, Cardiovascular
Research Institute Maastricht (CARIM), Universiteitssingel 50, 6200 MD
Maastricht, The Netherlands
Introduction: EV-mediated intercellular communication between mono-
cytes (MC) and endothelial cells (EC) plays an active role in vascular
inflammation that in turn can lead to cardiovascular diseases. The pro-
and anti-inflammatory functional effects of inflammatory EV subpopu-
lations at the site of inflamed vascular cells is poorly understood.
Therefore, we aim to unravel the pro/anti-inflammatory responses of
MC and EC to inflammatory EV.
Methods: TEM, NTA and western blot were used to study the size
distribution and concentration of UC- purified EV from the culture
supernatant of HUVEC, either untreated (uEV)or treated with TNF-α
to induce an inflammatory stress (tEV). Thereafter, MC and EC in mono
and co-culture systems were exposed to the uEV and tEV. Relevant pro/
anti-inflammatory markers (IL-1β, IL4, IL-6, IL8, IL10, IL-13, TNF-α,
ICAM-1, VCAM-1, PECAM-1, E-Selectin, MCP-1, CD40 and HSP70)
were evaluated on RNA level (qPCR) and protein level (ELISA, IF,
western blot) in both cell types. the functionality of uEV and tEV were
assessed using cell migration and adhesion tests.
Results: EV having an approximate size range between 30-300nm were
successfully isolated from EC which can be taken up by MC and EC in
culture. We observed that the level of pro-inflammatory markers (IL-1β,
IL-6, IL8, ICAM-1, VCAM-1 and MCP-1) in EC and MC treated with
tEV at both RNA and protein level were significantly increased while a
significant decrease in anti-inflammatory marker (IL4, IL10, IL13 and
CD40) was detected. We also discovered that tEV and uEV do induce
anti-inflammatory responses in recipient cells as indicated by the
increased level of IL4, IL10, IL13 and CD40. Moreover, tEV promoted
both the migration of EC and the adhesion of MC to EC.
Summary/Conclusion: Taken together, our current findings confirmed
that both pro and /anti-inflammatory cross talk between EC and MC is
established via EV-carrying corresponding (RNA and proteins)
mediators.
Funding: This work was co-financed by the EU through the Interreg IV
Flanders-the Netherlands project VaRiA (IVA-VLANED-3.65) and
Interreg V Flanders-the Netherlands project Trans Tech
Diagnostics (TTD).
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Cryogenic-temperature electron microscopy imaging of extracellular
vesicles shedding
Naama Koifman1, Idan Biran1, Anat Aharon2, Benjamin Brenner3 and
Yeshayahu Talmon4
1Department of Chemical Engineering and the Russell Berrie Nanotechnology
Institute, Technion-Israel Institute of Technology, Haifa, Israel; 2Department
of Hematology, Rambam Health Care Campus; 3Department of Hematology
and Bone Marrow Transplantation, Rambam Health Care Campus;
4Department of Chemical Engineering and The Russell Berrie
Nanotechnology Institute (RBNI), Technion-Israel Institute of Technology
Introduction: Cryogenic scanning electron microscopy (cryo-SEM) is a
unique imaging technique, by which cells can be imaged at a high resolution
avoiding the addition of fixatives or contrast agents. Cryo-SEM is highly
advantageous for imaging shedding cell membranes, which remain unal-
tered during specimen preparation, thus generating a more accurate and
reliable morphological analysis. Moreover, cryogenic temperature electron
microscopy is still not widely used for the study of extracellular vesicles
(EVs), although it is optimal for the investigation of those systems. The
human leukaemia monocytic cell line (THP1) is known to shed EVs under
various stimulations. We study the effects of stimulation by exposure to the
endotoxin lipopolysaccharide (LPS) or by starvation on THP1.
Methods: Unstimulated and stimulated cells were thermally fixed by
high pressure freezing, and imaged by cryo-SEM. EVs isolated from
unstimulated and stimulated cells were imaged by cryogenic transmis-
sion electron microscopy (cryo-TEM). We also characterised the isolated
EVs by nanoparticle tracking analysis (NTA).
Results: Cryo-SEM images show blebbing of cells stimulated by LPS, which
is in good agreement with previously suggested models. Micrographs show
extensive membrane blebbing as round, vesicular invaginations. Cells that
underwent a 48-hour starvation stimulation exhibited a different morphol-
ogy, including elongated membrane protrusions and shrunken membrane
and nucleus. EV morphologies were shown to be highly heterogenous in
size and nanostructure. EVs isolated from cells undergoing starvation were
fewer and larger than EVs isolated from LPS-stimulated cells.
Conclusions: Cryo-SEM provides a high magnification view of cells under-
going shedding, revealing the size and morphology of the EVs prior to their
release from the cell. Cryo-TEM of the isolated EVs complemented by NTA
provides a statistical and morphological characterisation of the EVs after
their release. Although both starvation and endotoxin-exposure are com-
mon stimulations, they most probably lead to a different cellular response,
resulting in differences in size and concentration of the isolated EVs.
OPT03.02 = PS04.01
Easy extracellular vesicle detection on a surface-functionalised
power-free microchip
Ryo Ishihara1, Tadaaki Nakajima2, Asuka Katagiri1, Yoshitaka Uchino1,
Kazuo Hosokawa3, Mizuo Maeda3, Yasuhiro Tomooka2 and Akihiko
Kikuchi1
1Department of Materials Science and Technology, Tokyo University of Science,
Tokyo, Japan; 2Department of Biological Science and Technology, Tokyo
University of Science, Tokyo, Japan; 3Bioengineering Laboratory, RIKEN
Introduction: Extracellular vesicles (EVs) are expected as novel cancer
biomarkers (1). However, rapid and easy EV detection is challenging,
hence conventional detection methods require large sample volumes
and long detection times. For point-of-care (POC) diagnosis, the
microchip-based analytical system has attracted attention because of
its cost effectiveness, i.e., small sample sizes with short analysis times.
Hosokawa et al. have developed various biomarker detection methods
on the portable power-free poly(dimethylsiloxane) (PDMS) microchip
(2). Recently, we proposed a surface-functionalised power-free micro-
chip (SF-PF microchip), in which the inner surface of the microchip
was chemically modified by radiation beam-induced graft polymerisa-
tion (RIGP), as a platform towards POC diagnosis (3). In this study,
to detect EVs rapidly and easily, the SF-PF microchip for EV was
prepared.
Methods: By UV light-induced graft polymerisation, inner surface of
microchannels of the microchip was modified with poly(2-aminoethyl
methacrylate). Then, anti-CD63 antibodies were immobilised to the
grafted polymer chains. Finally, the obtained microchip was degassed.
For EV detection, laminar flow-assisted dendritic amplification (4)
was adopted. EVs from mammary epithelial cell line (MCF10A) and
breast cancer cell line (MCF7) were isolated by differential
ultracentrifugation.
Results: Isolated EVs were characterised by a nanoparticle tracking
device (NanoSight). The amount of anti-CD63 antibody immobilised
on the surface of the microchannels, which depends on graft initiator
and anti-CD63 antibody concentrations, was evaluated by fluorescent-
labelled secondary antibody adsorption. The solutions were injected into
the microchip by power-free sequential injection. EVs were successfully
detected on the SF-PF microchip. The required sample volume was 1.0
μL and the total analysis time was 20 min.
Conclusion: Rapid and easy EV detection on the SF-PF microchip was
demonstrated. Since most existing methods take more than a few hours,
the proposed microchip-based EV detection method would play an
important role in establishment of POC cancer diagnosis.
References
1. Im et al., Nat. Biotechnol., 2014; 32: 490–495.
2. Hosokawa et al., Lab Chip, 2004; 4: 181–185.
3. Ishihara et al., Anal. Sci., 2017; 33: 197–202.
4. Hosokawa et al., Anal. Chem., 2007; 79: 6000–6004.
OPT03.03 = PS03.01
Sweating the small stuff: extracellular vesicles from sweat
Prateek Singh and Seppo Vainio
University of Oulu, Oulu, Finland
Sweat has been an untouched territory in the extracellular vesicles (EVs)
field owing to its complex composition, and lack of standard collection
strategies in large volumes. Previously sweat has been used to monitor
hydration state, detect drugs of abuse and diagnose cystic fibrosis. We
have developed protocol to isolate sweat in a quantifiable manner, and
purify EVs from the same. Proteomics has been a powerful tool in
identifying and characterise the biochemical composition of exosomes.
We present the mass spectrometry data of the sweat extracellular vesi-
cles, providing a valuable bank of potential biomarkers.
Sweat was collected from healthy volunteers performing physical activity
sessions. Informed consent was obtained from the volunteers before-
hand. The collected sweat was immediately processed for extraction of
the extracellular vesicles. Sequential ultracentrifugation was performed
to separate cell debris at 1000g, apoptotic bodies at 10,000g and the
extracellular vesicles at 100,000g. The vesicles were washed and resus-
pended in PBS and stored in aliquots at −80 °C. The supernatant from
the 100,000g spin step was retained.
Transmission and scanning electron microscopy was used to struc-
turaly characterise the vesicles. LC-ESI-MS/MS analyses were





























performed on a nanoflow HPLC system coupled to a mass spectro-
meter equipped with a nano-electrospray ionisation source. MS data
was searched against SwissProt database (version 2016_09) with a
taxonomy filter “human”.
Proteomics analysis yielded 454 proteins identified. The extracellular
vesicles contain the characteristic exosome associated proteins, CD63,
CD9, Annexin V, HSP90, EGS, and stained positive for CD63 in immu-
nogold electron microscopy.
To the best of our knowledge, we are the first to systematically characterise
the extracellular vesicles from human sweat. This study used the most
effective method (LC-MS/MS) to identify protein content of sweat vesi-
cles. This will enable rapid diagnostic capabilities using sweat as a source
of extracellular vesicles, which are being pursued as putative biomarkers
for diseases and health conditions. Sweat has the advantage of being
collected non-invasively, like saliva and urine, but unlike them, can be
collected from a topical site without the possibility of being adulterated.
OPT03.04 = LBO.03
Monitoring standardised treatment efficacy of multiple sclerosis on
molecular level
Fatemeh Vafaee1, Saeideh Ebrahimkhani2, Michael Barrnet3, Catherine Suter4
and Michael Buckland3
1Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia,
School of Mathematics and Statistics, The University of Sydney, Sydney,
NSW, Australia; 2Brain and Mind Center, Sydney University; 3Sydney
Medical School, Brain and Mind Centre, The University of Sydney, Sydney,
NSW 2006 Australia; 4Victor Chang Cardiac Research Institute
Introduction: Multiple Sclerosis (MS) is a chronic inflammatory demye-
linating disease of the central nervous system. In most MS patients,
disease starts with relapsing remitting (RR) symptoms followed by
secondary progression. While different effective disease-modifying treat-
ments are currently available, no molecular markers exist to monitor
disease progression and treatment efficacy. Additional studies are there-
fore required to investigate the disease suppression at the molecular
level. We aimed to determine the impact of a standardised treatment
on small RNAs in serum-derived exosomes.
Methods: We profiled exosomal miRNAs from 33 RRMS patient serum
samples in baseline, 6 months and 12 months after starting the treatment
along with 21 matched controls using high-throughput sequencing. The
RPA Hospital Human Research Ethics Committee ethically approved the
study, and all patients provided written informed consent. Full clinical
data was accumulated for all patients and healthy individuals.
Results: We reported that RRMS patient sera exhibit dysregulation of
miRNAs in relation to the treatment. Furthermore, we used advanced
machine learning approaches to identify the predictive power of signa-
tures derived from the discovered miRNAs and characterized dynamic
regulatory patterns of miRNAs in active and quiescent phases.
Summary/Conclusion: Circulating exosomes with selective package of
small noncoding RNAs represent promising non-invasive, cost effective
and accurate detectable biomarker of disease diagnosis and response to
therapy. To our knowledge, this is the first proof-of-principle demonstrat-
ing that miRNAs from serum exosomes can be used to determine the
impact of the standardised treatment to suppress the RRMS disease at the
molecular level.
OPT03.05 = LBO.04
Metastatic efficiency is dependent on cell volume loss due to
extracellular vesicle release during cancer cell extravasation
Yohan Kim1, Andrew Chun-Him. Poon2, Fabrice Lucien3, Janice Gomes4,
Florence Deng1 and Hon S. Leong1
1Western University, Ontario, Canada; 2University of Western Ontario,
Ontario, Canada; 3Lawson Health Research Institute; 4University of
Western University, Ontario, Canada
Introduction: Metastasis is the main cause of mortality and morbidity in
cancer patients. Tumor cells from primary tumor enter the bloodstream
(intravasation) and cross the vessel wall (extravasation) to form second-
ary colonies. Our laboratory has shown previously that inhibiting cancer
cell extravasation is a potential target for halting cancer metastasis.
Surprisingly, we observe circulating cancer extracellular vesicles (EVs)
during cancer cell extravasation in vivo. Using intravital imaging, we
observe that extravasating cancer cells lose significant cell volume, nega-
tively impacting metastatic colony formation rates. Since induction of
necroptosis (programmed necrosis) also resulted in a significant increase
of EV release, we hypothesize that inducing cancer cell necroptosis leads
to cell volume reduction, inhibition of cell extravasation and metastasis.
Methods: Invasive human breast/prostate cancer cell lines were cultured
and injected into the chorioallantoic membrane (CAM) of chicken
embryos. We performed intravital imaging of cancer cell EV release
and extravasation. To quantitate EVs released from cancer cells, we
used a nanoscale flow cytometer to analyze plasmas from the CAMs or
conditioned media.
Results: Our results show that an increase in circulating cancer cell EV
release significantly reduces extravasation rates of cancer cells and meta-
static colony formation rates. Although pro-apoptotic cancer cells
released elevated amounts of EVs that resulted in reduced extravasation
rates, extravasating cancer cells showed the absence of caspase-3 activity
on EV release. Pro-necroptotic cancer cells showed an increase in cancer
cell EV release with cell volume reduction and a decrease in cancer cell
extravasation rates. Inhibition of intravascular cancer cell necroptosis
improved extravasation rates remarkably and reduced EV release
drastically.
Summary/Conclusion: Our findings recapitulated that a reduction in cell
volume by releasing EVs facilitates extravasation, at the cost of reduced
efficiency in forming secondary colonies. Although the pro-apoptotic
process of cancer cells can stimulate more EV release, our results on the
inhibition of necroptosis and the pro-necroptotic process implicate that
necroptosis is an emerging regulator of cancer metastasis.
Funding: Prostate Cancer Canada, Ride for Dad, AMOSO, OGS
OPT03.06 = LBO.05
Exosomal microRNA signatures in multiple sclerosis reflect disease
status
Saeideh Ebrahimkhani1, Fatemeh Vafaee2, Michael Barrnet3, Catherine Suter4
and Michael Buckland3
1Brain and Mind Center, Sydney University; 2Charles Perkins Centre, The
University of Sydney, Sydney, NSW, Australia, School of Mathematics and
Statistics, The University of Sydney, Sydney, NSW, Australia; 3Sydney
Medical School, Brain and Mind Centre, The University of Sydney, Sydney,
NSW 2006 Australia; 4Victor Chang Cardiac Research Institute
Introduction: Multiple Sclerosis (MS) is a chronic inflammatory demye-
linating disease of the central nervous system (CNS). There is currently
no single definitive test for MS; current diagnosis and disease monitor-
ing are associated with high cost and have limited utility in distinguish-
ing active inflammatory from progressive disease. Circulating exosomes
represent promising candidate biomarkers for a host of human diseases.
Exosomes contain RNA, DNA, and proteins, can cross the blood-brain
barrier, and are secreted from almost all cell types including cells of the
CNS. We hypothesized that serum exosomal miRNAs could present a
useful blood-based assay for MS disease detection and monitoring.
Methods: Exosome-associated microRNAs in serum samples from MS
patients (n=25) and matched healthy controls (n=11) were profiled using
small RNA next generation sequencing.
Results: We identified differentially expressed exosomal miRNAs in both
RMS (miR-15b-5p, miR-451a, miR-30b-5p, miR-342- 3p) and progres-
sive MS patient sera (miR-127-3p, miR-370-3p, miR-409-3p, miR-432-
5p) in relation to controls. Critically, we identified a group of nine
miRNAs (miR-15b-5p, miR-23- 3p, miR-223-3p, miR-374a-5p, miR-
30b-5p, miR-433-3p, miR-485-3p, miR-342-3p, miR- 432-5p) that dis-
tinguished relapsing-remitting from progressive disease.
Summary/Conclusion: This study shows that serum exosomes from MS
patients are meaningfully altered in their miRNA profiles, which can
potentially be utilized as biomarkers. To our knowledge, this is the first
proof-of-principle demonstration that microRNAs associated with cir-
culating exosomes are informative biomarkers for the diagnosis and
monitoring of MS.
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OT7.01
Flow cytometric analysis of extracellular vesicle subsets in body
fluids: impact of coincidence and swarm by particles of non-interest
Sten F.W.M. Libregts1, Ger J.A. Arkesteijn1, Andrea Németh2, Esther N.M.
Nolte-’t-Hoen1 and Marca H.M. Wauben1
1Department of Biochemistry & Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, Utrecht, The Netherlands; 2Department of Genetics, Cell-
and Immunobiology, Faculty of Medicine, Semmelweis University, Budapest,
Hungary
Introduction: For flow cytometric analysis of extracellular vesicle (EV)
subsets in clinical samples, isolation and preparation should be swift and
comprise minimal handling, while permitting high throughput, multi-
parameter analysis of EVs. One potential approach is to stain EV subsets
by directly applying fluorophore-conjugated antibodies to body fluids,
after which EVs are isolated and separated from unbound antibody
using size-exclusion chromatography (SEC). Here we explored whether
fluorescence-based flow cytometric analysis allows reliable detection of
subsets of fluorescently labelled EVs against a background of non-fluor-
escent EVs or differently labelled submicron-sized particles.
Methods: We performed spike-in experiments using various body fluids,
PKH67-stained EVs, and various fluorescent and non-fluorescent beads.
Where needed, EVs were purified from body fluids using SEC after
spiking. Flow cytometric analysis of events of interest was done by
performing fluorescence threshold triggering on a BD Influx optimised
for the detection of small particles.
Results: We found that upon fluorescence threshold triggering high
concentrations of particles of non-interest can severely interfere with
the light scatter detection of EVs of interest as a result of coincidence
and swarm. When interfering particles were labelled with different
fluorophores, the coincidence caused false positivity for these fluoro-
phores on the EVs of interest. We show that by performing serial
dilutions and monitoring light scatter and fluorescence parameters,
interference of particles of non-interest can be checked and controlled.
Conclusion: Although it is technically possible to detect a subset of fluores-
cently labelled EVs in a background of non-fluorescent or differently-labelled
submicron-sized particles upon fluorescence threshold triggering, our find-
ings imply a precaution for its application on clinical samples in which the
ratio between EVs of interest and other particles is unknown and variable.
Funding: This research is supported by the Dutch Technology
Foundation STW (Perspectief Program Cancer ID, project 14191),
which is part of the Netherlands Organization for Scientific Research
(NWO), and which is partly funded by the Ministry of Economic Affairs.
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Glenn Vergauwen1, Bert Dhondt1, Jan Van Deun1, Evy Timmerman2, Kris
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Hannelore Denys4, Olivier De Wever1 and An Hendrix1
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Introduction: Identification and validation of extracellular vesicle (EV)-
associated functions and biomarkers requires robust isolation and
characterisation protocols. We assessed the impact of commonly imple-
mented but modified analytical variables on EV analysis.
Methods: We compared five different centrifugal filters that are often
used to reduce large volume biofluids or concentrate EVs on three
sample types: plasma, urine and EV-spiked PBS. Protein and nanopar-
ticle tracking analysis was performed on the concentrate, membrane and
flow through to determine EV recovery. Next, we compared three
colorimetric and three fluorometric protein assay kits for their efficiency
in measuring protein concentration of EV samples. In all protein assay
kits the same sample volume of 5 µL EVs (1 × 1010 particles) was used.
The presence and influence of OptiprepTM remnants in EV samples was
assessed by DC protein assay kit-based interference of OptiprepTM at
750 nm and Q-Exactive protein analysis respectively.
Results: Regenerated cellulose with 10k pore size generated highest
particle and protein recovery of EV-spiked PBS. Other centrifugal mem-
branes did not efficiently recover EVs with 80% reduction in particle
concentration and protein concentration measurements below detection
threshold due to aspecific adherence of EVs to the centrifugal mem-
branes. Similar findings were observed for plasma and urine, however
the differences were less pronounced, probably due to abundant proteins
masking centrifugal filter membranes. The Qubit® protein assay kit
obtained a respectively 1.5-fold and 2-fold higher protein concentration
measurement with the least variance as compared to microBCA and
Bradford. The OptiprepTM concentration of EV samples obtained by
pelleting density fractions was estimated 1.5–2.5%, whereas no
OptiprepTM remnants were detected after EV retrieval from density
fractions by size-exclusion chromatography. In addition, removal of
OptiprepTM remnants from EV samples improved protein identification
by 40-fold as measured by number of unique proteins identified.
Conclusion: The choice of centrifugal filters and protein assay kits as
well as residuals of EV isolation media can confound EV analysis and
should be carefully considered when performing omics approaches and
functional assays.
OT7.03
RNA profiling limits for nanoFACS-sorted extracellular vesicles
Aizea Morales-Kastresana1, Christopher Grant2, Peter Choyke3, Jane Trepel4,
James Gulley5, Min-Jung Lee4, Jenn Marte5, Kevin Camphausen6, Xiaolin
Wu7, Kenneth Witwer8, Jay A. Berzofsky9 and Jennifer C. Jones9
1National Cancer Institute, National Institutes of Health; 2National Institutes
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Branch, NCI; 5Genitourinary Malignancy Branch, NCI; 6Radiation Oncology
Branch; 7Leidos Biomedical Research, Inc; 8The Johns Hopkins University
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Introduction: One of the major aims of our research programme is to
delineate the molecular profiles of the contents of sorted extracellular
vesicle (EV) subsets. The sensitivities of most EV profiling methods
(such as RNAseq, NanoString nCounter miRNA Expression Assay,
HTG EdgeSeq) are commonly reported as how many microliters of
input biofluid are required, rather than how many EVs are required.
However, in our studies of sorted EV subsets, it is critical to know how
many EVs are required for these profiling methods. In order to system-
atically delineate the limits of RNA cargo profiling methods for EVs, we
performed three different miRNA-omic profiling methods with titra-
tions of EVs, ranging from 10,000 to 1 trillion.
Methods: EVs were isolated by differential ultracentrifugation and size
exclusion chromatography. Nanoparticle tracking analysis (NTA)
demonstrated that the EVs in this study ranged in size between 70 and
150 nm. NanoFACS was performed with a high-resolution jet-in-air flow
cytometer, as previously described, as well as with a next-generation
Avalanche Photodiode-equipped instrument. We compared the miRNA
signatures of titrated EV populations, using three different RNAseq and
high-sensitivity small RNA-omic analysis platforms.





























Results: We found a wide range of sensitivity of the RNA-omic profiling
methods, in terms of minimum required EV number to observe a robust
RNA profile. Not surprisingly, one method that we tested, which does
not use any form of amplification, failed to produce a robust profile
when fewer than 1–10 billion EVs were used for the assay. On the other
hand, next-generation sequencing methods, which used an amplified
library, required fewer EVs (as few as 0.5–1 million EVs) to produce a
characteristic small RNA profile.
Conclusions: After EV analysis and sorting, the limits of detection of
down-stream assays must be well known and wisely selected, in order to
optimise the amount of information that can be obtained with the sorted
EVs. NanoFACS is a useful method for the identification and isolation of
tumour, immune cell and treatment-associated EV subsets, but optimal
sensitivity is equally as important for the next-step assays, and amplifi-
cation may be required for all -omic studies with nanoFACS-sorted EV
subsets, or any other -omic studies that seek to profile populations of
fewer than 1 billion EVs.
OT7.04
Morphological plasticity of EVs – do some EVs have motility?
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Per Widlund3, Thomas Nyström3, Johanna Höög2* and Jan Lötvall1*
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Gothenburg, Sweden; 2Department of Chemistry and Molecular
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Introduction: Extracellular vesicles (EVs) are generally thought of as
inert information-packages used by cells in intracellular communica-
tions. Their shape was previously thought to be round. However, several
recent studies have, with the help of cryo-electron microscopy (cryo-
EM), shown that there is a great variance in EV morphology. Here we
show that some EVs are not necessarily static in their shape, but rather
plastic, being able to alter their morphology.
Methods: EVs from yeast, a human mast cell line (HMC-1) and human
body fluids were isolated with differential ultracentrifugation. The EVs
were then allowed to settle on glass bottom dishes and were subse-
quently fluorescently dyed with PKH67. They were then visualised
with a fluorescence microscope, and time lapse photos were acquired.
Moreover, cryo-EM was conducted on EV isolates.
Results: Cryo-EM revealed the presence of elongated EVs in both HMC-
1 samples as well as human ejaculate. Some of these EVs contained
filamentous structures, reminiscent of actin, in their lumen.
Fluorescence microscopy time lapse series showed that a fraction of
the vesicles undergo morphological changes within minutes. Most
observed events show elongated fluorescent structures round up to
spheres. However, EVs also extended protrusions from their main body.
Conclusion: A subset of EVs have the ability to alter their shape.
CryoEM suggests that actin dynamics might be a mechanism that allows
EVs to shape-change. The ability of EVs to move has a number of
implications that could be relevant to both EV biogenesis and uptake.
One could also envisage a more directed and active role of EVs in
cellular communication than previously assumed.
OT7.05
Microflow cytometry: the Apogee A50 is a sensitive standard tool for
extracellular vesicle analyses in liquid biopsies
Desmond Pink, Robert Paproski, Deborah Sosnowski, John Lewis and
Catalina Vasquez
University of Alberta, Canada
Detection of biomarkers in liquid biopsy samples is a rapidly expanding field,
yet standardised protocols for detection limits have still not been set. Levels of
extracellular vesicle (EV) biomarkers in liquid biopsy samples often consti-
tute a very small fraction of the total EVs (<1%). We estimate that in liquid
biopsy samples, with most EVs in the 80–200 nm range, there may only be
10’s to hundreds of available antibody binding sites for biomarker on each
EV.Microflow cytometry analysis of EVs is not trivial, but here we report that
quantitative and reproducible detection of these rare biomarker signals on
single EVs in complex fluids.
In order to establish parameters for maximal sensitivity and quantitative
stability of biomarker signal, we have utilised the optical reporter palmitoy-
lated-EGFP to label membrane EVs in cancer cells as a surrogate biomarker.
Conditioned media from healthy LNCaP cells (PALMGFP) was used as a
positive signal spike in plasma, serum and urine from healthy volunteers. To
mimic the variability in patient EV concentration, PALMGFP was spiked
into increasing concentrations of EVs (~105–5 × 106 total EVs) from different
fluids. To test signal stability and machine reliability, PALMGFP spiked into
plasma at high/low levels was aliquoted into 96 samples over 8hrs using an
autosampler to test signal stability. Replicate samples were likewise tested for
30 s to 2min to determine the mean analysis time required to achieve a stable
detection rate. All samples were analysed using the Apogee A50, triggering on
large angle/small angle scatter.
PALMGFP conditioned cell culture media typically has >10% of the
whole sample as GFP positive compared to ~0.1% of standard LNCaP
GFP which permits a greater dynamic range for testing. Detection of
PALMGFP spike in both serum and plasma was linear from 35–2000
total events when diluted in samples with 105–2.5 × 106 background EVs
with 100% recovery of the total spike – a 0.001% detection rate. When
background EVs reached 5 × 106 events, the analysis was still linear, but
recovery was reduced. Single EV analysis was further confirmed by
maintenance of light scattering intensity of the positive GFP signal
across the dilution. PALMGFP spike into urine was confounded by
high levels of fluorescent signal. These are being further optimised.
Detection rate of positive PALMGFP signal events in plasma and
serum was highly reproducible over 8hrs with 5–5 × 105 EVs). The
detection rate of PALMGFP signal was stable after only 30 s of analysis.
These tests have been replicated using PSMA, CD9 and CD63 antibo-
dies. To utilise the PALMGFP EV label as a measure of tumour growth,
we established PALMGFP tumours in mice and avian embryo models.
We have successfully measured PALMGFP EV signal in plasma, and are
now validating the EV signature with human leucocyte antigen (HLA-
ABC) signal.
We have confirmed that using microflow cytometry, we can detect rare
positive signal events that match the expected biomarker levels on EVs
in liquid biopsies. Using the Apogee A50 platform EV analysis in com-
plex fluids is fast, yet sensitive, reproducible and can be used to assess
disease biomarkers both in the lab and in clinic.
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Introduction: The extracellular vesicle (EV) proteome is of particular interest,
as it contains information of diagnostic value and biological function.
Nevertheless, EV proteome analysis is challenging due to difficulties in
isolating pure EV populations, making the establishment of an effective
workflow for EV proteome analysis a top priority. The purpose of this
study was thus to compare three different plasma EV isolation methods
and their usability for downstream discovery based EV proteome analysis
when using tandem mass spectrometry.
Methods: The EV isolation methods included: (1) Centrifugation (18,890g),
(2) size exclusion chromatography (SEC), and (3) EV precipitation using a
peptide (Vn96) that specifically bind to EVs. For EV proteome characterisa-
tion, trypsinised EV-isolates were analysed using a Q-Exactive HF. EVs were





























characterised using transmission electron microscopy (TEM), nanoparticle
tracking analysis (NTA) and western blotting (WB).
Results: EVs were recovered in all isolation methods, confirmed by
NTA, TEM and WB. The largest particles were found in centrifuga-
tion (~170 nm) followed by subsequently smaller particles in Vn96
(~123 nm) and SEC (~107 nm). Proteomic characterisation identi-
fied 1500, 959, and 372 proteins in centrifugation, SEC, and Vn96,
respectively. Of these proteins ~96% (centrifugation), ~95% (SEC),
and ~91% (Vn96) were EV associated, determined by vesiclepedia
and gene ontology (GO) analysis. When compared to specified EV
subtype markers proposed by Kowal and colleagues (1).smaller EVs
were enriched in SEC while larger EVs were enriched in centrifuga-
tion. Vn96 displayed similar enrichment of both small and large EV
markers. Additionally, the GO analysis revealed some isolate con-
tamination, where SEC was highly abundant in lipid components
while centrifugation was abundant in protein complexes. Vn96 con-
tained minimal contamination. Finally, a strong correlation was seen
between APO-B-100 intensity and particle concentration, showing
that co-isolation of lipid contaminants affect NTA results.
Conclusion: We have shown that the isolation methods used are capable
of isolating different EV proteome fractions, thereby demonstrating that
EV isolation method can be chosen based on which EV proteome
fraction one wants to study and/or the EV purity needed.
Reference
1. Kowal et al., Proc Natl Acad Sci U SA. 2016; 113: E968–977.
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Human adipose stem cells originated exosomes improving survival
rate of rats with acute liver failure probably by releasing lncRNA H19
Yinpeng Jin and Qingchun Fu
Shanghai Liver Disease Research Center, The 85th Hospital of PLA
Introduction: It has been confirmed that the stem cells promote the
regeneration of damaged tissues mainly through the “paracrine effect”.
As the major carrier responsible for exocytosis of the stem cells, exosome
is highly likely to play an important role in stem cell therapy.
Methods: 1. Human adipose-derived stem cells (hASCs) were separated
from human adipose tissues and used to prepare hASCs exosomes with
modified multi-ultrafiltration concentration method of our research
group; scanning electron microscope, Nanosight granulometer and anti-
body microarrays were employed to identify the morphology, particle
size and phenotypes of the hASCs exosomes, and the protein mass
spectrometry as well as the second generation sequencing technology
used to determine the protein and RNA components in the hASCs. 2. 78
rats with acute liver failure were randomly assigned to 5 groups to
receive treatment with the same volume of low concentration (20 μg/
rat) and high concentration (100 μg/rat) of hASCs exosomes, low con-
centration (20 μg/rat) and high concentration (100 μg/rat) of hASCs lysis
buffer as well as hASCs (2 x 106 cells/rat) or phosphate buffer solution
(PBS), respectively, through femoral vein infusion. The survival rate of
rats was observed, and analyses on gene sequencing and signal pathways
conducted to explore the potential mechanism of hASCs exosomes in
treating the rat models with acute liver failure. 3. 25 rats with acute liver
failure rats were randomly assigned to 3 groups to receive the treatment
of the same volume of hASCs exosomes (100 μg/rat), hASCs exosomes
with silent H19 gene (100 μg/rat) or phosphate buffer solution (PBS),
respectively, by femoral vein infusion. The survival rate of the rats was
analyzed.
Results: 1. The high-purity hASCs exosomes were collected from the
supernatant of hASCs culture using multi-ultrafiltration concentra-
tion method, presenting spherical bodies under scanning electron
microscopy and Nanosight granulometer with a uniform size of 30-
200 nm in diameter; The antibody microarrays indicated high
expression of the characteristic markers, such as CD63, CD81,
FLOT1, ALIX and ANXA5, on the surface of hASCs exosomes. 2.
With protein mass spectrometry and the second-generation sequen-
cing technology, more than 300 types of proteins 2000 kinds of
microRNAs were detected in hASCs exosomes. 3. The rat survival
curves showed that rat survival rate was 100% and 62.5% respectively
in the high concentration and low concentration hASCs exosome
group, significantly higher than in the PBS control group (27.3%)
(P < 0.05); According to the results of gene sequencing for rat liver
tissues, hASCs exosome transplant significantly upregulated the
genes associated with blood coagulation function and drug metabo-
lism pathways, and dramatically downregulated the genes related to
inflammatory responses and chemokine signaling pathways. 6.
Signaling pathway analysis revealed an evident upregulation in long
chain non-coding RNA (lncRNA) H19 in the liver tissues of rats in
hASCs exosome groups, which is likely associated with the upregula-
tion of pathways related to blood coagulation function as well as
drug metabolism. A decrease in the rat survival rate to 40% was
observed in the rats with acute liver failure when treated with H19
gene silencing hASCs, with a statistical significance as compared with
the hASCs exosome groups.
Summary/Conclusion: hASCs exosomes can accelerate the regeneration
of the damaged liver cells and improve the survival rate of rats with
acute liver failure probably by upregulate the pathways associated with
blood coagulation function and drug metabolism as a result of lncRNA
H19 release.
Funding: We wish to acknowledge support from the following funding
sources: financing for key medical innovation projects of the Nanjing
Military (project number: 14ZX01); China Hepatitis Prevention and
Treatment Foundation - Tian Qing Liver Research Fund Project (project
number: TQGB20150104)
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Introduction: RNA-based therapeutics represent one of the most promising
new areas of drug development. Unfortunately, despite recent progress in the
development of RNA delivery systems, delivery efficiency of RNAmolecules
remains unsatisfactory. Recent evidence has established that extracellular
vesicles (EVs), including exosomes and microvesicles, form an endogenous
transport system through which macromolecules, including RNA, are
exchanged between cells. Understanding the biology underlying EV-based
intercellular transfer of RNA is of great importance for the development of
EV-based delivery vehicles. Here, we sought to characterise the cellular
mechanisms involved in EV uptake.
Methods: EVs from A431 cells were isolated using a novel size-exclusion
chromatography-based method. Vesicles were analysed by nanosight
analysis, western blotting and electron microscopy. Internalisation of
fluorescently-labelled EVs was evaluated in HeLa cells, in 2D (mono-
layer) cell culture as well as 3D spheroids. Uptake was assessed using
flow cytometry and confocal microscopy, using chemical and siRNA
approaches for inhibition of individual endocytic pathways.
Results: Experiments with chemical inhibitors revealed that EV uptake
by HeLa cells depends on cholesterol and tyrosine kinase activity, which
are implicated in clathrin-independent endocytosis, and on Na+/H+
exchange and phosphoinositide 3-kinase activity, which are important
for macropinocytosis. Furthermore, EV internalisation was inhibited by
siRNA-mediated knockdown of caveolin-1, flotillin-1, Rac1, RhoA and
Pak1, but not clathrin heavy chain and CDC42.
Conclusion: Together, these results suggest that A431 EVs enter HeLa cells
predominantly via clathrin-independent endocytosis and macropinocytosis.
Identification of EV components that promote their uptake via pathways that
lead to functional RNA transfer might allow development of more efficient
delivery systems through EV-inspired engineering.
Acknowledgements: PV is supported by a VENI Fellowship (# 13667)
from NWO-STW.
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and intra-cisterna magna administration
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Introduction: 89Zr is widely used as a tracer for imaging the biodistribu-
tion of monoclonal antibodies, owing to its commercial availability, well-
developed radiochemistry and suitability for positron emission tomo-
graphy (PET). Here we describe a method for 89Zr labelling of





























extracellular vesicles (EVs) and demonstrate its application for PET
combined with anatomical imaging by X-ray computed tomography
(PET/CT).
Methods: EVs were generated from human amniocyte-derived (CAP)
cells and human embryonal kidney-derived (HEK) cells, and purified
by differential centrifugation and sucrose density gradient ultracentri-
fugation. Prior to 89Zr labelling, EVs were analysed by SEC-HPLC,
western blotting, and electron microscopy. EVs were sequentially trea-
ted with p-SCN-Bn-Deferoxamine and 89Zr4+ to achieve stable 89Zr
labelling, and administered to mice by intravenous (IV) and intraper-
itoneal (IP) routes and to rats by intrathecal (IT) and intra-cisterna
magna (ICM) routes. Animals were imaged by PET/CT at several time
points up to at least 24 h, and co-registered 3D image reconstruction
was performed. Organs were harvested to assess levels of 89Zr-labelled
EV accumulation. Selected organs were sectioned and subjected to
autoradioluminography.
Results: Biodistribution patterns following IV and IP administration did
not significantly differ for EVs of disparate cellular origin (CAP and
HEK), but varied greatly as a function of route of administration. The
liver and the spleen were the primary sites of uptake following IV
administration. Following IP administration, a pattern of punctate thor-
acic and abdominal distribution was observed, with predominant uptake
in the pancreas and spleen. Autoradioluminography revealed EV accu-
mulation within the parenchyma of the pancreas. Following IT admin-
istration, broad distribution was observed in the spinal cord and
ventricular network of the brain, and more restricted ventricular dis-
tribution was observed following ICM administration.
Conclusions: Labelling of EVs with 89Zr is highly suitable for live PET/
CT imaging with 3-D image reconstruction, the assessment of biodis-
tribution after organ harvest, and histological evaluation by autoradio-
luminography. Biodistribution patterns differed greatly as a function of
administration route, but not of EV cellular origin.
OT8.03
Determining the fate of extracellular vesicles in C. elegans: trafficking
of the released organelle, the post-mitotic midbody
Gholamreza Fazeli, Michaela Geisenhof, Linda Irmisch and Ann Wehman
Rudolf Virchow Centre for Experimental Biomedicine, University of
Wuerzburg, Germany
Introduction: Cells release organelles in addition to extracellular vesicles.
For example, in animals, the midbody coordinates the end of cytokinesis
when two daughter cells separate through an intercellular bridge and the
midbody remnant is released extracellularly by abscission on both sides
of the bridge. Released midbody vesicles can be found in body fluids, but
are often phagocytosed in vivo. The fate of phagocytosed midbodies was
unclear.
Methods: To determine the fate of midbodies, we used genetics and live
imaging to examine the role of phagocytic, endosomal, and autophagic
proteins on individual midbodies in developing C. elegans embryos.
Results: We first confirmed that midbodies are released in vesicles using
the ZF1 degradation tag to label extracellular vesicle membranes.
Released midbodies are internalised via actin-driven phagocytosis,
which we show requires the RAB-5 GTPase to localise the Class III
phosphoinositide 3-kinase (PI3K) complex at the cortex, leading to
recycling of the phagocytic receptor CED-1 to the plasma membrane.
Further, we found that RAB-5 and RAB-7 appear on midbody phago-
somes, directing their maturation similar to endosomes. Proteins nor-
mally associated with macroautophagy, such as the Atg8/LC3
homologues LGG-1 and LGG-2, localise around the midbody phago-
some and are required for midbody degradation. Additionally, we
observed that the Rab2 homologue UNC-108 is required for acidification
of the midbody phagosome, demonstrating that LC3-associated phago-
somes (LAPosomes) acidify via a common pathway with classical
phagosomes.
Conclusion: These studies reveal that internalised midbody remnants are
degraded via LC3-associated phagocytosis (LAP). Phagocytosis of mid-
bodies is likely to terminate midbody signalling after their release. The
recruitment of LC3 to the phagosome is likely necessary for the degra-
dation of a double membrane-wrapped phagosome. The fate of the
midbody reveals how cells cope with released extracellular organelles.
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Introduction: Extracellular vesicles (EVs, 30–200 nm), secreted by various
cell types, contain bioactive molecules (e.g. microRNAs and enzymes).
EVs are anticipated to be the next generation of drug delivery tools owing
to their pharmaceutical advantages, including controlled immunogeni-
city, utilisation of cell-to-cell communication pathways, and modification
and encapsulation of functional molecules. For effective intracellular drug
delivery by EVs, the efficacy of EV uptake by cells must be improved. In
this study, we developed EVs modified with arginine-rich cell-penetrating
peptides (CPPs) that actively induce macropinocytosis in cells for
enhanced cellular EV uptake and cytosolic release of EV contents.
Methods: All peptides were prepared via Fmoc solid-phase synthesis.
Secreted EVs were isolated via ultracentrifugation of HeLa cells stably
expressingGFP-fused CD63 (an EV (exosome)membranemarker protein).
Results and Conclusion: We recently found that macropinocytosis (accom-
panied by actin reorganisation, ruffling of the plasma membrane, and
engulfment of large volumes of extracellular fluid) is an important cellular
uptake pathway for EVs. We modified EVs using oligoarginine peptides
that are arginine-rich CPPs and induce macropinocytosis via the proteo-
glycan on plasma membranes. Oligoarginine peptide (Rn, n = 4–16)-mod-
ified exosomes were prepared by cross-linking the peptides and EVs via
N-ε-maleimidocaproyl-oxysulfosuccinimide ester. When we examined the
effects of the Rn modification on cellular exosome uptake, the number of
arginine residues on the peptide-modified EVs significantly affected both
macropinocytosis induction and cellular uptake. To confirm our findings,
we artificially encapsulated the ribosome-inactivating protein, saporin, in
oligoarginine peptide-modified EVs (saporin-EVs). We found that saporin-
EVs modified with hexadeca-arginine (R16) peptides showed effective
anticancer activity. Our findings may contribute to the development of
EV-based intracellular drug delivery systems.
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Surface glycosylation of extracellular vesicles and implications on
their interaction with target cells
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Introduction: Glycosylation is a common post-translational modification
of proteins from eukaryotes. Cell surface contains glycans that mediate
interactions with other cells. Extracellular vesicles (EVs) are rich in
glycoconjugates. Here, we aimed at characterising glycosignatures from
EVs having in view the investigation of their functional role in uptake.
Methods: EVs were purified from cell supernatants (HEK-293, glioma
Tu-2449 cells) by ultracentrifugation, and were analysed by immuno-
blotting, nanoparticle tracking analysis (NTA) and transmission electron
microscopy (TEM). Membranes (MBs) were obtained by cell sonication
and ultracentrifugation. Glycomics included lectin blotting (1), HPAEC-
PAD, NP-HPLC and mass spectrometry (2).
Results: EVs were detected with markers, including CD63, CD81, flotil-
lin-2 and LGALS3BP. EVs had heterogeneous size, presented average
diameters around 100 nm by NTA, and cup-shape by TEM. Lectin
blotting showed that EVs were rich in glycoproteins with α2,3/6-linked
sialic acid and fucose among other sugars. Specific N-glycan profiles
were found by HPAEC-PAD and NP-HPLC combined with exoglycosi-
dase digestions and mass spectrometry. EVs had predominantly complex
glycans with sialic acid and some high mannose glycans, whereas MBs
were rich in high mannose glycans. We found that HEK-293 EVs
interacted with Tu-2449 cells and the impact of some glycans on the





























interaction, based on glycosidase digestion and effect of competitive
sugars, will be discussed.
Conclusion: EVs displayed specific glycosignatures, which opened novel
perspectives to explore their role in the interaction with other cells.
Acknowledgements: We thank: Linda Streich, GlycoThera, Germany for
help with glycan mapping, Dr. Erin Tranfield, Ana Sousa, IGC EM
Facility, Portugal for TEM analysis, project ENMed/0001/2013, FCT,
Portugal.
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The Amnis imaging stream flow cytometer platform allows
discrimination of different vesicles types in mesenchymal stem cell-
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Human mesenchymal stem/stromal cells (MSCs) represent a promis-
ing tool in regenerative medicine and in immune therapy. Up to now,
more than 700 NIH-registered clinical trials investigated their
therapeutic potential in various diseases. Maybe due to the existence
of therapeutically more and less active MSC-subtypes, controversial
outcomes have been described for the MSC treatment of several
different diseases. As MSCs seem to exert their beneficial therapeutic
via extracellular vesicles, we hypothesised that extracellular vesicle
(EV) fractions being released by independent MSCs differ in their
functional properties. Indeed, by comparing immunomodulatory fea-
tures of independent MSC-EV fractions, we observe huge differences,
e.g. in the capability to supress T cell proliferation of PHA stimulated
T cells.
Since we raise MSCs in human platelet lysat (hPL) supplemented media
which contain a high proportion of nano-sized vesicles, obtained MSC-
EV fractions contain a mixture of non-processed hPL vesicles and EVs
secreted by the MSCs. To this end obtained EV fractions should be
considered to contain heterogeneous vesicle types. For now, standard
analysation platforms such as nanoparticle tracking analyses (NTA),
dynamic light scattering (DLS), tunable resistive pulse sensing (TRPS)
and western blotting do not allow discrimination of different vesicle
types.
In our ongoing experiments we have optimised the analyses of nano-
sized single vesicles on the Amnis imaging flow cytometer platform and
are now able to characterise vesicles and EVs including exosomes,
microvesicles and apoptotioc bodies at the single vesicle level. Upon
staining with different antibodies, we indeed can discriminate hPL
derived vesicles from MSC released EVs, now. While most hPL vesicles
express CD9, MSC-EVs are CD9 negative. However, in contrast to hPL
vesicles most MSC-EVs express CD81. By implementing additional
antibodies, we can further discriminate different hPL vesicle and MSC-
EV subtypes. Amongst others, the optimised analysis platform enables
us now to determine the content of hPL vesicles being consumed by
independent MSC preparations and the content of the EVs being
released by these cells.
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LBO.07
HER2-targeted drug-resistance is associated with immune evasion in
cancer cells and their derived extracellular vesicles
Vanesa Martinez1, Sadhbh O’Neill1, Josephine Salimub2, Susan Breslin1, Aled
Clayton3, John Crown4 and Lorraine O’Driscoll5
1Trinity College Dublin, Ireland; 2Cardiff University, Cardiff, United Kingdom;
3Division of Cancer and Genetics, School of Medicine, Cardiff University and
Velindre Cancer Centre, Cardiff, United Kingdom; 4St. Vincent’s University
Hospital, Dublin, Ireland; 5Trinity College Dublin, Ireland
Introduction: Recent we established that Neuromedin U (NmU) plays a
substantial role in HER2-overexpressing breast cancer, correlating with
increased aggressiveness, resistance to HER2-targeted therapies and poor
survival outcome for patients. Here we aimed to elucidate NmU’s
mechanism-of-action.
Methods: Drug-sensitive HER2-positive breast cancer cells were engi-
neered to stably over-expressing NmU. In parallel, drug-sensitive cells
were exposed to HER2-drugs for ~6 months, to acquire drug-resistance.
Approved by SVUH Ethics Committee, serum specimens were procured
from consenting patients with HER2-tumours before they received neo-
adjuvant treatment with HER2-targeted drugs. Extracellular vesicles
(EVs) were isolated from the cultured cells’ media and patients’ sera
using filtration and ultracentrifugation. EVs were characterised by
immunoblotting, nanoparticle tracking analysis and electron micro-
scopy. ELISA measured TGF-β1, PD-L1, IL-2 and IFN-gamma. Flow
cytometry analysed PD-L1; CD24/CD44 as markers of stem cells; and
apoptosis. Trastuzumab-mediated antibody-dependent cell cytotoxicity
(ADCC) was assessed using T cells from PBMC, measuring cell lysis by
LDH release.
Results: NmU-overexpressing cells and their EVs have increased immu-
nosuppressive cytokine TFGM-β1 and lymphocyte activation inhibitor
PD-L1. These cells also showed resistance to ADCC, implicating NmU
in enhancing immune evasion. All these features were also found in
acquired drug-resistant cells that express higher levels of NmU than
their drug-sensitive counterparts. Interestingly, EVs from drug-resistant
cells transmitted increase levels of TGF-β1 to drug-sensitive cells.
Furthermore, TGF-β1 levels were significantly higher on EVs from
patients who subsequently did not respond to treatment, compared to
those who gained some benefit.
Summary/Conclusion: We report a new mechanism-of-action for NmU
that enhances resistance to the anti-tumour immune response.
Furthermore, EV levels of TGF-β1 correlating with patients’ response
versus resistance to HER2-targeted drugs suggests a potential use of EV-
TGF-β1 as a minimally-invasive companion diagnostic for such anti-
cancer treatment.
Funding: HRB [HRA-POR-2014-658]; Breast Cancer Now
[2015NovSP686]; Irish Cancer Society [CCRC13GAL]; H2020 ME-
HaD [BM1202].
OT9.01
Intercellular communication mediated by exosomes as a new
therapeutic target for pancreatic cancer
Nuno Bastos1, Carolina de Freitas. Ruivo2, Carlos Melo3, José Machado1 and
Sónia Melo1
1i3S – Ipatimup; 2i3S – Instituto de Investigação e Inovação em Saúde; 3The
Gurdon Institute, University of Cambridge, United Kingdom
Cancer treatment experienced significant advance over the last years,
mainly due to the development of targeted therapies against key biological
pathways. Despite this promising scenario, targeted therapy in pancreatic
cancer (PDAC) is still not a reality and the available therapies are limited,
with dismal contribution for patient survival. Cell communication, in spite
of playing a fundamental role in all steps of tumour progression, is still off
the cancer therapy landscape. Exosomes, a subtype of extracellular vesi-
cles, are an important cell-to-cell communication system with neighbour
and/or distant cells. Exosomes are derived from the endocytic pathway
and formed within multivesicular bodies (MVBs). Our main aim is to
study the role of exosomes biogenesis during pancreatic cancer progres-
sion and understand if targeting cancer exosomes biogenesis could be a
new therapy avenue in pancreatic cancer. Rab GTPases are crucial pro-
teins in exosomes biogenesis and are involved in all stages of the endocytic
pathway. We show that during pancreatic cancer progression Rab-5, -7,
-27a and -27b are differently expressed. Increased expression of Rab-27a
and -27b correlates with an increase in exosomes number, and these
features are associated with a more aggressive phenotype. In contrast,
Rab-5 and -7 do not show correlation between their protein levels and the
number of exosomes released. Additionally, when treated with gemcita-
bine, the standard care chemotherapeutic for pancreatic cancer, cancer
cells change their exosomes biogenesis pattern, increasing exosomes
release. Finally, we are using an inducible and conditional genetically
engineered Rab-27a knockout mouse model, crossed with a mouse
model that spontaneously develops PDAC, to study the function of exo-
somes and its biogenesis in disease progression and therapy response, and
to evaluate exosomes-mediated communication as a new therapeutic
option in pancreatic cancer.
OT9.02
Exosomes from bovine milk reduce the tumour burden and
attenuates cancer cachexia
Monisha Samuel1, Markandeya Jois1 and Suresh Mathivanan2
1Department of Physiology, Anatomy and Microbiology, La Trobe
University, Victoria, Australia; 2La Trobe Institute for Molecular Science,
Victoria, Australia
Introduction: Milk has long been associated with good health and is one
of the most consumed beverages throughout the world. Exosomes are
30–150 nm membranous vesicles of endocytic origin that are released by
all cell types and are also detected in bodily fluids including milk.
Whether these milk-derived exosomes can serve as cross-species mes-
sengers and have a biological effect on host organism has been poorly
understood. Here, we examined the stability of bovine milk exosomes in
degrading conditions and studied their biodistribution using mouse
models and IVIS imaging after oral administration. We also unravel
the role of bovine milk derived exosomes in colon cancer progression.
Methods: Milk exosomes were isolated using differential centrifugation
and OptiPrepTM density gradient centrifugation. They were further
characterised and examined for stability under harsh conditions using
western blotting and nanoparticle tracking analysis. IVIS imaging system
was used to study the biodistribution of these exosomes on oral gava-
ging. Mice models were used to understand the role of milk exosomes in
cancer progression.
Result: On examining the stability of bovine milk exosomes in harsh
conditions, it was concluded that these exosomes are remarkably stable
in both acidic and high temperature conditions while colorectal cancer
cell-derived exosomes were not. Next, we studied the biodistribution of
bovine milk exosomes which suggested that orally administered milk
exosomes can survive the harsh intestinal environment and can be
trafficked to various organs. Interestingly, after 24 h, the milk-derived
exosomes reached multiple organs including liver and spleen in the
mice. To understand the role of milk-exosomes in cancer progression,
in vivo mouse models implanted with colorectal cancer were orally
administered with milk-derived exosomes. Remarkably, exosomes iso-
lated from both raw and commercial (grocery store) milk significantly
reduced the tumour burden. Furthermore, orally administered milk





























exosomes prolonged the survival of the mice by inhibition of tumour-
induced weight loss in cancer cachexia mice models.
Summary: Thus this study provides new insights on the significance of
milk exosomes in context of mammalian physiology as well as prompt
their use as drug delivery vehicles in therapeutic interventions.
OT9.03
Oligodendroglioma cells communicate with neighbouring tumour
and normal neural cells via extracellular vesicles
Lata H. Adnani1, Christian Perotti2, Jennifer Chan2 and Carol Schuurmans1
1Sunnybrook Research Institute, University of Toronto and Biochemistry and
Molecular Biology Department, University of Calgary, Canada; 2Hotchkiss
Brain Institute, University of Calgary, Canada
Gliomas are malignant brain tumours comprised of abnormal glial-like
cells with stem cell-like properties. In vitro screens have identified
numerous drugs with activity against glioma cells, yet their in vivo effects
are frequently disappointing. The discrepancy between in vitro and in
vivo data may be due in part to the inability of in vitro screens to
recapitulate disease complexity, including interactions between cancer
cells and other cells in the microenvironment. Consistent with the
importance of homotypic and heterotypic cell interactions in the tumour
micro-environment, we found that oncogenes such as RasV12 and
bRafV600E act both cell autonomously and non-cell autonomously to
confer an abnormal glial cell phenotype in mouse glioma models. Here
we assessed the role of extracellular vesicles (EVs) in intercellular com-
munication in a patient-derived oligodendroglioma cell line (BT88). To
first assess whether BT88 cells secrete factors that influence tumour-
tumour cell interactions, BT88 cells were plated at clonal density in fresh
and BT88-conditioned media (CM). Strikingly, BT88-CM inhibited the
formation of BT88 tumorspheres. In contrast, BT88-CM promoted the
proliferation and sphere-forming capacity of embryonic day (E) 13.5
mouse neural stem cells (mNSCs). To determine whether these effects
were EV-mediated, we first used a Cre-based reporter line to demon-
strate that BT88 cells secrete EVs that transfer bioactive molecules to
neighbouring cells, in this case, the cre recombinase. Next, we targeted
the neutral sphingomyelinase 2 (nSMase2) pathway of EV synthesis
using a shRNA to Smpd3, which encodes for this enzyme. Knockdown
of Smpd3 in BT88 cells reduced tumorsphere number, indicating that
EVs are responsible for the inhibitory effects that BT88 cells have on one
another. Currently, we are studying whether BT88 cell interactions with
mNSCs is also EV-mediated. Taken together, our data supports the idea
that EVs mediate at least some aspects of cell-to-cell communication in
oligodendroglioma.
OT9.04
HOTAIR affects bladder cancer epithelial-to-mesenchyme transition
through both the Canonical WNT-pathway and extracellular vesicles
Claudia Berrondo1, Thomas Osinski1, Jonathan Flax2, Samuel Richheimer2
and Carla J. Beckham2
1URMC; 2University of Rochester, NY, USA
Introduction: Previously we showed the long non-coding RNA Hox
antisense intergenic transcript (HOTAIR) is enriched in urothelial blad-
der cancer (UBC) cell lines, extracellular vesicles (EVs), patient tumours
and urinary EVs. Importantly, HOTAIR affects genes involved in epithe-
lial-to-mesenchyme transition (EMT). Loss of HOTAIR correlates with
reduced in vitro migration and invasion. Several genes affected by
HOTAIR are in the Wnt-pathway. HOTAIR facilitates EMT via the
Wnt-pathway in several tumours. We show that HOTAIR is necessary
for Wnt-responsiveness and its expression increases with Wnt activa-
tion. EMT is also regulated through intercellular communication by
EVs. HOTAIR regulates thousands of genes. We discovered that
HOTAIR knockdown cells produce fewer EVs with altered protein
cargo and do not facilitate migration or invasion. Targeting HOTAIR
therapeutically may affect EMT through the Wnt-pathway and EVs
function.
Methods: LiCl or rWNT treated UBCs gene expression was analysed by
qRTPCR, western blot and immunohistochemistry. Scratch and 3D
spheroid invasion assays measured in vitro EMT. shRNA or siRNA
against HOTAIR were used. WNT target and antagonist gene expression
was measured by qRT-PCR. Sequencing revealed TCF7L2 binding sites
in the promoter region of HOTAIR. siRNA against TCF7L2 or beta-
catenin reduced HOTAIR expression. EVs isolatedd by ultracentrifuga-
tion and sucrose gradient were analysed using Nanosight. LC MS/MS
mass spectrometry and western blot were used to analyse EVs protein.
Results: TCGA data reveals WNT-pathway genes are affected in UBC.
LiCl or rWNT treated UBCs have increased EMT related gene expres-
sion. rWnt facilitates in vitro migration and invasion dependent on
HOTAIR. Reduced HOTAIR correlates with decreased WNT-target
and increased antagonist gene expression. Importantly, HOTAIR is a
target of canonical WNT signalling. Reduced HOTAIR expression
affects UBC EV number, content and in vitro migration and invasion.
Conclusions: The canonical WNT-pathway is critical in UBC and is
functionally dependent on HOTAIR. Therapeutic targeting of the
WNT-pathway may affect UBC tumour progression through loss of
HOTAIR as loss of HOTAIR affects hundreds of genes that results in
reduced EVs number, content and in vitro migration and invasion.
OT9.05
Oncolytic adenoviruses encapsulated into the extracellular vesicles as
carriers for targeted drug delivery
Mariangela Garofalo1, Heikki Saari1, Elisa Lazaro-Ibanes2, Petter Somersalo1,
Laura Aksela3, Cristian Capasso4, Matti Jalasvuori5, Vincenzo Cerullo4, Paolo
Ciana6, Lukasz Kuryk4 and Marjo Yliperttula1
1Division of Pharmaceutical Biosciences and Centre for Drug Research,
Faculty of Pharmacy, University of Helsinki, Finland; 2Division of
Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki,
Finland; 3Orion Corporation; 4Laboratory of Immunovirotherapy, Division
of Pharmaceutical Biosciences and Centre for Drug Research, Faculty of
Pharmacy, University of Helsinki, Finland; 5Biological and Enviromental
Science, University of Jyväskylä, Finland; 6Division of Oncology and Onco-
Haematology, University of Milan, Italy
Introduction: Lung cancer is a highly invasive and rapidly metastasising
cancer type. Althoughmany kinds of treatment have been developed during
the past decades there is still a lack of effective therapy, since it is still
diagnosed at the end-stage of the disease and associated with poor prog-
nosis. Therefore new treatment strategies are in high demand. Efficient
anticancer agent and its targeted delivery into the tumour mass is a key
prerequisite for the successful cancer therapy. Oncolytic virotherapy is
emerging as a potential approach to treat cancer, using viruses, which are
specifically engineered to selectively infect, replicate in and kill cancer cells
without causing damage to normal cells. However this approach has also
disadvantages like low efficacy and production of neutralisation antibodies
against virus. Additionally oncolytic viruses are administered intratumo-
rally, thus many solid tumours cannot be treated using this approach.
Extracellular vesicles (EVs), which are naturally occurring cargo delivery
agents, have a potential to be used as vehicles for drug delivery. Therefore
EVs can be used for targeted delivery of the therapeutic agents into the
tumour cells and to finally decrease drug toxicity. For these reasons we
hypothesised that oncolytic adenoviruses encapsulated into EVs loaded
with chemotherapeutic drugs should enhance specific drug delivery for
tumour targeting, and thus improve efficacy of cancer treatment.
Methods: Electron and confocal microscope were used to check the
encapsulation of adenovirus into EVs, while fluorescent microscope
was used to test the EV–virus complex for the functional cell viability
assay. The in vivo efficacy of EV–virus–drug complex was tested in Balb/
c nude mice after intravenous injection.
Results and Conclusions: We found by electron and confocal microscope
that oncolytic adenoviruses are encapsulated into EVs. EV–virus and
EV–virus–paclitaxel complexes were able to enhance cell death and
transduction efficacy in lung cancer (A549) cell line, while in vivo
efficacy studies showed that tested platform was able to control tumour
growth after intravenous injection. Our findings support the idea that an
oncolytic adenovirus encapsulated into EVs loaded with therapeutic
agents could be used as anticancer drug treatment.






























TGFBR2-dependent alterations of exosomal cargo and functions in
DNA mismatch repair-deficient colorectal cancers
Fabia Fricke, Jürgen Kopitz and Johannes Gebert
Department Applied Tumour Biology, Institute of Pathology, University
Hospital Heidelberg, Heidelberg, Germany; Department Cancer Early
Detection, German Cancer Research Centre (DKFZ), Heidelberg, Germany
Introduction: DNA mismatch repair-deficient (dMMR) colorectal can-
cers (CRCs) exhibiting the microsatellite unstable (MSI) phenotype
represent about 15% of all CRCs. These tumours show a high frequency
(>90%) of inactivating frameshift mutations in the tumour suppressor
transforming growth factor beta receptor type 2 (TGFBR2). How altered
TGFBR2 signalling affects communication between tumour cells and
their environment has not been resolved. Here, we report on MSI-
specific molecular and proteomic alterations of exosomes shed by
dMMR cells and resulting effects on potential target cells.
Methods: Exosomes were isolated and characterised by electron micro-
scopy, nanoparticle tracking, and western blot analysis. TGFBR2-depen-
dent effects on exosomes were analysed in a MSI CRC cell model system
(HCT116-TGFBR2) enabling inducible TGFBR2 expression/signalling.
Microsatellite frameshift mutations of exosomal and cellular DNA were
determined by PCR-based fragment analysis and protein profiles exam-
ined by mass spectrometry. CFSE-labelled exosomes were used to con-
firm uptake. Exosomal effects on cytokine profiles of recipients were
analysed by Luminex and ELISA.
Results: Coding microsatellite frameshift mutation types and pattern in
TGFBR2 and other MSI target genes were found to be shared by MSI
tumour cells and derived exosomes. Reconstituted TGFBR2 expression
and signalling in HCT116-TGFBR2 cells uncovered two exosomal pro-
tein subsets specifically originating from TGFBR2-deficient (n = 14) or
TGFBR2-proficient (n = 5) donor cells. Uptake of MSI tumour cell
exosomes by HepG2 cells was confirmed by confocal microscopy and
caused significant alterations of cytokine secretion levels in a TGFBR2-
dependent manner (>1.5-fold) predominantly affecting IL-4 (2-fold),
stem cell factor (2.5-fold) and platelet-derived growth factor-B (6-fold).
Conclusion: Our results point to a biological activity of MSI tumour cell
derived exosomes on recipient cells. These effects are influenced by
TGFBR2 signalling in the donor cell, which was also found to impact
the exosomal proteome. Since the molecular MSI phenotype of these
cells is mirrored in their exosomal DNA, exosomes might facilitate
molecular MSI tumour diagnostics complemented by specific exosomal
protein markers linked to the donor cell expression status of TGFBR2.
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PT01.01
Role of extracellular vesicles in thyroid folliculogenesis
Jonathan Degosserie and Christophe E. Pierreux
de Duve Institute, Université Catholique de Louvain, Belgium
Introduction: Intercellular communication is essential for biological
processes such as cellular differentiation and pathological processes
such as cancer. Our lab has recently shown that reciprocal communica-
tion between epithelial and endothelial cells is of major importance for
pancreatic and thyroid organogenesis during murine development. In
the developing thyroid, epithelial cells first secrete huge amount of
VEGFa that stimulates recruitment of endothelial cells. In turn, recruited
endothelial cells invade the thyroid epithelial bud and induce thyroid
progenitors to reorganise and form thyroid follicles.
Methods: Using an original ex-vivo thyroid culture system that faithfully
reproduces in vivo thyroid development and follicle formation, we
demonstrated that medium conditioned by endothelial cells stimulate
folliculogenesis. In addition, this folliculogenic activity could be further
purified by high-speed centrifugation of the conditioned medium in a
sedimentable material. Morphological and biochemical characterisation
of this material lead us to identify round shape membrane structure with
an average size of 100 nm and a density of 1.10 g/mL corresponding to
extracellular vesicles (EVs). EVs have been recently identified as sophis-
ticated vehicles, containing soluble proteins and nucleic acids, and
involved in short and long distances communication processes.
Results and Conclusion: Mass spectrometry analysis of the EVs uncovered
the presence of specific vesicular markers as well as of abundant laminin
a1, b1 and g1 peptides. EVs purified from endothelial cells pre-infected
with laminin a1 shRNA have no folliculogenic activity, indicating that
laminin present in the sedimentable material is required for the folliculo-
genic activity. Our current working hypothesis is that laminins are impor-
tant for EVs targeting and incorporation in thyroid progenitor cells.
PT01.02
Shuttle mechanisms of extracellular vesicle-enclosed bioactive
molecules in ex-vivo and in-vivo systems
Thamara Dayarathna1, Andrew Chun-Him Poon2 and Hon S. Leong3
1LHRI, St. Joseph’s Health Care; 2University of Western Ontario, Canada;
3Western University, Ontario, Canada
Introduction: Communication between cells is essential for life and survival
in multicellular organisms. Apart from signal transduction via chemical
transmitters produced by paracrine, endocrine, neurocrine and lumencrine
signalling, extracellular vesicles (EVs) play a crucial role in information
exchange, particularly in the form of mRNA, protein, bioactive molecules
and carbohydrates. However, the total microparticle fraction of EVs in the
extracellular matrix (ECM), their roles and mode of action are poorly
understood among molecular biologists. Here we present cell-specific EV
fraction identification and cell-to-cell shuttle mechanisms of EV-enclosed
biomolecules that contribute to various cellular functions including cell
differentiation, organ development and cell death.
Methods: EV fractions of endothelial, platelet, leucocyte and erythrocyte
were isolated using their explicit protein markers and analysed by
nanoscale flow cytometry. To understand the targeting organelles in
receiving cells and cellular uptake mechanisms, benign prostatic hyper-
plasia (BPH) cells were treated with purified EVs stained with SYTO®
RNASelect™ specific for RNA. Micro RNA-enriched EV uptake by
receiving cells, EV localisation post-uptake, and their time-dependent
release from newly received cells were examined and captured by con-
focal microscopy. Furthermore, lactate dehydrogenase (LDH) content of
BPH cells was measured after incubation with purified EVs released
from BPH cells which were treated with the cytotoxic agent dimethyl
fumarate.
Conclusion: Light scatter plots of nanoscale flow cytometric analysis
revealed tetraspanin-specific exosome markers and enriched EV frac-
tions of cell-specific origins. Endothelial, platelet, leucocyte and erythro-
cyte enriched EV fractions displayed a clear difference in both size and
the amount of EVs within the heterogeneous population of healthy
human plasma. Cellular fragments or EVs shed by healthy cells contain
visible RNA fragments and target to the cell membrane or in the
cytoplasm, to specific organelles like the mitochondria and nucleus.
Studying components in organelle-specific EV fractions will be the
next target on elucidating their physiological functions.
PT01.03
In vivo biodistribution of CTX human neural stem cell derived
exosomes delivered by various routes of administration
Patrick Joseph Walters, Caroline Hicks and Randolph Corteling
ReNeuron, Bridgend, United Kingdom
Introduction: ExoPr0, is an exosome product derived fromCTX (CTX0E03),
a human neural stem cell line currently under clinical evaluation for stroke
and limb ischaemia. Using a defined good manufacturing process scalable
production of clinical grade cells and their extracellular vesicle products
demonstrate batch to batch consistency. ExoPr0 product isolated and pur-
ified by tangential flow filtration from spent conditioned media collected
during the CTXmanufacturing process show reproducible product specifica-
tion in validated purity and identity tests. We have identified the potential for
ExoPr0 as a drug delivery vehicle and as a novel therapeutic product realised
by its potential to modulate fibroblasts, immune cells and glioblastoma cell
lines in various assays in vitro.
Methods: In this study we evaluated the biodistribution of ExoPr0 in vivo
using the most common clinical and disease applicable routes of adminis-
tration identified for this product. ExoPr0 was fluorescently labelled prior to
administration and detected by optical imaging and histology methods.
Results: Local administration showed tissue specific cell uptake of ExoPr0. In
the brain astrocytes in the corpus collosum demonstrated specific targeting
and uptake following migration of ExoPr0 from the site of injection in the
striatum. In the skin fibroblasts demonstrated uptake of ExoPr0, distribution
was also seen to mononuclear and cells of dendritic morphology of lymph
nodes draining the injection site. In contrast systemic delivery by the intra-
venous route resulted in the highest accumulation of ExoPr0 in the liver and
bladder. Imaging and histological evaluation of organs confirmed the pre-
sence of ExoPr0 in the brain, spleen, lungs and kidneys.
Conclusion: These studies demonstrate the ability to target ExoPr0 to
specific tissues and organs. This together with the tissue specific activity
of ExoPr0 suggests there is great potential to develop this product for the
treatment of more than one disease.
PT01.04
Amoeboid cancer cells shed extracellular vesicles enriched with
nuclear derived material
Mariana Reis Sobreiro1, Jie-Fu Chen1, Samantha Morley1, Sungyong You1,
Kenneth Steadman1, Navjot Kaur Gill2, Gina C-Y Chu1, Leland W.K. Chung1,
Hisashi Tanaka1, Wei Yang1, Amy C. Rowat2, Hsian-Rong Tseng2, Edwin M.
Posadas1, Dolores Di Vizio1 and Michael R. Freeman1
1Cedars Sinai Medical Center, CA, USA; 2University of California, Los
Angeles, CA, USA
Please see OPT01.01






























Discrete biogenic vesiculation pathways reside malignant and non-
malignant breast cells
Jack Taylor and Mary Bebawy
The Graduate School of Health, The University of Technology Sydney,
Sydney, Australia
Introduction: Microparticle (MP) biogenesis occurs following cellular activa-
tion and follows loss ofmembrane phospholipid asymmetry and activation of
calcium dependent cytosolic cysteine protease activity. MPs confer the trans-
fer and acquisition of cell phenotypes through the intercellular transfer of
bioactive molecules. In the context of cancer, Bebawy and colleagues (1)
discovered that MPs provide a “non-genetic”mechanism for the acquisition
of multidrug resistance and increased metastatic capacity in cancer cell
populations.The aim of this study was to define the biogenic pathways
involved in MP vesiculation in malignant and non-malignant cells using
high resolution biological atomic forcemicroscopy (AFM) (Nanowizard, JPK
Instruments, Germany). Identification and elucidation of cancer specific
biogenic pathways would provide novel therapeutic targets and strategies to
circumvent deleterious traits acquired through MPs in cancer.
Methods: A comparative analysis was performed using non-malignant
human brain endothelial cells (HBEC-D3), human mammary epithelial
cells (MBE-F), and drug sensitive and resistant human breast adenocar-
cinoma cells, MCF-7 and MCF-7/Dx respectively. Vesiculation of resting
cells and cells activated with calcium ionophore, A23187, were stu-
died ± calpain inhibitor II (ALLM). Cell surface topography and the
extent of vesiculation was determined using contact mode methodology.
Results: At rest, malignant cells exhibit an intrinsically higher degree of
vesiculation relative to non-malignant cells. In the presence of ALLM,
vesiculation was inhibited in malignant cells whilst non-malignant cells
exhibited enhanced vesiculation. The latter supports the presence of a
calpain independent pathway for vesiculation of normal cells at rest.
Increasing intracellular calcium release with A23187 resulted in an
increase in vesiculation across all cell types, however this was especially
pronounced in non-malignant cells.
Conclusion: We conclude that vesiculation at rest in malignant breast cells is
driven by a calcium-calpain dependent pathway, whereas, an alternative
pathway governsMP biogenesis in resting normal cells. These results support
therapeutic approaches to selectively target malignant cells.
References
1. Bebawy et al., Leukemia. 2009; 23: 1643–1649.
PT01.06
Identifying intrinsic components that regulate the secretion of
stroma-activating exosomes in prostate cancer
Vincent Yeung1, Mark Gurney1, Zsuzsanna Tabi1, Rachel Errington1, Jason P.
Webber1 and Aled Clayton2
1Cardiff University, Cardiff, United Kingdom; 2Division of Cancer and
Genetics, School of Medicine, Cardiff University and Velindre Cancer
Centre, Cardiff, United Kingdom
Introduction: Exosomes originate in multivesicular endosomes, and are
expelled into the extracellular space to mediate a host of pro-tumourigenic
effects. We have previously demonstrated activation of stromal cells within
the tumour microenvironment, to a disease-associated myofibroblast-like
phenotype, in response to prostate cancer exosomes. Secreted exosomes
are, however, heterogeneous in terms of biophysical and molecular proper-
ties. Multiple parallel pathways coexist and give rise to this exosome hetero-
geneity, and the exact pathway for generating exosomes with disease-
promoting function remains unclear. Here, we investigated the roles of six
proteins (CD9, Rab5a, Rab11b, Rab35, VAMP7 andVPS25) in the generation
of stroma activating exosomes.
Methods: Lentiviral-delivered shRNAs were used to knockdown these
targets in prostate cancer cells (DU145). Vesicle concentrates were
characterised by NTA, western blot and plate-based assays. Fibroblasts
were stimulated with cancer cell conditioned media, or vesicle
concentrates and their ability to differentiate into alpha-smooth muscle
actin positive myofibroblasts was determined by immuno-fluorescent
microscopy. Fibroblast/myofibroblast functionality was determined
using in vitro vessel formation and 3D invasion assays.
Results: Knockdown of Rab11b or Rab35 resulted in a modest attenuation of
exosome secretion (~20% by NTA). The remaining vesicles (~80%) exhibited
a distinct protein profile, and were insufficient in number or composition to
trigger fibroblast differentiation, angiogenesis or mediate pro-invasive beha-
viour within tumour:stroma spheroids.
Conclusion: Rab11b or Rab35 regulate distinct exosome secretion path-
ways, but generate essential sub-populations for triggering a cancer-
associated fibroblast phenotype. Targeting these elements may offer
novel modalities to limit tumour promoting stromal influence in the
cancer microenvironment.
PT01.07
The Pseudomonas quinolone signal drives outer membrane vesicle
biogenesis in Pseudomonas aeruginosa
Catalina Florez, Julie E. Raab, Adam C. Cooke and Jeffrey W. Schertzer
Binghamton University, NY, USA
Introduction: Quorum sensing, the phenomenon of cell-to-cell communica-
tion in bacteria, induces virulence and promotes human disease. An impor-
tant quorum sensing signal in P. aeruginosa is the Pseudomonas quinolone
signal (2-heptyl-3-hydroxy-4-quinolone, PQS). In addition to signalling, PQS
mediates its own packaging and transport between cells by stimulating outer
membrane vesicle (OMV) formation. It has been shown that 85% of PQS
produced is found in OMVs, demonstrating that these vesicles are the
transport vehicle of PQS. We proposed the “bilayer-couple” model for
OMV formation, a biophysical model where PQS intercalates into the
outer membrane resulting in the induction of membrane curvature. We
hypothesise that in accordance with the bilayer-couple model, PQS must be
transported from its place of synthesis, the cytoplasm, to the outer cell surface
before it can initiate OMV formation.
Methods: We examined two strains of P. aeruginosa under different growth
conditions to investigate PQS export and to correlate this with OMV forma-
tion. PQS was extracted with ethyl acetate and separated and visualised on a
thin-layer chromatography plate. OMVs were isolated by ultracentrifugation
and were quantified by lipid and nanoparticle tracking analyses. Cellular
membranes were separated using sucrose density gradients.
Results: We identified significant strain- and growth medium-dependent
differences in the extent of PQS export. Conditions giving rise to the
most PQS export also resulted in the greatest level of OMV production.
We found that PQS export phenotypes are independent of growth phase
and stable throughout the lifecycle of the bacterial culture. We further
discovered that cell associated PQS under poor-OMV- producing con-
ditions was largely localised to the inner membrane.
Conclusion: These results suggest that diminished OMV biogenesis is a
consequence of failure to export PQS to the outer membrane. We conclude
that OMV formation is correlated to the amount of PQS exported from the
cell (rather than simply to the amount of PQS produced) and that exporting
ability is independent of growth phase. These results are consistent with the
bilayer-couple model and underscore the possible presence of dedicated PQS
export machinery involved in the mechanism of OMV formation.
Funding: NIH.
PT01.08
BAG6 regulates the release of a subgroup of endosomal-derived
extracellular vesicles
Maximiliane Schuldner1 and Elke Pogge von Strandmann2
1Department I of Internal Medicine, University Hospital of Cologne,
Cologne, Germany; 2Experimental Tumour Research, Centre for Tumour
Biology and Immunology, Clinic for Haematology, Oncology and
Immunology, Philipps University, Marburg, Germany
Extracellular vesicles (EVs) are increasingly recognised as intercellular
mediators by functionally transferring biomolecules to recipient cells.





























Depending on their composition, EVs can have either pro- or anti-
cancer activity playing a role in diverse steps during tumourigenesis.
Recently, our group has identified the multifunctional chaperone BAG6
as a negative regulator of an ESCRT-mediated release of EVs in HEK293
cells (unpublished data). In this project, the melanoma cell line B-16V is
used to investigate whether tumour cell-derived EVs are characterised by
the expression of BAG6 and/or BAG6-recruited molecules and whether
these EVs are taken up by immune cells modulating the anti-tumour
immune response.
First experiments showed that CRISPR-Cas9 generated BAG6KO B-16V
cells release an increased amount of EVs compared to wild type cells.
This phenomenon is reminiscent to human BAGKO cell line HEK293.
Strikingly, mass spectrometry of BAG6KO EVs released from hypoxia-
stressed B-16V cells revealed a de-regulated expression of vesicle-asso-
ciated proteins compared to wild type EVs. This specific protein profile
most prominently included the up-regulation of ESCRT components
and might correspond to a BAG6-regulated subgroup of endocytically
derived EVs. Moreover, differential expression of proteins with tumouri-
genic and angiogenic activity including several integrin subunits was
observed.
In order to investigate the significance of BAG6-regulated EVs, a Cre-
loxP system visualising EV uptake by recipient cells will be applied.
Preliminary experiments have validated the feasibility of the system
using in vitro co-cultures of cre-expressing B-16V clones and primary
reporter spleen cells. Future experiments will focus on the in vivo
identification of recipient cell types of BAG6KO and wt EVs and how
these recipient cells, in turn, are modulated on the molecular level
thereby influencing tumour progression.
PT01.09
Kinetics of extracellular vesicle secretion in relation to hyaluronan
synthesis
Kai Härkönen1 and Kirsi Rilla2
1Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland;
2Faculty of Health Sciences, School of Medicine, Institute of Biomedicine,
University of Eastern Finland
Extracellular vesicles (EVs) have attracted extremely increased interest as
a research topic during the recent years. Because of a huge rush to reveal
the most fascinating features of these tiny membrane bubbles, many
critical steps at basic research may have been overshadowed. One of
those steps that have been neglected is the kinetics of vesicle secretion in
cell cultures. Factors like cell seeding density, growth rate and time
between seeding and vesicle isolation should be taken into account
while optimising vesicle isolation protocols.
We have recently shown that activity of hyaluronan synthesis induces
shedding of EVs. hyaluronan (HA) is the most abundant glycosami-
noglycan of the extracellular matrix, and one of the key components of
the niche that promotes renewal of cells and tissues in health and
disease. The observed connection between HA and EVs is revolution-
ary, but the more detailed mechanisms have not been elucidated so far.
Activity of HA synthesis is strictly controlled, and cell density and
contact inhibition are among the factors that regulate the HA secretion
rate.
The aim of this work was to correlate the kinetics of EV shedding with
HA synthesis activity in cell cultures. We utilised breast cancer cell lines
with naturally high (MDA-MB-231) and low (MCF-7) HA secretion
levels. To manipulate HA synthesis activity of these cells, inducible
overexpression of HA synthase 3 and a specific inhibitor for HA synth-
esis, 4-methylumbelliferone were used.
Extracellular vesicles were isolated from cell culture media with ultra-
centrifugation at different time points after seeding and their concentra-
tions were analysed with nanoparticle tracking analysis (NTA). Levels of
HA in the same samples were measured with specific enzyme-linked
sorbent assay (HA-ELSA) and correlated with the EV secretion levels
and cell counts in the cultures.
This study provides novel information about the kinetics of vesicle
secretion in cell cultures and its relation to the activity of HA synthesis.
The results suggest that continuous monitoring of the EV yield is
important when isolations are performed. The results also show that
cell density and growth phase have a strong impact on EV release,
suggesting that the kinetics of EV release is highly dynamic and strictly
regulated.
PT01.10
Fractionation of discrete extracellular vesicle sub-populations reveals
distinct RNA profiles and distinct mechanisms of sorting
Jeremy Henderson, Matthew Shurtleff and Randy Schekman
UC Berkeley, CA, USA
Cells release an array of extracellular vesicles (EVs) consisting of a lipid
bilayer and transmembrane proteins enclosing soluble cellular content,
including RNA and proteins, and encompassing a broad size range
(~30 nm to 1000 nm). By using differential velocity centrifugation
coupled with buoyant density flotation we were able to separate two
distinct EV sub-populations in MDA-MB-231 cells. The densities of the
two sub-populations were 1.07–1.10 g/ml and 1.13–1.15 g/ml for the
low-density (LD) and high-density (HD) sub-populations respectively.
Immunoblots for soluble and membrane EV markers in the linear
gradient, showed a differential distribution, having classical EV markers
such as CD63, Alix, Tsg101 present only in HD.
We next probed the RNA content of the distinct vesicle populations. The
amount of RNA was similar for LD and HD sub-populations, however
the RNA species varied among the sub-populations. Bioanalyzer traces,
later confirmed by sequencing experiments, showed that the LD RNA is
predominantly tRNA, whereas the HD is also enriched in small RNAs
such as miRNAs. At analysing selected miRNAs in deeper detail, we
showed that whereas HD miRNAs can display a great enrichment
compared to cell lysates (in several cases over 100 fold enrichment),
the LD miRNAs don’t show enrichment compared to cell lysates, and
most of them show the opposite pattern (depletion compare to cells).
These observations lead us to think that there is a selective sorting
mechanism responsible for packaging miRNAs in HD, but such
mechanism is absent in LD, being the LD miRNAs the result of random
sampling of cellular RNAs. In vitro packaging of miRNAs into exosomes,
developed in our laboratory previously, showed that the MDA-MB-231
specific enriched miRNAs are efficiently packaged in this reaction and
that their packaging is independent of YBX1, an RNA binding protein
found to be essential for packaging miRNAs in HEK 293T derived EVs.
This suggests that other mechanisms of sorting miRNAs into EVs play a
role in MDA-MB-231 cells, and ongoing experiments are trying to
depict them.
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PT02.01
A rigorous method for exosome isolation from tissue
Laura J. Vella1, Benjamin J. Scicluna2, Lesley Cheng2, Kevin J. Barnham1 and
Andrew F. Hill2
1The Florey Institute of Neuroscience and Mental Health, The University of
Melbourne, Parkville, Victoria, Australia; 2Department of Biochemistry and
Genetics, La Trobe Institute for Molecular Science, La Trobe University,
Victoria, 3084, Australia
Introduction: Understanding the role of exosomes in the brain is a
fundamental scientific objective with clinical relevance. Realisation of
this goal, however, has been hampered by an inability to isolate genuine
exosomes from the brain. Relative to the routine isolation from extra-
cellular fluids, many technical issues must be overcome to successfully
isolate exosomes from solid tissue. Exosomes share many physical and
molecular properties with other vesicles imposing important limitations.
Cell integrity needs to be maintained to minimise co-isolation of parti-
cles masking as exosomes and rigorous characterisation needs to be
undertaken to confirm enrichment of exosomes relative to exosome
mimetics. Here we have taken a critical approach to the enrichment
and characterisation of exosomes from human frontal cortex and mouse
tissue.
Methods: Vesicles were isolated from human (frontal cortex,
Alzheimer’s disease or neurological control) or mouse (whole) brain
tissues (n = 50 human/n = 30 mouse) and systematically assessed for
morphology, density, size distribution and proteomic and genomic con-
tent to validate the approach and fulfil the experimental requirements as
to be defined as exosomes.
Results: Immunoblot, electron microscopy, proteomics, size distribution,
RNA and density gradient analysis confirmed successful isolation of
endosome derived exosomes (enriched for syntenin, tsg101 and CD81)
from brain tissue. Upon comparing exosomes from Alzheimer’s disease
(AD) subjects versus aged matched controls we discovered a previously
unidentified pool of the disease associated proteins in vesicles isolated
from the frontal cortex of AD subjects.
Conclusion: Progression in understanding the role of extracellular vesi-
cles in the nervous system has been hindered by a lack of appropriate
methodology to isolate genuine exosomes, as defined by a minimal set of
experimental requirements, from tissue. Our innovative methods have
enabled us to isolate human brain exosomes and in doing so discover a
new pool of neurodegenerative disease associated protein.
PT02.02
Isolation of exosomes from large volumes of cell culture media by
ultrafiltration is superior to ultracentrifugation for the analysis of
exosomal RNA
Csilla Terezia Nagy1, Krisztina Pálóczi2, Ágnes Kittel3, Zsófia Onódi1, Edit I
Buzás2, Péter Ferdinandy1 and Zoltan Giricz1
1Department of Pharmacology, Semmelweis University, Budapest, Hungary;
2Department of Genetics, Cell- and Immunobiology, Semmelweis University,
Budapest, Hungary; 3Institute of Experimental Medicine, Hungarian
Academy of Sciences, Budapest, Hungary
Introduction: Here we analysed protein and nucleic acid content of samples
obtained from large volumes of cell culture supernatants by ultracentrifuga-
tion and different ultrafiltration methods to assess their applicability in
downstream protein and nucleic acid analyses.
Methods: 3T3 fibroblasts and H9c2 cardiomyocytes were cultured in
FBS-free DMEM-based medium for 24 h. Supernatants of 2.5 × 107
cells (200 mL) were centrifuged at 2500g, filtered on 0.8 µm PVDF
membranes, centrifuged at 13,500g for 40 min. Supernatants were then
either ultracentrifuged (UC) for 6 h at 100,000g or ultrafiltered on
regenerated cellulose membranes with 100 kDa (UF100) or 10 kDa
(UF10) cutoff rate. Filtrates from 100 kDa filters were ultrafiltered on
10 kDa cutoff rate filters (UF100 + 10). Protein content was measured by
BCA method, then relative quantity of exosomal markers was assessed
by western blot. Nucleic acids were studied by A260/280 method and
capillary gel electrophoresis before and after DNase treatment. Micro-
RNA content was measured by PCR.
Results: Total protein concentration of UC, UF100, UF10 and UF100 + 10
samples were comparable. However, TSG101, Alix and Syntenin content of
UC samples were higher than UF100 and UF10 samples. Exosomal protein
content of UF100 + 10 samples was negligible. These results demonstrate that
isolation of exosomes by 100 kDa filter is less efficient than UC and that
10 kDa filters retain more non-vesicular substances. UF100 samples con-
tained more nucleic acid than UC samples. Gel electrophoresis and DNase
treatment indicated that DNA contamination was the highest in UC samples,
and that RNA content of UF100 samples were the highest, however, DNA
contamination was significant in all samples. MicroRNA content of UF100
samples were the highest.
Conclusion: Although ultracentrifugation retains more exosomes than
ultrafiltration, the latter method results in exosomal RNA of higher
quantity and quality, therefore, more suitable for RNA analyses after
DNase treatment.
PT02.03
Isolation of serum exosomes by optimised size-exclusion
chromatography
Jik Han Jung and Ji Ho Park
KAIST, Daejeon, Republic of Korea
Introduction: Exosomes are natural nanoparticles ranging from 20 to
150 nm in size and having phospholipid bilayers. Recently, size-exclu-
sion chromatography (SEC) have been studied as one of isolation meth-
ods for improving purity of isolated exosomes. However, SEC isolation
of exosomes from phygiological sources such as serum still has been
challenging in the aspect of purity because serum contains lipoproteins
whose size is simillar to that of exosomes. Thus, we studied size dis-
tribution of exosomes and lipoproeins from cell supenatant and serum,
and optimised SEC to improve the purity of isolated exosomes.
Methods: Luekemia cells (THP-1) were cultured for cell supenatant and
human serum samples were kindly provided by “Korea University Anam
Hospital”. Column was packed with 10 ml of sepharose 2B and 6B resin
to prepare SEC with different pore size. Then 0.5 ml of sample was
loaded on the top of column, and each 0.5 ml eluate was collected. Each
fraction of eluates was analysed by bicinchoninic acid (BCA) assay,
dynamic lighting scattering (DLS), western blot, and transmission elec-
tron microscopy (TEM).
Results: In case of cell supenatant, exosomal marker CD63 was detected
in fractions 9–11 and lipoprotein marker ApoB was mainly detected in
fractions 10–13 with sepharose 2B column. Interestingly, In case of
serum, CD63 was detected in fractions 11–15 and ApoB was still
detected in fractions 9–13. To improve purity of isolated exosomes,
serum was seperated by sepharose 6B column. As a result, CD63 was
detected in fractions 12–14 and ApoB was detected in fractions 9–11.
Conclusion: In this work, we studied size distribution of exosomes and
lipoproteins from cell supenatant and serum. We found that size dis-
tribution of lipoproteins was not dependent on sample type, and size of
serum exosomes was smaller than that of exosomes from cell supenatant.
We demonstrated that sepharose 6B is more suitable than sepharose 2B
to isolate exosomes from serum.






























The importance of isolation technique when analysing adipocyte
markers in plasma-derived extracellular vesicles
Katherine D. Connolly1, Rebecca M. Wadey1, Aled Rees2 and Philip James1
1Cardiff Metropolitan University, Cardiff, United Kingdom; 2Cardiff
University, Cardiff, United Kingdom
Introduction: Despite the known release of extracellular vesicles (EVs)
from adipocytes, few reports exist detailing the presence of adipocyte-
derived EVs in the circulation. One reason for this may be the lack of a
distinct marker for adipocyte EVs, further complicated by the solubility
of adipocyte-specific proteins such as adiponectin, fatty acid binding
protein (FABP)-4 and peroxisome proliferator-activated receptor
(PPAR)-γ2. We aimed to compare the detectability of adipocyte markers
in plasma EVs isolated by differential ultracentrifugation and size exclu-
sion chromatography.
Methods: Citrated blood was double-spun to yield platelet-poor plasma
which was then either directly ultracentrifuged or loaded onto a size
exclusion column to isolate plasma-derived EVs. Thirty fractions were
collected from the column and analysed for protein content using
Nanodrop and particle count using nanoparticle tracking analysis.
Lysates of ultracentrifuged plasma EVs and pooled column fractions
were compared by Western Blot for a series of hallmark adipocyte
markers.
Results: Particle concentration, protein content and Western Blot ana-
lysis for markers indicative of an EV population, such CD9, identified
fractions 5–10 as “EV rich”. These fractions were pooled and ultracen-
trifuged in subsequent experiments. Adiponectin, FABP-4 and PPARγ2
were detected in both ultracentrifuged and column-derived EVs, how-
ever the signal was greatly reduced in column-derived EV fractions.
Conclusion: The soluble nature of many adipocyte-specific proteins
poses difficulties when analysing a mixed population of EVs for adipo-
cyte markers. Our results indicate that isolation of plasma-derived EVs
by differential ultracentrifugation alone may result in contamination of
the EV population with soluble adipocyte markers. Use of size exclusion
chromatography columns followed by ultracentrifugation appears to
separate EVs from the majority of soluble protein, thus reducing poten-
tial overestimations in adipocyte markers within plasma EVs isolates.
Our data suggest that care must be taken when analysing plasma-derived
EV fractions for adipocyte markers and the effects of the pre-isolation
technique must be considered.
PT02.05
Filtration based method to deplete bovine extracellular vesicles from
foetal bovine serum
Roman Kornilov1, Maija Puhka2, Hanna Hiidenmaa1, Hilkka Peltoniemi3,
Bettina Mannerström1, Riitta Seppänen-Kaijansinkko1 and Sippy Kaur1
1Department of Oral and Maxillofacial Diseases, University of Helsinki and
Helsinki University Hospital, Finland; 2Institute for Molecular Medicine
Finland FIMM, University of Helsinki, Finland; 3Laser Tilkka Ltd, Helsinki,
Finland
Introduction: Foetal bovine serum (FBS) is the most common supple-
ment used in cell culture experiments. Based on the recent evidence, FBS
contain a large amount of extracellular vesicles (EVs) which hamper
downstream analyses of secreted EVs. Therefore, it is important to
eliminate EVs from FBS prior to cell culturing. Our primary aim in
this study was to develop the cost-effective protocol to deplete the
bovine EVs from FBS, and to analyse the effects of our EV depleted
FBS on cell proliferation and metabolism.
Methods: EVs were measured from our EV-depleted FBS (ultra-15
centrifugal filters) and compared with commercially available (Shop)
EV-depleted FBS and 19 hours ultracentrifuged (UC) EV-depleted FBS
by nano tracking analysis, electron microscopy and Western blotting.
The response of all three EV-depleted FBSs on cell proliferation and
metabolism were measured on 3 different donors of mesenchymal stem
cells.
Results: Efficiency of our FBS-EV elimination method was improved as
compared with Shop EV-depleted FBS, and clearly better than 19 hours
UC-FBS. Mesenchymal stem cells were grown in culture media using
Shop-FBS, 19 hours UC-FBS and our EV-depleted FBS. Based on cell
proliferation and metabolism analysis, all three EV-depleted FBSs main-
tained cell growth and metabolism up to 96 hours.
Conclusion: Our results indicate that our protocol shows efficient deple-
tion of EVs, is cost effective, easy to use and maintains the cell growth
and metabolism of mesenchymal stem cells in vitro.
Roman Kornilov and Sippy Kaur are having equal contribution.
PT02.06
Increasing the isolation yield of EVs from oral cancer cells in culture
Eduarda M. Guerreiro1, Anne-Marie Trøseid2, Reidun Øvstebø2, Tine M.
Søland1 and Hilde Galtung1
1Department of Oral Biology, Faculty of Dentistry, University of Oslo,
Norway; 2The Blood Cell Research Group, Department of Medical
Biochemistry, Oslo University Hospital, Ullevål, Norway
Introduction: To get a high yield of extracellular vesicles (EVs) from cell
culture experimental set-ups, classic cell culture methods require a high
number of flasks, which is a practical and economic burden. A promis-
ing approach was found in the work by Mitchell and colleagues (1) using
the Integra CELLine culture system (Integra Biosciences AG, CH). The
use of this semi-continuous, three-dimensional culture system allows a
high cell density, that yielded an increase in isolated EVs. Therefore, the
aim of this study was to test and determine if the Integra CELLine
system is a better alternative to increase the yield of EVs from an oral
squamous cell carcinoma (OSCC) cell line compared to traditional
flasks.
Methods: PE/CA-PJ49 (OSCC) cells were cultured in Advanced DMEM
(Gibco) with L-glutamine, PSA, and exosome-depleted FBS (1% V/V,
Thermo Fisher Scientific) in T-175 flasks for 96 h and in the Integra
CELLine system for 8 days. Conditioned culture media were collected
and concentrated by ultrafiltration (Amicon Ultra centrifugal filters,
Ultracel 50 K – 50 kDa cut-off) and loaded into size exclusion chroma-
tography columns (Sepharose CL-2B, GE Healthcare). Particle number
in the different fractions was determined by nanoparticle tracking ana-
lysis (NTA) using Nanosight NS500, followed by western blot using anti-
CD9 antibody.
Results: There was a sixfold increase in the total amount of vesicles in
the Integra CELLine system cell culture supernatant when compared
with the T-175 supernatant, as shown by preliminary results from NTA.
We also documented, by western blot, increased CD9-levels in the
samples from the Integra CELLine supernatant in comparison to that
of the T-175 flasks.
Conclusion: Our results support that the use of the Integra CELLine
system is a promising approach to increase the yield of EVs from oral
cancer cells in culture. More details on the recovered EVs are to be
elucidated by magnetic bead-bound CD9 positive EVs by flow cytome-
try, electron microscopy and western blot analysis of other markers.
References
1. Mitchell JP et al., J Immunol Methods. 2008; 335: 98–105.
PT02.07
Exosome isolation with carbonate treatment from cell culture
supernatant and human serum
Lifang Yang, Vanessa L. Correll, Jamie L. Eisner, Cristinia M. Risi, Vitold E.
Galkin and Oliver J. Semmes
Eastern Virginia Medical School, VA, USA
Introduction: Exosomes are small vesicles which have been implicated as
potential vehicles of targeted drug delivery and important reservoirs of novel
disease biomarkers. The current “gold-standard” for exosome purification is





























ultracentrifugation (UC)-based method, which typically involves an addi-
tional clean-up step by applying PBS wash between two UCs. However, this
method is known to suffer from non-vesicular macromolecule contamina-
tion. To this end, we integrated alkaline carbonate treatment (pH = 11.0) into
UC-based protocol and optimised it for exosome isolation. We tested the
utility for the efficiency, yield, purity and function of isolated exosomes both
from cell culture supernatants and complex biological body fluids such as
serum.
Methods: Exosomes were isolated from the conditioned media from
prostate cancer DU145 cells and human normal serum using new pro-
tocol (UC-Alk) and compared with those using traditional UC-based
protocol (UC-PBS). The concentration and size distribution of vesicles
were analysed by nanoparticle tracking analysis (NTA). The morphology
was visualised by transmission electron microscopy (TEM). The floating
density was measured in a linear sucrose density gradient. The specificity
was evaluated by western blot and flow cytometry. The function was
assessed by uptake of labelled DU145-derived exosomes by prostate
stromal WPMY-1 cells.
Results: Both isolations from DU145 supernatants contained 50–150 nm
vesicles, were positive for canonical exosome markers (Alix, TSG101,
syntenin-1, CD9, CD63) and absent for intracellular organelles.
However, UC-Alk outperforms UC-PBS in terms of purity as illustrated
by the cleaner nanovesicles on TEM, the higher enrichment in exosomal
membrane proteins, and the narrower buoyant density (1.11–1.16 g/ml).
When the new method was applied for human serum, UC-Alk demon-
strated significantly lower background and enhanced exosome signal
devoid of highly abundant serum proteins. In the context of cellular
uptake, the exosomes isolated by UC-Alk were internalised by target
cells indicating that they were not damaged by alkaline wash and indeed
biologically active.
Conclusion: Our optimised exosome isolation strategy is a valuable tool
to investigate exosome-specific functions and clinical applications.
PT02.08
Purification method affects biological functionality of stem cell-
derived EVs
Sander A.A. Kooijmans1, Sara Previdi2, Daniel Moya Rull3, Sharad Kholia1,
Pieter Vader2, Raymond M. Schiffelers4 and Giovanni Camussi5
1Bioindustry Park Silvano Fumero SpA; 2University Medical Centre Utrecht,
Utrecht, The Netherlands; 3Laboratori Experimental de Nefrologia i
Trasplantament (LENIT); 4Department of Clinical Chemistry and
Haematology, University Medical Centre Utrecht, Utrecht, The Netherlands;
5University of Turin, Department of Medical Science, Torino, Italy
Introduction: Extracellular vesicles (EVs) from a variety of stem cells are
believed to harness regenerative capacity, which may be exploited for
therapeutic purposes. For example, EVs from human liver stem cells
(HLSCs) and mesenchymal stem cells (MSCs) have been shown to
stimulate regeneration of damaged kidney tissue. However, EV activity
may depend on the employed purification method, which limits cross-
study comparisons. Here, we investigated the effect of the purification
method on in vitro regenerative effects of HLSC- and MSC-derived EVs.
Methods: Human proximal tubule cells (HK2) were exposed to HLSC-
and MSC-derived EVs, which were purified using a standard ultracen-
trifugation (UC), ultracentrifugation + wash (UCW) or size-exclusion
chromatography (SEC) protocol. EVs were quantified and characterised
by NTA, protein assays and bead-based flow cytometry. HK2 prolifera-
tion was determined using BrdU proliferation assays.
Results: EV particle yield was generally similar among purification
methods, although EV purity (defined as particle/protein ratio) was
different, and decreased in the order SEC > UCW > UC. EV purity
markedly correlated with their ability to stimulate proliferation of HK2
cells. Importantly, “non-EV” fractions from SEC purifications also
showed biological activity in this readout assay.
Conclusion: Our data show that purification methods (and resulting EV
purity) greatly influence regenerative effects of stem cell-derived EVs in in
vitro readout assays. This may lead to data misinterpretation and thereby
hamper therapeutic development. Hence, the presence and quantity of EV
contaminants should be considered when assessing biological activities
of EVs.
PT02.09
Influence of commercially available, exosomal isolation kits on
holistic small RNA expression profiles of serum in healthy and
critically ill individuals
Benedikt Kirchner1, Dominik Buschmann1, Stefan Kotschote2, Michael
Bonin2, Marlene Reithmair3, Gustav Schelling4 and Michael Pfaffl1
1Division of Animal Physiology and Immunology, TUM School of Life
Sciences Weihenstephan, Technical University Munich, Germany; 2IMGM
Laboratories GmbH; 3Institute of Human Genetics, University Hospital, of
Ludwig-Maximilians-University Munich, Germany; 4Department of
Anaesthesiology, University Hospital, Ludwig-Maximilians-University,
Munich, Germany
Introduction: Due to the unique role that extracellular vesicles (EVs) and
their cargo play in cell-to-cell communications of a multitude of physio- and
pathophysiological conditions, exosomes have become an important object
of research especially in biomarker development. A number of kits have
emerged on themarket, taking advantage of various biochemical and physical
properties to isolate exosomes from biofluids or cell-culture supernatant.
Unfortunately a thorough comparison of the different isolation strategies
(e.g. membrane affinity, precipitation, size exclusion chromatography), espe-
cially in the context of clinically relevant settings or samples like liquid
biopsies, is still missing.
Methods: EVs were isolated from 1 ml serum of healthy individuals and
critically ill patients (n = 10 each) using four different commercially available
isolation kit alongside differential ultra-centrifugation (n = 8). Total RNA
yield and integrity were evaluated using capillary gel electrophoresis and
holistic small RNA expression profiles were generated by NGS. EV isolation
kit-specific influences were assessed by comparing library size, sequence
length distribution, unsupervised clustering and differential expression ana-
lysis between sample matrices as well as isolation strategies.
Results: Total RNA yield differed greatly (p = 0.002) between isolation
strategies with precipitation (4505 ± 3329 pg/µl) greatly outperforming
size-exclusion chromatography (157 ± 197 pg/µl). Sampling from criti-
cally ill patients reduced RNA yield for all methods by a factor of 1.5–3.8
(p = 0.002). Even more striking differences were revealed by small RNA
NGS. Although all isolation strategies were able to distinguish between
samples from healthy and critically ill individuals to a certain degree,
mapped miRNA expression profiles varied significantly.
Conclusion: A major impact on small RNA expression profiles could be
shown for all EV isolation kits and strategies, respectively. Our findings
highlight the importance of further optimisation and standardisation of
exosomal isolation methods in differing sample matrices and special
attention needs to be paid to obtain reproducible and comparable
biomarker signatures from liquid biopsies.
PT02.10
Assessing cell culture parameters for enhanced bioactive extracellular
vesicle production
Divya Patel1, Kelsey Gray2, Yasasvhinie Santharam2, Kim Stroka2 and Steven
M. Jay1
1University of Maryland, College Park, MD, USA; 2University of Maryland,
MD, USA
Introduction: Although extracellular vesicles (EVs) derived from bone
marrow derived mesenchymal stem cells (MSCs) and other cell types are
implicated in promoting vascularisation, their clinical translation is
limited by the lack of a large-scale biomanufacturing approach.
Increased understanding of how cell culture parameters such as cell
passage and cell seeding density influence EV biogenesis and bioactivity
has the potential to enhance therapeutic EV production. Here, we
investigate the impact of these parameters on MSC-derived EV produc-
tion and vascularisation bioactivity.
Methods: Conditioned media was collected after 24 h from MSCs seeded
at different densities (1E2, 5E2, 1E3, 1E4 cells/cm2) or passages (P2-P5).
EVs were isolated from the conditioned media via differential centrifu-
gation and quantified by nanoparticle tracking analysis (NTA) using a





























Nanosight LM10 and CD63 ExoELISA. Vascularisation bioactivity of
isolated EVs was assessed in a wound healing assay.
Results: NTA and ExoELISA results indicated increased EV production
rates per cell when MSCs were seeded at lower initial densities, regard-
less of the cell passage. The average fold decrease in EVs production per
cell between cells seeded at 1E2 cells/cm2 and 1E4 cells/cm2 for P2, P3,
P4, and P5 was 100, 85, 110, and 50, respectively (n = 5, p < 0.01).
Additionally, multiple EV collection time points (12 and 24 h) from the
same cells increased total EV production more than 3 fold compared to a
single collection over the same time period (24 h) (n = 3, p < 0.05).
Seeding density had no affect on the vascularisation bioactivity of MSC
EVs produced as assessed by the wound-healing assay (n = 3). In
contrast, increasing cell passage was correlated with diminished EV
bioactivity (n = 3).
Conclusion: These results suggest that high EV production rates can be
achieved by seeding cells at lower initial seeding densities. Low cell passage
number is critical to retaining MSC EV vascularisation bioactivity. The
implications of these findings are that higher amounts of bioactive EVs can
be achieved using a lower number of producer cells with increased frequency
of collection. This may allow for significant reduction in cost of EV produc-
tion and begin to inform the rational design of a large-scale biomanufacturing
approach for therapeutic EV production.
PT02.11
Evaluation and optimisation of a hollow fibre bioreactor system for
standardisation of large scale production of extracellular vesicles
Ulrika Felldin1, Giulia Corso1, Bernd Giebel1,2, Helmut Hanenberg3, Joel Z.
Nordin1, Samir El-Andaloussi1,4 and André Görgens1,2
1Department of Laboratory Medicine, Karolinska Instiutet, Stockholm,
Sweden; 2Institute for Transfusion Medicine, University Hospital Essen,
University of Duisburg-Essen, Essen, Germany; 3Department of Pediatrics
III, University Children’s Hospital Essen, University of Duisburg-Essen,
Essen, Germany; 4Department of Physiology, Anatomy and Genetics,
University of Oxford, United Kingdom
Almost all types of cells release extracellular vesicles (EVs) which are
involved in a plethora of both physiological and pathological processes.
EVs have inecent years been connected to various therapeutic
approaches including anti-tumour therapy, vaccination, modulation of
the immune system and drug-delivery. Translating exosome-based
therapies to the clinic, however, requires a large-scale production of
exosomes, and a subsequent comprehensive evaluation, optimisation
and standardisation of all parameters during production. Bioreactors
are regularly used to grow cells in 3D-matrices at high densities, which
may be more similar to native in vivo conditions than classical 2D
cultures.
Aiming to scale-up EV production, we are setting up and evaluating a
commercially available hollow fibre bioreactor system with 20 kDa
molecular weight cut off pores. So far, we started to culture different
cell types, including a stable HEK293T-CD63eGFP cell line that secretes
eGFP-positive EVs. Cell proliferation kinetics within bioreactors are
monitored by glucose uptake, and the production of EVs both under
serum-supplemented and defined serum-free conditions is currently
evaluated. The concentration and size distribution are measured by
nanoparticle tracking analysis (NTA) and surface marker expression
profiles and uptake kinetics in recipient cells of harvested EVs are
analysed via flow cytometry. All parameters are compared to classical
2D culture. Also, different schedules for EV harvesting are compared in
order to optimise and standardise the production. Preliminary results
and experiences using hollow fibre bioreactors for the large-scale pro-
duction of EVs from different cell types will be presented here.
PT02.12
Purifying and molecular profiling extracellular vesicles (EVs) from
various biological specimens
Abiodun Ogunjimi1 and Liang Zhang2
1Lunenfeld-Tanenbaum Research Institute; 2City University of Hong Kong,
China
Introduction: It is known that all cell types release extracellular vesicles
(EVs), which are membrane vesicles with sizes in the nanometre to
micrometre range. EVs carry a broad spectrum of bioactive molecules
including proteins, lipids, RNA, DNA, etc, which may specifically reflect
not only the identity, but also the physiological and pathological status
of the source cells. Therefore intense research efforts are undergoing to
characterise the molecular profiles and mechanisms of EVs-mediated
cellular communications in healthy and disease conditions. Such efforts
have the potential to identify EVs-based biomarkers and/or therapeutic
targets for various diseases. Advances in isolating and profiling technol-
ogies have greatly improved our knowledge of EVs in various biological
specimens. However, biological specimens including serum, urine, spinal
fluid, semen, etc. display huge variations in available volumes, as well as
their biophysical and biochemical properties, such as viscosity and
protein concentration. Currently, a major limitation in the field of EVs
study is the lack of standardisation for isolating and profiling of EVs
from different specimens.
Methods: We compared major isolation methods in the field for their
efficiency in purifying EVs from cell-culture conditional media, serum
and urine. The isolated EVs are subjected to proteomic and RNA
analysis to evaluate the effects of different isolating strategies on the
results of molecular profiling.
Results: Depending on the nature of biological specimens and available
volumes, different isolating methods display large variations in the
efficiency of EVs purification. Interestingly, molecular profiling of the
EVs from the same biological specimen also vary significantly among
different isolating methods.
Conclusion: Our studies indicate that it is preferable to use distinct
isolating method for different biological specimens and that optimised
workflow is key to obtaining reliable molecular profiling of EVs.
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PT03.01
Protective role of extracellular vesicles in diabetic microangiopathy
Chiara Gai, Tatiana Lopatina, Yonathan Gomez, Maria Felice Brizzi and
Giovanni Camussi
Department of Medical Sciences, University of Turin, Torino, Italy
Please see OPT02.01
PT03.02
Significant improvement of survival of rats with acute liver failure by
high concentration exosome of human adipose-derived stem cells
Yinpeng Jin, Hongchao Li, Junyi Wang, Lingyu Meng, Li Li, Xiaojin Wang,
Chengwei Chen and Qingchun Fu
Shanghai Liver Disease Research Centre,The 85th Hospital of PLA
Please see OPT02.02
PT03.03
Exosomes derived from GATA-4 overexpressing mesenchymal stem
cells rejuvenate cardiomyocytes through transfer miRNAs to regulate
the related signalling pathway
Bin Yu1, Min Gong1, Yigang Wang1, Muhammad Ashraf2 and Meifeng Xu1
1University of Cincinnati, OH, USA; 2University of Illnois in Chicago,
IL, USA
Our previous studies indicate that mesenchymal stem cells (MSC) which
overexpress GATA-4 (MSCGATA-4) are capable of reducing infarction size of
ischemic myocardium and promoting cardiac function recovery. Here, we
investigated whether exosomes (EXO) released from MSCGATA-4 rejuvenate
cardiomyocytes (CMs) as evidenced by reducing CM apoptosis and senes-
cence, enhancing proliferative capacity of CM through transferring miRs and
regulating related signalling pathways.
EXO were isolated from rat bone marrow MSC transduced with GATA-
4 or with its vector-empty control. Mature CMs were harvested from
adult Sprague-Dawley rat ventricles. EXO significantly increased CM
survival, reduced cell damage caused by exposure to hypoxia for 48 h
in a concentration-dependent manner and the action was enhanced in
EXO obtained from MSCGATA-4 (ExoGATA-4). CMs were cultured in
serum free medium containing either EXO or 1% BSA for 3 weeks.
ExoGATA-4 significantly reduced the number of senescence-associated β-
galactosidase positive CMs and restored their beating frequency. The
dedifferentiation and proliferation of mature CMs was recorded by a
real-time imaging system. The cell number was significantly greater in
CMs cultured in the serum-free medium contained EXO than those
treated with BSA. The percentages of Ki67+ CMs and EdU+ CMs were
significantly higher in the group treated with ExoGATA-4 compared to
that of the groups treated with BSA and EXO obtained from control
MSC (Exonull). Furthermore, the data of MicroRNA-seq showed that 358
miRs were found in EXO and 44 miRs were significantly increased in
ExoGATA-4 compared to Exonull, including let-7 family members.
Addition of EXO pre-labelled with PKH26 into CM cultures showed
that EXO were quickly internalised by CMs and the expression of let-7
miRs in CMs was significantly upregulated. PTEN, one target of let-7
and several enriched miRs in ExoGATA-4, was significantly down-regu-
lated in CMs treated with ExoGATA-4. In contrary, loss-function experi-
ments showed that down-regulation of let-7 in ExoGATA-4 significantly
abrogated the therapeutic effect of ExoGATA-4.
All these data suggested that ExoGATA-4 rejuvenated CM and promoted
mature CM cell-cycle re-entry and proliferation through delivering miRs
and regulating signalling pathways.
PT03.04
Evaluation of the contribution of extracellular vesicles secreted by
multipotent mesenchymal stromal cells in MSC-mediated
regenerative effects
Georgy Sagaradze1, Anastasia Efimenko2, Liudmila Ageeva1, Natalia
Kalinina1, Natalia Basalova3, Pyotr Nimiritskiy1, Anna Vnukova4, Evgeniy
Evtushenko5, Olga Makarevich1 and Vsevolod Tkachuk1,2
1Department of Biochemistry and Molecular Medicine, Lomonosov Moscow
State University, Moscow, Russia; 2Institute of Regenerative Medicine,
Lomonosov Moscow State University, Moscow, Russia; 3Department of
Cytology and Histology, Lomonosov Moscow State University, Moscow,
Russia; 4I.M. Sechenov’s First Moscow State Medical University, Moscow,
Russia; 5Department of Chemical Enzymology, Lomonosov Moscow State
University, Moscow, Russia
Introduction: Adipose-derived mesenchymal stem/stromal cells (MSC)
represent a promising source of stem and progenitor cells for regenerative
medicine. MSC were shown to support regeneration and reparation in
various experimental conditions and clinical trials.MSC functionby secreting
growth factors, cytokines, extracellularmatrix proteins, as well as extracellular
vesicles (EV). Thus, conditioned medium (CM) containing cell-secreted
components stimulate regenerative processes comparable with MSC them-
selves in many clinical models. By present data, EV are considered to be the
most potent components in MSC secretome. EV carry a set of proteins,
bioactive lipids, nucleic acids, protected by a lipid bilayer, and demonstrate
persistent regenerative effects, when absorbed by target cells. However, many
investigators show, that CM components, other than EV, also participate in
MSC function. Thus, to clear themechanisms ofMSC regenerative effects it is
important to estimate contribution of EV in these processes.
Methods: We separated EV and soluble components of MSC CM using
the ultracentrifugation. To visualise EV and to identify major EV mar-
kers we performed transmission electron microscopy and western blot-
ting, respectively. We estimated effects of EV in angiogenesis,
neuritogenesis, and wound healing models in vitro.
Results: We found that impact of EV in the stimulation of endothelial
cell capillary-like structure formation and neuroblastoma cell line neur-
itogenesis was substantial. In contrast, EV less stimulated functions of
dermal fibroblasts in wound healing models. We also enriched EV
fraction with distinct EV subtypes using chemical inhibitors to analyse
the impact of these subtypes in MSC effects.
Conclusion: Identity of the most potent components secreted by MSC,
particularly EV subtypes, and selection of distinct conditioned medium frac-
tions affecting different cell types will allow to produce more efficient ther-
apeutic formulations for stimulation of regeneration and reparation in the
future.
PT03.05
Neural stem cell-derived exosomes protect the enteric nervous
system and promote intestinal motility after necrotising enterocolitis
Yu Zhou1, Chris McCulloh2, Jacob Olson2 and Gail Besner2
1Department of Pediatric Surgery, Nationwide Children’s Hospital;
2Nationwide Childen’s Hospital
Introduction: Necrotising enterocolitis (NEC) is the most common cause of
gastrointestinal-related mortality in premature babies. We have shown that
neural stem cell (NSC) transplantation protects the enteric nervous system
(ENS) during experimental NEC, but it is unclear whether SC engraftment or
SC-secreted products mediate these effects. SC-secreted exosomes are cell-





























derived nanosized microvesicles that are involved in mediating intercellular
communication. The aim of this study was to test the effects of SC-derived
exosomes in animals subjected to experimental NEC.
Methods: Enteric NSC were isolated from neonatal rat intestine,
neurosphere-like bodies cultured, and NSC-secreted exosomes iso-
lated from the condition medium. Exosomes were labelled with
PKH26 red dye and delivered to intestinal neurons subjected to
anoxia/reoxgenation (A/R) injury. Neuronal apoptosis was deter-
mined by caspase 3 immunohistochemistry and flow cytometry
using Annexin V. In vivo, fluorescently labelled exosomes were admi-
nistered intraperitoneally (IP) to rat pups exposed to experimental
NEC. Intestinal exosome distribution was examined using a Xenon
imaging system. Intestinal injury was graded histologically and the
incidence of NEC determined. Intestinal motility was examined in
intestinal segments mounted in an organ bath using electrical field
stimulated (EFS) electromyography.
Results: NSC-derived exosomes specifically targeted injured neurons in
vitro, and significantly decreased A/R-induced neuronal apoptosis
(36.7% ± 3.2% vs. 6.49% ± 2.4% ratio of apoptotic neurons/total neu-
rons, p < 0.05). In vivo, exosomes administered IP homed to injured
intestinal myenteric neurons in pups exposed to NEC, leading to
decreased intestinal histologic injury and significantly decreased mortal-
ity (71% vs. 40%, p < 0.05). NEC-induced impairment in EFS isometric
contractility was restored by NSC-derived exosome administration.
Conclusion: NSC-derived exosomes protect intestinal neurons from
injury in vitro, and protect the intestines from NEC in vivo, suggest-
ing that they mediate the therapeutic efficacy of NSC. NSC-derived
exosomes may represent a novel non-cell based therapy for improv-
ing the recovery of neuromuscular function and protecting the ENS
from NEC.
PT03.06
Exosomes derived from human mesenchymal stem cell accelerate
wound healing in a mouse model of radiation-induced injury
Alexandre Ribault1, Stephane Flamant1 and Radia Tamarat2
1IRSN/PRP-HOM/SRBE/LR2I; 2IRSN/PRP-HOM/SRBE
Introduction: Mesenchymal stem cells (MSCs) are multipotent cells
which have been reported to promote the regeneration of skeletal muscle
and skin wound healing in pre-clinical animal studies. MSCs derived
exosomes, containing diverse proteins, mRNAs and micro-RNAs, med-
iating various biological functions, might be a main paracrine mechan-
ism for stem cell to mediate their therapeutic effect. Recent studies have
shown that exosomes derived from MSCs have regenerative functions in
several tissues, including skin, skeletal muscle, kidney and heart. We
hypothesised that exosomes could participate to the wound closure of
radiological burns in mice.
Methods: Mice were irradiated with X-ray at 80 Gy. 14 d after irradiation,
PBS or Adipose derived MSCs (106 per animal) or exosomes (400 µg or
800 µg) were injected all around the injury. Exosomes were obtained from
culture of human embryonnic stem cells-derived c-myc-immortalised
MSCs. Every 7 d after irradiation mice were scored according to the the
limb retraction, the wound extent, inflammation and humidity. 28 d after
irradiation mice were euthanised and the skin and muscle of the irradiated
limb were recolted for further analyses.
Results: From 7 d after injections we observed that animals injected with
800 µg of exosomes tended to have a similar wound compared to the day
of injection while animals injected with PBS, MSCs and 400 µg of
exosomes showed a bigger one. 14 d after injections, the trend was
confirmed and animals injected with 800 µg had the smaller scoring
(81[±9]) compared to the other groups (88[±8], 90[±10] and 93[±9] for
PBS, MSC and 400 µg of exosomes groups respectively).
Conclusion: Our preliminary data seem to show that MSCs-derived
exosomes had a beneficial effect on the wound closure of radiation
induced-injuries in a dose effect manner. 400 µg of exosomes are not
sufficient to promote an efficient wound healing while 800 µg are.
Further analyses are necessary to determine what parameters are influ-
enced by exosomes.
PT03.07
Human amnion epithelial cells release vesicles that rescue bleomycin
induced lung injury in mice
Jean Tan1, Sinnee Lau1, Euan Wallace2, Lois Salamonsen1, Hong Nguyen3,
Dandan Zhu4, Carla Kim5 and Rebecca Lim1
1Hudson Institute of Medical Research, Clayton, Australia; 2Monash
University, Clayton, Australia; 3Melbourne University, Melbourne,
Australia; 4Postdoc; 5Harvard University, MA, USA
Introduction: The human amnion epithelial cells (hAECs) release extra-
cellular vesicles (EVs) that appear to reflect the pro-reparative properties
of the hAECs themselves. A proteomics screen confirmed that hAEC-
EVs package immunomodulatory molecules such as HLA-G, and ligands
associated with stem cell niche maintenance, such as Wnt5A. RNA-Seq
analysis revealed that eight miRNAs with associated anti-fibrotic effects
were amongst the most abundant transcripts.
Aim: Given that lung fibrosis is though to be perpetuated by stem cell
attrition, we sought to evaluate the potential of hAEC-EVs to reverse
lung fibrosis in aged mice.
Methods: Eleven-to-twelve month old female C57Bl6 mice (n = 6 per group)
were challenged with bleomycin (0.15 U/kg) and fibrosis allowed to develop.
On the 14th day post challenge, either 10 mg EVs resuspended in saline, or
vehicle alone, was instilled intranasally. Mice were culled 28 days post
challenge. Tissues were collected for histological analysis and endogenous
lung stem cells (bronchioalveolar stem cells, CD31-, CD45-, EpCAM+,
Sca1hi) were flow sorted for gene expression analysis using the Fluidigm
Biomark HD.
Results: The hAEC-EVs were well-tolerated, with no morbidity or mor-
tality associated with the intervention. Indeed, the hAEC-EVs reversed
fibrosis to levels comparable to healthy controls and this was associated
with a 50% reduction in myofibroblast activation.
Conclusion: hAEC-EVs exert potent anti-fibrotic effects when delivered
intranasally to aged mice challenged with bleomycin. This appears to be
associated with their ability to either activate endogenous stem cells within
the lung or protect the stem cell niche during the injurious process.
PT03.08
Biological properties and regenerative potential of murine bone
marrow mesenchymal stem cell-derived extracellular vesicles in heart
repair
Anna Labedz-Maslowska1, Guangming Cheng2, Malgorzata Sekula3, Yu-Ting
Xuan2, Elzbieta Karnas3, Sylwia Kedracka-Krok3, Robert Vincent2, Michal
Sarna3, Zbigniew Madeja4, Buddhadeb Dawn2 and Ewa K. Zuba-Surma1
1Department of Cell Biology, Jagiellonian University, Krakow, Poland;
2Cardiovascular Research Institute, University of Kansas Medical Center,
Kansas City, KS, USA; 3Malopolska Centre of Biotechnology, Jagiellonian
University, Krakow, Poland; 4Jagiellonian University, Krakow, Poland
Extracellular vesicles (EVs) represent membrane-enclosed vesicles released
by normal and activated cells including stem cells (SC) playing a role in cell-
to-cell communication. Although, growing evidence indicates that
mesenchymal SC (MSC)- derived EVs may play a pivotal role in several
organ repair, their role in heart regeneration has not been well studied.
Thus, the aim of this study was to examine the bioactive content and
regenerative capacity of murine bone marrow MSC- derived EVs in
murine model of acute myocardial infarction (AMI) in vivo.
MSC-EVs were isolated from conditioned media via sequential centri-
fugation including ultracentrifugation at 100,000g. The morphological
analysis of the 100 K EV fraction (including ectosomes and exosoms) by
Izon system, revealed the presence of vesicles in average size about
200 nm. The vesicular morphology was confirmed by atomic force
microscopy, while the protein markers were assessed accordingly to
ISEV recommendations by western blotting. High-sensitivity flow cyto-
metry (Apogee Flow system) confirmed the presence of several MSC-
specific markers on MSC-EVs including receptors and adhesions. We
also found MSC-EVs to be enriched in mRNAs, miRNAs and several





























proteins from donor MSC cells as shown by real-time RT-PCR and mass
spectroscopy, respectively. We found MSC-MVs to carry several tran-
scripts regulating SC cardiac and angiogenic differentiation capacity.
Importantly, our data (i) indicated a great impact of MSC-EVs on
proangiogenic capacity of heart endothelial cells in vitro as well as (ii)
confirmed their regenerative potential in vivo by showing improved
heart histology, anatomy and function in murine AMI model. The
increase in number of new capillaries in the place of EV injection, may
suggest the increased perfusion as one of the major mechanisms
involved in the MSC-EV regeneration capacity in vivo.
In summary, our data demonstrated that MSC-derived EVs represent
natural nanocarriers transferring bioactive content to mature target cells
and playing an effective role in heart regeneration in vivo.
We conclude that MSC-EVs may represent novel safe therapeutic tool in
heart tissue regeneration, alternative or supporting to whole cell-based
therapy in heart repair.
PT03.09
Biodistribution and efficacy of extracellular vesicles from
cardiosphere-derived cells
Jennifer L. Johnson1, Ahmed Ibrahim1, Chris Sakoda1, Kenny Gouin2, Kiel
Peck1, Liang Li1, Travis Antes3, Houman Hemmati1, Rachel Smith1, Linda
Marban1 and Luis Rodriguez-Borlado1
1Capricor Therapeutics; 2Cedars Sinai, CA, USA; 3Cedars-Sinai Medical
Centre, Heart Institute, CA, USA
Introduction: Extracellular vesicles produced by cardiosphere-derived
cells (CDC-EVs) have been shown to recapitulate the therapeutic activity
of parent cells in heart-related diseases. The ability of CDC-EVs to
reduce inflammation, attenuate fibrosis, and activate regeneration
make them very attractive for inflammatory diseases treatment.
Capricor is evaluating the use of CDC-EVs for the treatment of ocular
graft versus host disease (oGVHD), an indication where the product can
be locally delivered. No previous studies have been published analysing
EVs biodistribution after eye delivery. Here, we show in vivo biodistri-
bution of CDC-EVs in an ocular alkali burn mouse model after sub-
conjunctival or topical delivery, using a novel qPCR-based method. We
also analysed the therapeutic potential of CDC-EVs in mouse and rabbit
models. Finally, CDC-EVs uptake by different cellular types was ana-
lysed in vitro to identify CDC-EVs target cells.
Methods: Unmodified human CDC-EVs were injected into the subcon-
junctival space or administered topically to healthy or injured mouse
eyes. In vitro uptake of dye-labelled EVs was measured by detecting
intracellular fluorescence in treated cells by flow cytometry. In vivo
biodistribution tracking was then performed using a sensitive qPCR
method tracking a YRNA fragment abundant in CDC-EVs.
Therapeutic activity of CDC-EVs was evaluated in a rat model of corneal
alkali burn injury and a rabbit model of Sjӧgren’s syndrome.
Results: Biodistribution studies showed a higher presence of EV-CDCs
in the eyes after subconjunctival injection when compared to topical
delivery. Retention of CDC-EVs in the eye was stronger in the presence
of ocular damage. Biodistribution of CDC-EVs was different when
compared to MSC-EVs. Efficacy studies showed that CDC-EVs have
the potential to repair injured eye tissue in chronic and acute models.
Finally, uptake studies revealed variable CDC-EVs uptake kinetics across
different cell types following incubation.
Conclusion: Here we show uptake of human CDC-EVs by several cell
types, reliable measurement of biodistribution after in vivo delivery
using two administration routes, and efficacy of CDC-EVs in two disease
animal models. These findings are critical in the advancement of EV
therapy to clinical applications.
PT03.10
Hepatocyte-secreted extracellular vesicles modify endothelial
function by an arginase-dependent mechanism
Félix Royo1, Laura Moreno2, Justyna Mleczko3, Laura Palomo1, Esperanza
Gonzalez1, Angel Cogolludo2, Francisco Vizcaíno-Perez2, Sebastiaan van
Liempd1 and Juan M. Falcón-Pérez1
1CIC bioGUNE; 2Universidad Complutense Madrid, Madrid, Spain; 3CIC
bioGUNE-Liverpool University, Liverpool, United Kingdom
Introduction: Hepatocytes release extracellular vesicles (EVs) loaded
with signalling molecules and enzymes into the bloodstream. Although
the importance of EVs in the intercellular communication is already
recognised, the metabolic impact of the enzymes carried by these vesicles
is still unclear.
Methods: We isolated EVs secreted by primary rat hepatocytes by
differential ultracentrifugation, and we evaluated the metabolic effect
of these vesicles by performing untargeted metabolomic profiling of
serum samples exposed to them. Afterwards, by using sucrose density
gradients, biochemical and molecular analysis in in vitro and in vivo
models we validated that some of the observed metabolic effects are
caused by the arginase activity that is associated to small EVs. Finally, by
using ex vivo pulmonary arteries we measured the effect of these argi-
nase-carrying vesicles on the vascular function.
Results: We found significant changes in the abundance of 94 serum
metabolic signals of different chemical nature including metabolites
related to arginine metabolism, which regulates vascular function. We
demonstrated the presence of arginase-1 protein and its activity in the
hepatic EVs carrying the exosomal markers CD81 and CD63.
Remarkably, the arginase activity was also detected in EVs isolated
from the serum in vivo, and this vesicular activity significantly increased
under liver-damaging conditions. Finally, we demonstrated that EVs
secreted by hepatocytes inhibited the acetylcholine-induced relaxation
in isolated pulmonary arteries, via an arginase-dependent mechanism.
Conclusion: The study demonstrates that hepatocytes secrete small EVs
into the extracellular environment that are metabolically active and
modify the levels of blood metabolites associated with energy and
redox metabolisms, and endothelial regulation. Importantly, they are
involved in an arginase dependent mechanism regulating the endothelial
function locally and, possibly, at distant locations. This phenomenon
could be relevant and have pathological implications for hepatopulmon-
ary syndrome.
T03.11
Characterization of extracellular vesicles from different tumor cell
lines
Corinna Plattfaut, Annika Freund, Tabea Quecke and Frank Gieseler
University of Luebeck, Luebeck, Germany
Introduction: Extracellular vesicles (EVs) are released by various cell
types and can be found in body fluids. They contain biological material
such as DNA and mRNA, they are able to activate the coagulation
system and induce cellular signaling pathways through their membrane
surface components. The amount of EVs in blood samples from patients
has been correlated to inflammation and tumor activity; nevertheless,
the clinical relevance is unclear. Here we show that cells from various
tumors release EVs in substantial amounts and, that the release can be
increased by cytokines. EVs were then characterized structurally and
functionally.
Methods: Cell lines (all ATCC, human): OVCAR3, ovary adeno;
Colo357, pancreas adeno; A549, lung epithelial; CaCo2, colon adeno;
breast, epithelial. Incubation w/wo cytokines (TNF-alpha, TGF-beta).
EVs were isolated by sequential centrifugation steps including high-
speed (10.000 x g) as well as by capturing PS-presenting EVs by
annexin-coated magnetic beads. Counting, characterization by
Novocyte flow cytometer (488 nm laser) and MP-activity assay (PS
presentation). Functional assays: MPTF-activity assay (TENase activity),
ERK phosphorylation and tumor cell migration (Oris).
Results: We were able to isolate EVs from all tumor cell lines; EV release
was doubled by stimulation with TNF alpha (inflammation). EVs were
isolated by high-speed centrifugation or by capturing using annexin-
coated magnetic beads. Although the amount of EVs released by the
different tumor cells was comparable (MD 0.05), they differed signifi-
cantly as well in the amounts of PS presented on the surface (MD 1.88),
as their TENase activity (MD 0.50). Tumor cell EVs induced ERK
phosphorylation and some induced tumor cell migration. Inhibition of
ERK phosphorylation as well as PAR2 inhibition reduced tumor cell





























migration notably, which points to the involvement of PAR2 - small G
proteins - ERK signaling pathway.
Conclusion: These observations indicate that clinical effects such as the
activation of coagulation or tumor cells are not only related to the
amount of EVs; structural and functional characteristics should be
considered in further studies.
LBP.01
Extracellular vesicles isolated from the liver accelerate recovery of
carbon tetrachloride-induced hepatic necrosis
Lee Changjin, Sae Rom Kim, Yong Song Gho, Gyeongyun Go, Hyun Taek
Park and Nhung Thi Hong. Dinh
POSTECH
Introduction: Liver transplantation is still a major treatment for
end-stages of liver diseases. Cells such as hepatocytes have shown
promise effects on both acute and chronic liver damages. However,
issues on survival and differentiation of isolated hepatocytes are
remained unsolved. Cells secrete proteolipid-enclosed extracellular
vesicles (EVs) which exert important biological roles in intercellular
communication. However, EVs from in vitro cell culture do not fully
recapitulate the function of EVs present in vivo due to environmen-
tal differences of cells. Therefore, we here examined the character-
istics of in vivo EVs isolated from fresh liver tissue, where
hepatocytes make up 70-85% of their mass, and their therapeutic
efficacy on a mouse model of carbon tetrachloride (CCl4)-induced
liver damage.
Methods: EVs were extracted from fresh mouse liver tissues.
Combinational method comprising differential centrifugation, ultracen-
trifugation, and buoyant density gradient ultracentrifugation was
employed in isolating EVs from crude liver tissue extract. Nanoparticle
tracking, dynamic light scattering, electron microscopic, and immuno-
blotting analyses are used to characterize the liver EVs. To examine
effect of liver EVs on damaged liver, mice intraperitoneally received
with CCl4 were subsequently treated with or without the purified liver
EVs and time course experiments were performed. Multiple analyses
such as blood markers for liver damages, histology of damaged liver
tissues, and immunohistochemistry for several molecules are followed.
Results: EVs isolated from fresh liver tissues exhibited typical physicochem-
ical characteristics of EVs regarding sizes around 100 nm in diameter,
spherical morphology, density of 1.14 g/ml, and enrichment of tetraspanins.
Exogenous application of liver EVs to the mouse received with CCl4 has
shown that 1) rapid decrease of blood levels of liver damage makers, ALT,
AST, and LDH that are elevated upon CCl4 treatment, 2) early recovery of
necrotic lesion in damaged liver, 3) suppression of apoptotic progression, and
4) spatial elevation of hepatocyte growth factor as compared to the animal not
received with liver EVs.
Summary/Conclusion: Collectively, we suggest that the liver EVs have of
great potentials as a new type of intervention especially for liver injuries.
LBP.02
Role of human corneal keratoinocyte-derived extracellular vesicles in
corneal wound healing
Aleksandra Leszczynska1, Mangesh Kulkarni1, Kavita Patel1, Talia
Barkhordari1, Nima Natanzi2 and Mehrnoosh Saghizadeh Ghiam1
1Cedars-Sinai Medical Center, CA, USA; 2Cedar-Sinai Medical Center,
CA, USA
Introduction: The interaction between stromal keratinocytes and the epithe-
lial cell is known to provide supportive mechanism to repair the injured
epithelial cells. Traditionally, this interaction has been shown to be mediated
by paracrine factors. We now know that extracellular vesicles (EVs) are
bioactive molecules that play important role in cell communication and
many physiological processes during wound healing and regeneration. We
hypothesized that corneal keratinocyte-derived EVs (kerato-EVs) deliver the
supportive miRNA to injured limbal epithelial cells (LECs) and that disease
states such as diabetes affects their ability to deliver factors to target cells for
tissue regeneration after injuries.
Methods: EVs were isolated from normal (N) and diabetic (DM) pri-
mary keratinocytes by ultracentrifugation or using Exoquick precipita-
tion kit. Their size and number of the vesicles was confirmed by
Nanosight. We also assessed the expression of EVs markers CD63 and
CD81 on N and DM kerato-derived EVs by flow cytometry using
magnetic beads. Proliferation was done by MTS assay and migration
was checked by in vitro scratch assay.
Results: The number of EVs isolated from normal keratinocytes was an order
of magnitude higher than from DM samples. We showed the expression of
EVs markers CD63 and CD81 on N and DM keratinocyte-derived EVs by
flow cytometry using magnetic beads. Transwell migration assay performed
with Dil labeled keratinocytes showed that EVs can migrate from keratino-
cytes to epithelial cells. Thus, we observed an active transfer of EVs.
Simultaneously, direct addition of labeled EVs was performed as controls.
There was greater uptake of N Kerato-EVs than DM Kerato-EVs. Results of
MTS assay showed that both N and DM keratinocyte derived EVs induced
proliferation in human corneal epithelial cells (HCEC); to a greater extent by
N vs. DM keratinocyte-derived EVs. We performed in vitro scratch assay on
HCECs that were treated with N and DM keratinocyte-derived exosomes.
The results demonstrated that the migration of HCECs increased at 24h in
presence of EVs as compared to control group.
Summary/Conclusion: We have demonstrated that EVs derived from
keratinocytes are taken up by corneal epithelial cells even without direct
contact. Also, we have shown that Diabetes affects the production of EVs
from corneal keratinocytes and also their ability to affect proliferation
and migration of epithelial cells.
Funding: CSMC





























Poster Session PT04 – EVs in Cancer Therapy and Drug Resistance
Chairs: Jun Chung and Mary Bebawy 5:15–6:30 p.m.
PT04.01
Withdrawn at author’s request.
PT04.02
EVs in cisplatin resistance and transmitting resistance in calu1 non-
small cell lung cancer cells
Ilgin Kisiogu1, Gokce Lara Bodur1 and Mustafa Kotmakçı2
1Ozel Ege High School, Bornova, Izmir, Turkey; 2Department of
Pharmaceutical Biotechnology, Ege University, Bornova, Izmir, Turkey
Introduction: In recent decades, extracellular vesicles (EVs) were shown to
play important roles in a plethora of biological processes, including che-
moresistance development and transmission between cancer cells. The aim
of this study was to investigate whether EVs isolated from cisplatin-resistant
Calu1 (CR-Calu1) cells transport the drug out of the cell cytoplasm, and to
study the effect of isolated EVs on the parental Calu1 cells.
Methods: CD-Calu1 cells were previously developed by incubating of
Calu1 cells in culture medium containing cisplatin at continuously
increasing concentrations. CD-Calu1 cells were maintained in DMEM
containing 100 μM cisplatin. 48 h prior to EV isolation, culture medium
was replaced with fresh EV-free DMEM. EVs were isolated by sequential
centrifugation followed by ultracentrifugation at 120,000g. Protein con-
centration of EVs was measured with Bradford protein assay. Particle
size measurement of EV isolate was perfotmed by dynamic light scatter-
ing. Presence of cisplatin in EV isolates was analysed by X-ray photo-
electron spectroscopy (XPS) analysis of Pt 4f. This method has a
sensitivity of 0.1% atomic percentage. Transmission of drug resistance
to sensitive cells was investigated by simultaneous administration of EVs
and cisplatin to native Calu1 cells. Cell viability was investigated by XTT
cell proliferation assay and trypan blue exclusion.
Results: DLS results revealed that isolated vesicles vere of exosome and
microvesicle type, according to the peak values at 44 and 295 nm,
respectively. XPS measurements revealed that EVs isolated from CR-
Calu1 cells do not contain cisplatin, which was supported by the absence
of Pt 4f doublet peak at 80–70 eV of XPS spectrum. Cisplatin at 20 μM
dose reduced viability of Calu1 cells to approx. 40%, while coadminis-
tration of CR-Calu1 EVs and cisplatin reduced viability of native Calu1
cells to approx. 80%.
Conclusion: Cisplatin resistance in Calu1 cells does not seem to be accom-
panied by excretion with EVs. EVs from cisplatin resistant Calu1 cells
increased viability of native Calu1 cells in the presence of cisplatin. Further
investigatinon of molecules responsible for transmission of the resistance in
cisplatin resistant Calu1 cells can provide better therapeutic strategies for lung
cancer.
PT04.03
Paclitaxel-loaded milk exosomes overcome immunotoxicity following
oral administration
Ashish Kumar Agrawal1, Farrukh Aqil2, Jeyaprakash Jeyabalan1, Varun
Kushwah1, Wendy Spencer3, Josh Beck3, Beth Gachuki4, Sarah Alhakeem4,
Karine Oben4, Radha Munagala2, Subbarao Bondada4 and Ramesh C. Gupta5
1JG Brown Cancer Center, University of Louisville, Louisville, KY, USA;
2Department of Medicine and JG Brown Cancer Center, University of
Louisville, KY, USA; 33P Biotechnologies, Inc., Louisville, KY, USA;
4Department of Microbiology, Immunology & Molecular Genetics and
Markey Cancer Center, University of Kentucky, Lexington, KY, USA;
5Department of Pharmacology and Toxicology and JG Brown Cancer
Center, University of Louisville, Louisville, KY, USA
Introduction: Paclitaxel (PAC) has been recognised as a first-line treatment
for various cancers. However, severe toxicities associated with the conven-
tional i.v. therapy, and its carrier Cremophor EL, make it disadvantageous for
many patients. Here we investigated exhaustively immunotoxicity of PAC-
loaded exosomes (ExoPAC) following oral administration, as well as poten-
tial mechanism of drug loading.
Methods: ExoPAC was prepared by mixing the PAC solution (in ethanol:
acetonitrile, 1:1) with milk exosomes (Exo), and the particle size was mea-
sured by zetasizer, and the mechanism of drug loading studied by fluores-
cence spectroscopy. In vitro release of PAC from ExoPAC was determined in
simulated-gastrointestinal fluids and PBS. To determine potential toxicity,
wild-type female C57BL/6 mice were treated with PBS, Exo (80 mg/kg), and
ExoPAC (12 mg/kg) by oral gavage, five times a week, and PAC i.v. (12 mg/
kg) once a week. After three weeks, animals were euthanised and blood and
select tissues were collected to measure immunotoxicity.
Results: High PAC loading was observed due to hydrophobic interactions
between PAC and Exo proteins as principal mechanism of drug loading
based on significant quenching of fluorescence of the native Exo, particle size
of ExoPAC was somewhat increased compared with Exo (75 vs. 108 nm).
ExoPAC showed excellent physicochemical stability under simulated condi-
tions. The PAC was released time-dependently – ≈20% in case of FeSSGF
after 2 h,≈40% in FeSSIF after 4 h and >90% in PBS, after 48 h, suggestive of a
minimal effect of pH and different enzymes present in the FeSSGF and
FeSSIF. A significant reduction in immune toxicity was observed with orally
administered ExoPAC vs. PAC i.v. based onimmune cell quantification by
single cell suspension of spleen cells and flow cytometry analysis of bone
marrow stem and progenitor cells.
Conclusion: Rigorous data on multiple immunological parameters rule
out the immunological adverse effects due to foreign biological material
and cross-species reaction; in fact, PAC administered orally as an exo-
somal formulation seems to overcome adverse immunological effects
associated with PAC i.v. treatment.
Financial support: USPHS grant R41-CA-189517, KSTC-184-512-15-
209, the Duggan Endowment, and Helmsley Fund.
PT04.04
Transference of resistance phenotype mediated by extracellular
vesicles in gastric cancers
Edson Kuatelela Cassinela, Gabriela Pintar de Oliveira, Antuani Baptistella,
Fernanda Giudice, Michele Christine Landemberger; Fabio Marchi and
Vilma Regina Martins
A.C. Camargo Cancer Center, Sao Paulo, Brazil
Introduction: Gastric adenocarcinoma (GAd) is one of the most common
cause of cancer death worldwide and one of the tumours with higher
mortality rates in Brazil. The mechanisms of GAd pathogenesis are largely
unknown what causes limitations in the personalised treatment and neoad-
juvant therapy has been largely applied in these tumours because it can
improve tumour resectability and survival of patients. However, tumours
develop resistance to chemotherapy, which is the major reason for the
failure of treatment. Indeed, the understanding of the mechanisms asso-
ciated to chemotherapy resistant is of great relevance.
Methods: A GAd cells line (AGS) was used to generate a cell line
resistant to 5-fluorouracil (rAGS_FU). Extracellular vesicles (EVs)
secreted from AGS and rAGS_FU cell lines were isolated by ultracen-
trifugation, quantified and evaluated regarding their aggressiveness
through invasion assays. Proteomics and Next generation sequencing
analysis of EVs and secreting cells were also performed
Results: rAGS_FU cells secrete more EVs and presented increased invasion
rates than AGS cells. Extracellular vesicles (EVs) derived from rAGS_FU
cells were able to promote resistance to chemotherapy and to induce an
increase in invasion in AGS cells. Thus, cells resistant to chemotherapy have
a more aggressive phenotype and are able to transfer this acquired char-
acteristics to the non-resistant ones using EVs. Proteomics analysis revealed
that proteins involved in resistance to therapy such as FSCN1, are over-
expressed or exclusively expressed in rAGS_FU EVs when compared to





























AGS cells. Next generation sequencing analysis of the entire transcriptome
(long and short RNAs) from EVs and secreting cells revealed transcripts
differentially expressed between AGS and rAGS_FU cell lines such as hsa-
miR-181a-5p and hsa-miR-372-3p which may be directly or indirectly,
involved in the resistant phenotype.
Conclusion: A deep investigation of these data is needed to understand
and create new opportunities for the discovery of new biomarkers of
response to chemotherapy in gastric cancers and contribute to the better
understanding of the biological role of molecules shuttled by EVs.
PT04.05
Exosomal delivery of small molecules for the management of ovarian
cancer
Farrukh Aqil1, Jeyaprakash Jeyabalan2, Radha Munagala1, Ashish Kumar
Agrawal2, Lynne Parker3 and Ramesh C. Gupta4
1Department of Medicine and JG Brown Cancer Center, University of
Louisville, Louisville, KY, USA; 2JG Brown Cancer Center, University of
Louisville, Louisville; 3Norton Healthcare Pavilion, Louisville, KY, USA;
4Department of Pharmacology and Toxicology and JG Brown Cancer
Center, University of Louisville, Louisville, KY, USA
Introduction: Ovarian cancer is the fifth deadliest cancer among US
women. Resistance to chemotherapy, lack of oral bioavailability and
off-site toxicity of chemo drugs present major obstacles in the treatment
of patients with ovarian cancer. We hypothesised that drug molecules
administered via exosomes will increase their oral bioavailability, and
folic acid (FA)-functionalised exosomes will further enhance therapeutic
response and reduce off-target toxicities.
Methods: Exosomes (Exo) were isolated from bovine milk and their size
was measured by zetasizer. Small drug molecules (withaferin A (WFA),
anthocyanidins (Anthos) and paclitaxel (PAC)) were loaded onto the
Exo. Antiproliferative activity of Exo formulations was determined
against ovarian cancer drug-sensitive (A2780) and drug-resistant
(OVCA432) cells. Anti-tumour activity was determined against A2780
tumour xenografts in nude mice delivering the Exo formulations by oral
gavage, except PAC which was given i.p. Tumour targeting was achieved
by co-loading of the tumour-targeting ligand, FA.
Results: The isolated Exo showed the size of 93 ± 8 nm. Test agents
(WFA, Anthos and PAC) could be loaded onto Exo with 8–20% drug
load. ExoWFA and ExoAnthos showed significantly higher (2–10 fold)
antiproliferative activity versus the free drugs, antiproliferative activity of
ExoPAC was only slightly higher than free PAC. Anthos and WFA both
demonstrated modest but insignificant anti-tumour activity. However,
the tumour growth inhibition was significantly higher with the
ExoAnthos (65%) and ExoWFA (60%), which was further enhanced
when these formulations were functionalised by FA. Similarly, ExoPAC
administered orally showed the same therapeutic efficacy as free PAC
given i.p. However, significantly higher antitumor activity was achieved
when the ExoPAC was FA-functionalised. A modest, but insignificant
tumour inhibition was also observed with the Exo alone. Our data
showed significantly enhanced antitumor activity by ExoPAC formula-
tion when combined with ExoAnthos or ExoWFA.
Conclusion: Our data indicate that the milk-derived exosomes serve as
excellent nano-carriers for small drug molecules to enhance oral bioa-
vailability against ovarian cancer.
Funding: Supported from Agnes Brown Duggan Endowment, and
Helmsley Trust Fund.
PT04.06
Evaluation of drug resistance transfer via extracellular vesicles in
human ovarian cancer cells
Jennifer F. Power and Susan P.C. Cole
Department of Pathology & Molecular Medicine, Queen’s University,
Ontario, Canada
Ovarian cancer (OCa) is the fifth most common cancer and has the highest
mortality rate of all gynaecologic malignancies. Symptoms of early stage
OCa are rarely detectable resulting in late stage diagnoses and poor prog-
noses. First-line chemotherapy of OCa includes paclitaxel (PXL) and car-
boplatin. Unfortunately, patients almost always relapse with drug-resistant
disease, resulting in 5-year survival rates < 45%. Extracellular vesicles (EVs)
can facilitate cell–cell communication, and have been implicated in pro-
moting cancer growth and metastasis, as well as drug resistance. Resistance
can be caused by many mechanisms including elevated levels of the ATP-
binding cassette (ABC) drug efflux transporters P-glycoprotein/ABCB1 (P-
gp), MRP1/ABCC1, and/or ABCG2/BCRP. Our aim is to determine
whether resistance via an ABC transporter may be transferred by EVs
derived from OCa cells. Paired sensitive and resistant human OCa cell
lines (parental A2780-9S and resistant A2780-AD645) were cultured
under standard conditions. The relative resistance of A2780-AD645 cells
was determined by sulforhodamine B cytotoxicity assays after 48 h drug
exposure. Cells were grown in EV-free media for 24 h prior to collection of
conditioned media and EVs isolated by differential centrifugation.
Fractions collected at 20,000g (20 K) and 100,000g (100 K) were solubilised
and immunoblotted for P-gp and established EV tetraspaninmarkers CD63
and CD81. Cytotoxicity assays confirmed that A2780-AD645 cells were 17-
fold and >50-fold resistant to doxorubicin and PXL, respectively, and
elevated P-gp levels were detected in whole cell and membrane enriched
extracts by immunoblot, as expected. CD63 and CD81were readily detected
and highly enriched in the 100 K fraction but only CD63was detected in the
20 K fraction, as well as in whole cell and membrane enriched extracts. Our
results indicate the feasibility of using OCa cell lines to explore how EVs
might mediate drug resistance. Ongoing studies include optimising P-gp
detection in EVs, co-culture assays to determine if EVs from resistant OCa
cells can reduce the sensitivity of parental cells, and identification of the
messenger(s) in the EVs (i.e. protein, nucleic acid) responsible.
Funding: This work was supported by CIHR MOP-133584 and the TFRI
Transdisciplinary Training Program in Cancer Research.
PT04.07
Extracellular vesicles confer a complex multidrug resistance and
survival profile in cancer through the transfer of drug efflux capacity,
drug sequestration, metastasis, altered tissue biomechanics and
immune evasion
Deep Pokarel, Jamie Lu, Jack Taylor, Ariane Roseblade, Sabna Rajeev
Krishnan and Mary Bebawy
The Graduate School of Health, The University of Technology Sydney,
Sydney, Australia
Multidrug resistance (MDR) contributes to treatment failure in over 90%
of patients with metastatic cancer. MDR is a unique type of resistance in
which cancer cells become cross-resistant to a wide range of drugs used
in combination chemotherapy. Synonymous with this phenotype is the
overexpression of plasma membrane drug transporters which efflux
drugs out from cancer cells. These transporters limit the intracellular
accumulation of chemotherapeutics by virtue of ATP dependent drug
efflux, rendering cancer cells unresponsive to treatment.
We discovered that extracellular vesicles, specifically, microparticles (MPs),
provide a novel pathway(s) for the dissemination and acquisition of cancer
MDR. This occurs through the intercellular transfer of functional resistance
proteins and nucleic acids and through a capacity for active and passive drug
sequestration byMPs.We have also shown thatMPs derived fromMDR cells
readily confer the donor cell traits within recipient cancer cell populations,
including MDR, enhanced metastatic capacity and altered tissue biomecha-
nical properties. Our most recent studies demonstrate the presence of a
distinct and parallel MP meditated pathway supporting the survival of
MDR cancer cells through immune evasion.
These findings provide the necessary insight and basis for the design of
novel therapeutic strategies, targeted at the prevention and circumven-
tion of MDR clinically. From a clinical perspective, these results have
recently led us to establish MPs as valuable systemic biomarkers for
assessing treatment responsiveness, risk of relapse and the evolution of
disease in individual myeloma patients.
Funding: This work was supported by research funds from the Cancer
Council NSW (Grant RG-09-02), National Health and Medical Research
Council, Australia (Project Grant APP1007613) and University of
Technology Sydney to M.Bebawy.






























Direct effects of anti-angiogenic therapies on glioblastoma cells
interactions with astrocytes via extracellular vesicles
Thomas Simon, Sotiria Pinioti, Franz Wendler and Georgios Giamas
University of Sussex, Brighton, United Kingdom
Introduction: Glioblastoma (GBM) is the most aggressive type of primary
brain tumours in humans. Hence, anti-angiogenic therapies (AAT) have
been developed to target the tumour blood supply in order to reduce its
invasiveness. However, mechanisms of AAT-resistance have been observed.
Among them, an effect ofAAT directly onGBM cells through the blocking of
autocrine signalling, such as VEGF signalling, has been speculated but still
remains unknown. We believe that such direct effect could affect the tumour
cells communication with their stromal counterparts, including astrocytes,
through secreted extracellular vesicles (EVs). Such alterations in the GBM
cells relationships with their microenvironment in response to AAT could be
involved in therapeutic resistance.
Methods: Human astrocytes and GBM cell lines were treated with three
different AAT. Amount of EVs produced by astrocytes and GBM cells
following treatments with AAT were quantified. Mass spectrometry and
western blotting were used to characterise EVs protein content. In
particular, effects of AAT and EVs from AAT-treated GBM cells on
the phenotype of astrocytes (paracrine) and GBM cells (autocrine) were
being examined.
Results: Direct inhibitory effects of two out of three AAT have been
observed on astrocytes and GBM cells viability. In addition, alterations
in the amount of EVs produced by astrocytes and GBM cells have been
noticed in response to AAT. Furthermore, it appears that EVs derived
from AAT-treated cells can affect astrocytes and GBM cells viability.
Finally, in EVs from AAT-treated cells, proteomic analyses identified
protein hits that could be involved in GBM aggressiveness.
Conclusion: According to the type of drug, GBM cells and astrocytes are
differently affected by AAT. In addition, regarding the effects of EVs
from AAT treated-GBM cells on other GBM cells and astrocytes phe-
notype, we suggest that EVs-driven communication between GBM cells
and astrocytes could be affected following AAT treatment. Further
proteomic and genomic analyses are needed to decipher the molecular
mechanisms underlying such effects. Consequently, this study can bring
new insights about a potential “direct” effect of AAT on GBM cells
during therapeutic resistance.
PT04.09
Analysis of the fate of chemotherapeutic drugs expelled by
pancreatic cancer cells into microvesicles
Vandhana Muralidharan-Chari and Shaker Mousa
Albany College of Pharmacy and Health Sciences, NY, USA
Introduction: High mortality in pancreatic cancer patients is partly due to
resistance to chemotherapy. We identified that pancreatic cancer cells utilise
microvesicles (MVs) to expel and remove chemotherapeutic drugs. Using
human pancreatic cancer cells that exhibit varied sensitivity to gemcitabine
(GEM), we showed that GEM exposure triggers the cancer cells to release
MVs in an amount that correlates with that cell line’s sensitivity to GEM. The
inhibition of MV release sensitised the GEM-resistant cancer cells to GEM
treatment, both in vitro and in vivo. Mechanistically, MVs remove drugs that
are internalised into the cells and that are in the microenvironment. We also
explained the differences between the GEM-resistant and GEM-sensitive
pancreatic cancer cell lines tested based on the variable content of GEM-
transporter proteins, which control the ability of MVs either to trap GEM or
to allow GEM to flow back to the microenvironment. In this study, we
describe the fate of GEM that has been expelled by the cells into the MVs.
Methods: Human pancreatic cancer cells were treated with GEM, and
MVs were isolated at various time points. The presence of GEM-meta-
bolising enzymes within the isolated MVs was analysed with western
blotting techniques. MV-lysates were further analysed for the activity of
the metabolising enzymes, and their by-products were analysed with
HPLC-MS/MS analysis.
Results and Summary: We show data for the first time of the presence of
metabolising enzymes and their by-products within MVs released by
pancreatic cancer cells upon exposure to GEM. Data are compared
between GEM-resistant pancreatic cancer cells and GEM-sensitive pan-
creatic cancer cells, and the significance of the results will be discussed in
the context of biological relevance of the presence of GEM within the
released MVs, given that MVs can fuse with various cell types in the body.





























Poster Session PT05 – Novel Developments in EV Characterisation
Chairs: Matias Ostrowski and Sten Libregts 5:15–6:30 p.m.
PT05.01
Raman tweezers microspectroscopy of single extracellular vesicles:
towards measuring the relative content of proteins, lipids, and
nucleic acids
Sergei G. Kruglik1, Irène Tatischeff2, Pierre-Yves Turpin1, Jean-Michel
Guigner1, Félix Royo3 and Juan M. Falcón-Pérez3
1University Pierre & Marie Curie Paris 6, France; 2Consulting company
REVINTERCELL; 3CIC bioGUNE
Introduction: Extracellular vesicles (EVs) contain a wealth of informa-
tion on health and disease, possessing a great potential in theranostics of
cancer (1). In addition to «omics» techniques sensitive to individual
biomolecules, Raman tweezers microspectroscopy (RTM) is arising as
a label-free analytic tool, providing information on global biomolecular
composition of EVs, especially promising in combination with cryogenic
transmission electron microscopy (Cryo-TEM) (2). Our study focuses on
potentialities of RTM for rapid characterisation of single (or very few)
EVs through their specific biomolecular content.
Methods: In RTM experiment, bioparticles were optically trapped by a
strong 785-nm laser beam and their Raman spectra were analysed for the
presence of major constituent biomolecules. We studied EVs released by
Dictyostelium discoideum cells, mouse cell line MLP29, and primary rat
hepatocytes, as well as extracted from human urine (exosomes). Size
distribution of all studied bioparticles was characterised by Cryo-TEM.
Results: The RTM technique was optimised for EVs in 50–200 nm size range,
and high-quality Raman spectra of single (or a few, depending on particles
size) EVs were obtained for all samples. Contributions from proteins, lipids
and nucleic acids were analysed, and their relative content was estimated. The
lower concentration limit for Raman detection of biomolecules in water is in
the order of a few mM, however, due to the effect of optical trapping in the
focus of a laser beam, RTM can effectively detect high local concentrations of
biomolecules in trapped EVs.
Conclusion: RTM is a promising tool for characterisation of individual
EVs on relative biomolecular content. One immediate application,
among many others, is discrimination between EVs, lipid bodies, protein
aggregates, and possibly viruses, in hardly accessible 100 nm size range.
References
1. Tatischeff, Cancer Res. Front. 2015; 1: 208.
2. Tatischeff et al., JEV 2012; 1: 19179.
PT05.02
Magnetic nanoparticle-enhanced surface plasmon resonance
biosensor for extracellular vesicle analysis
Agnes T. Reiner1, Ruenn Chai Lai2, Sai Kiang Lim2 and Jakub Dostalek1
1BioSensor Technologies, AIT-Austrian Institute of Technology GmbH,
Seibersdorf, Austria; 2A*STAR
Even though extracellular vesicles (EVs) are emerging as new tools in
clinical applications for disease diagnosis, monitoring and treatment,
reliable detection methods are still lacking. In this work we propose a
biosensor with wavelength interrogation of grating-coupled surface
plasmon resonance (SPR) for the analysis of EVs. In order to over-
come diffusion-limited binding kinetics and allow for detection of
trace amounts of vesicles present in complex samples, magnetic
nanoparticles are employed for collecting the target analyte on the
sensor surface. The grating-coupled SPR is demonstrated as an effi-
cient platform, that allows pulling of the target analyte to the sensor
surface by usage of a magnetic field gradient applied through the
sensor chip. By this means, the sensor response is greatly enhanced
by the more efficient yield in collecting and affinity binding of the
target analyte on the sensor surface and by the magnetic nanoparti-
cle-enhanced change in the surface mass density associated to the
analyte capture. The capability of this sensor to detect EVs is demon-
strated by the analysis of different EV populations derived from
mesenchymal stem cells, which carry different lipid and protein
moieties.
PT05.03
Probing nanosized extracellular vesicle (EV) populations by surface-
enhanced Raman spectroscopy (SERS)
Lucia Paolini1, Nicolò Bontempi2, Annalisa Radeghieri1, Anna Castelli1,
Andrea Zendrini1, Sara Busatto1, Eugenio Monti1, Ivano Alessandri2 and
Paolo Bergese3
1Department of Molecular and Translational Medicine, University of Brescia,
KY, USA; 2Department of Mechanical and Industrial Engineering, Chemistry
for Technologies Laboratory, University of Brescia and INSTM UdR Brescia,
KY, USA; 3Department of Molecular and Translational Medicine and INSTM
UdR Brescia, University of Brescia, KY, USA
Introduction: Surface-enhanced Raman spectrosctopy (SERS) is a
powerful resource to provide information about the biochemical content
of extracellular vesicles (EVs) in a fast and reproducible way. We
explored the ability of plasmonic and non-plasmonic SERS to probe
nanosized EV populations separated from human serum of patients
affected by multiple myeloma (MM) or Parkinson’s disease (PD) and
from healthy (H) donors. Typically, metal nanoparticles (NPs) with a
plasmonic resonance (e.g. Au) are utilised to enhance the Raman
response (plasmonic SERS). However, excited plasmonic NPs generate
local heating and energy release, thereby inducing instability and low
reproducibility, especially with organic or biological analytes. For this
reason we also considered to probe EVs with innovative T-rex beads
made of SiO2/TiO2 core/shell colloids that enhance the Raman finger-
print of the analyte by non-plasmonic SERS, thus expected to show a
lower ability impact on the stability of the adsorbed EVs.
Methods: EVs from serum of H patients and those with MM or PD were
purified using sequential centrifugation steps and discontinuous sucrose
gradients. Samples were biochemically characterised by western blot ana-
lysis. Positive fractions to typical exosomalmarkers were pooled and further
characterised for biophysical characteristics by atomic force microscopy
(AFM), colloidal nanoplasmonic assays and an agarose gel. EVs were then
targeted with 15 nm Au NPs and analysed by conventional SERS. In
alternative EVs were coupled with T-rex beads for non-plasmonic SERS.
Results: The colloidal nanoplasmonic assay allowed us to assess purity
and determine the molar concentration of the EV formulations, AFM
imaging confirmed the formulation to be composed of nanosized EV
populations (50–100 nm). Both plasmonic and non-plasmonic SERS
experiments gave promising results in terms of the possibility to use
SERS profiling to identify each of the H, MM and PD EV populations.
Our contribution will focus on presenting and discussing the last
updates of these results (further experiments are ongoing).
The institutional review board of Azienda Ospedaliera Spedali Civili of
Brescia approved the study in adherence with the Declaration of
Helsinki. This project was financed by the BIOMANE grant from the
University of Brescia 2015.
PT05.04
Multiplexing characterisation of neuronal exosomes from human
plasma by surface plasmon resonance imaging
Silvia Picciolini1, Alice Gualerzi2, Carlo Morasso2, Renzo Vanna2, Marzia
Bedoni3, Massimo Masserini4 and Furio Gramatica2
1Laboratory of Nanomedicine and Clinical Biophotonics LABION,
Fondazione Don Gnocchi – University of Milano-Biocca, Milano, Italy;





























2Laboratory of Nanomedicine and Clinical Biophotonics LABION,
Fondazione Don Gnocchi; 3Laboratory of Nanomedicine and Clinical
Biophotonics LABION, Fondazione Don Carlo Gnocchi ONLUS;
4University of Milano-Biocca, Milano, Italy
Introduction: Exosomes have emerged as a new class of biomarkers of
neurological disorders showing an involvement in neurodegenerative
processes. The big interest in this field is supported by the fact that
exosomes are able to cross the blood brain barrier and can thus offer the
unique possibility to study the biochemical processes inside the central
nervous system from a biofluid easy to access as human blood. Inspired
by recent progresses in plasmonic biosensors that demonstrated their
ability to detect exosomes from biological samples, we have designed a
biosensor based on surface plasmon resonance imaging (SPRi) for the
isolation of exosomes of neuronal origin and to study their membrane
surface and interactions with specific biomolecules.
Methods: The SPRi microarray was optimised for the detection of
different subpopulations of exosomes extracted by size-exclusion chro-
matography from plasma of healthy volunteers. Bare gold SPRi chips
were coated with a self assembled monolayer and further activated by
EDC/NHS chemistry, in order to be functionalised with different anti-
bodies, deposited by automated microspotting. After exosomes injection
on the SPRi chip, we evaluated the interaction between their membrane
molecules and specific antibodies.
Results: The surface chemistry was optimised for the immobilisation of
antibodies and we tested simultaneously different antibodies such as
CD9 and CD63 that are generic exosomes markers, and CD171/L1 as
neuronal marker. Once the exosomes were adsorbed on the chip, the
injection of other antibodies was followed by a signal in correspondence
of specific exosomes subpopulations, demonstrating the possibility to
characterise exosome membranes with a sandwich approach.
Conclusion: These results suggest that the use of SPRi can help to
simultaneously discriminate and immobilise different exosomes subpo-
pulations and to evaluate the interaction with biomolecules, with a
perspective of investigating biological role of these biomarkers.
PT05.05
Cryogenic-temperature electron microscopy imaging of extracellular
vesicles shedding
Naama Koifman1, Idan Biran1, Anat Aharon2, Benjamin Brenner3 and
Yeshayahu Talmon1
1Department of Chemical Engineering and the Russell Berrie Nanotechnology
Institute (RBNI), Technion – Israel Institute of Technology, Haifa, Israel;
2Department of Haematology, Rambam Health Care Campus; 3Department of
Haematology and Bone Marrow Transplantation, Rambam Health Care Campus
Please see OPT03.01
PT05.06
Membrane vesicles – examination of biophysical properties with
atomic force microscopy
Melissa C. Piontek and Wouter H. Roos
Zernike Institute for Advanced Materials, University of Groningen,
Groningen, The Netherlands
Extracellular vesicles (EVs) are not only intensively studied to increase
our fundamental knowledge on their functioning, but also for diagnosis,
therapeutics and drug delivery purposes. To improve the current and
potential applications of EVs, a fundamental understanding of their
stability, structure, and function is crucial. Such studies can be con-
ducted at the single particle level to gain biological and physical infor-
mation about the vesicles and the particle to particle variability. A
suitable technique to investigate EVs under near-to physiological condi-
tions is atomic force microscopy (AFM). Operated in liquid, it provides
images of the EVs while mechanical properties of the particles can be
obtained as well. Here we present our approach and the latest results in
studying the structure and mechanics of these particles.
Funding: This work is supported by NWO through a Vidi grant and by
STW through the Perspectief grant Cancer-ID. (Both to Wouter H.
Roos).
PT05.07
Detection and characterisation of exosomes in TEM images using
ExosomeAnalyzer: a novel software tool
Anna Kotrbová1, Karel Štěpka2, Martin Maška2, Jakub Jozef Pálenik2,
Ladislav Ilkovics3, Dobromila Klemová3, Aleš Hampl3, Vítězslav Bryja1,
Vendula Pospíchalová1 and Pavel Matula2
1Department of Experimental Biology, Faculty of Science, Masaryk University,
Czech Republic; 2Centre for Biomedical Image Analysis, Faculty of
Informatics, Masaryk University, Czech Republic; 3Department of Histology
and Embryology, Faculty of Medicine, Masaryk University, Czech Republic
Introduction: Exosomes (exs) are nano-sized extracellular vesicles that func-
tion as conveyers of information between cells. Their content reflects the cell
of their origin and its condition. Different cargo of vesicles underlines their
function andmay have effect onmorphological characteristics (shape, size) of
exs. So far, there has been a lack of studies correlating morphological
characteristics of vesicles with their content and possible function. This is
caused partially by the fact, that analysis of individual exosomes in electron
microscopy images is time-consuming if performed manually. Therefore we
present here a software for computer-assisted evaluation of exosomes in TEM
images.
Methods: Exosomes were isolated using differential centrifugation followed
by a purification step in sucrose/D2O cushion. Morphology of exs was
observed using negative contrasting followed by visualisation using TEM.
Morphological characteristics were analysed by ExosomeAnalyzer software
based on their shape and edge contrast criteria. The exosome segmentation
was carried out using morphological seeded watershed on gradient magni-
tude image, with the seeds established by applying a series of hysteresis
thresholdings, followed by morphological filtering and cluster splitting.
Results: We developed a software tool capable of analysing morpholo-
gical features of exs (size and roundness) in often not so clear TEM
images. Even images with exs both lighter and darker than the back-
ground, or containing artefacts or precipitated stain, can be successfully
processed. If the fully-automatic processing fails to produce correct
results, the program allows the user to adjust the detection seeds as
well as exosome boundaries manually.
Conclusion: Our software is an easy to use tool that might be of high
interest to the ISEV community. It is publicly available at: http://cbia.fi.
muni.cz/exosome-analyzer.
Funding: Grant Agency of Masaryk University (MUNI/M/1050/2013).
PT05.08
Immunogold labelling of extracellular vesicles and liposomes in the
liquid phase
Naama Koifman1, Maayan Nir-Shapira1, Idan Biran1, Anat Aharon2,
Benjamin Brenner3 and Yeshayahu Talmon1
1Department of Chemical Engineering and the Russell Berrie
Nanotechnology Institute (RBNI), Technion – Israel Institute of
Technology, Haifa, Israel; 2Department of Haematology, Rambam Health
Care Campus; 3Department of Haematology and Bone Marrow
Transplantation, Rambam Health Care Campus
Introduction: Extracellular vesicles (EVs) have sizes ranging from tens of
nanometres to >1 µm and carry a variety of membrane antigens emanating
from their original cells. The detection of such compositional markers is of
great importance both diagnostically and mechanistically. Immunogold
labelling in transmission electron microscopy (TEM) utilises the high elec-
tron density of gold nanoparticles conjugated to antibodies. Cryogenic tem-
perature-TEM (cryo-TEM) enables a single-vesicle examination, probing
specific molecules on EVs, while covering the whole range of EV diameters,
and preserving their nanostructure.
Methods: 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-
dioleoyl-sn-glycero-3-phospho-l-serine (DOPS) liposomes were





























prepared by extrusion, and used as model systems for the labelling
optimisation. Labelling included a two-step process using biotinylated
annexin-V and gold-conjugated streptavidin. We labelled different cell
lines for annexin, and compared both the labelling levels and the
morphology of the labelled vesicles. EVs isolated from platelets-rich
plasma were used as a positive control for the presence of annexin-V.
Antigens on cells of origin and on the EVs fraction were detected using
flow cytometry.
Results: We selectively labelled DOPS liposomes versus DOPC lipo-
somes. DOPS liposomes were shown to form aggregates in the presence
of binding buffer due to the high electrostatic forces formed by the
presence of Ca2+ ions on the surface of the DOPS-rich liposomes.
Various annexin-V labelling levels were observed on EVs isolated from
different cells lines. Preliminary results from THP1-isolated EVs show
that only a fraction of the EVs present extensive immunogold-labelling
for annexin-V. We have also attempted to label CD-14 on EVs isolated
from monocytes and EGFR on EVs from MDA468.
Conclusion: The results present promising beginning for the development of
a simple labelling technique, focusing on the pivotal issue of the lipid content
of EVs. This entire methodology is carried out in the liquid phase, avoiding
drying artefacts. Immunogold labelling in cryo-TEM of extracellular vesicles
grants highly important information as to the morphology of the vesicles,
paving the way for a high-resolution diagnostic method at a single-vesicle
level.
PT05.09
Monitoring the progression of cell death and detailed
characterisation of apoptotic bodies by flow cytometry
Lanzhou Jiang, Rochelle Tixeira, Stephanie Paone, Sarah Caruso, Georgia
Atkin-Smith, Amy Baxter, Mark Hulett and Ivan Poon
La Trobe Institute for Molecular Science, Melbourne, Australia
More than 200 billion cells undergo apoptosis every day in human bodies. It
is an integral part of the maintenance of tissue homeostasis. It is also related
to many diseases such as systemic lupus erythematosus. During apoptosis,
cells will break apart and form numerous membrane-limited vesicles
known as apoptotic bodies. Recently, we have developed a new protocol
based on flow cytometry which can accurately differentiate apoptotic bodies
from other particles in a mixed sample. This protocol uses a combination of
Annexin A5 and TO-PRO-3 (a commercially available nucleic acid-binding
dye that stains early apoptotic and necrotic cells differentially), and a logical
seven-stage analytical approach to distinguish six types of particles in a
sample, including apoptotic bodies and cells at three different stages of cell
death. The method can be used to study the characteristics of apoptotic
bodies in details, especially how cellular contents are distributed into the
apoptotic bodies and how to trace biomarkers that indicate the origins of
apoptotic bodies. For example, to study organelle distribution, we can use a
combination of intracellular organelle staining (such as Hoechst,
Mitotracker green, Lysotracker red etc.) and correlated stains such as TO-
PRO-3 and Annexin A5-V450/Annexin A5-FITC etc. The established
methodologies can enable us to better characterise the apoptotic cell dis-
assembly process, which is a key downstream process of cell death.
PT05.10
Novel triggering threshold strategy for discovery of rare microvesicle
phenotypes on flow cytometers dedicated to small particle analysis
Mathilde Sanden, Jaco Botha, Morten Hjuler Nielsen and Aase Handberg
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg,
Denmark
Introduction: Detection and characterisation of microvesicles (MVs)
have clinical relevance as they can function as potential biomarkers for
diseases. Recent advances have led to the development of flow cyt-
ometers dedicated to the detection and characterisation of small parti-
cles. However, current protocols are insufficient as they are developed
and optimised for conventional flow cytometers. Aim: To compare the
purity and quantity of phosphatidylserine-exposing (PS+) MVs between
different triggering threshold strategies to determine optimal settings for
discovery and quantification of rare MV phenotypes.
Methods: Size-calibrated green fluorescent silica beads were used to
determine the MV-regions on the Apogee A60-Micro PLUS flow cyt-
ometer. Plasma from one healthy donor was labelled with Lactadherin-
FITC, CD41-APC and CD36-PE. Three different threshold strategies
were examined: threshold on light scatter; fluorescence; light scatter
and fluorescence combined.
Results: The number of PS+, CD36+/CD41+, CD41+ or CD36+MVs did not
differ between the three threshold strategies. Large differences were observed
in total number of events and file sizes between light scatter (3.65 × 105, 50.1
Mbyte), fluorescence (0.40 × 105, 5.59Mbyte) and combined (0.14 × 105, 1.87
Mbyte) strategies. Serial dilutions indicated linearity for all three strategies
suggesting that swarm detection is unlikely (R2 = 0.957–0.999).
Conclusion: The sensitivity of dedicated flow cytometry is sufficient to
detect comparable numbers of PS+ MVs and different phenotypes regard-
less of the thresholding strategy. However, thresholds on both light scatter
and fluorescence is the most optimal strategy allowing data acquisition
over longer periods of time, thereby increasing the purity and quantity by
collecting more specific events with a minimised file size. These initiatives
render dedicated flow cytometry more suitable to discover rare MV
phenotypes and thereby more specific and sensitive biomarkers.
PT05.11
Non-linearities in nanoscale flow cytometry of extracellular vesicles
and standards
Janice Gomes1, Fabrice Lucien2, Christopher McIntyre3 and Hon Sing Leong2
1University of Western Ontario, Ontario, Canada; 2Lawson Health Research
Institute, Ontario, Canada; 3London Health Sciences Centre, London, United
Kingdom
Introduction: Extracellular vesicles (EVs) have gained tremendous attention
within the scientific community in recent years as these submicron particles
have shown to be involved in many pathological conditions and diseases.
Isolation and analysis of EVs from various bodily fluids represent an impor-
tant challenge because there are currently few standardisedmethods that have
been established. In contrast to conventional flow cytometry, nanoscale flow
cytometry allows for analysis of particles that are between100–1000nm,while
still utilising similar properties such as forward and side angle light scatter and
more sensitive photomultiplier tubes. Even though nanoscale flow cytometry
is an exquisite tool for EV analysis, improvements are still necessary to limit
“swarm effect” and the false quantification of “true events” in samples. Our
study aims to identify improvements to nanoscale flow cytometry and reduce
inaccurate linearity associated with extracellular vesicles and standards.
Methods: We utilised the A50-Micro nanoscale flow cytometer (Apogee
FlowSystems Inc.) to identify and measure 100–1000 nm sized extracellular
vesicles and standards. We used patient plasma, conditioned media, latex
beads, and silica beads at successive dilutions to determine the events based
on forward and side angle light scatter, aswell as quantification established by
fluorescent markers
Results: We found that solely using forward and side angle light scatter
was limiting and produced non-linear results following serial dilutions of
patient plasma and conditioned media, and this further resulted in false
EV quantification. Additionally, we found that while the threshold is a
useful parameter to eliminate noise and undesired events without elim-
inating true events, adjusting the threshold of the fluorescent channels
was more effective than merely the threshold of forward and side angle
light scatter parameters.
Conclusion: While nanoscale flow cytometry is a major advancement in the
identification of EVs at a submicron level, our results suggest that optimising
functions such as threshold, and utilising fluorescent labelling for enumera-
tion of EVs will result in a more accurate estimation of observed events.
PT05.12
Using flow cytometry and imaging flow cytometry to resolve the
heterogeneity of extracellular vesicles including exosomes
André Görgens1,2, Michel Bremer2, Giulia Corso1, Ulrika Felldin1, Rita
Ferrer-Tur2, Dhanu Gupta1, Helmut Hanenberg3, Joel Z. Nordin1, Helena





























Sork1, Svenja Meiler4, Stefan Wild4, Bernd Giebel1,2 and Samir EL-
Andaloussi1,5
1Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden;
2Institute for Transfusion Medicine, University Hospital Essen, University of
Duisburg-Essen, Essen, Germany; 3Department of Pediatrics III, University
Children’s Hospital Essen, University of Duisburg-Essen, Essen, Germany;
4Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; 5Department of
Physiology, Anatomy and Genetics, University of Oxford, United Kingdom
Extracellular vesicles (EVs) can be harvested from cell culture superna-
tants and from all body fluids. They can be roughly classified based on
their size and origin as exosomes (70–150 nm) which are released when
multivesicular bodies fuse with the plasma membrane, and microvesicles
(100 nm to 1 µm) which are formed by the outward budding of the plasma
membrane. In addition to these different EV subtypes, it is nowadays
commonly accepted in the field that there is a much higher degree of EV
heterogeneity within these two subgroups. The content, the protein com-
position and the surface signature of EVs vary and are likely to be
dependent on the cell type source, the cell’s activation status and multiple
other parameters. Until today, no specific markers to discriminate even
exosomes from microvesicles have been identified, and only few EV sur-
face markers have been related to specific cell sources. In general, the
question of heterogeneity in EV samples is rarely addressed at the experi-
mental level, mainly due to the lack of qualified methods to analyse
multiple parameters of single EVs. However, the identification of specific
vesicular surface markers will be of high relevance to further understand
the molecular content and related functions of subsets of EVs.
In the last few years, we and others developed different multi-parameter
methods for flow-cytometric analysis of EVs, including bead-capturing
methods. Of note, we recently optimised an imaging flow cytometry-
based method and demonstrated its use to analyse multiple parameters
on single exosomes in heterogeneous samples. Now, we have started to
apply those flow cytometric approaches to analyse EVs derived from
various sources, including cell lines of mesenchymal, epithelial, endothe-
lial and hematopoietic origin. First, we are applying a multiplex bead-
based method to screen for new EV surface markers. In a second step,
we will validate newly identified markers at the single vesicle level by
using imaging flow cytometry. Here, we present preliminary results
obtained, and with this study we expect to further unravel heterogeneity
of EVs and identify new and cell source specific EV surface signatures.
PT05.13
The use of a violet laser (405 nm) for scatter detection of EVs on an
ImagestreamX MKII imaging flow cytometer
Joanne Lannigan1, Luca Musante2 and Uta Erdbruegger2
1School of Medicine, Flow Cytometry Core, University of Virginia, VA, USA;
2Department of Medicine/Nephrology Division, University of Virginia,
VA, USA
Introduction: It has been noted that scatter intensity of small particles is
inversely proportional to the fourth power of the wavelength, indicating that
more light is scattered at lower wavelengths than higher wavelengths. Using
conventional flow cytometry, the use of violet lasers for scatter in analysing
extracellular vesicles (EVs) has become more common. Imaging flow cyto-
metry (ISX) is an important tool for characterising EVs. Traditionally, the
ISX uses a far-red excitation source (758 nm) for side scatter. In this study, we
explored whether the use of the 405 nm laser for side scatter would yield
greater number of EVs detected by side scatter.
Methods: A variety of samples were used to assess the impact of laser
wavelength on scatter detected by the 758 nm laser compared to the
405 nm laser. These included 180 nm silica particles, hUrine/plasma EVs
(mean 225 nm), and 200 nm liposomes. All samples were acquired with
each laser wavelength. Numbers of particles detected/mL and intensity
of scatter signals were calculated and compared for each laser wave-
length. Buffer alone was run to account for differences in background
detection. These values were compared to the concentrations and sizes
obtained by TRPS (qNano). In cases where samples contained fluores-
cence, these parameters were also assessed for concentration differences.
Results: In all cases, the number of particles detected by scatter with the
405 nm laser was significantly higher than with the 758 nm laser. This was
also true of background detection in the buffer only sample, however,
subtracting the additional background still led to higher numbers of detect-
able events with the 405 nm laser. In cases where samples were labelled with
EV or lipid specific fluorochromes, the increased detection was shown to be
specific particles of interest. The number of particles detected with the
405 nm laser was closer to the concentrations determined using the
qNano. Scatter intensity values obtained with the 405 nm laser were also
significantly higher than those obtained with the 758 nm laser, making
them easier to distinguish from low level background particle detection.
Conclusion: Use of the 405 nm laser for scatter detection of EVs using
the ISX imaging flow cytometer yields greater detection of EVs by
scatter. The higher scatter intensity from this laser allowed for better
separation from background signals.
PT05.14
Flow cytometers dedicated to the analysis of small particles: a
powerful tool for EV characterisation
Jaco Botha, Mathilde Sanden, Morten Hjuler Nielsen and Aase Handberg
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg,
Denmark
Introduction: Flow cytometry (FCM) is a widely used method for quan-
titation and characterisation of extracellular vesicles (EVs). Limitations
with FCM has prevented detection of EVs below 200 nm corresponding
to approximately a third of all EVs. Although flow cytometers specifi-
cally developed for measurement of small particles (SP-FCM) have been
made available, they are scarce and their performance remain untested.
Thus, we aimed to determine the sensitivity and resolution of SP-FCM.
We further assessed the reproducibility of enumeration and character-
isation of EVs in plasma.
Methods: Flow cytometry was performed on an Apogee A60 Micro-
PLUS flow cytometer. Sensitivity and resolution were assessed using
100 nm fluorescent silica beads and a cocktail of non-fluorescent silica
beads ranging from 180–1300 nm, respectively. Reproducibility of mea-
surements was assessed by measuring aliquots of silica beads (n = 42)
and platelet-free plasma (PFP) from one healthy donor (n = 22) labelled
with lactadherin-FITC, anti-CD41-APC and anti-CD36-PE. EVs were
defined as phosphatidylserine-exposing (PS+) events <1000 nm.
Concentrations were determined directly based on sample flow-rate
and acquisition time without a bead control.
Results: We demonstrated that SP-FCM has sufficient sensitivity to
discriminate 100 nm silica beads from background and resolution to
discriminate silica beads ranging from 100–1300 nm from each other. In
addition, EVs could be measured down to 100 nm, and we demonstrated
that the bulk of EVs are within the 100–300 nm range, consistent with
previous studies. Some variability was observed in concentration deter-
mination of silica beads (CV = 12.75–17.39%). However, concentration
determination of EVs was reproducible (CV = 3.68–7.32%), as was
median fluorescence intensities of EV phenotypes (CV = 1.44–6.63%).
Conclusion: This study demonstrates that SP-FCM is a powerful tool for
EV characterisation with sufficient sensitivity and resolution to repro-
ducibly measure the bulk of EVs present in bio-fluids. We believe that
SP-FCM holds great potential for increasing our understanding of EVs
in pathological conditions which could lead to discovery of sensitive,
disease-specific biomarkers.
LBP.03
EVucation: Freely available interactive public engagement tools for
scientists to communicate the role Extracellular Vesicles in the body
and healthcare
Ryan C. Pink, Findlay R. Bewicke-Copley, Paschalia Pantazi, Bianca Paris,
Priya Samuel and David RF. Carter
Oxford Brookes University, Oxford, United Kingdom
Introduction: It is widely understood throughout international Science
and Technology that Public Engagement is required for healthy scientific
research dialogue and a deeper public understanding of its importance.
This engagement is fundamental in a growing field such as Extracellular





























Vesicles (EVs), especially with its potential impact on the public through
novel diagnosis and treatment.
Methods: Here we present a set of freely available interactive public
engagement tools to provide an ‘off-the-shelf’ kit to help scientists
communicate the diversity of EVs in the body and their beneficial role
in healthcare. We have designed and tested these outreach tools:
Results:
● ‘Exosome Monsters’– children decorate polystyrene balls for
fridge-magnets while we explain to the child about cells and
adults about EVs surface diversity (Key Stage 0, ages 3-5),
● ‘Squishy Blood’ – Using a body map with color-coded organs they
put their hands in a blood bowl of slimy balls (that represent EVs)
and have to find and sort them while we explain about the
specifically loaded EV contents and how we can use that informa-
tion in healthcare (Key Stage 1-2, ages 6-11).
● ‘EV health scanner’ – The audience pick a barcoded ball (blood
EV) at random and scan it on a camera linked to a Raspberry pi
running a pseudo diagnosis programme giving out a clinical
report, while we talk about how EVs are used in diagnosis and
therapy (Key stage 2+, ages 8 – adults).
Summary/Conclusion: These have been tested at various science festi-
vals. The PDF instructions to recreate these along with downloadable
Raspberry pi code and supporting posters are available from the group’s
website: www.carterlab.co.uk/Engagement/. We also propose to use this
site as a two-way resource in which others are welcome to add their own
public engagement ideas. The availability of such tools will help disse-
minate the excellent work being done by the EV community and will in
Funding: None
LBP.04
Identifying immune related miRNAs, studying the differences
between erythrocyte and human rhinovirus infected HeLa cells
derived microvesicles, a profiling using Firefly particle technology
Roberta F C. Freezor and Sheelagh Heugh
London Metropolitan University, London, United Kingdom
Introduction: Encapsulated in microvesicles (MV) are proteins and
nucleic acids including miRNA molecules. The discovery of miRNAs
added a new dimension to our understanding of complex gene regula-
tory networks, inter-cellular/organ communication, and now MV as
miRNA transporters. The remarkable stability of extracellular miRNAs
is interlinked with the formation of miRNA-vesicle packages; MV forms
a protrusion then detaches from the cell surface translocating across the
cell membrane, allowing miRNAs enter recipient cells and mediate cell-
to-cell communication.
Methods: We investigated 68 miRNAs (immunology panel) in (1) ery-
throcyte, eMV control (2), eMV induced with CaCl2 (3) eMV induced
with CaCl2 and human serum (4) in parallel with: HeLa cells (5), HeLa
infected with Human Rhinovirus type 16 (6), HeLaMV Control (7), and
HeLa infected with Rhinovirus type 16 MV (8). All MV samples were
prepared using the classical ultracentrifugation method, miRNA samples
were prepared using mirVana™miRNA Isolation Kit. miRNA concentra-
tion was measured by NanoDrop® ND-1000 UV-Vis (5µg) and processed
by multiplex miRNA assay-Firefly particle technology (triplicates) and
analysed with Firefly™Analysis Workbench software.
Results: 25 miRNAs out of 68 were expressed equally in all samples
(excluding normalisers, negatives and haemolysis markers). hsa-miR-
10a, 30a-5p, 34a-5p, 132-3p, 196a-5p, 203a-3p, 210-3p, 422a, 181b-5p
and 744-5p did not show expression in 1, 2,3, and 4 samples, but was
expressed in 5, 6, 7, and 8 samples.hsa-miR-223-3p was not detected in
5,6,7 and 8 but strongly expressed 1, 2,3, and 4 samples. hsa-miR-146a-
5p and 150-5p was not detected in 1, 5, 6,7 and 8 samples, but were
slightly expressed in 2, 3, and 4. hsa-miR-23a-3p was not expressed in 1
but slightly expressed in 2, 3 and 4 and highly expressed in 5,6,7,8
samples. The hsa-miR- 16-2- 3p, 33a-5p, 125a-5p, 129-5p, 140-3p, 142-
3p, 154-5p,155-5p, 200a-3p, 205-5p, 339-5p, 375, 376b-3p, 429, 431-3p
and 523-5p did not show expression in the samples used here.
Summary/Conclusion: By analysing specific markers for each MV sam-
ple here, it can be suggested that our findings can positively contribute
towards identifying MV involvement with; miRNA regulation, immu-
nological, infective and intracellular actions.
LBP.05
Aptamer-based isolation of extracellular vesicles subpopulations:
Finding the needle in a haystack
Sören Kuypers1, Revathy Munuswamy1, Jan D’Haen2, Inge Nelissen3, Joy I.
Irobi1, Baharak Hosseinkhani1 and Luc Michiels1
1Hasselt University, Biomedical research institute, Martelarenlaan 42, 3500
Hasselt, Belgium; 2IMO-IMOMEC, Hasselt University, Wetenschapspark 1,
3590, Diepenbeek, Belgium; 3VITO NV, Boeretang 200, 2400 Mol, Belgium
Introduction: EV are considered as promising diagnostic targets, carry-
ing valuable biomarkers for liquid biopsies. However, the downstream
analysis of EV struggles with masking of disease specific information due
to the vast majority of the EV coming from the homeostatic intercellular
communication. Being able to isolate EV subsets while maintaining their
functionality will increase their diagnostic potential. Therefore, our aim
was to develop an aptamer based methodology to isolate potential intact
disease involved EV subsets.
Methods: EV bulk was isolated from cells conditioned with TNF-α using
SEC. The compatibility of the in-house developed monomeric C-reactive
protein (mCRP) aptamer towards EV was confirmed using surface
plasmon resonance (SPR). Next, a specific subset of EV was isolated
using magnetic beads, covalently coated with aptamer. Release of the
captured EV subset from the beads was confirmed using SPR, WB, NTA
and TEM analyses. The integrity of the isolated EV was confirmed by
monitoring the uptake of fluorescently labelled mCRP + EV subset into
HUVEC.
Results: The EV bulk with a size range of about 100–200 nm was first
isolated. SPR shows specific binding of EV under binding conditions and
EV release was observed under non-binding conditions. Afterwards, the
release of the EV subset was confirmed by different analyses. WB
analysis showed the presence of classical EV markers such as CD63.
Additionally, NTA and TEM verified that the EV subset was successfully
isolated. The fluorescently labelled EV subset was taken up by HUVEC
confirming that the EV isolated in this procedure are biologically intact.
Summary/Conclusion: This study shows that the proposed aptamer-
based methodology can be used to successfully isolate intact EV subsets
that are functionally active. This approach opens new ways to study the
behavior of disease related EV subsets in target cells.
Funding: This work was financed by Hasselt University and by EFRO
through the Interreg V Grensregio Vlaanderen Nederland project Trans
Tech Diagnostics.
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Free flow electrophoresis allows preparation of EV fractions with high
recovery and purity rates
Gerhard Weber1, Robert Wildgruber1, Simon Staubach2, Robin Dittrich3,
Peter Horn3, Verena Boerger4 and Bernd Giebel2
1FFE Service; 2Institute for Transfusion Medicine, University Hospital Essen,
University of Duisburg-Essen, Essen, Germany; Department of Laboratory
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Transfusion Medicine, University Hospital Essen, University of Duisburg-
Essen, Essen, German; 4Institute for Transfusion Medicine, University
Hospital Essen, University Duisburg-Essen, Essen, Germany
Introduction: Currently, it remains a challenge to prepare extracellular
vesicles (EVs), especially those from body fluids, such as plasma, to high
purity. Neither fractionation by density nor by size is sufficient to
separate EVs from all contaminants e.g. high and low density lipoprotein
(HDL/LDL) and other contaminating components. For now, a time-
consuming combination of two methods (density and size) is required
to enrich EVs to high purities, regularly resulting in low EV recoveries.
Free Flow Electrophoresis is a well-established preparative and micro-
preparative method to separate analytes with inherent difference of
charge density and/or difference of pI-value.
Methods: Free Flow Interval Zone Electrophoresis (FF-IZE), using media
of different pH-values, ranging from pH = 8 to pH = 4.8 offers most
suitable protocols for the quantitative separation of amphoteric analytes,





























like proteins and peptides from non-amphoteric analytes like lipid
vesicles, DNA and RNA.
Results: Within our ongoing project we have optimized FF-IZE-pH
protocols for the purification and isolation of EVs as well DNA and
RNA from cell culture supernatants and human plasma samples. Upon
screening for EV-specific samples in a dot blot system, EV-specific
antigens are specifically recovered in a selected number of fractions.
Currently, we characterize the identified fractions in more detail. For
the enumeration of prepared EVs we use the Nanoparticle Tracking
Analysis (NTA). Furthermore, the presence of EV markers and the
absence of contaminants are analyzed by Western Blot. We document
the appearance of isolated EVs by transmission electron microscopy and
determine the miRNA profiles of the obtained fractions.
Summary/Conclusion: The principle of FFE, the EV isolation strategy
and our ongoing results will be presented.
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Visualization of extracellular vesicles derived from human bone
marrow mesenchymal stem cells using fluorescent and magnetic
labels; in vitro and in vivo studies
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Introduction: Mesenchymal stem cells (MSCs) have shown both anti-
inflammatory and pro-regenerative activity in a variety of disorders.
Recent studies support the notion that the signals responsible for these
therapeutic effects are at least partially conveyed by extracellular vesicles
(EVs). Despite growing interest in EVs as therapeutic tools, little infor-
mation is available on the fate of these nanoparticles following in vivo
administration because of methodological hurdles. The aim of the study
was to optimize the method of EVs visualization for in vitro and in vivo
biodistribution studies.
Methods: The experiments were performed using human bone marrow
mesenchymal stem cells (hBM-MSCs) (Lonza). hBM-MSCs were
labelled with PKH26 (Sigma) and iron nanoparticles conjugated with
rhodamine (Molday, BioPAL) and co-stained with anti-CD9, -CD63 and
-CD81 (tetraspanins) and MSCs antibodies. EVs were isolated from the
culture media of previously labelled hBM-MSCs. The size, number,
morphology and biomarker expression of hBM-MSC-EVs were identi-
fied by Nanosight analysis, high-resolution flow cytometry, transmission
electron microscopy, superresolution illumination microscopy and MRI.
The in vivo studies were performed in adult male Wistar rats with focal
brain injury of 1μl/50nmol ouabain injection into the right hemisphere.
Two days after the brain insult1.3x109hBM-MSC-EVs labelled with
Molday or stained with PKH26 were infused into the right internal
carotid artery and analysed in rat brain immunohistochemically using
confocal microscopy.
Results: In vitro studies revealed the presence of intracellular vesicles
positively stained with Molday ION or PKH26 visible inside hBM-MSCs
co-expressed CD44, CD73, CD90, CD9, CD63 and CD81 markers. The
isolated EVs represented heterogeneous population of various size (50-
300 nm) and kept their markers after isolation. hBM-MSC-EVs trans-
planted intraarterially in focal brain injured rats migrated into the right
hemisphere near the ischemic injury.
Summary/Conclusion: PKH26 and Molday ION enable to visualize
hBM-MSC-EVs in vitro and in vivo after their intra-arterial transplanta-
tion. Molday ION tagging may allow additional imaging of EVs delivery
using MRI.
Funding Supported by the Polish National Centre for Research and
Development STRATEGMED1/235773/19/NCBR/2016 ‘‘EXPLORE ME’’.
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MicroRNA biogenesis and heterogeneous miRNA distribution in
cancer EVs
Nils J. Groenewegen, Catrin Lutz, Alba M. Losada, Monique A.J. van
Eijndhoven and D. Michiel Pegtel
Exosomes Research Group, Department of Pathology, VU University Medical
Center, Amsterdam, The Netherlands
Introduction: It is now firmly established that mature 22nt miRNAs are
detected in populations of extracellular vesicles (EVs) and exosomes.
Exosomal miRNAs have physiological effects in recipient cells but the
question remains whether they can non-cell autonomously modulate gene
expression. Presumably, loading of a single guide strand of miRNAs into
RISC (a prerequisite for active repression of mRNA translation) is ineffi-
cient compared to loading of miRNA duplexes that are typically not found
in exosomes. Possibly a chaperone system exists that can catalyze this
process, but such evidence is lacking. One study described that cancer cells
secrete a subtype of EVs, that support cell-independent but Dicer-depen-
dent miRNA biogenesis as an essential feature of their reported pro-
tumorigenic potential in mice (Melo et al., Cancer Cell 2014).
Methods: We used RT-PCR to measure miRNA levels in cancer EVs
purified by standard ultracentrifugation protocol and in addition also in
EVs purified by Size-exclusion chromatography (SEC), including serial
dilutions of SEC-purified EVs to reveal miRNA distribution amongst EV
subpopulations.
Results: We repeated these experiments but were unable to measure
significant miRNA biogenesis in cancer EVs purified by standard ultra-
centrifugation protocol. We reasoned that abundant protein-complex
bound miRNAs might obscure results and calculations. We next set out
to recapitulate the process of cell-independent miRNA biogenesis in SEC-
purified cancer EVs from cancer cell-lines and bio-fluids from cancer
patients. Our results suggest that cell-independent miRNA biogenesis in
SEC-purified EVs is very inefficient or occurs only in a very small sub
population of vesicle such as large oncosomes or apoptotic bodies.
However using limiting dilution analysis we could not find evidence for
miRNA biogenesis in a small subpopulation of EVs, agreeing with stoi-
chiometry calculations suggesting that EV populations carry less than 1
mature miRNA copy of a single species (Chevillet et al., PNAS 2014).
Summary/Conclusion: Our observations rule out pervasive miRNA-bio-
genesis in SEC-purified EVs and disfavor miRNA biogenesis in small EV
subpopulations. Studies are ongoing, aimed at defining cancer EV sub-
populations with distinctive RNA content.
Funding: Cancer Center Amsterdam Foundation (CCA-2016)
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Analysis of coat and whole proteins from exosomes using MS
compatible surfactants
Ayako Kurimoto and Tatsutoshi Inuzuka
Fundamental Research Department, FUJIREBIO Inc.
Introduction: Exosomes are a type of extracellular vesicles secreted from
all types of cells via endosomal pathway and found in most body fluids,
including blood, urine, saliva, blood, breast milk, and cerebrospinal fluid.
Many biologically active molecules such as protein, mRNA,miRNA, DNA
and phospholipid are found in exosomes. Exosomes have been suggested
to mediate cell-to-cell communication via proteins e.g. integrins, and to be
associated with various disease conditions. In order to explore the func-
tion of exosomes, highly efficient, comprehensive proteomic analysis is
essential. To this end, surfactants are generally used to enhance protein
digestion efficiency, which results in the increased total sequence coverage
and number of identified peptides and proteins in LC-MS.
In this study, we compared the efficiency of commercially available
surfactants using cancer cell conditioned medium. We have also assessed
the presence of cancer marker within the exosomes.





























Methods: Exosomes are collected from hepatocellular carcinoma HepG2
conditioned medium by ultracentrifugation, and lysed using commer-
cially available MS-compatible acid-labile surfactants (e.g., AALS, and
NALS) before being digested by proteases. Obtained peptides were
analyzed using Triple TOF5600+ system and ProteinPilot software. A
tumor marker, carcinoembryonic antigen (CEA) contained in the exo-
somes from pancreatic cancer cell line AsPC-1 was quantified using
immunoassay analyzer.
Results: HepG2 conditioned medium has increased by the addition of
lysis step using various kinds of MS-compatible surfactants compared to
guanidine-HCl treatment, with the exception of AALS II. Immunoassay
analysis revealed that CEA in exosomes from AsPC-1 has increased by
the solubilization treatment using detergents, except for AALS II as well.
These results suggest that AALS II detergent may be beneficial for
identifying coat proteins on the surface of exosomes from HepG2.
Summary/Conclusion: Addition of solubilization step using detergents
for proteomic analysis has increased the number of identified proteins
from exosomes. However, AALS II treatment has resulted in the reduc-
tion of identified protein number, as well as the amount of CEA
detected. AALS II surfactant may be applicable to identify the outer
coat proteins of exosomes from HepG2.
LBP.10
Nanocellulose filters for extracellular vesicle purification
Prateek Singh1, Jonne Ukkola2, Henrikki Liimatainen2 and Seppo Vainio1
1University of Oulu, Finland; 2Fibre and Particle Engineering, University of
Oulu, Finland
Introduction: Extracellular vesicle purification is key in deducing the
precise function of the EVs in biological processes. Here we have devel-
oped a nanocellulose based EV filter which allows specific capture of EVs
from solution. Nanocellulose-based materials are based on long, poly-
meric cellulose chains consisting of hundreds to several thousand repeat-
ing glucopyranose units forming strong and stable crystalline regions and
more flexible amorphous regions. Cellulose can be found in various fungi,
algae or bacterial sources, but the most of the nanocellulosic materials are
produced from wood- or plant-derived sources via mechanical disintegra-
tion techniques coupled with chemical or biological pretreatment meth-
ods. Nanocellulose refers to cellulose particles with at least one dimension
in nanoscale (1-100 nm) and it can be divided into two main categories:
cellulose nanocrystals (CNC) and cellulose nanofibrils (CNF).
Methods: EVs from RENCA, LNCaP cell lines were used to assess the
performance of the nanocellulose filters. Cellulose nanofibrils with vary-
ing surface groups were prepared. Three different qualities of cellulose
nanofibrils (deep eutectic solvent (DES) CNF, aldehyde functionalized
DADES CNF and dicarboxylic cellulose nanofibrils (DCDES NFC)) were
prepared from bleached birch (Betula verrucosa and pendula) chemical
wood pulp obtained in dry sheets.
Results: Three different nanocellulose filters were prepared and used to
pull down EVs from dilute solutions. In our preliminary tests, bare, non-
functionalized nanocellulose is neutral towards EVs. Carboxyl –modified
nanocellulose on the other hand, showed preferred binding to the EVs.
BCA protein assay and transmission electron microscopy were utilized
to verify EV filtration.
Summary/Conclusion: The nanocellulosic filters were rapid alternative
to EV purifications as compared to lengthy ultracentrifugation.
Antibody functionalized nanocellulose filters can offer specific EV cap-
ture from
LBP.11
Porous nanomaterials for exosome capture and in situ processing
Wenwan Zhong1 and Xiaoni Fang2
1Department of Chemistry; 2University of California, Riverside, CA, USA
Introduction: The exosome-derived analytes including RNA, DNA, pro-
teins, metabolites and lipids may mirror the altered state of the cell of
origin. Therefore, profiling exosomal contents can help to identify
valuable markers for better understanding of the function and origin
of exosomes in the circulating system. However, Exosomes are only 30-
100 nm in diameter, and the total amounts of the enclosed biomolecules
are small. Thus, exosome analysis always starts with exosome enrich-
ment from biological fluids. Isolations are typically based on their size
and density using ultracentrifugation, or with microfluidic devices; but
these methods cannot completely remove other lipid-structures like the
high- or low-density lipoprotein complexes, and downstream analysis
remains challenging due to the membrane structures.
Methods: Herein, we propose a new approach that combines efficient
isolation of exosomes enabled by porous nanomaterials with in situ sample
processing for rapid profiling of exosomal proteins. The uniform pore
structures (about 100 nm size) of the graphene forms can trap the exosomes
while excluding the large microvesicles (> 100 nm). Specific exosome
recognition can also be obtained by antibodies targeting exosome’s surface
markers. Moreover, in situ protein digestion can be achieved within the
porous structures and the peptides can be purified easily.
Results: We proved that our material could trap the polystyrene beads
with sizes ranging from 50-200 nm, while the ones with larger sizes were
excluded. The enrichment took less than 30 minutes, followed by rapid
protease digestion. The high surface-area-to-volume ratio and signifi-
cantly improved the total number of proteins identified. To further
improve the proportion of membrane protein identification, we did
the second enrichment step employing the unmodified graphene form
to adsorb the membranous peptides via after in situ protease digestion,
and > 60% of the identified peptides were membrane peptides.
Summary/Conclusion: We report a new method that utilizes porous
nanoamterials to enhance content analysis of exosomes. We expect our
method can help to identify more surface markers for exosomes and




A dielectrophoretic nanopore device with spatiotemporal resolution
for microvesicles entrapment and quantification near living cells
Leilei Esfandiari, Ankit Esfandiari and Leyla Esfandiar
University of Cincinnati, OH, USA
Introduction: Exosomes are small membrane vesicles, ~100nm in dia-
meter, secreted by cells and can be found in body fluids. They play
important roles as molecular cargoes to deliver gene regulating
microRNAs and key proteins between cells and thus, they have become
a molecule of interest to many researchers as a circulating diagnostic and
prognostic biomarker. The major challenge associated with exosomes
has been the effective and selective isolation and quantification.
Currently, tedious and time-consuming ultracentrifugation steps com-
bined with filtration techniques have been utilized for separation and
purification of these vesicles from cell culture medium or body fluids. In
this work, we have developed a new low-voltage, ultra-sensitive, and
rapid DC dielectrophoretic (DEP) nanopipette tool with the capability to
isolate and quantify biomolecules based on their surface charge and size.
Methods: A borosilicate nanopipette with 500nm diameter was back
filled with electrolyte solution and was inserted into two electrically
neutral reservoirs by means of a PDMS chamber structure.
Nanoparticles and artificial liposomes with various surface charge den-
sity and diameters were used as model system for the proof of concept
experiments. The particles with different concentration were injected in
to the chamber in front of the pipette’s tip and a DC potential was
applied across the nanopipette. Upon the applied potential, the ionic
current across the pipette was measured and the movement of particles
was recorded microscopically.
Results: The correlation between the trapping efficiency and electric field
strength, salt concentration in buffer, particle type and diameter, pore
size was studied empirically and compared with simulation results. A
mixture of nanoparticles and liposomes with different diameters were
selectively trapped at the tip of the pipette. Upon entrapment, the unique
conductance change across the pore was measured which indicated the
quantitative detection of the specific molecule.
Summary/Conclusion: This novel nanopore-DEP device can isolate the
target molecules with DC voltage as low as 0.6V/Cm in a buffer with a





























high ionic concentration in less than five minutes. Also, this device has a
high special resolution and thus has a potential to entrap secreted
biomolecules including exosomes near living cells.
Funding: University of Cincinnati Startup Fund
LBP.13
Two-dimensional electrophoresis-based proteomic analysis for
urinary extracellular vesicles
Aki Nakayama Howley, Hideka Shigeta and Shiro Iijima
Bunkyo Gakuin University, Tokyo, Japan
Introduction: Extracellular vesicles (EVs) produced form renal epithelial
cells are increasing in interest the last 5 years. The main problem
encountered during purification of urinary EVs is co-precipitated
Tamm Horsfall protein (THP), which is the most abundant protein in
urine of healthy subjects secreted from the thick ascending limb of
Henle’s loop. We previously reported that the PVDF membrane filtra-
tion was an easy and effective method for removing co-precipitated
THP. Two-dimensional polyacrylamide gel electrophoresis (2DE) was
also useful for proteomic analysis of urinary EVs because the isoelectric
point of THP is about 3.5 and the other majority of protein spots are
isolated from it. Using this method, in the present study, we developed a
protein map of urinary EVs.
Methods: Urinary EVs were isolated from a pooled urine sample of
healthy subjects by differential ultracentrifugation. PVDF membrane
filtration was performed after ultracentrifugation at 200,000g. Urinary
EVs were characterized by immune electron microscopy, Western blot
and flow cytometry. Isolated EVs were analyzed by 2DE Protein spots
were subsequently trypsin-digested and analyzed by liquid chromatogra-
phy-tandem mass spectrometry.
Results: Immune electron microscopy verified the presence of urinary
EVs. The mean diameter of urinary EVs was 42.1 ± 13.9 nm. Eighty-nine
proteins were identified from protein spots on 2DE by proteome analysis
and classified using Gene Ontology that 44% were cytoskeleton and
membrane 15% were cytosol, and 10% were endocytosis related proteins.
A functional biomarker of tubular stress of tropomyosin alpha-4 chain
was found in this protocol.
Summary/Conclusion: We have developed a protein map of urinary EVs
by using 2DE. Urinary EVs contain renal specific markers and 2DE-
based analysis was useful and effective for identification of candidate
biomarker proteins. These results contribute to clarifying the functional
characteristics of urinary EVs.
LBP.14
Membrane markers profiling: Comparative analysis of microvesicles
derived from erythrocyte and HeLa cells infected with Human
Rhinovirus type 16
Roberta F. C. Freezor and Sheelagh Heugh
London Metropolitan University, London, United Kingdom
Introduction: The detection and profiling of markers on microvesicles
(MV) is important in the context of developing a potential tool for early
diagnosis of diseases and profiling surface proteins can contributes
towards the understand of MV acting as a form of long-distance cell-
cell communicator.
Methods: In order to determine the expression of surface markers, MV
samples including (1) erythrocyte MV (eMV) control, (2) eMV
induced with CaCl2 (3) and eMV induced with CaCl2 and human
serum, HeLa cells MV Control (4) and Hela cells infected with
Human Rhinovirus (HRV) type 16 MV (5) were labelled with a variety
of cluster differentiation(CD) FITC-Conjugated antibodies through the
direct method and analysed by Flow cytometry Guava Express Plus
software along with the Sub-micron Particle Size Reference Kit (side
scatter signals against green scatter signals of reference microspheres
sizes 0.5 to 2.0µm) acting as a template for fluorescence intensity using
the ExpressPlus software.
Results: Annexin V (+VE) and IgG (-VE) were important and relevant
parameters (controls) considered to ensure that only MV was detected,
this was also used to ensure the correct gate was created (fluorescent and
size). Signals from erythrocyte markers (CD235ab) were clearly +VE on
eMV >93%, and it was highly -VE for 4 and 5 samples >91%. CD54
(HRV marker) showed >78% +VE for 4 and >96% for 5 but >78% -VE
for all eMV samples. CD46 was >66% -VE in eMV samples and >92%
+VE in 4 and 5 samples. Moreover, MV samples did not bind to CD14
demonstrating that eMV samples were only derived from erythrocyte
cells and were not contaminated with any other blood cells type, it also
showed -VE staining in 4 and 5. CD58 and CD36 were expressed in all
samples, in contrast to CD63 that was not expressed in eMV control but
slightly expressed in 4 and 5 (>66%). Whereas, HLA-ABC was >55%
negative in all eMV samples but highly expressed in 4 and 5 sam-
ples (>91%).
Summary/Conclusion: The selected panel of CD expression including
known (-VE) and (+VE) markers revealed that MV express the same
antigenic markers as those present in the parent cell. The groups of MV
populations did not have a huge significance of expression within itself,
being the same level of expression for almost all samples (each label) for
the majority of the CD chosen here.
LBP.15
Lipidomic analysis of extracellular vesicles derived from
propionibacterium acnes
Jin Her1, Jinseong Jeon1, Sangeon Shin2 and Changill Ban1
1Pohang University of Science and Technology, Pohang, Republic of Korea;
2POSTECH
Introduction: Propionibacterium acnes is an anaerobic normal flora,
mainly found in the skin and gastrointestinal tract. Recently, the patho-
physiological effects of P. acnes not only in acne progression but in
various diseases has been reviewed. As an emerging mode of commu-
nication in bacteria, extracellular vesicle (EV) has been reported to
conduct critical pathophysiological functions.
Methods: For the comprehensive understanding of the lipidomic profiles
of P. acnes, we report comparative lipidomic analysis of P. acnes and P.
acnes EV for the first time and identified 290 vesicular lipids with high
confidence using triplicate LC-MS/MS analyses.
Results: In this research, we suppose that P. acnes EV might conduct
distinguishing functions in micro-environments for the distinct patho-
genicity and lifestyle of P. acnes.
Summary/Conclusion: We expect these findings to provide useful clues
for understanding biological and pathophysiological mechanisms of P.
acnes and for clinical applications such as vaccine development, diag-
nostics and therapeutics.
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PT06.01
Specific types of miRNAs from urinary extracellular vesicles identify
pathogenesis of kidney stones and Randall’s plaque in humans
Muthuvel Jayachandran1, Xiangling Wang2, Robin Chirackal3, John
Knoedler3, Amy Krambeck2, Felicity Enders3, Andrew Rule3, Pritha
Chanana3 and John Lieske3
1Mayo Clinic College of Medicine, MN, USA; 2Mayo Clinic, MN, USA;
3Mayo Clinic Rochester, MN, USA
Introduction: Micro RNAs (miRNAs) regulate various cellular processes
through modification of post-transcription and translation of target
mRNAs. The role of miRNAs in the pathogenesis of kidney stones and its
likely precursor Randall’s plaque (RP) is not known. This study was
designed to compare specific miRNAs within urinary extracellular vesicles
(EVs) between stone formers with varying disease severity and controls.
Methods: Bio-banked cells-free urine samples from kidney stone formers
with low plaque (LP, n = 4, <5% papillary surface area coverage) and high
plaque (HP, n = 4, >5% papillary surface area coverage), first time stone
formers (n = 4) and non-stone forming controls (n = 4) were used in this
study. Urinary EVs were isolated by ExoQuicKTc and miRNAs within EVs
were quantitated by XRNA Exosome RNA-Seq Library Kit (System
Biosciences, Palo Alto, CA). Differentially expressed miRNAs between
HP and LP stone formers, and between first time stone formers and
controls with a p-value of 0.05 or lower were selected for pathway analysis.
Results: A group of miRNAs that contribute to calcification, cell prolifera-
tion, acute kidney injury, renal fibrosis, pro-apoptotic and pro-inflamma-
tory processes including miR-223-5p, miR-199a-3p, miR-664a-3p, miR-
489-3p, miR-26b-3p, miR-146b-5p, miR-148b-3p, miR-1299 and miR-24-
2-5p were increased 6 to10- fold, whereas miRNAs that contribute to anti-
apoptotic and anti-inflammatory processes, prevent renal fibrosis, ischemic
injury, and chronic kidney disease such as miR-499a-5p, miR-455-3p, miR-
483-5p, miR-6087 and miR-532-3p were decreased 2 to 5-fold in first time
stone formers compared to controls. MiR-489-3p and miR-146b-5p were
increased 5.8–6.6 fold whereasmiR-483-5p, miR532-3p andmiR-6087were
decreased 4.5–7 fold in low-RP compared to high-RP stone formers.
Conclusion: These specific miRNAs in EVs may provide new insights
into early renal cellular pathogenesis in kidney stone and RP formation,
and new tools for the screening, diagnosis, and risk stratification of
persons with calcium stone disease.
PT06.02
Proteomic identification of exosomal VDAC1: a potential urinary
biomarker for detecting early renal fibrosis
Dekun Wang, Chuanai Chen, Zhujun Zhang and Xiaoyue Tan
The Medical School of Nankai University, Nankai, China
Introduction: Non-invasive tools for evaluation of early renal fibrosis are
of great value for either detecting the kidney fibrotic lesion or predicting
the prognosis and therapeutic reaction.In this study, we aimed to iden-
tify the fibrosis related biomarkers in the urinary exosomes via proteo-
mic screening of the exosomes in the legumain knockout mice.
Methods and Results: Firstly, we set up a novel age-related mouse model
of kidney fibrosis via genomic knockout of legumain, a conseverd
asparaginyl endopeptidase physiologically expressed at renal tubuli.
Level of renal fibrosis was evaluated via hydroxyproline assay and
masson-trichrome staining. Legumain knockout mice showed significant
renal fibrosis beginning at 3 months old with normal serum creatinine
value. We isolated urine exosomes of 2 months old mice by ultracen-
trifugation and authenticated them by electron microscopy and western
blot. Exosomal proteins were then separated by 1-D SDS-PAGE and the
differentially expressed bands between 25 and 35 kDa were cut-off from
the gel. Through LC-MS/MS analysis, Voltage dependent anion channel
1 (VDAC1) was identified from 45 candidate proteins and the differ-
ential expression of Vdac1 was further validated in urinary exosomes by
Western blot and PCR. Via immunofluorescence study, we verified that
expresssion of Vac1 was located on the outer membrane of mitochon-
dria and mainly at renal tubuli. Then we examed exsomal vdac1 level via
western blotting in the fibrosis mouse model at different ages. Our data
showed exosomal vdac1 volume correlated positively with fibrosis level
in the fibrotic kidney assessed by thehydroxyproline assay, as well as the
activity of TGF-β measured by ELISA. In the human urine exosome
samples, Vdac1 expression was high in the patients with renal fibrotic
diseases compared with the normal control. In vitro, Vdac1 could be
identified in the exsomes isolated from cultured renal tubular cells. And
it could be induced by different pro-fibrotic stimuli, such as TGF-β1 and
aristolochic acids in the culture renal tubular epithelial cells.
Conclusion: In this study, we identified Vdac1 in the urine exosomes as
an potential index to evaluate early stage of renal fibrosis.
PT06.03
Urinary extracellular vesicles carrying markers of kidney injury and
renal stem cells differ between women and men and with age in
living kidney donors
Muthuvel Jayachandran1, Rangit Vallapureddy2, Aleksandar Denic2, Virginia
Miller2, John Lieske3 and Andrew Rule3
1Mayo Clinic College of Medicine, MN, USA; 2Mayo Clinic, MN, USA;
3Mayo Clinic Rochester, MN, USA
Introduction: The prevalence of kidney disease increases with age and is
higher in men than in women. Injured or activated renal cells release extra-
cellular vesicles (EVs) that could reflect ongoing renal pathophysiology.
Methods: This study was approved by Mayo Clinic Institutional Review
Board. Bio-banked cells-free randomurine from living healthy kidney donors
aged from 20 to 70 years old was studied. Urinary EVs >0.2 micron were
analysed by an established digital flow cytometry method and appropriate
antibodies. EV counts were calculated as EV/µL urine and normalised to EV/
mg creatinine. Ratios of EV/CD63 (exosome) or EV/annexin-V (microvesi-
cle) were also calculated for data analyses.
Results: Median age (47 and 44 years) and glomerular filtration rate (GFR,
101 and 102 ml/min/1.73 m2) were similar between women (n = 88) and
men (n = 54). Urinary EVs positive for renal injury markers (beta-2
microglobulin (beta-2M), cystatin C, laminin alpha-5 (LAMA5), and neu-
trophil gelatinase-associated lipocalin (NGAL)) were greatergreater
(p < 0.05) in women than men. Glomerular (CD90)- and tubular
(CD133)-stem/progenitor cell-derived EVs did not differ by sex. Urinary
EVs positive for beta-2M, cystatin C, LAMA5 decreased (p < 0.05) whereas
tubular stem/progenitor cell-derived EVs increased (p < 0.05) with age. EVs
positive for LAMA5 positively (p < 0.05) but EVs positive for CD133
negatively (p < 0.05) correlated with GFR. Tubular stem/progenitor-derived
EVs increased (p < 0.05) with percentage of globally sclerotic glomeruli
observed in kidney biopsy obtained before transplantation.
Conclusion: These results demonstrate that among apparently healthy
living adults there are sex-and age-associated differences in urinary EVs
bearing renal injury markers. Results may also provide clues regarding
mechanisms of sex differences in the prevalence of kidney disease.
LAMA5 and CD133 positive EVs merit further study as potential bio-
markers of kidney function among healthy and diseased patients.
PT06.04
Specific types of urinary extracellular vesicles differentiate type 1
primary hyperoxaluria patients without and with nephrocalcinosis or
kidney stones
Stanislav Yuzhakov1, Neil Sha1, John Lieske2, Andrew Rule2, Dawn Milliner1
and Muthuvel Jayachandran3





























1Mayo Clinic, MN, USA; 2Mayo Clinic Rochester, MN, USA; 3Mayo Clinic
College of Medicine, MN, USA
Background: Primary hyperoxaluria type 1 (PH1) is an autosomal recessive
disorder characterised by hepatic overproduction of oxalate. The resulting
hyperoxaluria can cause nephrocalcinosis and calcium oxalate stones. Kidney
cell-derived extracellular vesicles (EVs) could reflect these pathophysiologic
processes.
Methods: Bio-banked (cells-free) urine from 15–30 years oldmale and female
PH1 patients without (n = 10) and with nephrocalcinosis (n = 6) or stones
(n = 9) and age-/sex-matched (± 5 years) living kidney donors (n = 25) was
studied. Urinary EVs (>0.2 μm) were analysed by digital flow cytometry and
analysed as EVs/µL urine and EVs/mg urine creatinine.
Results: PH1 patients had significantly (PConclusion: Distinct urinary EV
populations were observed among PH1 patients without and with nephro-
calcinosis or stones. These results suggest that EVs released from specific
populations of renal cells of PH1 patients reflect nephrocalcinosis or stone
status, and further study of urinary EVs may allow identification of novel
biomarkers and provide clues regarding the pathogenesis of renal calcifica-
tion in this disease.
PT06.05
Characterisation and mechanism of increased exosomal CYP2E1 and
other P450 isoforms in alcoholic patients and alcohol-exposed rodents
Young-Eun Cho1, Esteban Mezey2, James P. Hardwick3, Norman Salem Jr1
and Byoung-Joon Song1
1Laboratory of Membrane Biochemistry and Biophysics, National Institute on
Alcohol Abuse and Alcoholism, NIH; 2Department of Medicine, The Johns
Hopkins University School of Medicine, MD, USA; 3Department of
Integrative Medical Sciences, College of Medicine, Northeast Ohio Medical
University, OH, USA
Introduction: The ethanol-inducible cytochrome P450-2E1 (CYP2E1)
and P450 isoforms are involved in the metabolism of many substrates
with the production of metabolites and reactive oxygen species in the
liver and other tissues. We hypothesised that elevated amounts of
CYP2E1 and other P450 isoforms can be secreted into circulating exo-
somes in alcohol-exposed rodents and alcoholic patients in a CYP2E1-
dependent manner. Thus, this study was aimed to investigate the role of
CYP2E1 in increasing the levels of CYP2E1 and other P450 proteins in
plasma exosomes from alcohol-exposed rodents and human alcoholics.
Methods: Female Fischer rats and wild-type (WT) or Cyp2e1-null mice
were exposed to three oral doses of ethanol (4–6 g/kg/dose) or dextrose
(as control) at 12 h intervals and sacrificed at 1 h after the last ethanol
dose. Plasma exosomes from alcohol-exposed rodents, alcoholics and
their respective controls were isolated and confirmed by immunoblots
for exosomal marker proteins and size measurements. The exosomal
proteins were characterised by immunoblot analyses.
Results: The amounts of exosomes and exosomal CYP2E1, CYP2A6, CYP4B
proteins were markedly elevated in alcoholics and alcohol-exposed rats and
mice, which exhibited hepatic steatosis, than the respective controls. The
elevated amounts of exosomes and exosomal P450 proteins were significantly
reduced in ethanol-exposed rats fed a diet containing n-3 polyunsaturated
fatty acids. Further, the increased number of exosomes and the exosomal
CYP2E1 and P450 isoforms in alcohol-exposed WT mice were significantly
blunted by co-treatment with a CYP2E1 inhibitor chlormethiazole or an
antioxidant N-acetylcysteine or in the ethanol-exposed Cyp2e1-null mice.
Conclusion: These results suggest the role of CYP2E1 and oxidative
stress in promoting the ethanol-mediated secretion of exosomal pro-
teins. Additionally, exosomal CYP2E1 could be used as a potential
biomarker for alcohol exposure and/or alcohol-induced fatty liver.
PT06.06
Hepatocyte-derived exosome enrichment and cell culture methods
optimisation for the identification of novel DILI biomarkers
Sarah Thacker1, Manisha Nautiyal1, Natalie Holman2, Monicah Otieno3, Paul
Watkins1 and Merrie Mosedale1
1UNC Chapel Hill Eshelman School of Pharmacy, NC, USA; 2UNC Chapel
Pharmacy, NC, USA; 3Janssen Research and Development, LLC
Introduction: We have previously demonstrated that hepatotoxicants induce
alterations in hepatocyte-derived exosomes (HDE) prior to overt necrosis,
supporting a role for HDE in the pathogenesis of drug-induced liver injury
(DILI). Because HDE contain liver-specific mRNAs, miRNAs, and proteins,
they may have value as sensitive and specific biomarkers of DILI. In order to
explore the DILI biomarker potential of HDE, the objectives of this study
were to (1) identify the best method for enrichment and (2) optimise cell
culture methods to compare the number and content of HDE released from
primary human hepatocytes (PHH) in response to DILI compounds.
Methods: To evaluate exosome enrichment, vesicles were isolated from the
culture medium of HepG2 cells using ultracentrifugation (UC), OptiPrep
density gradient ultracentrifugation (ODG), and ExoQuick-TC™ (EQ). To
evaluate the effect of a Matrigel® overlay on exosome release, exosomes were
enriched from the culture medium of HepaRG cells using UC. Nanoparticle
tracking analysis was performed to assess vesicle number and size. Total RNA
extracted from vesicles was used to determine the quantity (Quant-iT™
RiboGreen®) and fraction of miRNA that was vesicular vs. AGO2 bound
(immunoprecipitation). Total protein was quantified and exosomal protein
enrichment was evaluated via Western blotting.
Results: EQ resulted in a significantly higher number of exosome-sized
particles than UC (p < 0.001) or ODG (p < 0.0001). Particle size and
variation using UC and EQ were similar (~100 ± 10 nm), however ODG
enriched for particles significantly larger in size (p < 0.05). EQ and UC
resulted in comparable levels of vesicular RNA and protein, however UC
had significantly more vesicular RNA and CD63 protein when compared
to EQ or ODG (p < 0.05). No significant differences in particle number
were observed across Matrigel concentrations ranging from
0–0.25 mg/mL.
Conclusion: These data suggest that both UC and EQ enrichment result in
significantly more HDE than ODG, but UC produces a purer population of
HDE.Matrigel overlay does not inhibit the release of HDE.We conclude that
UC-based enrichment provides the optimal combination of HDE quantity
and purity and Matrigel overlay can be used in PHH culture for the identi-
fication of novel exosome-based biomarkers for DILI.
PT06.07
Elevations in circulating extracellular vesicle miR-21 as a biomarker of
developing Type 1 diabetes mellitus
Alexander Lakhter1, Farooq Syed2, Bernhard Maier2, Raghavendra Mirmira1,
Carmella Evans-Molina3 and Emily Sims1
1Department of Pediatrics, Section of Endocrinology and Diabetology, Center
for Diabetes and Metabolic Diseases, IU School of Medicine; 2Center for
Diabetes and Metabolic Diseases, IU School of Medicine; 3Department of
Pediatrics, Section of Endocrinology and Diabetology, Department of Cellular
and Integrated Physiology, Center for Diabetes and Metabolic Diseases, IU
School of Medicine
Type 1 diabetes (T1D) develops over time, such that by the time of typical
diagnosis, patients have already lost 80% of their pancreatic beta cell mass.
Strategies for detection of T1D, prior to widespread loss of the β cells, are
acutely needed for improved outcomes of preventative interventions.
MicroRNAs (miRNAs) released in extracellular vesicles (EVs) have been
proposed as ideal biomarkers due to their stability and feasibility of detection.
Previous work from our lab demonstrated that β cell miR-21 production is
induced by inflammation, and RT-qPCR analysis of diabetic NOD mouse
islets revealed a ~4-fold increase in miR-21 expression compared to NOR
controls. We hypothesised that the inflammatory milieu of developing T1D
may also increase miR-21 in β cell EV cargo. EVs released by INS-1 β cells
exposed to a cytokine mix of IL-1β, INFγ and TNFα were isolated using
ExoQuick reagent. RT-qPCR revealed an 8-fold increase in EV miR-21.
Similarly, a 5-fold increase in miR-21 content was observed in EVs from
cytokine-treated human islets. Nanoparticle tracking analysis showed no
changes in EV quantity or size distribution in response to cytokine exposure,
implicating transcript upregulation and changes in EV cargo as responsible
for the observed increases. To assay changes in circulating EV miR-21, we
performed longitudinal serum collections on NOD mice and insulitis resis-
tant NOR controls, from 9 wks of age and until diabetes onset (defined as
blood glucose > 200 mg/dL × 2, n = 7). Starting 3 weeks prior to diabetes





























onset, EV miR-21 levels progressively increased in serum of diabetic NODs
compared to age-matched NOR controls, peaking at a 10-fold increase from
baseline levels. To validate relevance to human diabetes, serum EV miR-21
was assayed in samples collected from paediatric T1D patients at the time of
diagnosis, as well as age-matched healthy controls (n = 19/group). Consistent
with our NOD data, serum EVmiR-21 was significantly increased in diabetic
samples compared to controls. We propose that EV miR-21 may be a
promising marker of insulitis and developing T1D in susceptible individuals.
Ongoing studies will further define relationships between EVmiR-21 content
and β cell inflammation and death.
PT06.08
Circulating Tie2+ microvesicles as potential indicators of diabetic
retinopathy progression
Aleksandra Tokarz1, Anna ElżbietaDrożdż2, Iwona Szuścik3 and Ewa Stępień2
1Department of Clinical Biochemistry, Jagiellonian University Medical College,
Krakow, Poland; 2Department of Medical Physics, Faculty of Physics,
Astronomy and Applied Computer Science, Jagiellonian University, Krakow,
Poland; 3Private Ophthalmology Practice, OKO-LASER Outpatient Clinic
Introduction: Retinopathy is the most commonly occurring microvascular
complication of diabetes, which is a major cause of vision loss. Although
this complication covers substantially the retina, diabetic retinopathy (DR)
has a systemic importance. The course of DR is very complex and multi-
faceted. In the initial phase of the dominant process is an increase in the
permeability of the blood-retina barrier, inflammation and loss of endothe-
lial function hypoxia. Angiopoietin-2 is considered to be involved in the
increased endothelium permeability and dysfunction. Its autocrine action is
regulated by angiopoietin receptor (Tie-2), present on the surface of
endothelial cells and endothelial origin MVs.
Methods: DM patients (n = 61) aged 63 (59–68) and healthy controls
(n = 25) aged 50 (45–56) were enrolled. The diagnosis and classification
of retinopathy were carried out on the basis of the Polish Diabetes
Association recommendations (2016). Finally, among examined DM
patients, 7 had soft non-proliferative diabetic retinopathy (SNPDR), 5
had moderate non-proliferative (MNPDR), 13 had heavy non-prolifera-
tive (HNPDR) and 6 had PDR. MVs profiling (Tie2+) in plasma was
performed by means of Gigamix (BioCytex) calibrated CytoFLEX
(Beckman Coulter). This study has permission of the Bioethical
Committee of Jagiellonian University (KBET/206/B/2013).
Results: Ang-2 levels were significantly higher in DM patients when
compared to healthy controls (3.5 [2.0–4.3] vs. 1.8 (1.5–2.1), p+ MVs
than controls (p = 0.016); however, the number of platelet and endothe-
lial origin MVs was the same. There was no correlation between Ang-2
and the total number of MVs and Tie2+. The significant increase in the
number of Tie2+positive MVs was observed in HNPDR (293 [108–391]
n/µL) to decrease in PDR (90 [70–198] n/µL).
Summary: The number of pro-angiogenic MVs is lower in DM patients
then in control. The critical point in DR progression is the most
advanced non-proliferative DR (HNPD), where the number of Tie2+
MVs is significantly elevated.
Funding: This study was supported by the Polish National Science
Centre grant (2012/07/B/NZ5/02510).
PT06.09
Urine extracellular vesicles transcriptome in diabetic kidney disease
Maija Puhka1, Om Dwivedi1, Carol Forsblom2, Erkka Valo2, Karina
Barreiro1, Harry Holthöfer1, Per-Henrik Groop2 and Leif Groop1
1Institute for Molecular Medicine Finland FIMM, University of Helsinki,
Finland; 2Folkhälsan Institute of Genetics, Folkhälsan Research Centre,
Helsinki, Finland
Introduction: Diabetic kidney disease (DKD) lacks non-invasive early bio-
markers.We examined the transcriptome of urine extracellular vesicles
(EVs) via RNAseq as a biomarker for DKD. We also compared storage
conditions of the urine samples (−20°C vs. −80°C) to clarify whether sample
collections in −20°C can be used for biomarker discovery.
Methods: EVs were isolated from 24 h urine samples of 20 type 1
diabetic patients (T1D): 6 macro- and 2 microalbuminuric cases and
12 normoalbuminuric controls. EV quality was controlled with EM and
Western blotting (WB). RNAs were profiled with Bioanalyzer Pico kit
and subjected to RNAseq after cDNA library preparation with low
amount protocols. Reads were aligned to human reference genome and
counted with GENCODE gene annotations. Gene expression was mea-
sured as FKPM (Fragments per Kilobase of exon Per Million).
Results: EVs appeared typical at EM and positive for the EV-marker CD9
and kidney-derived podocalyxin inWB. RNA quantity and quality sufficed
for RNAseq producing >15 million reads from all samples. Samples stored
at different temperatures clustered in their own groups. On average, we
detected expression (FKPM >1) of 13,161 genes. Analysis of 182 kidney-
specific genes revealed that >70% (total 132) were expressed in EVs.
Principal component analysis of these 132 genes discriminated macro-
from normoalbuminuric T1D patients. Six genes were differentially
expressed in DKD (puncorr < 0.001, fold change >1.5 or < 0.66) with the
most striking difference in the KL gene previously linked to chronic kidney
disease. Highly expressed genes in EVs (N = 5153, FKPM ≥ 10) were
enriched in pathways of cellular metabolism, vesicle trafficking, mitochon-
drial and ribosome function.Pathway and gene enrichment analyses of all
nominal differentially expressed genes implicated TGF-beta signalling,
PI3K-Akt signalling and immune pathway in DKD (N = 956, p < 0.002)
Conclusion: Urine EVs can capture a significant part of the kidney-specific
transcriptome and differentiate macro- from normoalbuminuric T1D
patients. Technically, samples stored at different temperatures cannot be
directly compared calling for meticulous standardisation of protocols.
These should include comparison of, for example, EV isolation and storage
methods to allow large-scale studies required for biomarker discovery.
LBP.16
Role of exosomal miRNAs in RPE cell mitochondrial dysfunction in
AMD
Michael Paulaitis1, Ju Young Ahn1, Sayantan Datta2, Elga Bandeira3, Marisol
Cano2 and James Handa2
1Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins
University School of Medicine, MD, USA; 2Wilmer Eye Institute, Johns
Hopkins University School of Medicine, MD, USA; 3Krefting Research
Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Introduction: Mitochondrial function declines with aging, and when
significant, contributes to the onset of neurodegenerative diseases, such
as Parkinson’s and Alzheimer’s disease, and age-related macular degen-
eration (AMD). Exosome formation/release is related to mitochondrial
dysfunction through the lysosomal and exocytic pathways that process
and eliminate intracellular fragments. Relevance to AMD is through
retinal pigmented epithelial (RPE) cells, which maintain a healthy retina
by phagocytosis of photoreceptor outer segments, an energy intensive
process that requires highly functional mitochondria and a robust autop-
hagic system for removing unwanted intracellular material. We hypothe-
size there cells with impaired mitochondria will release exosomes with a
unique miRNA signature that reflects both mitochondrial breakdown
within these cells and stress placed on the lysosomal and exocytic path-
ways, and as such, may be a diagnostic for AMD.
Methods: We screened for >700 human miRNAs in ARPE-19 cells,
mitochondria isolated from these cells, and ARPE-19 exosomes charac-
terized by their size distribution, morphology, and the presence of CD63.
Validation of specific mitochondrial miRNAs (mito-miRs) and their
presence in ARPE-19 exosomes was performed by qRT-PCR assay.
ARPE-19 cells transfected with locked nucleic acid inhibitors targeted
to specific mito-miRs served to validate their mitochondrial function.
Mitochondrial injury was induced in the cells by treatment with rote-
none, which impairs mitochondrial complex I.
Results: We identified miR-494-3p and miR-579-3p as mito-miRs that
are also present at statistically significant levels in exosomes derived
from untreated ARPE-19 cells. We also measured a significant enhance-
ment in exosomal miR-494-3p in response to rotenone treatment of the
ARPE-19 cells.
Summary/Conclusion: Our finding of enhanced levels of miR-494-3p in
exosomes derived from rotenone-treated ARPE-19 cells identifies this
mito-miR as a potential exosomal biomarker for AMD. The presence of
this mito-miR in ARPE-19 exosomes also raises the possibility that





























mitochondrial function in RPE cells can be regulated by exosome-
mediated intercellular transfer of mito-miRs, such as miR-494-3p.
LBP.17
Salivary EV expression in traumatic brain injury
Mandy Pereira1, Yan Cheng1, Neha Raukar2, John Reagan3, Mark Dooner4,
W. Curt LaFrance5, Matt Quesenberry1 and Peter Quesenberry6
1Rhode Island Hospital/Alpert Medical School of Brown University,
Department of Medicine, Divisions of Hematology/Oncology, RI, USA;
2Rhode Island Hospital/Alpert Medical School of Brown University
Emergency Medicine, RI, USA; 3Rhode Island Hospital/Alpert Medical
School of Brown University, RI, USA; 4Brown University/Rhode Island
Hospital Divisions of Hematology/Oncology, RI, USA; 5Rhode Island
Hospital/Alpert Medical School of Brown University, Psychiatry and
Neurology, RI, USA; 6Brown University/Rhode Island Hospital Department
of Medicine, Divisions of Hematology/Oncology, RI, USA
Introduction: In 2013, 50,000 traumatic brain injury (TBI) related deaths
occurred. Mild TBI (or concussions) is clinically difficult to diagnose due to
limited sensitivity with CT and MRI. Studies have shown possible biomar-
kers in body fluids such as cerebral spinal fluid (CSF) and blood as predictive
of degenerative brain disease in patients’ post-traumatic brain injury (TBI).
Increased levels of β-amyloid, and tau associated with Alzheimer’s disease
(AD) have also been seen in patients post-TBI (Blennhow 2010). For
example, increased levels of Caspase-3, S100β, GFAP, and TrkB have been
found in the brains of patients that died due to TBI (Staffa 2012) and found
in blood and CSF samples. We wished to determine if aberrant levels of
similar genes, or specific genetic profiles could be found in salivary extra-
cellular vesicles (EVs) of subjects after TBI.
Methods: Saliva was collected fromemergency room (ER) patients who either
had a confirmed head impact or no recorded impact (as a control), and
chronic concussion patients to isolate EVs. Healthy volunteers were used as a
control. EVs were isolated via differential centrifugation and analyzed for
mRNA and microRNA content using real time quantitative PCR.
Results: Concussion clinic patients had 14 microRNAs significantly chan-
ged. ER patients had significant elevation of 9 genes associated with AD,
such as APLP2, MAPT, AND CSNK1D, and 12 inflammation genes such
as ALOX5, ANXA3, CASP1. Concussion clinic patients had 21 AD genes
elevated, such as APBA3, CAPNS2, CDK5R1 and 12 inflammation genes,
such as ADRB1, ADRB2, and BDKRB1. The Wilcoxon sum test was used
to compare gene expressions of patients to healthy controls.
Conclusion: Salivary EV profiling could be developed as a non-invasive
test that might predict the development and progression of degenerative
brain disease associated with TBI.
Funding: This project was supported by the National Institute of General
Medical Sciences (NIGMS) of the National Institutes of Health through
Grant Number (COBRE) P20GM103468 (PJQ) and the National Heart,
Lungs, and Blood Institute (NHLBI) Grant T32HL116249.
LBP.18
ExRNAs in human cerebrospinal fluid are biomarkers for Alzheimer’s
disease
Julie Saugstad1, Theresa Lusardi2, Jay Phillips3, Jack Wiedrick3, Jodi Lapidus3,
Christina Harrington3, Trevor McFarland3, Babette Lind3 and Joseph Quinn4
1Anesthesiology and Perioperative Medicine, Oregon Health and Science
University, OR, USA; 2Computational Biology, Oregon Health and Science
University, OR, USA; 3Oregon Health & Science University, OR, USA;
4Neurology, OHSU School of Medicine
Introduction: Currently available biomarkers of Alzheimer’s disease
(AD) are limited. The discovery of extracellular microRNAs (miRNAs)
in cerebrospinal fluid (CSF) raises the possibility that miRNA may serve
as novel biomarkers of AD. We investigated miRNAs in CSF from living
donors as biomarkers for AD.
Methods: We profiled miRNAs in CSF from 50 AD patients and 49
controls using TaqMan® arrays. Replicate studies on a subset of
original CSF samples verified 20 high confidence miRNAs. Stringent
data analysis using a four-step statistical selection process including
log-rank and receiver operating characteristic (ROC) tests, followed
by random forest tests, identified 16 additional AD miRNA candi-
dates. Multi-marker modeling evaluated linear combinations of these
miRNAs to ascertain classification performance, and this was com-
pared to that of ApoE4 genotype. In addition, incremental improve-
ment adding miRNA biomarkers to ApoE4 was assessed. Validation
studies of 36 AD miRNA biomarker candidates on an independent set
of 47 AD patients and 71 control CSF samples are complete, and
classification performance of high-confidence miRNA biomarkers for
AD ascertained using a targeted analytic pipeline to refine marker
combination algorithms and suggest thresholds for positivity will be
presented. The added value of ApoE4 genotype and other potential
classifiers (i.e., Aβ:tau ratio) on biomarker performance will also be
presented.
Results: We discovered 36 miRNAs that discriminate AD from
control CSF. 20 of these retested in replicate studies verified differ-
ential expression between AD and controls. Stringent statistical
analysis identified these 20 miRNAs, and 16 additional miRNAs, as
candidate biomarkers for AD. Top-performing linear combinations
of 3 and 4 miRNAs have AUC of 0.80–0.82. Addition of ApoE4
genotype to the model improved performance. Validation studies for
the 36 AD miRNA biomarker candidates on a new and independent
cohort to determine whether miRNAs in CSF, alone or in combina-
tion with other classifiers, can serve aa a biomarker for AD, will be
presented.
Summary/Conclusion: CSF miRNAs can discriminate AD patients from
controls. Combining miRNAs improves sensitivity and specificity of
biomarker performance, and adding ApoE4 genotype, and possibly
other classifiers, improves classification.
Funding: NIH NCATS UH2/3 TR000903 (JAS, JFQ)
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PT07.01
Lipidomic profiles of exosomes and microvesicles from human
mesenchymal stem cell
Sicheng Wen1, Patrycja Dubielecka-Szczerba1, Michal Grzybek2, Mark
Dooner1, Giovanni Camussi3 and Peter Quensenberry1
1Brown University/Rhode Island Hospital, OR, USA; 2Membrane
Biochemistry, Paul Langerhans Institute Dresden, Medical Faculty TU
Dresden, Dresden, Germany; 3Department of Medical Sciences,University
of Turin, Torino, Italy
Introduction: Extracellular vesicles (EVs), including exosomes and
microvesicles (MVs), are the small spherical membrane particles released
from cells, which have been shown to be involved in cell-to-cell com-
munication and modification of the phenotype of target cells.
Mesenchymal stem cells (MSCs) derived EVs have been shown to
mediate reversal of different tissue injuries including kidney, brain,
bone marrow and myocardium.
Methods: To advance our understanding of the biology and physiologi-
cal functions of MSCs-EVs and to explore their therapeutic potential, we
have used shotgun mass spectrometry to provide comprehensive char-
acteristics of the lipid content of EVs isolated from MSCs. We designed
our experimental strategy to answer two questions: (i) are MSCs-derived
EVs differ from their parental cell line in terms of the lipid composition
and (ii) are there differences in lipid compositions between various
MSCs-derived EVs types.
Results: Three fractions of EVs including exosomes, MVs, and the
combined fraction of exosomes and MVs were obtained from human
MSCs using differential ultracentrifugation steps (2000g, 10,000g and
then 100,000g). Lipidomic data reveal significant differences in lipid
content within vesicle subtypes, and between EVs and parental MSCs.
When compared with their parental cells, all three fractions of EVs are
significantly enriched in lyso-phosphatidylcholine (LPC), sphingomyelin
(SM), cholesterol esters (CE) and phosphatidylcholine-ether (PC(O-)),
whereas levels of phosphatidylglycerol (PG), phosphatidylethanolamine-
ether (PE(O-)) and triacylglycerol (TAG) are lower in all three fractions
of EVs. In comparison to MSCs parental cells, no TAG and cardiolipin
(CER) are present in exosomes, and only little amount of TAG present
in MVs. Comparison of the lipidomic profiles of exosomes vs MV
showed significant differences between these two fractions. Exosomes
showed enrichment in LPC, LPC (-O) and SM, whereas MVs charac-
terised enrichment in CER, PE(-O) and diacylglycerol (DAG). A princi-
pal component analysis clearly indicated different lipid profile between
EVs and parent MSCs.
Conclusion: Our data indicate that both Exosome and MV membranes
are enriched in certain classes of lipids, which may indicate potential
role of these lipids in general function and biology of EVs.
PT07.02
Non-targeted metabolite profiling reveals differences in the lipid
composition of extracellular vesicles derived from prostate cells
grown in traditional 2D cultures versus in 3D bioreactor
Mari Palviainen1, Jenna Pekkinen2, Heikki Saari3, Marjo Yliperttula4, Kati
Hanhineva2, Maija Puhka5 and Pia R-M. Siljander6
1EV-core, Division of Biochemistry and Biotechnology, Department of
Biosciences/Division of Pharmaceutical Biosciences, Centre for Drug
Research, Faculty of Pharmacy and Institute of Molecular Medicine Finland
FIMM, University of Helsinki, Finland; 2LC-MS Metabolomics Centre,
University of Eastern Finland, Finland; 3Division of Pharmaceutical
Biosciences, Centre for Drug Research, Faculty of Pharmacy, University of
Helsinki; 4Division of Pharmaceutical Biosciences and Centre for Drug
Research, Faculty of Pharmacy, University of Helsinki; 5Institute for
Molecular Medicine Finland FIMM, University of Helsinki, Finland;
6Division of Biochemistry and Biotechnology, Department of Biosciences/
Division of Pharmaceutical Biosciences, Centre for Drug Research, Faculty of
Pharmacy, University of Helsinki, Helsinki, Finland
Background: Extracellular vesicles (EVs) have a lipid bilayer membrane that
is structurally comparable to cell membranes making them optimal drug
delivery vehicles. Since the production of EVs in traditional 2D cell culture
setup results in relatively low amounts of EVs, 3D bioreactors have come
more popular as a way to increase the EV yield. In addition to the EV yield
and proteome, comparative analyses between 2D and 3D culture-derived
EVs have been scarce. Since lipids play important roles in EV functions, we
assessed how the cell culture setup affects the EV lipid metabolome.
Methods: Prostate cell lines PC-3, VCaP and PNT2 cells were grown in
both traditional 2D cultures and in bioreactors. EVs were isolated from
cell cultures using differential centrifugation at 20,000g (20 K pellet,
microvesicles), and subsequently at 100,000g (100 K pellet, exosomes).
EVs were characterised with nanoparticle tracking analysis (NTA) and
western blotting, and the lipid metabolites were analysed using non-
targeted LC-qTOF-MS approach.
Results: EV yield was superior from cells cultured in bioreactors com-
pared to traditional 2D cultures. The size distribution of EVs did not
differ between the 2D- and 3D-derived 20 K samples, but in the 100 K
samples the EVs from all cell lines grown in the traditional 2D cultures
were bigger that the EVs from bioreactors. More than 130 individual
lipid metabolites were identified from all sample groups, belonging to
glycerophospholipids, sphingolipids, sterol lipids and fatty amides. EVs
derived from the cells grown in the traditional 2D cultures tended to
have a broader spectrum of individual lipid metabolites than the EVs
derived from cells grown in the bioreactors.
Conclusion: The results suggest that the environment where the cells are
grown alters the EV features. Deeper metabolomics analyses will reveal
information about the cell status and next we will study how these
changes affect the functionality of EVs.
PT07.03
Quantitative comparison between small and large extracellular
vesicles reveals enrichment of adhesion proteins in small extracellular
vesicles
Lizandra Jimenez1, Hui Yu1, Andrew McKenzie2, Qi Liu1 and Alissa Weaver1
1Vanderbilt University, TN, USA; 2Sarah Cannon Research Institute
Introduction: Extracellular vesicles (EVs) are important mediators of cell-cell
communication due to their cargo content of proteins, lipids and RNAs. We
previously reported smaller EVs, such as exosomes, promote a variety of
aggressive cancer cell traits, such as cell motility and invasion. In contrast
larger EVs, such as microvesicles, were not active in our systems. The goal of
this study was to identify differences in the protein cargos of small and large
EVs that may contribute to their different functional properties.
Methods: We utilised isobaric tag for relative and absolute quantitation
(iTRAQ)-LC-MS/MS to perform a comprehensive comparison of pro-
tein cargos in small and large EVs obtained from the colorectal cancer
line DKs-8. Statistically significant differences in proteins between the
two EV types were identified by differential expression and gene set
enrichment analysis methods. Proteins of interest were validated by
Western blot analysis of EVs purified from the DKs-8 cells as well as
from HT1080 fibrosarcoma cells.
Results: This proteomic analysis showed that small EVs were enriched in
proteins associated with cell-cell junctions, cell-matrix adhesion and the
exosome biogenesis machinery. In contrast, large EVs were enriched in
proteins associated with ribosome and RNA biogenesis and processing,
and metabolism. Western blot analysis confirmed the presence of integ-
rins, thrombospondin and Ephrin receptors in small EVs. In addition,
another highly abundant protein in the small EVs was arrestin-domain
containing protein 1 (ARRDC1), which has been implicated in budding





























of small microvesicles from the plasma membrane. We are currently
trying to analyse the protein cargos carried by small EVs derived by
ARRDC1-mediated budding versus exosomes.
Conclusion: iTRAQ is a useful method to identify protein differences in
complex EV populations. Adhesion proteins appear to be particularly
enriched in small EVs and may function to promote cell motility.
PT07.04
Advancement of multi-parametric profiling of extracellular vesicles:
comparison of protein extraction by Laemmli and Trizol reagents
using nanoLC-MS/MS
D. Craig Ayre1, Andrew Joy1, David Barnett1, Anirban Ghosh2, Rodney J
Ouellette2 and Stephen M. Lewis2
1Atlantic Cancer Research Institute, New Brunswick, Canada; 2Department of
Chemistry and Biochemistry, Université de Moncton, New Brunswick,
Canada
Introduction: Extracellular vesicles (EVs) are anticipated to be valuable
sources of disease-specific biomarkers, but yields are often limited by the
amount of starting material. Trizol-based extraction can generate both
RNA and protein fractions from the same EV sample, enabling a multi-
parametric analysis that minimises time, cost, sample volume and varia-
bility. Here we compare the protein complement of EVs isolated from
conditioned culture media of two breast cancer cell lines, MCF-7 and
MDA-MB-231, using Laemmli and Trizol extraction.
Methods: EVs from two sets of biological triplicates (3 mL each of
conditioned media) were isolated from each cell line using the Vn96
affinity peptide. For each set of triplicates, proteins were extracted from
EV/Vn96 pellets using either Laemmli or Trizol buffer and subsequently
digested for analysis by LC-MS/MS. Peptide extracts were separated by
gradient nanoLC chromatography and detected using a hybrid quadru-
pole-Orbitrap mass spectrometer. LC-MS/MS data was searched against
a Uniprot database using Proteome Discoverer 2.0. Aqueous phases of
Trizol extracts were saved for RNA extraction.
Results:Trizol and Laemmli replicates were each analysed in technical tripli-
cate by LC-MS/MS. Within a set of LC-MS/MS triplicates, approximately
75–81% of the identified proteins were found to be present in two out of three
replicates. Comparisons of common protein lists between the two extraction
methods show a lower degree of similarity than the technical replicates. In
addition to comparing extraction methods, we also looked at similarities
between cell lines in terms of gene ontology. No significant differences in
cellular component ontology between the two extraction methods were
observed for either of the cell lines.
Conclusion: Our results demonstrate that Trizol extraction of protein
from EVs gives comparable results to Laemmli extraction while also
allowing for parallel RNA isolation from the same sample. This method
is particularly relevant to the development of multi-parametric protocols
for liquid biopsy samples in clinical studies. A comparison of the RNA
profile in relation to protein profile is in progress.
PT07.05
Comparative analysis of extracellular vesicle proteome and small RNA
transcriptome reveals global abundance of RNA binding proteins but
the relative depletion of miRNA related proteins and transcripts
Imre Mäger1, Helena Sork2, Yi Xin Fiona Lee3, Henrik Johansson4, Janne
Lehtiö4, Matthew J. Wood1 and Samir EL-Andaloussi1,2
1Department of Physiology, Anatomy and Genetics, University of Oxford,
Oxford, United Kingdom; 2Department of Laboratory Medicine, Karolinska
Instiutet, Stockholm, Sweden; 3Genome Institute of Singapore, Singapore;
4Science for Life Laboratory, Department of Oncology-Pathology,
Karolinska Institutet, Stockholm, Sweden
Introduction: Extracellular vesicles (EVs) are known to contain a range
of bioactive molecules, including lipids, proteins and nucleic acid that
could be transferred and result in an altered functional state of the
recipient cell. Primarily due to that, there is an increasing interest in
the detailed composition of these vesicular components, especially
miRNAs, representing one of the most potent gene expression modula-
tors. In addition, comparative “omics” analysis is encouraged to provide
a global understanding of the mechanisms underlying vesicular cargo
sorting.
Methods: Our study combines the proteome and small RNA transcrip-
tome analysis of EVs extracted from conditioned medium of Hek293T
and C2C12 cell lines using an ultracentrifugation protocol. Cell-line
specificity and abundance profiling as well as gene ontology (GO) term
annotation of the identified EV proteins were investigated and compared
to the entries in the Vesiclepedia database. The aforementioned data was
further matched with smallRNA sequencing results to understand the
detailed composition of the vesicle associated small RNAs and match
them to the abundance of the related proteins for integrated “omics”
analysis.
Results: The study revealed a high abundance of proteins related to GO
terms describing ribosomes and protein targeting to membrane.
However, we observed a notable scarcity of proteins classified under
GO terms describing miRNA related proteins. This corroborated with
our transcriptomic data exposing an extreme abundance of ribosomal
RNA fragments, however only under 1% of all RNA reads matched
current miRNA annotations in miRBase.
Summary: This study outlines the combined proteomic and transcrip-
tomic profile of EVs derived from two different cell sources, aiming to
shed light to the interplay of vesicular components for future untangling
of global molecular cargo sorting mechanisms.
PT07.06
Proteomic analysis of extracellular vesicles obtained from
Toxoplasma gondii and toxoplasma-infected cells
Pryscilla F. Wowk1, Maria Luisa Zardo1, Halisson Tesseroli. Miot1, Samuel
Goldenberg1, Paulo C. Carvalho1 and Patricia A. Morking1,2
1Instituto Carlos Chagas/FIOCRUZ-PR, Curitiba, Brazil; 2Institut Curie,
Paris, France
Introduction: Toxoplasma gondii is an opportunistic pathogen, which is
the causative agent of toxoplasmosis, a worldwide zoonosis. It is known
that, like other protozoan, it produces functional extracellular vesicles
(EVs). The effect of EVs derived from T. gondii on the immune response
and its relevance in a physiological context is presently unknown. In
order to bring new insights into the participation of EVs in the
Toxoplasma dissemination and in the regulation of the host immune
systems we disclose here the first proteomic profiling of T. gondii EVs
(TgEV) compared to EVs isolated from a human foreskin fibroblast
(HFF) infected (ICEV), and non-infected cells (NICEV) cultured in a
vesicle-free medium.
Methods: T. gondii tachyzoites (RH strain) were maintained by serial
passage in HFF monolayers at 37°C in a humid 5% CO2 atmosphere.
Three days after peal, a billion parasites were washed and cultured in
DMEM HG for 2 h at 28°C. Supernatants free from parasites were
filtered in a 0.45 μm membrane, and EVs isolation was performed
using total exosome isolation kit. Dimensional characterisation was
performed using NanoSight LM10. TEM was carried out in JEOL
JEM-1400 Plus EM. Protein levels were assessed by the Qubit fluoro-
metric quantification. Three EV sample preparations, independently
obtained from T. gondii, HFF-infected, and non-infected cells were
separated by SDS-PAGE. The gel lanes were excised, sliced and digested
with trypsin. Five micrograms of protein were analysed in triplicate by
LC-MS/MS in a Thermo Scientific Easy-nLC 1000 system coupled to a
LTQ Orbitrap XL ETD. Peaklist picking, protein identification, were
done using the MaxQuant version 1.5.0.25 and Pattern Lab platform.
Results: TEM shows vesicles of about 100 nm size for all samples.
Proteomics analysis identified 346, 69 and 15 proteins as being unique
to TgEV, ICEV and NICEV, respectively. When the common content
from the three targets was analysed, a broad range of identified proteins
correspond to classical EVs markers as annexins, HSP70, serpins, and
tetraspanins. Data are available via ProteomeXchange (ID: PXD004895).
Conclusion: We present here the first characterisation of EVs protein
contents and the contribution of the T. gondii and HFF cell in its
formation. It is noteworthy that our proteomic data is in accordance
to the legitimated proteins reported at EVpedia.






























Proteomic analysis of extracellular vesicles derived from
propionibacterium acnes
Jinseong Jeon, Jin Her and Changill Ban
Pohang University of Science and Technology, Pohang, Republic of Korea
Extracellular vesicle (EV) has been reported to conduct critical patho-
physiological functions as an emerging mode of communication in
bacteria. Recently, Propionibacterium acnes, an anaerobic Gram-positive
human commensal found in the skin and gastrointestinal tract, has
drawn increasing attention as an underestimated pathogen in a variety
of diseases. For the comprehensive understanding of P. acnes, here we
report the isolation of P. acnes EVs for the first time and identification of
252 vesicular proteins with high confidence using triplicate LC-MS/MS
analyses. Comprehensive proteomic profiling reveals that P. acnes EVs
harbour various proteins involved in biochemical processes, antibiotic
resistance, bacterial competition, cell adherence, virulence and immu-
nogenicity. We believe that this report will provide valuable information
for investigating the biological role of P. acnes EVs and effective targets
for developing clinical applications against P. acnes.
PT07.08
Proteomic analysis of mouse lung tissue-derived vesicles, a
comparison of ultracentrifugation and density flotation isolation
Cecilia Lässer1, Shintaro Suzuki1, Kyong-Su Park1, Ganesh Shelke1, Lilit
Hovhannisyan2, Rossella Crescitelli1 and Jan Lötvall1
1Krefting Research Centre, Institute of Medicine, University of Gothenburg,
Sweden; 2Institute of Molecular Biology, Armenian National Academy of
Sciences, Yerevan, Armenia
Introduction: Analysis of the proteome of extracellular vesicles (EVs) is
of great importance both to identify biomarkers of disease but also to
understand cell-to-cell communication in diseased tissue. The aim of
this study was to establish an isolation method that isolates lung vesicles
of high purity for proteomic analysis.
Methods: A mouse model for allergic asthma was used by sensitisation
and challenge of C57BL/6 mice to ovalbumin (OVA). Animals were
sacrificed and lungs were removed and chopped in to smaller pieces
that were incubated in medium for 30 minutes at 37°C and 5% CO2.
Vesicles were isolated from medium either by a differential ultracentri-
fugation protocol (UCF) or by an Optiprep density gradient protocol
(OD). Isolated vesicles were evaluated by electron microscopy (EM) and
the proteome was analysed with mass spectrometry (LC-MS/MS).
Results: EM showed that both protocols isolated vesicles that where on
average 40–200 nm in size. LC-MS/MS identified 1223 and 1383 proteins in
the UCF and OD vesicles, respectively. Out of these, 989 proteins were
detected in both samples and 88 of the top 100 exosomal proteins from the
database EVpedia was identified here. Using GO Term finder it was shown
that the 989 common proteins were most significantly associated with the
cellular component, “extracellular exosome”, “focal adhesion” and “mem-
brane”. The 398 uniquely identified proteins in the OD vesicles were asso-
ciated with “extracellular exosome” and “membrane”, while the 234 uniquely
identified proteins in the UCF vesicles were associated with “proteasome
complex” and “cytoplasm”.
Conclusion: This study shows that EVs can be isolated directly from lung
tissue, and these vesicles contain previously identified EV proteins. Both
protocols can be used for the isolation of tissue-derived vesicles. However,
flotation removes a number of contaminant proteins, including those related
to the proteasome and furthermore it enriches for protein associated with
membrane.
PT07.09
Proteomic analysis of exosomes derived from acute myeloid
leukaemia as maturation
Jihye Hong1 and Kwang Pyo Kim2
1KHU, Seoul, Republic of Korea; 2Department of Applied Chemistry, College
of Applied Sciences, Kyung Hee University, Seoul, Republic of Korea
Introduction: Acute myeloid leukaemia (AML) is a malignant disease
categorised by blocking monocyte differentiation and maturation as
hematopoietic cells. AML is divided into several subtypes by degree of
differentiation. Only a few proteomic studies of subtype-specific AML
have been studied, and proteomic studies AML exosome are still insuffi-
cient. As exosomes reflect the nature of the original cell and convey
cellular information, it is important to profile and compare exosomal
proteome changes to understand pathophysiology of AML differentiation.
Methods: To elucidate the proteomic characteristics of the exosome
from AML, we isolated exosomes using size-exclusion chromatography
(SEC) from three subtypes of human AML according to FAB classifica-
tion, acute promyelocytic leukaemia (HL60, M3), acute myelomonocytic
leukaemia (KG-1, M4), acute monocytic leukaemia (THP-1, M5). For
quantitative comparison, we analysed the protein profiles using the
isobaric tag based tandem mass tag (TMT) labelling and liquid chroma-
tography-tandem mass spectrometry (LC-MS/MS).
Results: A total of 2341 proteins were identified in all three groups. The
commonly identified proteins were enriched in the categories of extracel-
lular exosome and membrane and engaged in the pathways of focal adhe-
sion and ECM-receptor interaction. And the protein profiles of each group
were compared. The 496 proteins of M3 and M4, 325 proteins of M3 and
M5 and 560 proteins ofM4 andM5were differentially expressed with a 1.5-
fold change (p < 0.05). Gene ontology analysis of DEP found characteristic
changes for each AML including cell and cell adhesion and SRP-dependent
cotranslational protein targeting to membrane between M3 and M4,
response to estradiol and lectin pathway between M3 and M5, and protein
folding and retrograde vesicle-mediated transport for M4 and M5.
Conclusion: In the present study we performed proteome profiling of
exosomes isolated from different AML cell lines. Also we compared
enriched proteins in each AML cell lines in different maturation stages.
Understanding maturation specific biological processes in AML cell
lines could provide pathophysiological regulating factors for AML
maturation.
PT07.10
The impact of oncogenic EGFRvIII on the proteome of extracellular
vesicles released from glioblastoma cells
Dong-Sic Choi, Laura Montermini and Janusz Rak
The Research Institute of the McGill University Health Centre, Quebec,
Canada
Glioblastoma multiforme (GBM) is the most common, highly invasive,
and aggressive astrocytic brain tumour associated with poor prognosis.
EGFR is amplified in a subset of GBMs and influences the invasion and
proliferation of tumour cells. EGFR amplification is also often accom-
panied by gene rearrangements leading to the expression of constitu-
tively active oncogenic mutant, EGFR variant III (EGFRvIII). In addition
to intrinsic transformation of GBM cells themselves, EGFRvIII may also
act in a non-cell-autonomous manner by virtue of intercellular traffick-
ing of this receptor between cellular populations as cargo of extracellular
vesicles (EVs). Notably, EGFRvIII may also influence EV biogenesis and
alters the expression of multiple genes, but links between these events
are poorly understood. To better understand how EGFRvIII contributes
to tumour aggressiveness mediated by EVs, we investigated the effect of
this oncogene on the EV protein composition. Thus, we employed the
quantitative proteomics to analyse EVs derived from indolent parental
U373 glioma cells and their EGFRvIII-expressing isogenic counterparts
(U373vIII). EVs were purified using Optiprep density gradient ultracen-
trifugation and analysed with an UHPLC-Orbitrap Fusion Tribrid mass
spectrometer. Compilation of three experimental replicates revealed
remarkable changes in the expression profiles of the EV proteins, as
well as changes in the release rate and concentrations of secreted EVs.
For example, U373vIII-derived EVs exhibited a distinct profile of integ-
rin expression, including elevated content of integrin α6β4, known to
direct EVs to the lung. In contrast, parental U373 derived EVs carried
integrin αVβ5, known to direct EVs to the liver. Thus, while GBMs
generally do not metastasise to these respective organs their EVs may





























home to these sites and contribute, in an oncogene-specific manner, to
systemic pathologies associated with brain tumours (inflammation,
thrombosis). Moreover, U373vIII cells secreted EVs contained high
levels of other invasion-promoting proteins including CD44, CD151,
BSG. In conclusion, our results suggest that oncogenic EGFRvIII pro-
foundly impacts the proteome of EVs released by GBM cells, and may
define their biological activities beyond the content of EGFRvIII onco-
protein itself.
PT07.11
Diabetic microenvironment alters circulating microparticle protein
composition
Maddison Turner1, Jean-Francois Thibodeau1, Chet Holterman1, Christopher
Kennedy2 and Dylan Burger2
1University of Ottawa, Canada; 2Kidney Research Centre, Ottawa Hospital
Research Institute, University of Ottawa, Canada
Background: People with diabetes are three times more likely to develop
cardiovascular complication, however the molecular alterations responsible
for this increased cardiovascular risk are not fully understood. As micropar-
ticle (MP) composition may reflect underlying pathology we examined the
protein composition of circulating MPs isolated from OVE26 type 1 diabetic
mice their wildtype (WT), non-diabetic litermates.
Methods: Platelet-free plasma samples were obtained from male OVE26
type 1 diabetic WT non-diabetic mice (20 weeks) by cardioac puncture
following baseline characterisation. Circulating MPs ewre isolated by
differential centrifucation and protein composition was assessed via
mass spectrometry (MS). Gene Ontology pathway analysis was used to
identiy signalling pathways with associated with the dysregulated pro-
teins (>2 proteins/pathway).
Results: Compared with their age-matched WT littermates, OVE26 mice
(20 weeks) displayed increased plasma glucose levels (29.9 ± 0.8 vs
11.3 ± 0.7 mM, p < 0.001, n = 3), decreased body weight (27.3 ± 0.9
vs. 32.4 ± 1.2 g, p < 0.05) and ~3-fold increase in urinary albumin/
creatinine ratio (p < 0.01). Blood pressures were not significantly differ-
ent between OVE26 and WT mice (123.5 ± 8.8 vs 115.6 ± 5.7, p = 0.51).
MS of plasma-derived MPs identified 396 independent proteins with at
least two peptides per protein with an average sequence coverage of 16%.
87 proteins were significantly downregulated while 21 were significantly
upregulated in the diabetic mice using a 1.5-fold cut-off and p < 0.05
(Fisher’s exact test). Functional pathway analysis revealed that MPs
obtained from diabetic mice were enriched in proteins associated with
blood coagulation, glucose metabolism, apoptosis and inflammation.
Conclusions: Taken together our results suggest that MPs obtained from
diabetic mice display a distinct protein composition compared with MPs
isolated from non-diabetic mice. In particular, diabetes-induced MPs are
enriched in proteins associated with thrombosis, apoptosis, and inflam-
mation. Further assessment of specific proteins involved in these pro-
cesses may provide novel insights into the pathogenesis of vascular
injury in diabetes.
PT07.12
Compositional changes in ageing platelet concentrate
Sami Valkonen1,2, Feven Tigistu-Sahle3, Birte Mallas2, Minna Holopainen2,
Anne Valkeajärvi2, Kaija Javela2, Reijo Käkelä2, Pia R-M. Siljander1 and Saara
Laitinen2
1Division of Biochemistry and Biotechnology, Department of Biosciences/
Division of Pharmaceutical Biosciences, Centre for Drug Research, Faculty of
Pharmacy, University of Helsinki, Helsinki, Finland; 2Finnish Red Cross
Blood Service, Helsinki, Finland; 3Department of Biosciences, University of
Helsinki, Helsinki, Finland
Introduction: Adverse transfusion reactions are a clinically relevant pro-
blem of platelet concentrates and a link with the storage time of the
concentrate and an increased incidence of adverse transfusion reactions
has been proposed. Although measurements to monitor platelet activation
have been developed, no clear indicators for platelet activation in the
concentrates or good quality controls exist. If the compositional changes
of ageing platelet concentrate were understood better, monitoring could be
improved and the storage time of platelet concentrates could be extended
from the current standard, 5 days.
Methods: Alterations in the composition of platelet concentrate were stu-
died by determining (1) platelet activation state by CD62P-exposure and
soluble glycoprotein V, (2) the concentration and size distribution of
platelet-derived extracellular vesicles (EVs) and (3) changes in glyceropho-
spholipid content and signalling lipid species of whole product, platelets
and EVs. In total, 10 platelet concentrates were studied on days 1, 2, 5 and 8.
Results: From days 1–8, platelet activation increased according to both
indicators. The EV in the concentrates increased on average 800% and
the size of the produced EVs increased as a function of time. The whole
concentrate, platelets, and EV resembled each other well in the main class
level of lipids and only minor changes occurred in them as a function of
time. However, when the components were compared in lipid species level,
some differences were observed. Also, a time-dependent increase in both
pro-resolvin and pro-inflammatory lipid mediators was observed, although
only a few signalling lipid species were present in detectable amounts.
Conclusion: Compositional changes in lipids do occur in ageing platelet
concentrates and further studies are needed to link these changes with
the possible functional effects, as they may be relevant for the adverse or
beneficial effects of platelet transfusions.
LBP.19
Acoustic Electrospray Mass Spectrometry of Extracellular Vesicle
Lipids
Xabier Osteikoetxea1, Martin Bachman2, Ian Sinclair3, Nikki Heath1, Lois
Grant2, Niek Dekker1, Ross Overman2 and Lorenz Mayr2
1Astrazeneca; 2AstraZeneca; 3Associate Principal Scientist
Introduction: In the last decade the field of extracellular vesicle research
has attracted much interest due to several studies showing that these
particles carry and protect from degradation various proteins and RNAs
and thus participate in diverse biological processes. Recent studies also
point towards the potential of utilizing extracellular vesicles for diag-
nostics and therapy. In contrast to the wide availability of proteomic and
transcriptomic data there are still relatively few reports on the lipid
content and composition of extracellular vesicles. Here we aim to
adapt a high throughput mass spectrometry approach to investigate
the lipid composition of extracellular vesicles secreted by various cell
lines.
Methods: Extracellular vesicle subpopulations (apoptotic bodies, micro-
vesicles and exosomes) were isolated from cell line conditioned media by
differential centrifugation and filtration. Extracellular vesicles were also
characterized by nanoparticle tracking analysis and the presence of
vesicle markers was assessed by western blot. Finally, extracellular vesi-
cles were subjected to high throughput acoustic electrospray mass spec-
trometry for analysis of lipid composition.
Results: We found that acoustic electrospray was suitable for transfer of
extracellular vesicles to the mass spectrometer allowing for fast label free
analysis of lipids from small sample volumes. We observed hundreds of
features in both positive and negative ion modes in the mass range of
400 to 1000 Da, mainly belonging to glycerophosphocholines, sphingo-
myelins and other glycerophosphate derivatives. The MS signal was
significantly enhanced by adding ether to the well and spraying directly
from the liquid-liquid interface. We found that extracellular vesicle
subpopulations and their releasing cells differ in their lipid composition
and also in the ratio of sodium and potassium adducts they form for
identical species. Principle-component analysis was used to analyze and
visualize spectral differences.
Summary/Conclusion: We have established acoustic electrospray mass
spectrometry as a suitable high-throughput strategy for extracellular
vesicle lipid analysis and found that cells and distinct extracellular
vesicles subpopulations differ in their lipid composition.





























Poster Session PT08 – EVs in Viral and Bacterial Infections
Chairs: Cherie Blenkiron and Metka Lenassi 5:15–6:30 p.m.
PT08.01
Role of circulating Epstein–Barr virus-encoded microRNAs in immune
evasion
Manuel Albanese, Kathrin Gärtner, Corinna Hüls and Wolfgang
Hammerschmidt
Department of Gene Vectors, Helmholtz Zentrum München, München,
Germany
Epstein–Barr virus (EBV) is a prevalent herpesvirus and infects the
majority of the human population. EBV causes a latent infection in its
host for a lifetime, which is generally asymptomatic and governed by an
efficient T cell control. In contrast to other herpesviruses, EBV encodes
only three proteins, which act as immunoevasins. Among these genes,
two viral immunoevasins, BNLF2a and viral IL-10, inhibit the recogni-
tion of infected cells by EBV-specific effector T cells and natural killer
cells, respectively, but these two viral proteins are insufficient to prevent
T cell recognition.
Twnety-five miRNA precursors have been identified in EBV, which are
reported to interfere with cell death, innate immune responses and
inflammation. We recently demonstrated that EBV miRNAs inhibit
antiviral T cell responses early in infection acting as important immu-
noevasins. They efficiently inhibit the antigen presentation of EBV-
infected B cells to CD8+ and CD4+ T lymphocytesthrough multiple
mechanisms contributing to the maintenance of a lifelong infection.
It is known that EBV’s miRNAs are also released from EBV infected B
cells via extracellular vesicles (EVs) and taken up by surrounded antigen
presenting cells.
In this study, we investigate if these viral circulating miRNAs can be
transfered from cell to cell and if they are able to act as immunoevasins
also in recipient cells.
EVs secreted by B cells infected with an EBV lab strain or with a mutant
virus deficient of all miRNAs are isolated using a combination of
differential centrifugation, ultracentrifugation, ultrafiltration and density
gradient, and characterised by nanoparticle tracking analysis (NTA),
AMNIS Imagestream, western blotting and quantitative PCR.
We found that that EVs secreted by infected B cells contain mature
EBV’s miRNAs which are taken up by several cell types but to different
extents. Our data suggests that viral miRNAs released by infected B cells
influence the environment and can support the virus to evade elimina-
tion in the host in spite of strong adaptive cellular immune responses.
Further investigations are required to completely unravel the impact of
EBV microRNAs in the different recipient cells and whether they act
through the same mechanisms as in infected B cells.
PT08.02
Recombinant extracellular vesicles (EVs) are a tool to study the
function of packaged viral RNAs from Epstein–Barr virus (EBV)
Corinna Hüls and Reinhard Zeidler
Department of Gene Vectors, Helmholtz Zentrum München, München,
Germany
Introduction: Extracellular vesicles (EVs) are able to transfer proteins,
lipids and nucleic acids. Moreover, they share similarities with enveloped
viruses and virus-like particles. The human herpesvirus Epstein–Barr
virus (EBV) packages its DNA genome as well as viral RNAs into virions
and transfers them to their target cells where they are instantly func-
tional. Until today, the biological function of packaged viral RNAs
remains unclear. By using recombinant EVs, harbouring selected viral
RNAs we investigated the role of transduced viral RNAs (tvRNAs) for
the early phase of EBV-infection. We focused on the viral transactivators
BZLF1 (Z) and BRLF1 (R) that are important for the initiation of a pre-
latent phase and trigger the viral transcription during the early phase of
infection.
Methods: Recombinant EVs were generated by transfecting HEK293 produ-
cer cells with plasmids encoding for Z and R and an additional plasmid
encoding for the viral glycoprotein 350 (gp350) that mediates the B cell
tropism to engineered EVs. EVs were purified via serial centrifugation,
including ultracentrifugation, and filtration. Characterisation was performed
by dot blot, flow cytometry and RNA isolation, followed by qRT-PCR. To
investigate the impact of the tvRNAs on infected cells, primary human B cells
were incubated with EVs and analysed by RNA sequencing.
Results: The recombinant EVs were positive for several EV-associated
proteins (CD63, CD81) and the viral gp350 in dot blot and flow cyto-
metry. The concentration was determined by nanoparticle tracking
analysis and packaging of viral RNAs was successfully proven by qRT-
PCR. Preliminary experiments showed effects on the expression of
downstream genes after incubation with EVs carrying both viral trans-
activators. RNA-sequencing will reveal the influence on the cellular
expression pattern.
Conclusion: We could show that recombinant extracellular vesicles
provide the possibility to study individual sets of particles containing
viral RNA and their impact on the early phase of infection and the
establishment of latency of EBV.
PT08.03
Nef-exosomes as putative biomarkers for inadequate treatment
regimen of HIV-1 infected individuals
Jana Ferdin1, Katja Goričar1, Vita Dolžan1, Ana Plemenitaš1, Jeffrey N.
Martin2, B. Matija Peterlin3, Steven G. Deeks3 and Metka Lenassi1
1Institute of Biochemistry, Faculty of Medicine, University of Ljubljana,
Slovenia; 2Department of Epidemiology & Biostatistics, University of
California San Francisco, USA; 3Department of Medicine, University of
California San Francisco, USA
Introduction: Antiretroviral therapy (ART) reduces plasma HIV-1 RNA
levels to below the limit of detection in most infected individuals, however
virus persists in cellular reservoirs and contributes to diverse non-AIDS-
related disorders (cancer, cardiovascular disease, neurocognitive disorders).
Viral proteins, likeNef, can promote this through chronic inflammation and/
or with direct toxic effects. Nef protein is a key HIV-1 pathogenic factor, as it
affects cellular signalling and metabolism, and viral infectivity. It is released
fromHIV-1 infected primary T cells with exosomes, which were also detected
in plasma of HIV-1 infected individuals. The aim of this study was to explore
if Nef-exosomes are present in plasma of aviremic HIV-1 infected individuals
and if their levels correlate with patient’s clinical status.
Methods: Plasma Nef-exosome levels were measured indirectly with Nef-
ELISA assay. In total 134 subjects from the SCOPE cohort were
included: 26 uninfected, 28 viremic (non-controllers) and 80 aviremic
(38 treated (ART), 42 elite controllers (EC)). All subjects were charac-
terised with respect to age, gender, ethnicity, HIV status (CD4+ and
CD8+ counts, and HIV-1 RNA level) and ART regimen. Statistical
analysis was performed using IBM SPSS Statistics (v19.0). All subjects
provided informed consent and the parent study was approved by the
UCSF Committee on Human Research.
Results: Protein Nef was detected in 63 subjects: 23 non-controllers
(Mdn = 11.6 ng/ml), 18 ART (Mdn = 8.3 ng/ml) and 22 EC
(Mdn = 8.8 ng/ml). Nef concentration positively correlated with HIV-1
RNA level (p = 0.048) only in non-controllers, which implies that the
source of plasma Nef in aviremic individuals are not viruses. In ART
treated subjects, plasma Nef correlated positively with protease inhibi-
tors (PI)-based ART (OR (95% CI) 4.28, p = 0.045), whereas Nef
negatively correlated with non-nucleoside reverse transcriptase inhibi-
tors (NNRTI)-based ART (OR (95% CI) 0.11, p = 0.005).
Conclusion: Nef is present in plasma of half of aviremic HIV-1 infected
individuals and is, based on literature, most likely part of exosomes. In
ART-treated patients, plasma Nef correlates with the drug regimen.





























Therefore, Nef-exosomes could be used as biomarkers to predict inade-
quate treatment with ART to prevent later health complications.
PT08.04
Single-particle characterisation: discriminating enveloped viruses and
extracellular vesicles by flow virometry
Tyler M. Renner, Vera A. Tang and Marc-Andre Langlois
University of Ottawa, Canada
Introduction: Discriminating between host-derived extracellular vesicles
(EVs) and enveloped viruses, such as retroviruses, represents a major
technical challenge. In addition to being similar in size and density, these
particles often have overlapping biogenesis and release pathways, and
thus also share similar surface markers. As such, they often co-purify
even under the most stringent methods, thereby compromising the
results of single-particle characterisation studies.
Technological advancements are pushing single-particle characterisation
techniques to the nanometre level. However, the challenge of discriminat-
ing between retroviruses and EVs remain. Surface antigen staining
approaches with labelled antibodies have yet to provide a suitable solution,
as antibodies themselves are nanometre-sized and have a propensity to
aggregate the particles they target. Here we set out to develop new flow
cytometry-based approaches to distinguish retroviruses from EVs and
characterise the different EV sub-populations released during infection.
Methods: NIH 3T3 cells were infected withMoloneymurine leukaemia virus
(MLV) with an eGFP insertion in its surface envelope glycoprotein. Infected
cells were stained with lipophilic tracer dye DiD. EVs and MLVs produced
were analysed directly from the cell supernatant by nanoscale flow cytometry,
also known as flow virometry, on a BD SORP LSRFortessa (300 mW 488 nm
laser). Laser power and detector voltages were optimised for resolution of
particles of interest fromnoise. A newly developed biological ladder enabled a
more accurate evaluation of the sizes of particles being analysed by side
scattered light
Results: Our approach detects the release of DiD+ EVs from uninfected
cells. Infected cells produced large amounts of eGFP+ particles which were
associated with a two fold increase in eGFP-DiD+ EVs. Interestingly, the
presence of eGFP-DiD+ particles suggests that some populations of EVs did
not bud at the cell surface or acquire the viral envelope glycoprotein.
Conclusion: We have developed methods to indirectly label single-par-
ticle EVs and viruses without the use of antibodies. These approaches
allow us to characterise and quantify populations of submicron-sized
particles released in the context of a viral infection.
PT08.05
Characterisation of extracellular vesicles purified from HIV-1 Nef
overexpressing HEK293 cell supernatants
Julia L. Sanwald1, Alexandra Boeske2, Andreas Weber3, Payam Akhyari3,
Silke Hoffmann2 and Dieter Willbold1
1Institut für Physikalische Biologie, Heinrich Heine University Düsseldorf,
Düsseldorf, Germany; 2Institute of Complex Systems (ICS-6), Research
Centre Jülich, Jülich, Germany; 3Department of Cardiovascular Surgery,
Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Human immunodeficiency virus type 1 (HIV-1) accessory protein Nef
(negative factor) provokes many pathogenic effects during acquired
immunodeficiency syndrome progression. Amongst others, Nef, which
has no signal peptide sequence, induces extensive secretion activities
including its own unconventional protein secretion. Distribution of
Nef via extracellular vesicles (EVs) is regarded as a crucial pathogen-
esis-relevant function. To date knowledge about the respective secretion
path(s) is insufficient.
Our data demonstrate that Nef secretion strictly depends on the availability
of at least one of the three human GABARAPs, a protein family involved in
intracellular transport of vesicles and autophagosome formation. All
GABARAPs exhibit direct Nef interaction, for which tryptophan 13 of
Nef is essential. Here, we characterise EV pools obtained from untrans-
fected HEK293 and cells overexpressing Nef wild type (WT), the
GABARAPs-binding deficient variant Nef(W13A) or another secretion
relevant variant, Nef(SMR5A). EVs were isolated with precipitation and
ultracentrifugation based methods. Vesicle count and size distribution were
determined by nanoparticle tracking analysis (NTA).
In accordance with Nef’s function as secretion inducer, an increase in
vesicle count was obtained for cells expressing Nef(WT) but also its var-
iants. Applying density gradient centrifugation in combination with immu-
noblotting against Nef and EV markers the density distribution of the EVs
was analysed and compared. In parallel, we performed time-resolved ima-
ging of FM1-43 stained cells overexpressing Nef(WT) or Nef(W13A). In
Nef(WT) expressing cells we found extensive, Nef containing bleb-like
membrane patches. Nef(W13A) expressing cells produced smaller vesicles
that possibly passed the plasma membrane in a more scattered manner.
This hints towards the existence of more than one secretion pathway
used by Nef. Since we found the GABARAP-binding deficient Nef
(W13A) in EVs, too, obviously not each Nef secretion path depends
on the observed direct Nef-GABARAP interaction. Identification or
separation of EV subpopulations specific for the different Nef variant
expressing cells by size or density was not feasible, what can have several
reasons. Proxitome based techniques may help to overcome this issue.
PT08.06
Ceramide- and CD63-dependent trafficking of Epstein–Barr virus
LMP1 to extracellular vesicles
Sara B. York, Stephanie N. Hurwitz, Dingani Nkosi, Xia Liu and David G.
Meckes
Florida State University College of Medicine, FL, USA
Introduction: Epstein–Barr virus (EBV) is a human herpesvirus that is asso-
ciated with a multitude of epithelial and lymphoid cancers. Latent membrane
protein 1 (LMP1) encoded by EBV is expressed in most EBV-associated
cancers and is believed to be the major viral oncogene. LMP1 is secreted
from infected cancer cells in small membrane-enclosed extracellular vesicles
(EVs). LMP1-modified EVs can inhibit immune cell function and enhance
cell growth andmigration. In spite of the potential significance of extracellular
LMP1, very little is known about how this viral protein traffics to vesicles,
especiallywithin lymphoblastoid cells. Recently, the tetraspaninproteinCD63
has been found to form a complex with LMP1 and knock-out of CD63 in
epithelial cell lines resulted in a reduction of exosomal LMP1. In certain cell
lines, CD63 is trafficked to EVs through a ceramide-dependent mechanism.
Therefore, we hypothesise that interaction with CD63 in ceramide-rich
microdomains drives the trafficking and incorporation of LMP1 into EVs.
Methods: EVs from an EBV-infected lymphoblastoid cell line (LCL)
were purified on density gradients to examine vesicle subpopulations
containing LMP1. To analyse the effects of CD63 on exosome secretion
and protein trafficking, CRISPR/Cas9 technology was used to knockout
CD63 in LCLs. The requirement for ceramide in LMP1 exosomal traf-
ficking was tested using GW4869.
Results: LMP1 was determined to be secreted by LCLs in small CD63-
enriched exosome populations by gradient purification. Nanoparticle track-
ing analysis of EVs from CD63 CRISPR cells demonstrated a significant
decrease in relative particle secretion. Similarly, decreases in vesicle secre-
tion were found following GW4869 treatment. Immunoblotting of EV
lysates revealed a reduction in exosomal LMP1 from both CD63 CRISPR
and GW4869-treated cells.
Conclusion: Altogether, these data reveal that efficient secretion of
LMP1 into small EVs from infected cells requires CD63 and ceramide.
PT08.07
Epstein–Barr virus LMP1 extracellular vesicle sorting is mediated by
the N-terminus and transmembrane domains
Dingani Nkosi, Lauren A. Howell, Mujeeb Cheerathodi, Stephanie N.
Hurwitz, Deanna C. Tremblay, Xia Liu and David G. Meckes
Florida State University College of Medicine, FL, USA
Introduction: The Epstein–Barr virus (EBV) latent membrane protein 1
(LMP1) is released from latently infected tumour cells in small





























membrane-enclosed vesicles called exosomes. Accumulating evidence
suggests that LMP1 is a major driver of exosome content and functions.
LMP1-modified exosomes have been shown to influence recipient cell
growth, migration, and differentiation, in addition to regulating immune
cell function. Even though the importance of LMP1-modified extracel-
lular vesicles (EVs) on the infected microenvironment is well recognised,
very little is known about how this viral protein enters or manipulates
the host exosome pathway.
Methods: In this study, LMP1 deletion mutants were generated to assess
protein regions required for EV trafficking. Following transfection of LMP1
plasmids, cell-derived extracellular vesicles were collected by differential
centrifugation and levels of specific cargo were evaluated by immunoblot
analysis.
Results: The results demonstrate that together the N-terminus and
specific domains within the transmembrane regions of LMP1 are
required for efficient sorting into the exosome pathway. Consistent
with these findings, a mutant lacking the N-terminus and transmem-
brane domains 1 through 4 (TM5-6) that fails to be packaged into EVs
exhibited higher co-localisation with endoplasmic reticulum and early
endosome markers when compared to the wild-type protein. Other
mutations within LMP1 resulted in enhanced levels of secretion, allud-
ing to potential positive and negative regulatory mechanisms for LMP1
extracellular vesicle sorting. Surprisingly, TM5-6 maintained the ability
to co-localise and form a complex with the tetraspanin CD63, an
abundant exosome protein that is important for the incorporation of
LMP1 into exosomes.
Conclusion: These data suggest new functions of the N-terminus and
transmembrane domains in the role of LMP1 intra- and extracellular
trafficking that are likely downstream of an interaction with CD63.
PT08.08
Proteomic analysis of the CD63 interaction network reveals important
functions of CD63 in LMP1-dependent protein trafficking
Mujeeb Cheerathodi, Xia Liu and David G. Meckes
Florida State University College of Medicine, FL, USA
Introduction: CD63 is a common exosome marker belonging to the
tetraspanin family of proteins, which are important in extracellular
vesicle cargo sorting and protein trafficking within the cell. Indeed,
our previous work has demonstrated the importance of CD63 in
exosomal targeting and subcellular localisation of the Epstein–Barr
virus oncoprotein LMP1, and in positively regulating small extracel-
lular vesicle production. However, very little is known about the
protein-protein interactions that could be driving these important
CD63 functions. Here we sought to utilise the recently developed
proximity-based BioID approach to identify CD63 interacting pro-
teins and to further evaluate how this interactome changes in the
presence of LMP1.
Methods: CD63 interacting proteins were identified using BioID pull
down with streptavidin beads followed by LC-MS/MS and further ana-
lysed using DAVID and FunRich bioinformatics programs. Extracellular
vesicle content was analysed by immunoblot following ExtraPEG and
ultracentrifugation enrichments.
Results: Mass spectrometry analysis detected more than one thousand
potential direct or indirect CD63 interacting partners. Bioinformatics
analysis revealed the identified proteins are enriched in protein traffick-
ing, vesicle transport, exosome targeting and cell signalling. Selected
known and novel interaction partners were verified by immunoblot
analysis. Interestingly, two proteins previously known to be regulated
by LMP1, EGFR and vimentin, were identified as CD63 interacting
proteins and efficient trafficking of these proteins to extracellular vesicles
required CD63.
Conclusion: Overall, this study defines the protein interaction network
of CD63 and provides new insights into the functions of CD63 in
protein trafficking, vesicle biogenesis, and signal transduction in context
of LMP1 expression. Based on these findings, it is likely that CD63 is an
important host factor in LMP1-driven modification of extracellular
vesicle content and function.
PT08.09
The inflammatory and immunological roles of S. aureus derived
exosome-like vesicles in septic arthritis
Farah Fatima1, Majd Mohammad1, Abukar Ali1, Muhammad Nawaz1,2, Hadi
Valadi1, Manli Na1 and Tao Jin1
1University of Gothenburg, Gothenburg, Sweden; 2University of Sao Paulo,
Sao Paulo, Brazil
Introduction: Staphylococcus aureus is the most common pathogen of septic
arthritis worldwide with increasing incidence each year. Virulence factors
from S. aureus trigger host immune response and propagate infection sever-
ity. It has been shown that S. aureus secrete exosome-like extracellular vesicles
(EVs) that not only mediate host-pathogen interaction but also serve as
modulators of infection. However, their role in S. aureus induced septic
arthritis has not been studied so far. In this study we explored the role of S.
aureus derived EVs for stimulating immune responses and infection in a
mice model of septic arthritis.
Methods: S. aureus strain Newman was cultured overnight and EVs were
isolated by ultracentrifugation and filtration. Mice splenocytes were
cultured in vitro and were stimulated with various doses of EVs. Cell
proliferation was observed and cytokines level was measurement by
ELISA. EVs were injected intra-articularly to induce local joint inflam-
mation. Histopathological analysis of knee joints was performed to
evaluate synovitis and joint erosion.
Results: EVs induced a differential production of cytokines as compared
to controls with significantly elevated levels of TNF-α and IL-6 in a dose
dependent manner. Histopathological analysis of intra-articularly
injected knee joints showed degree of synovitis.
Conclusion: S. aureus derived EVs could potentially provoke inflamma-
tory and immunological responses both in vitro and in vivo. Collectively,
our results suggest that S. aureus secreted EVs are functional extensions
of S. aureus acting as virulence factors however to understand the
underlying mechanisms further studies are needed.
PT08.10
Differential diagnosis of pulmonary tuberculosis and lung cancer by
microRNAs in serum extracellular vesicles
Taixue An, Sihua Qin, Yong Xu, Yiyao Huang, Shaopeng Li and Lei Zheng
Department of Laboratory Medicine, Southern Medical University Affiliated
Nanfang Hospital, Guangdong, China
Introduction: As the sensitivity of imagology enhanced the detection rate of
pulmonary nodules increases rapidly. Differentiating lung cancer and tuber-
culosis (TB) have become a troubling problem. It has been universally
reported that miRNAs in extracellular vesicles (EVs) are aberrant in patho-
logic state. It is, therefore, meaningful to explore if miRNAs in EVs derived
from serum can serve as a biomarker to differentiate these two diseases.
Methods: We collected the serum of 204 patients with lung cancer, and
132 patients with TB and 181 health people. Classic three-step strategy
was employed to find the differential diagnostic biomarker. Serum EVs
were isolated with regents and characterised by WB, nanosight, electron
microscope and superresolution microscope. miRNAs in EVs were
extracted with miRNA isolation kit. Cel-39 was used as the spike-in
control in qPCR. This study was approved by medical ethics committee.
Results: Profile of miRNAs in serum EVs was done with Illumina high-
throughput sequencing system. 179 differentially expressed miRNAs were
of statistical significance and with reads more than 30. To verify our
sequencing result, EVs from TB, lung cancer and health control group
were used, seven cases in each group. There were 22 miRNAs with
p < 0.01 and change tendency in accordance with sequencing result.
Further training step was performed with samples from above three
group, and the sample size increased to 20 cases in each group. Only
for four miRNAs was the p value smaller than 0.001. Then these four
miRNAs were validated in samples from 105 TB patients, 171 lung cancer
patients and 154 health control. The miR-1290 level was different among
the three groups and had the highest diagnostic role between lung cancer





























and TB group (area under the curve = 0.781, p < 0.01). In addition, the
area under the curve increased to 0.96 (p < 0.01) when miR-1290,
C-reactive protein and carcinoembryonic antigen were combined.
Conclusion: This study confirms that profiles are different between TB,
lung cancer and healthy people. In these miRNAs, 4 miRNAs are
differentially expressed in these three groups, and miR-1290 showed a
high accuracy in differential diagnosis between lung cancer and TB
patients. These results indicate that miRNAs in serum EVs possess the
potential as a differential biomarker in pulmonary nodules.
PT08.11
The art of war: exosomes as carrier pigeons of the cell to protect from
bacterial spread during infection with yersinia pestis
Adam Fleming1, Heather Hobbs1, Sherwin Parandeh1, Valentin Giroux2,
Weidong Zhou3, Valerie Calvert3, Carolina Salvador-Morales2, Nitin
Agrawal2, Emanuel Petricoin3 and Ramin M. Hakami4
1School of Systems Biology and NCBID, George Mason University, Manassas,
Virginia, USA; 2Bioengineering Department, George Mason University, VA,
USA; 3Center for Applied Proteomics and Molecular Medicine, George Mason
University, VA, USA; 4School of Systems Biology and NCBID, George Mason
University, VA, USA
Introduction: Our laboratory has been among the pioneering groups
researching exosome (EX) effects during infection with highly pathogenic
agents such as Yersinia pestis (Yp), the agent of plague. Yp is a Category A
pathogen that causes high mortality and has the potential to be used for
bioterrorism. There are no approved vaccines or highly effective treatments.
Methods: EXs were purified from naïve (uninfected and untreated) U937
cells (EXu) and Yp-infected U937 cells (EXi) by differential centrifuga-
tion followed by sucrose density gradient purification, and characterised
by TEM and western blot analysis. Naïve monocytes were treated with
EXi or EXu (as control) and analysed for effects on bacterial uptake and
clearance, differentiation, and cytokine release. Proteinase K-treated EXi
(PK-EXi) were also tested. Analysis of intracellular signalling events in
response to EXi was performed using our protein microarray platform.
EX content was also analysed using LC-MS/MS.
Results: EXi induce phenotypes in naïve monocytes that are identical to
when they are infected with Yp: (a) induction of differentiation to
macrophages, as indicated by a significantly prolonged G1phase of the
cell cycle, increased attachment, and appearance of CD68 marker; (b)
induction of significantly improved capacity for bacterial clearance; (c)
significant release of the inflammatory cytokines IL-6, IL-8 and IL-10.
Knockdown of IL-6 in the recipient naïve cells prior to EXi treatment
abrogated EXi ability to induce increased bacterial clearance.
Furthermore, PK-EXi failed to induce differentiation or IL-6 release
and increased bacterial clearance, even though they are internalised by
the recipient cells. Several protein pathways were identified that are
strongly modulated in response to EXi, including strong activation of
the p38 kinase pathway that is known to regulate IL-6 release and
monocyte differentiation. Also, several EXi-associated Yp proteins were
identified that are reported to have immunogenic properties.
Conclusion: Our results suggest a model in which surface proteins of the EXi
prime distant naïve target cells by activating pathways such as p38 to mount
immune responses similar to when they get infected, thus equipping them to
fight off infection more efficiently once the Yp bacteria reach them.
PT08.12
Secretion of Toll-like receptor mRNAs via exosomes: a possible way of
communicating messages against pathogens
Muhammad Nawaz1,2, Jessica Wahlgren1, Luisa Statello1, Marco Maugeri1,
Alexandros Papadimitrio1 and Hadi Valadi1
1University of Gothenburg, Gothenburg, Sweden; 2University of Sao Paulo,
Sao Paulo, Brazil
Introduction: Toll-like receptors (TLRs) are transmembrane receptors
usually expressed in sentinel cells and are thought to play an important
role in the recognition of invading microorganisms, such as viruses,
bacteria, fungi and protozoa. During host–pathogen interactions, the
microbes could penetrate into physical barriers of the first line of defence
and are recognised by TLRs, which activate innate immune responses.
Recent data indicate that sentinel cells secrete exosomes that may have a
role in immune responses and could contribute to TLR-mediated antimi-
crobial defence. We hypothesised that TLR-mRNA could be packaged into
exosomes during microbial infection and shuttled to other cells in order to
alert neighbouring cells against pathogenic signals.
Methods: Exosomes were isolated by ultracentrifugation from bio-fluids
(urine, synovial fluid) of individuals with microbial infections and from
healthy controls. Exosomes were filtered using 0.22 µm filter and total
RNA was isolated using miRCURY RNA isolation kit (Exiqon, DK).
Differential expression of TLR-mRNA content against each infection
was assessed by real time PCR. In addition, B and T-cells were stimu-
lated in vitro and exosomes were examined for TLR-mRNA as compared
to exosomes from non-stimulated cells.
Results: As compared to healthy subjects the TLRs 5, 6, 7 and 9 were
strongly upregulated in exosomes from urine of E. coli infected patients.
Wherease, TLRs 2–7 and 9 were downregulated from arthritic patient
derived synovial fluid exosomes as compared to healthy individuals.
TLRs in exosomes from stimulated B-cells were upregulated, whereas
those from T-cells were downregulated as compared to exosomes from
non-stimulated cells. This indicates the secretion of differentially
expressed TLR-mRNA from infected individuals as well as stimulated
cells as compared to healthy donors and non-stimulated cells.
Conclusion: Secretion of TLR-mRNA via exosomes is a potent way of
communicating defensive messages against pathogen invasion. This
indicates the roles of exosomes in mediating host–pathogen interac-
tions by shuttling TLR messages which raises the possibility to use
exosomes as prospective biomarkers aginsat infections. However,
furthers studies would be required to elucidate underlying
mechanisms.
PT08.13
Extracellular vesicles from Staphylococcus aureus and Staphylococcus
epidermidis are associated with small RNA
Forugh Vazirisani1,2, Margarita Trobos1,2, Furqan A. Shah1, Peter Thomsen1,2
and Karin Ekström1,2
1Department of Biomaterials, Institute of Clinical Sciences, Sahlgrenska
Academy, University of Gothenburg, Gothenburg, Sweden; 2BIOMATCELL,
VINN Excellence Centre of Biomaterials and Cell Therapy, Gothenburg,
Sweden
Introduction: Delivery of bacterial components, proteins, and toxins by
extracellular vesicles (EVs) from Gram-positive bacteria can affect modula-
tion of the host immune response and cell death. However, little is known if
genetic materials are associated with these EVs. The aim of the present study
was to investigate whether EVs from Staphylococcus aureus and S. epidermi-
dis contain RNA, and if so, whether the RNA content and profile differ
between EVs isolated from different bacterial species and strains.
Methods: EVs were isolated from S. aureus ATCC 25923, S. epidermidis
ATCC 35984, and two clinical strains S. aureus 64516 and S. epidermidis
64518 isolated from osteomyelitis associated with orthopaedic implants,
by filtration and centrifugation steps. EVs were characterised by Western
blot, Nanosight and electron microscopy. RNA was extracted, detected
and quantified by Ribogreen fluorescence and Bioanalyzer. RNase treat-
ment was used to confirm that the detected nucleotides were RNA and
not DNA.
Results: All staphylococcal strains released EVs with a size of ~100 nm.
Protein A, SCP-A, α- and δ-toxins were detected in S. aureus EVs while S.
epidermidis EVs contained only δ-toxin. The S. epidermidis 35984 released a
higher number of EVs than S. aureus 25923 (50.9 × 108/ml and 6.1 × 108/ml,
respectively). RNA was detected in EVs from all strains. The electrophero-
grams showed that S. aureus 25923 and S. epidermidis 35984 EVs contained
mainly small RNA, while the EVs from clinical strains also contained ribo-
somal RNA peaks. RNase treatment removed most of the nucleotides,
supporting the finding that the EVs contain RNA. A higher amount of EV
RNA was obtained from the clinical strains compared with ATCC strains,
and from EVs isolated from S. epidermidis compared to S. aureus.
Conclusion: EVs from Gram-positive bacteria, and in particular staphy-
lococci, contain RNA. The knowledge of the molecular content of EVs is
of importance to understand the mechanisms of EV function.






























Membrane vesicle subpopulations in Escherichia coli UPEC: a
methodological comparison
Priscila Dauros-Singorenko1, Alana Whitcombe1, Vanessa Chang2, Denis
Simonov3, Anthony Phillips1,3, Simon Swift2 and Cherie Blenkiron1,2
1School of Biological Sciences, University of Auckland, Auckland, NZ;
2Department of Molecular Medicine and Pathology, University of
Auckland, Auckland, NZ; 3Department of Surgery, University of Auckland,
Auckland, NZ
Introduction: Formation of membrane vesicles (MVs) in bacteria is now
found to be a common but still understudied process. These MVs have
shown to be a heterogeneous population, carry diverse cargos and have
different biological roles in an infectious disease scenario. The isolation and
purification method is critical in interpreting meaningful results and under-
standing MV functionality in the disease, but is lacking standardised proto-
cols or guidelines in the prokaryotic field. Here, we compare standard
purification method density gradient centrifugation (DGC) method with
alternative labour, cost and time effective method of size exclusion chroma-
tography (SEC).
Methods: “Crude” MVs preparations from independent Escherichia coli
Uropathogenic 536 cultures were used for fractionation with DGC (N = 3)
or SEC (N = 3). Molecules (particles, protein, RNA, LPS) of interest were
quantified in resulting fractions. Characterisation of fractions was also done
by polyacrylamide gel electrophoresis (PAGE) and electron micro-
scopy (EM).
Results: MV preparations separated by DGC consistently generated six
fractions/layers, whereas second and third lightest density fractions
contained most of particles (96%), protein (94%), LPS (94%) and RNA
(91%). There were no differences in quantified molecules, protein profil-
ing and microscopic analysis between these two DGC vesicle-enriched
fractions. EM revealed single membrane structured vesicles only in
fractions 2 and 3. On the other hand, 14 fractions were arbitrarily
collected by SEC method. Fractions 8, 9, 10 and 11 contained most
(>84%) of particles (90%), protein (90%), LPS (66%) and RNA (86%).
All analysed molecules, except for LPS, in these fractions constantly
decreased as their elution times increased. Differences in MV crude
load affected SEC fractionation; higher MV loads shifted vesicle-
enriched fractions to later eluted fractions. EM also showed well struc-
tured vesicles in vesicle-enriched fractions along with the presence of
flagella aggregates.
Conclusion: Depending on the vesicle molecule/population of interest,
SEC can be an effective, highly reproducible and quick alternative
method for E. coli’s MV purification. Attention is recommended to
MV crude load optimisation prior definitive use on samples.
PT08.15
Qualitative changes in the proteome of milk-derived extracellular
vesicles during induced staphylococcus aureus mastitis
Zuzana Krupova1,2, Anne Chaize1, Natayme Rocha3, Christine Péchoux1,
Celine Henry4, Pierre Defrenaix2, Yves Le Loir3 and Patrice Martin1
1GABI, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France;
2EXCILONE, Elancourt, France; 3STLO, INRA, Rennes, France; 4INRA
UMR1319 MICALIS, PAPPSO, Jouy-en-Josas, France
Introduction: Mastitis affects the hygienic quality of milk and its com-
position, leading to production losses, payment penalties and additional
costs associated with antibiotic treatments. Little is known about changes
in extracellular vesicle (EV) composition and contribution to mastitis
development in regard to host immune response. S. aureus also releases
EVs which are known to play a role in delivery of toxins, enzymes and
other structural molecules to host cell, modulating the host immune
response. Our project is focusing on the host response induced by an
experimental S. aureus infection to sensitive and resistant goats selected
on the basis of somatic cell counts (SCC) in milk. The objective of this
study is to precisely assess the impact of S. aureus-induced mastitis on
EVs secretion and to characterise the components that underlie the
resistance to mammary infection.
Methods: Goats divergently selected according to SCCs in milk were
experimentally infected with S. aureus 122.25 strain. Milk was sampled
before and after inoculation of a half-udder at several time-points after
infection. Milk-derived EVs and S. aureus-derived EVs isolated from
culture supernatants were purified using a sucrose gradient ultracentri-
fugation method. EVs were validated by TEM, exosome specific protein
markers were detected by WB and the size distribution and particle
concentration were measured by TRPS and NTA. The proteome was
acquired by LC-MS/MS.
Results: The average size of EVs purified from culture supernatant
of S. aureus was 113 ± 55.8 nm with particle concentration of 4.59E
+5/mL culture supernatant. Due to proteolysis of the major milk
proteins after infection, an optimisation of the milk-derived EV
purification method was necessary. The milk-derived EV concentra-
tion and size distribution varied along the infection. A total of 74
proteins were identified in the EVs of 122.25 S. aureus strain. More
than 205 proteins were identified in milk-derived EVs before
induced infection with important variation in protein composition
after bacterial challenge. Several virulence-associated proteins are
found in the S. aureus EVs and can be detected in the infected
milk-derived EVs.
Funding: This project was funded in part by the French NRA
(MilkChEST project) and by Région Centre (Caprimam).
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PT09.01
Serum exosome miRNA profiles have the potential to diagnose and
predict disease stage in multiple sclerosis
Saeideh Ebrahimkhani1, Fatemeh Vafaee2,3, Paul Young4, Michael Barrnet1,
Catherine Suter4 and Michael Buckland1
1Sydney Medical School, Brain and Mind Centre, The University of Sydney,
Sydney, NSW, Australia; 2Charles Perkins Centre, The University of Sydney,
Sydney, NSW, Australia; 3School of Mathematics and Statistics, The
University of Sydney, Sydney, NSW, Australia; 4Victor Chang Cardiac
Research Institute, South Wales, Australia
Introduction: Multiple sclerosis (MS) is a chronic inflammatory autoim-
mune disease of the central nervous system (CNS) and typically strikes
young adults, disproportionally women. There is currently no one defini-
tive test for MS. Diagnosis, and disease activity monitoring is based on
clinical examination, MRI, CSF studies, and neurophysiology, but these
are associated with high costs and limited accessibility. Therefore, blood-
based biomarkers for MS are urgently needed. We hypothesise that
selective package of small RNA in serum-derived exosomes can be devel-
oped into a blood-based assay for MS detection and monitoring.
Methods: In this study we profiled exosome-borne sncRNAs from MS
patient serum samples in different disease courses and also a subtype of
MS patients (relapsing–remitting multiple sclerosis, RRMS) in four-time
points (two years), along with matched controls using high-throughput
sequencing. Furthermore, we used sophisticated bioinformatics
approaches to refine the predictability power of identified miRNAs.
Results: We reported that MS patient sera exhibit dysregulation of
miRNAs in relation to controls and that the panel of such miRNAs
shows specificity to the disease subtype. Importantly, we have also
identified a group of miRNAs that are associated with MS progression
from RRMS to S/PPMS.
Conclusion: This study shows that serum exosomes from MS patients
are meaningfully altered in their miRNA profiles, which can potentially
be utilised as biomarkers. To our knowledge, this is the first proof-of-
principle demonstration that miRNAs from serum exosomes can be
used to distinguish stages of MS in patients.
PT09.02
Systems-modelling and biological evidence for alteration of
extracellular vesicles in Huntington’s disease
Francesca Farina1, François-Xavier Lejeune1, Frédéric Parmentier1, Jessica
Voisin1, Satish Sasidharan Nair1, Clotilde Théry2 and Christian Neri1
1Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Paris, France;
2Institut Curie, PSL Research University, INSERM U932, Paris, France
Intercellular communication mediated by extracellular vesicles (EVs) is
emerging as a mechanism that is important to neuronal homeostasis and
integrity. However, there is little information available on the impor-
tance of EV signalling in response to proteotoxic stress in Huntington’s
disease (HD). Using network methods to integrate HD gene expression
datasets, we reconstructed a computational model of the transition from
the early (cell differentiation) to intermediate (dysfunctional striatum)
and late (advanced neurodegeneration) phases of the HD process. This
model indicates that gene deregulation in HD could impact on EV
signalling across biological phases of the disease. To test for this hypoth-
esis, we analysed EVs in striatal cells derived from HD knock-in mice. In
studies of EVs, it is important to discriminate different subtypes of EVs
based for instance on vesicular size as this may determine function. In
these experiments, we used protocols and EV markers that allow for
differential analysis of EV subtypes to be performed, testing for changes
in secreted amount and protein cargo composition. The results suggest
that EV subtypes may be altered in cells expressing mutant huntingtin.
PT09.03
The ratio between oligomer to monomer amyloid beta in neuronal
exosome extracted from plasma discriminates Alzheimer’s patient
from normal control
Kyeong-sik Shin1, Jae Hoon Ji2, Seong-chan Jun3 and Ji Yoon Kang2
1Cantis; 2KIST, Seoul, Republic of Korea; 3Yonsei University, Seoul, Republic
of Korea
Introduction: Amyloid beta oligomer has been considered as a biomar-
ker of Alzheimer’s disease (AD) but it is hard to quantify the concentra-
tion due to its diverse forms in blood, much low concentration and lack
of specific antibody. Hence, this paper suggests ‘the oligomer to mono-
mer ratio of amyloid beta in neuronal exosome’ as a new biomarker and
validate it with electrochemical biosensor.
Methods: Plasma samples were processed with ExoQuick and agarose gel
to extract neuronal exosome. The samples were diluted by 4 times with a
repeated factor of 5, and the impedance of sensor was measured for each
diluted sample. The slope with respect to dilution factors (1/5, 1/25, 1/
125) was used to calculate the ratio based on the slope of sensor signal
with respect to dilution factors since the sensor’s impedance is propor-
tional to the size of detected molecules. The sensor was bead-based
electrochemical impedance spectrometry (BEIS) sensor comprising of
two electrodes, microwell array and permanent magnet. The magnetic
beads coated by capture antibody were incubated with neuronal exo-
somes and trapped in each microwell by a magnetic bar.
Results: The plasmas of patients and normal control were collected at
SNUBH (AD:25, NC: 21). The ratios of AD patients were almost per-
fectly discriminated from that of NC (normal control) with the sensitiv-
ity of 100% and the selectivity of 100%.
Conclusion: The oligomer to monomer ratio of amyloid beta measured
by BEIS sensor was demonstrated to be a valuable biomarker to dis-
seminate AD from NC. The reliability of diagnosis will be validated by
additional testing with multi-centre samples.
PT09.04
Neuroprotective mechanisms of extracellular small heat shock
proteins in neuroinflammation
Joy I. Irobi
Hasselt University, Hasselt, Belgium
Heat shock binding proteins (HSPB) provide protection from cellular
and environmental stress factors as molecular chaperones to keep pro-
tein homeostasis. Extracellular or membrane-bound HSBP have a pro-
tective role in mediating immunological functions and
immunomodulatory activity. Multiple sclerosis (MS) is a chronic auto-
immune disease of the central nervous system, featured by immune cell
mediated destruction of the insulating myelin around neuronal pro-
cesses. Previously we showed that small heat shock binding proteins
(HSPB1 and HSPB8) have critical neuroprotective functions in the
peripheral nervous system where mutations in these molecular chaper-
ones cause peripheral neuropathy and neuronal death. We showed that
expression of mutant HSPB1 decreased acetylated α-tubulin abundance
and induced severe axonal transport deficits. HSPB have pleiotropic
cytoprotective functions and interacts with diverse key molecular part-
ners. HSPB5 was identified as candidate autoantigen in MS. HSPB are
induced during MS lesion development and are found in the blood of
MS patients, peaking during relapses.
Intracellular HSPB are released out and their potential extracellular
functions during neuroinflammation have not been studied extensively.
Interestingly HSPB are expressed in brain glial cells known to secrete
exosomes or extracellular vesicles expressing HSPB. Exosomes are nano-
vesicles which are of great importance for their biomarker potential in





























disease diagnosis and therapy. We hypothesise that dysfunctional
trophic support of HSPB in transcellular exosome signalling during
neuroinflammation could result in deficits in the remyelination repair
process. Investigating the extracellular signalling of released HSPB in
response to local brain inflammation and understanding the HSPB-
exosome-mediated uptake in brain glial cells, could offer key molecular
targets on how this process may be harnessed for remyelination
strategies.
PT09.05
Extracellular vesicles as regulators of inflammation in ischemic stroke
Nea Bister1, Paula Korhonen1, Henna Konttinen1, Nikita Mikhailov1, Sanna
Loppi1, Laura J. Vella2, Andrew F. Hill3, Katja Kanninen1, Rashid Giniatullin1
and Tarja Malm1
1A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland;
2The Florey Institute of Neuroscience and Mental Health, The University of
Melbourne, Parkville, Victoria, Australia; 3Department of Biochemistry and
Genetics, La Trobe Institute for Molecular Science, La Trobe University,
Victoria, 3084, Australia
Introduction: Extracellular vesicles (EVs), such as exosomes, microvesi-
cles and apoptotic bodies, are released to the body fluids by all cell types.
EVs have shown to be taken up by recipient cells in which their cargo
can modulate cellular functions. Altered vesicle secretion has been
implicated in several pathological conditions, including neurodegenera-
tive disorders such as Alzheimer’s disease. However, the effect of
ischemic stroke on EV secretion is completely unknown. Continuously
failing clinical trials suggest that pathological mechanisms of stroke are
still poorly understood. As EVs are appreciated as important players in
cell-to-cell communication, and stroke is well known of its progressive
pathology and associated neuroinflammation, it is likely that EVs play a
role in stroke pathology.
Methods: The aim of this study was to investigate whether ischemic
stroke alters the secretion of EVs in the brain. Mice were subjected to
permanent middle cerebral artery occlusion after which the brains were
collected and EVs isolated by sucrose density gradient ultracentrifuga-
tion. The morphology and size distribution of EV preparations were
characterised by transmission electron microscopy and nanoparticle
tracking analysis (NTA), respectively. In addition, NTA was used to
determine the EV concentration of the samples. The impact of EVs on
microglial viability and cytokine secretion was evaluated by MTT assay
and cytokine bead assay, respectively.
Results: Ischemic stroke increases the amount of EVs in the brain tissue
at 2 h post-surgery. Brain derived EVs increase microglial mitochondrial
activity but do not alter the activity of neurons. However, at 12 h post-
stroke this effect is lost also in microglia, suggesting cell specific and
time dependent changes in the cellular impact of EVs after stroke.
Conclusion: This preliminary data suggets that EVs may have a role in
stroke pathology. Further studies are needed to characterise molecular
composition of EVs, leading to better understanding of the specific
mechanisms of EVs and their relevance in stroke.
PT09.06
Flow cytometry analysis of blood microvesicles in patients with
multiple sclerosis
Jakub Soukup1,2, Marie Kostelanska1, Eva Havrdova3 and Karel Holada1
1Institute of Immunology and Microbiology, First Faculty of Medicine,
Charles University and General University Hospital in Prague, Prague,
Czech Republic; 2Department of Genetics and Microbiology, Faculty of
Science, Charles University, Prague, Czech Republic; 3Department of
Neurology, First Faculty of Medicine, Charles University and General
University Hospital in Prague, Prague, Czech Republic
Introduction: Several studies reported elevated numbers of diverse cel-
lular microvesicles (MVs) in blood of patients with Multiple Sclerosis
(MS). To explore the diagnostic potential of MVs in MS we utilised flow
cytometry for simultaneous analysis of platelet, erythrocyte, B-cell, T-cell
and endothelial MVs.
Methods: Blood of MS patients in exacerbation of the disease (n = 16) or
healthy controls (n = 16) was collected in K2EDTA and processed within
20 minutes. MVs were isolated from platelet free plasma (14,000g,
70 min), washed with PBS-BSA and incubated with antibody CD105,
CD235a, Annexin V or with combination of antibodies (CD41+CD36)
or (CD45+CD19+CD3) to distinguish MVs derived from different cells.
Labelled MVs were immediately analysed on BD FACSCanto II flow
cytometer. The vesicles were divided by size in 3 groups using
ApogeeMix beads: >1.2 µm, 0.5–1.2 µm (MVs gate) and <0.5 µm.
Results: Relative number of endothelial (CD105+) MVs was higher in
healthy controls (HC) than in MS patients (7.6% vs. 4.5%, p = 0.0098).
Similarly, also relative number of B-cell (CD19+) and T-cell (CD3+)
MVs was higher in HC than in MS patients, 6.7% vs. 3.4% (p = 0.0268)
and 14.3% vs. 6.9% (p = 0.0037), respectively. The differences in the rest
of analysed populations of MVs were not statistically significant as were
not the counts of MVs/µl of plasma. In plasma deprived of MVs (super-
natant after 14,000g, 70 min) remained particles positive for the selected
markers, but on contrary analysis of these MVs suggested more Annexin
V+ MVs in MS patients 260 MVs/µl vs. HC 175 MVs/µl (p = 0.0249).
Conclusion: The analysis of washed plasma MVs did not reproduce
previously published results demonstrating higher counts of non-washed
platelet or endothelial MVs in blood plasma of MS patients. In contrast,
relative numbers of T-cell, B-cell and endothelial MVs were lower than
in HC demonstrating critical effect of sample preparation on the results
of MVs analysis.
Funding: The study was supported by the Ministry of Health of the
Czech Republic, grant no. 15-32961A and the Charles University, project
GA UK No. 360216.
PT09.07
Enrichment of non-coding RNA-species in exosomes: potential
biomarkers for Alzheimer’s disease
Rhodri Thomas1, Elisa Majounie1, Rebecca Sims1, Juan M. Falcón-Pérez2,
Aled Clayton3 and Julie Williams1
1Cardiff University, Cardiff, United Kingdom; 2CIC bioGUNE; 3Division of
Cancer and Genetics, School of Medicine, Cardiff University and Velindre
Cancer Centre, Cardiff, United Kingdom
Introduction: Identifying exosomal RNA as biomarkers of disease is a
growing field of research, yet there is little known about the relationship
between this vesicular RNA cargo and the RNA present in the cell of
origin. Past studies have often used small RNA sequencing approaches,
which pre-selects for a subset of smaller length transcripts, as opposed to
total RNA.
Methods: Next-generation total RNA sequencing was performed com-
paring total cellular and total exosomal RNA extracted from a neuro-
glioma cell-line, with only the ribosomal RNA depleted. Exosomes were
isolated by ultracentrifugation at 200,000g for 2 h followed by washing
with PBS and a second ultracentrifugation to pellet. These were thor-
oughly characterised by nanoparticle tracking analysis, cryo-electron
microscopy, sucrose density gradient, western blot and enzyme-linked
immunosorbent assay.
Results: Exosomal RNA is dramatically distinct from source cell RNA.
Only 1% of the exosomal RNA mapped bases resided in exonic regions
of the human genome compared to 40% with the cellular RNA. Rather
the majority of exosomal RNA was intronic and intergenic. Further
analysis revealed 1554 long non-coding RNAs, which passed
Bonferroni correction for multiple testing, that were differentially
expressed between cells and exosomes.
Conclusion: The constitution of RNA in exosomes is distinct from
source cells and they may act as a repository for precursor-messenger
RNA and other untranslated species. This suggests that biomarkers of
disease that have previously been identified in cells is unlikely to corre-
late with what is detectable in exosomes. This highlights the potential of
discovering new biomarkers of Alzheimer’s or other diseases that lie in
the non-coding genome, and suggests that the pursuit of biomarker
discovery in exosomes could be a fruitful avenue of research.






























Cell-type specific exosome signalling and disease propagation in ALS
Eoin D. Brown1, Ming Sum Chiang1, Julia Yelick2 and Yongjie Yang1
1Department of Neuroscience, Tufts University, MA, USA; 2Tufts University,
MA, USA
Introduction: Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset
neurodegenerative disorder characterised by the degradation and subse-
quent death of motor neurons in the spinal cord and motor cortex. The
mechanisms responsible for ALS propagation are not yet fully understood,
but are likely to involve the transmission of disease associated proteins and
other toxic factors. Emerging evidence fromour group and current literature
has provided evidence that exosomes play an important role in facilitating
the pathology of ALS and other neurodegenerative diseases. Therefore, it is
crucial to understand the in vivo characteristics, distribution and pathologi-
cal behaviour of exosomes within the CNS. To enable this investigation, we
have developed a novel Cre-dependent CD63 exosome reporter mouse to
allow cell specific GFP labelling of endogenous exosomes in vivo.
Methods: Our model utilises the Cre-Lox recombination system, featur-
ing a floxed stop codon upstream of copGFP tagged CD63, which labels
CD63 expressing exosomes in a cell specific manner when induced with
promoter driven Cre recombinase.
Results: To validate the system, we stereotactically injected the cortex of
copGFP-CD63/Ai14-tdt mice with AAV8-CAMKII-cre or AAV5-GFAP-
cre, with GFP expressing puncta being observed in a cell specific man-
ner. These puncta were detected both intracellularly and extracellularly
of the parent cell (as visualised by Cre-activated Ai14-tdt expression).
The identity of the copGFP/CD63 puncta as exosomes was confirmed
with immunohistochemical staining against common exosome markers.
Using this model, we observed cortical neurons to secrete a more
abundant population of exosomes that migrate to a further degree
than astrocyte exosomes. Comparison of small RNA content in primary
cultured neurons and astrocytes show that small RNA populations are
enriched in neuronal exosomes, as compared to astrocytes exosomes.
Summary: In summary, we have developed and validated a novel mouse
model that enables the cell-specific labelling of endogenous exosomes by
expressing copGFP-CD63. This system offers a new and invaluable tool
that will prove key in deciphering exosome biogenesis, cargo loading,
recipient cell processing, and the role exosomes play throughout devel-
opment and disease propagation.
PT09.09
Increased miR-124 cargo in circulating extracellular vesicles after
experimental traumatic brain injury
Jenni Karttunen1, Vicente Navarro Ferrandis1, Mette Heiskanen1, Kirsi Rilla2,
Arto Koistinen3, Shalini Das Gupta1, Niina Vuokila1, Noora Puhakka1, David
J. Poulsen4 and Asla Pitkänen1
1University of Eastern Finland, A.I. Virtanen Institute for Molecular Sciences,
Department of Neurobiology, Joensuu, Finland; 2Faculty of Health Sciences,
School of Medicine, Institute of Biomedicine, University of Eastern Finland,
Joensuu, Finland; 3SIB labs, University of Eastern Finland, Joensuu, Finland;
4University at Buffalo, The State University of New York, School of Medicine
and Biomedical Sciences, NY, USA
Introduction: Traumatic brain injury (TBI) is a worldwide problem with
~10 million new cases annually. Impact-induced primary injury after
TBI occurs within seconds to minutes. Post-TBI secondary brain pathol-
ogies progress for weeks to months, and worsen the evolution of co-
morbidities. Extracellular vesicles (EVs) have recently been recognised as
mediators of intercellular communication. However, little is known
about their contribution to the evolution of post-TBI secondary damage
or recovery. We assessed the characteristics of plasma EVs and their
contents of brain-enriched miR-124-3p during the first week post-TBI.
We also tested whether EV miR-124-3p levels would serve as biomarkers
for TBI diagnosis.
Methods: Adult male rats were subjected to lateral fluid-percussion
injury. Trunk plasma was collected at 2 or 7 d post-TBI. Naïve and
sham-operated animals served as controls. EVs were isolated from
plasma using commercial kit based on membrane particle precipitation.
The purification method was evaluated using nanoparticle tracking
analysis (NTA), scanning electron microscopy, and western blot. The
number and size distribution of plasma EVs after TBI were measured
with NTA. miR-124-3p concentration was measured from isolated EV-
RNA with quantitative PCR. Gene set enrichment analysis (GSEA) was
conducted for three EV related gene sets using available mRNA-seq
(3 month post-TBI) and microarray (32 h post-TBI) data from brain
tissue as rank lists.
Results: NTA showed a decrease in the number of plasma EVs at 2 d and
7 d post-TBI. GSEA revealed transcriptomic-level enrichment of gene
sets related to EVs, especially in the perilesional cortex. The level of
plasma EV miR-124-3p concentration was increased a 2 d post-TBI as
compared to controls or 7 d post-TBI samples. Receiver operating
characteristic analysis indicated that plasma EV miR-124 level differen-
tiated TBI animals from controls (AUC 0.922, p < 0.05)
Conclusion: Our data demonstrate dynamic changes in the number of
plasma EVs, regulation of genes related to EV production in the brain,
and regulation of plasma EV contents of brain-enriched miR-124-3p
during the first week post-TBI.
PT09.10
Adherent proteins may account for some of the bioactivity of small
extracellular vesicles (exosomes) secreted by mesenchymal stem/
stromal cells (MSCs)
Dong-Ki Kim1, Hidetaka Nishida2, Su Yeon An1, Eun Hye Bae1, Ashok K.
Shetty1,3 and Darwin J. Prockop1
1Institute for Regenerative Medicine, Texas A&M University College of
Medicine, College Station, TX, USA; 2Joint Department of Veterinary
Medicine, Faculty of Applied Biological Sciences, Gifu University; 3Olin E.
Teague Veterans’ Medical Center, Temple, TX, USA
We recently developed a protocol for chromatographically isolating
small extracellular vesicles from the culture media of human mesench-
ymal stem/stromal cells (hMSCs). The vesicles lack a series of epitopes
found on hMSCs, are CD9-CD63+CD81+, are about 100 nm in dia-
meter, and have anti-inflammatory properties. Therefore we have
referred to them as A1-exosomes. In a mouse model of traumatic
brain injury, a single intravenous administration of A1-exosomes
decreased brain inflammation after 12 h and rescued behavioural deficits
present in controls after about 1 month (1). Proteomic analysis of the
A1-exosomes by HPLC/MS/MS indicated the presence of over 100
proteins, about a third of which were secreted factors, plasma membrane
ligands, or matrix proteins. SDS-gel assays after tryptic digestion con-
firmed that a large fraction of the proteins were extracellular. Further
fractionation of the A1-exosomes by chromatography generated two
peaks that differed in their protein profiles. The results indicated that
exosomes secreted by MSCs contain a large number of adherent proteins
that may account for some of their biological activities.
Funding: Supported in part by NIH grant P40OD11050.
Reference
1. Kim et al., Proc Natl Acad Sci USA. 2016; 113: 170–175.
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Neuroprotective mechanisms of extracellular small heat shock
proteins (HSPB1 and HSPB8): The role of HSPB in transcellular EV
signaling in neuroinflammation
Joy I. Irobi1, Joel Beaumont2, Simona Cecchi2, Vincent Timmerman3 and Luc
Michiels1
1Hasselt University, Biomedical research institute, Martelarenlaan 42, 3500
Hasselt, Belgium; 2Hasselt University, Hasselt, Belgium; 3Antwerp University,
Antwerp, Belgium
Introduction: Multiple sclerosis (MS) is a chronic autoimmune disease
affecting the central nervous system. The repair mechanism of MS is still





























unknown but small heat-shock proteins (HSPBs) have been shown to be
upregulated in the blood of MS patients. We showed that mutations in
HSPB1 and HSPB8 caused peripheral neurodegeneration commonly
known as Charcot-Marie-Tooth (CMT) disease. The HSPB1 and
HSPB8 genes are ubiquitously expressed and have vital function in
preventing axonal damage. In addition, skin fibroblasts of CMT patients
exhibit HSPB8 protein aggregates indicating defects in HSPBs chaper-
oning activity. Although the intracellular role of HSPBs has been proven,
the extracellular functions remain unclear. One way that HSPBs are
released into the extracellular space is though extracellular vesicles
(EV). Neural cells release EVs either carrying beneficial or detrimental
biomarkers into the environment. We study the protective activities in
early inflammation and use extracellular vesicles expressing HSPB8
complexes as a delivery vehicle.
Methods: The effect of inflammation on the protective mechanisms of
EV-HSPBs is investigated. We will: 1) Establish EV-HSPBs expressing
stable cell lines for the production of EV-rich conditioned medium
(CM). 2) Isolation, purification and characterization of EV-HSPB (nor-
mal and inflamed EV-HSPB8). 3) Measuring the survival and chaperone
activity of neural cells stimulated with nEV-HSPB8 and iEV-HSPB8.
Results: Our pilot study shows that in early inflammation (24h), there is
an upregulation of total EV RNA including microRNA and mRNA in
inflammation triggered cells. Our results also show a downregulation of
HSPBs mRNA levels in TNF-α stimulated microglial and oligodendro-
cyte cells. These observations in early inflammation of an upregulation
of total EV RNA and a downregulation of HSPB1 and HSPB8 in neural
cells together with the lack of neuroprotection observed in chronic
inflammation support the hypothesis that there is an impairment in
the molecular chaperoning and cytoprotective activities
Summary/Conclusion: Understanding the extracellular function of EV
loaded with HSPB8 chaperoning activities in neuroinflammation will
provide new insights to advance the development of MS therapeutic
strategies
Funding: This work was financed by FWO travel grant, Hasselt
University and Trans Tech Diagnostics project.
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Reactive astrocytes-derived exosomes promote neurogenesis through
Wnt signaling: implication for Parkinson’s disease therapy
Lu Yang, Fei Qu and Min Zheng
University of Electronic Science and Technology of China, Sichuan, China
Introduction: The phenomenon of adult dopaminergic neurogenesis
intrinsic to the dopamine-depleted striatum has been indicated in
Parkinson’s diseaseï¼ˆPDï¼‰. However, the underlying mechanisms
are not completely clarified. Reactive astrocytes exhibit their ability to
influence neuroprotection, including regulation of neurogenesis through
Wnt signaling in PD. Currently, exosome has merged as a novel med-
iator for cell-cell communication. Importantly, recent evidence indicated
that exosomal Wnt proteins are involved in multiple processes including
angiogenesis and development. Thus, we hypothesize that exosomal Wnt
derived from reactive striatal astrocytes play a role in regulating the
dopaminergic neurogenesis in PD.
Methods: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was
used to induce astrogliosis in vitro and in vivo. Exosomes were collected
by ultracentrifugation and assessed by EM and Nanosight. Wnt-contain-
ing exosome mediated neurogenesis was examined by CyQuant assay &
BrdU labeling.
Results: In our study, we detected a significant increase of Wnt
expression in both MPTP-pretreated striatal astrocytes as well as
their released exosomes. Wnt-enriched exosomes could be taken up
by the NSCs, resulting in increased proliferation of NSCs. This effect
was inhibited by either pre-treating astrocytes with exosome inhibi-
tors or siRNA-mediated knocking down of Wnt gene in astrocytes.
Our result also revealed that the canonical Wnt signaling was acti-
vated while the NSCs were exposed to those exosomes. Our In vivo
study further demonstrated the effect of Wnt-containing exosomes in
promoting neurogenesis in the striatum of MPTP-lesioned mouse
model.
Summary/Conclusion: We conclude that exosomal Wnt were released
from MPTP-activated striatal astocytes, which activate the canonical
Wnt signaling pathway in the NSCs and can be used to promote
neurogenesis both in vitro and in vivo. Our studies reveal novel regula-
tory strategies of neurogenesis in PD, indicating the therapeutic poten-
tial of Wnt-containing exosomes in PD.
Funding: The National Science Foundation of China (grant no.
NSFC81601125)
LBP.23
Fast or slow moving in ALS patients: Role of immune MVs in
neuroinflammation
Sabrina La Salvia1, Uta Erdbruegger2, Luca Musante3, Daisy Sproviero4,
Marta Giannini4, Susanna Zucca5, Orietta Pansarasa4, Mauro Ceroni6,
Joanne Lannigan7 and Cristina Cereda4
1Genomic and post-Genomic Center, IRCCS, C. Mondino National Institute
of Neurology Foundation; 2Department of Medicine/Nephrology Division,
University of Virginia, VA, USA; 3Department of Medicine, Nephrology
Division, University of Virginia, VA, USA; 4Genomic and Post-Genomic
Center, IRCCS, C. Mondino National Institute of Neurology Foundation,
Pavia, Italy; 5Genomic and Post-Genomic Center, National Institute of
Neurology Foundation, Pavia, Italy; 6Neurology Department, National
Institute of Neurology Foundation, Pavia, Italy; 7School of Medicine, Flow
Cytometry Core, University of Virginia, VA, USA
Introduction: Amyotrophic lateral sclerosis (ALS) is an idiopathic, fatal
neurodegenerative disease of the human motor system. Immune
responses from active T cells play likely an important pathogenic role.
However, there is no particular diagnostic biomarkers available.
Microvesicles (MVs) are candidate biomarkers. An improved under-
standing of MVs biological processes in ALS will help to define markers
related to the progression of the disease and contributing to future
therapeutic nanovesicles. The aim of our study was to characterize
MVs as novel biomarkers in plasma of ALS patients by Imaging Flow
Cytometry (IFC) focusing on MVs deriving from immune cells.
Methods: MVs from 20 ALS patients and 20 healthy volunteers were
obtained by differential centrifugation from platelet poor plasma (1000g
for 10 minutes, 1600g for 20 minutes). Enumeration and phenotyping
was performed with IFC (AmnisImage-StreamX Mark II) using the
following markers: CD4, CD8, CD25, CD45RO and CD45RA; Annexin
V (AnnV) and Calcein were used as general MV membrane markers.
MVs concentration was measured with qNano gold with a NP400 nm.
Results: There is no difference in concentration and size distribution of
MVs between ALS and controls. In addition, no difference in numbers
of AnnV+ and AnnV- MVs was found. However, we observed high
levels of CD4+/CD25+/AnnV+ MVs in plasma samples from ALS
patients (MVs 2,5 particles/ul; p=0.04) compared to controls (Mvs 0,9
particles/ul.) There is also a difference between fast and slow ALS
patients using CD45RA/AnnV+ (1,0 particles/ul in fast vs 5,4 particles/
ul in slow ALS; p=0.02) and CD45RO/AnnV+ (25,2 particles/ul fast vs
9,1 particles/ul slow; p=0.036).
Summary/Conclusion: Imaging flow cytometry is a new sensitive tool to
provide comprehensive phenotyping of MV origin in ALS. We found
high levels of CD4+/CD25+/AnnV+ T-regulatory cells (Tregs) MVs in
our cohort of ALS patients. This supports previous finding that Tregs are
neuroprotective in ALS (Henkel, 2013). In addition, our data indicates
that MVs of ALS patients carry markers of naive T lymphocytes
(CD45RA) and activated and memory T lymphocytes (CD45RO).
Further studies are needed to understand this new phenotype of
CD45RA/AnnV+ and CD45RO/AnnV+ MVs in the slow and fast pro-
gression group of ALS patients. This finding might indicate different
steps of T cell activation.






























Cerebrospinal fluid exosomal small RNA profiling by next-generation
sequencing
Yohsuke Yagi and Takanori Yokota
Tokyo Medical and Dental University, Tokyo, Japan
Introduction: MicroRNAs (miRNAs), especially those contained in
human body fluids, have been reported as potential biomarkers.
Among various body fluids, the cerebrospinal fluid (CSF) is an impor-
tant profiling target for diagnosis and monitoring of various neurologi-
cal diseases. However, relevant genome-scale studies are limited and no
studies have profiled exosomal miRNAs in CSF. Therefore, we con-
ducted a next-generation sequencing-based genome-wide survey of
small RNAs in the exosomal and non-exosomal (supernatant) fractions
of healthy human CSF as well as serum in each donor.
Methods: The first batch of samples was derived from three donors
and subjected to a genome-wide NGS-based survey. CSF samples
were obtained via lumbar puncture and corresponding serum sam-
ples were simultaneously isolated from peripheral blood. Samples
were further divided into exosomal and supernatant fractions via
the ultracentrifugation method. Seven milliliters of CSF and 3 ml
of serum from each donor were subjected to ultracentrifugation.
Total RNA was isolated from each individual fractionated sample
and subjected to a NGS analysis. The second batch of samples from
three additional donors was subjected to focused validation via digi-
tal PCR (dPCR).
Results: MiRNA was enriched in the exosomal fractions relative to the
supernatant fractions of both CSF and serum. We also observed sub-
stantial differences in exosomal miRNA profiles between CSF and
serum. Half of the reported brain miRNAs were found in CSF exosomal
fractions and the majority (97.7%) of miRNAs detected in CSF exosomes
were reported to be expressed in brain tissue. Our data suggest that the
brain is a major source of CSF exosomal miRNAs. In particular, miR-
1911-5p, specifically expressed in brain tissue, was detected in CSF but
not in serum, as confirmed by dPCR.
Summary/Conclusion: Here we provide the important evidence that
exosomal miRNAs in CSF may reflect brain pathophysiology.
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Cholangiocarcinoma exosomes: proteomic insights and plausible role
in carcinogenesis
Suman Dutta and Arthit Chairoungdua
Mahidol University, Salaya, Thailand
Introduction: Cholangiocarcinoma (CCA), a severe malignant tumour of
bile duct epithelia, is highly prevalent in Asian countries and is unre-
sponsive to chemotherapeutic agents. Thus, a novel biological entity
with high target specificity for early diagnosis and treatment are urgently
needed. Exosomes are small membrane-bound vesicles found in biolo-
gical body fluids, released by most cell types including cancer cells.
Exosome contains cell and cell state specific subset of proteins and
nucleic acids corresponding to particular cell types and play essential
roles in pathophysiological events. The present study aimed to identify
biomarkers in exosome released by CCA cells and to assess their cargo
contents in the development and progression of CCA.
Methods: Sequential centrifugation and ultrafiltration were used to iso-
late exosomes from CCA cells. derived from patients. The exosomes
were characterised by TEM and western blot with marker antibodies.
PKH67 linker-dye was used for uptake assay. Matrigel chambers were
used for migration and invasion analysis. Confocal microscopy was
employed for protein localisation and Nano LC-MS/MS was used to
identify proteins. Ingenuity pathway and gene ontology analysis tool
were used to categorise protein class and to predict underline molecular
pathways.
Results: Upon incubation, exosomes were internalised into H69 cholan-
giocytes and had no effects either on viability or proliferation of the host
cells. Interestingly, only the exosomes from KKU-M213 cells, isolated
from the most aggressive form of CCA cells, induced migration and
invasion of H69 cells. Proteomic analysis, by nano LC-MS, of the exo-
somes from KKU-M213 cells, disclosed multiple cancer-related proteins
that were absent in H69 exosomes. On the other hand, a few proteins
observed in H69 cell-derived exosomes were absent in KKU-M213
exosomes. Consistent with the proteomic profile, treatment with KKU-
M213 exosomes induced β-catenin and reduced E-cadherin expressions
in H69 cells.
Conclusion: Collectively our results suggest a direct cell-to-cell transfer
of oncogenic proteins via the exosomal pathway that plays a pivotal role
in CCA pathogenesis. The identified exosomal cargo may serve as a
composite biomarker for early detection of the disease and thus might
enlighten new treatment strategies.
PT10.02
Functional roles of CaF-derived extracellular vesicles in scirrhous type
gastric cancer
Yutaka Naito1, Masakazu Yashiro2, Kosei Hirakawa2, Tohru Kiyono3, Wataru
Yasui5 and Takahiro Ochiya1
1Division of Molecular and Cellular Medicine, National Cancer Centre Research
Institute, Japan; 2Department of Surgical Oncology, Osaka City University
Graduate School of Medicine, Japan, Osaka, Japan; 3Division of
Carcinogenesis and Cancer Prevention, National Cancer Centre Research
Institute, Japan; 4Department of Molecular Pathology, Institute of Biomedical
and Health Sciences, Hiroshima University, Japan, Hiroshima, Japan
Introduction: Advanced diffuse type gastric cancer (GC) includes a
distinct form, termed scirrhous type GC. It is characterised by highly
metastatic and rapid proliferation with abundant stromal fibrosis.
Reflecting these characteristics, it carries a poor prognosis compared
with other type GC. In this study, we aimed to investigate the role of
carcinoma-associated fibroblast (CaF)-derived extracellular vesicles
(EVs) on scirrhous type GC progression.
Methods: To check the difference of EVs amount and size between CaFs
and normal fibroblasts (NFs), we performed nanoparticle tracking ana-
lysis (NTA). To confirm the presence of EVs obtained by ultra-centri-
fugation, western blot analysis was performed. We also investigate the
effect of EV derived from NF and CaF on the invasive activity of HSC-
44PE scirrhous type GC cell line by invasion assay. Furthermore,
miRNA microarray analysis was performed to identify specific
miRNAs in CaF-derived EVs.
Results: NTA showed that the size distribution of both fibroblast-derived
EVs were approximately 100–150 nm, and also the EV amounts did not
differ between NFs and CaFs. The amount of CD9 and CD63 as EV
markers were not significant differences among these fibroblast-derived
EVs. We investigated the effect of fibroblast-derived EVs on the invasive
activity in HSC-44PE cells. Although total EV amounts and its inter-
nalisation did not significantly differ, CaF-derived EVs promoted GC
cell invasion, but not NF-derived EVs. These results indicated that the
components included in these fibroblast-derived EVs were different.
miRNA microarray analysis revealed that oncogenic miRNAs, miR-21
and miR-125b, were highly enriched in CaF-derived EVs as compared
with NF-derived EVs.
Conclusion: Our finding indicated that CaF-derived EVs contributed to
scirrhous type GC progression by transferring oncogenic miRNAs.
PT10.03
MicroRNA-335-5p is expressed in gastric cancer derived extracellular
vesicles and modulates the invasiveness of gastric cancer cells
Iva Polakovicova1, Lorena Lobos-Gonzáles2, Nicolás Carrasco3, Manuel
Varas-Godoy4, Alejandra Sandoval-Bórquez1 and Alejandro Corvalán1
1Laboratory of Oncology, Faculty of Medicine, Advanced Centre for Chronic
Diseases, Pontifícia Universidad Católica de Chile, Santiago, Chile;
2Fundación Ciencia y Vida, Advanced Centre for Chronic Diseases, Faculty
of Medicine, Universidad de Chile, Santiago, Chile; 3Departament of
Chemistry, Faculty of Science, Pontifícia Universidad Católica De
Valparaíso, Advanced Centre for Chronic Diseases, Pontifícia Universidad
Católica de Chile, Santiago, Chile; 4Reproductive Biology Laboratory, Centro
de Investigación Biomédica, Faculty of Medicine, Universidad De Los Andes,
Bogota, Colombia
Introduction: Gastric cancer (GC) is molecularly complex and ethnically
heterogeneous disease. Studies of exclusively Asian origin have reported
a controversial role of microRNA-335-5p (miR-335) in GC thus we have
analysed the expression of miR-335 in hispanic/Amerindian GC tissues
relative to their paired adjacent non-tumour tissues and validated that
miR-335 is downregulated in GC. We have also demonstrated that miR-
335 overexpression correlates with a variety of biological processes in the
tumour cell, including migration, invasion, viability and clonogenic
capacities. To further evaluate the role of miR-335, we aimed to inves-
tigate the expression of miR-335 in GC derived extracellular vesicles
(EVs) and the behaviour of these vesicles on the cell invasiveness.
Methods: EVs were isolated from supernatants from two GC cell lines, a
primary tumour-derived cell line AGS and metastatic derived cell line
HS746T, from cells transfected with miR-335 mimics, and from plasma
patients’ samples and characterised by western blot and nanosight.MiR-
335 expression levels in cell lines, patients’ samples and EVs were
analysed by qPCR. First, the invasive properties of both cell lines and
cells transfected with miR-335 mimics were studied. Next, the effect of
EVs derived from untreated cells and cells transfected with miR-335
mimics on the invasive activity of AGS and HS746T GC cell lines was
investigated by invasion assay.
Results: Expression of miR-335 is significantly lower in metastatic
HS746T than in primary tumour AGS cell line. AGS also shows less
invasive properties. In accordance with these findings cells transfected
with miR-335 mimics show significantly decreased invasive properties.
MiR-335 is also expressed in the EVs derived from both GC cell lines
and patients’ plasma. EVs isolated from AGS and HS746T vary in their
effect on invasive properties. EVs derived from GC cells overexpressing





























miR-335 significantly suppress invasion in both GC cell types though the
effect is more pronounced in HS746T cells.
Conclusion: These data complement the clinical relevance of miR-335
and provide further evidence to support the potential role of miR-335 as
a metastatic tumour suppressor gene in GC.
PT10.04
High-throughput screening to investigate mechanisms of exosome-
driven planar cell polarity signalling
Ainsley Q. Underhill1,2, Liang Zhang2, Valbona Luga3, Mikhail Bashkurov2,
Jacob Belman2, Mark Jen2, Jenny Wang2, Alessandro Datti2 and Jeffrey
Wrana1,2
1University of Toronto, Toronto, Canada; 2Lunenfeld-Tanenbaum Research
Institute, Toronto, Canada; 3Cornell University, NY, USA
Non-canonical Wnt signalling is known to regulate planar cell polarity
(PCP), an essential process during development. However, aberrant
non-canonical Wnt signalling in cancer can also contribute to the
dynamics of metastasis and tumour progression. Recent research from
my lab identified that breast cancer cells were undergoing increased
cellular motility and metastasis by activating the PCP signalling path-
ways. This pathway was stimulated by extracellular vesicles (EVs) from
cancer-associated fibroblasts (CAFs), which were modified by interac-
tions with the breast cancer cells, causing the addition of Wnt11. Other
PCP components such as Prickle1, Smurf2, Frizzled6 and Vangl1 were
shown to be key to stimulate cellular motility. In my research, I am
working to identify additional essential elements up and downstream in
this pathway and further investigate this method of PCP signalling.
Utilising MATLAB, I have developed a script that can track cells over
an imaging series. This system was then tested extensively to ensure it
could identify differences in cellular motility, and was observed to
produce a dynamic range of ~2 in addition to replicating results pro-
duced from manual tracking. With this platform, I can screen for
changes in PCP-induced cellular motility, and I recently investigated a
cohort of kinase inhibitors, and identify various compounds that affect
cellular motility. This included targets from PCP signalling and cytoske-
leton control, such as JNK, JAK, FAK, and LIMk. Additionally, other
targets included targets from pathways involving protein synthesis, cell
proliferation and cycling, metabolomics, and development. I am cur-
rently screening a siRNA kinase library available within our facility to
further elucidate these results.
PT10.05
Ovarian cancer exosomes have the capacity to mediate the epithelial
to mesenchymal transition in target cells
Shayna Sharma1, Mona Alharbi1, Katherin Scholz-Romero1, Carlos Palma1,
Richard Kline2, Katrina Wade2, Jacob Estes2, Andrew Lai1, John Hooper3,
Gregory Rice1 and Carlos Salomon1
1Exosome Biology Laboratory, Centre for Clinical Diagnostics, University of
Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane, Australia; 2Department
of Obstetrics and Gynecology, Ochsner Baptist Hospital, New Orleans, LA,
USA; 3Mater Research Institute, University of Queensland, Translational
Research Institute, Woolloongabba, Australia
Introduction: Annually, approximately 222,000 women present with
ovarian cancer globally. It is considered the most lethal gynaecological
cancer. This is often due to the disease being diagnosed late where the 5-
year survival rate decreases to approximately 20%. In comparison, the
survival rate at an earlier stage is approximately 90%. Therefore, novel
diagnostic techniques are being examined. The past decade has seen a
great increase in research in the field of extracellular vesicles (EVs),
specifically in a subtype of EVs known as exosomes. Therefore, in this
study, we explore exosomes in the context of ovarian cancer metastasis.
Methods: Patient derived exosomes were obtained using differential
centrifugation and ultrafiltration. Exosomes were characterised using
nanoparticle tracking analysis, electron microscopy and western blot.
The effect of exosomes on Epithelial to Mesenchymal Transition (EMT)
were validated by the ratio of E-cadherin (epithelial marker) to
N-cadherin (mesenchymal marker) using western blot and the expres-
sion of 84 key genes involved in the EMT (RT2 Profiler™ PCR Array,
QIAGEN) in target cells, CAOV-3 (representative of the primary
tumour cells).
Results: Exosomes were identified as spherical vesicles with a typical
cup-shape, diameters ranging from 50 to 100 nm, with the expression of
TSG101, CD9 and CD81. Expression of WNT5A was increased by 1.16
fold in cells treated with cancer exosomes. Furthermore, cells treated
with patient derived exosomes had greater N-cadherin expression
although E-cadherin expression was not affected.
Conclusion: Ovarian cancer patient derived exosomes have a role in
mediating ovarian cancer progression by influencing the process
of EMT.
PT10.06
Exosomes derived from carcinoma-associated fibroblasts induce pre-
metastatic niche formation in lung
Jing Kong and Tingjiao Liu
College of Stomatology, Dalian Medical University, Liaoning Sheng, China
Introduction: Salivary gland adenoid cystic carcinoma (ACC) is one of
the most common malignant tumours in the oral and maxillofacial
region and tends to metastasise to lung. Cancer-associated fibroblasts
(CAFs) are a special stromal cell type that actively contributes to tumour
growth and malignant behaviour. We explored the function of CAF-
derived exosomes in the formation of ACC metastases in mice.
Methods: Exosomes from CAFs were isolated and injected into the tail
vein of C57BL-6 J mice. The expression of Fibronection, periostin, and
lysyl oxidase (LOX) were examined by immunofluorescent staining.
ACC cancer cells were implanted subcutaneously in nude mice and
exosomes from CAFs were injected three times a week for 3 weeks.
After 4 weeks, the lungs of nude mice were collected and confirmed
metastasis by histological examination.
Results: Exosomes from CAFs increased the metastatic behaviour of
ACC. CAF-derived exosomes also induced vascular leakiness at pre-
metastatic sites. Fibronection, periostin, and LOX are critical for pre-
metastatic niche formation.
Conclusion: Our findings demonstrate a critical role for CAF-produced
ECM components in premetastatic niche formation and support target-
ing CAF for the treatment and prevention of metastatic disease.
PT10.07
Exosomal miRNAs derived from mesenchymal phenotype lung cancer
cells promote epithelial–mesenchymal transition and serve as
potential biomarkers for lung cancer
Yiyao Huang1, Yue-Ting Tang2, Si-Hua Qin1, Yong Xu3, Taixue An4, Chun-
Chen Liu1, Qian Wang1 and Lei Zheng4
1Department of Laboratory Medicine, Nanfang Hospital, Southern Medical
University, Guangdong, China; 2Department of Clinical Laboratory,
Zhongnan Hospital, Wuhan University, Wuhan, China; 3Southern Medical
University Affiliated Nanfang Hospital; 4Department of Laboratory Medicine,
Southern Medical University Affiliated Nanfang Hospital, Guangdong, China
Introduction: Epithelial–mesenchymal transition (EMT) is regarded as a
critical event during tumour metastasis. Recent studies have revealed
changes in and a contribution of proteins in/on exosomes during EMT.
microRNA (miRNA) is another important functional component of
exosomes. We hypothesised that the miRNA profiles of exosomes may
change following EMT and that these exosomal miRNA may promote
EMT and metastasis of cancer cells, thus have potential to be the
circulating biomakers of lung cancer.
Methods: Transforming growth factor-β (TGF-β1) was used to induce
EMT of A549 lung cancer cells. We compared the small RNA profile and
function of exosomes from epithelial (E-exosomes) and mesenchymal
cancer cells (M-exosomes) by high-throughput sequencing and co-





























culture experiments. Then, we preliminarily validated exosomal miRNAs
in 2 serum sample sets (25 healthy controls and 22 lung cancer patients)
by quantitative real-time RT–PCR. Every research subject signed a prior
informed consent that was approved by the Human Research Ethics
Committee from Southern Medical University.
Results: The small RNA profile of exosomes was changed following
EMT. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway
analysis revealed that the specific miRNA profile of M-exosomes has
the potential to drive signal transduction networks in EMT and cancer
progression. Co-culture experiments confirmed that M-exosomes can
enter epithelial cells and promote migration, invasion and expression of
mesenchymal markers in recipient cells. Exosomal miR-7a, miR-21 and
miR-320 expression levels in serum were significantly increased in
patients with lung cancer as compared with healthy individuals.
Conclusion: Our research has provided a new insight into the role of
exosomes produced by mesenchymal cells, the specifically expressed
miRNA in which was associated with the function of EMT and metas-
tasis, and may promote transfer of the malignant phenotype (mesench-
ymal phenotype) to epithelial recipient cells. These miRNAs differently
expressed between healthy individuals and lung cancer patients, and may
serve as source of new biomarkers in lung cancer.
PT10.08
Quantitative proteomics of exosome derived from isogenic metastatic
and non-metastatic breast cancer in mouse model reveal differential
expression of intravasation factors
Jae Won Oh1, Hye Won Jung2, Yi Rang Na2, Seung Hyeok Seok2 and Kwang
Pyo Kim1
1Department of Applied Chemistry, College of Applied Sciences, Kyung Hee
University, Seoul, Republic of Korea; 2Department of Microbiology and
Immunology, Institute of Endemic Disease, Seoul National University
College of Medicine, Seoul, Republic Korea
Introduction: Breast cancer is a malignant carcinoma which metastasises
anywhere in body but mainly metastasises to bone, lungs, regional
lymph nodes, liver and brain. The spread of cancer usually happens
through following steps. Firstly, cancer cells invade nearby healthy cells,
and the cancer cells penetrate into the circulatory or lymph system, this
is called as intravasation.
To investigate physiological roles of exomes in the breast cancer metastasis,
it is crucial to reveal the key factor of intravasation from exosomal proteins.
Previous studies showed that exosome is significant in metastasis.
Methods: We studied two isogenic breast tumour cell lines, highly
metastatic 4T1 and nonmetastatic 67NR, to identify differences in the
exosomal proteins. To isolate exosome in in vivo environment, 4T1 cells
and 67NR cells were injected to BAlB/c mice. Primary cells from the
induced tumours by 4T1 and 67NR were isolated and subcultured. The
cultured cell media from primary cell cultures were used for exosome
isolation by size exclusion chromatography.
We performed quantitative proteomic analysis of prepared exosomes
derived from breast cancer in mouse model using isobaric tag based
tandem mass tag (TMT) and liquid chromatography coupled with tan-
dem mass spectrometry (LC-MS/MS).
Results: We identified 1254 exosomal proteins and significantly 53 up-
regulated proteins and 93 significantly down-regulated proteins in exo-
somes from 4T1 (p < 0.05). Interestingly, migration related pathways
and factors are specifically up regulated in exosomes from 4T1. These
results suggest that migration factors from exosomes play critical roles in
intravasation through specific migration pathways.
Conclusion: Taken together, our exosomal proteome analyses showed
key factors of intravasation were enriched in exosomes isolated from
metastatic breast cancer.
PT10.09
Tumour exosome-mediated promotion of adhesion to mesothelial
cells in gastric cancer cells
Tomohiro Arita, Daisuke Ichikawa, Hirotaka Konishi, Katsutoshi Shoda,
Shuhei Komatsu, Atsushi Shiozaki, Daiki Matsubara, Shinpei Ogino, Yuji
Fujita, Toshiyuki Kosuga, Hitoshi Fujiwara, Kazuma Okamoto and Eigo
Otsuji
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural
University of Medicine, Kyoto, Japan
Introduction: Peritoneal metastasis consists of a highly complex series of
steps, and the details of the underlying molecular mechanism remain
largely unclear. In this study, the effects of tumour-derived exosomes
(TEX) on the progression of gastric cancers were investigated in perito-
neal metastasis.
Methods: TEX were extracted from cell-conditioned medium by ultra-
centrifugation. The effects of TEX on the malignant potential of gastric
cancer were investigated in adhesion, invasion, and proliferation assays.
PCR array as well as western blotting were performed to determine the
underlying molecular mechanisms. The molecular changes in mesothe-
lial cell after internalisation of TEX derived from malignant pleural
effusion were also con rmed.
Results: TEX were internalised in both mesothelial and gastric cancer
cells in a cellular origin non-speci c manner. Internalisation of TEX
into mesothelial cells promoted signi cant adhesion between mesothe-
lial and gastric cancer cells, and TEX internalisation into gastric
cancer cells signi cantly promoted migratory ability, while internalisa-
tion of mesothelial cell-derived exosomes did not. Expression of
adhesion- related molecules, such as bronectin 1 (FN1) and laminin
gamma 1 (LAMC1), were increased in mesothelial cells after inter-
nalisation of TEX from gastric cancer cell line and malignant pleural
effusion.
Conclusion: TEX may play a critical role in the development of perito-
neal metastasis of gastric cancer, which may be partially due to inducing
increased expression of adhesion molecules in mesothelial cells.
PT10.10
Tumour microenvironment affects the composition of endothelial
cell-derived extracellular vesicles: impact in tumour progression
Makon-Sébastien Njock1, Christina O’Grady2, Franck Dequiedt2 and Ingrid
Struman1
1Laboratory of Molecular Angiogenesis, GIGA Centre, University of Liège,
Belgium; 2Laboratory of Protein Signalling and Interactions, GIGA Centre,
University of Liège, Belgium
The tumour microenvironment plays a crucial role in the progression
of tumour growth and metastasis by deregulating various physiological
processes including angiogenesis and inflammation. Several studies
have previously demonstrated that tumour-derived extracellular vesicles
(EVs) are actively involved in the mediation of tumorigenesis by
“reprogramming” target cells (e.g. endothelial cells (ECs)) through
transfer of pro-angiogenic microRNAs. But the function of EVs
released by target cells is poorly studied. Consequently, we sought to
determine the composition of EVs released by ECs under tumour
microenvironment, and to assess whether these vesicles present differ-
ent functional properties. Using RNA-seq approaches, we demonstrated
that EVs released by ECs in tumour microenvironment context present
a specific repertory of microRNAs associated to tumour angiogenesis
and inflammatory pathways. Interestingly, some of the dysregulated
microRNAs are differently expressed at the cellular and exosomal
levels. Furthermore, we showed that these vesicles were able to dereg-
ulate angiogenesis pathway by transferring several dysregulated
microRNAs to target cells. Currently, we are identifying the molecular
targets and pathways modulated by EC-derived EVs under tumour
microenvironment.
PT10.11
A role of exosomal miR-10a in bone marrow stromal cells obtained
from patients with multiple myeloma
Tomohiro Umezu1, Satoshi Satoshi2, Seiichiro Yoshizawa1, Kazuma
Ohyashiki1 and Junko H. Ohyashiki2





























1Department of Haematology, Tokyo Medical University, Tokyo, Japan;
2Institute of Medical Science, Tokyo Medical University, Tokyo, Japan
Introduction: Multiple myeloma (MM) is refractory haematologic malig-
nancy. Bone marrow stromal cells (BMSCs) interact with MM cells in
the bone marrow (BM), and also create a permissive microenvironment
for MM cell growth and survival. Recent evidence indicated that exo-
some-mediated MM cell-BMSC communication plays an important role
in the MM microenvironment. In this study, we investigated the biolo-
gical property of the exosomes and exosomal miRNAs derived from
BMSCs, aiming to establish the emerging strategies to target MM micro-
environment to prevent tumour growth and spread.
Methods: BM samples were obtained from MM patients, and BMSCs
(mmBMSCs) were isolated using the classical plastic adhesion method.
BMSCs from healthy donors (normalBMSCs) were purchased from
Lonza Inc. The exosomes were isolated from conditioned medium of
BMSCs using Exoquick-TC Reagent (System Biosciences). Cellular and
exosomal miRNA profiling was done using a TaqMan low-density array
(Applied Biosystems). For functional analysis, the miRNA mimic
(Ambion) was overexpressed in BMSCs, and WST-8 (Dojindo) and
Caspase-Glo assays (Promega) were performed to determine the impact
on cell proliferation and apoptosis, respectively.
Results: We found that exosomal miRNA expression was different
between mmBMSCs and normalBMSCs. We found that miR-10a was
significantly upregulated in the exosomes derived mmBMSCs, while the
expression of miR-10a was low in mmBMSCs. We hypothesised that low
expression of cellular miR-10a might be important for survival of
mmBMSCs, therefore the miR-10a packaged into exosomes may be
released into the extracellular space. Of note is that overexpression of
miR-10a inhibited proliferation, and promoted apoptosis in mmBMSCs.
Conclusion: Our results provide the possibility that the inhibition of
exosome release may induce mmBMSC apoptosis.
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PT11.01
In vivo analysis of the potential of exosomes isolated from menstrual
blood-derived mesenchymal stem cells in regeneration of insulin-
producing cells in diabetic type 1 animal model
Elahe Mahdipour, Zahra Salmasi and Nona Sabeti
Department of Medical Biotechnology, School of Medicine, Mashhad
University of Medical Sciences, Mashhad, Iran
Introduction: Diabetes type 1 is characterised by the lack of insulin produc-
tion as a result of degeneration of insulin-producing beta cells in the
pancreas. The autoimmune response against beta cells is the main reason
for this disease; therefore, any strategies that help immune response regula-
tion can be beneficial. Studies have shown the effectiveness of mesenchymal
stem cells (MSCs) in regulation of T cell response and pancreatic islet
repair. However, application of MSCs accompanies the cell therapy safety
issue. The unknown fate of injected stem cells is one of the major safety
concerns regarding stem cell therapies; therefore, in this study we have used
the exosomal secretome of MSCs to regenerate insulin-producing cells.
Methods: MSCs were isolated from menstrual blood as a rich and non-
invasive source of MSCs. Exosomes were isolated and characterised using
western blot and AFM, TEM techniques. Exosomes were injected intrave-
nously at different time points after induction of diabetes using STZ. Blood
glucose and insulin levels weremeasured at pre-determined time points and
animals were sacrificed at day 60 and regeneration of beta cells and insulin
production at pancreas were analysed using immunohistochemistry.
Results: flow cytometric and differentiation assays confirmed the char-
acters of MSCs derived from menstrual blood. The presence of CD81,
CD63, Tsg-101, Calnexin markers on exosomes was confirmed using
western blotting and AFM and TEM analysis verified the presence of
purified exosomes. Altogether, the blood levels of glucose and insulin
and the histochemistry analyses represented the regenerative potential of
exosomes isolated from menstrual blood-derived mesenchymal stem
cells in the restoration of insulin-producing cells.
Conclusion: although very successful in preclinical studies, mesenchymal
stem cells have still very limited therapeutic applications in clinics
mainly because of its safety concerns. Secreted exosome from these
cells exerts most beneficial properties of stem cells; however, they follow
fewer safety issues as they are not active agents as cells are. This work
represents the effectiveness of mesenchymal stem cell-derived exosomes
in the regeneration of pancreatic beta cells.
PT11.02
The CD24 receptor induces changes to the surface protein composition
of B cell microvesicles with variable effects on RNA and protein cargo
D. Craig Ayre1, Ian C. Chute2, Andrew Joy2, David Barnett2, Andrew Hogan1,
Marc P. Gruell3, Lourdes Pena-Castillo4, Andrew S. Lang3, Stephen M. Lewis5
and Sherri L. Christian1
1Department of Biochemistry, Memorial University of Newfoundland,
Newfoundland, Canada; 2Atlantic Cancer Research Institute, New Brunswick,
Canada; 3Department of Biology, Memorial University of Newfoundland,
Newfoundland, Canada; 4Departments of Computer Science and Biology,
Memorial University of Newfoundland, Newfoundland, Canada; 5Department
of Chemistry and Biochemistry, Université deMoncton, New Brunswick, Canada
Introduction: CD24 is a cell surface receptor that promotes the apoptosis
of developing B lymphocytes (B cells). We recently found that antibody
stimulation of CD24 induces B cells to release CD24-bearing, plasma
membrane-derived microvesicles (MVs). As these MVs have not pre-
viously been characterised we performed a systematic characterisation of
B cell MVs from WEHI-231 B lymphoma cells.
Methods: We examined CD24-induced changes to MV using TEM and
nanoparticle tracking. After isolation with the Vn96 peptide, we analysed
MV RNA content by RNA-Seq and the MV proteome by nanoLC-MS/MS
and western blotting. We analysed the surface receptor repertoire by flow
cytometry using bead-based isolation of CD24-bearing MVs.
Results: We found that B cells release MVs of approximately 120 nm, regard-
less of stimulation, but CD24 stimulation caused an increase in phosphati-
dylserine-positiveCD24-bearingMVs. TheRNAcargo fromMVs released by
both control and CD24-stimulated cells contained predominantly 5S rRNA,
but 18S and 28S rRNAwere not detected. CD24 stimulation caused a decrease
in the abundance of protein coding transcripts and a potential increase in
miRNA transcripts, but no statistically significant differential packaging of
individual transcripts was detected. The MV proteome was enriched with
mitochondrial and metabolism-regulating proteins, and proteins involved in
RNA or miRNA shuttling after CD24 stimulation. However, these changes
were variable and could not be fully validated by western blotting. Finally, we
found that CD24-bearingMVs carry the cell surface proteins Siglec-2 (CD22),
CD63, IgM, and, unexpectedly, Ter-119, but do not carry Siglec-G or MHC-
II. In response to CD24 stimulation we found that there was a decrease in
CD63 and IgM on the surface ofMVs, which was not mirrored by changes in
cell surface expression.
Conclusion: Overall, our data show that CD24 promotes differentially
incorporation of surface receptors duringMVbiogenesis.While a definitive
function for these MVs remains unknown, their composition suggests that
they may be involved in release of mitochondrial components from B cells
in response to pro-apoptotic stress, with the changes to the surface recep-
tors potentially altering the cell type(s) that interact with the MVs.
Funding: Funding fromNSERC and a trainee award to DCA from BHCRI.
PT11.03
Mesenchymal stem/stromal cell-derived extracellular vesicles
attenuate immune responses in two murine models of autoimmune
diseases: type 1 diabetes and uveoretinitis
Taeko Shigemoto-Kuroda1, Joo Youn Oh2, Dong-Ki Kim1, Hyun Jeong
Jeong2, Se Yeon Park2, Hyun Ju Lee3, Tae Wan Kim4, Darwin J. Prockop1
and Ryang Hwa Lee1
1Institute of Regenerative Medicine, College of Medicine, Texas A&MUniversity,
College Station, TX, USA; 2Department of Ophthalmology, Seoul National
University Hospital, Seoul, Republic of Korea; 3Laboratory of Ocular
Regenerative Medicine and Immunology, Biomedical Research Institute, Seoul
National University Hospital, Seoul, Republic of Korea; 4Department of
Ophthalmology, Seoul National University Boramae Medical Centre, Seoul,
Republic of Korea
Accumulating evidence shows that extracellular vesicles (EVs) produced by
mesenchymal stem/stromal cells (MSCs) exert their therapeutic effects in
several disease models. We previously demonstrated that MSCs suppress
autoimmunity in models of type 1 diabetes (T1D) and experimental auto-
immune uveoretinitis (EAU). Therefore, we herein investigated the ther-
apeutic potential of MSC-derived EVs using our established mouse models
for autoimmune diseases affecting the pancreas and eye: T1D and EAU.
The data demonstrate that MSC-derived EVs effectively prevent the onset
of disease in both T1D and EAU. In addition, the mixed lymphocyte
reaction assay with MSC-derived EVs indicated that EVs suppress devel-
opment of T helper 1 (Th1) cells by inhibiting activation of antigen
presenting cells. These results raise the possibility that MSC-derived EVs
may be a novel alternative to cell therapy for autoimmune diseases.
PT11.04
Exosomes derived from human autologous conditioned serum are
nanocarriers for IL-6 and TNF-alfa
Jamal Ghanam, Shaun Gaji, Mustafa Haddouti, Stephan Irsen, Julio Reinecke,
Peter Wehling and Maria Weisshaar
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Introduction: Local injection of autologous conditioned serum (ACS) is a
common therapeutic regimen for rheumatoid and orthopaedic diseases
(ODs). ACS is obtained by incubating of patients’ blood and subsequent
centrifugation. During blood incubation, immune cells produce high
amounts of growth factors and cytokines, including interleukin-1 receptor
antagonist (IL-1ra), interleukin-6 (IL-6), tumour necrosis factor alpha
(TNF-α) and transforming growth factor beta 1 (TGF-β1). The aim of this
study was to analyse exosomes release into ACS and their cytokine cargo.
Methods: 8 mL of healthy donor whole blood was left at 37°C for 3, 6, 9
and 24 h in a specialised CE marked medical device to obtain ACS.
Polyethylene Glycol (PEG) precipitation method was used to isolate
exosomes from ACS. The characteristics of exosomes were determined
using transmission electron microscopy (TEM). The exosomes’ protein
pattern was determined by SDS-PAGE and western blot. ELISA was
used to quantify IL-6 and TNF-α carried by isolated exosomes.
Results: SDS-PAGE analysis shows the presence of some intense bands
with molecular weight in the range of 25 and 58 kDa, corresponding to
the main markers of exosomes, CD9 and CD63 (CD81). Bands intensity
increases with incubation time of ACS. TEM analysis shows that the
sample obtained after 6 h of incubation contains the highest amount of
exosomes (8.77 × 107 exosomes/mL) with an average size between 25
and 58 nm. The western blot shows that all purified exosomes contain
CD63 and HSP70 markers. An intense band of CD63 was obtained after
6 h, suggesting exosomes accumulation in ACS. The concentration of IL-
6 increases over time to a value of 105.20 ± 13.75 pg mL−1 after 24 h.
The exosomal content of TNF-α decreases in time from a value of
92.14 pg mL−1 (t0) to 0.40 pg mL
−1 (t24).
Conclusion: Incubation time affects exosomes release and protein inven-
tory. Results from SDS-PAGE, western blot and TEM reveal the pre-
sence of exosomes isolated by PEG precipitation. These nanoparticles
derived from a biological treatment for ODs carry players in inflamma-
tory reaction (IL-6 and TNF-α). More researches including measure-
ment of other cytokines are required to shed light on the involvement of
ACS’ exosomes in inflammation management of ODs.
PT11.05
IL35-coated exosomes facilitate an expanded impact of regulatory T
cells-mediated suppression
Yusuke Tomita1, Ewa Jankowska-Gan1, Ying Zhou1, Dario Vignali2 and
William Burlingham1
1Department of Surgery, Division of Transplantation, University of
Wisconsin-Madison, WI, USA; 2Department of Immunology, University of
Pittsburgh, PA, USA
Introduction: We reported that donor-specific splenocytes transfusion
(DST) plus anti-CD40L costimulatory blockade treatment causes allo-spe-
cific regulation approximately 5 weeks after the tolerisation. The regulation
may include IL10, TGFb and IL35 (both Ebi3 and p35 subunit) secreted by
allo-specific regulatory T (Treg) cells. We observed exosomes-like struc-
tures on the surface of both Foxp3+ and Foxp3 negative CD4 T cells.
Hypothesis: (1) Foxp3+ Treg cells are the main source of surface Ebi3
(sEbi3) acquired by bystander CD4 T cells after tolerisation. (2) IL35 will
be secreted as components of exosomes by antigen-specific Treg cells.
Methods: CBA (H2k) spleen cells were injected i.v. on day 0 into a two
types of double reporter transgenic mice (C57BL/6, H2b background):
(1) ones which expressed YFP under the Foxp3 and TdTomRed under
the Ebi3 promoter [Ebi3+ mice], and (2) ones in which both reporters
were present, but Ebi3 production was knocked out [Ebi3Floxed mice].
Anti-CD40L blockade (MR-1) was injected i.p. into the mice of 125 ug
dose on day 0, 2 and 4. Mice were sacrificed on day 35, spleens were
harvested, restimulated with allo-specific CBA antigens overnight, and
purified exosomes by ultra-centrifugation. In order to investigate func-
tions of IL35 containing exosome purified from tolerised mice, we used
ELISA, trans vivo-delayed type hypersensitivity linked-suppression assay
and heart transplantation.
Results: By ImageStream population microscopy, the sEbi3 appeared to
be secreted as exosomes by the Treg cells and captured by bystander
CD4 non Treg cells. ELISA was able to provide exosome detection, and
CD81 enriched exosomes could be captured in ELISA by CD39-, CD73-
or Ebi3-specific, but not by p35- or p28-specific coating antibodies.
However, both p35- and Ebi3-specific antibodies could significantly
(p < 0.05) reverse suppression caused by adding the exosomes to a
TT-specific recall response, indicating that both chains of IL35 were
present and active in suppression. Finally, CBA-tolerised donor strain
(B6) exosomes administered day. 0 substantially prolonged graft survival
of a B6 to CBA heart transplant (mean survival times, 22 days, p < 0.05
vs. untreated groups).
Conclusion: IL35-coated exosomes facilitate an expanded impact of allo-
specific Treg cells in peripheral tolerance.
PT11.06
Soluble factors, not extracellular vesicles, are key determinants of
MSC: T cell suppression
Anastasia Cheng1, Natalia de França Shimabukuro2 and Inés Colmegna1
1McGill University, Montreal, Canada; 2Research Institute of the McGill
University Health Centre, Montreal, Canada
Introduction: Mesenchymal stromal cells (MSCs) possess potent immune
modulatory properties and are promising candidates for the treatment of
chronic inflammatory diseases. It is not clear whether MSC derived
extracellular vesicles (EV) recapitulate MSC suppressive effects on T cell
proliferation and thus could be potential alternatives to cellular therapy.
Methods: Human adipose tissue-derived MSCs (n = 7) were characterised
according to the minimal criteria proposed by the International Society
for Cellular Therapy. 72-hour conditioned media (CM) was collected
from resting, and cytokine primed (IFN-γ + TNF-α) MSC. Exosomes
were purified from CM by ultracentrifugation and characterised by flow
cytometry, nanoparticle tracking analysis (NTA), and transmission elec-
tron microscopy. EV depletion was performed by filtration of CM with
100 kDa MWCO and confirmed by NTA. Suppression of proliferating T
cells by either (1) MSC (contact dependent vs independent conditions),
(2) MSC CM, (3) EV-Free CM, or (4) MSC exosomes (EXO) was assessed
in 4-day allogeneic co-culture systems.
Results: MSC remain potent suppressors of T cell proliferation in the
absence of direct cell contact, emphasising the relevance of soluble
factors and possibly the role of EV (n = 6, contact 86.4 ± 10.4 vs
transwell 87.9 ± 11.0, % T cell inhibition, p > 0.05). MSC priming
increased EV release (n = 7, resting 3.4 ± 1.9 × 109 vs primed
9.8 ±4.9 × 109 EVs/ml, p = 0.02), and T cell inhibition by MSC CM
(n = 7, resting CM 27.7 ± 8.0 vs. primed CM 33.6 ± 5.8, % T cell
inhibition, p = 0.02). However, fractionation of MSC CM showed that
EV were not responsible for T cell inhibition (n = 7, CM 35.5 ± 11.5 vs.
EV-free CM 31.3 ± 13.5, % T cell inhibition, p > 0.05). Moreover,
enrichment of MSC EXO (size: 100 nm, markers: CD90/CD81/CD63)
did not impact immunopotency (n = 7, EXO 10.9 ± 5.8 vs. CM
10.1 ± 6.0, % T cell inhibition p > 0.05).
Conclusion: Non-EV soluble factors (<100 kDa) of the MSC CM are
mainly responsible for the MSC:T cell suppression.
PT11.07
The role of apoptotic cell disassembly in immunogenic cell death and
antigen presentation
Sarah Caruso, Rochelle Tixeira, Thanh Kha Phan, Sara Oveissi, Mark Hulett
and Ivan Poon
La Trobe Institue for Molecular Science, Melbourne, Australia
Introduction: Disassembly of apoptotic cells into extracellular vesicles
called apoptotic bodies, once considered a random fragmentation event,
has recently been shown to consist of highly regulated morphological
steps. It has been suggested that apoptotic bodies may aid efficient
clearance by phagocytic cells and potentially carry antigen, ultimately
promoting immunity towards dying cells. In cancer therapy this offers
the potential to develop an anti-tumour immune response. Therefore,
this study aims to determine the molecular factors that regulate cell
disassembly and examine functional role of apoptotic bodies in eliciting
anti-tumour immunity.





























Methods: Squamous cell carcinoma and lymphoma cells were induced to
undergo anti-Fas or UV-mediated apoptosis in vitro. Simultaneously, the
key regulators of apoptotic cell disassembly, rho-kinase 1 (ROCK1) and
pannexin 1 (PANX1) channel, were targeted pharmacologically and cell
morphology and apoptotic body formation was monitored by confocal
microscopy and flow cytometry, respectively. To determine the role of
apoptotic bodies in immunogenicity, assays assessing clearance and
antigen presentation were used.
Results: Targeting ROCK1 and PANX1 during cancer cell apoptosis
inhibited and enhanced apoptotic body formation, respectively, demon-
strating that apoptotic cell disassembly can be manipulated by pharma-
cological means. Engulfment assays demonstrated that cells undergoing
enhanced disassembly are cleared more effectively by dendritic cells.
These data suggest that cell disassembly can promote cell clearance by
antigen presenting cells.
Conclusion: Overall, this study demonstrated that apoptotic cell disas-
sembly can be manipulated by targeting key regulators. Enhanced apop-
totic body formation by cancer cells can contribute to more effective
clearance by dendritic cells and potentially aid antigen presentation. This
has implications for cancer therapy, where modulating cell disassembly
may be a feasible future approach to generating anti-tumour immunity.
PT11.08
Fine particulate matter (PM2.5) exposure consequences on
macrophages polarisation and released extracellular vesicles (EVs)
Amélie Héliot1, Gauthier Trémolet1, Yann Landkocz1, Dorothée Dewaele2,
Frédéric Ledoux1, Dominique Courcot1 and Perrine J. Martin1
1Université du Littoral Côte d’Opale, Dunkerque, France; 2Centre Commun
de Mesures
The increasing incidence of lung diseases in morbidity and mortality rates
worldwide generally results from inhalation of air pollution, infectious
agents, and various toxic antigens with concomitant immune responses.
Airway injury from exposure to particulate matter (PM) is a major risk
factor in the development of various lung diseases, including lung cancer
(Class I human carcinogen, IARC 2013). Fine PM (diameter below 2.5 μm,
PM2.5)may deposit in the alveoli leading to a strong inflammatory reaction
by stimulation of the release of different types of mediators from resident or
infiltrating immune cells. Among them, macrophages respond to external
stimuli with rapid changes in expression of many genes, resulting in the
activation of several macrophage phenotypes that played specific regulatory
roles in lung cancer processes. Generally, macrophages can be polarised in
two distinct phenotypes: the classically activatedmacrophages (M1), mainly
implicated in the pro-inflammatory response, and alternatively activated
macrophages (M2), that generally display anti-inflammatory function.
They also produce and secrete several factors, among which soluble circu-
lating molecules and extracellular vesicles (EVs) that have a role in orches-
trating the inflammatory responses induced by exposure to air pollutants.
Depending on their stimulation, macrophages polarised as M1 or M2 can
impact their microenvironment to be more or less tumorous. Here, we
wondered if PM2.5 exposure has effects on polarisation of human macro-
phages as well as on profile of the EVs released in response. To answer this
question, we have exposed monocytes/macrophages to two concentrations
of PM2.5 during 6, 24 and 48 h and assessed their polarisation by evaluating
substantial shifts in gene expression (mRNA and miRNA), cytokines pro-
duction and surface markers. In parallel, EVs have been isolated from
exposed macrophages supernatants. Obtained EVs have been characterised
for their amount and size distribution by nanoparticle tracking analysis and
electron microscopy and miRNA profile has been performed. For the first
time we showed that depending on the amount of PM2.5 and time expo-
sure, macrophages display specific phenotype leading to the release of
specific EVs.
PT11.09
Identifying exosome binding and internalisation in blood cell subsets
by multispectral imaging flow cytometry
Haley R. Pugsley, Sherree L. Friend, Brian E. Hall, Christine E. Probst and
Philip J. Morrissey
Amnis part of MilliporeSigma
Introduction: Only recently has the importance of extracellular vesicles
as key mediators of intercellular communication been appreciated.
Extracellular vesicles are membrane derived structures that include exo-
somes, microvesicles and apoptotic bodies. Quantifying and characteris-
ing exosomes in a reproducible and reliable manner has been difficult
due to their small size (50–100 nm in diameter). Exosomes analysis can
be done using high-magnification microscopy, however, this technique
has a very low throughput. Attempts to analyse exosomes using tradi-
tional flow cytometers has been hampered by the limit of detection of
such small particles and low refractive index. To overcome these limita-
tions we have employed multispectral imaging flow cytometry that has
the advantage of combining high throughput flow cytometry with higher
sensitivity to small particles and the added benefit of imaging that can
provide visual confirmation of particle integrity and characterisation.
Methods: In this study we use multispectral imaging flow cytometry to
investigate the interaction of exosomes with white blood cells. Exosomes
derived from Jurkat cells were labelled with anti-human CD63-AF647
and added to human white blood cells. The cells were labelled for
immunophenotyping, fixed, and then labelled with anti-human CD63-
PE to identify external exosomes.
Results: Plotting internalisation vs. bright detail similarity facilitated the
identity three populations: internal exosomes, external/internal exo-
somes, and external exosomes. Neutrophils, monocytes and lymphocytes
were identified by immunophenotyping, the % of each blood cell subset
associated with the CD63-AF647 labelled exosomes and whether the
exosomes were internalised or external was investigated.
Conclusion: The monocytes had the highest % of cell associated with
CD63-AF647 labelled exosomes. And in all of the cell types the majority
of the cells associated with CD63-AF647 labelled exosomes were either
internalised or partially internalised.
PT11.10
Chimerism-related allotolerance is induce by extracellular vesicle
acquisition and reprogramming of host dendritic cells
Diego Lema1, William Bracamonte-Baran2, Ewa Jankowska-Gan1, Frans
Claas3, Jon van Rood3, Arend Mulder3 and William Burlingham1
1Department of Surgery, Division of Transplantation, University of
Wisconsin-Madison, WI, USA; 2Department of Pathology Johns Hopkins
University School of Medicine, MD, USA; 3Department of
Immunohaematology and Blood Transfusion, Leiden University Medical
Centre, Leiden, The Netherlands
Introduction: Maternal microchimerism (MMc) has been associated with
allo-specific graft tolerance in mice and humans. This phenomenon is
associated with membrane allo-antigen acquisition (mAAQ, “cross-dres-
sing”), which is mediated by extracellular vesicles (EVs) released by rare
maternal resident cells within the offspring. In murine models, MMc-
derived EVs induce functional changes in host dendritic cells (DCs),
leading to MHC II-restricted allo-peptide presentation (indirect pathway)
in co-localisation with mAAQ-induced PD-L1 as an inhibitor signal, thus
inducing anergy in indirect antigen-specific effector T cell clones.
Methods: Circulating myeloid DCs (from fresh PBMCs) from a kidney
transplant patient (A2,24 B35,57 DR4,11) with excellent renal function
11 years after a 1-HLA haplotype-mismatched sibling transplant (A2,24
B44,57 DR4,11) were stained for HLA-B44, PD-L1 and CD80/86.
PBMCs from an HLA-identical non-transplanted sibling were cultured
with EVs isolated from plasma of the transplanted patient or a proper
syngeneic control and stained likewise. Microscopy flow cytometry
(ImageStream) was used to determine mAAQ/co-signalling molecule
co-localisation.
Results: In the transplant patient’s circulating mDCs a similar pattern of
mAAQ as seen in murine models was observed. In cultures patient-
derived, but not control-derived, exosomes replicated HLA-B44 mAAQ
in myeloid (m)DCs and plasmacytoid (p)DCs. We propose that EVs can
induce PD-L1 and CD80/86 expression on human DCs. Furthermore,
the co-localisation pattern of PD-L1 or CD80/86 with mAAQ patches in
mDCs and pDCs (as determined by microscopy flow cytometry, Image
Stream) might modulate the anergy/activation balance of allo-specific T
cell clones.





























Conclusion: Taken together, these data suggest a potential mechanism
similar to that of MMc-induced tolerance in mice by which graft cells
are able to induce allo-tolerance via EVs by generating clustering of
indirectly presented allo-peptides/MHC complexes with co-inhibitory
signals in specific microdomains on recipient mAAQ+ DCs. These
findings could explain important mechanisms of chimerism-related tol-
erance, translate into better transplant outcomes and lead to potential
therapeutic targets.
PT11.11
Suppression of inflammatory markers and exosome formation in
human lung epithelial cells by near-infrared photobiomodulation
Adam Bartos1; Elisa Ghelfi2; Magda Bortoni-Rodriguez1; Yohann Grondin1;
James Carroll3; Rick Rogers4; Rosalinda Sepulveda1
1Harvard Chan School of Public Health, University of Harvard, Boston, USA;
2Harvard Chan School of Public Health, Department of Environmental
Health, MIPS Program, Harvard University, Boston, USA; 3THOR
Photomedicine Ltd; 4Harvard T.H Chan School of Public Health, Harvard
University, Boston, USA
Exosomes are small secreted membrane vesicles found in tissues, syno-
vial fluids and all other compartments in the body. Intercellular mes-
sengers, cargo delivery of effector or signalling macromolecules, and
cytokine communication between specific cells are a few of the essential
functions ascribed to exosome to date. Exosomes have been reported in a
number of acute inflammatory processes in disease or by environmental
causes. In this report we investigate the exosome formation and cargo
content during inflammation in lipopolysaccharide stressed human
A549 human lung epithelial cells and the restoration effect of inflamma-
tion and oxidative stress by near-infrared photobiomodulation, as a new
therapeutic approach in pulmonary inflammation model.
PT11.12
Tetraspanin CD63 in exosomes derived from human monocytes
participates as co-stimulatory molecule in the immunological synapse
during dengue virus infection
Pedro Pablo Martínez Rojas, Verónica Monroy-Martínez and Blanca Ruiz-
Ordaz
Biomedical Research Institute, National Autonomous University of Mexico,
Mexico City, Mexico
Introduction: Dengue fever (DF) is the most important arthropod-borne
viral disease in tropical areas. Dengue virus (DENV) infection affects
more than 100 million people worldwide each year. DF is caused by any
of the four serotypes of DENV and presents a broad clinical spectrum,
ranging from a benign self-limiting infection to the severe dengue (SD).
DENV mainly infects antigen presenting cells (APC) and monocytes
(MO). The contact area between APC and T cells (TC) is called immu-
nological synapse (IS). Tetraspanins are integrins that function as co-
stimulatory molecules during TC activation. Tetraspanin CD63 is abun-
dantly in endosomes of APC and MO. The role of tetraspanin CD63 in
exosomes, in the absence of CD80/CD86, on the increased TC activity
observed in DF is still not described and could be important for the
cytokine storm reported in SD cases.
Methods: DENV-2 amplification in C6/36 cells and viral titration by
lytic plate assay. Cell culture of THP-1 ATCC TIB-202 (MO) and Jurkat
ATCC TIB-152 (TC). Infection of MO with DENV-2 (MOI 1). Exosome
isolation by differential ultracentrifugation and continuous density gra-
dient. Exosome morphological characterisation by transmission electron
microscopy (TEM), quantification by nanoparticle tracking analysis, and
CD63+ identification by flow cytometry. Immunological synapse
between TC and CD63+ exosomes by immunofluorescence. Kinetics of
mRNA expression of Th1 transcription factors (T-bet, STAT-1, and
STAT-4) by RT-PCR and IL-2/IFN-γ quantification by ELISA.
Results: DENV-2 had a titer of 1.0 × 107PFU/mL. Infection caused
morphological changes in MO such as filipodia formation and surface
adhesions. Exosome concentration was 7.0 × 1010 particles/mL in
2.0 × 107 infected MO. A significant difference (p < 0.05) was obtained
in concentration between infected and mock MO. All fractions of the
gradient were enriched with CD63+ exosomes. TEM showed an exo-
some heterogeneous (shape and size) population. The rest of the experi-
mental strategy is under development.
Results: In this study, we are evaluating the role of tetraspanin CD63 in
exosomes as co-stimulatory molecule in an in vitro model of DENV
infection.
PT11.13
Uncovering the immunomodulatory potential of mesenchymal
stromal cells-derived extracellular vesicles
Raquel Cunha1, Alisa Ugodnikov1, Thomas Kuncewicz1, Helena Lan1, Heidi
Kuang1, Kelvin Ng1, Oren Levy1,2, Rachelle Prantil-Baun2, Cláudia Lobato da
Silva3, Joaquim Cabral3, Jeffrey Karp1 and Donald Ingber2
1Brigham and Women’s Hospital, Harvard Medical School, MA, USA; 2Wyss
Institute for Biologically Inspired Engineering at Harvard University, MA,
USA; 3Department of Bioengineering and iBB-Institute for Bioengineering
and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisbon,
Portugal
Introduction: Mesenchymal stromal cells (MSCs) are a promising cell
source for cell-based therapies as they exhibit a potent immunomodu-
latory action in different diseases. It has been reported that MSC secre-
tome is responsible for their immunomodulatory potential. Specifically,
MSC-derived extracellular vesicles (EVs) were shown to play a key role
in mediating the immunomodulatory effect of MSC. Clinical translation
of MSC-EV therapies requires optimised protocols for isolation, char-
acterisation and functional evaluation. This work aims to develop func-
tional assays to assess the immunomodulatory potential of MSC-EV
isolated from different MSC donors.
Methods: EVs were harvested from bone marrow MSC and EV isolation
was performed by series of ultracentrifugation. EVs were visualised by
cryo-electron microscopy, size distribution and concentration were eval-
uated by nanoparticle tracking analysis and purity by MicroBCA. For the
monocyte potency assay, EVs from different MSC donors were incu-
bated with lipopolysaccharide-treated THP-1 cells and secreted inflam-
mation-related cytokines were analysed. For the endothelial potency
assay, TNF-α-treated HUVECs (to induce inflammatory stress) were
co-incubated with MSC-derived EVs. The secretion of inflammatory
cytokines and expression of surface markers were assessed.
Results: Our EV characterisation analysis indicates consistent EV isola-
tion and purity from different MSC donors. The monocyte and endothe-
lial cell-based assays developed were able to distinguish between
different MSC-EV donors based on their immunomodulatory properties.
Conclusion: These functional assays are useful tools that can be used to
select potent MSC-EV donors towards the evaluation of their therapeutic
potential in in-vitro and in vivo disease models.
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Room: Metropolitan Ballroom West and Centre
Symposium Session 10 – Novel Developments in EV Isolation
Chair: Alain Brisson and Dylan Burger 9:00–10:00 a.m.
OF10.01
Study of exosome therapeutic and diagnostic roles via microfluidic
on-demand analysis and harvesting
Mei He1 and Yong Zeng2
1Kansas State University, Terry C. Johnson Cancer Research Center, KS,
USA; 2University of Kansas, KS, USA
The finding of exosomes opens new opportunities for liquid biopsy of
cancers, and developing nature, non-toxic therapeutic delivery systems.
Exosomes play important biological roles via transferring selectively
enriched proteins, RNAs, and mitochondrial DNA, which presents dis-
tinctive opportunities for liquid biopsy analysis of cancers. Meanwhile,
the nano-sized exosomes are highly biocompatible with intrinsic payload
and exhibit much stronger antigen loading flexibility, compared to other
polymer nano-platforms. In spite of the significant roles in therapeutics
and diagnostics, the study and development of the utility of exosomes is
hampered by substantial technical difficulties in obtaining sufficient and
pure immunogenic exosomes. Current production protocols (e.g. ultra-
centrifugation and filtration) are un-scalable, often labour-intensive and
time-intensive, and in low-yield and purity (<25%). In this work, we
report a versatile, scalable microfluidic approach for processing exo-
somes with precise control and specificity, and on-demand harvesting.
Current microfluidic exosome isolation approaches either handle limited
quality of exosomes in microliter scale, or the processed exosomes are
bound to solid surface/particles and unable to stay intact. We report
continuous-flow, light-triggered on-demand harvesting of exosomes
over millilitre scale of volumes. We also demonstrated simultaneously
multiplexed detection of three tumour markers (EpCAM, CA-125,
CD24) for non-invasive diagnosis of ovarian cancer, and monitoring of
exosomal surface IGF-1R associated with its intravesicular phosphoryla-
tion levels in non-small-cell lung cancer patients plasma. A training set
plasma from ovarian cancer patients was obtained from University of
Kansas Cancer Center Biospecimen Repository. The blood exosome-
based non-invasive diagnosis of ovarian cancer showed significant accu-
racy and diagnostic power (a.u.c. = 1.0, p = 0.001) compared with the
standard Bradford assay (a.u.c. = 1.0, p = 0.0009). We foresee that
microfluidic technology will provide game changer roles for exploring
the utility of exosomes in therapeutics and diagnostics.
OF10.02
Sequential size exclusion chromatography and density gradient
separation of human circulating extracellular vesicles from
lipoproteins
Nasibeh Karimi1, Aleksander Cvjetkovic1, Su Chul Jang1, Rossella Crescitelli1,
Rienk Nieuwland2, Jan Lötvall1 and Cecilia Lässer1
1Krefting Research Centre, Institute of Medicine, University of Gothenburg,
Sweden; 2Clinical Chemistry Department, Academisch Medisch Centrum
Introduction: Isolation of extracellular vesicles (EVs) from plasma and
serum is of great importance in the field of using EVs as biomarkers for
diseases such as cancer. However, blood is one of the most cumbersome
body fluids to isolate EVs from, due to the high concentrations of
proteins and lipoproteins. The aim of this study was to develop a
method to isolate EVs from blood with minimal contamination of
lipoproteins.
Methods: Blood was collected from overnight fasting subjects, from
which plasma and serum were prepared according to standard protocols.
EVs were isolated either by size exclusion chromatography (SEC, 28
fractions) or by different combinations of SEC and iodixonol gradients
and cushions. Purity and yield of EVs were determined by electron
microscopy (EM), Western blot, nanoparticle tracking analysis and
mass spectrometry (LC-MS/MS).
Results: Using SEC, most particles were present in fractions 8–12 as deter-
mined by Zeta View®, while the bulk of the proteins were present in fractions
11–28. Vesicle markers, such as flotillin-1 (detected by western blot), and
CD9,CD63 andCD81 (detectedby ELISA) peaked in fractions 8–10, butwere
also observed in later fractions. However, EM, LC-MS/MS and western blot
(againstApo-A) also showed presence of lipoproteins in fractions 8–12 aswell
as the later fractions. Lipoprotein particles outnumbered EVs by several fold
differences as determined by Zeta View®. When iodixonol density cushion
was combined with SEC, the presence of lipoproteins in the EV-enriched
fractions was reduced significantly, as determined by EM, Western blot
(against Apo-A) and LC-MS/MS.
Conclusion: SEC alone was unable to separate lipoproteins and EVs,
whereas an iodixonol cushion followed by SEC improved separation of
EVs from lipoproteins.
OF10.03
Isolating neuronal exosomes using cell-type specific protein markers
Emma J. K. Kowal1, Dmitry Ter-Ovanesyan2, Michael Burgess3, Hasmik
Keshishian3, Steven Carr3, Aviv Regev1,3 and George M. Church4
1Massachusetts Institute of Technology, MA, USA; 2Harvard University, MA,
USA; 3Broad Institute, MA, USA; 4Harvard Medical School, MA, USA
Introduction: As all cell types secrete exosomes, human biofluids contain a
mixture of vesicles from different cell types. Exosomes have tremendous
potential as a new class of diagnostics, but their utility is hampered by the
the difficulty of determining which exosomes come from which cells.
Methods: We used a combination of methods to identify proteins that
are specific to neuron exosomes. We differentiated human induced
pluripotent cells (iPSCs) into neurons and then collected exosomes
from these neurons. We performed mass spectrometry to identify neu-
ron exosome markers and then developed a computational pipeline to
determine which exosome markers are specific to neurons. We then
optimised a protocol to efficiently isolate exosomes bearing these mar-
kers from heterogenous mixtures of vesicles.
Results: We have found hundreds of proteins present in neuron exo-
somes, but most of these proteins are not neuron specific. We have
identified transmembrane proteins that are neuron specific by overlap-
ping our results with other gene expression and human proteomics
datasets. We have further developed a pulldown protocol to isolate
neuron specific exosomes from human biofluids.
Conclusion: We have developed an approach for determining cell-type
specific exosome protein markers, and demonstrate a proof of principle
with neuron exosomes. We have also developed an exosome isolation
method which uses these markers to extract neuron-specific exosomes
from human biofluids such as cerebrospinal fluid (CSF). We envision this
method will be useful in diagnosing a variety of neurodegenerative diseases.
OF10.04
Liquid biopsy on a chip: isolation of exosomes and detection of
surface biomarkers for early diagnosis of cancer
Navneet Dogra1,2, Carlos Cordon-Cardo2, Jungreem Woo2 and Gustavo
Stolovitzky1,2
1IBM; 2Icahn School of Medicine, NY, USA





























Introduction: Exosomes are an exciting target for “liquid biopsies”.
However, isolation of exosomes and detection of their surface biomar-
kers remains an ongoing challenge. We have developed a nanoscale DLD
(Deterministic lateral displacement) device that brings capabilities with
size based sorting of colloidal particles at the tens of nanometres scale.
Furthermore, we have successfully demonstrated on-chip separation of
exosomes and detection of important surface biomarker on exosomes
derived from cancer cells.
Methods: Nanofluidic pillar array is manufactured in an SiO2 mask using
optical contact lithography, electron beam (e-beam) and deep ultra violet
lithography. Exosomes are derived from prostate cancer cell lines and
prostate cancer patients.
Results: We demonstrate size-based separation and quantification of
exosomes. Combined with fluorescence microscopy, our technology
can sort and identify multiple epitopes simultaneously on single exo-
somes surface.
Conclusion: These extremely exciting preliminary results indicates the
potential of this technology for sorting exosomes and detection of
certain disease related biomarkers from plasma, urine, serum or circu-
lating tumour-derived exosomes.





























Room: Metropolitan Ballroom East
Symposium Session 11 – EVs in Tumour Metastasis
Chair: Lei Zheng and Yves DeClerck 9:00–10:00 a.m.
OF11.01
Oncosomes as a novel liquid biopsy biomarker for quantifying
metastatic cancer dynamics in real-time
Florence Deng1, Yohan Kim1, Andrew Chun-Him Poon2, Tom Liao1, Karla
Williams3 and Hon S. Leong1
1Western Ontario, Ontario, Canada; 2University of Western Ontario,
Ontario, Canada; 3University of British Columbia, British Columbia, Canada
Introduction: Tumour cells acquire qualities that enable them to succeed
at key steps of the metastatic cascade, but very little is known about how
individual cells accomplish these feats in a challenging hemodynamically
active environment. Using intravital imaging, we observe that oncosome
release is a key event during cancer cell extravasation in various prostate
cancer cell lines. Oncosomes are large cell fragments released by cancer
cells at various stages of cancer progression. Having observed their
release in vivo during cancer cell extravasation, we sought to determine
at what other stages of metastasis oncosomes were released.
Methods: Using PC-3, LnCAP and Du145 cells, intravenous injection
into the chorioallantoic membrane (CAM) of chick embryos, a gold
standard of visualising cancer cell extravasation, was employed and
confocal resonance scanning microscopy was used to visualise the
release of oncosomes and other smaller extracellular vesicles in vivo.
Blood at various timepoints was also collected to enumerate the number
of CD9+ve and STEAP1+ve oncosomes released by extravasating cells.
Primary tumours were also formed and blood collected in the same
manner to ascertain the extent of oncosome release in vivo.
Results: At the key step of extravasation, arrested cancer cells release
oncosomes into the microcirculation which are observed to exhibit a
diameter >900 nm and expressing surface antigens found on the surro-
gate prostate cancer cell such as CD9 and STEAP1. We explored the
abundance and biophysical characteristics (size diameter range) of extra-
cellular vesicles (EVs) released during the metastatic cascade and found
that oncosomes are not consistently released by primary tumours or
metastases and that these large cancer cell fragments are specifically
released by actively extravasating cancer cells.
Conclusions: We show that oncosome biogenesis is a specific byproduct
of extravasating cells and not by primary tumours or metastatic deposits
even in the presence of pro-apoptotic or pro-necroptotic stimuli. Our
findings in plasma samples from patients on first-line treatment for
metastatic prostate cancer support the concept of oncosomes as a pro-
mising biomarker for monitoring cancer metastasis dynamics in
realtime.
OF11.02
Malignant extracellular vesicles carrying MMP1 mRNA facilitate
peritoneal dissemination in ovarian cancer
Akira Yokoi1, Yusuke Yoshioka2, Yusuke Yamamoto2, Tomoyasu Kato3,
Hiroaki Kajiyama4, Fumitaka Kikkawa4 and Takahiro Ochiya2
1National Cancer Centre Research Institute, Tokyo, Japan; 2Division of
Molecular and Cellular Medicine, National Cancer Centre Research
Institute, Tokyo, Japan; 3National Cancer Centre Hospital, Tokyo, Japan;
4Nagoya University Graduate School of Medicine, Nagoya, Japan
Introduction: Advanced ovarian cancers are highly metastatic due to
frequent peritoneal dissemination, resulting in a dismal prognosis.
However the underlying molecular mechanisms remains unknown.
Here, we report for the first time evidences that ovarian cancer-derived
extracellular vesicles (EVs) are emerging as important mediators of
peritoneal dissemination.
Methods: The mouse model of peritoneal metastasis orthotopically
established by injecting 4 types of ovarian cancer cell lines into left
ovarian bursa, and EVs was injected intraperitoneally to confirm the
metastatic effects. To clarify the detail function of EVs, 2 types of
mesothelial cells, which are main components of peritoneum, were
used. The EVs derived from cell culture supernatant and patients’ ascites
were isolated using standard serial ultracentrifugation methods.
Results: Each ovarian cancer cell line possessed different metastatic traits
in vivo, and the EVs from highly metastatic cells, ES-2 cells, strongly
induced metastatic behaviour. Notably, the metastatic cancer EVs effi-
ciently induced apoptotic cell death in mesothelial cells in vitro and in
vivo, resulting in the destruction of the peritoneal mesothelium barrier,
and promoted dissemination of cancer cells in peritoneal cavity. Whole
transcriptome analysis showed that MMP1 was significantly elevated in
mesothelial cells treated with ES-2 EVs, and intact MMP1 mRNAs were
selectively packaged in the EVs. Importantly, MMP1 expression in
ovarian cancer is tightly correlated with a poor prognosis, particularly
in stage I patients. Moreover, we found MMP1 mRNA-carrying EVs in
the ascites of cancer patients, and these EVs also induced apoptosis in
mesothelial cells.
Conclusion: Our findings clarify a previously unknown mechanism of
peritoneal dissemination via EVs, which can be novel biomarkers of
prognosis, and suggest a new therapeutic strategy for inhibiting metas-
tasis by disrupting the EVs.
OF11.03
Cancer stem cell exosomal tetraspanins network regulate pancreatic
cancer metastasis
Shuo Liu, Jun Li, Teng Wang and Shijing Yue
School of Medicine Nankai University, Nankai, China
Introduction: Exosomes derive from multiple cell types and are found in
all body fluids. Many studies indicate that exosomes represent the most
important, including long distance intercellular communication system.
Tumour exosomes play a pivotal role on cancer metastases. Tetraspanins
are the transmembrane 4 superfamily (TM4SF) proteins, which enrich in
exosomes and involve in a multitude of functional activities. However, it
is obscure that the components of cancer stem cells (CSCs) derived
exosomes and the functional role of tetraspanins network in the progress
of cancer metastases.
Methods: In this study, we used sphere culture and FACS sorting to
obtain the specific CSCs population. Ultracentrifugation was used to
prepare and enrich cancer cell and CSCs derived exosomes. The com-
ponent and tetraspanins network of CSCs derived exosomes were ana-
lysed by MALDI-TOF for proteome and RNA-seq for mRNA and
miRNA. The pancreatic cancer cell lines Aspc1, CFPAC-1, Bxpc3,
Capan1 were used as the models. Knockout mouse was established to
explore the regulation of Tspan8 in cancer metastasis.
Results/Conclusion: We found that CD9, CD151, and Tspan8 are
enriched in different exosomes derived from cancer cell and CSCs.
CD151 and Tspan8 promote the uptake of exosomes by endothelial
cell and induce angiogenesis. Furthermore, in vivo culture SP-Dio18-
labelled exosomes derived from CSCs or cancer cells in mice model
indicated that CD151 and Tspan8 increase exosomes targeting liver,
spleen, mesentery, pancreases and lung. Coculture exosomes with dif-
ferent cancer cells in SCID mice model demonstrated that exosomal
CD151 and Tspan8 promoted pancreatic cancer in liver and lung metas-
tasis. Tspan8 deficient mice reduced the B16 cell metastasis significantly.
We concluded that exosomal CD151 and Tspan8 targeting different
tissues to form the pre-metastatic niche for inducing metastasis.






























Comprehensive EV proteomics revealed EV-driven intercellular
communications in gastric cancer microenvironment and
macroenvironment
Naomi Ohnishi1, Risa Fujii1, Kentaro Murakami2, Hisahiro Matsubara2 and
Koji Ueda3
1Japanese Foundation for Cancer Research, Tokyo, Japan; 2Chiba University,
Chiba, Japan; 3Project for Personalised Cancer Medicine, Cancer Precision
Medicine Centre, Japanese Foundation for Cancer Research, Tokyo, Japan
Introduction: Extracellular vesicles (EVs) play various roles in mutual
communications between cancer cells and extracellular environment. To
understand the significance of EV-mediated protein transportation in
cancer development or progression, we developed a high-purity EV
isolation tool (EV-Second columns) and performed proteome-wide
quantitative profiling of serum EVs derived from gastric cancer (GC)
patients or healthy donors.
Methods: Serum samples were collected from 58 individuals (healthy
donors, n = 10, GC patients, n = 48). Following isolation of EVs by EV-
Second columns based on mixed mode of size exclusion and weak hydro-
phobic interaction, EV proteins were subjected to LC/MS analysis. Protein
identification, label-free quantification, and subsequent statistical analysis
were performed on Expressionist proteome server platform. Proteins spe-
cifically detected in GC-derived EVs were functionally evaluated.
Results: The LC/MS analysis identified 822 EV proteins in which 13
proteins showed significant up-regulation in GC patients’ EVs (t-
test, p < 0.05, fold change >2.0). Among them, frequent overexpres-
sion of PN-1 protein in GC cells (80.0% of undifferentiated carci-
noma or 59.1% of adenocarcinoma) was confirmed by multiple
tissue array analysis (n = 327). Interestingly, incorporation of PN-
1++ EVs drastically prevented the recipient cells from chemically-
induced apoptosis in vitro. Further single cell pH reporter assay
revealed that PN-1 enzyme inhibited pre-apoptotic intracellular pH
change, leading to survival of cancer cells in, for instance, hypoxic
conditions.
CagA, a pathogenic factor of H. pylori, was also found in serum EVs
from GC patients (1). CagA in GC cell-derived EV was efficiently
transferred into recipient cells and induced typical morphological
change, indicating that H. pylori proteins were transported EVs in
blood circulation and may be involved in cancer development and also
extragastric diseases. Indeed, H. pylori infection increases incidence of
non-gastrointestinal diseases such as cardiovascular diseases.
Conclusion: These data suggested that cancer-related EVs are served as
key mediators controlling both tumour microenvironment and macro-
environment, which could provide novel mechanisms underlying
tumour development or progression.
Reference
1. Shimoda A et al., Sci. Rep. 2016; 6: 18346.






























Symposium Session 12 – EVs in Viral Infections
Chairs: Marc-Andre Langlois and Caroline Gilbert 9:00–10:00 a.m.
OF12.01
Communication via extracellular vesicles enhances viral infection of a
cosmopolitan alga
Daniella Schatz, Shilo Rosenwasser, Sergey Malitsky, Sharon Wolf, Ester
Feldmesser and Assaf Vardi
Weizmann Institute of Science, Rehovot, Israel
Massive oceanic algal blooms that cover thousands of square kilometres,
often display a synchronised “boom and bust” dynamics, despite being
composed of unicellular organisms.
The cosmopolitan alga Emiliania huxleyi belongs to the coccolitho-
phores, a class of unicellular phytoplankton that dominates the modern
ocean and mediates the oceanic carbon and sulfur cycles. E. huxleyi
blooms are routinely terminated following infection by a large, specific,
lytic virus, the Emiliania huxleyi virus (EhV).
Communication between microorganisms in the marine environment has
immense ecological impact by mediating trophic-level interactions and
thus determining community structure. However, very little is known
about modes of cell-cell communication that may coordinate biotic inter-
actions (e.g. between cells or with grazers, bacteria and viruses) that
control the fate of these blooms. Despite recent advances in the studies
of extracellular vesicles (EVs) and their role in cell-cell communication in
metazoans and protists, almost nothing is known about EV production
during microbial interactions in the marine environment.
We investigated the signalling role of EVs produced during interactions
between the cosmopolitan alga E. huxleyi and its specific virus, EhV.
Using Nanosight technology we found that EVs are highly produced
during viral infection or when bystander cells are exposed to infochem-
icals derived from infected cells. Lipidomics and transcriptomic analyses
of these EVs demonstrated that they have a unique lipid composition
that differs from that of their infected host cells, and their cargo is
composed of selected small RNAs that are predicted to target sphingo-
lipid metabolism and cell-cycle pathways. E. huxleyi cells can uptake
vesicles, consequently leading to a faster viral infection dynamic and
prolonging EhV half-life in the extracellular milieu. We propose that
extracellular vesicles are exploited by viruses to sustain efficient infectiv-
ity and propagation across E. huxleyi blooms. Since these algal blooms
have immense impact on cycling of carbon and sulfur, this novel mode
of cell–cell communication may influence the fate of the blooms and,
consequently, the composition and flow of nutrients in the microbial
food webs in the ocean.
OF12.02
Apoptotic bodies – a novel Trojan horse for influenza A virus
Georgia Atkin-Smith, Erika Duan, Damien Zanker, Stephanie Paone, Sara
Ovessi, Mark Hulett, Weisan Chen and Ivan Poon
La Trobe Institute for Molecular Sciences, Melbourne, Australia
Introduction: For many years the fragmentation of an apoptotic cell into
apoptotic bodies (ApoBDs), via a process termed apoptotic cell disas-
sembly, was thought to be a random process dependent mainly on
plasma membrane blebbing. However, we have recently demonstrated
that monocytes generate long, membrane protrusions, which are beaded
in morphology and thus coined beaded-apoptopodia. These beaded-
apoptopodia undergo a segmentation-like event to release abundance
of ApoBDs. As ApoBDs can facilitate intracellular communication
through the trafficking of biomolecules (e.g. DNA, RNA and proteins)
and monocytes undergo apoptosis during infection, we asked whether
monocyte apoptotic cell disassembly played a role in influenza A virus
(IAV) infection, in particular whether ApoBDs could traffic virus bio-
molecules and aid viral propagation.
Methods: To analyse the formation, content and function of ApoBDs
generated from IAV infected monocytes, we used a series of flow
cytometry-based assays and mouse infection models. Additionally, we
recently developed a novel protocol to isolate ApoBDs from cell culture
and tissue samples to high purity for specific analysis.
Results: We first demonstrated that IAV can induce apoptosis and
apoptotic cell disassembly in THP-1 monocytes in vitro and in mouse
monocytes in vivo. Secondly, data suggests that IAV proteins, genomic
material and lethal virions are distributed into beaded-apoptopodia and
ApoBDs of infected monocytes. When incubated with viable cells,
ApoBDs derived from IAV-infected cells could induce apoptosis and
viral infection, whereas control ApoBDs (UV treatment) did not.
Strikingly when administered intranasally to mice, ApoBDs from
infected THP-1 cells could induce a severe inflammatory response,
viral infection and also aid viral antigen presentation.
Conclusion: For the first time, these results demonstrate that apoptotic
cell disassembly may act as a double edged sword during infection by
both aiding viral propagation and immune detection. As we have
recently identified a series of commonly used pharmaceutical com-
pounds which can manipulate the disassembly process, further studies
may unveil novel therapeutic strategies to combat viral infection.
OF12.03
Extracellular vesicles released by HIV-infected CD4+ T cells promote
the secretion of proinflammatory cytokines by uninfected bystander
lymphocytes: role of hypoxia inducible factor 1 alpha
Gabriel Duette1, Pehuen Pereyra Gerber1, Andrea Morales1, Julia Rubione1,
Alvaro Lopez Malicia1, Maria Pia Holgado1, Clovis Palmer2 and Matias
Ostrowski1
1INBIRS Institute, School of Medicine, University of Buenos Aires, Buenos
Aires, Argentina; 2Burnet Institute, Melbourne, Australia
Introduction: Chronic T cell activation and dysfunction are hallmarks of
HIV infection. Taking into consideration that T cell metabolism influ-
ences T cell functionality, we hypothesised that CD4+ T cell dysfunction
during HIV infection could be associated to virus-induced metabolic
alterations. A critical transcription factor in the coordination of T cell
metabolism, differentiation and effector function is Hypoxia inducible
factor-1 alpha (HIF-1). Herein, we analysed the role of extracellular
vesicles in the bystander modulation of HIF-1 activity and CD4+ T
cell function during HIV infection.
Methods: CD4+ T cells isolated from the blood of healthy donors were
infected in vitro with HIV mutants unable to produce progeny viral
particles. Extracellular vesicles were isolated by differential centrifuga-
tion and/or analysed by immunocapture on CD63-coated beads followed
by detection with fluorescently-labelled antibodies. The role of EVs
released by HIV infected cells in bystander CD4+ T cell metabolism
and function was assessed.
Results: HIV-1 infection triggers HIF-1 expression and activity, promot-
ing aerobic glycolysis and the production of the proinflammatory cyto-
kines IL-17A and interferon-gamma. Moreover, HIV-1 induces the HIF-
1-mediated secretion of Extracellular Vesicles. These vesicles, in turn,
promote HIF-1 activity and the secretion of gamma-interferon in
bystander cells.<
Conclusion: HIV infection induces the activity of HIF-1 in productively
infected cells and the secretion of EVs that, in turn, induce glycolytic
activity and a proinflammtory phenotype in bystander CD4+ T cells.
Overall, our results suggest that EVs released by HIV infected cells
contribute to chronic immune activation and inflammation in HIV-1-
infected patients.






























Extracellular vesicles carry HIV Env and facilitate HIV infection of
human lymphoid tissue
Anush Arakelyan1, Wendy Fitzgerald2, Soina Zicari2, Christophe Vanpouille2
and Leonid Margolis1
1Eunice-Kennedy National Institute of Child Health and Human Development,
MD, USA; 2Section of Intercellular Interactions, Eunice-Kennedy National
Institute of Child Health and Human Development, MD, USA
Introduction: Cells productively infected with HIV-1 release virions
along with extracellular vesicles (EVs). The biogenesis, size and physical
properties of EVs resemble those of viruses, particularly of HIV. Here,
we found that EVs carry viral surface proteins and these EVs ex vivo
affect HIV replication in human lymphoid tissue, where critical events of
HIV infection occur in vivo.
Methods: We analysed individual EVs in HIV-1 suspensions using our
recently developed magnetic nanoparticle (MNP) based technology. We
immunocaptured EVs released by HIV-infected PBMCs with 15-nm
MNPs coupled to antibodies recognising viral surface protein Env,
separated the captured particles on magnetic columns, and analysed
them with a flow cytometer. The captured EVs were distinguished
from the virions, also captured by these anti-Env MNPs, by the presence
of CD45 and/or acetylcholinesterase (AchE), the proteins that are not
incorporated in virions.
Results: Flow cytometry analysis of particles immunocaptured from
HIV-1-infected PBMC with anti-Env MNPs revealed that 52.6 ± 5.7%
(n = 5) and 40 ± 0.6% (n = 3) of them were CD45+ or AchE+,
respectively, thus identified as EVs. Next, we evaluated the effects of
these EVs on HIV infection of human lymphoid tissue ex vivo. Depletion
of an HIV-1 preparation of CD45+ EVs resulted in a significantly lower
level of infection 54.5 ± 8.0% (n = 4, p = 0.03) compared to mock
depleted preparation. To evaluate whether this effect was caused by the
depletion of general CD45+ EVs or by EVs that carry Env, we first
depleted the viral preparation of particles carrying Env with MNPs
coupled to anti-Env antibodies (2G12- or PG16) and then additionally
depleted with anti-CD45 MNPs. Depletion of the viral preparation of
particles (virions and EVs) that are recognised by anti-Env antibodies
decreased the tissue infection level to 41.6 ± 6.1% (n = 3, p = 0.03) in the
case of PG16 and to 43.8 ± 7.5% (n = 4, p = 0.003) in the case of 2G12.
Additional depletion of these preparations of CD45-positive EVs did not
result in a significant (p > 0.2) additional decrease of infection.
Conclusions: EVs that carry viral Env facilitate HIV-1 replication and
constitute a factor in HIV infection. These EVs may become to be a new
target for anti-HIV therapy.
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Pathways and Mechanisms of Extracellular Vesicle Formation
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States)
Mechanisms and Functions of Lysosome Positioning
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LBO.08
Real-time quantification of multi-vesicular body-plasma membrane
fusion reveals modulation of exosome release by G protein-coupled
receptor signaling
Frederik J. Verweij1, Maarten P. Bebelman2, Juan J. Garcia-Vallejo3, Marc G.
Coppolino4, S. Rubina Baglio5, Hans Janssen6, Jacques Neefjes7, Matthijs
Verhage8, Jaap M. Middeldorp5, Anoek Zomer9, Jacco van Rheenen9, Jaco
Knol10, Richard de Goeij- de Haas10, Sander R. Piersma10, Ilse Hurbain11,
Graça Raposo12, Martine J. Smit13, Connie R. Jimenez14, Ruud F. G. Toonen8,
Guillaume Van Niel15 and D. Michiel Pegtel16
1Exosomes Research Group Department of Pathology VU University Medical
Center Cancer Center Amsterdam (CCA); 2Exosomes Research Group,
Department of Pathology, VU University Medical Center, Amsterdam, The
Netherlands; 3Dept. Molecular Cell Biology & Immunology, VU University
Medical Center, Amsterdam, The Netherlands; 4Dept. of Molecular and
Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, Canada;
5Dept. Pathology, Cancer Center Amsterdam, VU University Medical
Center, Amsterdam, The Netherlands; 6Electron Microscopy Facility,
Netherlands Cancer Institute NKI-AvL, Amsterdam, The Netherlands;
7Department of Chemical Immunology, Leiden University Medical Center
LUMC, Leiden, The Netherlands; 8Department of Functional Genomics and
Department of Clinical Genetics, Center for Neurogenomics and Cognitive
Research, VU University Amsterdam and VU Medical Center; 9Cancer
Genomics Netherlands-Hubrecht Institute-KNAW & University Medical
Centre Utrecht, Utrecht, The Netherlands; 10Department of Medical
Oncology, Cancer Center Amsterdam, VU University Medical Center,
Amsterdam, The Netherlands; 11Institut Curie, PSL Research University,
Paris, France; 12Centre National de la Recherche Scientifique and Institut
Curie, PSL Research University, Paris, France; 13Division of Medicinal
Chemistry, Amsterdam Institute for Molecules Medicines and Systems, VU
University Amsterdam, Amsterdam, The Netherlands; 14Department of
Medical Oncology, Cancer Center Amsterdam, VU University Medical
Center; 15Institut Curie, PSL Research University, CNRS, UMR 144, Paris,
France /Center for Psychiatry and Neuroscience; 16Exosomes Research
Group, Department of Pathology, VU University Medical Center,
Amsterdam, Netherlands
Introduction: Exosomes are endosome-derived small extracellular
vesicles (EVs) implicated in cell-cell communication and secreted
by Multi-vesicular Bodies (MVBs) fusing with the plasma
membrane. Current techniques to study exosome physiology are
based on isolation procedures post-secretion, precluding direct
dynamic insight into the mechanics of exosome biogenesis and the
regulatory mechanisms involved in exosome release. Here we pro-
pose real-time visualization of MVB-PM fusion to overcome these
limitations.
Methods: We designed tetraspanin-based optical reporters that spot
MVB-PM fusions using live Total Internal Reflection Fluorescence
(TIRF) microscopy and dynamic Correlative Light-Electron
Microscopy (CLEM).
Results: Detailed single-cell analysis demonstrates that MVB-PM
fusion activity is reduced by depletion of the tSNAREs SNAP23 and
Syntaxin-4 and can be induced by stimulation of the Histamine H1
Receptor (H1HR). Activation of this G protein-coupled receptor in
HeLa cells increases Ser110 phosphorylation of SNAP23 promoting
MVB-PM fusion.
Summary/Conclusion: Using this single-cell live imaging approach, we
highlight the modulatory dynamics of MVB exocytosis that will increase
our understanding of exosome physiology and help identify druggable
targets in exosome-associated pathologies.
Funding: This work was funded by the Dutch Cancer Fund (KWF-5510)
a CCA grant to DMP and an EMBO long-term fellowship to FV (EMBO
ALTF 1383-2014).
FFA-01
Analysis of tumour-infiltrating innate immune cells after uptake of
glioblastoma-derived extracellular vesicles in vivo
Erik R. Abels1, Sybren Maas1, Lieke van de Haar1, Xuan Zhang1, Shilpa
Prabhakar1, Charles Lai2, Suzanne Hickman3, Marike Broekman1, Xandra
O. Breakefield1 and Joseph El Khoury3
1Department of Neurology and Radiology and Program in Neuroscience,
Massachusetts General Hospital and Harvard Medical School, Boston, MA,
USA; 2National Tsing Hua University; 3Center for Immunology and
Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA
Introduction: Extracellular vesicles (EVs) including exosomes are
50–1000 nm vesicles whose contents correspond to that of the donor
cell and consists of proteins, RNA and DNA. These vesicles are shed by
all cells and have been shown to play a role in various diseases, including
glioblastoma (GBM). Previously, we have shown that EVs shed by
glioblastoma cells can influence the cells in the tumour (micro)environ-
ment, including brain-resident microglia and infiltrating monocytes/
macrophages, making them more tumour-supportive. The aim of this
study was to study the influence of GBM-derived EVs on tumour-
associated microglia, monocytes and macrophages in vivo.
Methods: To this aim, we labeledmurine GL261 glioma cells using the
palmitoyated-GFP reporter, which labels membranes including those of
EVs. In addition, membrane-bound Gaussia luciferase (GlucB) was used
as a bioluminescence reporter. The resulting syngeneic GL261.palmGFP.
GlucB cells were implanted intracranially in adult C57/BL6.CCR2-RFP±
mice. The CCR2 promoter drives RFP expression in monocytes and cell
types derived from them. Four weeks after implantation, brains were
harvested and prepared for flow cytometric cell sorting. mRNA expres-
sion in the different cellular clusters was subsequently analysed using
Illumina mRNA sequencing.
Results: In tumour-bearing brains, EV-associated palmGFP uptake could
be detected and subsequently sorted in the different subpopulations of
microglia. In microglia from tumour-bearing mice, we detected the
activation of both immune-stimulatory and tumour-supportive path-
ways. In detail, we show microglia that took tumour derived EVs
(including exosomes) have a reduced ability to sense danger signals in
their environment and have upregulated Stat3, interleukin 4, interleukin
10 and angiogenesis pathways.
Conclusion: In conclusion, our data show that brain resident microglia take
up EVs on site and that EV uptake is associated with a stronger response of
both immune-stimulatory and tumour-supportive pathways in vivo.
FFA-02
Impaired angiogenesis and cancer metastasis by exosomes in Tspan8
deficient mice
Jun Li, Shuo Liu, Teng Wang and Shijing Yue
School of Medicine, Nankai University, Nankai, China
Introduction: Tetraspanins are highly conserved 4-transmembrane pro-
teins which form molecular clusters with a large variety of transmem-
brane and cytosolic proteins. By these associations tetraspanins are
engaged in a multitude of biological processes, which become further
expanded by the location of tetraspanin complexes in specialised mem-
brane microdomains, called tetraspanin-enriched microdomains (TEM).
TEM provide a signalling platform and are poised for invagination and
vesicle formation. These vesicles can be released as exosomes, indicating
that tetraspanins are also engaged in cell contact-independent intercel-
lular communication. The tetraspanin Tspan8 is a cancer initiating cell





























marker in gastrointestinal tumours promoting migration and invasion
via associated integrins and proteases. Depending on the cellular integrin
profile it supports angiogenesis and can induce disseminated intravas-
cular coagulation.
Methods: To shed light on its activities in non-transformed cells, we
generated a Tspan8 knockout (ko) mouse, comparing tumour growth,
angiogenesis and wound healing with that of control mice, mice with a
targeted deletion of CD151 (CD151ko) and Tspan8/CD151ko mice. The
serum exosomes were collected from wild type, Tspan8ko, CD151ko,
Tspan8/CD151ko mice. In vitro and in vivo assays were used to explore
the function of Tspan8, CD151 and the tetraspanin deficient exosomes.
Conclusion: Tspan8ko and Tspan8/CD151ko mice show no abnormal
breeding and develop alike control mice. No changes in organ structures
or behavioural anomalities were observed. With the exception of a
slightly impaired TH1-mediated DTH responses, hematopoiesis and
immune reactivity were not affected. No changes were seen in local
growth and metastasis of a wt melanoma, but angiogenesis was slightly
reduced. The latter also accounted for a pancreatic adenocarcinoma that
additionally, and distinct to CD151kd mice, showed reduced metastatic
capacity in Tspan8 and Tspan8/CD151kd mice. Impaired angiogenesis
was confirmed in vitro in the aortic ring assay. Mehtylcholanthrene-
induced tumours in Tspan8ko and CD151ko mice confirmed reduced
migratory and angiogenic activity, which prohibited tumour progression
most efficiently in Tspan8ko/CD151ko mice. Serum exosomes derived
from Tspan8ko, CD151ko, Tspan8ko/CD151ko mice impaired the migra-
tory activity of endothelial cells. The similar results were also observed
during wound healing, where epithelial cell migration, vessel recruit-
ment and matrix reorganisation were severely impaired, most strongly
by the serum exosomes derived from Tspan8/CD151ko mice.
Conclusion: We concluded that neither Tspan8ko nor Tspan8ko/CD151ko
mice exert a pathological phenotype. However, defects in migration and
angiogenesis become obvious in vivo and in vitro during wound healing
and tumour progression.
FFA-03
Presence of glypican-1 on extracellular vesicles fails to discern
pancreatic cancer from benign pancreatic diseases
Fabrice Lucien1, Vivian Lac2 and Hon S. Leong3
1Lawson Health Research Institute, Ontario, Canada; 2OVCARE;
3Western Institute, Ontario, Canada
Introduction: Pancreatic cancer is the fourth leading cause of cancer-
related deaths in North America and the five-year survival rate
approximately 5%, with most patients dying within several months.
One of the biggest problems faced by physicians is that pancreatic
cancer is clinically silent at its early stages and symptoms associated
with the disease often only appear once the cancer has invaded
neighbouring tissues or has metastasised to distant sitesthus providing
little opportunity for therapeutic intervention. Currently, there is no
effective early-detection screening test for pancreatic cancer exists
because current biomarkers suffer from poor specificity to pancreatic
cancer and are commonly elevated in benign pancreatic diseases
(BPD). A recent study suggests that the presence of Glypican-1
(GPC1) on extracellular vesicles (EVs) accurately identifies early- or
late-stage pancreatic cancer from healthy individuals or BPD patients
(1). Hence, we hypothesise that a liquid biopsy enumerating GPC1-
positive EVs will represent a blood test capable of discerning pan-
creatic cancer from BPD.
Methods: Plasma from patients with BPD, resected pancreatic cancer,
and metastatic (stage IV) pancreatic cancer have been analysed for
GPC1-positive EVs ranging from 100–1000 nm in diameter using
nanoscale flow cytometry. Since GPC1 is expressed in several other
types of cancers, we also tested the utility of a test enumerating EVs
concurrently positive for GPC1 and glycoprotein-2 (GP2), a pancreas-
specific marker.
Results: The majority of pancreatic cancer patients possessed low
GPC1 EV counts. Neither GPC1 nor GPC1-GP2 levels are signifi-
cantly elevated in pancreatic cancer patients compared to patients
with BPD. The lack of difference in EV counts between resected
and metastatic cancer groups reveals a lack of correlation of GPC1
levels with tumour burden. The sensitivity and specificity of the
GPC1 EV test were 26.67% and 87.50%, respectively, whereas the
sensitivity and specificity for the GPC1+GP2 EV test were 23.33%
and 90.00%, respectively.
Conclusion: The presence of GPC1, solely or in conjunction with GP2
analysis, was unable to effectively distinguish between BPD and pan-
creatic cancer. Consequently, GPC1 may not be useful in the early
detection of pancreatic cancer.
Reference
1. Melo SA et al., Nature. 2015; 23: 177–182..
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OF13.01
Extracellular vesicles isolated in evaporating droplets
Hwapyeong Jeong1, Youseok Hyun1, Yogesh Gianchandani2 and Jaesung
Park1
1Pohang University of Science and Technology, Pohang, Republic of Korea;
2University of Michigan, MI, USA
Introduction: Extracellular vesicles (EVs) commonly contain membrane-
associated tetraspanin, CD9, CD63 and CD81. However, no decisive
markers specifically distinguish subpopulations of EVs. Instead, subpo-
pulations of EVs are assumed to possess different physical as well as
biochemical characteristics due to the different biogenesis. To exploit the
physical characteristics of subpopulations of EVs for isolation, various
methods, such as differential centrifugation and size exclusion chroma-
tography, has been developed. However, due to multi-physical factors
dependence of isolation method, a subpopulation of EVs are not com-
pletely distinguishable from other populations. In this study, EVs were
isolated spatially based on their size in evaporating droplet. We then find
that the size of EVs is correlated with expression levels of certain
tetraspanin proteins and confirmed that the possibility of this method
can be used for diagnosis.
Methods: EVs from WM 266-4 and MCF-7 were suspended in a droplet
that was placed on a glass with various temperature gradient. EVs were
stained with anti-CD9, CD63 and CD81. After evaporation, EVs formed
ring near the contact line of the droplet. The expression levels of surface
proteins on dried ring patterns were observed under a fluorescence
microscope. For downstream analysis, EVs form prostate cancer patient
(PCa) were collected from evaporating droplet. Expression of PCA-3,
and PSMA in the collected EVs from cancer patients were analysed by
qPCR and western blotting.
Result: Chromatography using capillary and Marangoni flows provides
sufficient chromatographic resolution to spatially separate nanoparticles
by size with ~48 nm resolution. Using methods based on the deposition
and transfer of microdroplets, subpopulations of EVs were spatially
separated based on size. The average size of CD63 high-expressed EVs
was larger than CD9- or CD81-high-expressed EVs. For prostate cancer
diagnosis, both the level of PCA-3 expression and PSMA expression in
the isolated lager EVs from PCa was lower than the starting EV
population.
Conclusion: A remarkable consequence with this method is that the size
of EVs is correlated with expression levels of certain tetraspanin pro-
teins. Further, the size of EVs from prostate cancer patients is correlated
with expression levels of prostate cancer-associated markers.
OF13.02
Single cell analysis revealed cell-to-cell variations in physiologic state
influence EV secretion
Valya Ramakrishnan1, Johnny C. Akers1, Wei Cai2, Yi-Huan Tsai2, Roger
Chiu2, Yu-Hwa Lo2, Bob S. Carter1 and Clark C. Chen1
1Center for Theoretical and Applied Neuro-Oncology, University of
California, San Diego, CA, USA; 2Department of Electrical and Computer
Engineering, University of California, San Diego, CA, USA
Introduction: Most studies in the biogenesis of extracellular vesicle (EV)
are performed using a population of cells, under the assumption that
every cell in the population exhibits comparable biology. Here we per-
form analysis of EV secretion rate at the single cell level and provide data
suggesting heterogeneity in single-cell behaviour in terms of EV
secretion.
Methods: Lithographic patterning of polydimethylsiloxane (PDMS) was
used to construct a platform supporting culturing of GFP-labelled
GBM3 (a short-term passaged, patient-derived glioblastoma line). Cell
growth was monitored by time-lapse GFP microscopy. Arrays of single
cells in culture are overlaid with glass slides coated with CD63 antibody
to capture secreted EVs. Quantitation of EVs captured on this slide was
performed by probing with a biotinylated anti-CD9 antibody. Direct
quantitation of Qdot fluorescence was performed after the addition of
streptavidin conjugated Qdots to biotinylated EVs.
Results: Single cells derived from GBM3 culture that exhibit identical
growth rate and cell morphology showed a wide range of EV secretion
rates, ranging from 3 to 72 EVs secreted per hour.When fitted to Gaussian
models, three distinct model distributions were identified, suggesting
distinct cell states. The median secretion rates of this distribution were
10, 18, and 38 EVs per hour. The rate of EV secretion did not significantly
vary as a function of the cell cycle. Single-cell qPCR analysis showed that
cells in distinct model distributions differed in the expression of OLIG2
and SOX2, two genes that play a critical role in maintaining and defining
glioblastoma cancer stem cell state. We showed that single cells sponta-
neously transition between these cell states.
Conclusion: Single cell analysis suggests that dynamic heterogeneity in
cell states influences EV secretion.
OF13.03
Time-resolved surface enhanced raman spectroscopy for
characterising extracellular vesicles
Tatu Rojalin1, Heikki Saari2, Petter Somersalo2, Saara Laitinen3, Tapani
Viitala2, Zachary J. Smith4 and Marjo Yliperttula2
1University of Helsinki, Helsinki, Finland; 2Division of Pharmaceutical
Biosciences, Centre for Drug Research, Faculty of Pharmacy, University of
Helsinki, Helsinki, Finland; 3Finnish Red Cross Blood Service, Helsinki,
Finland; 4Department of Precision Mechanics and Precision
Instrumentation, University of Science and Technology of China, Hefei,
Anhui
Introduction: The aim of this work is to develop a platform for char-
acterising extracellular vesicles (EVs) by using gold-polymer nanopillar
surface-enhanced Raman spectroscopy (SERS) substrates simultaneously
circumventing the photoluminescence-related disadvantages of Raman
with a time-resolved approach. Currently, straightforward, label-free and
fast EV characterisation methods with low sample consumption are
warranted. In this study, SERS spectra of red blood cell (RBC) and
platelet (PLT) derived EVs were successfully measured and their bio-
chemical contents analysed using multivariate data analysis techniques.
Methods: RBC and PLT vesicles were isolated using differential centri-
fugation. 2 µLs of EV samples were pipetted on the gold-polymer
nanopillar SERS substrates that provided Raman signal amplification.
The SERS spectra were recorded with a pulsed picosecond 532 nm laser
in combination with a single-photon counting array detector.
Complementary EV characterisation was carried out by nanoparticle
tracking analysis and western blot.
Results: The acquired SERS spectra were in abundance of distinguishable
spectral features and the interfering photoluminescent spectral back-
grounds were effectively suppressed. Very small volumes of EV samples
were needed. Multivariate data analysis revealed that RBC and PLT
vesicles can be accurately identified using this platform. In our previous
studies Raman spectra of single RBCs had been recorded using the
Raman laser trap system. Herein, comparison between RBC EV SERS
and RBC laser trap spectra demonstrated strong resemblance to each
other reporting on the biochemical similarities between the RBC EVs
and their parent cells. These perceptions supported the feasibility of the
designed SERS method in the context of EV characterisation.
Conclusions: The introduced label-free, time-resolved SERS method
provides detailed biochemical information on the investigated RBC





























and PLT EV samples. SERS measurements of biological samples, such as
EVs, typically suffer from photoluminescence backgrounds swamping
important SERS spectral features; these difficulties can be overcome by
resolving the photoluminescence and SERS signals in the time domain.
The developed platform is a promising tool for characterising various
types of EVs in general.
OF13.04
Raman spectroscopy for the label-free identification of the source-
related biochemical fingerprint of extracellular vesicles
Alice Gualerzi1, Stefania Niada2, Marta Gomarasca2, Silvia Picciolini3, Valeria
Rossella4, Carlo Morasso1, Renzo Vanna1, Marzia Bedoni5, Fabio Ciceri6,
Maria Ester Bernardo4, Anna Teresa Brini2 and Furio Gramatica1
1Laboratory of Nanomedicine and Clinical Biophotonics LABION,
Fondazione Don Gnocchi; 2IRCCS Galeazzi Orthopaedic Institute,
Università degli Studi di Milano; 3Laboratory of Nanomedicine and Clinical
Biophotonics LABION, Fondazione Don Gnocchi – University of Milano-
Bicocca; 4TIGET, Paediatric Immunohematology and Stem Cell Programme,
San Raffaele Hospital; 5Laboratory of Nanomedicine and Clinical
Biophotonics LABION, Fondazione Don Carlo Gnocchi ONLUS;
6Haematology and Bone Marrow Transplantation Unit, San Raffaele Hospital
Introduction: Extracellular vesicles (EVs) are crucial intercellular com-
munication vehicles for bioactive molecules with diagnostic and ther-
apeutic relevance. The recent growth of studies on EV effects in disease
pathogenesis, tissue regeneration, and immunomodulation has led to the
application of multiple isolation and characterisation techniques poorly
standardised and with scarcely comparable outcomes. Current methods
for EV characterisation mainly rely on general biomarkers and physical
features that do not mirror the actual heterogeneity of vesicles. Raman
spectroscopy is a label-free, rapid, non-destructive, sensitive method that
can become a useful tool for the biochemical characterisation and dis-
crimination of EVs from multiple cell types.
Methods: Human mesenchymal stromal cells from bone marrow and
adipose tissue, and dermal fibroblasts were cultured for 72 h in serum
free conditions. Ultracentrifuged vesicles obtained from conditioned
media were analysed by confocal Raman microspectroscopy with
532 nm laser sources in the spectral ranges 500–1800 cm−1 and
2600–3200 cm−1. Multivariate statistical analysis (PCA-LDA) and classi-
cal least squares (CLS) fitting with reference lipid molecules (cholesterol,
ceramide, phosphatidylcholine, phosphatidylethanolamine, phosphatidic
acid and GM1) were performed on recordings obtained on air-dried
drops of EV suspensions.
Results: When vesicles were irradiated, Raman bands of nucleic acids,
proteins, and lipids (cholesterol, phospholipids) were visible in the spectra
providing a biochemical fingerprint of the considered vesicles. CLS fitting
allowed the calculation of the relative contribution of lipids to the
recorded spectra. By Raman spectroscopy we can clearly distinguish
vesicles originated by different cell-types with good accuracy (around
93%) thanks to biochemical features typical of the cell/tissue of origin.
Conclusion: Our results suggest Raman spectroscopy as a valuable
approach for EV characterisation prior to their use in complex disease
models. In particular, requiring minimal amount of samples and no
sample preparation, Raman analysis can be used as a routine quality
check method for EVs before in vitro or in vivo use, being also more
informative compared to other complementary techniques.
OF13.05
EV-TRACK: transparent reporting and centralising knowledge in
extracellular vesicle research
Jan Van Deun1, Pieter Mestdagh2, Patrizia Agostinis3, Geert Berx4, Jan
Gettemans5, Bernd Giebel6, Andrew F. Hill7, Suresh Mathivanan8, Esther N.M.
Nolte-’t-Hoen9, Lorraine O’Driscoll10,Michael Pfaffl11, Susmita Sahoo12, Johannes
Swinnen13, Clotilde Théry14, Guillaume Van Niel15, Marca H.M. Wauben9,
Kenneth Witwer16, Olivier De Wever17, Jo Vandesompele2 and An Hendrix17
1Laboratory of Experimental Cancer Research, Cancer Research Institute Ghent
(CRIG), Ghent University, Ghent, Belgium; 2Center for Medical Genetics,
Cancer Research Institute Ghent (CRIG), Bioinformatics Institute Ghent
(BIG), Ghent University, Ghent, Belgium; 3Cell Death Research & Therapy
(CDRT) Lab, KU Leuven University of Leuven, Leuven, Belgium; 4Department
of Biomedical Molecular Biology, Cancer Research Institute Ghent (CRIG),
Ghent University, Molecular and Cellular Oncology Lab, Inflammation
Research Centre, VIB, Ghent, Belgium; 5Department of Biochemistry, Faculty
of Medicine and Health Sciences, Ghent University, Ghent, Belgium; 6Institute
for Transfusion Medicine, University Hospital Essen, University of Duisburg-
Essen, Essen, Germany, Department of Laboratory Medicine, Karolinska
Institutet, Stockholm, Sweden; 7Department of Biochemistry and Genetics, La
Trobe Institute for Molecular Science, La Trobe University, Victoria, Australia;
8La Trobe Institute for Molecular Science; 9Department of Biochemistry & Cell
Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The
Netherlands; 10School of Pharmacy and Pharmaceutical Sciences and Trinity
Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland;
11Division of Animal Physiology and Immunology, TUM School of Life
Sciences Weihenstephan, Technical University Munich, Munich, Germany;
12Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai,
New York, USA; 13Laboratory of Lipid Metabolism and Cancer, Department of
Oncology, LKI – Leuven Cancer Institute, KU Leuven, Leuven, Belgium;
14Institut Curie, PSL Research University, INSERM U932, Paris, France;
15Institut Curie, PSL Research University, CNRS, UMR 144, Paris, France;
16The Johns Hopkins University School of Medicine; 17Laboratory of
Experimental Cancer Research, Department of Radiation Oncology and
Experimental Cancer Research, Cancer Research Institute Ghent (CRIG),
Ghent University, Ghent, Belgium
Introduction: Transparent reporting is a prerequisite to facilitate inter-
pretation and replication of extracellular vesicle (EV) experiments. We
convened an international consortium to develop a resource to improve
the rigour and interpretation of experiments, record the evolution of EV
research and create a dialogue with researchers about relevant experi-
mental parameters.
Methods: We analysed 1226 articles with keywords “exosomes” or
“extracellular vesicles” published in 2010–2015. Publications that
included multiple sample types or isolation methods were separated
into multiple entries, resulting in 1742 experiments. Experiments were
analysed using a matrix containing 115 parameters related to sample
type and EV isolation/characterisation methods. The database is freely
accessible and expandable, allowing online deposition of new experi-
ments (http://evtrack.org)
Results: To assess current practice in EV experiments, we performed an in-
depth analysis of recorded data in the EV-TRACK knowledgebase. This
revealed heterogeneity in EV isolation methods and inconsistent reporting
of experimental parameters.Differential ultracentrifugation is themost used
isolation method (>50%) but with a large heterogeneity in centrifugation
steps. In less than 20% of experiments a density gradient was implemented
to obtain or at least validate results. Quality controls are often omitted, with
more than 2 proteins being checked in 40% and non-EV enriched proteins
in less than 15% of experiments (dependent on sample type). From these
analyses, 9 relevant experimental parameters were extracted and condensed
into a singlemetric, the EV-METRIC (toMEasureTransparent Reporting of
Isolation and Characterisation methods). It represents a checklist to assess
the completeness of reporting of generic and method-specific information
necessary to interpret and repeat an experiment. The EV-TRACK platform
is a knowledge centre for EV biology and methodology that allows data
queries, coaches users by providing EV-METRICs and involves them in
decision-making on future improvements to the platform.
Conclusion: Established for and supported by the EV research commu-
nity, the EV-TRACK platform aims to ensure that experimental guide-
lines are timely, and transparently met. It is accessible at http://
evtrack.org.
OF13.06
Size and concentration determination of extracellular vesicles as
small as 50 nm in diameter at a rate beyond 10,000 EV/s
Jean-Luc Fraikin1, Leonie de Rond2, Chi Hau2, Franklin Monzon1 and Edwin
van der Pol3
1Spectradyne LLC; 2Academic Medical Centre, University of Amsterdam,
Amsterdam, The Netherlands; 3Biomedical Engineering & Physics and
Vesicles Observation Centre, Academic Medical Centre





























Introduction: Clinical applications of extracellular vesicle (EV) charac-
terisation methods demand both fast count rates to detect rare particles
(e.g. tumour-derived EV in plasma) and sensitivity spanning the entire
EV size range (~50–1000 nm). Traditional methods fail to meet one or
both metrics. Here, a rapid and commercially available on-chip technol-
ogy, microfluidic resistive pulse sensing (MRPS), is validated in a head to
head comparison against five established techniques and used to char-
acterise a variety of clinically relevant samples. MRPS is shown to be a
rapid and highly sensitive method with significant potential for use in
clinical applications.
Methods: MRPS was first validated using two standard samples: a
mixture of reference beads and EV from human cell-free urine (n = 5).
The samples were analysed by MRPS (Spectradyne, nCS1) and the
results were compared to measurements of equivalent samples obtained
by nanoparticle tracking analysis (NTA, Nanosight NS-500), tunable
resistive pulse sensing (TRPS, iZon qNano), flow cytometry (Apogee
A50-Micro) and tunnelling electron microscopy (TEM, Philips CM10).
Finally, the utility of MRPS in clinically-relevant applications was
evaluated using real-world EV samples: plasma, blood bank concen-
trates, and two tumour cell lines (LNCaP, PC-3).
Results: MRPS successfully characterised the standards and revealed
significant differences between the real-world EV samples. Measured
peak diameters in the bead mixture agreed with TEM to within an
average of 8%. A power law dependence of EV concentration c, on
diameter d, of c ~ d−4.2 was observed in the urinary vesicles over five
orders of magnitude in concentration (on a size range of 50–1000 nm),
with remarkable agreement to TEM and TRPS measurements of similar
samples. Measurements of the clinically-relevant EV samples demon-
strated an average sample turnaround time under 10 minutes, and
revealed other power law distributions and significant, quantitative
differences between samples.
Conclusion: MRPS proved a powerful technique for measuring the size
and concentration of EV in clinically relevant samples, demonstrating
accuracy higher than NTA and similar to TRPS with faster measurement
time. The performance and ease-of-use of this technique support its
potential for EV-based clinical applications.
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OF14.01
The pericardial fluid exosomes as new cell-to-cell communicators
worsening ischaemic heart disease in diabetes
Jaimy Saif1, Sezin Aday1, Giovanni Biglino1, Kate Heesom1, Maryam Anwar2,
Gianni Angelini1, Enrico Petretto3 and Costanza Emanueli4
1University of Bristol, Bristol, United Kingdom; 2Imperial College London,
London, United Kingdom; 3Duke-NUS Medical School, NC, USA; 4Bristol
Heart Institute, University of Bristol, Bristol, United Kingdom
Cardiovascular disease is prevalent in type 2 diabetes mellitus (T2DM)
and is associated with both macrovascular disease and microangiopathy,
contributing to ischaemic heart disease(IHD). Functional studies focuss-
ing on exosomes in human biological fluids are important to investigate
the relevance of exosome-based communications in human pathophy-
siology. The pericardial fluid (PF) located in the pericardial sac, is an
ultrafiltrate of plasma obtained by capillary permeability and osmotic
pressure from the epicardium and interstitial fluid underlying the myo-
cardium. We previously showed that PF exosomes promote cardiovas-
cular cell survival and angiogenesis in vitro and in vivo. Here we
hypothesise that the vascular protective and reparative actions of PF
exosomes are perturbed by T2DM, which could hijack and modify these
exosomes to amplify and spread its deleterious programme. Under
ethical approval, PF samples were collected (at the beginning of the
operation) from T2DM and non-diabetic (NDM) patients with IHD
undergoing CABG surgery. The quality of exosome preparations were
validated by Nanosight, Western blotting for exosome antigens and by
electron microscopy. The internalisation of exosomes by recipient cells
was confirmed by confocal microscopy. T2DM exosomes increased
apoptosis in recipient ECs in hypoxia and reduced the formation of
capillary networks on Matrigel in EC maintained in high glucose in
hypoxia. Proteomic profiling of PF exosomes from T2DM(vs NDM)
showed significantly higher expression of proteins involved in cardiac
hypertrophy, fibrosis and cell death. A higher expression of WD-repeat
proteins was seen in T2DM exosomes. WD-repeats regulate APAF-1
(apoptotic peptidase activating factor-1) self-association for apoptosome
formation and procaspase activation. Western blot confirmed higher
expression of APAF-1 in DM-exosomes. MicroRNA profiling of PF
exosomes showed downregulation of pro-angiogenic microRNAs,
including let-7b-5p which targets and inhibits capsase-3 expression, in
PF exosomes from T2DM. In conclusion, the study shows pro-apoptotic
and anti angiogenic effect of PF exosomes from patients with IHD and
T2DM. T2DM exosomes also showed altered proteomic and microRNA
profile, suggesting increased formation of apoptosomes and delayed
angiogenesis.
OF14.02
Endothelial cell-derived extracellular vesicles in acute myocardial
infarction
Naveed Akbar1, Janet Digby1, Thomas Cahill1, Abhijeet Tavare1, Sushant
Saluja1, Sam Dawkins1, Laurienne Edgar1, Nadia Rawlings1, Klemen
Ziberna1, Eileen McNeil1, Errin Johnson1, Alaa Aljabali1, Rebecca
Dragovic1, Mala Rohling1, Grant Belgard2, David Greaves1, Keith
Channon1, Daniel Anthony1 and Robin Choudhury1
1University of Oxford, Oxford, United Kingdom; 2Verge Genomics
Background: The mechanism by which acute myocardial infarction
(AMI) mobilises monocytes from the spleen into peripheral blood and
induces transcriptional activation remains unknown. Here we report the
role of endothelial cell (EC)-derived extracellular vesicles (EVs) in
monocyte mobilisation and transcription activation.
Methods and Results: EV were isolated by ultra-centrifugation and analysed
by nanoparticle tracking analysis, TEM, western blot, ELISA and qPCR.
AMI increased plasma EV in humans (p < 0.01) and mice (p < 0.01).
Plasma EV display EC integrins including VCAM-1, which is enriched after
injury (p < 0.05). In vitro, pro-inflammatory but not anti-inflammatory
cytokines increase EC-EV release (p < 0.001) and enrich for EV-VCAM-1
(p < 0.05). In vivo EC-EV localise to the spleen and mobilise splenic-
monocytes in naive mice (p < 0.01). In vitro EC-EV stimulates monocyte
motility (p < 0.05) and enhance their migration in response to chemokines
(p < 0.05) in a VCAM-1 dependent-way (p < 0.05). 12miRNAs are enriched
in plasma EV following AMI including EC-associated miR-126-3p, which
regulates cell motility genes including plexin-b2, a negative regulator of cell
motility. EC-EV exposure to monocytes lowers plexin-b2 mRNA (p < 0.01)
and enhances integrin and chemokine receptor expression (p < 0.01).
Conclusion: EC-EV release may be one mechanism by which the injured
myocardium signals monocyte mobilisation and transcriptional activa-
tion post-AMI.
OF14.03
Hypoxic pre-conditioning on human CD34+ stem cells enhances
exosome therapeutics of ischemic tissue repair through ETS-1-
regulated pathway
Yaxuan Liang1, Prabhu Mathiyalagan1, Sol Misener2, Douglas Losordo3 and
Susmita Sahoo1
1Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai,
New York, USA; 2Feinberg Cardiovascular Research Institute, Feinberg
School of Medicine, Northwestern University, IL, USA; 3Caladrius
Biosciences, NY, USA
Previous studies in our lab have discovered that therapeutically impor-
tant human CD34+ hematopoietic stem cells secrete exosomes (Exo) to
induce angiogenic activity both in vitro and in vivo. MicroRNA micro-
array analysis suggests that CD34+ exosomes (CD34Exo) carry proan-
giogenic miRNAs, such as miR-126, which affect the therapeutic
function of CD34Exo.
Here, we hypothesise that hypoxic treatment of CD34+ stem cells can
modulate the miRNA content and regenerative efficacy of CD34Exo.
Exosomes from human CD34+ cells cultured under hypoxia (H-Exo)
were more proliferative, anti-apoptotic and angiogenic in vitro, com-
pared to exosomes from cells under normoxia (N-Exo). In a mouse
model of hind limb ischemia (BalbC nude), H-Exo treatment signifi-
cantly enhanced limb perfusion, increased capillary density, and pre-
vented ischemic limb amputation compared to N-Exo. To identify the
factors responsible for improved therapeutic function of H-Exo, we
compared both protein and miRNA components of H- and N-Exo.
Using 2D-DIGE and mass spectrometry analysis, we found that expres-
sion of major proteins in H-Exo did not differ significantly than N-Exo.
However, expression of proangiogenic miRNAs was increased signifi-
cantly in H-Exo (e.g. miR-210 and miR-126) compared to N-Exo. We
have examined the role of ETS-1, a transcription factor induced by
hypoxia-inducible fator-1 (HIF-1), in regulating the expression of miR-
126. We propose that HIF-1/ETS-1 regulatory mechanisms affect the
expression of exosomal miR-126 under hypoxia. These results are being
confirmed using siRNA silencing and using HIF hydroxylase inhibitor
dimethyloxalylglycine.
We conclude that hypoxia-induced miR-126 expression in CD34 cell-
derived exosomes stimulating exosomes-mediated angiogenesis and
therapeutic recovery via ETS-transcriptional pathway. Our work has
important clinical implications to improve therapeutic angiogenesis,
especially in diabetic and cardiovascular patients, who have stem cells
with diminished angiogenic potential.






























Circulating exosomes correlate with metabolic syndrome severity and
evoke changes of mitochondrial dynamic which are associated with
endothelial dysfunction
Marine Malloci1, Madlyne Esnault2, Zainab Safiedeen2, Severine Dubois3,
Jerome Boursier4, Frederic Gagnadoux4, Ramaroson Andriantsitohaina1,
Gilles Simard3 and M. Carmen Martinez1
1INSERM U1063; 2INSERM UMR1063 – University of Angers, France;
3INSERM U1063/Angers University Hospital, Angers, France; 4CHU
d’Angers, Angers, France
Metabolic syndrome (MetS) is characterised by a cluster of interrelated
risk factors -hyperglycemia, dyslipidemia, hypertension and obesity-
leading to an increased risk of cardiovascular events. Exosomes can be
considered as new biomarkers of different pathologies, and can be
involved in intercellular communication. Here, we hypothesise that
exosomes could be implicated in MetS-associated endothelial dysfunc-
tion. Therefore, circulating exosomes of non-MetS subjects and MetS
patients have been isolated from plasma and characterised. Thereafter,
exosomes effects on endothelial function were analysed by measuring
nitric oxide (NO) and reactive oxygen species (ROS) production and
mitochondrial dynamic proteins, on human endothelial aortic cells
(HAoECs). Whereas circulating levels of exosomes positively correlated
with the number of MetS criteria, their size was negatively correlated
with the number of MetS criteria. Moreover, exosomes were mainly
originated from leukocytes and platelets in both non-MetS and MetS
subjects. In HAoECs, exosomes from MetS patients decreased NO pro-
duction through the inhibition of the endothelial NO-synthase activity.
Furthermore, exosomes from MetS patients increased Mitosox-asso-
ciated fluorescence, reflecting enhanced mitochondrial ROS production,
leading to increased protein tyrosine nitration. This was associated with
a decreased expression of mitochondrial fusion proteins (Mfn1 and
OPA1) and an increase of FIS1 expression, without modification of
mitophagy. Furthermore, MetS exosome treatment decreased mtDNA/
nDNA ratio but had no effect on expression of mitochondrial biogenesis
actors (PGC1, NRF1 and TFAM). These results provide evidence that
exosomes from MetS patients could be new biomarkers for this pathol-
ogy and may contribute to endothelial dysfunction in MetS, by decreas-
ing NO production, increasing oxidative stress and disturbing
mitochondrial dynamic. Thus, exosomes may be a future target to
prevent and treat this pathology.
OF14.05
Fibronectin regulates exosome secretion by human vascular smooth
muscle cells
Catherine M. Shanahan1, Chris Molenaar1, D. Michiel Pegtel2, Frederik
Verweij3, Maddy Parson4 and Alexander N. Kapustin1
1King’s College London British Heart Foundation Centre of Excellence,
London, United Kingdom; 2Exosomes Research Group, Department of
Pathology, VU University Medical Centre; 3Exosomes Research Group
Department of Pathology VU University Medical Centre, Cancer Centre
Amsterdam (CCA), Amsterdam, The Netherlands; 4Kings College London,
United Kingdom
Introduction: Atherosclerotic plaque rupture causes stroke and heart
attack. Plaque stability is defined by the composition of the extracellular
matrix and the balance between vascular smooth muscle cells (VSMCs)
and macrophages in the fibrous cap. We recently identified fibronectin
as a novel marker of plaque vulnerability. Moreover, ablation of circulat-
ing fibronectin prevented VSMC accumulation in the fibrous cap indi-
cating that fibronectin may regulate VSMC proliferation and migration.
Methods: Exosomes were isolated using differential ultracentrifugation.
To visualise MVBs and exosome secretion, VSMC were transfected with
CD63-GFP, vinculin-RFP or CD63-pHluorin using electroporation and
analysed by total internal reflection fluorescence microscopy or spinning
disc confocal microscopy (Nikon).
Results: Fibronectin has been identified as a crucial exosomal compo-
nent regulating tumour cell migration so we studied fibronectin loading
into VSMC exosomes. Exogenously added fibronectin-Alexa555 was
integrated in the matrix fibrils and endocytosed by VSMC. Internalised
fibronectin colocalised with early and late endosome markers and was
further secreted in exosomes. Inhibition of exosome secretion using an
inhibitor of sphingomyelin phosphodiesterase 3 reduced VSMC migra-
tion. Notably, immobilised fibronectin stimulated exosome secretion
and inhibition of Arp2/3 blocked this effect. Time-lapse microscopy
revealed actin “tails” pushing CD63-positive endosomal organelles indi-
cating that the branched actin network may play a crucial role in the
delivery of MVB to exosome exocytosis sites. Using a CD63-pHluorin
vector we identified that exosomes are secreted juxtaposed to focal
adhesion sites.
Conclusions: In conclusion, fibronectin stimulates exosome secretion by
VSMC which in turn, modulates VSMC migration. Modulation of the
branched actin network and/or exosome secretion opens a new avenue
for atherosclerosis treatment and prevention.
OF14.06
The role of exosomes in mesenchymal stem cell mediated
enhancement of cardiac contractility
Joshua Mayourian, Delaine Ceholski, Irene Turnbull and Kevin Costa
Icahn School of Medicine at Mount Sinai, NY, USA
Introduction: An emerging therapy for non-ischemic cardiomyopathy
involves the delivery of human mesenchymal stem cells (hMSCs).
Clinical trials document modest benefits on cardiac contractility, under-
scoring a need to better understand and exploit the underlying mechan-
isms governing hMSC-cardiomyocyte interactome. Recent studies on
hMSC-mediated heart therapies demonstrated that paracrine signalling
via secreted factors is a crucial mediator of reduced cardiac fibrosis and
enhanced angiogenesis. Moreover, hMSC paracrine factors have been
shown to impact contractility by altering cardiomyocyte ion channel/
pump activity. However, these findings fail to identify the key compo-
nents of the hMSC secretome, such as exosomes, for enhancing
contractility.
Methods: We utilise three-dimensional human engineered cardiac tis-
sues (hECTs) as an in vitro model to investigate the role of hMSC
exosomes in the enhancement of cardiac contractility. Following baseline
hECT contractile function testing on day 5, hECTs cultured in serum-
free defined media (SFDM) were replaced with the following treatments:
(1) SFDM (Control); (2) hMSC conditioned media (hMSC CdM); (3)
SFDM supplemented with hMSC exosomes (hMSC exo); or (4) hMSC
exosome-depleted conditioned media (hMSC exo-depl). hECTs were
cultured an additional 5 days, and then developed force (DF) was
measured again.
Results: The hMSC CdM and hMSC exo treatments led to statistically
significant increases in DF, whereas the control and hMSC exo-depl
groups were unchanged relative to pre-treatment. hECTs were then
snap-frozen for prospective real time quantitative polymerase chain
reaction of cardiac-specific, apoptosis, and calcium handling genes,
where mRNA levels of SERCA2a and LTCC significantly increased
only for hECTs treated with hMSC CdM and hMSC exo, while they
significantly decreased for the BAX/BCL2 ratio, an established apoptosis
marker.
Conclusion: These findings demonstrate at functional and molecular
levels that hMSC exosomes play a key role in hMSC paracrine mediated
enhancement of hECT function, motivating further investigation of the
key exosomal cargo responsible for these cardioactive effects.
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miR-145 in urinary extracellular vesicles as biomarkers for prostate
cancer
Yong Xu1, Si-Hua Qin2, Taixue An3, Yue-Ting Tang4, Yiyao Huang2 and Lei
Zheng3
1Southern Medical University affiliated Nanfang Hospital, Guangdong,
China; 2Department of Laboratory Medicine, Nanfang Hospital, Southern
Medical University, Guangdong, China; 3Department of Laboratory
Medicine, Southern Medical University affiliated Nanfang Hospital,
Guangdong, China; 4Department of Clinical Laboratory, Zhongnan
Hospital, Wuhan University, Hubei, China
Introduction: Extracellular vesicles (EVs) are known can be detected in
body fluids, and miRNAs in EVs may serve as disease biomarkers.
Hydrostatic filtration dialysis (HFD) is a method separating EVs without
the need for trained laboratory personnel and heavy initial investment.
Increasing evidence suggests circulating miRNAs in serum and urine
may be potential non-invasive biomarkers for prostate cancer (PCa). In
the present study, we aimed to investigate the whether HFD is suitable
for urinary EVs isolation and weather such reported miRNAs can be
detected in urinary and serum EVs as PCa biomarkers.
Methods: We compared the efficiency of HFD and conventional ultra-
centrifugation (UC) in isolating urinary EVs. Subsequently, EVs were
isolated from the urine of patients with PCa, patients with benign
prostate hyperplasia (BPH) and healthy individuals. Differential expres-
sion of 5 PCa-related miRNAs were measured in urine and paired serum
EVs using SYBR Green-based quantitative reverse transcription-poly-
merase chain reaction.
Results: The performance of HFD was similar to UC except lower EVs
concentration. In miRNA yield, both HFD and UC meet the needs of
follow-up analysis. 4 miRNAs, which were reported abundant in human
urinary EVs, were found no significant differences in HFD-EVs and UC-
EVs. We validated miRNAs in 60 PCa patients, 37 BPH patients and 24
healthy individuals. Written informed consents were obtained from all
patients and healthy individuals. The level of miR-145 in urinary EVs were
significantly increased in patients with PCa compared with the patients
with BPH. Significant increases were observed in miR-145 levels when
patients with Gleason score ≥ 8 tumours compared with Gleason score ≤ 7.
The same tendency were found in paired serum EVs samples. Receiver-
operating characteristic curve revealed that miR-145 in urinary EVs
combined with PSA could differentiate PCa from BPH better than PSA
alone (AUC 0.863 and AUC 0.805 respectively). In serum EVs, all of these
5 miRNAs were significantly higher in patients with PCa than with BPH.
Conclusion: HFD was appropriate for urinary EVs miRNA analysis when
compared with conventional UC. Urinary EVs miR-145 is upregulated
from PCa patients compared BPH patients and healthy controls. We
suggest the potential use of urinary EV miR-145 as a biomarker of PCa.
OF15.02
Novel platform for extracellular vesicle mRNA characterisation and
mutation detection in cancer patient blood
Zhaogang Yang1, Xinmei Wang1, Kwang J. Kwak2, Jiaming Hu1 and L. James
Lee3
1The Ohio State University, OH, USA; 2Chemical and Biomolecular
Engineering at Ohio State University, OH, USA; 3Chemical and
Biomolecular Engineering
Introduction: Extracellular vesicles (EVs) contain proteins and RNAs
that can affect the recipient cells and serve as biomarkers for diseases.
Non-coding microRNAs in EVs have been studied extensively, however,
the characterisation of EV-mRNAs remains challenging due to their
extremely low expression and the fragmentation of mRNAs in EVs.
Therefore, novel techniques that can detect the mRNA fragments in
EVs at high sensitivity and specificity are needed. Here,we aim to
develop a novel biochip for the detection of EV-mRNAs and their
mutations in cancer patient blood.
Methods: We designed new toehold-initiated molecular beacons (Ti-
MBs) that are much more stable and sensitive than conventional hairpin
molecular beacons (Co-MBs) and can detect mRNA targets with a
single-base mis-match. Those Ti-MBs are encapsulated in cationic lipo-
plex nanoparticles (CLNs) and tethered on the surface of a thin glass,
which can capture individual EVs in plasma via EV-CLN fusion and
identify EV mRNA targets via MB-mRNA hybridisation using a high
resolution fluorescence microscope in a single step. Well defined plasma
samples from lung cancer, liver cancer and pancreatic cancer patients
were tested.
Results: Comparing to qRT-PCR, our tethered lipoplex nanoparticle
(TLN) biochip is much more sensitive for EV mRNA detection, requires
smaller sample size (20 µL), uses less assay time (<4 h), and can detect
single-point mutated mRNAs in EVs. We examined a glucose regulation
gene, transketolase 1 (TKTL1), and thyroid transcription factor 1
(TTF1), a well-known upregulated mRNA in lung cancer tissue, to
demonstrate the applicability of TLN biochip in non-small cell lung
cancer (NSCLC) detection. We also examined two genes related to
hepatocellular carcinoma (HCC), alpha fetoprotein (AFP) and glypi-
can-3 (GPC3), for liver cancer detection. Those 2-mRNA classifiers
can distinguish cancer patients from healthy individuals with high accu-
racy, not achievable by any existing methods. Our TLN biochips with Ti-
MBs can also identify EGFR mutations in lung cancer and KRAS muta-
tions in pancreatic cancer via EVs in cell line culture medium or patient
plasma without qRT-PCR amplification and gene sequencing.
Conclusion: Our TLN biochip may serve as a platform for EV capture
and characterisation of mRNAs and mutations in cancer patient blood.
OF15.04
Extracellular RNA is promising biomarker for eary detection of
cancers
Yukie Nishiyama1, Yumiko Koui2, Yuki Yamamoto1, Genki Nishimura1,
Masaki Kinehara1, Akira Shimamoto1, Morito Okada2 and Hidetoshi Tahara1
1Department of Cellular and Molecular Biology, Hiroshima University
Institute of Biomedical & Health Sciences; 2Department of Surgical
Oncology, Hiroshima University, Hiroshima, Japan
Introduction: Extracellular vesicles (EVs) including exosomes released
into the extracellular environment from a variety of cells, and can be
used for cell-to-cell communication in vivo. It is well known that
circulating RNA and exRNA are powerful tool for cancer biomarker.
We focused on exRNA and circulating RNA using serum for cancer
biomarker.
Methods: Cell were cultured with DMEM with FBS and the cell super-
natant were collected without FBS medium. Extracellular vesicles (EVs)
were purified by ultracentrifugation or sucrose gradient fractionation.
The size and amount of isolated EVs were measured by qNano (iZON).
Circulating RNA is purified using miRNeasy Mini Kit (Qiagen). Next
generation sequencing (NGS) is performed using IonPGM and IonS5
(Thermo Fisher Scientific Inc.). All of the patients provided written
informed consent to participate in the study (Approved by IRB commit-
tee in Hiroshima university).
Results: We identified several microRNAs biomarker specific for pan-
creatic cancer, head and neck cancer and breast cancer using serum and
plasma. We also identified cancer specific pre-miRNAs, pri-miRNA and
isomiR which is distinguish between cancer and healthy volunteer. It is
known that isomiRs are not caused by RNA degradation during sample





























preparation for NGS. Some of isomiR profiling is well correlated in
exRNA profiling in cultured EVs from cancer cell lines. Therefore,
isomiR alterations in circulating RNA should be powerful and significant
tools to identify the origin and the type of cancers.
Conclusion: We believe that our NGS platform based biomarker dis-
covery may provide the useful information to use for early detection,
prognosis and companion diagnosis in cancers.
OF15.05
Extracellular vesicle mRNA and miRNA characterisation in ovarian
cancer ascites and peritoneal fluid
Cindy Yamamoto1, Taku Murakami1, Melanie Oakes1, Michael Muto2, Ross
Berkowitz2 and Shu-Wing Ng2
1Hitachi Chemical Co. America, Ltd. R&D Center; 2Brigham and Women’s
Hospital, MA, USA
Ovarian cancer has the highest mortality rate of all gynaecological
cancers worldwide, partly due to the lack of early signs or symptoms
leading to diagnosis at relatively advanced stages for this disease. Our
goal was to determine if potentially novel biomarkers could be identified
for early screening using ovarian cancer ascites extracellular vesicles
(EVs). Here, we describe characterisation of ovarian cancer ascites and
peritoneal fluid EVs and detection of specific mRNA and miRNA. Fluids
were collected from subjects with benign cysts, endometrioma, or low/
high grade serous ovarian carcinoma. EVs isolated from these fluids
were found to be EpCAM positive by ELISA and have concentrations
greater than 2.0 × 1010 particles/mL by nanoparticle tracking analysis.
Particle sizes from peritoneal fluids were 158.7 ± 28.3 nm while ascites
were 87.3 ± 18.0 nm (p < 0.05). Using a 96-well exosome collection
filterplate, both peritoneal fluids (n = 10) and ascites fluids (n = 8) were
processed in parallel and subsequently, qPCR screening of 34 mRNA
and 18 miRNA was performed. These studies identified five and six
significantly differentially expressed normalised EV mRNA and miRNA
(p < 0.05), respectively. At least one of these markers was shown to be
present in healthy plasma (n = 3) and significantly increased in condi-
tioned media of SKOV3 and OVCAR3, which are high-grade serous
ovarian cancer cell lines compared respectively to immortalised ovarian
surface and fallopian tube epithelial cells, the hypothesised cells of origin
for ovarian cancer development. Further studies are necessary to deter-
mine if this marker is differentially expressed in ovarian cancer plasma.
EVs may provide a potentially novel source for discovery of biomarkers
for early detection of ovarian cancer.
OF15.06
Characterisation of exosomes and exosomal circular RNA from
pancreatic ductal adenocarcinoma carcinoma cell lines
Keith Laderoute1, Daniel Renouf2, David Shaeffer2, Marcel Bally3, Emma
Guns4 and Jessica Kalra3
1SRI, Inc.; 2Pancreas Centre BC; 3BC Cancer Research Center, British
Columbia, Canada; 4Vancouver Prostate Center, Vancouver, Canada
Introduction: Pancreatic ductal adenocarcinoma (PDAC) continues to
demonstrate poor outcomes due to its late stage of diagnosis. Research
has concentrated on finding biomarkers for early detection while the
cancer is still localised and amenable to therapy, however, these markers
remain elusive. Exosomes are quickly becoming a prominent tool in
biomarker research, and PDAC exosomes are showing promise in the
development of liquid biopsies for early screening programmes. The
studies described focus on characterising exosomes collected from the
conditioned media of PDAC cell lines as well as inventorying the RNA
contents of these extracellular vesicles. We are particularly interested in
exploring a novel class of non-coding RNA, circular RNA (circRNA) for
our studies. We believe that aberrantly expressed genes in PDAC pro-
duce different types of circRNAs that become enriched in tumour-
secreted exosomes.
Methods: Exosomes were isolated from a normal pancreatic exocrine cell
line (htert-HPNE) as well as three PDAC cell lines ranging from well to
poorly differentiated, including PANC-1, BxPC3and MIAPaCa-2. The
size and relative abundance of exosomes was quantified by transmission
electron microscopy (TEM) and nanotracker analysis (NTA). Circular
RNA was purified from exosomes (exo-circRNA) and used to construct
RNA-Seq libraries. Characteristics of exosomes and exo-circRNA com-
parisons were made between cell lines.
Results: Exosome size ranged from 40 nm to 160 nm. The smallest
structures were observed from the PANC-1 cell line and concentrations
varied with the lowest abundance coming from HPNE and MiPaCa cells.
CircRNAs in exosomes were easily isolated from all 4 cell lines, and
comparative RNA-seq analyses revealed a number of interesting
circRNA species that show cell line specificity.
Conclusions: The studies described demonstrate that specific circRNAs
can be readily extracted from the exosomes secreted into the conditioned
media of PDAC cell lines. We hope that this novel tool can be further
developed to help to diagnose pancreatic carcinoma when it is amenable
to surgical resection and/or chemotherapy, thereby reducing the mor-
tality associated with this disease.
OF15.03
In vivo characterisation of EV miRNA secretion into cerebrospinal
fluid (CSF) by glioblastoma
Johnny C. Akers, Valya Ramakrishnan, Bob S. Carter and Clark C. Chen
Center for Theoretical and Applied Neuro-Oncology, University of
California, San Diego, CA, USA
Introduction: Glioblastoma is the most common form of primary brain
neoplasm and remains one of the deadliest of human cancers. Robust
platform for minimally invasive biomarkers that would allow assessment
of tumour burden or therapeutic response remains an unmet clinical
need. While efforts to analyse clinical cerebrospinal fluid (CSF) for such
biomarkers are ongoing, initial efforts were plagued by heterogeneity in
patient demographics, characteristics, and variation in sample acquisi-
tion. Here we establish a murine model for in vivo characterisation of
CSF changes that occur secondary to glioblastoma growth.
Methods: Patient derived glioblastoma line expressing was orthotopically
implanted into nude mice. 4 weeks after injection, brain tissue and
murine CSF from the cisterna magna were collected from tumour-
bearing mice and age-matched, mock injected nude mice. We modified
a PCR method designed to assess RNA derived from single cells to
characterise miR-21 level in CSF.
Results: In glioblastoma xenograft specimens, miR-21 was expressed at
levels 10–160 fold higher than that seen in murine brain. There was a
>10 fold increase in the CSF miR-21 level of mice with glioblastoma
tumour relative to those that underwent mock injection. The level of
CSF miR-21 did not directly correlate with glioblastoma tumour size,
suggesting potential influences of microenvironment factors in this
process. While miR-16 and miR-10b were similarly elevated in glioblas-
toma xenograft specimens, we did not detect increased levels of these
miRNAs in xenograft bearing mice relative to the mock injected mice.
Conclusion: Our results suggest that glioblastoma selectively export
miRNAs through EV secretion in vivo. The model established here lays
the foundation for interpretation of clinical CSF data as well as future
mechanistic studies of EV transport between anatomic compartments.





























Room: Metropolitan Ballroom West and Centre
Symposium Session 16 – EV Omics
Chairs: Juan Falcon-Perez and Suresh Mathivanan 3:45–5:15 p.m.
LBO.09
Extracellular vesicles containing Chs3 and Fks1 rescue cell wall
defective yeast and protect from antifungal agents
Kening Zhao, Mark Bleackley, Marilyn Anderson and Suresh Mathivanan
La Trobe Institute for Molecular Science, Melbourne, Australia
Introduction: Though most of the knowledge pertaining to Endosomal
Sorting Complex Required for Transport (ESCRT) machinery interac-
tions were obtained from yeast, very little is known about their role in
extracellular vesicle (EVs) biogenesis in yeast. Furthermore, it is unclear
whether EVs have any role in cell wall remodeling.
Methods: EVs were isolated using differential centrifugations from var-
ious ESCRT knockout yeast strains. Protein quantification, electron
microscopy, nanoparticle tracking analysis, quantitative proteomics and
carbohydrate analysis were done to characterize these EVs. Yeast cells
were treated with specific drugs to enrich for different EV types. Survival
assays were carried out with EVs and antifungals.
Results: A series of 10 yeast knockout strains including Vps2âˆ†,
Vps23âˆ†, Vps36âˆ†, Bro1âˆ†, Hse1âˆ†, Fks1âˆ†, Chs3âˆ†, Atg8âˆ†,
Mrpl32âˆ† and Mst27âˆ† were established. Characterization and quanti-
tative proteomic analysis revealed that ESCRT knockout and cell wall
mutant EVs were altered in terms of protein amounts, morphologies,
size and protein cargo compared to WT. Carbohydrate analysis of EVs
revealed enrichment of glucose and mannose in Bro1âˆ† and Hse1âˆ†
EVs. In spite of 85% proteome coverage in EVs, ESCRT components were
found to be significantly depleted in yeast EVs. These results suggest that
yeast EVs are significantly different from mammalian exosomes.
Proteomic analysis highlighted the enrichment of cell wall remodeling
enzymes, glucan synthase Fks1 and chitin synthase Chs3, especially in
Vps2âˆ† and Vps23âˆ† EVs. To understand whether yeast EVs can remo-
del the cell wall, functional uptake assays were performed with WT and
cell wall mutant (Chs3âˆ†) strains. Interestingly, EVs were able to protect
WT and cell wall mutant strains from antifungal caspofungin and the
plant defensin NaD1. However, EVs from Fks1âˆ† or Chs3âˆ† were
unable to rescue the yeast cells from antifungals. Furthermore, the protec-
tion from antifungals were abrogated when EVs from Chs3âˆ† Vps23âˆ†
double knockout strain were incubated with yeast cells. Co-culture of
Chs3âˆ† strain expressing GFP and WT or Vps23âˆ† strain increased
Chs3âˆ† strain survival upon caspofungin treatment.
Summary/Conclusion: Overall, we were able to confirm that yeast EVs
are different from mammalian exosomes. Secondly, EVs with cell wall
remodeling enzymes were able to rescue yeast from antifungal agents.
OF16.01
Differences and similarities in full-length and fragmented non-coding
RNA biotypes in EV from differentially stimulated dendritic cells
Tom A.P. Driedonks1, Susanne G. van der Grein1, Yavuz Ariyurek2, Henk P.
J. Buermans2, Henrike Jekel1, Franklin W.N. Chow3, Amy H. Buck3, Marca
H.M. Wauben1, Peter-Bram A.C. 't Hoen4 and Esther N.M. Nolte-'t-Hoen1
1Department of Biochemistry & Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, Utrecht, The Netherlands; 2Leiden Genome Technology
Centre, Leiden University Medical Centre, Leiden, The Netherlands;
3Institute of Immunology and Infection Research, Centre for Immunity,
Infection and Evolution, School of Biological Sciences, University of
Edinburgh, Edinburgh, UK; 4Department of Human Genetics, Leiden
University Medical Centre, Leiden, The Netherlands
Introduction: The presence and function of miRNA in extracellular
vesicles (EVs) have been widely studied. However, the majority of EV
RNA consists of other small RNA types such as tRNA, Y-RNA, SRP-
RNA, Vault RNA, snoRNA and snRNA. Fragmented forms of these
RNAs have been proposed to exert gene regulatory functions. It is
unknown if and how incorporation of these RNAs in EVs is regulated,
and how they function in EV-mediated communication. We differen-
tiated dendritic cells (DC) into immunogenic and tolerogenic pheno-
types, which release EVs that differently affect T cell responses. We
investigated which RNA types were consistently present in EVs and
which types were differentially incorporated depending on the signal
imposed on DC.
Methods: EVs released by in vitro cultured DC that were left unstimu-
lated or differentiated into highly immunogenic or tolerogenic pheno-
types were isolated using differential centrifugation and density gradient
purification. Deep sequencing was performed on small RNA (15–300 nt)
isolated from EVs and parent cells (n = 3). Observations were validated
by Northern blot or RT-qPCR.
Results: miRNA were underrepresented in EVs compared to cells, but
the miRNA content showed large differences between immunogenic and
tolerogenic EVs. snoRNA and snRNA were underrepresented in EVs but
were highly similar between the two conditions. tRNA were highly
abundant and enriched in EVs compared to cells, but no major differ-
ences were found between immunogenic and tolerogenic EVs.
Interestingly, tolerogenic and immunogenic EV differed in levels of
Y-RNA and incorporated Y-RNA fragments. Importantly however,
Northern blot showed a very different full length:fragments ratio for
tRNA and Y-RNA than expected based on sequencing data.
Conclusion: Differentiation signals imposed on dendritic cells affect the
miRNA and Y-RNA content of released EVs, while other non-coding
RNA types remain largely unchanged. This suggests that RNA types
other than miRNA potentially contribute to EV function.
OF16.02
CD63, MHC class 1 and CD47 identify subsets of extracellular vesicles
containing distinct populations of micro-RNA
Sukhbir Kaur1, Abdel G Elkahloun2, Anush Arakelyan3, Tim G Myers4,
Otaizo-Carrasquero Francisco4, Weiwei Wu5, Leonid Margolis3 and David
D Roberts1
1Laboratory of Pathology, Center for Cancer Research, National Cancer
Institute, National Institutes of Health, Bethesda, MD, USA; 2Cancer
Genetics Branch, National Human Genome Research Institute, National
Institutes of Health, Bethesda, MD, USA; 3Eunice-Kennedy National
Institute of Child Health and Human Development; 4Genomic
Technologies Section, Research Technologies Branch, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD,
USA; 5Cancer Genetics Branch, National Human Genome Research Institute,
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Recent publications have identified complex functions of extracellular
vesicles (EVs) in mediating cell-cell communication. Some of these
functions are mediated by intercellular transfer of mRNA, miRNA and
other small RNAs that post-transcriptionally alter the transcriptome of
target cells. RNA sequencing of EVs derived from cancers or biological
fluids from patients to identify disease-specific bioactive RNAs is also of
increasing diagnostic interest. However, the heterogeneity in sizing,
density, and composition of EVs has limited progress towards under-
standing their functions and diagnostic utility. CD63 and MHC-1 have
been used as markers to purify EVs, but it is unclear whether EVs
expressing different markers differ functionally. We and others have
identified CD47 on EVs and shown that its presence on EVs can alter
their functional signalling in target cells. To further investigate the
functional heterogeneity of EVs, we have captured EVs from Jurkat T
cells and colon carcinoma cells using CD47, CD63 and MHC-1 anti-
bodies and evaluated each subset using flow cytometry and miRNA
expression analysis. EVs expressing CD47, CD63 and MHC class I differ





























in their size distribution and miRNA content based on RNA sequencing.
EVs captured by each marker also differed from EVs lacking the respec-
tive markers. Marker-specific sorting of some miRNAs into EVs was
conserved between T cells and colon carcinoma cells. Our results suggest
that CD63+, MHC-1+, and CD47+ EVs of EVs, contain distinct but
overlapping populations of miRNAs. Our findings also suggest that EVs
exhibit functional heterogeneity, and specific surface biomarkers may be
useful to identify EVs with specific functions and to enrich disease-
specific EVs from liquid biopsy.
OF16.03
miRNAs enclosed in small extracellular vesicles are selectively
secreted and retained in cellular senescence and modulate
keratinocyte functionality
Lucia Terlecki Zaniewicz1, Vera Pils1, Julie Latreille2, Ingo Lämmermann1,
Madhusudhan Reddy Bobbili3, Regina Weinmüllner1, Dietmar Pum4,
Matthias Hackl5, Michael Mildner6, Frederique Morizot2, Florian Gruber1,6
and Johannes Grillari1
1Christian Doppler Laboratory for Biotechnology of Skin Ageing,
Department of Biotechnology, BOKU University Vienna, Austria,
2Department of Skin Knowledge and Women Beauty, Chanel R&T, Pantin,
France; 3University of Natural Resources and Life Sciences, Department of
Biotechnology; 4University of Natural Resources and Life Sciences, Institute
of Nanobiotechnology; 5TAmiRNA GmbH; 6Department of Dermatology,
Medical University of Vienna, Austria
The senescence-associated secretory phenotype (SASP) is one hallmark of
senescent cells, and characterised by the secretion of pro-inflammatory
factors that alter the tissue microenvironment. Recently, miRNAs packaged
into extracellular vesicles (EV-miRNAs) have been found as part of inter-
cellular communication. Here, we investigated whether miRNAs, especially
those enclosed in small EVs might also be part of the SASP and if specific
miRNAs are preferentially secreted or retained after entry into cellular
senescence. Therefore, small EVs of stress-induced premature senescent
(SIPS) and quiescent control cells (Q) were harvested by differential cen-
trifugation.We observed a fourfold higher increase of exosome-like vesicles
in SIPS cells and consequently and elevated abundance of almost all
miRNAs. Correlation of intra- and extracellular miRNA abundance indi-
cated a selective packagingmechanism and identified prominent candidates
thatmight be able to confer a biological role on recipient cells. Furthermore,
to test if EV-miRNAs are part of the paracrine crosstalk between fibroblasts
(HDF) and keratinocytes (NHEK), we confirmed uptake of c.elegans spe-
cific cel-miR-39 enclosed in EVs derived from HDF by NHEK in mono-
layers and in in-vivomimicking skin-equivalents. Finally, we evaluated how
sEVs derived from senescent HDF influence differentiation potential and
wound healing capacity of NHEK and identified miR-23a as a crucial
mediator of the miR-SASP. To summarise, our data indicate that EV-
miRNAs of senescent fibroblasts are bona fide members of the SASP and
suggest the term “miR-SASP”. The selective sorting of specific senescence-
associated EV-miRNAs contributes to the communication between fibro-
blasts and keratinocytes in 2D and 3D human skin models. However, the
underlying specific molecular mechanism and the biological role of other
highly abundantly and selectively secreted SA-miRNAs, such as miR-23a,
and their implications in ageing and age-associated diseases remains to be
determined.
OF16.04
Molecular lipidomics of urinary exosomes: can molecular lipid species
serve as cancer biomarkers?
Skotland Tore1, Ekroos Kim2, Kauhanen Dimple3, Simolin Helena3, Seierstad
Therese4, Berge Viktor5, Sandvig Kirsten1 and Alicia Llorente6
1Department of Molecular Cell Biology, Institute for Cancer Research, Oslo
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Nuclear Medicine, Oslo University Hospital, Oslo, Norway; 5Oslo
University Hospital, Oslo, Norway; 6Oslo University Hospital-The
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Introduction: The protein and nucleic acid composition of urinary exo-
somes has been extensively characterised during the last decade and several
exosomal proteins and nucleic acids have been identified as biomarkers for
several diseases. There is however limited information about the lipid
composition of urinary exosomes. We have here performed a mass spectro-
metry study to reveal the lipid composition of urinary exosomes and
investigated the potential use of lipid species as prostate cancer biomarkers.
Methods: Urinary exosomes were isolated by sequential centrifugation
and characterised by electron microscopy, nanoparticle tracking analysis
and western blot to analyse their quality/purity. Then, a high-throughput
mass spectrometry quantitative lipidomic analysis was performed to
characterise their molecular lipid composition.
Results: The lipid composition of exosomes isolated from urine samples
of healthy individuals was first analysed. Over 100 lipid species were
quantified in urinary exosomes. The comparison of urinary exosomes
and cell line derived-exosomes revealed several differences between the
two exosome populations, for example, in cholesterol and phosphatidyl-
choline. Then, the lipid composition of 15 prostate cancer patients and
13 healthy controls were analysed. Several lipids species were found to be
significantly different when the two groups were compared. The highest
significance was shown for phosphatidylserine (PS) 18:1/18:1 and lacto-
sylceramide (d18:1/16:0). Furthermore, combinations of these lipid spe-
cies and PS 18:0–18:2 were shown to have high sensitivity and specificity
for prostate cancer.
Conclusion: This study shows that lipids in urinary exosomes are pro-
mising prostate cancer biomarkers. Moreover, it also shows the impor-
tance of in vivo studies for biomarker studies.
OF16.05
Mining the new human reference interactome to investigate
interaction-mediated protein sorting into extracellular vesicles
Dae-Kyum Kim1, Katja Luck2, Dong-Sic Choi3, Hanane Ennajdaoui1, Atina
G. Cote1, Ghazal Haddad4, Jochen Weile1, Fan Yang1, Dayag Sheykhkarimli1,
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Communication among cells and their environment is pivotal for their
survival and function. Extracellular vesicles (EVs) have drawn great
interest as one mean of cell-cell communication. However, the reper-
toire of proteins sorted into EVs is incompletely known, as is the
mechanism of protein sorting. Recruitment to EVs is frequently accom-
plished by protein-protein interaction (PPI). Unfortunately, current
knowledge of PPIs is greatly biased by gene popularity and expression
level. Here, we assembled information on the EV-related proteome,
and analysed it in the context of a new human reference interactome
(HuRI) with ~50,000 interactions derived from Y2H screening of
~300 M pairs amongst ~17.5 K human protein-coding genes. Pairs of
EV-associated proteins found in the same experimental conditions are
more likely to interact physically according to HuRI, which supports a
role for PPIs in EV protein-sorting. HuRI interactions within the EV
proteome showed 6 clusters, each centred on a well-connected “hub”
protein. Of these six, three (TSG101, HGS and ACTB) were previously
known to be important in EV biogenesis, more specifically, TSG101
and HGS for exosome and ACTB for ectosome biogenesis. The other
three – KRT, HNRNPK and SGTA – represent new candidate EV-
sorting proteins. The mRNA-binding protein HNRNPK is a candidate
for acting both in protein and mRNA sorting into EVs. KRT, which
was considered as an artefact of contamination, seems to be important
for EV biogenesis. The six corresponding lists of protein partners may
represent distinct classes of EV-sorted proteins or EVs themselves.
Thus, systematic evaluation of EV-associated PPI interactions yields
new clues for classification and protein sorting mechanisms of extra-
cellular vesicles.






























In-depth proteomics of cancer-associated fibroblasts secretome and
role of exosomes in tongue cancer progression
Simona Principe1, Salvador Mejia-Guerrero1, Vladimir Ignatchenko1, Ankit
Sinha2, Keira Pereira2, Laurie Ailles1 and Thomas Kislinger1
1Princess Margaret Cancer Centre, Toronto, Canada; 2Department of Medical
Biophysics
Introduction: Bidirectional communication between cells and their
microenvironment is crucial for both normal tissue homeostasis and
for tumour growth. During the development of tongue cancer (TC),
cancer-associated fibroblasts (CAFs) create a supporting niche by main-
taining a bidirectional crosstalk with cancer cells, mediated by classically
secreted factors and nanometre-sized vesicles, called exosomes. Little is
known about the activation of normal fibroblasts into CAFs and what
determines CAFs unique functional properties. Therefore, a better
understanding of CAF-derived exosomal cargo and its functional effects
on tongue cancer cells are required. This will provide novel insights on
the complex molecular interactions underlying stromal-tumour crosstalk
and help to elucidate their roles in regulating carcinogenesis.
Methods: To better elucidate the role of CAFs in the tumour stroma and
how secreted proteins contribute to TC progression, we have isolated
nine matched pairs of human primary fibroblasts from resected tumours
(CAFs) and adjacent tissue (AFs) and characterised them according to
established CAF markers. We employed shotgun proteomics to compre-
hensively characterise CAFs secretome in order to: (1) evaluate the effect
of CAFs conditioned media and exosomes on TC cells; (2) identify CAF-
associated proteins and investigate their roles as potential biomarkers
using richly annotated tissue microarrays (TMA).
Results: We have generated a comprehensive dataset of 4247 proteins
which represents a detailed signature of a pro-tumorigenic stroma. First
we show the different characteristics and effects of CAFs-secreted frac-
tions (exosomes and conditioned media) on TC cells growth and migra-
tion. Next, we perform quantitative proteomics to highlight CAF-
enriched proteins and identify candidates specific to the CAF-like state.
We identify one novel secreted CAF protein involved in TC progression
and currently investigate its use as a prognostic biomarker using a 90
patient TMA.
Summary: We use an in-depth proteomic approach to characterise the
complexity of CAF secreted factors and evaluate the effects of CAF
exosomes on tumour progression. Our data provides a comprehensive
resource that can be used to identify CAF-enriched proteins and novel
exosomal cargo with functional relevance in TC.
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The role of platelet-derived extracellular vesicles in the GPIb-
dependent adhesion of monocytes in models of thrombo-
inflammation
Aigli Evryviadou1, Myriam Chimen1, Clare Box2, Matthew Harrison3, Sahithi
Kuravi1, Holly Payne1, Dean Kavanagh1, Steven Thomas1, Neena Kalia1,
Alexander Brill4, Steve Watson1, Paul Harrison5, Gerard Nash1 and Ed Rainger1
1Institute of Cardiovascular Sciences, University of Birmingham, United
Kingdom; 2Institute of Cancer and Genomic Sciences, University of
Birmingham, United Kingdom; 3Mars Petcare; 4Institute of Cardiovascular
Sciences; 5Institute of Inflammation and Ageing, University of Birmingham,
United Kingdom
Introduction: Our previous studies had identified a novel pathway where
monocytes could bind to platelets adherent to appropriately activated
endothelium in a model of vascular inflammation. Given this observa-
tion, we wondered whether formation of platelet-monocyte aggregates in
blood might also support the thrombo-inflammatory recruitment of
monocytes to the vessel wall.
Methods: We employed FACS, confocal microscopy, in vitro flow assays
and intravital microscopy in order to carry out our studies.
Results: Upon addition of platelet stimulants to blood, we assessed binding of
platelets to leukocytes by measuring acquisition of the platelet-specific mar-
ker GPIb. Heterotypic aggregate formation was time-dependent and largely
monocyte-specific. Monocytes accumulated GPIb in quanta significantly
lower than that on a single platelet, suggesting that monocytes acquired
GPIb from platelet-derived extracellular vesicles. Provision of pre-stained
platelet-derived extracellular vesicles in blood also resulted in rapid accumu-
lation of GPIb specifically on monocytes with similar dynamics. Confocal
microscopy demonstrated abundant GPIb-positive particles, sized in the sub-
micron range in the cytoplasm of monocytes.
The GPIb delivered to monocytes was functional in in vitro flow assays,
as it enhanced monocyte adhesion to immobilized recombinant vWF, or
to TGF-β-stimulated endothelial cells. In order to test this function in
vivo we used a transgenic strain of mice in which human IL4-R is
expressed under the GP1bα promoter. This allows endogenous platelets
to be cleared using an anti-human IL4R antibody. Using intravital
microscopy of the cremaster circulation which had been stimulated by
the topical application of TGF-β1, we observed adoptively transferred
monocytes decorated with platelet microvesicles were recruited and
rolled on the vessel wall in a GPIb-dependent manner.
Summary/Conclusion: Thus, we describe a novel role of platelet-derived
extracellular vesicle accumulation by monocytes. This thrombo-inflam-
matory pathway of monocyte recruitment may be important in vascular
disease, as it is likely to bypass the usual regulatory pathways that control
monocyte recruitment during inflammation.
Funding: This work was funded by the British Heart Foundation.
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Osteoblast-derived extracellular vesicles represent a novel and highly
potent method for stimulating bone formation
Owen Gareth Davies1,2, Sophie C. Cox2, Mark P. Lewis1 and Liam M.
Grover2
1Loughborough University, Loughborough, United Kingdom; 2University of
Birmingham, United Kingdom
Introduction: Over 300,000 osteoporosis-related fragility fractures are
reported annually in the UK with an associated cost of over £1.5 billion.
These numbers are expected to double by 2020, putting tremendous strain
on the healthcare system. Over the last decade, considerable attention has
been focussed on cell-based approaches to solve this problem. Although
these methods have yielded promising results, their translation is fre-
quently hindered by insurmountable regulatory and ethical hurdles. By
harnessing the regenerative capacity of extracellular vesicles (EVs) we
have developed an acellular yet biological therapy able to regenerate bone.
Methods: EVs were isolated from mineralising murine osteoblasts using
ultracentrifugation and profiled using atomic force microscopy (AFM),
direct light scattering (DLS), transmission electron microscopy (TEM)
and ImageStream flow cytometry. Their effects on MSC osteogenic differ-
entiation were assessed against the clinical gold-standard, BMP-2. MSC
osteogenesis was analysed using alizarin red calcium staining, alkaline
phosphatase (ALP) quantification, and PCR. Mineral phase and quality
was determined using X-ray fluorescence (XRF) and infrared spectro-
scopy (IR). LC-MS/MS was used to define the EV proteome and raw data
files processed usingMaxQuant. MS/MS spectra were searched against the
mouse proteome and analysed using Gene Ontology Enrichment analysis.
Results: EVs (CD9+/CD63+/CD81+) of ~160 nm were able to signifi-
cantly enhance ALP levels, mineralisation rate and mineral volume
beyond the current gold-standard, BMP-2. XRF elemental mapping
identified considerable co-localisation of calcium and phosphorus. IR
analysis of the mineral phase confirmed the presence of brushite, a
mineral only stable at more acidic pH conditions, such as those found
in multivesicular bodies (MVBs). The presence of amide peaks indicative
of collagen were also distinguished when compared with the control.
Proteomic analysis of EVs revealed the presence of collagens and extra-
cellular binding proteins associated with osteogenesis.
Conclusion: Our data suggests that EVs function to enhance MSCs
capacity to utilise local calcium/phosphates. As such, they hold consid-
erable potential as an acellular yet biological approach to regenerative
medicine.
OF17.02
Myofibroblast-derived extracellular vesicles promote epithelial cell
senescence in idiopathic pulmonary fibrosis
Tsukasa Kadota1, Yusuke Yoshioka1, Yu Fujita2, Jun Araya2, Kazuyoshi
Kuwano2 and Takahiro Ochiya1
1Division of Molecular and Cellular Medicine, National Cancer Centre
Research Institute, Japan; 2Division of Respiratory Disease, Department of
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Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronically pro-
gressive and lethal fibrosing interstitial lung disease of unknown aetiol-
ogy. Aberrant phenotypic alterations of alveolar epithelial cell, including
accelerated cellular senescence, have been proposed to be responsible for
regulating fibrosis development. However, the mechanisms leading to
the cell senescence are poorly understood. Here, we investigated the
involvement of extracellular vesicles (EVs)-mediated intercellular com-
munication between lung fibroblasts (LFs) and primary human bron-
chial epithelial cells (HBECs) in regulating epithelial cell senescence
during IPF pathogenesis.
Methods: LFs were obtained from IPF and non-IPF patients who under-
went lobectomy. EVs from LFs were isolated by ultracentrifugation and
characterised by electron microscopy, western blot and nanoparticle
tracking analysis. The profiles of EV microRNAs (miRNAs) were exam-
ined by microarray. Cellular senescence was evaluated with senescence-
associated β-galactosidase staining and expression levels of p21Waf1/Cip1
and p16INK4A. LFs stimulated with TGF-β1 were used as an in vitro
model of myofibroblast differentiation.
Results: LF-derived EVs were characterised by the presence of EV
marker proteins such as CD9 and CD63. EVs derived from IPF-LFs
and TGF-β-treated LFs demonstrated decrease in particle counts and





























protein levels as compared with those derived from non-IPF and non-
TGF-β-treated LFs. Confocal microscopic examination elucidated
uptake of labelled EVs derived from LFs by HBECs. Intriguingly, EVs
derived from TGF-β-treated LFs and IPF-LFs promoted cellular senes-
cence in HBECs. EV microarray analysis elucidated that several miRNAs
were downregulated in EVs derived from IPF-LFs, which negatively
regulate cellular senescence.
Conclusion: IPF-LFs may accelerate epithelial cell senescence via EV
secretion as a part of aberrant mesenchymal-epithelial interactions in
IPF pathogenesis.
OF17.03
Intranasal A1-exosomes decrease inflammation and preserve
neurogenesis in the hippocampus as well as prevent memory
dysfunction after status epilepticus
Qianfa Long1,2, Dinesh Upadhya1,2, Bharathi Hattiangady1,2, Dong-Ki Kim1,
An Su Yeon1, Bing Shuai1,2, Darwin J. Prockop1 and Ashok K. Shetty1,2
1Institute for Regenerative Medicine, Texas A&M University College of
Medicine, College Station, TX, USA 2Olin E. Teague Veterans’ Medical
Center, Temple, TX, USA
Introduction: Status epilepticus (SE), a medical crisis that is typically
terminated through antiepileptic drug treatment, leads to hippocampus
dysfunction typified by neurodegeneration, inflammation, altered neu-
rogenesis as well as cognitive and memory deficits. Here, we examined
the effects of intranasal (IN) administration of extracellular vesicles
(EVs) secreted from the human bone marrow derived mesenchymal
stem cells on SE-induced adverse changes. The EVs employed in this
study are CD9−CD63+CD81+ and referred to as A1-exosomes because of
their robust anti-inflammatory properties (1).
Methods: We subjected young mice to pilocarpine induced SE for 2 h and
then intranasally administered A1-exosomes or vehicle twice over 24 h.
Results: Intranasally administered A1-exosomes invaded the cerebral cortex
and reached the hippocampus within 6 h of administration and animals
receiving them exhibited diminished loss of glutamatergic and gamma-
aminobutyric acid-ergic neurons, and greatly reduced inflammation in the
hippocampus. Moreover, the neuroprotective and anti-inflammatory
effects of A1-exosomes were coupled with the long-term preservation of
normal hippocampal neurogenesis and cognitive and memory function, in
contrast to waned and abnormal neurogenesis, persistent inflammation and
functional deficits in animals receiving vehicle.
Conclusion: These results provide the first evidence that IN administra-
tion of A1-exosomes is efficient for minimising the adverse effects of SE
in the hippocampus and preventing SE-induced cognitive and memory
impairments.
Acknowledgments: Supported by Emerging Technology Funds from the
State of Texas, a Merit Award from the VA (I01 BX002351) and an NIH
grant (P40OD11050).
Reference
1. Kim DC et al., Proc Natl Acad Sci U S A. 2016; 113: 170–175.
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PDGF enhances the pro-regenerative properties of EVs released form
adipose stem cells
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Renato Romagnoli2, Maria Felice Brizzi1 and Giovanni Camussi1
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Introduction: Adipose mesenchymal stem cells (ASCs) promote angio-
genesis and tissue regeneration through paracrine mechanisms. We have
previously shown that platelet derived growth factor (PDGF) stimulate
ASC to secret EVs (PDGF-EVs) with a stronger pro-angiogenic potential
than EVs secreted in basic conditions (bEVs). The aim of the present
study was to investigate the molecular mechanism involved in angio-
genic and immunomodulatory activity of PDGF-EVs.
Methods: For this purpose we studied in vitro the effects of PDGF-EVs
on the secretion of inflammatory factors by peripheral blood mono-
nuclear cells (PBMCs) as well as their influence on PBMC adhesion on
endothelial cells (EC). bEVs were used for comparison. In vivo we have
also studied the effects of bEVs and PDGF-EVs in an acute limb
ischemia pre-clinical model. The molecular differences between bEVs
and PDGF-EVs were also investigated.
Results: bEVs but not PDGF-EVs stimulated secretion of IFNg, IL-1 and
TNFa by PBMCs while secretion of IL-10 was significantly enhanced
after stimulation with PDGF-EVs. The adhesion of PBMCs to EC was
enhanced by bEVs, but not by PDGF-EVs. In addition, PDGF-EVs were
able to stimulate nitric oxide production in EC. In vivo results demon-
strate that PDGF-EVs was significantly more effective in restoring large
vessel reperfusion and in inhibiting muscle damage and inflammatory
cell recruitment than bEVs. PDGF-EV proteomic analysis demonstrated
differences in pro-angiogenic and pro-inflammatory protein content
when PDGF-EVS and bEVs were compared. In particular PDGF-EVs
were enriched in HGF, TGFa/b and their receptors, IL-1 ra, VEGF, Tie,
OSM, uPA, uPAR, MMPs, thrombospondins, BDNF, ICAM, IGF. While
bEVs carried high levels of IFN-γ, G-CSF, GM-CSF and CD40/
TNFRSF5. PDGF-EVs were also enriched in pro-regenerative
microRNAs, such as miR-130a, miR-19a, miR-296, miR-17, miR-21,
miR-92a, miR-34b, miR-520d, miR-100, miR-146b and long non-coding
RNA such as MALAT1.
Conclusion: This study demonstrates that PDGF stimulates ASCs to
secrete EVs enriched in anti-inflammatory and pro-regenerative factors,
which could account for PDGF-EV-mediated protection against ische-
mia reperfusion injury.
OF17.05
VEGF-induced damage of glomerular endothelial cells in Alport
syndrome: effect of amniotic fluid stem cell-derived extracellular
vesicles
Laura Perin1, Sargis Sedrakyan1, Stefano Porta2 and Benedetta Bussolati3
1Children’s Hospital Los Angeles, CA, USA; 2University of Torino, Italy;
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Introduction: Injection of amniotic fluid stem cells (AFSC) delays the
course of progression of renal fibrosis in animals with Alport syndrome,
enhancing kidney function and improving survival. The mechanisms
responsible for these protective outcomes are still largely unknown. We
here evaluated whether extracellular vesicles produced by the AFSC (AFSC-
EVs) could be responsible for the observed renoprotection.
Methods: Glomerular endothelial damage was assessed by histology and
electron microscopy. AFSC (1 × 106) and deriving EVs (30 mg) were
administered by single intracardiac injection. Levels of proteinuria and of
intraglomerular VEGF were also analysed. AFSC-EVs were isolated by
ultracentrifugation, characterised for the expression of angiogenic surface
markers by FACS and for the presence of angio-modulating microRNAs
by RT-PCR. VEGFR1 knockout AFSC were generated by transfection and
deriving EVs isolated. VEGFR1 neg and VEGFR1+ EVs were tested in an
in vitro model of endothelial cytotoxicity induced by high VEGF doses.
Results: Alport mice were characterised by glomerular endotheliosis,
proteinuria and increased glomerular VEGF levels. Intra-ventricularly
injected AFSC showed strong modulation of glomerular endothelial cell
damage in Alport mice and reduced the elevated VEGF signalling and
proteinuria. Similar effects were obtained by a single injection of AFSC-
derived EVs. AFSC-EVs expressed VEGFR1 and VEGFR2, and con-
tained angio-modulatory microRNAs. In vitro, AFSC-EVs prevented
the cytotoxic effect of high VEGF levels. This was due to VEGF trapping
through its binding to the EV surface VEGFR1, as shown by immuno-
precipation analysis. In contract, VEGFR1 knockout EVs failed to show
endothelial protection, thus indicating that VEGF trapping is a poten-
tially viable mechanism for AFSC mediated renoprotection in mice.
Conclusion: Taken together our findings identify a new mechanism of
action, i.e. VEGF trapping, by AFSC-EVs suggesting that AFSC-EVs
could target a specific signalling pathway within the glomerulus thus
representing a new potential glomerulus-specific targeted intervention.
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Host exosomes released during infection with Rift Valley fever virus
play a protective role by destroying the virus cell reservoirs and by
inhibiting viral replication and release
Ramin M. Hakami1, Noor Ahsan2, Gavin Sampey3, Benjamin Lepene4, Robert
Barclay3, Sergey Iordanskiy3 and Fatah Kashanchi3
1School of Systems Biology and NCBID, George Mason University; 2George
Mason University; 3Laboratory of Molecular Virology, George Mason
University, Manassas, Virginia, USA; 4Ceres Nanosciences Inc., Manassas,
Virginia, USA
Introduction: Our laboratory studies exosome (EX) effects during infec-
tion with highly pathogenic biodefense agents such as Rift Valley fever
virus (RVFV). RVFV has been classified as a pathogen of highest con-
cern (Category A) that causes a devastating zoonotic disease and has the
potential to be used for bioterrorism. There are no approved vaccines or
therapeutics available. Intriguingly, unlike exosome studies reported for
several other viral infections, the EXi released during RVFV infection
play a protective role for the host.
Methods: EX were purified from both naïve Vero cells (EXu) and infected
Vero cells (EXi) by serial centrifugation followed by sucrose density
gradient purification, and characterized by TEM and Western analysis.
Plaque assays were performed on purified exosome fractions to demon-
strate that they are free of virus particles. In addition, clones infected with
RVFV that remained viable (resistant clones) were generated and shown
not to release virus, and exosomes released from these cells were also
isolated and characterized. Both naïve immune and non-immune recipi-
ent cell types were treated with EXi or EXu (as control) and analyzed for
effects on viability. Effects of pre-treatment with EXi on virus replication
and release were also analyzed. qRT-PCR was performed on biological
replicates of EXi to determine whether they contain viral genome.
Furthermore, using both Western and mass spectrometry analyses of
four biological replicates, the viral protein content of EXi were analyzed.
Results: Our results demonstrate that although immune cell types (T-
cells and monocytic cells) stay viable after infection with RVFV they
show a drastic rate of apoptosis through PARP cleavage and caspase 3
activation following treatment with EXi, a novel mechanistic finding for
RVFV infection. Furthermore, pre-treatment with EXi followed by
RVFV infection significantly reduces virion production and release.
The EXi carry all three viral RNA genome segments (L, M, and S) and
also the viral envelope glycoprotein and the viral nucleocapsid protein.
Summary/Conclusion: As it has been proposed that RVFV uses immune
cells as replication reservoirs, our results present a model in which the
released EXi act to combat infection in two ways, by targeting the RVFV
cellular reservoirs for destruction and also by interfering with viral
replication and release.
OF18.01
Virosomes: the interplay between viral infection and exosome
production
Robert Barclay1, Catherine DeMarino1, Angela Schwab1, Michelle Pleet1,
Gavin Sampey1, Sergey Iordanskiy1, Ramin M. Hakami2, Benjamin Lepene3,
Nazira El-Hage4 and Fatah Kashanchi1
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Immunology, Herbert Wertheim College of Medicine, Miami, FL, USA
Introduction: HIV infection results in a chronic illness since long-term
HAART can lower viral titers to an undetectable level. However, dis-
continuation of therapy rapidly increases virus burden. Moreover,
patients under HAART frequently develop various metabolic disorders,
neurocognitive abnormalities and cardiovascular diseases.
Methods: We use a combination of ultracentrifugation and nanoparticle
capture to concentrate our EVs from various bodily fluids for down-
stream assays.
Results: We have previously shown that exosomes containing trans-
activating response (TAR) element RNA enhance susceptibility of
undifferentiated naïve cells to HIV infection. Up to a million copies
of TAR RNA/mL were also detected in the serum from HIV infected
humanised mice suggesting that TAR RNA may be stable in vivo. We
recently have found another viral non-coding RNA that we termed
TAR-gag which does not code for a protein, but is present in the
exosomes. Incubation of exosomes from HIV-1 infected cells with
primary cells resulted in a dramatic increase of pro-inflammatory
cytokines, IL-6 and TNF-β, indicating that exosomes containing TAR
RNA could play a direct role in control of cytokine gene expression.
Furthermore, the single stranded 5ʹ or 3ʹ processed stem RNA binding
to TLRs activates the NF-кB pathway and regulates cytokine expres-
sion. In our most recent data, we find that the exosomes from infected
cells are increased in numbers when cells are treated with specific anti-
viral drugs or innate immune molecules such as IFN-a. These findings
suggest that while the virus is being suppressed (specifically or non-
specifically), the amount of exosomes that contain viral products
increase after treatment.
Conclusion: Our results directly indicate that HIV viral release and
exosome release have overlapping biogenesis pathways including the
ESCRT pathway. Similar results are also seen from other neuro-tropic
RNA viral infections including HTLV, Ebola, RVFV, and Zika infection
which will be discussed. Our data implies that exosomes from virally
infected cells under either specific or non-specific treatment (i.e. latent
cells) control immune cells survival and pathogenesis. Therefore, target-
ing these particles may be a method to lower overall viral burden in
infected immunocompromised hosts.
OF18.02
Attempts to re-define cellular components specifically incorporated
in HIV as compared to sEVs and exosomes secreted by infected cells
Lorena Martin-Jaular1, Zhaohao Liao2, Pehuen Pereyra Gerber3, Matias
Ostrowski3, Kenneth Witwer2 and Clotilde Théry4
1Institut Curie, Paris, France; 2The Johns Hopkins University School of
Medicine, MD, USA; 3INBIRS Insitute, School of Medicine, University of
Buenos Aires, Buenos Aires, Argentina; 4Institut Curie, PSL Research
University, INSERM U932, Paris, France
Introduction: HIV, exosomes and/or other small extracellular vesicles
(sEVs) share biogenesis aspects and physicochemical characteristics,
making their separation difficult. Some cellular proteins are described
as excluded from virions (e.g. CD45), whereas others are incorporated
(e.g. CD63). We re-evaluated these results in light of our recent demon-
stration that many subtypes of sEVs are co-isolated by a protocol of EV
isolation similar to that used for HIV isolation, and of our recently
published sets of protein combinations distinguishing exosomal and
non-exosomal sEVs (1). Our goal is to obtain HIV-free sEVs to allow
assessing their functional properties.
Methods: Medium of Jurkat cells infected or not with VSV-G–pseudo-
typed NL4-3-IRES-EGFP was subjected to differential centrifugation,
and velocity top-to-bottom iodixanol gradient was used to separate
sEVs from virus in the 100,000g pellet (100 K). Gradient fractions





























were analysed by WB for the presence of different markers and by AChE
assay.
Results: Differential centrifugation showed that CD45 is more abundant
in large/medium EVs than in sEVs from both uninfected and infected
cells. Velocity gradients revealed at least two types of sEVs in the 100 K
pellet. Fractions from the top of the tube contained CD9 and some CD45
but little or no CD63 (i.e. non-exosomal sEVs), whereas intermediate
fractions contained CD9, CD63, and syntenin-1, hence probably exo-
somes. Gag and CD63 but little or no CD9, Syntenin-1 and CD45 were
detected in bottom fractions of infected cells’ 100 K pellet. Importantly,
AChE activity was found in fractions different from those enriched in
Gag but also from those enriched for the other sEVs/exosome markers.
Conclusions: Despite exclusion from virus containing fractions, neither
AChE activity nor CD45 are satisfying markers to distinguish HIV from
exosomes. Velocity gradients achieve some separation of sEVs/exosome
or virus markers, but overlap of distribution makes it difficult to use
them for unbiased proteomic comparisons. Further work will be
required to identify, if they exist, sEV and/or exosomal components
specifically excluded from HIV virions.
Reference
1. Kowal et al., PNAS 2016; 113: E968.
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Picornavirus infection induces the release of distinct EV populations
containing infectious virus and altered host-derived contents
Susanne G. van der Grein1, Kyra A.Y. Defourny1, Huib H. Rabouw2, Martijn
A. Langereis2, Frank J.M. van Kuppeveld2 and Esther N.M. Nolte-’t-Hoen1
1Department of Biochemistry and Cell Biology, Faculty of Veterinary
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Veterinary Medicine, Utrecht University, Utrecht, The Netherlands
Introduction: Picornaviruses are classically believed to release non-
enveloped progeny through the induction of cell lysis, yet were recently
shown to also exit from intact cells inside extracellular vesicles (EVs).
Enclosure of virus particles inside EVs may have a large impact on viral
dissemination or antiviral immunity and therefore on the pathology of
many infectious diseases. To better understand the function of picorna-
virus-induced EVs we performed in-depth analysis of host- and virus-
derived components enclosed in these EVs and their release dynamics
during infection.
Materials and Methods: EVs released by pre-lytic picornavirus-infected
cells were separated into subpopulations using differential ultracentrifu-
gation and density gradient purification. EV and viral particles were
quantified using high-resolution flow cytometry and end-point titration,
and viral or host-derived EV contents were analysed by western blot and
qPCR.
Results:We found that early after viral infection, before cell lysis occurs,
picornavirus triggers the release of several distinct EV populations. Small
EVs pelleted at 100,000g and floating to low-density fractions contained
mature infectious viral particles. In addition, EV pelleted at 10,000g,
which likely represent larger EV, also enclosed viral particles. Early after
infection these virus-containing EVs constitute a prominent portion of
the released infectious particles, and their contribution to infectivity
decreases over time. Interestingly, prior to the release of virus-containing
EVs, picornavirus also induces secretion of EV lacking viral products but
with altered host components.
Conclusion: Picornavirus infection induces major changes in the repertoire
of EVs released by cells. Moreover, the release dynamics of virus-containing
EVs and other virus-induced EVs is tightly regulated. These different EV
types may each play a distinctive role in virus propagation or host protec-
tion, contributing to the continuous battle between virus and host.
OF18.04
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Extracellular vesicle cargo delivery through membrane fusion:
regulation by factors that promote and restrict enveloped virus cell
entry
Michael Hantak, Enya Qing and Thomas M. Gallagher
Loyola University Chicago, IL, USA
Introduction: Extracellular vesicles (EVs) facilitate intercellular commu-
nications by transferring membrane-bound and cytosolic factors
between cells. Delivery of these factors into target cells requires fusion
of EV and cell membranes. Enveloped viruses also deliver their internal
cargo through membrane fusion. We hypothesised that EVs and envel-
oped viruses are similarly regulated at the level of membrane fusion.
Methods: EV-directed cargo delivery was measured using a membrane
fusion-dependent reporter complementation assay. EVs were loaded
with luciferase fragments, and then applied to target cells containing
complementary luciferase fragments. Fusion between EV and target cell
membranes permitted fragment complementation, which generated
quantifiable luciferase levels. Using this assay, we determined whether
known regulators of enveloped virus membrane fusion also controlled
EV-cell fusion. We also determined whether EV subtypes vary in their
capacity to mediate EV-cell fusion and subsequent cargo delivery.
Results: EVs definitively brought reporter cargoes into target cells
through a membrane fusion process. EV-mediated membrane fusion
was restricted by the anti-viral interferon-induced transmembrane pro-
tein 3 (IFITM3), and was promoted by the pro-viral transmembrane
protease serine 2 (TMPRSS2). Both IFITM3 and TMPRSS2 incorporated
into EV particles. Their incorporation required the ESCRT machinery of
EV-producing cells. Functional ESCRT machinery was also required for
EV-directed cargo transfers.
Conclusions: Cytoplasmic cargoes are primarily transferred by ESCRT-
generated EVs. These ESCRT-generated EVs are regulated by at least
two factors, IFITM3 and TMPRSS2, which restrict and promote cargo
delivery, respectively. These two factors are found on the EVs. These
findings are consistent with the hypothesis that EVs and enveloped
viruses have strikingly similar cargo delivery mechanisms.
OF18.06
Extracellular vesicles and lipoproteins influence cellular response to
HIV-1 Infection
Lisa Learman1, Zhaohao Liao1, Bonita Powell1, Dillon Muth1, Carol Cooke1,
Erez Eitan2 and Kenneth Witwer1
1The Johns Hopkins University School of Medicine, MD, USA; 2National
Institute on Aging, National Institutes of Health
Introduction: Cells grown in serum-containing, EV-depleted (EVD)
media display decreased proliferation and viability. We recently reported
both increased release and infectivity of HIV-1 from cells grown in EVD
media. Here, we interrogate effects of EV depletion on HIV-1 suscept-
ibility. We also examine the possibility that standard EV depletion
protocols affect non-EV particles.
Methods: Media were prepared with EVD FBS (Thermo Fisher), with
fewer particles per unit volume than FBS prepared in-house by various
methods as assessed by nanoparticle tracking analysis and protein assays
for EV markers. The HeLa-derived HIV-1 reporter line TZM-bl, encod-
ing luciferase under the control of the HIV-1 promoter, was grown in
media containing 10% EVD or non-depleted FBS. Cells were exposed to
titrated HIV-1, and susceptibility to infection was quantified by lucifer-
ase assay. Add-back experiments were done with purified EVs and
density gradient fractions of lipoprotein particles. Transmission electron
microscopy and lipid assays assessed purified serum components.
Statistics were done for matched samples and corrected as appropriate
for multiple tests (significance: alpha < 0.05).
Results: Cells grown in EVD media were significantly more susceptible
to infection by each of two strains of HIV-1, with interaction of passage
number and sensitivity. Like others, we noticed LDL and HDL depletion
by EVD protocols: EV depletion was accompanied by depletion of
lipoproteins, and EM of gradient-purified LDL and HDL revealed EV-





























like particles. Therefore, in addition to EV add-back, we examined the
effects of LDL and HDL on HIV-1 susceptibility of cells in depleted
media. Added to depleted cells 2 h before infection, physiologically
relevant levels of neither LDL nor HDL affected HIV-1 susceptibility.
However, with 24 h pre-treatment, LDL but not HDL partially restored
baseline levels of susceptibility in a dose-dependent manner.
Conclusions: Cellular lipid sensing may influence susceptibility to HIV-1
infection, but EVs are not the only contributors. LDL depletion by
standard EVD protocols also contributes to increased HIV-1 suscept-
ibility. Even density gradient-based purification methods may not com-
pletely separate EVs from lipoproteins, complicating assessment of
physiological roles of these particles.
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Gamma-glutamyltransferase activity in exosomes as a marker for
prostate and renal cell cancers
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Graduate School of Medicine, Gifu, Japan; 3Department of Pathology, Tokyo
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Introduction: Exosomes have the potential as a marker for various
diseases including cancer. In the present study, we performed proteomic
analysis of exosomes isolated from prostate cancer (PC) cell lines and
identified a candidate marker. We then examined the usefulness of the
exosomal marker in patients with renal cell cancer (RCC) as well as PC.
Methods: Exosomes isolated from LNCaP PC cell line and its sublines C4,
C4-2 and C4-2B were subjected to proteomic analysis. GGT (gamma-
glutamyltransferase) activity was measured using a fluorescent probe,
g-glutamyl hydroxymethyl rhodamine green. Immunohistochemical ana-
lysis of tissue specimens was performed with anti-GGT1 antibody.
Results: Among proteins upregulated in C4-2 and C4-2B cells than in
LNCaP cells, we focused on GGT1, a cell-surface enzyme that regulates
the catabolism of extracellular glutathione. The levels of GGT1 large and
small subunits were elevated in exosomes isolated from C4-2 and C4-2B
cells by differential centrifugation and immunocapture. In cell lysates
and exosomes, GGT1 expression correlated with GGT activity. In
human serum, size exclusion chromatography demonstrated the pre-
sence of GGT activity and GGT1 subunits in fractions positive for
CD9 and density gradient centrifugation revealed the co-presence of
GGT1 subunits with CD9. Since GGT activity correlated with GGT1
expression in serum exosomes isolated by differential centrifugation, we
measured serum exosomal GGT activity in patients. We found that
serum exosomal GGT activity was significantly higher in PC patients
than in benign prostatic hyperplasia (BPH) patients. In support of this
finding, immunohistochemical analysis showed increased GGT1 expres-
sion in PC tissues compared with BPH tissues. In RCC, we also found
that serum exosomal GGT activity was significantly increased in late-
stage patients than in early-stage patients.
Conclusion: Our results suggest that serum exosomal GGT activity could
be a useful marker for PC and RCC.
PF01.02
Isolation and characterisation of small RNAs in the extracellular
vesicles from washed stool samples for colorectal cancer diagnosis
Tae-Young Roh, Seung-ick Oh, Seokjin Ham, Hyungjoo Ko, Insoon Jang and
Sookil Tae
Pohang University of Science and Technology, Pohang, Republic of Korea
Introduction: The presence of nucleic acid in the extracellular vesicles (EVs)
has been known for its role in the intercellular communication. The EVs are
exfoliated from cells and can be detected in diverse sources such as tissues,
blood, urine and stools. Here, we examined the existence of small RNAs
includingmiRNAs in EVs of the washed stool from colorectal cancer patients
and analysed them as potential biomarkers.
Methods: The EV was isolated from washed stool of colorectal cancer
patients by using the aqueous two-phase system (ATPS) and its RNA
was purified by treating with TRIzol. The total small RNAs including
miRNAs were purified and analysed by small RNA-seq using next-
generation sequencing (NGS) technology.
Results: From comparative analysis of normal and colorectal cancer patient
samples, we could identify tens of novel small RNAs as well as known
miRNAs.The potential applicability ofnovel small RNAwas further explored.
Conclusion: For the non-invasive diagnosis of colorectal cancer, the
RNAs surrounded and protected the the EVs are useful targets for the
development of biomarkers. We examined the small RNAs in the EVs of
the washed stool from colorectal cancer patients. Some novel small
RNAs could be used as biomarker for colorectal cancer biomarkers
with further massive examination of clinical samples.
PF01.03
Phenotype analysis of extracellular vesicles secreted by pancreatic
cancer cell lines: exposition of EpCAM, Glypican-1 or
Phosphatidylserine
Etienne Buscail1, Sandrine Dabernat1, Olivier Degrandi1, Celine Gounou2,
Sisareuth Tan2 and Alain R. Brisson2
1INSERM 1035, Bordeaux, France; 2UMR-5248 CNRS, University of
Bordeaux, Bordeaux, France
Introduction: No reliable biomarker is yet available to diagnose pancreatic
cancer (PaCa). Extracellular vesicles (EVs) secreted by tumour cells are
attracting interest as potential biomarkers (1). However, caution is warranted
in considering EV literature, due to the difficulty of EV characterisation and
isolation. This study aims at describing the size, phenotype and concentration
of EVs released by four PaCa cell lines, using immuno-cryo-electron micro-
scopy (EM), flow cytometry (FC) and biochemistry (2,3).We focused on EVs
exposing EpCAM, antigen overexpressed in various carcinomas, glypican-1
(GPC-1), a proposed marker of PaCa (1), and phosphatidylserine (PS), a
procoagulant lipid with potential role in cancer-related thrombosis.
Methods: EVs were isolated from CaPan2, BXPC3, PanC1 and MiaPaCa-2
cells by low-speed centrifugation or with the total exosome isolation kit (Life
Technologies). EpCAM+, GLPC-1+ and PS+ EVs were detected by FC using
antibodies (Abs) against EpCAM (Novel Life Tech), GLPC-1 (Thermo
Fisher, ATLAS) or annexin-5 (Anx5)3. For immuno-cryo-EM, gold particles
were conjugated with anti-EpCAM or anti-GLPC-1 Abs or Anx52.
Results: By FC, we found that large amounts of EpCAM+ EVs were
released by CaPan2 and BXPC3 cells, and significantly less (>100×) by
PanC1 and MiaPaCa-2 cells. In addition, larger amounts (~4×) of PS+
EVs were released by PanC1 and MiaPaCa-2, as compared to CaPan2
and BXPC3 cells. No GPC-1+ EVs were detected with the two Abs used
here in the four cell lines.
By immuno-cryo-EM, we identified EpCAM+ EVs in CaPan2 and
BXPC3 supernatants. These EVs ranged in size from 100 nm to 1 µm.
Most EpCAM+ EVs of small size (<100 nm), the so-called exosomes,
were also labelled by Anx5. No labelling was observed with the anti-
GPC-1 Abs used. Western-blotting experiments revealed the presence of
GPC-1 in cell extracts for the two Abs. This suggests that GPC-1
proteins are present in the cell cytoplasm, but not at the EV surface.
Conclusion: This study provides a semi-quantitative analysis of EVs
secreted by PaCa cell lines, and is currently complemented by a study
of EVs present in plasma of PaCa patients.
References
1. Melo et al., Nature 2015; 523: 177–182.
2. Arraud et al., J. Thromb. Haemost. 2014; 12: 614–627.
3. Arraud et al., Cytom. A 2016 ; 89: 184–195.
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Surface glycosylation profiling of evs using lectin-nanoparticles
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Introduction: Extracellular vesicles (EVs) are secreted by almost all cells
and present variety of proteins, lipids and glycans on their surface. The
majority of the surface tumour markers reported to date are either
glycoproteins or glycolipids. Traditionally, the EV-surface glycosylation
profiling is either done using mass spectrometry or lectin microarrays.
However, both these methods require isolation of EVs. In this study, we
use lectins, which bind to the glycan part of the glycoproteins, conju-
gated with Eu3+-doped nanoparticles (NP) to identify the glycans pre-
sented on the surface of the EVs.
Methods: The EVs from cell-free cell culture supernatants of HEK293
and ovarian cancer (OvCa) cell lines (SKOV3, M022 and M019i) were
captured using biotinylated anti-CD63 antibody immobilised onto strep-
tavidin coated 96-well plate. The captured EVs were probed with lectins
conjugated with ~100 nm-sized polystyrene NPs containing 30,000 Eu3+
ions. The lectins used in this study were, galactose binding Macrophage
Galactose Lectin (MGL) fused with mouse FC, mannose-binding den-
dritic cell-specific intercellular adhesion molecule-3-grabbing non-integ-
rin (DC-SIGN) and mannose-binding lectin (MBL) and β-galactoside-
binding galectin-4. Anti-CD63 antibody conjugated NPs were also used
to validate the efficacy of the assay to capture the EVs. Detection of the
signals (λex: 340 nm, λem: 615 nm) was done using Victor 2, 1420
multilabel counter (Perkin-Elmer).
Results: The assay involving biotinylated anti-CD63 antibody and anti-
CD63-NPs showed the presence of EVs in all the cell culture supernatants.
Similarly, the signals were also obtained mannose binding lectin-NPs (DC-
SIGN-NP and MBL-NP). This confirms the presence of mannose contain-
ing glycoproteins, which has been reported in several studies, on the surface
of the EVs. However, the signals fromMGL-mouse FC-NP and galectin-4-
NP were obtained only OvCa EVs but not from HEK293 EVs.
Conclusion: This preliminary study shows the presence of galactose and
β-galactoside containing glycans only on the surface of EVs derived from
OvCa cell lines but not on the surface of the EVs from HEK293. Such
approach can further be exploited for diagnosis of various cancers by
identifying the differently glycosylated patterns on the surface of the EVs
obtained from the biofluids.
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miRNA profiling in uveal melanoma exosomes as a metastatic risk
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Introduction: Uveal melanoma (UM) is the most common primary intrao-
cular malignancy in adults. It is a highly aggressive cancer in which nearly
50% of patients die from liver metastasis. UM patients can be divided into
three groups based on their genetic profile and disease free survival, the low
risk, intermediate risk and high risk tumours. Recently, we have shown that
high risk patients can be identified based on the expression of five miRNAs.
Since tumour tissue is not always available and biopsies are not without risk,
it is important to develop a method that can identify high risk patients in a
non-invasive manner. Exosomal miRNAs are an excellent candidate for this
application. Our aim is to analyse the presence of ourmarkermiRNAs inUM
exosomes.
Methods: Exosomes were isolated from the cell culture medium of a non-
metastatic and high risk metastatic UM cell line by ultracentrifugation and
were characterised by western blot, electron microscopy and Nanosight
tracking analysis (NTA). RNA was isolated from exosomes by the Qiagen
RNeasy micro kit and quantified by an Agilent bioanalyzer. Subsequently,
miRNA expression was measured by Taqman miRNA qPCR assays.
Results: All exosome samples isolated from cell medium showed expression
of CD81. Bioanalyzer confirmed the absence of ribosomal RNA and an
abundance of small RNAs. qPCR analysis shows changes in the expression
of some classifier miRNAs in exosomes extracted from cell lines, demonstrat-
ing that the classifier miRNA signature in UM cells partially overlaps with the
miRNA signature in exosomes secreted by UM cells.
Conclusion: These exosomal miRNAs show great promise as a reliable
predictor of disease free survival in UM. Next goal is to detect these
exosomal markers in blood of UM patients since this will enable us to
provide all UM patients with a prognosis.
PF01.06
Analysis of extracellular vesicle-derived RNAs isolated with the Vn96
peptide from human renal and bladder cancer cell lines
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Annie-pier Beauregard1, Sami Benzina1, Awanit Kumar1, Sandra Turcotte3,
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Introduction: Renal cell carcinoma (RCC) and bladder cancer (BC) have
rising incidence and high rates of recurrence. Unfortunately, conventional
diagnostic methods are far from adequate, as cytology lacks sensitivity and
biopsy is an invasive procedure. There is an unmet need for accurate,
minimally invasive biomarkers to support clinical decision-making.
Extracellular vesicles (EVs) are nanosized membrane-bound vesicles that
mediate cell-cell communication. Due to the stability of EV-derived RNAs
(EV-RNAs) in body fluids and the functional implication of non-coding
RNA molecules in the tumour microenvironment, EV-RNAs have been a
subject of great interest in recent years, especially in the context of “liquid
biopsy” and circulating biomarkers. The aim of this study is to investigate
novel minimally invasive biomarkers for RCC and BC.
Methods: EVs released from nine cell lines were isolated using the Vn96
affinity capture peptide, then characterised by nanoparticle tracking analysis
(NTA), western blot (WB) and Agilent technologies. We have used tran-
scriptome sequencing (RNA-seq) to investigate the EV-RNAs.
Results: NTA, WB and RNA profiles confirmed the presence and the purity
of EVs in all cell lines. High-throughput RNA-seq revealed differences in the
RNA species content between cellular and EV-RNAs. We have derived an
EV-RNA expression signature for RCC and BC. These signatures are based
on statistically significant differences in expression levels and profiles in
tumour-derived EV-RNAs versus normal cell lines EV-RNAs. Interestingly,
we found altered expression of miRNAs and lncRNAs that are known to act
in epithelial-to-mesenchymal transition and angiogenesis in tumour-derived
EV-RNAs. Moreover, certain genes (GAPDH and miR16) are consistently
present at similar levels in all EV-RNA samples and conditions tested,
suggesting that these genes may be reliable internal standards.
Conclusion: Our RNA-seq data offers a catalogue of EV-RNAs for renal and
bladder cancer cell lines. This initial screening “in vitro” forms the basis for
validation of EV-RNA expression signatures in biological fluids of patients
with RCC or BC. Further mechanistic studies are needed to understand the
functional involvements of EV-RNAs in RCC and BC pathogenesis.
PF01.07
Exosomes as biomarkers in paediatric acute lymphocytic leukaemia
Shabirul Haque and Sarah Vaiselbuh
The Feinstein Institute for Medical Research at Northwell Health, NY, USA
Introduction: Exosomes are secreted by most cells including tumour cells
in biological fluids. Because exosomes are easily accessible by liquid biopsy
and carry the genetic fingerprint of parental cells, exosomes emerge as
promising biomarkers in cancer diagnostics. Although many hurdles such
as high throughput methods for exosome isolation and poor exosomal





























RNA recovery remain to be solved, clinical applications of exosomes as
biomarkers will certainly gain momentum in this rapidly expanding field.
Objective: To identify leukaemia-specific exosomes harvested from con-
ditioned medium (CM) of ALL cell lines as well as from serum of P-ALL
patients that correlate with disease status.
Methods: Exosomes were isolated from healthy donor (HD), P-ALL
patient serum and from conditioned medium (CM) of JM1, SUP-B15
and CL-01 human cell lines by ultracentrifugation. Exosomal identity
was confirmed with NanoSight Tracking Analysis as well as by Western
Blot. We used an innovative method for direct conversion of very small
starting volumes of purified exosomes into cDNA followed by gene
amplification by two-step PCR. Gene amplification was confirmed on
1.5% agarose electrophoresis.
Results: CM-exosomes of JM1 and SUP-B15 tested positive for CD10/
CD34 expression by 2-Step PCR in contrast to CL-01 cells (control) that
were negative. In addition, we evaluated serum exosomes in duos of
liquid biopsies for either CD10/CD34 or CD10/CD19 expression
(according to phenotypic expression of the parental leukaemic blasts).
P-ALL exosomes at Day 1 (diagnosis) tested positive for CD10/CD34 or
CD10/CD19 while P-ALL exosomes of the same patients at Day 29
(remission) became negative. Similarly, serum-derived exosomes from
P-ALL relapse patients (blast count in bone marrow aspirates range
60–85% by FCM) were positive in contrast to P-ALL-exosomes of the
same patients at time of 1st remission (blast count 0%) that tested
negative. HD exosomes (controls) tested negative for CD34 expression.
Conclusion: P-ALL exosomes secreted in serum can be detected by gene
expression analysis for leukaemia-specific markers CD10/CD34 or
CD10/CD19 and may serve as leukaemia biomarkers that correlate
with disease status in the bone marrow. These preliminary data need
validation in larger cohort clinical biomarkers studies.
PF01.08
Novel tissue- and cancer-specific markers identified by proteomic
profiling of extracellular vesicle cargo
Stephanie N. Hurwitz, Mark A. Rider, Joseph L. Bundy, Xia Liu, Rakesh K
Singh and David G. Meckes
Florida State University College of Medicine, FL, USA
Introduction: Circulating extracellular vesicles (EVs) hold great potential
for use in minimally-invasive disease detection, including cancer diag-
nostics. Accumulating evidence has shed light on differences in EV
biogenesis and content across cells of various origins.
Methods: Here, we analyse and compare the secretion and content of
EVs from cancer cells and non-tumorigenic cells using nanoparticle
tracking and mass spectrometry. We further characterise conserved EV
proteins by density gradient purification of vesicle sub-populations.
Results: We previously conducted a global proteomic profile of EV content
across 60 cancer cell lines derived from nine histological types compiled by
the National Cancer Institute (NCI-60), identifying 6071 proteins with 213
common to all isolates. Cargo found to be differentially expressed among EVs
from varying origins offer potential for cancer diagnosis and prognostic
monitoring. Here we provide new evidence of novel breast cancer biomarkers
by comparison of cancer cell-derived EV content to protein cargo in EVs
released by non-tumorigenic cells. Additionally, examination of common EV
cargo revealed sub-population specific markers of EVs, providing improve-
ment to current EV classification strategies.
Conclusion: Tumorigenic and non-tumorigenic cells may be distin-
guished based on their diverse EV profiles, and differences in content
of EVs may present novel diagnostic tools for cancer detection. On the
other hand, common EV proteins across cells likely reflect key players in
EV subpopulation biogenesis. The findings in this study contribute to
understanding the underlying mechanisms of EV formation and offer
promising targets for cancer diagnosis.
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Detection of exosomal microRNA using molecular beacon for cancer
diagnosis
Jeong Ah Kim1, Ji Hye Lee2 and Won Jong Rhee2
1Biomedical Omics Group; 2Incheon National University
Exosomes are small extracellular vesicles that contain biomarker miRNAs
produced from their originating cells and travel through the circulatory
system. Exosomal miRNA from the body fluids has been investigated as an
attractive biomarker in the diagnosis of disease. However, current techni-
ques, including real-time PCR analysis are still unsuitable for the in situ
detection of exosomal miRNA due to their time-consuming and laborious
process. In this study, we have developed a novel diagnosis system that
enables in situ single step detection of miRNA in a whole exosome for
applying to various diseases. We have demonstrated that miRNAs in exo-
somes can be detected directly using a nano-sized oligonucleotide probe,
molecular beacon (MB). MiR-21 in exosomes from breast cancer cells were
detected successfully by molecular beacons in a quantitative manner. We
tested exosomes that originated from different types of cells including
MCF-7 breast cancer cell line to determine whether MBs bind to miR-21
with high specificity. We also investigated whether MB is delivered into
exosomes by going through the exosomal membrane and discussed
whether permeabilisation treatment can be used to improve the delivery
of MBs inside exosome, giving a high level of hybridisation. This method is
simple, fast, and sensitive, so it will offer great opportunities for the high-
throughput diagnosis and prognosis of diseases.
PF01.10
Multiplexed detection of exosome microRNAs using molecular
beacons
Jin Hee Lee1, Jeong Ah Kim2 and Won Jong Rhee1
1Incheon National University, Incheon, Republic of Korea; 2Biomedical
Omics Group
Multiplexed detection of miRNAs in an exosome is developed, which
can be utilised as a PCR-free efficient diagnosis method for various
diseases. Exosomes are small extracellular vesicles that contain biomar-
ker miRNAs from their originating cells. Because they circulate through-
out bodily fluids, exosomal biomarkers offer great advantages for
diagnosis in many aspects. In general, PCR-based methods can be used
for exosomal miRNA detection but they are laborious and time-con-
suming, which make them unsuitable for high-throughput diagnosis of
diseases. Herein, we show that multiple miRNAs can be detected simul-
taneously in exosomes using miRNA-targeting oligonucleotide probes,
molecular beacons. Exosomes from MCF-7 were used for the production
of exosomes because MCF-7 has a high level of miR-21, miR-27a and
miR-375. Each molecular beacons successfully hybridised with multiple
miRNAs in the cancer cell-derived exosomes even in the presence of
high human serum concentration. The proposed method described in
this article is beneficial to high-throughput analysis for disease diagnosis,
prognosis, and response to treatment because it is a time-, labour-, and
cost-saving technique.
PF01.11
Del-1 promotes proliferation and migration of tamoxifen-resistant
MCF7 cells
Soo jung Lee1, Ho Yong Park2, Jae-hwan Jeong1, Byung Woog Kang1, Ji Yun
Jeong3, Jong Gwang Kim1 and Yee Soo Chae2
1Kyungpook National University Medical Centre, Daegu, Republic of Korea;
2Kyungpook National University Hospital, Daegu, Republic of Korea;
3Soonchunhyang University Gumi Hospital, Soonchunhyang University
College of Medicine, Gumi, Republic of Korea
Purpose: We previously demonstrated a prognostic role of exosomal
Del-1 with breast cancer patients. However, the mechanisms of Del-1
expression are barely understood. Development of resistance to tamox-
ifen is an important clinical issue in the treatment of breast cancer.
Accordingly, we investigated the function of Del-1 in tamoxifen-resis-
tant (TAMR) breast cancer cell line.
Methods: Del-1 expression in MCF7 and TAMR MCF7 cells was per-
formed by quantitative RT-PCR, western blot and ELISA. The effects of





























Del-1 with RNA interference on proliferation, migration and invasion of
TAMR MCF7 cells were observed by MTT, wound healing and Matrigel
transwell assay.
Results: Del-1 was highly expressed in TAMR MCF7 cells compared to
MCF7 cells. Moreover, down-regulation of Del-1 inhibited the prolifera-
tion and migration of TAMR MCF7 cells. There was no difference in the
invasion of TAMR MCF7 cells.
Conclusion: Prominent expression of Del-1 in TAMR MCF7 cells was
associated with the proliferation and migration of TAMR MCF7 cells.
Accordingly, our findings suggest that the expression of Del-1 promote
tamoxifen resistance in breast cancer cells and could be a novel target for
anti-breast cancer treatment.
PF01.12
Chloride intracellular channel protein 4 (CLIC4) is a serological cancer
biomarker released from tumour epithelial cells via extracellular
vesicles
Vanesa C. Sanchez1, Alayna Craig-Lucas2, Bih-Rong Wei2, Anjali Shukla2,
Abigail Read2, Ji Lou2, Mark Simpson2, Kent Hunter2 and Stuart Yuspa2
1NIH; 2LCBG NCI NIH
CLIC4 is a highly conserved metamorphic protein originally described as
an ion channel. It translocates to the nucleus serving as an integral
component of TGF-β signalling. In multiple cancers, CLIC4 is a tumour
suppressor, excluded from the nucleus and lost from the cytoplasm of
progressing cancer cells. In contrast, CLIC4 is upregulated in the tumour
stroma in response to TGF-β. CLIC4 lacks a secretory sequence, but
recent reports indicate that CLIC4 is detected in the circulation of cancer
patients serving a possible biomarker and has been detected in extra-
cellular vesicles (EVs).
EVs from cell culture supernatants or biological fluids from SKOV3/
SCID xenograft ovarian and 6DT1 orthograft breast cancer models, were
isolated by differential centrifugation, following ultracentrifugation and
Optiprep density gradients. EV size distribution and concentration were
analysed by NTA and TEM. The presence of markers and CLIC4 were
analysed by immunoblot.
We validated the presence of CLIC4 in EVs released into supernatants
from primary normal and multiple ovarian tumour cell lines.
Substantial increases in CLIC4 were measured in EVs of tumour cells
when compared to normal cells. TGF-β-induced myofibroblasts also
increased CLIC4 in both the cells and the EVs they released.
Immunostaining analysis of human ovarian cancer tissue arrays show
CLIC4 preferentially expressed in tumour stroma of multiple subtypes
with the exception of ovarian serous adenocarcinomas, where it is
upregulated in both compartments. In vivo, CLIC4 levels increased in
EVs released into the peritoneal cavity as tumour burden increased in a
heterotopic xenograft ovarian cancer model. Moreover, CLIC4 levels in
EVs isolated from plasma increased with tumour burden and lung
metastatic load in an orthotopic syngeneic mouse breast cancer
model. To dissect the contribution of stromal vs. tumour epithelial
compartments as the source of the EVs, CLIC4 was deleted in breast
cancer cell lines by CRISPR/Cas9. CLIC4 in circulating EVs is reduced
in CLIC4 KO tumour-bearing mice when compared to WT, indicating
that the major contribution of CLIC4 into circulation is from tumour
epithelium.
CLIC4 levels in EVs from biological fluids may have value as a cancer
biomarker, in conjunction with other markers, to detect or analyse
tumour progression or recurrence.
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PF02.01
Evolution of next generation affinity-based extracellular vesicle
isolation technologies for liquid biopsy and therapeutic purposes
Sébastien Fournier1, Ian C. Chute2, Annie-pier Beauregard2, Catherine
Taylor1, David Barnett2, Andrew Joy2, Nguyet Nguyen1, Biji Anish1, Jeremy
Roy1, Awanit Kumar2, Sheena Fry2, Nicolas Crapoulet3, Morgan Brianne
Dawn Stephenson1, Simi Chacko2, Sami Benzina2, Remi Richard1, Stephen
M. Lewis4, Rodney J. Ouellette4 and Anirban Ghosh5
1Atlantic Cancer Research Institute, New Brunswick, Canada; 2Atlantic
Cancer Research Institute, New Brunswick, Canada; 3Department of
Chemistry and Biochemistry, Faculty of Medicine, Université de
Sherbrooke, Quebec, Canada; 4Department of Chemistry and Biochemistry,
Université de Moncton, New Brunswick, Canada; 5Department of Chemistry
and Biochemistry, Université de Moncton, New Brunswick, Canada
Introduction: Given the tremendous potential of circulating extracellular
vesicles (EVs) for liquid biopsy and therapeutic applications, there is a great
demand for simple, robust and clinically-adaptable EV isolation methods.
Ultracentrifugation, ultrafiltration and antibody-based EV isolation meth-
ods provide significantly less yield compared to polymer-based EV preci-
pitation. Currently available polymer-based EV isolation methods are toxic
and non-specific, thereby hindering therapeutic and diagnostic applica-
tions. To address these challenges we have developed and validated next
generation affinity-based EV capture technologies that use a synthetic
peptide (Vn96) or non-toxic clinically-approved polysaccharides.
Methods: We have used electron microscopy, atomic force microscopy,
nanoparticle tracking analysis, immunoblotting, cellular uptake assays, a
cellular tra/nsformation assay, proteomic analysis and nucleic acid detec-
tion to analyse the EVs isolated using our affinity-capture methods.
Results: The Vn96 peptide provides an easy and efficient EV isolation
method using only small bench-top centrifugation for precipitation, and
is also amenable to bead-based batch purification. Similarly, hyaluronic
acid and chitosan-based affinity purification of EVs were developed,
validated and advanced for therapeutic isolation of EVs. We found
superior efficacy of our methods for multiparametric downstream mole-
cular analyses of nucleic acid and protein biomarkers, which enables
liquid biopsy assays for limited clinical sample volume. Our technologies
allow easy separation of EVs from the isolation matrices, which permits
functional assays such as cellular uptake, cargo delivery and cellular
transformation. These properties enable downstream manipulation of
captured EVs for therapeutic applications.
Conclusion: Our results indicate that the clinical compatibility, scalabil-
ity, quality, platform versatility, and cost-effectiveness of our EV isola-
tion technologies provide multiple advantages over currently-available
methods. Our development of scalable non-toxic EV isolation technol-
ogies opens new opportunities for future fundamental EV research, as
well as EV-based therapeutics.
PF02.02
Plasmonic detection of extracellular vesicles in a microfluidic
environment using synthetic-peptide (Vn96) based affinity capture
Srinivas Bathini1, Duraichelvan Raju1, Simona Badilescu1, Rodney J.
Ouellette2, Anirban Ghosh2 and Muthukumaran Packirisamy1
1Concordia University, Montreal, Canada; 2Department of Chemistry and
Biochemistry, Université de Moncton, New Brunswick, Canada
Introduction: Extracellular vesicles (EVs) are groups of nano-scale extra-
cellular communication organelles which contain disease biomarkers for
cancer and other pathological conditions. In this work, we have developed
a novel method to detect and characterise EVs by using a label-free
localised surface plasmon resonance (LSPR) method based on the sensi-
tivity of the gold plasmon bands to the environment of gold nanoparticles.
Methods: EVs from different sources are detected and characterised by
using a plasmonic platform, based on gold nanoparticles. First, a complete
plasmonic sensing protocol is established and carried out by using gold
nanoparticles on glass substrates and, subsequently, the procedure is
transferred in a microfluidic environment. Gold nanoparticles are depos-
ited on glass substrates by a thermal convection method and annealed to
form gold nano-islands that are highly sensitive plasmonic platforms. In
this protocol, EVs are affinity-captured by a polypeptide named Vn96,
attached to the biotin-streptavidin couple. Gold nano-islands on glass are
bonded to a 2 mm thick PDMS, containing a 200 µm wide channel with a
collection chamber of 5 mm diameter. The different chemicals involved in
the protocol are flown through the channel at a rate of 10 µL/min. After
each step, the spectrum is measured and the shift of the Au LSPR band is
determined with respect to the previous stage.
Results and Conclusion: A calibration curve showing the shift of the gold
plasmon band for different concentration of EVs is plotted for different
cell lines. A low detection limit of EVs is found in the case of breast
cancer cell-line (MCF7) generated conditioned media grown in small
bioreactor. Compared to the macro detection method, the microfluidic
detection of EVs proved to be highly reproducible and more sensitive as
very small amounts of chemicals and EVs are necessary for the analysis.
PF02.03
Acoustic trapping of extracellular vesicles in biological fluids
Anson T. Ku1, Hooi Ching Lim1, Mikael Evander2, Hans Lilja3, Thomas
Laurell1, Stefan Scheding1 and Yvonne Ceder1
1Lund University, Sweden; 2Department of Biomedical Engineering, Lund
University, Sweden; 3Memorial Sloan Kettering
The diverse role of extracellular vesicles (EVs) in physiological
function such as clotting, conferral of immunity, and cell signalling
have recently begun to emerge. It has been implicated that EVs in
urine and plasma may contain diagnostic and prognostic informa-
tion, i.e in cancer. Based on EVs’ accessibility as a non-invasive
source of biomarkers, large-scale investigations into the EV contents
in clinical cohorts should be a priority. To date, a major challenge in
evaluating whether molecular profiling of EVs contributes important
clinical value is the lack of a rapid, efficient, low cost method for
enriching EVs that are amendable to use in routine practice. Here,
we demonstrate a novel automated technique to enrich EVs, termed
acoustic trapping, based on secondary acoustic forces arising from
ultrasonic waves scattering between 12 μm seeding particles and
extracellular vesicles in a resonant cavity. Our data show that we
can successfully enriched EVs from conditioned media from
SHSY5Y neuroblastoma cell line, as well as from human-derived
urine and plasma samples. Furthermore, we found that, similar to
ultracentrifugation, acoustically trapped samples contained vesicles
ranging from exosomes to microvesicles, as demonstrated by nano-
particle tracking analysis and transmission electron microscopy.
Interestingly, we did not observe any Tamm Horsefall proteins con-
taminations in the urinary samples enriched by acoustic trapping
that were present when using ultracentrifugation. The enriched vesi-
cles were unaffected by ultrasonic waves as determined by TEM and
yielded detectable level of miRNAs by qRT-PCR and our data indi-
cates that that the bulk of the miRNAs are contained within the
vesicles. Importantly, EV preparation were obtained starting from
only 200 μL of sample volume, in less 30 min of enrichment time
per sample. Thus, the time, volume, and ease-of-use factors of the
acoustic trapping technology make it an ideal method for biomarker
discovery and potentially future routine clinical use. Taken together,
we have shown that acoustic trapping can overcome the challenges
inherent in ultracentrifugation method and prove to be a fast, auto-
mated, low-volume compatible, and robust method to enrich EVs
from different biological fluids.






























Capturing EpCAM-positive extracellular vesicles by programmable
bio-surface
Mitsutaka Yoshida1, Kazuhiro Hibino2, Sachiko Matsumura3, Tamiko
Minamisawa3, Kazuya Iwai1, Satoshi Yamamoto3 and Kiyotaka Shiba4
1Tokyo Dental College, Tokyo, Japan; 2Cancer Institute; 3Cancer Institute,
Japanese Foundation for Cancer Research, Tokyo, Japan; 4The Cancer
Institute of Japanese Foundation of Cancer Research, Tokyo, Japan
Introduction: Because extracellular vesicles (EVs) are released from
almost all types of cell, bodily fluids contain a mixture of these EVs. If
these mixtures are analysed without further differentiation, the results
will represent the average features of the mixtures, which would nega-
tively affect the precision of EV-based diagnosis.
Methods: For differentiating cancer-related EVs from other EV mix-
tures, a coating agent that could endow the surfaces of various inorganic
materials with an affinity to EpCAM (CD326) was developed.
Results: We focused on EpCAM because it is expressed in epithelial cells
and not in most blood cells, making it an ideal cancer marker for blood-
based diagnosis. The agent developed is composed of peptide aptamer
for EpCAM and a Zwitterionic polymer, 2-methacryloyloxyethyl phos-
phorylcholine (MPC). Preferential binding of EpCAM-positive EVs over
negative ones to the surface of polystyrene substrate coated with the
agent was confirmed through atomic force microscope observations.
Conclusion: This coating agent, EpiVeta, could be implemented with
various diagnostic devices, allowing for the concentration of cancer-
related EVs from EV mixtures.
PF02.05
Plasma microvesicles/exosome enrichment and purification by a
block-copolymer based method
Zhenyu Zhong, Matthew Rosenow, Janet Duncan, Mark Miglarese, Kiyotaka
Shiba1, Nick Xiao and David Speztler
Caris Life Sciences
Introduction: Microvesicles (MVs)/exosomes-based liquid biopsy has
recently attracted a great attention for both proteomic and cancer
diagnostics interests. However, lack of fast and reliable sample handling
protocol for enriching/purifying these micro particles undermines most
of the studies. Current approach to enrich MV/exosome in biological
fluid includes Ultra Centrifuge, PEG8000-based precipitation and affi-
nity capture. Unable to process a small amount of sample, this tedious
procedure prevents it from large-scale studies. Heterogeneity and lack of
clear MVs/exosome unique markers cast great limitation in affinity-
related methods. Lack of selectivity for PEG-related method results in
precipitation of too much free high abundant proteins in biological fluid;
it also might not be compatible with a variety of the downstream
applications.
Methods: Pluronic block copolymer F68 was adopted to precipitate MV/
exosomes. Various concentrations of the copolymer were tested for MV/
exosome precipitation efficiency in a plasma sample with spike-in cell
line exosome, the MV/exosome identity was examined by DLS, TEM,
FLOW as well as ELISA and the content of the enriched MV/exosome
fraction was profiled by NGS and semi-quantitative mass spectrometry.
The profile was also compared to two commercially available PEG-
related exosome enrichment protocols.
Results and Summary In a cell line exosome spike-in setting, it achieved
closed to 100% of recovery with much less protein contaminants com-
pared to the PEG-related methods. The isolated plasma MVs/exosome
was confirmed to be enriched in exosome related protein CD9 by multi-
ple applications (ELISA/FLOW/western blot/TEM), DLS and TEM
shows the isolated MVs/exosome consistent with the exosome size
range. NGS shows exosome-related microRNA, such as let-7 family.
MS analysis revealed more MVs/exosome-related protein enriched com-
pared to the PEG-based method. In summary, we have developed a
MVs/exosome purification method from biological fluid that could be
more convenience to apply on a larger scale study and perform multiple
level of downstream analysis.
PF02.06
Fast and reproducible purification of extracellular vesicles using
combined size exclusion and bind-elute chromatography
Giulia Corso1, Imre Mäger2, André Görgens1,3, Matthew J. Wood2, Joel Z.
Nordin1and Samir EL-Andaloussi1,2
1Department of Laboratory Medicine, Karolinska Instiutet, Stockholm,
Sweden; 2Department of Physiology, Anatomy and Genetics, University of
Oxford, Oxford, United Kingdom; 3Institute for Transfusion Medicine,
University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Introduction: Purification is one of the biggest challenges in the field of
extracellular vesicles (EVs) due to their small size and physiochemical
properties. Ultracentrifugation (UC) is the current gold standard isola-
tion method, however it has several disadvantages, recent studies indi-
cate that due to the high forces, the vesicles aggregate, fuse and break,
likewise it is operator dependant and time consuming. Here, we describe
a novel chromatography method for EV purification that overcome
these issues.
Methods: The commercially available chromatography column is built
on an activated core bead technology and combines bind-elute with size
exclusion chromatography (BE-SEC). To verify the feasibility of this
method for EV purification, cell-culture supernatant from different cell
sources was purified on the BE-SEC column. Isolated particles were
characterised by nanoparticle tracking analysis, western blot and elec-
tron microscopy. To investigate if the BE-SEC isolation method affected
the physical properties of EVs, an uptake study using flow cytometry was
performed.
Results: Our data show that the BE-SEC technique isolates intact vesi-
cles, ranging around 100 nm in size with a classical EV shape. Common
EV markers were present, whereas Golgi and ER contaminants were not
detected. Additionally, the BE-SEC samples were depleted of non-vesi-
cular proteins and RNAs according to SEC fractionation. When com-
pared to UC isolated EVs, the purity was higher in the BE-SEC purified
samples and the recovery yield was exceeding 70%. Moreover, UC and
BE-SEC isolated EVs exhibited the same surface proteins and were
equally taken up in recipient cells irrespective of the purification method
used.
Conclusion: In this study, we show that the BE-SEC method can be used
for EV purification from small to large amounts of cell-conditioned
media, achieving high-yield and pure EVs in a time-efficient manner.
Furthermore, the method does not affect EVs physical properties and
surface protein signature.
PF02.07
On-chip liquid biopsy: progress in isolation of exosomes for early
diagnosis of cancer
Navneet Dogra1,2, Carlos Cordon-Cardo2, Jungreem Woo2, Gustavo
Stolovitzky1,2
1IBM; 2Icahn School of Medicine, NY, USA
In contrast to a standard biopsy, the so-called “liquid biopsy” offers a
rapid, non-invasive, and cost effective alternative for cancer diagnosis.
Exosomes, which are vesicles secreted by most eukaryotic cells and range
in size from 30–150 nm, are the target biomarkers in this technique as
they carry a diverse variety of genetically rich cargo, including proteins,
RNA and DNA. Additionally, the size and quantity of exosomes corre-
late with cancer and other diseases. Hence, studying exosomes could
potentially provide vital information about undesirable genetic devia-
tions occurring in their cell of origin. Rapid isolation of exosomes from
blood, urine or other body fluids remains a key challenge in this growing
field.
Deterministic lateral displacement (DLD) pillar arrays have proven an
effective means to sort, segregate, and enrich micron-size particles, such





























as parasites and blood cells. Here, we have developed a nanoscale DLD
device, containing gap sizes as small as ~25 nm, with nanoscale sorting
resolution of biological particles. This development in nano-fluidics and
engineering has enabled us to sort colloidal particles at the tens of
nanometres scale. Additionally, we have developed predictive computa-
tional models to provide key insights into the behaviour of particles in
these systems. Furthermore, we have successfully demonstrated on-chip,
size-based separation of exosomes, indicating the potential of this tech-





Identification and characterisation of single-chain Fv antibodies
specific to CD9 for high efficient recovery of exosomal vesicles
Yoichi Kumada1, Ryota Akai1, Aranna Nemoto1, Kazutaka Matoba2, Junko
Katayama2 and Jun-ichi Horiuchi1
1Kyoto Institute of Technology, Kyoto, Japan; 2Nissan Chemical Industries Ltd
Introduction: Efficient, precise and inexpensive separation technologies
for exosomal vesicles are one of attractive topics, and they must be
essential for next-generation of miRNA-based clinical diagnosis. Here,
we demonstrated use of single-chain Fv (scFv) antibodies as a ligand
protein for specific separation of exosomal vesicles from culture super-
natant as well as human serum. ScFv antibodies are recombinant fusion
proteins of antibody fragments that VH and VL domains of monoclonal
antibody were connected via a flexible peptide linker (G4S)3. Isolation
and identification of scFvs specific to target biomolecules can be
achieved by conventional phage display technology, while characterisa-
tion of isolated scFvs, such as production level, binding affinity, speci-
ficity and remaining activity in immobilisation state would be
significantly important for industrial use. Here, we reported identifica-
tion and characterisation of anti-CD9 scFv antibodies for immuno-
affinity separation of exosomal vesicles.
Methods: Rabbit spleen immunised with 293T cells overexpressing native
CD9was used for preparation of scFv-displayed phage library. According to
the original biopanning procedure, five candidates of scFvs were identified
from the library. Antigen-binding affinity and specificity of these scFvs were
characterised by BIAcore, flow cytometry and western blotting.
Results and Conclusion: EC2-hFc that extracellular domain II of CD9
was genetically-fused with Fc fragment of human IgG was used as a
model antigen. Furthermore, their binding to antigen on cell mem-
brane of Hela cells was successfully confirmed by flow cytometer.
Site-specific immobilisation of scFv to PS latex beads could be
achieved via our original material-binding peptides and consequently,
anti-CD9 scFv was stably immobilised with high density and remain-
ing activity. It was revealed that the exosomal vesicles released from
Hela cells were selectively separated by our original scFv-immobilised
beads, according to the results of flow cytometry and western blot-
ting. Thus, the scFv antibodies identified by our original method will
be significantly useful for comprehensive and specific separation of
exosomal vesicles.
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PF03.01
Identification of non-invasive prostate cancer biomarkers by miRNA
deep sequencing analysis of urinary extracellular vesicles
Marta Rodriguez-Moreno1, Cristina Bajo-Santos2,3, Viktor Berge4, Aija Linē2
and Alicia Llorente1
1Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway;
2Latvian Biomedical Research and Study Centre; 3University of Latvia, Riga,
Latvia; 4Department of Urology, Oslo University Hospital, Oslo, Norway
Please see OPT01.03
PF03.02
Development and testing of EV- and prostate cancer specific
monoclonal antibodies
Maija Puhka1, Maarit Takatalo2, Teijo Pellinen1, Olli Kallioniemi1, Antti
Rannikko3, Marjo Yliperttula4, Elina Serkkola5, Saara Laitinen6, Pia R-M.
Siljander2, Taija af Hällström1,5, Laura-Leena Kiiskinen7 and Sari Tiitinen7
1Institute for Molecular Medicine Finland FIMM, University of Helsinki,
Helsinki, Finland; 2Division of Biochemistry and Biotechnology,
Department of Biosciences/Division of Pharmaceutical Biosciences, Centre
for Drug Research, Faculty of Pharmacy, University of Helsinki, Helsinki,
Finland; 3Helsinki University Central Hospital, Department of Urology,
Helsinki, Finland; 4Division of Pharmaceutical Biosciences and Centre for
Drug Research, Faculty of Pharmacy, University of Helsinki; 5Orion
Corporation, Orion Pharma, Espoo, Finland; 6Finnish Red Cross Blood
Service, Helsinki, Finland; 7Medix Biochemica, Espoo, Finland
Introduction: Extracellular vesicle (EV) research field needs analytical
tools to support the booming basic research and quest for better biomar-
kers. We developed monoclonal antibodies (Mabs) against urinary EVs
derived from patients with aggressive prostate cancer (Pca) and charac-
terised their binding to EVs from Pca patients and various other sources.
Methods: Small and large EVs were isolated with differential centrifuga-
tion from pooled urine samples derived from 12 Pca patients (Gleason
score 8–9) and used to immunise mice. The produced Mabs were
screened with our low-input ELISA-test for binding to Pca (Gleason
score 6–9, and post-prostatectomy) or control EVs from various sources
as well as to common contaminant proteins THP, BSA and PSA. Mabs
were further characterised for their binding to EVs or EV proteins (CD9
and CD63) by ELISA, quantitative immuno-EM, Apogee flow cytometry
and western blotting. Immunohistochemistry (IHC) was used to visua-
lise staining of different cancer and control tissues on tissue microarrays
(TMAs).
Results: Antibody titers indicated successful immunisation with both EV
types. ELISA screen of Mabs starting from >3000 clones revealed nine
clones that produced antibodies binding preferentially to Pca EVs, urinary
EVs, small or large EVs or many types of EVs. Out of the nine Mabs, one
showed preferential binding to the urinary EVs from Pca patients relative
to controls in ELISA, immuno-EM and Apogee flow cytometry, but was
not functional with the tested protocols in IHC or western blotting. The
other eight Mabs were also tested with these techniques, which mostly
confirmed the binding specificities detected by the initial ELISA testing.
With three Mabs, IHC revealed in most cases enriched staining to the
luminal side on the epithelium as expected from a secretory target.
However, the tested Mabs didn’t show any clear cancer specific staining
pattern. None of the nine Mabs recognised CD9 or CD63.
Conclusion: We have successfully produced and characterised novel EV-
specific Mabs, with one antibody showing potential for Pca detection in
urine samples and several others for ubiqutous or source-dependent
recognition of EVs. These Mabs can be used as novel tools in EV
research and diagnostics.
PF03.03
Purification and characterisation of plasma-derived EVs for early
cancer diagnosis
Eline Oeyen1, Hanny Willems1, Geert Baggerman1, Gerhard Weber2, Kurt
Van Mol3, Patrick Pauwels4 and Inge Mertens5
1University of Antwerp/VITO, Antwerp, Belgium; 2FFE Service;
3Pharmafluidics; 4UZA; 5University of Antwerp, Belgium
Introduction: Liquid biopsies offer great potentiel in cancer diagnostics
because they contain EVs that are secreted directly by the tumour. To
exploit this potential, the biggest challenge is the purification and char-
acterisation of these EVs, in order to start from pure samples in pro-
teomics-based biomarker discovery experiments
Methods: In this study we use plasma samples (approved by the Ethics
committee of the University of Antwerp) to optimise purification pro-
cedures as a first step in proteomics-based biomarker discovery. To
evaluate all used methods for purification (size exclusion chromatogra-
phy (SEC) and free-flow electrophoresis (FFE)), we used assymetrical-
flow field-flow fractionation coupled with UV and multi-angle light
scattering detectors (AF4/UV-MALS), western blot, NTA and TEM.
AF4 can also be used a s a separation technique and will also be
evaluated for purification. Protein content of the obtained fractions
was identified using LC-MS/MS on the Q-exactive mass spectrometer.
Results: Using SEC separation of plasma, we are able to enrich EVs in
certain fractions, as shown byWestern blot, TEM and NTA, but SEC is not
sufficient to separate EVs completely from platelets and bulk proteins,
mainly lipoproteins. When we combine SEC and AF4, the UV-MALS
output looks promising, but because of the large dilution factor during
SEC and AF4 separation, downstream applications are not yet possible.
Standalone AF4/UV-MALS and FFE are still under evaluation for platelet
free plasma. Preliminary results show great potential for both techniques.
Conclusion: Both FFE and AF4/UV-MALS show great potential for the
purification and characteriation of EVs, but both techniques need to be
optimised.
PF03.04
Plasma extracellular vesicles as source of biomarkers for treatment
response of patients with head and neck squamous cell carcinoma
Dorival Mendes Rodrigues1, Soon Sim Tan2, Sai Kiang Lim2, Andre Lopes
Carvalho3, N. Gopalakrishna Yier4 and Andre Luiz Vettore1
1Universidade Federal de São Paulo, Argentina; 2A*STAR; 3Hospital do
Câncer de Barretos; 4National Cancer Centre of Singapore, Singapore
Induction chemotherapy (IC) with cisplatin and paclitaxel followed by
chemoradiotherapy (CRT) based on cisplatin is safe, well tolerated and
improves overall survival for patients with locally advanced head and
neck squamous cell carcinoma (HNSCC) (stage III–IV). However, 30%
of the patients with locally advanced HNSCC treated with CRT have
incomplete response to the treatment and there is no biomarker able to
prospectively segregate these patients from those who respond to the
treatment. Extracellular vesicles (EVs) carrying proteins and nucleic
acids in the plasma may be an alternative novel source for discovery of
new specific markers for patients with HNSCC. In this study, Cholera
toxin B chain (CTB) and Annexin V (AV) which respectively binds GM1
ganglioside and phosphatidylserine, were used to isolate EVs from
pooled plasma samples from 6 HNSCC patients who responded (R)
and 6 patients who presented incomplete response (IR) to IC and CRT
treatment. The isolated EVs were screened by antibody arrays to exam-
ine the protein cargo. 327 proteins were identified in CTB-EVs, of which
54 and 19 proteins were presented exclusively in R and IR patients,
respectively. Further, 271 proteins were identified in AV-EVs, 20 of
them were present only into R patients while other 20 proteins were
restricted to IR patients. This study provides a list of 113 specific





























markers that may contribute to the development of new tools for pre-
diction and assessment of IC and CRT response and demonstrated that
CTB and AV could be used to isolate circulating plasma EVs for
biomarker discovery in HNSCC.
PF03.05
Metabolomics analysis of urinary exosomes reveals novel candidate
biomarkers of prostate cancer
Patricia Zuniga1, Pilar Sanchez-Mosquera1, Ana R Cortazar1, Esperanza
Gonzalez1, Cristina Alonso2, Miriam Perez-Comenzaba2, Ana Loizaga-
Iriarte3, Aitziber Ugalde-Olano3, Isabel Lacasa3, Azucena Castro2, Miguel
Unda3, Arkaitz Carracedo1 and Juan M. Falcón-Pérez1
1CIC bioGUNE; 2OWL Metabolomics; 3Hospital Basurto, Bizkaia, Spain
Introduction: Urine constitutes an ideal source of biomarkers, particularly
for diseases of the genitourinary system. However, direct analysis of urine
can be very inefficient due to low abundance of some molecules and to the
low sensitivity of some techniques. Apart from soluble molecules, urine
samples contain EVs that protect of degradation and in concentrate many
molecules that are present in urine. Thus, isolation and characterisation of
urinary EV could increase the efficiency of biomarker discovery. Our team
has previously identified some proteins and RNAs that are differentially
expressed in urinary exosomes from prostate cancer compared to benign
prostate hyperplasia. In the current work we focused on the analysis of the
metabolites contained in urinary EVs.
Methods: Urine samples were collected from patients with prostate
cancer (n = 31) and benign prostate hyperplasia (n = 14), and after
clearing at low centrifugation and ultrafiltration steps, EVs were isolated
by differential ultracentrifugation. Afterwards, targeted metabolomics
analysis of EVs was performed by ultra-high performance liquid chro-
matography–mass spectrometry. Correlations between metabolites and
clinical parameters were statistically studied, and differentially expressed
metabolites were detected and mapped into cellular pathways.
Results: In urinary EVs we have detected 300 metabolites belonging to
different chemical nature including amino acids, vitamins, as well as
different lipid species. We found some metabolites that significantly
correlate with current markers of prostate cancer (e.g. PSA). In addition,
we have detected 90 metabolites that are significantly different between
prostate cancer and benign prostate hyperplasia. Apart of being candi-
date biomarkers for prostate cancer, the mapping of these metabolites in
cellular pathways indicates that prostate cancer could altered amino
acids and sterol metabolisms in cells emitting EVs
Conclusion: In this work we demonstrated that urinary EVs contain
metabolites of different chemical nature. Importantly, we show that the
analysis of EVs in combination with high-sensitive metabolomics
approach could provide candidate biomarkers and insight in the mole-
cular mechanism of the disease.
PF03.06
Analysis of extracellular vesicles from plasma of advanced (IIIc or IV
stages) melanoma patients during kinase inhibitor and/or
immunotherapy treatments
Pascal Colosetti1, Henri Montaudié2, Philippe Bahadoran2, Robert Ballotti3,
Sophie Rome4 and Corine Bertolotto3
1UMR Inserm U1060/INRA 1397; 2Hospital; 3INSERM; 4INRA
Introduction: Extracellular vesicles (EVs) shaping tumour microenvir-
onment, contribute to pre-metastatic niche formation, favour tumour
dissemination and mediate resistance to treatments. We have previously
shown that senescent melanoma cells, in response to treatment with
chemotherapeutic drugs, release soluble (e.g. chemokine CCL2) and
insoluble factors. The origin and roles of these insoluble factors remain
to be elucidated but it is admitted that the amount of circulating EVs is a
factor of poor prognosis in melanoma. Moreover, increasing line of
evidences indicate that the composition of these vesicles exhibits tissue
specificity. In this study we propose a pilot clinical study on patients
with advanced non-resectable or metastatic melanoma to determine the
effect of targeted therapies (BRAF and/or MEK inhibitors, immunother-
apy) on the production (quantity and size) of EVs isolated from blood.
Methods: All patients gave written consent and the protocol was approved
by ethic committee. Plasmas were collected on EDTA tubes from patients
(n = 8) before treatment and 3 times during therapies. EVs were isolated
by using qEV original size exclusion columns (iZON). Protein concentra-
tion (Bradford assay) and acetylcholine esterase activity (AChE) were
determined on each fraction and only the fraction 8 containing the
vesicles was selected. EVs were characterised by nanoparticle tracking
analysis (NTA) and transmission electron microscopy (TEM).
Results: Analyses of the four EV samples per patient indicated that,
whatever the treatment considered, the number of plasma EVs increased
during the treatment (non-significant tendency). Concomitantly, we
observed a significant decrease in mean diameter of EVs before and
after treatment (46.4 ± 8.3 nm vs 33.6 ± 6.4 nm, p = 0.011).
Conclusion: These data indicate that EV size reduction might be a
marker of chemo-resistance in patients suffering from melanoma, thus
suggesting their possible use as theranostic tool in their management.
PF03.07
Isolation and characterisation of urinary exosomes
Eline Oeyen1, Geert Baggerman2, Hanny Willems2 and Inge Mertens3
1University of Antwerp/VITO, Antwerp, Belgium; 2University of Antwerp /VITO,
Antwerp, Belgium; 3University of Antwerp, Belgium
Introduction: Exosomes are nanosized extracellular vesicles that are
secreted by normal, diseased and tumour cells in all body fluids (i.e. plasma,
breast milk and urine). Since their origin, molecular content and function,
exosomes are suitable as a source of diagnostic biomarkers. In this way,
urine exosomes provide a targeted view into the urogenital tract to enhance
the ability to detect urological diseases or tumours and their progression.
Methods: Isolation of exosomes from urine was optimised to obtain a
pure exosome fraction. Size exclusion chromatography (SEC) combined
with a preprocessing step (ultrafiltration or a commercial kit) was used.
The urine sample collection was approved by the Ethics committee of
the University of Antwerp, comply with the Declaration of Helsinki.
Isolated extracellular vesicles were characterised by techniques such as
nanoparticle tracking analysis, western blotting, electron microscopy and
assymetrical-flow field-flow fractionation coupled with UV and multi-
angle light scattering detectors (AF4/UV-MALS). Isolated vesicles were
used in down stream proteomic analysis.
Results: Western blot data demonstrated the presence of EV-specific
proteins Flotillin-1, CD9, CD63 and CD81 in the EV-relevant fractions
of both isolation methods. NTA results and electron microscopy images
showed a higher enrichment of EVs using ultrafiltration and SEC.
Proteomic analysis also demonstrated that this isolation method gives
more identifications of EV-relevant proteins. The results of AF4/UV-
MALS demonstrated that fraction 9 after SEC was most enriched in EVs.
The size of the isolated vesicles ranged from 40 to 160 nm.
Conclusion: In conclusion, ultrafiltration combined with SEC is pre-
ferred as isolation method of EVs from urine. AF4/UV-MALS proved to
be a good quality control method for urinary EVs to determine their
purity and size.
PF03.08
Diagnostic and prognostic potential of miRNA alterations in blood
based extracellular vesicles from clear cell renal cell carcinoma patients
Joana Heinzelmann, Diana Kuhn, Sophie Baumgart, Sebastian Hoelters,
Michael Stoeckle and Kerstin Junker
Department of Urology and Paediatric Urology, Saarland University,
Saarbrucken, Germany
Introduction: In previous studies we identified 14 specific miRNA
alterations in tumour tissues of clear cell renal cell cancer (ccRCC)
with prognostic value relating to the presence of metastasis. We
hypothesise that in a simple blood based test tumour cell related





























miRNA alterations can be proven in EV as biomarkers for diagnosis and
evaluation of the metastatic risk.
Methods: EV were isolated from 1 ml serum of 20 ccRCC patients (6
metastatic and 9 non-metastatic tumours) and 10 healthy volunteers
using differential centrifugation and EV precipitation with exosome
isolation kit (Fisher Scientific). By nanotracking analysis (NTA) and
western blot we proofed the EV concentration and quality of isolation.
EV-totalRNA was isolated using miRNeasy Mini Kit (Qiagen).
Concentration of 14 miRNAs (miR-10b, -30a-3p/5p, -30c-5p/2-3p,
-30e-3p/5p, -126-3p/5p, -139-5p, -144, -204, -451 and -455-3p) was
revealed by qPCR. To this, 10 ng totalRNA was reverse transcribed
(TaqMan Reverse Transcription Kit, Fisher Scientific) and preamplified
(TaqMan PreAmp Master Mix, Fisher Scientific). Amplification was
performed using Gene Expression master mix (Fisher Scientific).
Results: CcRCC serum samples are characterised by threefold increased
EV concentration compared to non-malignant controls. In five out of 20
serum samples, miRNA expression was too low for qPCR analyses. In
the remaining 15 serum samples, two miRNAs (miR-30-2-3p and -455-
3p) were not detectable. Three out of 14 miRNAs (miR-10b, -126 and
-451) analysed in this proof of principle study exhibited a significantly
decreased expression in serum EV compared to the controls (p < 0.05).
But, patients with metastatic ccRCC showed no significant different
miRNA expression compared to non-metastatic counterparts.
Conclusion: These initial data confirm that the tissue based miRNA
signature could be used as biomarkers for detection of ccRCC analysing
EV from liquid biopsies. The identified miRNAs can be used as possible
markers for early detection and monitoring of metastatic disease. To
validate these results the expansion of the sample set is ongoing.
PF03.09
The content of circulating exosomes changes according to
malignancy of prostate cancer and trigger phenotypical changes that
may promote cancer progression and metastasis
Eliana Andahur1, Mei Yieng Chin2, Juan Fulla1, Alejandro Mercado1,
Christian Ramos1, Kim Chi2, Emma Guns2 and Catherine A. Sánchez1
1Clinica las Condes, Santiago, Chile; 2Vancouver Prostate Centre, Vancouver,
Canada
Introduction: Cancer cells release exosomes as a mechanism of cell
communication. Exosomes carry DNA, RNA and proteins that can
transform the surrounding cells, promoting their growth and progres-
sion. Exosomes also reach the distant sites to prepare the pre-metastasis
niche. Therefore, understanding the content of the circulating exosomes
and their effects on normal cells are critical to evaluate their use as
biomarkers for prostate cancer (PCa).
Methods: Blood from patients with and without PCa was collected. All
patients signed the informed consent forms. Exosomes were extracted
from plasma by Exoquick, then quantified by NanoSight. Total RNA and
protein content were measured by Nanodrop and BCA assay, respectively.
A panel of seven microRNAs was evaluated by TaqMan assay. Finally,
normal epithelial cells (RWPE-1) were treated with the patients’ plasma
exosomes, for 96 h to assess the cell viability using MTS assay and 48 h to
evaluate the expression of E-cadherin by immunocytochemistry. Exosome
uptake by RPWE-1 cells was also evaluated by confocal microscopy.
Results: Exosomes were isolated from plasma from individuals without
cancer (n = 10), PCa patients with Gleason score 6 (n = 10), ≥7 (n = 10)
and castration-resistant disease (CRPC) (n = 5). We found that the total
amount of plasma exosomes was similar between the four groups of sample.
However, the protein and RNA content, and the levels of the seven
microRNAs analysed were higher in exosomes extracted from plasma of
cancer patients. In the other hand, RWPE1 cells that had uptaken PCa
patient-derived exosomes showed an increased cell proliferation and
diminished expression of E-cadherin when compared to those treated
with exosomes extracted from normal individuals. Furthermore, such effect
was greater in RWPE-1 cells treated with CRPC patient-derived exosomes.
Conclusion: In this study, we showed that the amount of circulating
exosomes does not seem to differ between normal individuals and PCa
patients. However, their protein content and the 7 microRNA analysed
are increased in PCa patients compared to those without cancer, and
thus could be an interesting source for biomarkers. In addition, we
showed that exosomes isolated from PCa patients can trigger
phenotypical changes on normal prostate cells, and thus may promote
cancer progression and metastasis.
PF03.10
Diagnosis of prostate cancer using serum PSA and Del-1 positive
exosomes in plasma
Chan-Hyeong Lee1, Eun-Ju Im1 and Moon-Chang Baek2
1Department of Molecular Medicine, School of Medicine, Kyungpook
National University, Daegu, Republic of Korea; 2Kyungpook National
University, Daegu, Republic of Korea
Introduction: Despite the prostate-specific antigen (PSA) test is the most
important screening method for prostate cancer, there is an increasing
demand for biomarkers for diagnosis of prostate cancer because of high
false-positive rate that lead to unnecessary prostate biopsies and over-
diagnosis. Developmental endothelial locus-1 (Del-1) is an extracellular
membrane protein of exosomes and commonly upregulated in multiple
types of human cancers. In this study, we focused on development of
new test using Del-1 positive exosomes for prostate cancer diagnosis.
Methods: Del-1 positive exosomes were measured in plasma of prostate
cancer patients and healthy controls by sandwich ELISA.
Results: Del-1 positive exosomes of prostate cancer patients were sig-
nificantly elevated compared with healthy controls. In addition, level of
Del-1 positive exosomes was not correlated with serum PSA. Del-1
positive exosomes were increased in low PSA level prostate cancer
patients.
Conclusion: Those data support that combination of Del-1 and PSA can
improve sensitivity and specificity of prostate cancer screening.
PF03.11
Characterisation of small RNA content in urinary and plasma EVs and
matching prostate cancer tissues
Cristina Bajo-Santos1, Vita Melne2, Kristīne Sobolevska3, Pawel Zayakin4,
Arturs Ābols4, Vilnis Lietuvietis5, Alicia Llorente6 and Aija Linē4
1Latvian Biomedical Research and Study Centre/University of Latvia, Riga,
Latvia; 2Riga StradiņšUniversity/Rīgas Austrumu klīniskā universitātes slimnica,
Riga, Latvia; 3Latvian University, Riga, Latvia; 4Latvian Biomedical Research and
Study Centre, Riga, Latvia; 5Rīgas Austrumu klīniskā universitātes slimnica,
Riga, Latvia; 6Oslo University Hospital-The Norwegian Radium Hospital,
Oslo, Norway
Introduction: It has been estimated that approximately one in seven adult
men will develop prostate cancer (PCa) in the course of their life. Despite
of the current diagnostic methods, there is still an unmet need to find
specific biomarkers that could identify PCa in a non-invasive manner. The
aim of this study was to characterise the small RNA cargo in EVs isolated
from different biofluids (plasma and urine) before and after radical
prostatectomy, and to compare it with the small RNA content in the
matching tumour and normal prostate tissue.
Methods: Urinary and plasma derived EVs were isolated by size exclusion
chromatography. EVs were visualised by electron microscopy, quantified
by Nanosight and characterised by western blot analysis. Prior isolation of
RNA, EVs were treated with proteinase K and RNAse A. RNA quantity
and quality was assessed using Agilent Bioanalyser. Small RNA libraries
were constructed from EVs and matching tumour and normal prostate
tissues, and libraries were sequenced using Ion Proton platform.
Results: The isolated vesicles were positive for CD9, CD81, CD63 and Alix
and negative for GM130. A total of 2.4–4.6 million reads were obtained by
deep sequencing of the small RNA libraries (RNAseq). RNAseq data
analysis revealed that both, urinary and plasma EVs, contained various
classes of RNAs. Specifically, long non-coding (lncRNA), mitochondrial
(MtRNAs), ribosomal, small nuclear, small nucleolar, micro (miRNAs), Y,
vault, miscellaneous and protein coding RNAs were detected. No sub-
stantial variation in the representation of the different RNA species has
been identified among biofluids, except for MtRNAs, which have been
characterised mainly in plasma EVs. Interestingly, an increase in lncRNAs
was detected in EVs obtained from plasma after prostatectomy. A total





























number of 292 different mature miRNAs were identified. Among those,
17 miRNAs that were overexpressed in the tumour tissues were detectable
in the urinary EVs, 4 in the plasma EVs and 6 miRNAs were found both,
in urinary and plasma EVs, and may represent PCa biomarker candidates
that warrant further validation.
Conclusion: Both, urinary and plasma EVs contain small RNAs that may
be derived from the tumour tissues, yet the specific RNA signatures are
substantially different between the biofluids.
PF03.12
Exosomal Del-1 as a potent diagnostic marker for breast cancer: a
prospective cohort study
Soo jung Lee1, Ho Yong Park2, Byung Woog Kang1, Jong Gwang Kim1,
Jeeyeon Lee1, Jin Hyang Jung2, Ji Yun Jeong3, Pyong-Gon Moon4, Moon-
Chang Baek4, Jae-hwan Jeong1 and Yee Soo Chae2
1Kyungpook National University Medical Centre, Daegu, Republic of Korea;
2Kyungpook National University Hospital, Daegu, Republic of Korea;
3Soonchunhyang University Gumi Hospital, Soonchunhyang University
College of Medicine, Gumi, Daegu, Republic of Korea; 4Kyungpook
National University, Daegu, Republic of Korea
Introduction: We previously demonstrated a diagnostic role of exosomal
del-1 with two separated groups of breast cancer patients. In the current
study, therefore, we aimed to confirm the diagnostic role in a prospec-
tive study with breast cancer by measuring plasma exosomal del-1 before
and after surgery.
Methods: To identify the optimal time of sampling after surgery, serial
blood at day 1, 3, 5 and 7 after surgery was collected from 22 patients
with early breast cancer. Thereafter, 115 patients with breast cancer who
underwent curative surgery were enrolled in the prospective cohort
study to compare difference in plasma exosomal del-1 measured by
ELISA at the time of diagnosis and post-surgery.
Results: Among all 22 patients for optimal sampling time after surgery,
exosomal del-1 was higher than 0.5 at the time of diagnosis and then
normalised at POD1. Among 115 patients for the confirmatory set, 109
(94.8%) patients showed a normalisation of del-1 lower than 0.5 after
surgery and 10 patients showed del-1 >0.4. For median follow-up dura-
tion of 22 months, 9 patients experienced relapse (4 locoregional and 5
distant), with 3 out of 6 in high group (>0.5), 2 out of 4 in borderline
group (0.4–0.5) and 4 out of 105 in normalised group.
Conclusion: In a prospective cohort study, we confirmed that exosomal
del-1 has a potent diagnostic role in breast cancer. Furthermore, del-1
was also identified to dramatically decrease after curative surgery. Our
current findings suggest its potential prognostic role as well as diagnostic
role in breast cancer patients.
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PF04.01
Extracellular vesicles derived from cancer-associated fibroblasts may
have a role in oral cancer invasion
Mauricio R. Dourado1, Johanna Korvala2, Raija Sormunen3, Ilkka
Miinalainen4, Sami Yokoo5, Pirjo Åström2, Adriana Franco Paes Leme5,
Ricardo Della Coletta1 and Tuula Salo6
1Department of Oral Diagnosis, Piracicaba Dental School, Unicamp; 2Cancer
and Translational Medicine Research Centre, University of Oulu, Oulu,
Finland; 3Biocenter Oulu, University of Oulu, Oulu, Finland; 4Biocenter
Microscopy Service, University of Oulu, Oulu, Finland ; 5Mass
Spectrometry Facility, LNBio-CNPEM; 6Medical Research Centre,
University of Oulu, Oulu, Finland
Please see OPT01.02
PF04.02
Oral cancer EVs contain miRNA capable of promoting
protumourigenic fibroblast activation
Mark Ofield, Daniel Lambert and Stuart Hunt
University of Sheffield, United Kingdom
Introduction: Oral cancer mortality rates have increased by 10% in the
last decade. Efforts to reverse this are hampered by a limited under-
standing of the underlying molecular complexity of the disease. Recently,
interest has grown in the contribution of extracellular vesicles (EVs) to
cancer pathogenesis. Developing tumours consist of multiple cell types
including fibroblasts, however, these bear little resemblance to their
normal counterparts, but have a myofibroblast-like, protumorigenic
phenotype. This project aims to evaluate the impact of EVs from oral
cancer cells on normal oral fibroblasts (NOFs).
Methods: EVs were isolated from the culture media of dysplastic and carci-
noma cell lines for characterisation by western blotting, TEM and TRPS. The
miRNA contents of EVs were determined by next-generation sequencing.
EVs were transferred to NOFs and their uptake visualised by fluorescence
microscopy. The impact of this uptake on NOF proliferation (BrdU ELISA),
viability (live/dead staining) and activation (western blot and immunofluor-
escence microscopy of α-SMA protein levels) was assayed.
Results: Oral cancer cells produced between 1500–4000 EVs/cell/24 h
ranging in size from 50–200 nm and bearing the EV marker CD63. Kegg
pathway analysis identified several miRNA present in EVs that target
members of the TGF-β signalling pathway and are known to modulate
activation of fibroblasts. EVs were readily taken up by NOFs with no
significant impact on viability or proliferation. However, analysis of α-
SMA protein levels showed that EV uptake was sufficient to activate
NOFs to a myofibroblast-like phenotype.
Conclusion: Our data indicates that oral cancer cell-derived EVs are able to
transfer miRNA to NOFs causing an increase in α-SMA expression and the
adoption of a myofibroblast-like phenotype which would favour tumour
progression.
PF04.03
Immunotherapy in multiple myeloma using alfa-galactosylceramide
loaded sEVs from dendritic cells to stimulate NKT activity
Sylvia Faict1, Mérédis Favreau1, Elke De Bruyne1, Kim De Veirman1, Ken
Maes1, Karin Vanderkerken1, Rik Schots2 and Eline Menu1
1Haematology and Immunology Lab, Vrije Universiteit Brussel, Brussels,
Belgium; 2Department of Clinical Haematology, UZ Brussel, Brussels, Belgium
Introduction: Multiple myeloma (MM) is associated with an increase
in immune suppression. Our lab has focused on the role of invariant
natural killer T (iNKTs) in this immune suppression. A decline in
iNKT cell activity was previously demonstrated, leading to a defective
immune response to the myeloma cells. NKTs can be activated by
alfa-galactosylceramide (aGC) when presented by dendritic
cells (DCs).
Stimulation by these DCs induce a strong Th1 response, however clinical
trials have been disappointing. One of the reasons is that aGC stimula-
tion leads to such strong iNKT activation that they rapidly become
anergic, hindering repeated stimulation.
Here we try to overcome this anergy by using small extracellular vesicles
(sEVs) secreted by DCs loaded with aGC. sEVs derived from DCs
contain the CD1d molecule, and may, in this way, also present aGC to
iNKT cells, resulting in their activation.
Methods: For these experiments we use the 5T33MM model which
is immunogenic and represents the human disease closely. DCs were
derived from the bone marrow of naive mice and cultured for seven
days before adding aGC. sEVs were isolated from the conditioned
medium of 60 million DCs. The presence of CD1d positive sEVs was
confirmed by Western Blot and TEM. In vitro properties were
assessed by co-culturing the isolated sEVs with DCs and/or 2C12
cells (an iNKT hybridoma line), and measuring the IL-2 response.
Unfortunately, aGC-loaded sEVs induced no clear activation of the
iNKTs. Nevertheless, when injected intravenously, these sEVs did
elicit an IFNy response. When 5T33MM mice were treated again
seven days later, the aGC loaded sEVs produced a lasting response
in contrast to the aGC loaded DCs which resulted in iNKT anergy.
This sustained iNKT response translated into an anti-tumour effect in
the 5T33MM mice.
Conclusion: sEVs derived from DCs can be loaded with aGC and induce
an IFNy response from iNKT cells without inducing anergy in vivo,
resulting in a reduced MM tumour load.
PF04.04
Exosomes derived from gastric cancer cells activate NF-κB pathway in
macrophages to promote cancer progression
Xu Zhang and Wenrong Xu
Jiangsu University, Jiangsu, China
Exosomes are nano-sized membrane vesicles secreted by both nor-
mal and cancer cells. Emerging evidence indicates that cancer cells
derived exosomes contribute to cancer progression through the
modulation of tumour microenvironment. However, the effects of
exosomes derived from gastric cancer cells on macrophages are not
well understood. In this study, we investigated the biological role of
gastric cancer cells derived exosomes in the activation of macro-
phages. We demonstrated that gastric cancer cells derived exosomes
activated macrophages to express increased levels of proinflamma-
tory factors, which in turn promoted tumour cell proliferation and
migration. In addition, gastric cancer cells derived exosomes
remarkably upregulated the phosphorylation of NF-κB in macro-
phages. Inhibiting the activation of NF-κB reversed the upregulation
of proinflammatory factors in macrophages and blocked their pro-
moting effects on gastric cancer cells. Moreover, we found that
gastric cancer cells derived exosomes could also activate macro-
phages from human peripheral blood monocytes through the activa-
tion of NF-κB. In conclusion, our results suggest that gastric cancer
cells derived exosomes stimulate the activation of NF-κB pathway in
macrophages to promote cancer progression, which provides a
potential therapeutic approach for gastric cancer by interfering
with the interaction between exosomes and macrophages in tumour
microenvironment.






























TGF-β1-silenced leukaemia cell-derived exosome-targeted dendritic
cells induce stronger anti-leukaemic immunity
Siguo Hao, Fang Huang and Jiangbo Wan
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of
Medicine, Shanghai, China
Tumour-derived exosomes, which could induce a specific antitumor
immune response, have been developed as a promising tumour vac-
cine. However, the efficiency of exosomes-based vaccines in clinical
trials has been unsatisfactory. In this study, we investigated whether
DC pulsed with TGF-β1-silenced leukaemia cell-derived exosome
(LEXTGF-β1si) is more immunogenic than DC pulsed with non-mod-
ified leukaemia cell-derived exosome (LEX). We used a lentiviral vector
containing TGF-β1 small hairpin RNA (shRNA) to obtain LEXTGF-β1si.
The prepared LEXTGF-β1si facilitated the maturation of dendritic cells
(DCs) more effectively. Moreover, DCs which pulsed with LEX
（DCLEX-TGF-β1si) promoted more efficiently CD4
+ T cell proliferation
and Th1 cytokine secretion. In addition, DCLEX-TGF-β1si induced a
more potent tumour-specific CD8+ CTL response in vitro. Besides,
we conducted an animal study indicating that DCLEX-TGF-β1si signifi-
cantly inhibited the tumour growth and prolonged the survival time in
tumour-preventive and tumour-protective models. Taken together, our
findings revealed that DCLEX-TGF-β1si induced specific antitumor
immunity effectively, suggesting that the utilisation of DCLEX-TGF-β1si
might be a promising approach to optimised TEX-based tumour
vaccines
PF04.06
Phenotyping and quantification of cascade-primed immune cells
(CAPRI) and their EVs
Evo K. L. Soendergaard, Rikke Baek, Malene M. Jorgensen, Kim Varming and
Lotte H. Pugholm
Department of Clinical Immunology, Aalborg University Hospital, Aalborg,
Denmark
Introduction: Immunotherapies used for cancer treatment are based
on knowledge about the immune cells and their interactions with
tumour cells. However, the exact cellular function of each individual
immune cell subtype in relation to cancer cells are an ongoing
investigation and could be highly influenced by extracellular vesicles
(EVs). EVs have earlier been suggested to play a part in the progres-
sion of pathological conditions such as cancer and have shown to be
involved in a variety of important physiological and immunological
processes. EVs are one of several tools cells use to communicate with
each other. The communication is facilitated by a number of surface-
associated proteins and the cargo of the vesicles. The aim of this
project was to phenotypically characterise the cascade-primed
immune cell (CAPRI) culture used for immunotherapy (1) and their
corresponding EVs and compare them to peripheral blood mono-
nuclear cells and their corresponding EVs from five healthy blood
donors.
Methods: The cells from five healthy blood donors were cultured either
as peripheral blood mononuclear cells or as CAPRI cells. The cells and
the cell culture supernatants were harvested at several different time
points. The cellular phenotype were analysed by flow cytometry while
the EVs were phenotyped (for more than 20 EV markers) and semi-
quantified (CD9, CD63 and/or CD81 positive) using the EV Array
(JEV) (2).
Results: Based on the flow cytometric analysis, it can be concluded that
there is a general change in the composition of T cell subtypes when
peripheral blood mononuclear are cultured as CAPRI cells. Moreover, it
was observed that the amount of T cells was enhanced in these cultures.
Overall, the cellular phenotype show similarities between individuals
whereas the EV phenotypes seem to be more person-to-person affected
even though similarities can be drawn.
Conclusion: These data show a potential for learning more about the
cellular and vesicular communication in the immune system.
References
1. Laumbacher B et al., Scand J Immunol. 2012; 75: 314–328.
2. Jørgensen M et al., J Extracell Vesicles 2013; 2: eCollection 2013.
PF04.07
Ovarian tumour cells suppress antitumor immune response through
the release of arginase-1-containing exosomes
Malgorzata Czystowska-Kuzmicz1, Marta Szajnik1,2, Kavita Ramji1, Dominika
Nowis1,3,4, Slawomir Gruca1, Artur Stefanowicz5 and Jakub Golab1
1Department of Immunology, Centre of Biostructure Research, Medical
University of Warsaw, Poland; 2Department of Gynaecology and
Gynaecologic Oncology, Military Institute of Medicine, Warsaw, Poland;
3Genomic Medicine, Medical University of Warsaw, Poland; 4Laboratory of
Experimental Medicine Centre of New Technologies University of Warsaw,
Poland; 5Department of Gynecology and Obstetrics, “Praski” Hospital,
Warsaw, Poland
Introduction: Arginase-1 (Arg-1) is a cytosolic enzyme catalysing degrada-
tion of the semi-essential amino acid L-arginine. Abundant Arg-1 has been
detected in either tumour cells or in tumour-infiltrating myeloid cells and
correlates with depletion of L-arginine and consequent suppression of
antitumor immunity. Here we report that OvCa cells release Arg-1 in
tumour-derived exosomes (TEX) and investigate the influence of TEX-
derived Arg-1 on the antitumor effector mechanisms of immune response.
Methods: TEX were isolated by ultracentrifugation or exclusion chro-
matography and verified by Western blotting, NanoSight and electron
microscopy. The presence and activity of Arg-1 in TEX was determined
by Western blotting and arginase activity assay. Immunohistochemical
Arg-1 expression in primary OvCa were correlated to clinico-pathologi-
cal characteristics. Effects of exosomal Arg-1 on immune cells were
analysed by in vitro proliferation assay and flow cytometry.
Results: Enzymatically active Arg-1 was detected in TEX derived from
patients’ ascites as well as from ovarian cancer cell lines. OvCa ascites
contained higher levels of exosomal Arg-1 compared to fluids obtained
from benign ovarian cysts. High Arg-1 expression in primary lesions
correlated negatively with intratumoral T-cell infiltrates and CD3-zeta
expression and was associated with shorter time to recurrence (TTR). In
vitro, OvCa-derived Arg-1-positive TEX (Arg1-TEX) inhibited CD8+
and CD4+ T-cell proliferation and decreased T-cell receptor expression.
Co-culture of bone-marrow-derived dendritic cells (DC) with Arg1-TEX
resulted in the transfer of functionally active Arg-1 and inhibition of
DCs-primed proliferation of OVA-antigen specific OT-I T cells. All
these in vitro effects were reversed by a novel Arg-1 inhibitor.
Conclusion: Our findings provide the first evidence for the role of Arg-1
in the formation of an immunosuppressive microenvironment in OvCa.
We identify a novel mechanism of exosomal Arg-1 distribution from the
tumour cells to antigen presenting cells. Inhibition of Arg-1 activity may
be an attractive novel anti-cancer strategy.
Funding: National Science Centre – OPUS 6 Programme 2013/11/B/
NZ6/02790, National Centre for Research and Development –
STRATEGMED2/265503/3/NCBIR/15.
PF04.08
Natural killer extracellular vesicles: a functionally relevant and
measurable surrogate of the natural killer activity in cancer patients
Veronica Huber1, Cristina Federici2, Elisabetta Iessi2, Serena Cecchetti2,
Simona Ferro1, Agata Cova1 and Luana Lugini2
1Fondazione IRCCS Istituto Nazionale dei Tumori; 2Istituto Superiore di
Sanità
Introduction: Natural killer (NK) cells belong to the innate immunity,
represent the first-line defence in the control of tumour growth and are
key players in immunosurveillance. Defective NK activity is associated
with and increased risk to develop cancer. NK cells release extracellular
vesicles (EVs) endowed with cytotoxic activity against tumour cells.
Their anti-tumour effects appeared to be mediated by a surface-to-





























surface interaction and also by internalisation of EVs by the tumour
cells. The killer molecules carried by NK EVs included FasL and per-
forin. NK EVs, detectable in plasma, could thus represent a functionally
relevant and measurable surrogate of NK activity in cancer patients.
Methods: We developed an ad hoc exosome-immune enzymatic test
(NKExoELISA) to study the phenotype of plasmatic NK EVs. This test
measures the expression of exosome markers concomitantly with typical
NK markers and results were confirmed by Western blot and flow
cytometry analysis. NK EVs, isolated from NK cell conditioned media,
were also immunoassayed by Cytometric Bead Array. The functionality
of identified molecules was evaluated by tests of cell death induction,
proliferation and activation in flow cytometry.
Results: NKExoELISA can discriminate and measure NK EVs, identified
as exosomes, among the vesicles present in human plasma of both
healthy donors and cancer patients, based on their concomitant expres-
sion of tsg-101/CD9 and CD56/NKG2D. Apart from FasL and perforin,
NK EVs carry TRAIL, IFN gamma, IL-2 and marked amounts of
granzyme B. The expression of CD62L suggests that NK EVs possess
the potential to home to sites of injury and inflammation, such as
cancer. The cytotoxic potential, measured by AnnexinV and propidium
iodide, correlated with concentration of FasL and granzyme B carried by
EVs. Co-culture of NK EVs with PBMCs from healthy donors induced
rosette-forming cells, typical signs of proliferation.
Conclusion: Our results suggest that NK EVs may represent a measur-
able surrogate of NK cell activity in plasma. NK EVs exhibit a rich
equipment of killer molecules and appear to possess immunostimulating
activities. This could be potentially exploited to revive the anergic status
of anti-tumour immunity, commonly observed in cancer patients.
PF04.09
Heparan sulphate proteoglycans as regulators of exosome-induced
stromal cell differentiation
Alexandra Shephard1, Zsuzsanna Tabi1, Aled Clayton2 and Jason P. Webber1
1Cardiff University, Cardiff, United Kingdom; 2Division of Cancer and
Genetics, School of Medicine, Cardiff University and Velindre Cancer
Centre, Cardiff, United Kingdom
Introduction: We have shown that prostate cancer exosomes trigger
fibroblast differentiation to a disease-supporting myofibroblast pheno-
type, and have implicated heparan sulfate proteoglycans (HSPGs) in this
process. Here we characterise HSPGs present on prostate cancer exo-
somes and further explore the role of exosomal-HSPGs in regulation of
fibroblast differentiation.
Methods: A lentiviral-based shRNA approach was used to selectively
knockdown HSPGs in prostate cancer cells. Exosomes were isolated by
flotation and characterised by nanoparticle tracking, western blot and
plate-based assays. Fibroblasts were stimulated with exosomes, and dif-
ferentiation to a myofibroblast phenotype was determined by the onset
of α-smooth muscle actin (αSMA).
Results: Exosomes from different prostate cancer cell lines express vari-
able levels of TGFb, which correlate with expression of HSPGs on the
exosome surface. TGFb-high exosomes express syndecan 3, syndecan 4,
glypican 1, glypican 6 and betaglycan. We have generated prostate
cancer cell lines that secrete exosomes lacking specific HSPGs. These
HSPG-deficient exosomes show a reduced ability to drive fibroblast
differentiation.
Conclusion: Exosomal, not soluble, delivery of TGFβ is essential for
generating a disease-like stroma. This exosome function is dependent
on HSPGs, such as betaglycan, present on the exosome surface.
Exosomal-HSPGs may therefore represent novel targets for attenuating
tumour growth.
PF04.10
Exosomes derived from mesenchymal stem cells promotes bone
regeneration in hyperhomocysteinemia mice
Jyotirmaya Behera, Yuankun Zhai, Akash K. George, Suresh C. Tyagi and
Neetu Tyagi
University of Louisville, KY, USA
Introduction: It is critical that bone formation and angiogenesis are tightly
coordinated during bone regeneration, but the molecular regulator of
such intercellular communication in bone microenvironment is not well
studied. Cystathionine-β-synthase (CBS), an enzyme in homocysteine
metabolic pathway, plays an important role in osteoblast differentiation.
Therefore, we hypothesise that CBS as a novel molecular regulator in
mesenchymal stem cell derived osteoblasts, which regulates vascularisa-
tion during bone development in osteoblast derived exosomes.
Methods: To test this hypothesis, we used 12 weeks old male mice in our
study, including wild type mice (C57BL/6, WT) and CBS± mice. Bone
regeneration was evaluated by microCT and angiogenesis assay.
Results: Blocking the CBS function by either inhibitor hydroxylamine (HA)
prevented osteoblast differentiation andmineralisation. This was supported
by studies using osteoblasts cultured from bone marrow of CBS deficient
(CBS±) mice. Exosomes of mesenchymal stem cell derived osteoblasts
cultured stimulated endothelial migration and angiogenesis, which was
prevented by blocking CBS in osteoblasts using HA. Mass spectrometry
analysis and ELISA assay identified among others vascular endothelial
growth factor (VEGF)-A and VEGF homologue placental growth factor
(PIGF) to be present in CBS(+/+) mice osteoblasts but not in CBS±
osteoblasts. Metatarsal angiogenesis assay showed retarded vascularisation
in bone tissue of CBS±mice. CBS±mice showed significantly reduced bone
mineral density (BMD) and bone volume/tissue volume (BV/TV) by
microCT and showed increased plasma homocysteine levels compared to
CBC+/+mice (WT). Furthermore, real-time PCR and western blot analyses
revealed significant decreases Alkaline phosphatase (ALP) and Runt-related
transcription factor 2 (RUNX2) and Osteocalcin (OCN) expression in CBS-
deficient (CBS±) mouse bone marrow cells.
Conclusion: We demonstrate that CBS in mesenchymal stem cell derived
osteoblasts is at the crossroad of osteoblast differentiation/mineralisation
and angiogenesis. These findings uncover previously undefined molecu-
lar understanding of CBS that promote angiogenesis and osteogenesis in
bone development and regeneration.
PF04.11
Exosomes from mutant KRAS colorectal cancer cells reprogram the
metabolic state of recipient cells
Qin Zhang, Dennis Jeppesen, James Higginbotham, Henry Manning, Jeffrey
Franklin and Robert Coffey
Vanderbilt University Medical Center, TN, USA
Mutant KRAS colorectal cancer (CRC) cells exhibit increased aerobic glyco-
lysis with elevated levels of the glucose transporter SLC2A1 (hereafter
GLUT1). Whether mutant KRAS cells alter the metabolic state of the tumour
microenvironment is unknown. Herein, we show mutant KRAS CRC cells
(DLD-1 and DK0-1), compared to their isogenically matched wild-type
KRAS counterparts (DKs-8), release exosomes containing increased func-
tional GLUT1 as determined by 18F-fluorodeoxyglucose (FDG) uptake.
Exosomes released from GLUT1 knockdown DLD-1 cells exhibit dramati-
cally reduced FDG uptake, demonstrating that GLUT1 is the major glucose
transporter in these cells. In addition, we show that mutant KRAS-derived
exosomes induce cellular metabolic changes in recipient cells, including
enhanced glucose consumption and increased glycolysis, as determined by
an increased NADH to FAD ratio. Systemic delivery of mutant KRAS
exosomes also enhances glutamate/cystine exchange in ApcMin/+ colonic
tumours, using a novel PET tracer, 18F-FSPG. Thus, CRC cells with activating
KRASmutations may alter the metabolic state of recipient cells via exosomes
containing high levels of GLUT1, a process that may nourish the tumour
microenvironment and fuel tumour progression.
PF04.12
Extracellular vesicles released following heat stress induce bystander
effects in unstressed populations
Findlay R. Bewicke-Copley1, Laura A. Mulcahy2, Laura A. Jacobs3, Priya
Samuels1, Ryan C. Pink1 and David R.F. Carter1





























1Oxford Brookes University, Oxford, United Kingdom; 2Ashfield Healthcare
Communications; 3Technical University of Munich, Munich, Germany
Introduction: The bystander effect is a phenomenon where the effects of
stress occur in naïve cells through signalling from nearby stressed cells.
We previously showed that bystander effects induced by ionising radia-
tion are mediated by extracellular vesicles (EVs). Bystander effect can
also be induced by other types of stress, including heat shock, but it is
unclear whether EVs are involved.
Methods: Cells were heat shocked at 45°C and 24 h later EVs were
extracted from the cell culture medium using ultracentrifugation.
These EVs were then used to treat cells naïve to the stress conditions.
Cells were incubated with EVs for a further 24 h before being assayed for
DNA damage, Apoptosis and Cell viability using the Comet assay,
nuclear fragmentation assay and MTT assay respectively.
Results: Here we show that EVs released from heat shocked cells are also
able to induce bystander damage in un-stressed populations. Naïve cells
treated with media conditioned by heat shocked cells showed higher
levels of DNA damage and apoptosis than cells treated with media from
control cells. Treating naïve cells with EVs derived from media condi-
tioned by heat shocked cells also induced a bystander effect when
compared to control, with DNA damage and apoptosis increasing whilst
the level of cell viability was reduced. We demonstrate that treatment of
naïve cells with heat shocked cell-derived EVs leads to greater invasive-
ness in a trans-well matrigel assay. Finally, we show that naïve cells
treated with EVs from heat-shocked cells are more likely to survive a
subsequent heat shock, suggesting that these EVs mediate an adaptive
response.
Conclusion: We propose that heat shock causes the release of a sub-
population of EVs from cells that leads to apparent stress in neighbour-
ing cells but also greater robustness in the face of a subsequent insult.
PF04.13
Galectin-3 binding protein present at the surface of tumour exosomes
contributes to their capture by stromal cells
Rie Nakata1, Laurence Sarte1, Pascale Zimmermann2 and Yves A. DeClerck3
1Children’s Hospital Los Angeles, CA, USA; 2University of Marseille,
Marseille, France; 3University of Southern USA
Introduction: Galectin-3 binding protein (Gal-3BP/LGALS3BP aka:
MAC2-binding protein) is a 90 kDa secreted sialoglycoprotein that is
commonly present in the cargo of exosomes and is among the 25
common cancer proteins associated with extracellular vesicles (EVs)
secretion in all NCI-60 cancer cell lines (1). Here we have examined
its presence and function in exosomes from human neuroblastoma cells
that we had previously reported to secrete Gal-3BP (2).
Methods: The expression of Gal-3BP was examined in exosomes from
10 human NB cell lines by western blot analysis. Exosomes were
prepared by differential ultracentrifugation (DUC), Optiprep density
gradient centrifugation (ODGC) and size exclusion chromatography
(SEC). Gal-3BP localisation in cells and exosomes was performed by
confocal microscopy, flow cytometry and electron microscopy. Its role
in exosome biogenesis and capture by stromal cells was examined in
NB cells in which the LGAL3SBP gene was removed by CRISPR-Cas9
knock out.
Results: Gal-3BP was consistently present in all preparations of exo-
somes obtained from 10 NB cell lines. It was also present in exosomes
from the plasma of patients with NB. It was consistently associated with
exosome protein markers like CD-63, syntenin and ALIX in exosomes
obtained by DUC, ODGC and SEC, in addition to being present in a
soluble form in the culture medium of NB cells. However in NB cells
Gal-3BP was clearly segregated from CD-63, suggesting its absence in
mulitivesicular bodies and an absence of involvement in exosome bio-
genesis. This was further supported by the demonstration that syntenin
knock down in NB cells did not affect the presence of Gal-3BP in
exosomes. We then demonstrated by a combination of flow cytometry
and enzymatic digestion, that Gal-3BP is present on the surface of
exosomes. To better understand its function, LGALS3BP was knocked
out in NB cells. Whereas Gal-3BP KO did not affect the production of
exosomes in NB cells, it inhibited their capture by stroma cells.
Conclusion: Our data bring insight into the function of a protein
commonly identified in the cargo of cancer cell exosomes, suggesting
an absence of involvement in exosome biogenesis and a role in exosome
uptake by stromal cells.
References
1. Hurwitz et al., Oncotarget 2016; 7: 86999–87015.
2. Silverman et al., Cancer Res. 2012; 72: 2228–2238.
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PF05.01
Human podocyte microparticles impair proliferation of proximal
tubule epithelial cells
Suzy Sun1, Mercedes Munkonda1, Eldjonai Kamto1, Christopher Kennedy1
and Dylan Burger2
1Kidney Research Centre, Ottawa Hospital Research Institute, Ottawa,
Canada; 2Kidney Research Centre, Ottawa Hospital Research Institute,
University of Ottawa, Canada
Introduction: Tubular injury is a major pathogenic component of
advanced chronic kidney disease. Repair following tubular injury is
heavily dependent on proximal tubule epithelial cell (PTEC) prolifera-
tion. Our lab recently reported formation of microparticles (MPs) from
glomerular epithelial cells (podocytes) and release into the urine in
animal and human diabetes. In the present study we examined the effect
of podocyte MPs on PTEC proliferation and examined the role of cell
cycle inhibitory proteins and tumour suppressors in this process.
Methods: MPs were isolated from media of human podocyte (hPod)
cultures by differential centrifugation. PTECs were treated with 10 μg/
mL of isolated hPod MPs for 24 hrs. Proliferation was quantified by cell
counting, and BrdU incorporation. Proteins associated with cell cycle
arrest (p21, p27, p53), and DNA replication (proliferating cell nuclear
antigen, PCNA) were analysed by western blot.
Results: After 24 hrs, PTECs treated with hPod MPs exhibited signifi-
cantly lower cell viability compared to untreated PTECs (~73% reduc-
tion, p = 0.0054). A BrdU proliferation assay showed a 69% reduction in
absorbance of BrdU in MP-treated PTECs
Conclusion: MPs isolated from hPods inhibit PTEC proliferation, how-
ever the mechanism of action requires further investigation.
Nevertheless our data suggest that podocyte MPs may contribute to
kidney injury by inhibiting the tubular repair process.
PF05.02
Carbon dioxide-induced oxidative stress: microparticle production
and inflammasome activation by neutrophils are linked
Stephen R. Thom, Veena Bhopale and Ming Yang
University of Maryland School of Medicine, MD, USA
Introduction: We hypothesised that elevations of carbon dioxide (CO2)
often found in modern buildings will stimulate leukocytes to produce
microparticles (MPs, 0.1–1 µm diameter, annexin V-positive) and acti-
vate the nucleotide-binding domain-like receptor 3 (NLRP3) inflamma-
some due to mitochondrial oxidative stress.
Methods: Human and murine leukocytes were exposed ex vivo in buffer
equilibrated with air plus CO2 at 0.1–1% and the buffer and cells
separated for flow cytometer MPs analysis and biochemical assays.
Results: Neutrophils, but not monocytes, generate MPs with high inter-
leukin-1β (IL-1β) content after 30 or more minutes exposure to air + 0.1–
0.4% CO2. Enhanced MPs production requires mitochondrial reactive
oxygen species production (assessed with MitoSOX red), mediated by
activities of pyruvate carboxylase and phosphoenolpyruvate carboxykinase
(verified with small inhibitory RNA knock-down). Events leading to MPs
generation include perturbation of inositol 1,3,5-triphosphate receptors, a
transient elevation of intracellular calcium, activation of protein kinase C
and NADPH oxidase. Concomitant activation of type-2 nitric oxide
synthase yields secondary oxidants resulting in actin S-nitrosylation and
enhanced filamentous actin turnover. Proteins are linked to short fila-
mentous actin, including vasodilator-stimulated phosphoprotein, focal
adhesion kinase, the phospholipid translocation enzymes flippase and
floppase, and the critical inflammasome protein Apoptosis-associated
Speck protein with CARD domain (ASC). Oligomerisation of the
inflammasome components ASC, NLRP3, caspase 1, thioredoxin interact-
ing protein and calreticulin lead to IL-1β synthesis.
Summary: An increased production rate of MPs containing elevated
amounts of IL-1β persists for hours after short-term CO2 exposures.
Mean CO2 levels in many modern buildings exceed 0.1%. The so-called
“sick building syndrome” is without clear pathophysiology and MPs
ladened with IL-1β may play a role.
PF05.03
Exosomal miR-185-5p modulates ADAMTS13 transcription in liver
fibrosis
Qinqin Xiang, Yuanyuan Fu, Yi Ma, Fen Xu, Wen Chen and Zhou Zhou
State Key Laboratory of Cardiovascular Disease, Beijing Key Laboratory for
Molecular Diagnostics of Cardiovascular Diseases, Diagnostic Laboratory
Service, Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese
Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Metalloproteinase ADAMTS13, which is mainly derived from hepatic
stellate cells (HSCs), speciﬁcally cleaves multimeric VWF to regulate
thrombi formation. Recent studies have shown that miRNAs actively
regulated the transcription of ADAMTS family proteins. Exosomes, a
small vesicle known to mediate intercellular communication by deliver-
ing nucleic acids and proteins, draws our attention because of its ability
in packaging miRNAs and protecting them from degradation. To further
understand the underlying mechanisms of ADAMTS13 production and
provide insights into the molecular mechanisms of coagulation function
disorder in liver fibrosis, we focused on the regulation of ADAMTS13
transcription by exosomal miRNAs in both liver fibrotic mouse model
and primarily cultured HSCs. To induce liver fibrosis, CCL4 was deliv-
ered intraperitoneally into male Swiss Webster three times per week for
5 weeks, with Olive oil used as vehicle control. Primary HSCs were
isolated by in situ enzymatic dissociation and density gradient centrifu-
gation from livers of Swiss Webster male mice. Candidate miRNA miR-
185-5p was predicted to bind ADAMTS13 3ʹ-UTR to regulate its tran-
scription based on microRNA.org database. We observed that
ADAMTS13 levels was down-regulated while miR-185-5p was up-regu-
lated in the livers fibrosis mouse model or in activated primary mouse
HSC, which further confirmed that miR-185-5p was associated with the
down-regulation of ADAMTS13. ISH, luciferase assay and mimic, inhi-
bitor transfection experiment demonstrated that miR-185-5p can target
ADAMTS13 3ʹ-UTR to regulate its transcription. The exosomes was
isolated from medium or peripheral blood using ExoQuick kit, which
were bi-membrane vesicles, 50–150 nm nanoparticles under transmis-
sion electron microscopy, and positive for flotilin and CD9. miR-185-5p
was present in both mouse plasma and HSC exosomes. We observed
that miR-185-5p was up-regulated in the exosomes derived from plasma
of fibrosis mouse model. The transfer of Exosomes transfected with
miR-185-5p mimics to quiescent HSC lead to the down-regulation of
ADAMTS13 in target cells. Accordingly, exosomal transfer of miR-185-
5p may be a paradigm for the regulation of ADAMTS13 transcription.
PF05.04
Effects of human and porcine mesenchymal stem cell-derived
conditioned media on coagulation and T-cell function
Arezoo Mohammadipoor1, Ben Antebi1,2, Teryn R. Roberts1, Kerfoot P. Walker1,
Robbie K. Montgomery1, Andriy I. Batchinsky1,3 and Leopoldo C. Cancio1
1United States Army Institute of Surgical Research, TX, USA; 2ZCore
Business Solution; 3The Geneva Foundation, WA, USA
Introduction: Systemic administration of mesenchymal stem cells
(MSCs) is associated with several potential health risks. MSCs have
been shown to protect injured tissue, in part, by secretion of a large





























variety of bioactive factors and extracellular vesicles (EVs); thus, cell-free
products from MSCs are becoming more attractive candidates. In cell
culture, these mediators are found in conditioned media (CM). We
hypothesised that CM are safe for clinical application by evaluating the
thrombogenicity and immunomodulatory potential of CM in vitro.
Methods: To obtain CM, human and porcine bone marrow-derived
MSCs were incubated with serum-free medium. After 24 h, supernatant
was collected and cells were removed by centrifugation.
Thrombogenicity of CM was tested by thromboelastography (TEG).
Whole blood from healthy human and porcine donors was mixed with
CM at different ratios (CM: blood ratios of 1:1, 1:2.5, 1:5, 1:10, n ≥ 3). To
study the immunomodulatory effect of CM, mononuclear cells (MNCs)
derived from healthy donors were labelled with a proliferation dye and
stimulated to induce T-cell proliferation. MNCs were then plated with
MSCs or CM in triplicates. After 72 h, T-cells were collected and
assessed by flow cytometry.
Results: We observed that porcine CM significantly accelerated the
initiation of clot formation (R) in a dose-dependent manner. Porcine
CM also increased the rate (K, α-angle) of early clot formation related to
rapid fibrin accumulation. In addition, porcine CM increased the clot
strength (MA). By comparison, only the highest dose of human CM
(1:1) significantly reduced the R value. However, neither K, α-angle, nor
MA were affected by human CM at any ratio. MSCs reduced T-cell
proliferation via cell-cell contact, yet CM did not generate the same
effect.
Conclusion: In this study, we developed an in vitro method to evaluate
thrombogenicity of CM. Our results suggest that in a porcine model, but
not human, a pro-coagulant effect occurs. However, further studies are
required to determine if this response is repeated in vivo. Also, the fraction
of CM, EVs or EV-free CM, responsible for this effect remains to be
elucidated. While the CM did not inhibit T-cell proliferation, it remains
to be seen whether the EV fraction will produce the same results.
PF05.05
Circulating exosomes attenuate hepatic stellate cell activation and
are anti-fibrotic in vivo
Li Chen1, Ruju Chen1, Sherri Kemper1 and David Brigstock1,2
1The Research Institute at Nationwide Children’s Hospital, Columbus, OH,
USA; 2Department of Surgery, The Ohio State University, Columbus, OH, USA
Introduction: Exosomes are nanovesicles produced by many cells which
contain a complex molecular cargo that can be delivered to target cells to
cause functional re-programming. This study investigated if hepatic
stellate cells (HSC) are regulated by circulating exosomes. HSC are the
principal fibrosis-producing cells of the liver, undergoing a process of
activation by which they become collagen-producing αSMA-positive
myofibroblasts. Fibrosis is a major pathological feature of chronic liver
disease that affects individuals globally but lacks FDA-approved
therapeutics.
Methods: Exosomes were purified by ultracentrifugation from the serum
of healthy or fibrotic Swiss Webster male mice, or of healthy human
male donors, and characterised by nanoparticle tracking analysis, TEM
and western blot. The function of exosomes was tested by their effect on
(i) activation in primary cultures of mouse HSC, or (ii) CCl4-induced
liver injury in mice.
Results: Isolated exosomes from mice or human sera were bi-membrane
vesicles, 80–150 nm in diameter, and positive for CD81 and flotillin-1.
Exosomes (10 μg/ml) from the serum of healthy mice caused decreased
connective tissue growth factor (CTGF), αSMA or collagen α1(I) mRNA
levels after treatment of D9 (activated) primary HSC for 24 h (p < 0.01),
whereas gene expression was not diminished by serum exosomes from
fibrotic mice. The same dose of serum exosomes from healthy human
blood donors (22–27 yo) attenuated collagen expression after treatment
of human LX2 HSC for 36 hrs (p4 injury model in male transgenic mice
expressing GFP under the control of the CTGF promoter, liver fibrogen-
esis (assessed by hepatic GFP or αSMA expression) was attenuated by i.
p. administration (40 μg/g q.o.d.) of serum exosomes from healthy mice,
but not from fibrotic mice (p < 0.01). In 5-wk CCl4 fibrosis models, i.p.
administration of serum exosomes (40 μg/g q.o.d.) from healthy mice
during the last 2 wks of CCl4 treatment caused a dose-dependent
decrease in hepatic GFP-CTGF production. This was associated with
decreased expression of CTGF, αSMA or collagen, as well as suppressed
fibrosis.
Conclusions: These studies show that circulating exosomes from healthy
individuals are instrinsically anti-fibrotic and offer a new lead for ther-
apy of liver fibrosis.
PF05.06
Interplay of RANTES chemokine and CCR5+ bearing microvesicles in
diabetic retinopathy
Aleksandra Tokarz1, Anna Elżbieta Drożdż2, Iwona Szuścik3 and Ewa
Stępień2
1Department of Clinical Biochemistry, Jagiellonian University Medical College,
Krakow, Poland; 2Department of Medical Physics, Faculty of Physics,
Astronomy and Applied Computer Science, Jagiellonian University, Krakow,
Poland; 3Private Ophthalmology Practice, OKO-LASER Outpatient Clinic
Introduction: RANTES (regulated on activation, normal T-cell expressed
and secreted), otherwise known as CCL5, belongs to the C-C family of
chemokines, secreted by T cells, macrophages, platelets and certain types
of cancer. Among different receptors, the main one is the G-protein-
coupled CCR5, which was documented on membrane derived micrve-
sicles (MVs). In patients with diabetes mellitus (DM), it was observed
that the number of mesenchymal and monocyte origin MVs is higher in
those with microangiopathies. It was also observed that the number of
platelet and monocyte origin MV gradually increases with the severity of
non-proliferative diabetic retinopathy (NPDR) to the prolifera-
tive (PDR).
Methods: Total 61 DM patients (63 [59–68] y.e.) and 25 control subjects
(50 [45–56] y.e.) were included to the study. The diagnosis and classi-
fication of retinopathy were carried out on the basis of the Polish
Diabetes Association recommendations (2016). Finally, among exam-
ined DM patients 7 had soft non-proliferative diabetic retinopathy
(SNPDR), 5 had moderate non-proliferative (MNPDR), 13 had heavy
non-proliferative (HNPDR) and 6 had PDR. MVs profiling (CCR5+) in
plasma was performed by means of Gigamix (BioCytex) calibrated
CytoFLEX (Beckman Coulter). This study has permission of the
Bioethical Committee of Jagiellonian University (KBET/206/B/2013)
Results: RANTES concentration was significantly elevated in DM
patients with compere to healthy control, in plasma and in MV fraction
(15.5 [9.7–18.1] vs. 8.9 [0.9–14.6] µg/mL, p = 0.011 and 14.9 [8.9–17.8]
vs. 6.7 [0.9–14.1] µg/mL, p = 0.028). Higher concentrations of RANTES
MV fraction were observed in the HNPDR group (p = 0.041). Total
number of CCR5+ MV was significantly lower in DM patients with
compare to control (62 (21–185) vs. 108 (49–293) n/µL, p = 0.049).
Interestingly, HNPDR was characterised with the higher number of
CCR5+ MVs in compare to PDR and other forms of NPDR.
Conclusion: Correlation between NPDR retinopathy progression and the
RANTES axis was proven. The increased number of CCR5+ MVs
observed in HNPDR patients, it suggests pro-angiogenic activity of
MVs in the advanced stage of non-proliferative DR.
Funding: This study was supported by the Polish National Science
Centre grant (2012/07/B/NZ5/02510).
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Characterisation of microRNA-containing extracellular vesicles
secreted by bronchial epithelial cells in allergic airway inflammation
Sabine Bartel1, Jochen Behrends1, Andrea Schamberger2, Oliver Eickelberg2
and Susanne Krauss-Etschmann3
1Research Centre Borstel, Leibniz Centre for Medicine and Biosciences,
Member of the German Centre for Lung Research (DZL), Germany;
2Comprehensive Pneumology Centre, Institute of Lung Biology and
Disease, Member of the German Centre for Lung Research (DZL),
Helmholtz Zentrum München, Germany; 3Division of Experimental
Asthma Research, Research Centre Borstel, Leibniz-Centre for Medicine
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Background: microRNAs (miR) are critical regulators of signalling path-
ways and have been shown to be essential for the development both of
the immune system and the lung. miRNAs have also been shown to be
secreted into extracellular vesicles (EV) for inter-cell communication (1).
In previous work, we identified an up-regulation of miR-17 and -21 in
lung homogenate of mice upon ovalbumin (OVA) induced allergic air-
way inflammation (AAI).
Objective: To assess if miR-17 and -21 are secreted into EVs in murine
AAI and human bronchial epithelial cells.
Methods: EVs were isolated from broncho-alveolar lavage fluid (BALF)
from mice with OVA- or house dust mite (HDM) induced AAI. Primary
normal human bronchial epithelial (NHBE) cells (Lonza, Switzerland)
were cultured at the air-liquid interface and treated with Interleukin (IL)
13 to model a T-helper 2 environment. EVs were isolated by Exoquick-TC
(System Biosciences, USA) or qEV columns (Izon Science, UK) from
BALF or basal culture medium/apical surface wash of NHBE cultures
and characterised by pure or bead-based flow cytometry and western blot
for CD63, HLA-DR, HSP70. miRNA levels were assessed by qRT-PCR.
Results: In both murine models for AAI, miR-17 and -21 were signifi-
cantly up-regulated in isolated BALF EVs, while numbers of CD63+ EV
were similar. In human primary NHBE cells, CD63+ EVs were found in
both the apical surface wash as well as the basal culture medium. and
EVs from both compartments were positive for HSP70 and HLA-DR,
while secretion patterns changed with IL13 treatment. After 24 h of IL13
treatment, miR-17 (transiently) and miR-21 levels were increased in the
basal cell compartment and after 7 d on the apical surface.
Conclusion: miRNA-containing EVs are secreted upon IL13 treatment
of primary NHBE cells and contain more miR-17 and -21 in BALF of
murine AAI. Thus, we speculate that early miRNA secretion via EVs
might be involved in the development of allergic airway inflammation.
Currently, we are profiling miRNAs in EVs from primary NHBE cells to
investigate differences in apical and basal EV populations.
Reference
1. Valadi et al., Nat. Cell Biol. 2007; 9: 654–659.
PF05.08
IgM rheumatoid factor present on circulating extracellular vesicles
obtained from rheumatoid arthritis patients can result in false
positive immunoassays
Onno Arntz, Bartijn Pieters, Rogier Thurlings and Fons van de Loo
Radboudumc
Purpose: Rheumatoid arthritis (RA) is a systemic disease with autoanti-
bodies in the circulation. In this study we investigated whether auto-
antibodies such as rheumatoid factor (RF) interfere with the detection of
cytokines on plasma extracellular vesicles (pEVs) isolated from RA
patients.
Methods: pEVs were obtained from 32 RA patients and 35 healthy
controls (HC) by size exclusion chromatography. Protein content was
measured by micro-BCA, size and concentration by Nanoparticle
Tracking. TNFα, IL-1β and IL-6 were detected by bead-based multiplex
immunoassays (Luminex). TNFα was also detected by flowcytometry
(FC) and to control for specificity pEVs were preincubated with anti-
TNFα antibodies of a different isotype (Enbrell and Humira). IgM-RF
was measured in the pEV isolates by ELISA. RF+ and RF- pEVs were
preincubated with Protein L beads to bind RF-IgM before TNFα was
measured by FC. PKH26 labelled pEVs bound and unbound to protein L
beads were measured in a fluorometer.
Results: Total concentration of pEVs (2.46–4.09 × 1010/ml), particle size
(122–125 nm) and protein per EV particle (71–218 fg) of HC versus RA
was not statistically different. In 13 out of 32 RA patients levels of TNFα,
IL-1β and IL-6 were detectable (220, 18 and 47 pg/ml, respectively) in
pEVs by Luminex while in HC these cytokines were undetectable.
Presence of TNFa on RA-pEVs was confirmed by FC and preincubation
with anti-TNFα completely blocked the signal. Only in the cytokine
positive RA-pEV samples RF-IgM was detectable. More pEVs from RF
+ RA patients bound to protein L beads than RF− patients (8.4 vs. 1.2%).
No TNFα was detectable in pEVs by FC after preincubation with protein
L beads.
Conclusion: This study shows that IgM-RF is present on pEVs isolated
by SEC from RF+ RA patients. The presence of IgM-RF may lead to a
false positive signal in immunoassays and flow-cytometry. We advice to
measure RF in pEV samples and pretreat samples with protein-L when
pEVs will be analysed in immunoassays.
PF05.09
Outer membrane vesicles from Escherichia coli can contribute to
cardiac dysfunction in sepsis
Kyong-Su Park1, Kristina Svennerholm2, Cecilia Lässer1, Ganesh Shelke1,
Rossella Crescitelli1, Su Chul Jang1, Shintaro Suzuki1, Elga Bandeira1,
Charlotta Olofsson3 and Jan Lötvall1
1Krefting Research Centre, Institute of Medicine, University of Gothenburg,
Sweden; 2Anaesthesiology and Intensive Care Medicine, Institute of Clinical
Science, Sahlgrenska Academy, University of Gothenburg, Sweden;
3Department of Neuroscience and Physiology, Sahlgrenska Academy,
University of Gothenburg, Sweden
Introduction: Sepsis is commonly associated with cardiac dysfunction,
which significantly worsens the prognosis seriously for patients. It is
known that Gram-negative bacteria have the capacity to release outer
membrane vesicles (OMVs), which are the bilayered proteolipids with
nano-sized diameters. These OMVs are composed of lipopolysacchar-
ides, outer membrane proteins, and lipids, and can be recognised by the
innate immune system to induce inflammation. The aim of this study is
to determine whether OMVs from sepsis patients can induce cardiac
dysfunction and to elucidate the mechanism involved.
Methods: E. coli was collected from the blood of a patient with urosepsis.
OMVs were isolated from E. coli cultures by ultracentrifugation. OMVs
were analysed by nanoparticle tracking and transmission electron micro-
scopy (TEM). Cell viability, reactive oxygen species (ROS), and cytokine
production were evaluated for cytotoxicity and inflammation in the
cardiac muscle cell (HL-1). To check contractile dysfunction, intracellu-
lar Ca2+ measurements were performed using dual-wavelength ratio
imaging in fura-2 loaded HL-1. Mice were intraperitoneally injected
with OMVs (15 µg), and then sacrificed at 6 h. Innate inflammation
was assessed using quantification of cytokines in the heart lysates and
OMVs proteins were detected by polyclonal anti-OMVs antibody.
Results: The OMVs were characterised by spherical bilayered shape with
diameters of 25–200 nm in TEM. Nanoparticle tracking analysis showed
that the ratio of the particles (× 106) per ng of OMVs proteins was
5.3 ± 0.5. OMVs induced cell death with production of ROS, and
increased slightly the pro-inflammatory cytokines in vitro. Moreover,
HL-1 cells subjected to OMVs displayed irregular Ca2+ oscillations with
a decreased frequency. Using a mouse model, we showed that OMVs
caused a dramatic increased in the production of TNF-α and IL-6, and
delivery of OMVs proteins to the heart was confirmed.
Conclusion: This study shows that septic E. coli OMVs induce cardiac
injury in vitro and in vivo, and can be crucial a causative microbial
signals in septic cardiomyopathy. The role of OMVs in clinical disease
warrant further studies, as bacterial OMVs in addition to live bacteria
may be good therapeutic targets to control the infectious diseases.
PF05.10
Characterisation of exosomal miRNA profiles in patients with sepsis
and septic shock
Marlene Reithmair1, Dominik Buschmann2, Melanie Maerte3, Benedikt
Kirchner2, Daniel Hagl4, Ines Kaufmann4, Alexander Chouker5, Ortrud
Steinlein6, Michael Pfaffl2 and Gustav Schelling5
1Institute of Human Genetics, University Hospital of Ludwig-Maximilians,
University Munich, Munich, Germany; 2Division of Animal Physiology and
Immunology, TUM School of Life Sciences Weihenstephan, Technical
University Munich, Germany; 3Department of Anaesthesiology, University
Hospital, Ludwig-Maximilians-University, Munich, Germany; 4Department
of Anaesthesiology, Neuperlach Hospital, City Hospitals of Munich,
Germany; 5Department of Anaesthesiology, University Hospital, Ludwig-





























Maximilians-University, Munich, Germany; 6Institute of Human Genetics,
University Hospital, Ludwig-Maximilians-University Munich, Germany
Introduction. Septic shock is a medical condition with high mortality
and long-term negative consequences for cognitive and psychosocial
functioning. Pro- and anti-inflammatory responses of the organism are
key mechanisms in this highly lethal disorder. Cell-to-cell communica-
tion within the immune system plays an important role in regulating the
interaction between pathogens and the host immune system. Liquid
biopsies assessing exosomal microRNA (miRNA)-profiles could repre-
sent an important means of deciphering cell-to-cell communication in
sepsis-related states and allow an early diagnosis, as well as the timely
identification of patients at risk for a negative outcome.
Methods. In this study, we characterised blood-derived exosomal
miRNA profiles of sepsis and septic shock patients by next-generation
sequencing. We aimed at identifying differentially regulated miRNAs,
and detecting previously unknown sepsis-associated miRNAs. Informed
consent was obtained and the study was approved by the medical ethics
committee of the University Hospital Ludwig-Maximilians, University of
Munich.
Results. In septic shock, a total of 24 and 34 distinct exosomal miRNAs
were down- and upregulated, respectively. The majority of these differ-
entially regulated miRNAs in exosomes (n = 32) had not previously been
associated with sepsis. RT-qPCR experiments on 8 of these miRNAs
verified all of them except for one. Interestingly, exosome analysis
contributed significant information regarding disease staging and survi-
val prediction. Three miRNAs displayed stringent correlation of expres-
sion levels and disease severity, whereas miR-30a-5p and miR-125b-5p
predicted survival of sepsis patients with high confidence. In silico
analysis highlighted crucial signalling functions of differentially regu-
lated miRNAs in sepsis-relevant pathways including inflammation,
hypoxia signalling and pathogen sensing.
Conclusion. This study established robust miRNA expression profiles in
blood-derived exosomes of sepsis patients, suggesting new avenues for
sepsis research, early sepsis diagnosis, disease staging and survival pre-
diction via liquid biopsy.
PF05.11
Functional properties of lung-tissue derived extracellular vesicles in a
model of asthma
Shintaro Suzuki1, Lilit Hovhannisyan2, Cecilia Lässer1, Kyong-Su Park1,
Yasunari Kishino1, Ganesh Shelke1, Rossella Crescitelli1 and Jan Lötvall1
1Krefting Research Centre, Institute of Medicine, University of Gothenburg,
Sweden; 2Institute of Molecular Biology, Armenian National Academy of
Sciences, Yerevan, Armenia
Introductions: Asthma is a chronic airway disease associated with eosi-
nophilic inflammation. Immune cells such as Th2 lymphocytes play an
important role to aggravate the inflammation by producing multiple
pro-inflammatory cytokines. Multiple Th2 cytokines, including IL-13,
are known to be involved in allergic asthma, and influence airway hyper-
responsiveness and remodelling. Extracellular vesicles such as exosomes
and microvesicles are present in the lungs, but little is known concerning
their biological function in asthma. This study aims is to determine the
effects of EVs on T-cell migration and cytokine release.
Material and methods: Male C57 BL/6 mice were sensitised and exposed
to ovalbumin (OVA). EVs were isolated from lung tissue. EVs were
visualised by electron microscopy and characterised by western blotting,
and particle numbers were acquired by nano-tracking analysis (ZETA
view®). CD4+ T lymphocytes were separated from the spleen of using
magnetic separation. Migration of CD4+ T lymphocytes was performed
using a Boyden chamber assay. The supernatant of cultured CD4+ T
lymphocytes were collected 6 days after re-stimulation of OVA and
treatment with EVs and used for the analysis of cytokine release by
ELISA.
Results: Asthmatic lung EVs dose-dependently induced migration of
CD4+ spleen T lymphocytes (numbers of migrated cells, 1040, 1057,
1525, 2673 (concentration of exosomes – 0%, 0.1%, 1%, 10%), 791, 883,
1354, 1680 (concentration of microvesicles – 0%, 0.1%, 1%, 10%)). EVs
also increased IL-13 release by CD4+ cells, and microvesicles induced
greater cytokine release compared to exosomes, which seemed to be
suppressive (1523 pg/ml (control), 3676 pg/ml (exosome), 7357 pg/ml
(microvesicles), 3780 pg/ml (OVA re-stimulation + exosome), 9410 pg/
ml (OVA re-stimulation + microvesicles)).
Conclusion: Lung tissue derived EVs regulate T-cell migration and Th2
cytokine release. EVs from asthmatic lung may aggravate inflammation
further, but the role of exosomes and microvesicles may be different.
PF05.12
Altered miRNA expression in neutrophil derived-exosomes in severe
asthma
Amandine Vargas and Jean-Pierre Lavoie
Université de Montreal, Montreal, Canada
Asthma affects over 235 million individuals worldwide. Repeated expo-
sures to environmental antigens cause persistent inflammation and
damage to the lungs in asthma, leading to a progressive loss of airway
function and a decreased life quality. There is a clear association between
neutrophilic airway inflammation and severe asthma, but their causal
relationship remains largely unexplored. Neutrophils are known to
release a variety of mediators that promote the induction and recruit-
ment of other immune cells, and we have recently demonstrated that
they secrete exosomes abled to interact with airways smooth muscle
(ASM) cells, increasing proliferation. Exosomes are enriched in
miRNA fragments, which could influence the mRNA activities in reci-
pient cells and promoting different biological processes. Using TaqMan™
microRNA assays, we investigated the expression of 12 miRNAs capable
of regulating ASM fate (miR-21, miR-146a, miR-26a, miR-133a, miR-
145, miR-Let7 family, miR-25, miR-143, miR-221, miR-199, mir155 and
miR-214), in neutrophils derived-exosomes from severe asthmatic
horses (n = 6) and age-matched controls (n = 6). These animals
spontaneously developed a condition sharing marked similarities with
human neutrophilic asthma. All selected miRNAs were detected in
exosomal extracts, but only miR-21 was differentially expressed, with a
decreased expression in exosomes from asthmatic animals compared to
controls. Equine ASM cells were then transfected with miR-21 (or a
miR-negative control), stimulated with LPS (100 ng/ml) for 24 h and the
mRNA expression of PDCD4, IL-8 and IL-10 was measured using qPCR.
Survival was also analysis using a coulter counter. Our preliminary
results indicated that miR-21 increases ASM cell viability without alter-
ing the expression of the genes we studied. In conclusion, neutrophil
exosomes carry several miRNAs possibly implicating in the ASM biology
in asthma. MiR-21 related gene expression requires further
investigations.
PF05.13
Withdrawn at request of author.
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Mesenchymal stem cell-derived extracellular vesicles alter
differentiation competence of fibroblasts
Motohiro Komaki1, Masayuki Tooi2, Naoki Yokoyama3, Hirohito Ayame3,
Kengo Iwasaki1, Yuichi Izumi2 and Ikuo Morita4
1Department of Nanomedicine, Graduate School of Medical and Dental Science,
Tokyo Medical and Dental University, Tokyo, Japan; 2Department of
Periodontology, Graduate School of Medical and Dental Science, Tokyo
Medical and Dental University, Tokyo, Japan; 3Life Science Laboratory,
Research and Development Centre, Dai Nippon Printing Co., Ltd.;
4Department of Cellular Physiological Chemistry, Graduate School of Medical
and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan
Introduction: The therapeutic potential of mesenchymal stem cells
(MSCs) may be attributed partly to humoral factors and extracellular
vesicles (EVs). Human term placental tissue-derived MSCs (PlaMSCs),
or conditioned medium of these cells, have been reported to enhance
wound healing. Recently, the EVs, which can transport a diverse suite of
macromolecules, has gained attention as a novel intercellular commu-
nication tool. However, the potential role of the EVs in PlaMSC ther-
apeutic action is not well understood. The purpose of this study was to
evaluate whether PlaMSC-derived EVs modulate differentiation compe-
tence of fibroblasts in vitro.
Methods: MSCs were isolated from human term placental tissue by
enzymatic digestion. Conditioned medium was collected after 48-h
incubation in serum-free medium (PlaMSC-CM). EVs were prepared
by ultracentrifugation of PlaMSC-CM, and confirmed by transmission
electron microscopy (TEM), dynamic light scattering (DLS), and western
blot analyses. The expression of stemness-related genes, such as OCT4
and NANOG, in normal adult human dermal fibroblasts (NHDF) after
incubation with PlaMSC-exo was measured by real-time reverse tran-
scriptase PCR analysis (real-time RT-PCR). The effect of PlaMSC-exo on
OCT4 transcription activity was assessed using Oct4-EGFP reporter
mice-derived dermal fibroblasts. The stimulating effects of PlaMSC-exo
on osteoblastic and adipocyte-differentiation of NHDF were evaluated
by alkaline phosphatase (ALP), and Alizarin red S- and oil red
O-staining, respectively. The expression of osteoblast- and adipocyte-
related genes was also assessed by real-time RT-PCR
Results and Conclusion: The treatment of NHDF with PlaMSC-exo
significantly upregulated OCT4 and NANOG mRNA expression.
PlaMSC-exo also enhanced OCT4 transcription. The NHDF treated
with PlaMSC-exo exhibited osteoblastic and adipocyte-differentiation
in osteogenic and adipogenic induction media. PlaMSC-exo increase
the expression of OCT4 and NANOG mRNA in fibroblasts. As a result,
PlaMSC-exo influence the differentiation competence of fibroblasts to
both osteoblastic and adipocyte-differentiation. It shows a new feature of
MSCs and the possibility of clinical application of MSC-exo.
PF06.02
Stimulation of adipose tissue-derived mesenchymal stem cells by
monocyte- and osteoclast-derived extracellular vesicles
Arjen Gebraad1, Sippy Kaur1, Yusuf Khan2, Suvi Haimi1, Riitta Seppänen-
Kaijansinkko1 and Bettina Mannerström1
1Department of Oral and Maxillofacial Diseases, University of Helsinki and
Helsinki University Hospital, Finland; 2Department of Agricultural Sciences,
University of Helsinki, Helsinki, Finland
Introduction: In recent years, extracellular vesicles (EVs) have gained
interest as a biomimetic tool to induce lineage-specific differentiation of
stem cells. Osteoclasts are the bone-resorbing cells that are formed by
fusion of monocytes. Like monocytes, osteoclasts provide pro-osteogenic
signals to mesenchymal stem cells (MSCs). The role of EVs in these pro-
osteogenic signals is currently unknown. In this study, we performed a
genome-wide transcriptome analysis of the pro-osteogenic potential of
osteoclast-derived EVs in human adipose tissue-derived MSCs (AT-
MSCs).
Methods: Human monocytes were isolated from buffy coats by gra-
dient centrifugation and immunomagnetic selection. The monocytes
were either activated by lipopolysaccharide or stimulated to generate
osteoclasts using M-CSF and RANK-L on culture plastic or coatings
of hydroxyapatite. Hydroxyapatite mimics the mineral component of
bone. EVs were isolated from the conditioned medium of these
cultures using a commercial precipitation kit. Human AT-MSCs
were cultured for 18 days in control medium supplemented with
EVs from the monocyte- and osteoclast cultures. AT-MSCs cultured
in control medium and osteogenic differentiation medium without
EVs were used as controls. Microarrays will be used for genome-wide
transcriptome analysis of differences in pro-osteogenic potential of
monocyte-derived EVs, EVs from inactive osteoclast and EVs from
resorbing osteoclast.
Results: Stainings of osteoclast-marker TRAcP confirmed the formation
of osteoclasts. Osteoclasts on hydroxyapatite resorbed the coating.
Electron microscopy and nanoparticle tracking analysis showed EVs
between 50 and 400 nm isolated from the conditioned medium.
Additionally western blotting validated the presence of EVs.Our preli-
minary data show that osteoclast-derived EVs upregulated the expres-
sion of osteogenic marker gene RunX2 in AT-MSCs. The microarray
data is currently being processed.
Conclusion: We have successfully isolated EVs from monocytes, inactive
and resorbing osteoclasts. Our preliminary transcriptomics data show
that osteoclast-derived EVs have a pro-osteogenic effect in AT-MSCs.
Authors Gebraad and Mannerström contributed equally.
PF06.03
Characterisation of extracellular vesicle production during leukaemic
differentiation
Heather M. Duncan1, Isabelle Laverdière2, Héloïse Frison3 and Kolja Eppert4
1Division of Experimental Medicine, McGill University, Montreal, Canada;
2Faculty of Pharmacy, Laval University, Quebec, Canada; 3BioLegend;
4Deptartment of Paediatrics, McGill University, Montreal, Canada
Introduction: In acute myeloid leukaemia (AML), leukaemic stem cells
(LSCs) are resistant to therapy and lead to relapse. While a growing body
of evidence demonstrates that extracellular vesicles (EVs) from leukae-
mic cells promote disease progression and therapy resistance in AML,
little is known about the role of EVs produced by the LSCs. We aim to
quantify and characterise the content of EVs released by both the LSC-
enriched and differentiated cell populations of primary human AML.
Methods: EVs were isolated from cell-conditioned media by ultracen-
trifugation, quantified by nanoparticle tracking analysis and stained
using lipophilic dye PKH67. Uptake by the same cells was quantified
by flow cytometry.
Results: Preliminary experiments have been performed using a primary
human AML sample that maintains hierarchical organisation, including
a functional LSC population, during in vitro culture. We have success-
fully isolated EVs, quantified them, and observed uptake by AML cells,
confirming the functional nature of these EVs. Microscopy was also used
to confirm uptake of EVs visualised as distinct foci in recipient cells.
Proteomic analysis of the cargo of EVs produced by LSC and more
differentiated AML cellsis ongoing.
Conclusion: In primary AML samples, microscopy and imaging flow
cytometry can be used to determine EV uptake and co-localisation of
markers from EV producing cells with PKH67+ foci in recipient cells.
We are currently purifying EVs from LSC-enriched (CD34+/CD38−) and
blast (CD34−) cell populations isolated by flow cytometry and perform-
ing proteomic analysis to contrast the contents of EVs from these two
cell populations. Results of this analysis will be presented at the meeting.






























PTEN controls exportation of membrane-bounded proteins including
DSCAM and Megf10 via regulating exosome secretion pathway
Nobuhiko Tachibana1, Robert Cantrup2, Rajiv Dixit3 and Carol Schuurmans4
1University of Calgary, Sunnybrook Health Sciences Centre, Calgary, Canada;
2University of Calgary, Canada; 3Sunnybrook Health Science Centre, Calgary,
Canada; 4Sunnybrook Research Institute, University of Toronto and
Biochemistry and Molecular Biology Deparment, University of Calgary, Canada
In the retina, neurons of the same type are precisely positioned in two
orthogonal planes, in the radial plane, like-neurons are located in specific
strata, while in the horizontal/tangential plane, they are evenly distributed
in non-random arrays known as mosaics. We found that the retina-
specific conditional knockout (cKO) of Pten, encoding an intracellular
phosphatase, perturbs the mosaic patterning of dopaminergic amacrine
cells, phenocopyingDscammutants.It is unclear how cell surface adhesion
molecules, such as Dscam, or intracellular molecules, such as Pten, oper-
ate at a distance to repulse “like” cells so as to maintain cellular mosaics.
We found that Dscam is secreted in retinal extracellular vesicles, while
others found that mutations in Dscam that block its secretion also perturb
amacrine cell mosaics. We thus suggest that Dscam may create extracel-
lular repulsive gradients to control amacrine cell somal positioning, and
furthermore, suggest that Pten may control this secretion. Indeed, we
found that the number of Dscam puncta, speculated to be Dscam-packed
intracellular vesicles, is elevated in Pten cKO dopaminergic amacrine cell,
suggesting that Pten controls the processing of Dscam protein. Moreover,
the amount of truncated Dscam packaged in large extracellular vesicles is
reduced in Pten mutant retinas. Finally, for the critical functional test of
whether EV secretion of proteins is required to establish amacrine cell
mosaics, we manipulated nSmase2 (neutral sphingomyelinase 2 encoded
by Smpd3), a major biogenetic pathway. Strikingly, electroporation of
Smpd3 into retinal progenitors, which increases EV secretion, decreased
the number of dopaminergic amacrine cells in the vicinity of the electro-
porated patch, while knockdown using sh-Smpd3 caused amacrine cell
clumping. Taken together, our data supports the idea that Pten controls
amacrine cell spacing by controlling EV-mediated secretion of cell adhe-
sion molecules such as Dscam.
PF06.05
Extracellular vesicles modulate BMP signalling during early
embryogenesis
Thomas Draebing, Jana Heigwer, Lonny Juergensen, Hugo A. Katus and
David Hassel
Department of Internal Medicine III, University Hospital Heidelberg,
Heidelberg, Germany
Introduction: Bone morphogenetic proteins (BMPs) are essential para-
crine regulators of the formation of nearly every organ. The response to
BMP signalling in target cells is determined by the BMP concentration
in the surrounding extracellular space. It has been established for over
50 years that BMP forms gradients to achieve tissue patterning. But so
far little is known of how these gradients form. Recent theoretical
models and first experimental observations hinted at a role of vesicles
in morphogen gradient formation.
Methods: We used zebrafish embryos as an in vivo source for EVs
secreted during development. EVs were purified using an ultracentrifu-
gation-based method. BMP2/4 presence in EVs was verified by western
blotting. The ability of EVs to activate BMP-dependent transcription was
measured by a dual luciferase activity assay. EV-secretion was inhibited
by morpholino-based knockdown of Rab11 and Rab35 and quantified by
nanoparticle tracking analysis. In vivo BMP signalling activity was ana-
lysed with in situ hybridisation and qPCR of nkx2.5.
Results: We were able to observe the presence of BMP2/4 in EVs
purified from zebrafish embryos at the end of gastrulation, when
BMP2/4 induces the cardiac mesoderm. By analysing EVs from the
endodermic cell line End2, we could show that at least part of the EV-
delivered BMP2/4 originates from the endoderm, which is known as the
source of BMP2 during late gastrulation and early somite stages.
Strikingly, EVs of both origins were able to significantly activate BMP-
dependent transcriptional responses. Knockdown of Rab11 and Rab35 in
zebrafish embryos reduced the amount of secreted EVs significantly. The
expression of the BMP target gene nkx2.5, which is a cardiac lineage
marker, was strongly reduced upon Rab11/Rab35 knockdown coinciding
with a higher fraction of embryos showing a dorsalisation phenotype,
both signs for dysregulated BMP signalling.
Conclusion: Delivery of BMP in EVs is essential to ensure correct
embryonic development, indicating a role of EVs in morphogen gradient
formation.
PF06.06
Glycan profiling analysis of extracellular vesicles from mesenchymal
stem cells (MSCs) and osteogenic MSCs
Asako Shimoda and Kazunari Akiyoshi
Graduate School of Engineering, Kyoto University, Kyoto, Japan
Introduction: Extracellular vesicles (EVs) are released from various cells and
play an important role in cellular communication. Various molecules includ-
ing proteins, lipids, DNA, andmicro RNA are contained in EVs, and transfer
thembetween cells. Recent studies reported that the analysis of glycan profiles
of EVs provide their biophysical functions such as cellular recognition,
protein sorting, and so on. Here, we analysed glycan profiles of EVs from
different types of human cell lines (MSCs and osteogenic MSCs) using lectin
arrays and compared their differences.
Methods: EVs were isolated from adipose-derived stem cells (ADSCs). To
induce osteogenic differentiation, ADSCs were cultured in osteogenic media
for 21 days. In addition, EV-like vesicles known as matrix vesicles (MVs),
released by osteoblasts to induce mineralisation, were isolated from the
extracellular matrix (ECM) after 21 days of differentiation. The EVs from
both cells or MVs were characterised by immunoblotting, cytokine arrays,
transmission electron microscopy (TEM), nanoparticle tracking analysis
(NTA) and lectin microarray analysis.
Results: We obtained 150–200 nm-sized EVs from both ADSCs and
osteogenic ADSCs. Exosomal marker (CD81) was detected, and several
cytokines that are related with osteogenic differentiation were found in
osteogenic ADSCs-derived EVs. While the size and morphology of MVs
from ECM were similar to these of EVs, alkaline phosphatase (ALP)
activity, a marker for osteogenic activity was significantly higher in MVs.
In glycan profiling analysis, we found that α-2,6 sialic acids were highly
enriched in EVs compared with original cell membranes, and the cellular
uptake of EVs was influenced by the surface sialic acids moiety of the
EVs. Moreover, osteogenic MSC-EVs and MVs showed different glycan
profiles, indicating that glycan profiles reflect the biogenesis and cell
differentiation.
Conclusion: In this study, we revealed that the analysis of glycan profiles
of EVs using lectin microarray provides useful information including
cell interaction, differentiation, and biogenesis.
PF06.07
Mechanical force accelerates lung development via release of
extracellular vesicles
Tanbir Najrana1, Laura Goldberg2, Peter J. Quesenberry2 and Juan Sanchez-
Esteban1
1Department of Pediatrics, Division of Neonatology, Women & Infants
Hospital of Rhode Island, RI, USA; 2Department of Medicine, Division
of Hematology/Oncology, Rhode Island Hospital, RI, USA
Introduction: Lung underdevelopment secondary to extreme prematurity
and pulmonary hypoplasia can cause significant morbidity and mortality to
the neonatal population. Currently, there are no effective interventions to
accelerate lung development. Mechanical forces generated inside the foetal
lung are critical for normal lung development. However, the mechanisms
by which mechanical signals stimulate lung development are not fully
characterised. Extracellular vesicles (EVs), including exosomes and micro-
vesicles, are small, membrane-bound particles, increasingly recognised as a
novel mode of cell-to-cell communication. However, the role of EVs in





























foetal lung development is unexplored. Hypothesis: Mechanical signals
promote foetal lung development via release of EVs.
Methods: EVs were isolated from E18.5 mouse foetal lungs using differ-
ential centrifugation steps. Size and concentration of EVs were measured
by nanoparticle tracking analysis. Purity of EVs was analysed by western
blot and flow cytometry using anti-CD63 and anti-CD9 antibodies.
Isolated E18.5 mouse epithelial cells were cultured on Bioflex plates
coated with laminin and exposed to 5% cyclic stretch (to mimic mechan-
ical forces in lung development) for 24 h using the Flexercell Strain Unit.
Results: More than 80% of the EVs isolated from the foetal lung fluids
have a diameter of around 100 nm and tetraspanins surface markers
including CD9 and CD63, consistent with exosomes. Mechanical stretch
of foetal epithelial cells increased release of EVs by 2.4 fold when
compared to controls. Moreover, incubation of primary foetal epithelial
cells with EVs released from stretched cells or from EVs isolated from
foetal lungs promoted type I epithelial cell differentiation.
Conclusion: EVs are present in the lumen of the foetal lung. Mechanical
signals release EVs that are important for differentiation of foetal type I
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Contribution of extracellular vesicles from adult-derived human liver
stem cells to the correction of urea cycle disorders
Catherine Lombard1, Jiun-Pang Huang2, Joachim Ravau1 and Etienne Sokal3
1Université Catholique de Louvain, IREC-PEDI; 2Chang Gung University,
Taoyuan City, Taiwan; 3St Luc Hospital and Université Catholique de
Louvain, IREC-PEDI
Introduction: Adult-derived human liver stem cells (ADHLSCs) are
currently in clinical development for the treatment of urea cycle dis-
orders (UCD). Clinical and preclinical data seem to indicate a higher
clinical effect than what could be expected from the number of cells that
have engrafted, suggesting that other mechanisms may be at play. We
have previously demonstrated that ADHLSCs produce extracellular vesi-
cles (EVs, i.e. microparticles (MPs) and exosomes (EXO)), which have
been shown to mediate intracellular communication in other systems by
delivering proteins, lipids and/or genetic information (coding and non-
coding RNAs) to recipient cells. Therefore, the aim of this study was to
determine the precise role of EVs in ADHLSC-mediated correction
of UCD.
Methods: ADHLSCs were cultured for 2 days in DMEM supplemen-
ted with 10% EXO-free FBS and 1% P/S. The conditioned medium
was collected, and MP and EXO fractions were harvested by serial
ultracentrifugation. Transmission electron microscopy (TEM), wes-
tern blotting and nanoparticle tracking analysis were used to evalu-
ate the presence, purity and abundance of MP and EXO. RNA from
EVs was stained with SytoRNA, which only fluoresces upon integra-
tion into RNA, to investigate RNA transfer from EVs to rat hepa-
tocytes. Droplet digital PCR (ddPCR) was performed on RNA
extracted from the MP and EXO as well as rat hepatocytes pre-
viously incubated with EVs to investigate the presence of human
mRNAs of interest.
Results: We confirmed that ADHLSCs produce both MP and EXO.
Characterisation of the mRNA by ddPCR showed expression of ASL,
ASS and CPS1 in EVs, mainly in MPs. SytoRNA staining of the EV RNA
allowed us to show transfer of EV RNA to over 60% of rat hepatocytes in
vitro. Finally, we demonstrated transfer of human mRNAs of interest
from EVs to rat hepatocytes using ddPCR
Conclusion: In summary, our study shows that ADHLSC-derived EVs
contain mRNA encoding for some of the deficient enzymes in UCD and
are capable of transfering their mRNA content to recipient cells. mRNA
transfer via EVs may therefore be one of the modes of action of
ADHLSCs in UCD.
PF06.10
Osteoblast-secreted extracellular vesicles stimulate the expansion of
CD34+ human umbilical cord blood cells
Jess Morhayim, Jeroen van de Peppel, Eric Braakman, Elwin Rombouts,
Mariette ter Borg, Bram van der Eerden, Andre van Wijnen, Jan
Cornelissen and Johannes P. van Leeuwen
Erasmus MC
Introduction: Osteolineage cells represent one of the critical bone mar-
row niche components that regulate self-renewal and differentiation of
hematopoietic stem and progenitor cells (HSPCs). Recent studies
demonstrated that extracellular vesicles (EVs) regulate stem cell devel-
opment via horizontal transfer of bioactive cargo. In the present study,
we focused on the characterisation of human osteoblast-derived EV-
miRNAs and investigated their implications on HSPC-osteolineage-cell
crosstalk.
Methods: We used human pre-osteoblasts (SV-HFO cells) to isolate EVs
by a series of ultracentrifugation steps. We elucidated the overrepre-
sented EV-miRNAs by comparing parental cell- and EV-miRNA profiles
using next-generation sequencing. We performed in silico target predic-
tion analyses to delineate candidate hematopoietic development path-
ways affected by osteoblast-EVs and subsequently verified our results
with in vitro biochemical analyses. We investigated the potency of
osteoblast-EVs to promote ex vivo expansion of human umbilical cord
blood (UCB)-derived CD34+ HSPCs and subsets by enumeration using
single-platform flow cytometry. We further verified the functionality of
the expanded cells in vivo by performing xenogeneic transplantation in
immunodeficient mice.
Results: Using next-generation sequencing we show that osteoblast-EVs
contain highly abundant miRNAs specifically enriched in EVs, including
critical regulators of hematopoietic proliferation (e.g. miR-29a). EV
treatment of human umbilical cord blood-derived CD34+ HSPCs alters
the expression of candidate miRNA targets, such as HBP1, BCL2 and
PTEN. Furthermore, EVs enhance proliferation of CD34+ cells (2-fold,
p < 0.01) and their immature subsets (>2-fold, p < 0.005) in growth
factor-driven ex vivo expansion cultures. Importantly, EV-expanded cells
retain their differentiation capacity in vitro and successfully engraft in
vivo.
Conclusion: In this study, we demonstrate a novel osteoblast-derived
EV-mediated mechanism for regulation of HSPC proliferation and
expansion. These discoveries provide a foundation for the utilisation of
EV-miRNAs for the development of UCB-HSPC expansion strategies to
treat haematological disorders.
PF06.11
Withdrawn at author’s request.
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A rapid microflow analysis of cancer stem cell surface proteins in
circulating exosomes from breast cancer patients
Golam Kibria1, Erika Ramos2, Clifford Harding1, Jan Lötvall3 and Huiping
Liu2
1Case Western Reserve University, OH, USA; 2Northwestern University, CA,
USA; 3Krefting Research Centre, University of Gothenburg, Sweden





























Circulating exosomes provide a promising approach to assess novel and
dynamic biomarkers in human disease, due to their stability, accessibility
and representation of molecules from source cells. However, this poten-
tial has been stymied by lack of approaches for molecular profiling of
individual exosomes, which have a diameter of 30–150 nm. Existing
approaches to exosome characterisation include electron microscopy,
nanoparticle tracking analysis, protein and RNA analyses for collective
exosomes (immunoblotting, mass spec, RNA array, PCR and sequencing
etc.), and other biochemical assays. However, most of these approaches
are often not feasible to rapidly assess the heterogenous profiles of
individual exosomes. Here we report a rapid microflow analysis
approach for high throughput profiling of surface proteins at a single
exosome level, a major challenge to moving the field of exosome-based
biomarkers forward (1).
Cancer stem cells (CSCs) are a subpopulation of cancer cells with stem
cell-like properties of self-renewal and tumorigenesis. CSCs, often con-
sidered the root of cancer, seeds of metastasis, and sources of therapy
resistance, might communicate with the microenvironment through
secreted circulating exosomes. We hypothesised that circulating exo-
somes harbour surface protein markers of CSCs and correlate with the
status of these cells in vivo and the predictive outcome of cancer
patients. Using a micro flow cytometer Apogee, we optimised the micro-
flow analyses of CSC markers CD44 and CD47, of circulating exosomes
isolated from the blood of both breast cancer patients and healthy
populations. Our studies show a differential CD47 expression in
blood-purified individual circulating exosomes that is associated with
breast cancer status, demonstrating a great potential of individual exo-
some profiles in biomarker discovery. The sensitive and high throughput
platform of single exosome analysis can also be applied to characterising
exosomes derived from other patient fluids.
Reference
1. Kibria G et al., Sci Rep. 2016; 6: 36502.
PF06.13
Benefits of human neural stem cell derived extracellular vesicles
surpass those of mesenchymal stem cell derived vesicles in a murine
embolic stroke model
Robin Webb1, Shelley Scoville1, Tyler Thompson1, Nasrul Hoda2 and Steven
Stice1
1ArunA Biomedical; 2Augusta University, GA, USA
Introduction: Mesenchymal stem cell (MSC)-derived extracellular vesi-
cles (EV) have provided benefit in stroke animal models. However,
exosome cargos are cell type specific and the parental cell line plays a
prodigious role in the biological properties of the resultant vesicles.
Thus, compared to MSCs, neural sourced EVs may provide additional
benefit to the injured brain. To test this hypothesis, EVs were derived
from MSCs and neural progenitor cells (NPCs), originating from the
same parent human pluripotent stem cell line, enabling us to determine
the in vivo response in a stroke model to EVs from different cell types
that have the same genetic background.
Methods: Defined serum-free media conditioned by MSC or NSC were
thawed, subjected to dead end filtration, and enriched by ultrafiltration.
EVs were quantified using NanoSight. 2.7 × 1011 NPC and MSC vesicles/
kg (±10%) doses, referred to as NPEX and MSCEX, respectively, were
stored in individual dose aliquots at −20°C. After thaw, these were
administered by tail vein injection (N = 12 mice/group) at 2, 14 and
28 h post embolic stroke. Control animals received PBS injections at all
timepoints, blood collection for flow cytometry followed by euthanasia
occurred 96 h post-stroke.
Results and Conclusion: Preliminary proteomics data indicated over-
lapping but divergent protein profiles between MSCEX and NPEX in
angiogenic and neuroprotective proteins. Enrichment of these proteins
in NPEX led us to hypothesise that these EVs may provide enhanced
benefits in vivo. In the mouse embolic stroke model, NPEX decreased
mortality by 17%. Sensorimotor function (adhesive tape test), and neu-
rological deficit score were improved by NPEX treatment, with animals
that received MSCEX performing like controls. Infarct volume (% con-
trol) was significantly decreased following NPEX treatment, but
unchanged by MSCEX. NPEX increased circulating regulatory T-cells
(relative to both MSCEX and control treated groups), as well as anti-
inflammatory M2 macrophages, while decreased inflammatory T-cells
were detected. Taken together, these data indicate that NPEX provided
molecular and behavioural benefits that surpassed those provided by
MSCEX following stroke, supporting a role for NPC derived EVs as a
biological therapeutic following stroke in humans.
PF06.14
Extracellular vesicles derived from human umbilical cord perivascular
cells (HUCPVCs): a potential non-cell source for regenerative therapy
Nechama Lipton1, Paula Mackie1, Kathryn Lye1, Lianet Lopez1, Farwah
Iqbal1,2, Peter Szaraz1, Shlomit Kenigsberg1, Denis Gallagher1, Andree S.
Gauthier-Fisher1 and Clifford Librach1,3,4
1CReATE Fertility Centre; 2Department of Physiology, University of Toronto,
Toronto, Canada; 3Department of Obstetrics and Gynaecology, Department
of Physiology, Institute of Medical Sciences, University of Toronto, Toronto,
Canada; 4Department of Gynecology, Women’s College Hospital
Introduction: Intercellular transfer of extracellular vesicles (EVs) may
mediatekey paracrine regenerative activities of mesenchymal stem cells
(MSCs). First trimester (FTM) and term HUCPVCs are novel sources
of MSCs with high regenerative potential. The objective of this study
was to optimise methods for efficient production and purification of
HUCPVC-EVs and to investigate their potential regenerative proper-
ties in vitro.
Methods: FTM and term HUCPVCs, as well as human fibroblasts,
were expanded in multi-layer flasks using aMEM media containing
EV-depleted FBS for 72hrs. EVs were isolated from concentrated
conditioned media (CM) using ultracentrifugation (UC), sucrose
cushion UC or the ExoEasy kit (Qiagen). The presence, size and
morphology of the HUCPVC-derived EVs were determined by trans-
mission electron microscopy (TEM) and Nanoparticle Tracking
Analysis (NTA). To visualise EV uptake by target cells, rat endothelial
progenitor cells (EPCs) were treated with HUCPVC-derived EVs pre-
labelled with PKH26 dye. The paracrine angiogenic and neuroprotec-
tive properties of HUCPVCs and HUCPVC-EVs were evaluated using
the rat aortic ring assay and a murine in vitro diabetic neuropathy
model.
Results: EVs were successfully isolated from FTM, term HUCPVC and
fibroblasts CM but not basal media. UC with a sucrose cushion and
ExoEasy kit reduced contaminating proteins in concentrated media
compared to UC alone. From TEM, isolated EVs were 30–200 nm
with a cup-shaped morphology. Uptake of PKH26-labelled EVs derived
from both HUCPVCs and fibroblasts was observed in EPCs. Aortic rings
treated with HUCPVCs showed increased mean radial network growth
and mean number of loops when compared to untreated networks.
Neuronal cultures treated with EVs showed decreased axonal degenera-
tion following exposure to hyperglycemia, and increased neurite
outgrowth.
Conclusion: HUCPVCs secrete EVs which can be taken up by EPCs in
vitro. UC with sucrose cushion or ExoEasy kit isolate purer EV fractions
when compared to UC. HUCPVCs display paracrine angiogenic and
neuroprotective properties. Experiments utilising purified HUCPVC-
derived EVs are ongoing to determine the relative contribution of EVs
to these regenerative properties.
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PF07.01
Stroke extracellular vesicles express inflammatory markers and
induce macrophage activation
Yvonne Couch1, Naveed Akbar1, SimonDavis1, Roman Fischer1, KimWals1, Alex
Dickens2, Ain Neuhaus1, Annette Burgess1, Peter Rothwell1 and Alastair Buchan1




Activated monocyte-derived exosomes stimulate adhesion molecules
and cytokines in human brain endothelial cells: role of exosomes in
monocyte brain migration
Lynn Pulliam1, Pranjali Dalvi2, Norina Tang2, Peilin Li1 and Bing Sun2
1University of California, San Francisco, CA, USA; 2Veterans Affairs Medical
Center
Introduction: Widespread use of antiretroviral therapy (ART) by
HIV- infected subjects has improved their health and extended their
lives, however, with increased longevity, co-morbidities have become
significant. A subset of HIV-infected individuals continues to have
chronic immune activation with cognitive impairment in spite of
effective therapy.We reported that individuals with HIV infection
have a type 1 interferon (IFN) phenotype with elevated circulating
lipopolysaccharide (LPS). We modelled this in vitro to determine
whether monocyte-derived exosomes (exos) would increase adhesion
molecules and cytokine expression in human brain microvascular
endothelial cells (HBMECs) and thereby facilitate monocyte migra-
tion into the brain.
Methods: Monocyte exos were labelled with DiI-C16 and incubated
with HBMECs to confirm entry. Monocytes were activated with IFN,
LPS or IFN followed by LPS (I/L). Exos were harvested 24 h. later,
lysed to isolate total RNA and probed by RT-PCR for adhesion
molecules and cytokines. Conditioned media or cells from the acti-
vated monocyte exo-treated HBMECs were probed for protein expres-
sion. Monocytes were incubated on top of a transwell chamber with
HBMECs in the bottom, with or without GW4869, an inhibitor of exo
release to determine the impact of exos on monocyte migration.
HBMEC mRNA was quantified for adhesion molecules and cytokines
by qRT-PCR.
Results: Exos from LPS or I/L-treated monocytes stimulated CCL2,
ICAM-1, VCAM, IL-1β and IL-6 gene expression and protein in
HBMECs. Monocyte-derived exos were internalised and those stimulated
with LPS or I/L, activated NFkB nuclear translocation. An increase in the
migration of LPS or I/L-stimulated monocytes towards HBMECs was
observed. Inhibition of exo release significantly normalised the monocyte
migration to the level of unstimulated control cells. This was supported by
the simultaneous increase in CCL2, ICAM-1, VCAM, IL-1β and IL-6 in
HBMECs in the lower chamber of I/L-activated monocytes, the inhibition
of exo release notable reduced these activation markers.
Conclusions: In HIV positive individuals with elevated circulating LPS
and an IFN profile, exos may play a crucial role in causing brain injury
by stimulating chemotaxis of monocytes to brain endothelium.
PF07.03
Withdrawn at author’s request.
PF07.04
CNS-derived extracellular vesicles are heterogeneous and adaptive to
age and tissue of origin
Sarah M. Fernando1, Chih Chieh Shu1, Darren D. Christie1, Leslie I. Grad2,
Neil R. Cashman1 and Judith M. Silverman1
1University of British Columbia, Centre for Brain Health, British Columbia,
Canada; 2Michael Smith Foundation for Health Research, British Columbia,
Canada
Introduction: Extracellular vesicles (EVs) are secreted by myriad cells in
culture and unicellular organisms, and their identification in mamma-
lian biofluids suggests that vesicle release is occurring at the organism
level as well. However, despite clear importance to the understanding of
EVs in organismal biology, EVs in solid tissues have received little
attention.
Methods: We applied a protocol for primary neuronal cell culture and
modified it for the collection of EVs from neural tissues. Exosome (EX)
and microvesicle (MV) populations were isolated from frozen whole
neural tissues from WT and an ALS mouse model, SOD1G93A, by serial
centrifugation and purification on a sucrose cushion. Vesicles were
phenotyped by flow cytometry on a Miltenyi MACS-Quant using con-
jugated primary antibodies.
Results: Flow cytometric phenotyping found that the majority of brain
and spinal cord EVs are positive for the exosomal marker CD81 and the
astrocyte marker GLAST (60% MV and 25% EX), while markers for
neurons (NCAM/CD56) were less common (40% MV and 10% EX).
CD11b, a microglial marker, was in low abundance (G93A CNS-derived
EVs, and this was mostly unchanged by the age and disease status of the
mice, in contrast to the significant loading of misfolded SOD1 into
SOD1G93A CNS-EVs. Spinal cord vesicles were significantly reduced in
GLAST and NCAM/CD56 expression compared to BDEVs, while CD81
and CD11b expression levels were equal between brain and spinal cord
vesicles.
Conclusion: These results suggest that microglia contribute little to the
brain extracellular vesicle population in young to middle aged mice,
while the majority of vesicles are derived from astrocytes. The same is
not true for the spinal cord, where a lower percentage of astrocyte
marker bearing vesicles contribute to the population. Current work is
focused on determining the cell type primarily responsible for releasing
misfolded SOD1G93A in EVs in the brain and spinal cord.
PF07.05
Nogo-A as an extracellular vesicle-associated ligand in the central
nervous system
Mea M. Holm1,2, Matteo Egger1, Danielle van Rossum1,2, Oliver
Weinmann1,2, Michael Maurer2, Benjamin Ineichen1,2, Inge Hermann3 and
Martin E. Schwab1,2
1ETH Zurich, Zurich, Switzerland; 2University of Zurich, Zurich, Switzerland;
3EMPA Swiss Federal Laboratories for Materials Science and Technology,
Switzerland
Introduction: Nogo-A is a membrane protein initially identified as a
myelin-associated inhibitor of axonal growth and regeneration in the
central nervous system (CNS). It has since been discovered that Nogo-A
is expressed not only by oligodendrocytes, but also by neurons, in which
it plays complex roles in regulating migration, branching and synaptic
plasticity. The current view of Nogo-A signalling is that plasma mem-
brane-bound Nogo-A binds to the receptors S1PR2 and/or NgR1 in a
multi-subunit complex, thereby requiring a direct cell-to-cell contact.
However, the presence of Nogo-A sequences in culture media and
cerebrospinal fluid (CSF) has been anecdotally reported and recently
found in proteomic studies, raising the possibility of an alternative





























signalling mechanism independent of cell-to-cell contact. We therefore
sought to investigate if CNS-derived cells secrete Nogo-A in association
with extracellular vesicles (EVs) or free in solution, and whether Nogo-A
can act as an EV–associated or a soluble ligand in bodily fluids.
Methods: EVs were collected either through ultracentrifugation or
through the density gradient method, and analysed through western
blotting, nanoparticle tracking and transmission electron microscopy
(TEM). For assays of Nogo-A functionality, the fibroblast spreading
assay (1) was adapted for use with EV-associated Nogo-A in solution.
Results: We found that Nogo-A is secreted into the supernatant of both
neuron- and oligodendrocyte-derived cell cultures, as well as into the
CSF of adult rats. TEM analysis with immunogold labelling indicated
that Nogo-A is associated specifically with the EV membrane, rather
than free in solution or inside the EVs. Furthermore, we found that
Nogo-A positive EVs inhibited the spreading of fibroblasts, while Nogo-
A negative control EVs did not. The spreading inhibition could be
rescued by the addition of a blocker for the Nogo-A receptor S1PR2.
Conclusion: These data show that Nogo-A positive EVs are secreted by
CNS cells and can be isolated from the CSF. The EV-associated Nogo-A
is functional as a ligand in in vitro assays, raising the intriguing possi-
bility of an in vivo signalling function, which would have major implica-
tions for the administration of anti-Nogo-A antibodies as therapies.
Reference
1. Oertle T et al., J Neurosci. 2003; 23: 5393–5406.
PF07.06
Role of exosomes in axon outgrowth
Samar Ahmad1 and Liliana Attisano2
1University of Toronto, Toronto, Canada; 2Department of Biochemistry,
University of Toronto, Toronto, Canada
In the central nervous system (CNS), exosomes are involved in inter-
neuronal communication and modulate axon outgrowth and axon gui-
dance that are key processes during brain development and injury.
Exosomes derived from different sources have different compositions,
and thus the origin of exosomes may induce distinct cell responses.
Previously, mouse fibroblast (L-cell)-derived (FD) exosomes have been
shown to promote cell protrusion and motility in human breast cancer
cell lines. Thus, to begin to assess the differential activity of exosomes of
distinct origins in the CNS, the function of FD exosomes in axon out-
growth was investigated in this preliminary study. Treatment of isolated
primary mouse embryonic cortical neurons with exosomes purified by
ultracentrifugation, promoted axon outgrowth. Moreover, the effect of
exosomes isolated through various purification methods on axon out-
growth was evaluated. Though further investigation is required to exam-
ine the underlying mechanism of the exosome-induced axon outgrowth,
the current preliminary study highlights the potential role of FD exo-
somes on axon outgrowth. Altogether, this will increase our understand-
ing of exosome activity on neurons and the potential of exosomes to
overcome developmental defects and injury in the CNS.
PF07.07
Exosomal miRNA-induced lincRNA regulates microglial phagocytosis:
implications for morphine-mediated potentiation of
neurodegeneration
Guoku Hu, Ke Liao, Fang Niu and Shilpa Buch
Department of Pharmacology and Experimental Neuroscience, University of
Nebraska Medical Center, NE, USA
Introduction: Opioids such as morphine are the most potent and effica-
cious drugs currently available for pain management. Both in vitro and
in vivo studies have demonstrated that morphine potentiates the neuro-
degenerative effects of HIV in the central nervous system (CNS).
Impairment of microglial functions such as phagocytosis and activation
has been implicated as in mediating neurodegeneration underlying var-
ious CNS diseases. In recent times, roles of long intergenic noncoding
RNAs (lincRNAs) in regulating cellular processes is gaining attention.
While lincRNAs are known to maintain cellular homeostasis, dysregula-
tion of their expression by EV has been implicated in regulation of a
wide array of genes including those controlling phagocytosis. Based on
this we hypothesised that EVs released from morphine exposed astro-
cytes can be taken up by microglial cells leading in turn, to impaired
microglial phagocytosis via the TLR-NF-kB axis-induced lincRNA-Cox2.
Methods: Mouse primary astrocytes and human A172 astrocytoma cells
were exposed to morphine (10 µM) followed by isolation of EVs using
the standard differential ultracentrifugation technique. Transmission
electron microscopy, NanoSight and western blot analyses were used
to characterise EVs. Expression of lincRNA-Cox2 in EV-treated BV2
cells and mouse primary microglial cells was examined by qPCR.
Microglial phagocytosis was assessed by uptake of fluorescently labelled
latex beads. In vivo studies involved intranasal delivery of lincRNA-Cox2
siRNA to mice that were administered morphine.
Results: EVs released from morphine exposed astrocytes demonstrated
upregulation of miR-138, which in turn, was shown to bind to the endoso-
mal TLR7 in microglia, leading to activation of NF-kB pathway. This in
turn, resulted in upregulation of lincRNA-Cox2, leading to impairedmicro-
glial phagocytosis. Intranasal delivery of lincRNA-Cox2 siRNA ameliorated
microglial phagocytic activity in morphine-treated mice.
Conclusion: Exposure of microglial cells to EVs released from mor-
phine-exposed astrocytes resulted in impaired phagocytic function via
the TLR7-NF-kB-lincRNA-Cox2 axis. These findings have ramifications
for the development of EV-loaded RNA drug target(s) as therapeutics
for neurodegenerative disorders associated with opiate abuse.
PF07.08
Exosomes derived from ACE2-overexpressing endothelial progenitor
cells protect neurons from hemolysate-induced apoptosis and
inflammation
Jinju Wang1, Qunwen Pan2, Yanfang Chen1, Bin Zhao2, Xiaotang Ma2 and Ji
Bihl1
1Wright State University, OH, USA; 2Affiliated Hospital of Guangdong
Medical University, Guangdong, China
Introduction: We have previously demonstrated that angiotensin con-
verting enzyme 2 (ACE2)/angiotensin (Ang)-(1-7)/Mas pathway has
therapeutic effects on intracerebral haemorrhagic stroke through inhi-
biting necrosis factor nuclear factor-KappaB (NFκB) inflammatory
pathway. More recently, we found that exosomes of endothelial pro-
genitor cells (EPCs-EXs) could protect neurons from hypoxia/reoxy-
genation-induced apoptosis. In this study, we tested whether EXs
from ACE2 primed EPCs (ACE2-EPC-EXs) have combined beneficial
effects on neurons in an in vitro haemorrhagic model induced by
hemolysate.
Methods: EPCs cultured from the bone marrow of C57BL/6 mice
were transfected with Lenti-ACE2 (at 5 × 106 infection-forming
units). EXs were collected from the culture medium of EPCs by
ultracentrifuge. Neuron 2a cells were pretreated with vehicle (PBS),
EPC-EXs or ACE2-EPC-EXs (50 μg/ml) for 12 h, and then incubated
with hemolysate (10%) for 6 h. Hemolysate was prepared from the
fresh mouse arterial blood. The apoptosis of neurons was determined
by flow cytometry. The expressions of NFκB, inhibitor of κBα (IκBα),
cyclooxygenase-2 (COX-2) and interleukin-1β (IL-1β) were confirmed
by Western blot.
Results: Hemolysate induced neuronal apoptosis (by 40%), which was
accompanied by up-regulations of NFκB (~4-fold), COX-2 (by 44%) and
IL-1β (~2.8-fold), but a down-regulation of IκBα (by 50%). Pretreatment
with ACE2-EPC-EXswas more effective on decreasing hemolysate-
induced neuronal apoptosis (by 25 ± 2.8% and 34 ± 4.2%, ACE2-EPC-
EXs vs. EPC-EXs, p < 0.05). Similarly, the hemolysate-induced effects on
NFκB, COX-2 and IL-1β, and IκBα expression were more inhibited by
ACE2-EPC-EXs (by 25–48%, ACE2-EPC-EXs vs. EPC-EXs, p < 0.05).
Conclusion: Data suggest that ACE2-EPC-EXs have better efficacy than
EPC-EXs in protecting neurons from hemolysate-induced apoptosis and
inflammation.






























Proteomic analysis of microvesicles from CSF of multiple sclerosis
patients
Antonella D’Ambrosio1, Sandra Columba Cabezas1, Serena Camerini1, Maria
Luisa Casella1, Marco Crescenzi1, Marco Puthenparampil2, Silvia Zamboni1,
Marco Diociaiuti1, Francesca Aloisi1, Paolo Gallo3 and Paola Margutti1
1Istituto Superiore di Sanità; 2Department of Neuroscience DNS, University
of Padua, Padua, Italy; 3Multiple Sclerosis Centre, Department of
Neurosciences DNS, University Hospital – Medical School
Introduction: Multiple sclerosis (MS) is an inflammatory, demyelinating
and neurodegenerative disease of the central nervous system (CNS).
Emerging evidence indicates that different types of CNS cells release
high numbers of microvesicles (MVs) in the cerebrospinal fluid (CSF).
MVs, sharing the same antigenic repertoire as their parental cells, may
dynamically reflect pathologic mechanisms of CNS damage representing
a novel class of circulating biomarkers. The main goal of this study is to
identify CNS biomarkers related to brain damage in relapsing-remitting
MS and in clinically isolated syndrome (CIS), characterised by a single
neurological episode suggestive of MS and a high probability to convert
to clinically definite MS.
Methods: We performed a proteomics-based biomarker discovery
study in the CSF of two CIS patients, four relapsing–remitting MS
(RRMS) patients and two healthy subjects.The diagnostic work-up
included MRI, visual evoked potentials and CSF examination. CSF-
derived MVs were purified by size using Sephacryl S-500 gel filtration
column and concentrated by ultracentrifugation. Proteomic analyses
of purified CNS-derived MVs were carried out through pre-fractiona-
tion of MV protein samples by one dimensional SDS-PAGE followed
by LC-MS/MS. Peptide identification was performed using the NCBI
database.
Summary: For the first time, total CSF as well as purified CSF-
derived MVs from CIS and RRMS patients have been analysed by
a “proteomic phenotyping” approach. In the preliminary analyses,
two proteins were detected exclusively in one of the two CIS
patients with BBB damage but not in RRMS patients: neuronal cell
adhesion molecule (NCAM-140), derived from purified MVs, is
related to remyelination and Beta-Ala-His dipeptidase, derived
from total CSF, was previously identified as a predictive biomarker
of CIS to MS conversion.
Conclusion: Further studies in a larger patient cohort will be performed
to validate the potential relevance of these two proteins as biomarkers
associated to brain damage in early MS phases.
PF07.10
Primary culture photoreceptors release functional extracellular
vesicles
Aikaterini Kalargyrou1, Benjamin Davis1, Enrico Cristante1, Emma West1,
Anai Anai Gonzalez-Cordero2, Anastasios Georgiadis1, Matt Hayes3,
Francesca Cordeiro4, Sander Smith1, Robin Ali1 and Rachael Pearson1
1UCL Institute of Ophthalmology; 2Institute of Ophthalmology; 3UCL
Institute of Ophthalmology – EM Unit/Imaging SRF; 4Institute of
Ophthalmology – Visual Neuroscience
Introduction: Extracellular vesicles (EVs) are key players of intercellular
communication, enabling the transfer of proteins, lipids and RNA
between cells. The nervous system requires tightly regulated exchanges
between sensory and motor neurons, interneurons and glial cells. Recent
studies have attributed some of these exchanges to EVs and they have
been found to modulate diverse processes, including neuronal survival
and degeneration, the microglial immune response, synapse assembly
and plasticity. Very little is known about the presence and potential roles
of EVs in the neuroretina, in either health or disease. As a first step, we
investigated whether photoreceptors (PRs) in the normal mammalian
retina have the capacity to make and release EVs.
Methods: CD73+ primary PRs were isolated from postnatal day P8
wildtype mouse retinae using MACS and cultured for 14 days. EVs
were isolated from culture medium using differential UC. Pellets from
10,000g and 100,000g spins analysed with DLS and TEM. EV composi-
tion analysed using western blot, dot-blot and RTqPCR. Functional
read-outs utilised a transwell co-culture system with a Cre-loxP recom-
bination read-out.
Results: P8 rod PRs survive in culture conditions without serum and
release EVs within 72 h. Protein profiling of 100,000g pellets revealed
expression of Alix and Tsg101 but not CD63. RTqPCR shows enrich-
ment for rod specific mRNA though at the lower limits of technical
detection. DLS revealed distinct populations at diameters of 100 nm,
300–500 nm and 1000 nm, which were further confirmed with TEM. To
assess whether PR-derived EVs are functional, we employed a transwell
co-culture system with Cre+ PRs placed in the top insert and dissociated
Ai9 TdTfloxed dissociated retina cultured at the bottom of the well. TdT+
microglia and astrocytes were observed after 14 days of incubation with
Cre+ PRs while no recombination was seen in control PRs.
Conclusion: Primary culture PRs release EVs with morphological and
molecular profiles typical of neuronal EVs and contain photoreceptor
specific RNA and/or protein, which may serve as marker of EV cell
origin. Further work is required to determine whether these EVs are
being taken up by other cells in the retina. Limitations in PR survival
currently preclude any conclusion regarding communication with
other PRs.
PF07.11
Extracellular vesicles as mediators of periphery-to-brain
communication: relevance for stress-induced neuropsychiatric
disorders
Giorgio Bergamini1, Hannes Sigrist1, Sandra Auer1, Tobias Suter2, Erich
Seifritz3 and Christopher Pryce1
1Preclinical Laboratory for Translational Research into Affective Disorders,
Psychiatric Hospital, University of Zurich, Zurich, Switzerland; 2Clinical
Immunology, University Hospital Zurich, Zurich, Switzerland; 3Psychiatric
Hospital, University of Zurich, Zurich, Switzerland
Introduction: There is evidence that inflammation is important in the
aetiology of several psychiatric disorders, including major depressive
disorder (MDD). Psychosocial stress, a major risk factor for MDD, is a
primary source of peripheral low-grade inflammation. A state of chronic
inflammation can induce MDD symptoms through a multiplicity of
effects on the functioning of brain neurocircuitry, including the dopa-
minergic system. Understanding of the aetio-pathophysiological path-
ways mediating between stress, inflammation, altered brain function and
psychopathology is currently limited. Interestingly, extracellular vesicles
(EVs) derived from hematopoietic cells can deliver miRNAs to CNS cells
during inflammatory conditions. The aim of this study is to (a) investi-
gate the effects of psychosocial stress on the peripheral immune system
and on dopamine (DA) neurons, and (b) assess if stress modifies blood
EVs miRNA content and their communication to brain DA cells.
Methods: Mice exposed to chronic social defeat (CSD) stress are assessed
for depression relevant-behaviours, peripheral inflammation markers
and dopamine system de-regulation. To investigate the effect of CSD
on EVs, plasma EVs are isolated and miRNA content is analysed using
qPCR. To investigate the hypothesis that stress stimulates EVs-mediated
periphery-to-brain communication, Vav1-iCre x Rosa26-GFP mice are
used. Neurons receiving EVs cargo from (Vav1+) hematopoietic cells are
identified by Cre-mediated GFP expression.
Results: Mice exposed to CSD exhibit increased splenic granulocytes,
inflammatory monocytes and T helper 17 cells. The immune response
co-occurs with attenuation of dopamine signalling and depression-rele-
vant behaviours. Future experiments will examine if (a) CSD affects the
miRNA cargo of blood EVs and (b) CSD-induced peripheral inflamma-
tion stimulates EVs-mediated transfer of RNA from blood immune cells
to the brain’s DA neurons, and affects DA cells gene expression.
Conclusion: These proposed experiments would serve to identify EVs-
RNA peripheral biomarkers, demonstrate their pathophysiological
importance in MDD-relevant brain and behavioural dysfunctions, and
allow for the identification of potential therapeutic targets for stress-
induced behavioural disorders.






























Misfolded proteins are carried by leucocyte-derived microvesicles in
amiothrophic lateral sclerosis
Daisy Sproviero1, Sabrina La Salvia1, Federico Colombo2, Marta Giannini1,
Luca Diamanti3, Paola Bini3, Orietta Pansarasa1, Laura Porretti4 and Cristina
Cereda1
1Genomic and post-Genomic Centre, IRCCS, C. Mondino National Institute
of Neurology Foundation; 2Istituto Clinico Humanitas IRCCS; 3Neurology
Department, IRCCS, C. Mondino National Institute of Neurology
Foundation; 4Flow Cytometry Centre and Experimental Hepatology Service,
IRCCS Ca’ Granda Ospedale Maggiore Policlinico Foundation
Introduction: The lack of biomarkers in amiothrophic lateral sclerosis
(ALS) makes impossible to determine the stage of the illness in patients
and that delays therapeutic trials. “Misfolded” proteins (SOD1, TDP-43
and FUS) are templates for the formation of protein oligomers that
accumulate and interfere with neuronal function, eventually leading to
cell death. Blood contains microvesicles (MVs), vesicles that bud directly
from the plasma membrane and “misfolded” proteins have been found
in plasma MVs of ALS patients highlighting a connection between
motoneurons and peripheral blood. The aim of the present study was
to characterise MVs in plasma of ALS patients, in order to discover a
new mechanism in disease progression.
Methods: Microvesicles were isolated from plasma of 40 ALS, 28 AD
patients and 36 healthy volunteers by ultracentrifugation. Markers for
MVs of leucocyte (CD45), endothelial (CD31), platelet (CD61), erythro-
cyte (CD235a) derivation and Annexin V were used for flow cytometry.
CD45 MVs were separated by immunoprecipitation and SOD1, TDP43,
FUS protein level was investigated in whole lysate and CD45 MVs byWB.
Results: Higher misfolded SOD-1 was found in plasma derived MVs of
ALS patients compared to healthy donors (ANOVA test, p < 0.0001), but
no difference in TDP43. Among four different markers detected by flow
cytometry, LMVs (leucocyte-derived microvesicles-CD45 MVs) were
mostly present in ALS patients compared to Alzheimer’s disease (AD)
patients and healthy donors (ANOVA test, p < 0.001). The percentage of
LMVs was inversely correlated with the progression rate in fast progres-
sing patients (Spearman r = −0.52, p = 0.02) and directly correlated with
the progression rate in slow progressing patients (Spearman r = 0.38,
p = 0.038). Isolated LMVs of slow progressing ALS patients carried more
misfolded SOD1 than the ones of healthy donors and fast progressors
and misfolded SOD1 protein level was strongly associated with the
percentage of LMVs in slow progressing patients (Pearson r = 0.71,
p = 0.0029).
Conclusion: Leucocyte-derived MVs are regulated by the rate of disease
progression in ALS patients and can act as “carriers” of misfolded
proteins, main cause of disease propagation.
PF07.13
Proteome analysis of cochlear pericyte-derived exosomes in normoxic
and hypoxic condition
Elisa Ghelfi1, Emil Millet2, Magda Bortoni2, Adam Bartos2, Yohann
Grondin2, Rosalinda Sepulveda2 and Rick Rogers2
1Harvard Chan School of Public Health, Department of Environmental
Health, MIPS Program, MA, USA; 2Harvard Chan School of Public Health,
MA, USA
Introduction: Ototoxic drugs such as gentamicin induce the forma-
tion of free radicals in the inner ear resulting in inflammation and
damage to the cochlear cells and microvasculature. Free radicals are
also considered the main culprit in noise induced hearing loss.
Hypoxia has been shown to occur in loud noise conditions due to
blood stagnation and stopped flow, leading to free radicals production
and potentiating noise induced hearing loss. The inner ear microvas-
culature, which is formed by two major vascular beds, the stria
vascularis and the spiral ligament (SL) vasculature, exhibits a blood–
inner ear barrier, the BLB, which is similar to the blood–brain barrier
(BBB). The SL microvasculature and SL pericytes have been shown to
share similarity with the brain capillaries. SL pericytes play an impor-
tant role in maintaining the integrity of the BLB. We investigated if
SL pericytes express markers of brain pericytes and if the ototoxic
drug gentamicin and hypoxia, induce inflammatory response in SL
pericytes. We then investigated the difference in exosome proteomics
in normoxia and hypoxia.
Methods: SL pericytes were obtained from Immortomouse®. Cells were
first incubated with gentamicin in normoxic and hypoxic conditions and
the level of inflammatory response was assayed. FBS exosome depleted
conditioned media was used for growing SL pericyte cultures in nor-
moxic and hypoxic conditions. Exosomes were isolated from condi-
tioned medium with basic differential ultracentrifugation and the
morphology examined by electron microscope. Exosome proteome was
obtained with a LTQ Orbitrap Velos Pro ion-trap mass spectrometer.
Results: SL pericytes showed positive signal for the validated brain
pericytes marker CD13. Incubation with the ototoxic drug gentamicin
induced SL phagocytic activity and increased the expression of cytokines
such as IL-6 and the LIF and MIP-2 and VEGF. The differences in the
exosome proteome from normoxic, hypoxic and gentamicin challenged
cells was analysed with bioinformatics tools for identifying and visualis-
ing enriched GO terms and the proteins function of the exosome
proteome.
Summary: Exosome proteomes from normoxic hypoxic and gentamicin
challenged SL pericites were investigated in physiological condition and
in inner ear pathological conditions induced by hypoxia and ototoxic
drug.
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PF08.01
Human seminal plasma exosomes carry key proteins for spermatozoa
capacitation
Valentina Murdica1, Elisa Giacomini2, Alessandra Alteri2, Natasa Zarovni3,
Andrea Salonia1, Paola Viganò2 and Riccardo Vago1
1Urological Research Institute, IRCCS San Raffaele Hospital, Milano, Italy;
2Reproductive Sciences Laboratory, Division of Genetics and Cell Biology,
IRCCS San Raffaele Hospital, Milano, Italy; 3Exosomics Siena SpA
Introduction: Male factor infertility is partially or fully responsible for up
to half of infertility cases and, among them, a relevant share results from
impairment of sperm maturation. Despite assisted reproductive technol-
ogies being increasingly used to cope with infertility, to date the fertilisa-
tion rate is only partially effective by employing apparently normal
semen. Recently, a certain attention has been directed to the role of
exosomes in spermatozoa maturation and in conferring overall fertilisa-
tion capacity by the transfer of key molecules along the male reproduc-
tive tract
Methods: We collectedseminal plasma from normozoospermic patients
upon obtaining approval by the local ethical committee and informed
consent by the patient. Exosomes were isolated and characterised by
nanoparticle tracking analysis, transmission electron microscopy and
western blot. The uptake of exosomes derived from seminal plasma
and labelled with a fluorescent dye by spermatozoa was monitored by
immunofluorescence.
Results: Seminal plasma contain both microvesicles and exosomes dis-
playing canonical protein markers such as CD9, CD63, Alix and
TSG101. In addition, exosomes, which represent a discrete population,
carry proteins involved in the spermatozoa maturation and fertilisation
capacity and in the mechanism of anti-oxidative protection. After eja-
culation, sperm cells are still receptive and can continue to receive
vesicle-delivered cargos. Indeed, we demonstrated that spermatozoa
uptake exosomes derived from different sources.
Conclusion: Exosomes play a strategic role in sperm maturation and
capacitation along the male reproductive tract, but also after ejaculation,
opening new perspectives for the assisted reproductive technology.
Funding: The project was funded by intramural grant programme.
PF08.02
Novel multiparametric high resolution flow cytometry to sort cell-
specific and size-specific extracellular vesicles
Terry K. Morgan1 and Kevin Judge2
1OHSU; 2BD Biosciences
Introduction: There is intense interest in developing new methods to
perform liquid biopsies of tumours using blood samples. This is possible
because tumours release millions of lipid encapsulated extracellular
vesicles (EVs)/ml into the blood stream. The term EVs includes small
exosomes (50–150 nm) and larger sub-micron sized microvesicles.
Progress in the field has limited, however, by the lack of cell and size-
specific rapid isolation methods. To address this issue, our group has
developed a new multiparametric high resolution flow cytometry
(HRFC) sorting method that can reliably identify, quantitate, and purify
cell- and size-specific EVs from any tumour of interest.
Methods: Submicron-sized polystyrene beads (100, 160, 200, 240, 300,
500, 900 nm) were used as sizing and sorting efficiency controls. We
used placental EVs present at high concentrations in maternal blood to
validate the method and then began experiments testing pancreatic
ductal adenocarcinoma specimens compared with negative controls.
Sorted EVs of various sizes and from various cell types (e.g. placenta,
platelets, pancreas) were characterised by electron microscopy, and used
to test whether there was enrichment of target-specific protein and
microRNA markers.
Results: Cell and size-specific EVs can be resolved and sorted to a high
level of purity (>99%) using as little as 10 ul of plasma to generate 105
isolated EVs (107/ml) within 10 minutes. Sorted placental EVs are
positive for exosome markers like CD9 and Annexins. They are positive
for trophoblastic markers like placental alkaline phosphatase and pla-
cental-related microRNAs. Electron microscopy confirms sorted EVs are
the expected size, purity, and concentration. CD41 positive platelet EVs
are present in similar concentrations, but are a distinctly different size,
ranging from 350–500 nm.
Conclusion: Using blood samples from pregnant women as a model for
enriched “tumour” EV populations we have validated our new multi-
parametric HRFC sorting method. This novel technology provides a
rapid means to characterise, count and isolate cell and size-specific
EVs from patient plasma.
PF08.03
Extracellular vesicle-associated TIMP-1 and PAI-1 significantly
enhanced pre-eclampsia predictive value of plasma placental growth
factor in low risk population
Kok Hian Tan1, Soon Sim Tan2, Mor Jack Ng1, Wan Shi Tey1, Wei Kian
Sim2, John Carson Allen3 and Sai Kiang Lim2
1KK Women’s and Children’s Hospital; 2A*STAR; 3Duke-NUS
Introduction: Circulating extracellular vesicles (EVs) such as cholera
toxin B chain (CTB)- or annexin V (AV)-binding EVs were previously
shown to be rich sources of biomarkers. Here we test if previously
identified pre-eclampsia (PE) candidate biomarkers, TIMP-1 in CTB-
EVs (CTB-TIMP) and PAI-1 in AV-EVs (AV-PAI) complement plasma
PlGF in predicting PE in a low risk obstetric population.
Methods: 843 prospectively banked plasma samples collected at 28 + 0 to
32 + 0 gestation weeks in the Neonatal and Obstetrics Risk Assessment
(NORA) cohort study were assayed by sandwich ELISAs for plasma
PlGF, CTB-TIMP and AV-PAI. 19 patients subsequently developed PE
7.3 (±2.9) weeks later at a mean gestational age of 36.1 ± 3.5 weeks. The
biomarkers were assessed for their predictive accuracy for PE using
stepwise multivariate logistic regression analysis with Firth correction
and areas under the curve (AUC).
Results: To achieve 100% sensitivity in predicting PE, the cut-off for plasma
PlGF, CTB-TIMP1 and AV-PAI1 were set at less than 1235, less or equal to
300 or more than 1300, and more than 10,550 pg/mL plasma, respectively.
The corresponding AUCs, specificity and PPV at 95% confidence interval
were 0.92, 52.1% and 4.7%, 0.72, 44.5% and 4.0%, and 0.69, 21.5% and 2.9%,
respectively. At 100% sensitivity, the three biomarkers had a combined
AUC of 0.96, specificity of 78.6%, and PPV of 9.9% PPV
Conclusion: This is the first large cohort validation of the utility of EV-
associated analytes as disease biomarkers. Specifically, EV biomarkers
enhanced the predictive robustness of an existing PE biomarker suffi-
ciently to justify PE screening in a low risk general obstetric population.
PF08.04
Identification of embryo competence by flow cytometric analysis of
nucleic acid-containing MVs in embryo culture media
Éva Pállinger1, Zoltán Bognár2, József Bódis3, Timea Csabai2, Nelli Farkas4,
Krisztina Gödöny3, Ákos Várnagy3, Edit I Buzás1 and Júlia Szekeres-Barthó5
1Department of Genetics, Cell- and Immunobiology, Semmelweis University,
Budapest, Hungary; 2Department of Medical Biology, Medical School, Pecs
University, Pecs, Hungary; 3Department of Obstetrics and Gynaecology,
Medical School, Pecs University, Pecs, Hungary; 4Department of
Bioanalysis, Medical School, Pecs University, Pecs, Hungary; 5MTA – PTE
Human Reproduction Research Group





























Introduction: Currently the efficiency of in vitro fertilisation (IVF) is
about 30% in humans. To increase the chances of implantation, many
IVF centres transfer more than one embryos, although multiple preg-
nancies are among the most common causes of preterm birth and
pregnancy complications. According to this, it would be crucial to select
the embryo that is most likely to implant and transfer that singular
embryo only.
Methods: We developed a test, based on flow cytometric detemination of
the nucleic acid containing (propidium iodide positive = PI+) extracel-
lular vesicle (EV) count in day 5 embryo conditioned media.
Results: 88 women undergoing IVF were included in the study. In most
cases more than one embryos were transferred. The intervention was
successful in 58 cases, while implantation failure was detected in 30
patients. PI+ EV count was correlated with clinical outcome of preg-
nancy. The number of PI+ EVs was significantly lower in the “clinical
pregnancy” group compared to the unsuccessful, “implantation failure”
group. Cut off level of PI+ EV count was calculated by the analysis of the
clinical outcome of single-embryo-transfer cases that resulted in a sin-
gleton pregnancy or, the two-embryos-transfers which eventuated twin
pregnancies. The embryo culture media of these “confirmed competent”
embryos contained lower level of PI+ EVs which suggests that a compe-
tent embryo can indeed be identified by low PI+ EV counts.
Conclusion: We developed a non-invasive, simple, cheap, rapid test,
which identifies the embryos that are most likely to implant.
PF08.05
Embryo-endometrium cross-talk: characterisation of extracellular
vesicles from in vitro cultured human embryos
Giacomini Elisa1, Riccardo Vago2, Ana Maria Sanchez1, Paola Podini3, Natasa
Zarovni4, Valentina Murdica2, Roberta Rizzo5, Daria Bortolotti5, Jennifer
Ovalle1 and Paola Viganò1
1Reproductive Sciences Laboratory, Division of Genetics and Cell Biology,
IRCCS San Raffaele Hospital, Milano, Italy; 2Urological Research Institute,
IRCCS San Raffaele Hospital, Milano, Italy; 3Department of Neuroscience,
Institute of Experimental Neurology, IRCCS San Raffaele Hospital, Milano,
Italy; 4Exosomics Siena SpA; 5Department of Medical Sciences, Section of
Microbiology and Medical Genetics, University of Ferrara, Italy
Introduction: Successful embryo implantation and consequent preg-
nancy is critically dependent on a two-way communication between
the maternal uterus and the blastocyst. However, given the ethical
restrictions and the lack of mechanistic studies, the identification of
key embryonic signals remains so far elusive. There are plenty evidence
on that extracellular vesicles (EVs) shuttled biomolecules can profoundly
affect the phenotype and activity of their target cell and proofs of EV
secretion have been reported in most cell types including embryonic
stem cells and in vitro produced embryos derived from some mamma-
lian species.
Methods: We collectedspent medium from embryo culture at day 3 and
day 5 after fertilisation, upon ethical committee approval and informed
consent. EVs were isolated and characterised by nanoparticle tracking
analysis and transmission electron microscopy. The presence of specific
EVs proteins and RNAs were investigated by western blot and RT-PCR.
The uptake of EVs derived from embryos and labelled with a fluorescent
dye by primary endometrial cell was monitored by immunofluorescence.
Results: Conditioned media from non-manipulated human embryos
cultured in vitro for 3 days or up to the blastocyst stage contain EVs
with a diameter of 30–300 nm and display traditional EV marker
proteins CD63, CD9 and Alix. The embryonic origin of these EVs was
confirmed by the presence of stemness gene transcripts (NANOG and
POU5F1) and their enrichment in the non-classical HLA-G protein at
appropriate stages of development, accordingly to their relative pattern
in blastocysts. We also show the preferential uptake of dye-labelled
embryo-derived EVs by primary endometrial cells.
Conclusion: Summary/conclusion: Our findings suggest EV exchange
as an emerging way of communication at the maternal–foetal interface
and raise some exciting possibilities regarding their potential therapeu-
tic use as a co-factor for promoting the establishment of a successful
pregnancy.
Funding: The project was funded by Merck Serono Grant For
Innovation.
PF08.06
Human follicular fluid-derived exosome (folliculosome) non-coding
RNA content is associated with ovarian reserve
Brandon A. Wyse1, Shlomit Kenigsberg1 and Clifford Librach2
1CReATe Fertility Centre; 2CReATE Fertility Centre, Department of
Obstetrics and Gynaecology, Department of Physiology, Institute of Medical
Sciences, University of Toronto, Department of Gynecology, Women’s
College Hospital
Introduction: The ovarian follicle is the basic female reproductive
unit containing the oocyte, somatic cells and follicular fluid (FF).
Proper intercellular signalling between these compartments is
required for optimal folliculogenesis, ovulation, and hormonal
secretion.
Recent studies have explored human FF exosomes, also known as folli-
culosomes (FFEs). FFE miRNAs have been implicated as potential bio-
markers for Polycystic Ovarian Syndrome (PCOS), blastocyst
development, and pregnancy outcome. However, other classes of non-
coding RNAs (ncRNAs) have yet to be characterised in FFEs.
Methods: This study was approved by the University of Toronto Ethics
Board. FF was collected from individual follicles at ovum retrieval
during in vitro fertilisation (IVF) procedures from consenting patients
with normal, low, or high anti-Müllerian hormone levels (AMH), which
is indicative of ovarian reserve (n = 9 patients). FFEs were isolated using
the exoEasy kit (Qiagen). The number and size of particles was deter-
mined using NanoSight and the purity was confirmed by Western
blotting. RNA was isolated using the NORGEN RNA isolation kit and
sequenced using the IonTorrent platform. Bioinformatic analysis was
conducted using Partek Flow.
Results: Several novel miRNAs were found to be differentially expressed
in FFEs from patient subgroups. Comparing high vs. normal subgroups,
miR125b, miR21 and miR22 were significantly downregulated by 4.6
fold (p < 0.01). We also observed significant downregulation of several
miRNAs in FFEs that have previously been identified as potential bio-
markers for PCOS and/or blastocyst development (miR30a and let7b).
Several piwi protein-interacting RNAs (piRNA) were also identified.
However, only two piRNAs (PIR36707 and PIR36741) were found to
be differentially expressed between the 3 subgroups.
Conclusion: We identified several novel miRNAs that are differentially
expressed between high, normal, and poor ovarian reserve subgroups.
This is the first report identifying piRNAs in FFEs by small RNA
sequencing. However, the biological significance of these piRNAs in
folliculogenesis is unknown. These sncRNAs further expand our under-
standing of the complex communication network in the follicle and
provide an opportunity for the development of novel biomarkers for
oocyte quantity.
PF08.07
Plasma exosomes miRNAs profile and placental dimensions in the
first trimester in gestational diabetes mellitus
Virginie Gillet, Larissa Takser and Annie Ouellet
Université de Sherbrooke, Canada
Introduction: Gestational diabetes mellitus (GDM), a common preg-
nancy complication, is related to placental dysfunction. Recent evidence
show differential miRNAs expression between GDM pregnancies and
uncomplicated pregnancies in the second and third trimester. Exosomes,
nanovesicles of 30–100 nm, are released by placenta in maternal circula-
tion and contained placental miRNAs. As well, it was noted that pla-
cental volumes are increased in second and third trimester in GDM
pregnancies.
Methods: The aims of the study were to determine the expression profile
of 15 selected miRNAs in plasma exosomes and to examine the associa-
tion between maternal plasma exosomes-miRNAs expression and pla-
cental measurements in cases of GDM in comparison to uncomplicated
pregnancies.
Results: Prospective case-control study nested in a cohort of pregnant
women recruited before 14 weeks of gestation was conducted. 14





























singleton pregnancies complicated by GDM and 15 singleton normal
pregnancies were matched for gestational age. miRNAs were extracted
from plasma exosomes (including placental exosomes) and their expres-
sion profile was determine by qRT-PCR. Placental maximal length and
placental thickness were measured on the first-trimester ultrasound
between 11–14 weeks of gestation.
Conclusion: We observed an overexpression of 7/15 miRNAs in GDM
group compare to normal group. We reported a negative correlation
between placental thickness and the expression of miR-122, miR-29a/
b, miR-376c and miR-517 for pregnant women who later develop a
GDM, but not for women with an uncomplicated pregnancy. Finally,
a negative correlation were found between maximal placental length
and expression of miR-1323, miR-136, miR-182, miR483 and miR-494
in controls groups but not in GDM group.CONCLUSION: Our data
suggest that the expression of specific miRNAs released by tropho-
blast through exosomes in GDM and normal pregnancy is closely
related to ultrasonographic placental measurements early in preg-
nancy. An inverse correlation between miRNAs expressions and pla-
cental dimensions in GDM could be the manifestation of an early
dysregulation in placental metabolism due to the disease. Further
studies are needed to explore the role of placental exosomes and
miRNAs as potential early non-invasive indicator of placental abnor-
mal development.
PF08.08
Role of the endogenous retroviral envelope glycoprotein Syncytin-2
in the uptake of placental exosomes by trophoblast and endothelial
cells
Caroline Toudic1, Xavier Elisseeff1, Yong Xiao1, Antoine Beaulieu1, Adjimon
Gatien Lokossou2, Éric Rassart1, Julie Lafond1 and Benoît Barbeau1
1Université du Québec à Montréal, Centre de recherche BioMed, Montreal,
Canada; 2École polytechnique d’Abomey Calavi, Centre Hospitalier et
Universitaire Mère et Enfant Lagune
Introduction: During pregnancy, the human placenta releases hor-
mones, growth factors, cytokines and extracellular vesicles (EV) that
modulate maternal physiology. Placental EV are released from the
syncytiotrophoblast (STB), a multinucleated structure at the contact
zone between maternal and foetal blood. Among EV, placental exo-
somes (Exo) are known to modulate the maternal immune system
and remodel spiral arteries. Interestingly, the human endogenous
retroviral protein Syncytin-2 (Syn-2), an important player of STB
formation, is also found on local and circulating placental Exo. Our
previous results showed that Syn-2 helps in the internalisation of
placental Exo in trophoblast cells. We investigate here the role of
Syn-2 in the entry of placental Exo in trophoblast and endothelial
cells.
Methods: Exo were isolated from cell supernatants of Syn-2-expressing
HEK293T and villous cytotrophoblasts (VCTB) using serial ultracentri-
fugation and characterised by TEM and NTA. Syn-2 was detected by
western blot and flow cytometry. Exo were stained with the fluorescent
dye PKH67 and their internalisation in VCTB, trophoblast-like BeWo
and HUVEC endothelial cells was monitored by live cell imaging and
flow cytometry.
Results: Flow cytometry confirmed the presence of Syn-2 on Exo from
transfected HEK293T and VCTB cells. The incubation of placental Exo
on VCTB, BeWo and HUVEC showed different internalisation rates but
similar perinuclear region localisation. Brefeldin-A treatment (2 µg/ml)
of HUVEC cells showed a 2-fold reduction in Exo internalisation com-
pared to control, suggesting an endocytosis-dependent entry, as it was
shown for BeWo and VCTB. The role of Syn-2 is now being assessed by
comparing internalisation of Syn-2+ and Syn-2- Exo in trophoblast and
endothelial cells.
Conclusion: Our data show that placental Exo are internalised in differ-
ent cells in a similar manner. We are currently investigating the role of
Syn-2 in this process and are further extending our analysis to exosomes
derived from extravillous cytotrophoblast. In term, this work will pro-
vide new knowledge on the uptake of placental exosomes by trophoblast
and endothelial cells and on the functional association between Syn-2
and placental exosomes.
PF08.09
Withdrawn at author’s request.
PF08.10
Genetic content of EVs from fish pathogens
Petter Langlete and Hanne Winther-Larsen
University of Oslo, Oslo, Norway
Introduction: Francisella noatunensis is a severe threat to the worldwide
fish farming industry, as there are currently no satisfactory vaccines
available. The bacteria induce francisellosis, which is characterised by
symptoms like discoloration, swollen kidney and spleen, formation of
granulomas and high mortalities, especially in farming enclosures. The
bacterium secretes extracellular vesicles (EVs), which have been pro-
posed as vaccine candidates for the pathogens, but their protection is
inconsistent and show varying levels of virulence. EVs from Gram-
negative sources have been shown to carry DNA between bacteria, so
there is significant reason to suspect that this is the case with F. noatu-
nensis as well. Little is known about whether specific sequences of DNA
are secreted in these EVs, or if the inclusion consists merely of random
fragments of the genome or plasmids.This naturally raises the concern of
how the use of EVs as vaccines could be affecting the spread of antibiotic
resistance genes.
Methods: F. noatunensis is grown in 200–300 ml of rich growth media
until a late exponential growth phase before vesicles are isolated by a
centrifugation-based protocol. Ultra-thin (~45 nm) cryosections of fixed,
DNAse-treated vesicle samples were imaged by transmission electron
microscopy under the addition of immuno-gold-labeling to confirm the
presence of DNA within the membranes.
Results: Vesicles are DNase treated, lysed and the DNA is isolated for
multiple displacement amplification (MDA) and bioanalyzer inspection,
to map concentrations and fragment lengths of present DNA.
Depending on concentration, a protocol for obtaining enough vesicle-
associated DNA will be constructed.
Conclusion: Immuno-gold electron microscopy confirmed the presence
of DNA inside vesicles, and this was also confirmed by MDA.
Summary: This project aims to investigate the DNA and RNA content of
extracellular vesicles from fish pathogens such as Francisella and
Piscirickettsia. So far in the project, I have confirmed the presence of
DNA inside the vesicles, and an analysis on DNA concentration and
fragment length distribution is in progress. After this is known, we
construct a protocol for quantitative sequencing on RNA and DNA to
assess preferential packing.
PF08.11
Orange juice contain two types of extracellular vesicles with
biological activities
Pascal Colosetti1, Emmanuelle Berger2, Alain Geloen3 and Sophie Rome2
1UMR Inserm U1060/INRA 1397; 2INRA; 3CNRS
Introduction: Our project is based on the concept that edible plants
contain extracellular vesicles (EVs) that may be used to restore muscle
homeostasis in the context of metabolic diseases. In this study we have
isolated and characterised EVs from juice of Citrus sinensis (L.) Osbeck
and have tested their activity on muscle cell proliferation.
Methods: Orange juice from untreated fruits was obtained by hand-
pressing, centrifugated at 3000g for 30 min, at 10,000g for 60 min, filtered
at 0.45 mm, centrifugated at 16,500g for 60 min and ultracentrifugated at
100,000g for 90 min. The resulting pellet was further purified on sucrose/
D2O gradiant or with qEVoriginal size exclusion columns of approxi-
mately 75 nm pore size (iZON). Protein concentrations and AChE activity
were measured on each fraction. EVs were labelled with PKH27 and their
captation was analysed on recipient cells. Their effect on cell proliferation
was tested on C2C12 muscle cells by using the xCELLigence real time cell
analysis system (Roche Applied Science).





























Results: EVs from the ultracentrifugation pellet (EVs-UC) modulated
proliferation, ROS production and triglyceride synthesis of C2C12.
EVs-UC were incorporated into intestinal CaCo-2 cells within 1 h.
Analyses with TEM and NTA showed that EVs-UC is composed of 2
types of EVs of different sizes and morphologies. The small EVs-UC
(SEVs-UC) were spheric and homogenous in size (150 nm).
Interestingly, SEVs-UC were excluded before LEVs-UC from iZON
columns suggesting a possible interaction with the resin carbohy-
drates. Sucrose/D2O gradient of EVs-UC subdivided LEVs-UC into
two populations of different densities and colours (orange and white).
Only LEVs-UC from the white ring had AChE activity. SEVs-UC
were found in the sucrose/D2O gradient pellet indicating that they
have higher density than the 2 LEVs-UC subpopulations. Moreover
only SEVs-UC repressed C2C12 proliferation.
Conclusion: These preliminary results indicate that EVs from orange
juice might have interesting properties to restore muscle homeostasis
during metabolic diseases and could participate in health benefits of
long-term orange juice consumption such as cardiovascular
protection.
LBP.26
Porcine in vitro maturation co-cultured with different donor age of
human adipose derived stem cell followed by parthenogenetic
activation
Erif Maha Nugraha Setyawan, Min Jung Kim, Hyun Ju Oh, Geon A Kim,
Seok Hee Lee, Jun-Xue Jin and Byeong Chun Lee
Seoul National University, Seoul, Republic of Korea
Introduction: Research efforts are increasing focused on extracellular
vesicles (EVs) as novel mediators of intercellular communication. EVs
are membrane-bound vesicles released by every cell type that has been
studied to date. Adipose derived stem cells (ASCs) secrete EVs which
have roles on oocyte maturation. The aim of this study was to determine
the porcine embryo development after maturated under co-culture sys-
tem with different donor age of ASCs.
Methods: The human ASCs (derived from young 1,2 (Y1 and Y2) and
old 1,2 (O1 and O2)) were seeded 1x105 cells into 12-wells plate with
AMSC medium and incubated in a 37 °C, 5% CO2 incubator for 24 h.
After reached 70% confluence, the media was changed to IVM media
and COCs were incubated with trans-well in first 22 h using hormone
and the second 22 h without hormone. Embryo developments such as
cleavage rate, blastocyst rate and blastocyst cell number were analyzed
using ANOVA continued with Duncan test in SPSS.
Results: Oocyte maturation and cleavage rates were significantly
increased in Y2 and O2 (88.0 and 86.3%, 83.2 and 83.5%, respectively)
than other groups (74.0, 78.5 and 75.0%, 67.0, 63.5 and 62.0%, respec-
tively). The ASCs co-culture with Y1 and Y2 groups showed higher
percentage of blastocyst rate compared to control group (23.8 and 23.0
vs. 16.1%, respectively, P < 0.05). Total cell number in all ASCs co-
culture groups exhibited higher number of cells compared with control
group.
Summary/Conclusion: Although oocyte maturation and cleavage rates
have variation with different human ASCs, the blastocyst formation rate
was increased in young human ACSs. There is a critical need for further
functional and mechanistic studies to provide conclusive experimental
evidence in intercellular communication mediated by EVs which might
be contributed to oocyte and embryo development.
Funding: This study was supported by Korea IPET (#114059-03-3-
SB010), Nature Cell (#550-20150030), Research Institute for Veterinary
Science, and the BK21 plus program.
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PF09.01
Impact of GP63 enrichment in Leishmania-derived exosomes in the
development of cutaneous leishmaniasis
Alonso da Silva Lira Filho and Martin Olivier
McGill University, Montreal, Canada
Protozoan parasites of the genus Leishmania are transmitted by the bite of
infected sand flies leading to a wide-range of diseases called leishmaniasis.
Depending on the species involved, it can produce a self-healing wound to a
potentially lethal visceral infection. Recently, we published a seminal work
demonstrating that leishmanial exosomes (Leish Exo) were released in the
lumen of the sand fly midgut and to be co-egested with the parasite during
the bloodmeal. Leish Exowere found to stimulate an inflammatory response
conducting to exacerbated cutaneous leishmaniasis, also it was shown that
these vesicles cargo important virulence factors like GP63, a metalloprotease
that regulate many important macrophage functions. First, we have been
interested to identify the immune sensors/receptors triggered by Leish Exo
leading to the skin hyperinflammatory response. Second, we wanted to
analyse the impact of GP63 in Leish Exo on the modulation of macrophage
inflammatory response and its infection in mice. C57BL/6 knockout mice
were used in the screening of receptors involved in the recognition of either
single or double stranded RNA, DNA, peptides or lipids enriched in these
vesicles, having their footpad infected with stationary Leishmania major
with or without Leish Exo. Additionally, using Leish Exo isolated from L.
amazonensis expressing different amounts of GP63 (WT, GP63low,
GP63high) we tested their capacity to induce the expression of various
cytokines (IL-1, TNF, IL-6) and chemokines (CCL2) on cultured macro-
phages. Finally, we infected Balbc mice in their footpad with stationary L.
amazonensis without or with Leish Exo from each three groups of parasites.
Results obtained revealed that specific sensors are involved in recognition of
Leish Exo and that GP63 enrichment in these vesicles induced differential
modulation of macrophage responses correlating with a distinctive skin
hyperinflammatory responses. Further information and discussion will be
provided during the poster session. This work was funded by a CIHR grant.
PF09.02
Characterisation of extracellular vesicles released by Leishmania
amazonensis and its role on macrophages activation
Fernanda MC. Barbosa1, Mayte dos S. Toledo1, Talita V. Dupin1, Kleber S.
Ribeiro2, Andre Cronemberger-Andrade3, Alison FA. Chaves2, Ana Cláudia
Torrecilhas4 and Patricia X. Batista5
1Universidade Federal de São Paulo campus Diadema, Sao Paulo, Brazil;
2Universidade Federal de São Paulo, Sao Paulo, Brazil; 3UNIFESP;
4Universidade Federal de São Paulo – UNIFESP, Sao Paulo, Brazil;
5Departamento de Ciências Farmacêuticas, Universidade Federal de São
Paulo campus Diadema, Sao Paulo, Brazil
Extracellular vesicles (EVs) are released by many pathogens. These EVs
perform several functions, such as delivering molecules that perform
effector activity on host cells. Some studies have demonstrated that EVs
released by some species of Leishmania appear to contribute to the
establishment of infection and immunomodulation. However, studies
have not been performed to verify the role of EVs produced by L.
amazonensis (specie responsible for cutaneous leishmaniasis in Brazil)
in the activation and/or modulation of phagocytic cells of the immune
system and disease progression. This work aimed to characterise the EVs
released by L. amazonensis promastigotes and its influence on macro-
phage activation. We showed by nanoparticle tracking analysis and
scanning electron microscopy that L. amazonensis promastigotes spon-
taneously released EVs at different time (1, 2, 4 and 24 h) and at several
temperatures (26, 34 and 37°C). These EVs modulated the medullary
macrophages response. It was also observed a significant reduction in
infection of bone marrow macrophages stimulated with vesicles com-
pared to unstimulated bone marrow macrophages. A different cytokines
profile was observed in stimulated macrophages as compared to
untreated cells. This data can contribute to a better understanding of
the host-parasite relationship and modulation/activation of the immune
system in L. amazonensis infection. These results can be further used in
the identification of new molecular targets as well as the development of
alternative therapeutic and diagnostic strategies.
PF09.03
B-1 cells infected with Leishmania amazonensis promastigotes release
extracellular vesicles that act as a novel mediator of macrophages
activation
Mayte dos S. Toledo1, Fernanda MC. Barbosa1, Andre Cronemberger-
Andrade2, Natasha FC. Reis1, Ana Cláudia Torrecilhas3 and Patricia X. Batista4
1Universidade Federal de São Paulo campus Diadema, Sao Paulo, Brazil;
2UNIFESP; 3Universidade Federal de São Paulo – UNIFESP, Sao Paulo,
Brazil; 4Departamento de Ciências Farmacêuticas, Universidade Federal de
São Paulo campus Diadema, Sao Paulo, Brazil
Immune cells can release different type of extracellular vesicles (EVs) that are
relevant vehicles of intercellular communication. EVs targeted various types
of immune cells and are involved in immune regulation depending on the
context. B-1 cells are a subtype of B lymphocytes with peculiar functions in
immunity. These cells are able to produce regulatory cytokines (mainly IL-
10), natural antibodies and differentiate into phagocytic cells. In this study
we evaluated the ability of B-1 cells in producing extracellular vesicles in the
presence or absence of L. amazonensis promastigotes and their influence on
macrophages activation. Our results showed that B-1 cells spontaneously
released EVs but there were increase in releasing after 24 or 48 h of in vitro
infection, as demonstrated by nanoparticle tracking analysis and scanning
electron microscopy. Macrophages from BALB/c mice treated with EVs
from infected B-1 cells led to a significant increase in IL-6 and IL-10, as
compared to the cells stimulatedwith EVs released by non-infected B-1 cells.
No differences were observed to TNF-alpha and iNOS. These macrophages
did not alter the phagocytic index (PI) after treatment with EVs from
infected or non-infected B-1 cells. To macrophages from C57BL/6 mice
we observed a significant reduction in the expression of IL-10 and iNOS but
the expression of IL-6 and TNF-alpha were increased in macrophages
stimulated with EVs from infected B-1 cells, as compared to macrophages
stimulated with EVs released by non-infected B-1 cells. Moreover, these
macrophages treated with EVs from infected B-1 cells have a significant
increase in the phagocytic index as compared to the same cells stimulated
with EVs from non-infected B-1 cells. Our work showed that B-1 cells are
able to release EVs but the infection stimulated an increase in their produc-
tion. These EVs modulated the expression of some cytokines and iNOS on
macrophages and led an increase in PI in macrophages from C57BL/6 mice.
PF09.04
Unravelling the exosome pathway in the human pathogen leishmania
Vanessa Diniz Atayde and Martin Olivier
McGill University, Montreal, Canada
Leishmania are ancient unicellular eukaryotes specialised in the infection
of macrophages. They cause a spectrum of diseases, in which severity is
related to the presence of numerous parasitic virulence factors that are
capable of triggering diverse inflammatory outcomes in the host. Recently,
we demonstrated that Leishmania exosomes are virulence factors, as they
are transmitted to the host during the sand fly bite alongside the parasite
and exert an important role in the establishment of the disease. Although
we have a quite good understanding on the role of Leishmania exosomes
during infection, little is known about their biogenesis and secretion by





























the parasite. In higher eukaryotes, the exosome pathway has been well
described. Efforts in finding exosome-specific markers have permitted
their characterisation as a unique population and have further confirmed
their biogenesis mechanisms. Proteomics studies are especially useful for
these means, since they catalogue vesicle content, which may hint at their
intracellular origin. Here, we analysed Leishmania exosome content by
mass spectrometry, using bioinformatics tools to fish out Leishmania
orthologues of described mammalian exosome-enriched proteins. We
found that Leishmania exosomes contain significant amounts of EHD4
and Annexin XI markers, as well as molecules involved in the exosome
pathway such as VPSs, Alix, Radixin and Rab11. In order to validate these
findings, we are currently in the process of knocking down some of these
proteins, to access their impact on exosome secretion and hence parasite
virulence. This work is relevant for its potential in finding new drug
targets to treat severe leishmaniasis and for unravelling Leishmania exo-
some biomarkers for diagnostics.
PF09.05
The protozoan parasite Trypanosoma cruzi viability is required for the
release of extracellular vesicles
Camilla Ioshida1, Rodrigo Soares2, Andre Cronemberger-Andrade1 and Ana
Cláudia Torrecilhas3
1UNIFESP; 2René Rachou Research Centre, Brazil, FIOCRUZ; 3Universidade
Federal de São Paulo – UNIFESP, Sao Paulo, Brazil
Introduction: Trypanosoma cruzi is a flagellated protozoan that causes
Chagas’ disease. It circulates in the bloodstream as trypomastigotes, which
invade several mammalian cell to proliferate as amastigotes. Trypomastigotes
hatched from infected mammalian cells in culture were found to release EVs
that modulate infectivity in the mammalian host. Parasite EVs contain the
major surface components of the parasite and their release depends on the
parasite strain. However, it is unknown the mechanism of EVs release and
whether it occurs as a consequence of parasite damaging. Here we investi-
gated EVs release in conditions that affect parasite viability.
Methods: Trypomastigotes were collected from infected mammalian
cells and incubated for 2 h under different conditions. After the incuba-
tion, parasites were tested for viability using Presto Blue Reagent.
Vesiculation was observed by scanning electron microscopy. EVs were
isolated by size exclusion chromatography (SEC) and characterised by
nanoparticle tracking analysis (NTA).
Results: The amount and size of EVs was similar from 4°C to 37°C,
conditions that did not affect parasite viability. In contrast, an increase
in size and decrease in concentration of the EVs were observed when
trypomastigotes were incubated with 0.01% of NaN3 with a parallel
decrease in the cellular viability. Maximal release was observed between
pH 5 and 7. Outside this range the release was reduced, with a simulta-
neous decrease in viability with visible changes in the parasite morphol-
ogy. Oxidative agents such as NaNO2 also affected EVs release at
conditions that cell viability was reduced.
Conclusion: We conclude that parasite viability and/or integrity is
required by EVs release.
PF09.06
Extracellular vesicles derived from heligmosomoides polygyrus
represent a novel target for vaccine-induced immunity
Gillian Coakley1, Jana L. McCaskill2, Jessica G. Borger3, Henry J. McSorley4,
Amy H. Buck2 and Rick M. Maizels1
1Wellcome Centre For Molecular Parasitology, Institute for Infection,
Immunity and Inflammation, University of Glasgow, United Kingdom;
2Institute of Immunology and Infection Research, Centre for Immunity,
Infection and Evolution, School of Biological Sciences, University of
Edinburgh, United Kingdom; 3The Peter MacCallum Cancer Centre,
Melbourne, Australia; 4MRC Centre for Inflammation Research, The Queens
Medical Research Institute, University of Edinburgh, United Kingdom
Introduction: Extracellular vesicles (EVs), including exosomes, facilitate
cellular communication through the transfer of small RNAs, lipids and
proteins. It has been shown that parasites secrete EVs which can play a key
role in both pathogenicity and host immunoregulation, and that parasite-
derived EVs directly modulate the host immune response. In particular,
we demonstrate that secreted vesicles from the murine gastrointestinal
nematode Heligmosomoides polygyrus interfere with epithelial cell and
macrophage innate responses to infection, inhibiting the type 2 immune
response in the host that is required for parasite expulsion.
Methods: Comparative studies between mammalian and H. polygyrus-
derived EVs highlight some of the key factors responsible for EV uptake,
and showed that specific antibodies against parasite EVs interfere with
their entry into mammalian cells in vitro, inhibiting any parasite-
mediated effects on the host cell. Additionally, immunisation of mice
using an EV/alum conjugate contributes to significant protection from a
subsequent H. polygyrus infection. Immunity against larval challenge is
seen through the initiation of specific antibody responses against EVs,
and results in a substantial reduction of parasitic egg counts and adult
worm burden. Using cross-link immunoprecipitation and mass spectro-
metry, we have identified the major candidate proteins from these EVs
that are recognised by antibodies generated by the EV/alum vaccination
schedule. Identification of these candidates has prompted further inves-
tigation into both the individual roles of these proteins during infection,
and whether they serve as appropriate targets for vaccination against a
subsequent H. polygyrus infection.
Conclusion: This work suggests that EVs secreted by nematodes could
mediate the transfer and uptake of parasitic products into host cells,
establishing cross-species communication to suppress the host immunity.
Furthermore, gaining a better understanding of the molecular complexity
of these EVs, and how they drive host immunity, will be crucial for the
development of an efficient vaccine against nematode infection.
PF09.07
Extracellular vesicles releades by strains of Leishmania enriettii with
different degrees of pathogenicity: extraction, purification and
preliminary characterisation
Larissa Paranaiba1, Armando Menezes-Neto2, Ana Cláudia Torrecilhas3 and
Rodrigo Soares2
1Universidade Federal de Minas Gerais; 2René Rachou Research Centre,
Brazil, FIOCRUZ; 3Universidade Federal de São Paulo – UNIFESP, Sao
Paulo, Brazil
Introduction: Leishmania enriettii is a non-infectious species toman, whose
reservoir is the guinea pig Cavia porcellus. Many aspects of the parasite-host
interaction were studied involving its main surface glycoconjugates includ-
ing lipophosphoglycans (LPGs) and glycoinositolphospholipids (GIPLs).
Those glycoconjugates were important for immunopathogenicity via
TLR2 and TLR4. Since those structures could be also present in the extra-
cellular vesicles (EVs) of the protozoa. This project aims to investigate the
role of those structures in L. enriettii pathogenicity.
Methods: Two strains (L88 and Cobaia), with different degrees of
immunopathology were studied. Parasites were grown until stationary
phase and vesicle release was stimulated by raising temperature (34–37°
C) for 2–4 h in serum-free conditions. Supernatants were processed by
differential centrifugation and vesicles were isolated by ultracentrifuga-
tion (100,000g) or size exclusion chromatography (SEC). Vesiculation
was observed by electron microscopy and vesicles were quantitated by
nanoparticle tracking analysis (NTA).
Results: Both strains were able to shed vesicles, as demonstrated by SEM
analysis. NTA quantitatively confirmed SEM data. The EVs released by
L88 and Cobaia strains had similar size distributions with modal sizes of
136 (±1.5) nm and 141 (±5.4) nm, respectively. After normalisation by
cultured parasite concentrations, a slightly higher amount of EVs was
observed for the cobaia strain, although this finding needs further con-
firmation. EVs from the Cobaia strain were isolated by size exclusion
chromatography (SEC) and fractions were analysed by NTA and dot-blot
for the detection of gp63, an important EV surface marker in Leishmania.
Conclusions: The detection of gp63 in the same fractions in which
particles were detected by NTA, not only corroborates their vesicular
nature but also suggests that L. enriettii EVs are likely to be involved in
the immunomodulation of host cells. Further characterisation will be
performed to qualitatively compare the EVs from both strains especially
regarding their contents and funcionality in macrophages.Those features
could help to understand the differences in their immunopathology.






























Leishmania-derived extracellular vesicles express lipophosphoglycan
(LPG) on their surface
Armando Menezes-Neto1, Blima Fux2, Frederic Frezárd3, Valéria Borges4,
Albert Descoteaux5, Ana Cláudia Torrecilhas6 and Rodrigo Soares1
1René Rachou Research Centre, FIOCRUZ, Brazil; 2Federal University of
Espírito Santo (UFES); 3Federal University of Minas Gerais (UFMG);
4Gonçalo Moniz Research Centre, FIOCRUZ, Brazil; 5Centre INRS–Institut
Armand-Frappier; 6Universidade Federal de São Paulo – UNIFESP, Sao
Paulo, Brazil
Promastigote forms of Leishmania release exosomes that modulate
microbicidal activities of macrophages. Previous studies have demon-
strated that GP63 is an exosome surface marker for Leishmania. In
the parasite surface, along with GP63, Lipophosphoglycan (LPG) is
the major surface glycoconjugate and a multi-virulence factor.
Among many functions, LPG modulates nitric oxide and cytokine
production via TLR2 and TLR4 and inhibits phagolysosome biogen-
esis and oxidative burst. However, its presence in parasite-derived
vesicles is yet to be demonstrated. We hypothesise that LPG is
present in parasite vesicles and is involved in communication
between parasite and host cell. Four strains (Leishmania braziliensis
M2903, L. infantum BH46, L. infantum Ba262 and L. infantum
Ba262-KO(lpg1-/-)) were grown to stationary phase and vesicle
release was stimulated by raising temperature (34–37°C) for 2–4 h
in serum-free conditions. Supernatants were processed by differential
centrifugation and vesicles were isolated by ultracentrifugation
(100,000g) or size exclusion chromatography (SEC). Vesiculation
was observed by electron microscopy and vesicles were quantitated
by NTA and Bradford assay. All strains produced vesicles in the
expected size range of exosomes. Immunodetection of glycoconju-
gates was performed in ELISA or dot-blot assays, using an mAb anti-
GP63 and the mAb CA7AE, specific for the Gal-Man-P epitope,
present in LPGs of most Leishmania. LPG and GP63 were detected
in the EV-containing SEC fractions. Our data strongly support that
LPG is present in promastigote-derived EVs. Molecular shaving of
EVs with proteinase K suggested that proteophosphoglycans (PPGs)
might also be present. The immunomodulatory properties of these
vesicles, specially the role of LPG, are being further investigated.
These findings expand current knowledge on glycobiology of
Leishmania and imply the applicability of vesicles as diagnostic or
therapeutic tools against leishmaniasis.
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PF10.01
A novel role for extracellular Hsp90 in exosome traffic from cancer
cells
Daniel Wong, Aaron Bernstein, Kofi Gyan and Dan Jay
Tufts University School of Medicine, MA, USA
We and others identified extracellular Hsp90 (eHsp90) as pro-invasive
using a FALI-based screen for proteins required for cancer invasiveness
and showed that Hsp90 activates Matrix Metalloproteinase-2 (MMP2) to
facilitate breast cancer invasion. Since then, many pro-invasive proteins
activated by eHsp90 for different cancers have been identified by several
labs suggesting that eHsp90 may serve as an activation hub for cancer
invasion. Hsp90 is released from cancer cells via exosomes and appear on
their outer surface and these exosomes enhance invasion in an Hsp-90
dependent manner. Together, these observations suggest that eHsp90 may
act in exosome trafficking. We tested this notion by treating MDA-MB-231
breast cancer cells in culture with the Hsp90 inhibitors ganetespib or STA-
12-7191 (a biotinylated and thus impermeant derivative of ganetespib) and
measured the release of exosomes from these cells and the uptake of
exosomes by stromal cells. Drug treatments resulted in a 50% reduction
in exosome release as assessed by protein concentration and Hsp90 com-
pared to no drug controls and markedly inhibited uptake of eHsp90-con-
taining exosomes by stromal cells. The general mechanisms of exosome
trafficking are poorly understood and we are examining and quantitating
subpopulations of exosomes from drug-treated cells to address this. Thus,
we have evidence that eHsp90 has roles in both exosome release and uptake
by stromal cells, important processes for the communication of tumours
with their extracellular milieu that enhance invasion.
PF10.02
Proteomic profiling of extracellular vesicles reveals differences in
glucose metabolism reflecting cancer invasiveness
Steven G. Griffiths1, Félix Royo2, Juan M. Falcón-Pérez2 and Alan A.
Doucette3
1X0S0ME; 2CIC bioGUNE; 3Dalhousie University, Halifax, Canada
Introduction: Cancer cells universally exhibit dysregulated metabolism
such as accelerated aerobic glycolysis, glutaminolysis and heme bio-
synthesis. These provide energy currency and precursors for new cells
and exosomes as well as reducing power and redox control for rapidly
proliferating cells. Lethality of a cancer and management options are
determined by the degree and combination of these proclivities. We
tested the hypothesis that vesicle-bound metabolic enzymes exported
from breast cancer cell lines could differentiate between invasive, mini-
mally invasive and non-transformed phenotypes.
Methods: EVs were recovered from bioreactor culture media by peptide
affinity (Venceremin, Vn96) to heat shock proteins (HSPs) common to
the surface of all cancer cells. Three breast cancer cell lines of varied
tumorigenic phenotype were examined: invasive (SKBR3), ductal carci-
noma (MCF7) and non-transformed (MCF10). EV proteins were
resolved with a solution-based procedure GELFrEE. Discrete molecular
weight ranges were subject to proteomic analysis via liquid chromato-
graphy/mass spectrometry (LC/MS).
Results: Enzymes typical of altered metabolic pathways were abundant in
EVs from cancer cells. Ingenuity pathway analysis indicated that glyco-
lysis/gluconeogenesis and the pentose phosphate pathway were at the
top of 14 canonical pathways represented in SKBR3, second and fourth
for MCF7 and absent from MCF10.
Conclusion: Invasiveness and stromal subjugation by cancer may be
dependent upon the export of pleiotropic enzymes that disseminate the
metabolic phenotype directly or through epigenetic influence among
localised subclones and surrounding cells. EVs may also
compartmentalise pathways from inhibitors. HSP affinity capture of
EVs combined with GELFrEE provides a rich source of proteomic
information to determine invasive capability of cell cultures with poten-
tial for use in screening EVs from liquid biopsy samples such as ascites,
plasma or urine for staging and treatment options.
PF10.03
Effect of hypoxia on the exosome release and migration activity of a
panel of ovarian tumour cell lines that mimic different stages of the
tumour
Mona Alharbi1, Shayna Sharma1, Carlos Palma1, Richard Kline2, Katrina
Wade2, Jacob Estes2, John Hooper3, Gregory Rice1 and Carlos Salomon1
1Exosome Biology Laboratory, Centre for Clinical Diagnostics, University of
Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane, Australia; 2Department
of Obstetrics and Gynecology, Ochsner Baptist Hospital, New Orleans, LA,
USA; 3Mater Research Institute, University of Queensland, Translational
Research Institute, Woolloongabba, Australia
Introduction: The aim of this study was to determine the effect of
hypoxia on the exosomes release and migration capacity of nine ovarian
tumour cell lines.
Methods: Ovarian tumours cell lines (i.e TOV-122, HEY, OVCAR429,
SKOV-3, CAOV-3, OVCA420, A2780, OV-90 and OVCAR-3) and
mesothelial cell line (MET-5A) were used in this study. Cells were
cultured under 21% O2 (normoxia) and 1% O2 (hypoxia) for 48 h.
Small extracellular vesicles were enriched from cell-conditioned media
by differential centrifugation from 800g, 2000g and 12,000–100,000g.
Exosomes were further enriched using 200 nm filter and ultrafiltration
(100 kDa cutoff). Exosomes were characterised by electron microscopy
and western blot (CD63 and TSG101), and quantified by nanoparticle
tracking analysis (NanoSight). Migration capacity of cells was deter-
mined using a real-time imaging system (Incucyte).
Results: Exosomes were identified as spherical vesicles, with a typical cup
or spherical-shape and diameters around of 100 nm and positive for
CD63 and TSG101. Hypoxia increased the exosomes release ~3.5, ~7.3,
~3.0, ~2.5, ~3.0, ~13.2, ~2.4 and ~1.2-fold in TOV-122, OVCAR429,
SKOV-3, CAOV-3, MET-5A, OVCA420, A2780 and OVCAR-3, respec-
tively. Finally, the exosome release was positively correlated with migra-
tion capacity of cells.
Conclusion: This study established that hypoxia increase the exosome
release in a wide range of ovarian cancer cell lines. Interestingly, exo-
some release was associated with the migration capacity of correspond-
ing cells. Therefore, we suggest that exosomes concentration may be an
indicator of tumour stage and invasiveness.
PF10.04
Impact of the oncogenic C19MC microRNA cluster on the vesiculation
of human paediatric embryonal brain tumour cells- ETMR as a
paradigm
Esterina D’Asti, Laura Montermini, Andrea Bajic, Nada Jabado and
Janusz Rak
The Research Institute of the McGill University Health Center, Montreal, Canada
Introduction: Disorganised intercellular communication due to deregu-
lated genetic and epigenetic molecular control represents a hallmark of
paediatric embryonal brain tumours. Embryonal tumour with multi-
layered rosettes (ETMR) represents a paradigm of these events due to
oncogenic amplification of the C19MC cluster, which drives widespread
epigenetic deregulation of gene expression, a highly malignant pheno-
type as well as enrichment in cancer cell stemness. Since oncogenic





























mutations often impact vesiculation and its related intercellular commu-
nication pathways, we explored the impact of C19MC and one of its key
components, miR-520g, on the vesiculation of embryonal brain tumour
cells.
Methods: ETMR cells (BT183) and embryonal brain tumour cells engineered
to express miR-520g (DAOY and UW228) were tested for overall vesicula-
tion, cellular RNA expression of vesiculation-related markers, and the pro-
teome of extracellular vesicles (EVs) as a function of oncomir activity.
Results: We observed that miR-520g upregulates EV emission while
changing the expression of genes involved in EV biogenesis (vesiculome)
and impacting EV cargo (e.g. by suppressing the vascular regulatory
protein known as tissue factor- TF). We verified the causality of miR-
520g in this context and described the related changes in the EV
proteome and RNA content, especially the levels of miR-520g itself.
EVs from brain tumour cells harbouring miR-520g were tested for
their effects on endothelial cell behaviour as ETMR exhibits highly
haemorrhagic morphology.
Conclusion: Oncogenic microRNA associated with ETMR alters cancer
cell vesiculation pathways in ways that may affect cell-cell communica-
tion and disease biology.
PF10.05
Impact of WNT signalling on the vesiculation of human
medulloblastoma cells
Esterina D’Asti, Laura Montermini and Janusz Rak
The Research Institute of the McGill University Health Center, Montreal, Canada
Introduction: The WNT signalling pathway regulates intercellular commu-
nication,morphogenesis, and stemness in health and disease and is frequently
overactivated in human brain tumours such as medulloblastoma (MB). This
activation state is either ligand-dependent or results from gain-of-function
mutations affecting beta-catenin (CTNNB1), the key mediator of WNT-
regulated gene expression and a known oncogene. Since oncogenic lesions
often exert their biological effects, at least in part, through their impact on the
formation, cargo, and function of extracellular vesicles (EVs), we asked
whether this pathway is affected by overactivation of WNT in MB cells in
culture.
Methods: MB cell lines (DAOY and D283), were stimulated using
soluble WNT3A ligand and characterised for EV emission as well as
the RNA and protein expression profile of vesiculation markers.
Results: We observed multiple changes in cellular RNA encoding EV-reg-
ulating genes (vesiculome) in MB cells treated with WNT3A, along with
changes in EV emission characteristics and protein cargo. Notably, a robust
and consistent WNT3A-dependent downregulation of exosomal markers
(CD63 and CD81) was noted in the total EV fraction by western blotting.
Conclusion: Activation of canonical WNT signalling may reduce and
reprogram exosomal release from brain tumour cells. The significance of
this finding in the context of MB biology is under study.
PF10.06
Detection, characterisation and function of extracellular vesicles in
resistant melanoma
Giulia Cesi1, Demetra Philippidou1, Francois Bernardin2, Yeoun Jin2,
Guillaume Van Niel3 and Stephanie Kreis1
1University of Luxembuourg, Luxembourg; 2Luxembourg Institute of Health;
3Institut Curie, PSL Research University, Paris, France, CNRS
Introduction: Extracellular vesicles (EVs) are nano-sized structures that
are released by all cell types under both physiological and pathological
conditions. As EVs can be released by “donor” cells and taken up by
“recipient” cells, they can be regarded as vehicles of intercellular com-
munication or “homing pigeons” influencing key biological functions by
delivering and transporting cytokines, growth factors, proteins, mRNAs
and microRNAs. Recently, EVs have also been identified as new mes-
sengers in transferring drug resistance to still sensitive cells. In mela-
noma patients, drug resistance is a pressing issue. Despite the promising
initial results obtained with vemurafenib and dabrafenib (BRAF kinase
inhibitors) in the clinic, it soon became evident that these molecules
were not able to provide durable responses, as resistance to treatment
soon develops within months in almost all patients.
Methods: The content of the EVs released by sensitive melanoma cells and
their corresponding drug resistant cells has been analysed by mass spectro-
metry. In addition co-culture experiments have been performed to under-
stand the potential involvement of EVs in the “spreading” of drug resistance.
Results: We could show that sensitive melanoma cells acquire the drug
resistant phenotype if co-cultured with EVs released by resistant cells.
Proteomic analysis revealed different content profiles with a panel of
proteins especially enriched in the “resistant extracellular vesicles”.
Hence, potential candidates that might play a role in conferring drug
resistance have been identified.
Conclusions: Our results suggest that “resistant extracellular vesicles”
have functional properties capable of making sensitive melanoma cells
more resistant to BRAF inhibitors.
PF10.07
Mutant BRAF inhibition changes the expression of exosomal coding
and non-coding RNAs released by melanoma cells
Taral Lunavat1, Lesley Cheng2, Robyn A. Sharples2, Cecilia Lässer3, Andrew
F. Hill2 and Jan Lötvall1
1Krefting Research Centre, Institute of Medicine, University of Gothenburg,
Sweden; 2Department of Biochemistry and Genetics, La Trobe Institute for
Molecular Science, La Trobe University, Victoria, Australia
Introduction: In melanoma, more than 50% of patients harbour BRAF
mutations, most commonly the valine-600 (V600) variant. Vemurafenib
is a BRAF-V600 inhibitor used for the treatment of late stage melanoma.
Here we determine the effects of vemurafenib on melanoma cells and the
RNA content in cells and exosomes.
Methods: Exosomes were isolated using a differential centrifugation
protocol, followed by ion torrent sequencing to identify coding and
non-coding RNAs. Sequences were aligned to the human genome
(HG19) using the Torrent Suite, and files were transferred to Partek
Genomic Suite and Flow (Partek Incorporated, Singapore) for mapping
against miRBase V.21 and Ensembl Release 75 to identify miRNA,
ncRNA and coding RNA species. Characterisation of exosomal proteins
were validated by using Western blot.
Results: Inhibition of BRAF mutant melanoma cells with vemurafenib
significantly altered the RNA contents in cells as well as in the exosomes.
Exosomes from the treated cells showed differentially expressed miRNAs
compared to the exosomes from the nontreated cells. Interestingly, hier-
archical clustering of coding and non-coding RNA between the exosomes
from treated and nontreated cells showed unique clusters in exosomes from
treated vs. non-treated cells. Differential expression of coding and non-
coding RNA showed vast changes of expression. As examples, we could
identify 6–7 fold upregulation of CTTN and LAMA5, as well as 11 and 6
fold downregulation of PQBP1 and KANK1 respectively.
Conclusion: The inhibition of mutant BRAF induces differential expres-
sion of coding and non-coding RNAs in melanoma cells and their
released exosomes. This work provides the framework for further inves-
tigations of significantly expressed coding and non-coding RNA in
exosomes, as well as in cells receiving this cargo.
PF10.08
Antagonistic GTPase signalling regulates the shedding of invasive
tumour microvesicles
James Clancy, Christopher Tricarico and Crislyn D’Souza-Schorey
Department of Biological Sciences, University of Notre Dame, IN, USA
Tumour cells utilise a complex and multifaceted approach to degrade
and invade through surrounding extracellular matrix (ECM). During
invasion through compliant matrices, we have previously demonstrated
that invading tumour cells convert to an amoeboid-like mode of inva-
sion, which is accompanied by the extensive release of protease-loaded
invasive tumour microvesicles (TMVs) directly into the extracellular





























environment. This process is in part facilitated by the activation of the
small Ras-related GTPase, ARF6, which regulates the outward flow of
recycling membrane and cargo to facilitate TMV formation at the cell
surface. Here we extend these findings and show that coordinated and
antagonistic regulation of the ARF6 and Rab35 GTPases, in concert with
regulation of the cell’s contractile machinery, governs TMV shedding
from invasive melanoma cells. These results, particularly in light of
ARF6 and Rab35 expression in various tumours, highlight the increasing
importance of GTPase signalling in the shedding of TMVs, which
underlie the morphological and functional changes during adaptive
tumour cell invasion.
Funding: Supported in part by the National Cancer Institute.
PF10.09
Leukaemic-derived exosomes induce paracrine and autocrine cell
proliferation in paediatric acute lymphocytic leukaemia
Shabirul Haque and Sarah Vaiselbuh
The Feinstein Institute for Medical Research at Northwell Health, NY, USA
Introduction: Exosomes represent the fingerprint of the parental tumour
and are loaded with bioactive markers such as proteins, RNA and DNA,
which may regulate tumour growth. Exosomal cargo can be transferred
into target cells changing their biological properties. Our data present
the first study to investigate a biological role of exosomes in paediatric
acute lymphoid leukaemia (P-ALL).
Methods: The aims were to (1) demonstrate that ALL exosomes
induce ALL cell proliferation; (2) confirm that exosome induction is
regulated by expression of proliferative and pro-survival genes with
suppression of pro-apoptotic genes in ALL cells; (3) analyse differ-
ences in miRNA profiling of ALL cell lines after induction with
leukaemic exosomes
Exosomes were isolated by ultracentrifugation from healthy donors
(HD), P-ALL serum and conditioned medium (CM) of SUP-B15 (B-
ALL), JM1 (B-ALL), and CL-01 (normal B cells) human cell lines. All
cell lines were exposed to different sources of leukaemia-derived exo-
somes in a paracrine or autocrine fashion. Proliferation was assessed by
microscopic cell counting and confirmed by colorimetric assay and gene
expression for proliferation (Ki-67, PCNA), pro-survival (MCL1, BCL2)
and pro-apoptotic (BAD, BAX) genes. Fold change was calculated by
comparing controls (naive) vs. exosome-induced cell lines. miRNA
profiling was performed with the Human Cancer Pathway Finder micro-
array (Qiagen).
Results: We elucidated that CM-derived exosomes from ALL cell lines
as well as from serum of ALL patients induce cell proliferation in
SUP-B15, JM1 and CL-01 cells. At a molecular level, we found that
exosomes from JM1 and SUP-B15 cells enhance expression of pro-
liferation genes (PCNA, Ki-67) and pro-survival genes (MCL-1,
BCL2), and suppress pro-apoptotic genes (BAD, BAX) in JM1 cells.
Heatmap analysis of miRNA profiles of ALL cell line exosomes will
be discussed.
Conclusion: Our data suggest that ALL exosomes induce cell prolifera-
tion in both paracrine and autocrine fashion of leukaemic and non-
leukaemic B cell lines. Exosomes regulate these phenomena in a highly
orchestrated way, by induction of proliferative and pro-survival genes,
with suppression of pro-apoptotic genes.





























Poster Session F11 – Cell and Tissue Remodelling and Repair
Chairs: TBD 5:15–6:30 p.m.
PF11.01
Human embryonic stem cell-released extracellular vesicles: effects on
cultured retinal Müller glial cells and NMDA-damaged mouse retinas,
in vivo
Edouard Baulier, Yingqian Peng, Yifeng Ke and Debora B. Farber
University of California, Los Angeles, CA, USA
Introduction: We have previously demonstrated that cultured retinal
progenitor Müller cells exposed to mouse embryonic stem cell (ESC)-
derived extracellular vesicles (ESEVs) show gene expression changes
associated with de-differentiation and activation of a retinogenic pro-
gramme of differentiation. Now we investigated whether human ESEVs
(hESEVs) and their fractionated microvesicles (MVs) and exosomes
(EXOs) cause similar effects on cultured human Müller cells and rescue
in vivo the function of damaged mouse retinas.
Methods: hESEVs, MVs and EXOs from culture medium of H9 hESCs
were characterised (size, molecular and biochemical components and
surface proteins). Their uptake by human cultured Müller cells and their
effects on the biochemical components of these cells were studied using
imaging flow cytometry, and qRT-PCR, western blots and immunocy-
tochemistry, respectively. Mice with both retinas NMDA-damaged were
injected in left eyes with hESEVs and in right eyes with PBS (control).
Electroretinograms (ERGs) were measured in each retina 10, 30 and
60 days post-injection.
Results: MVs and EXOs differed in size, RNA profiles, multiple
expressed genes and surface markers. hESEVs, MVs and EXOs were all
internalised by cultured Müller cells, but only hESEVs and MVs induced
changes in the cells (increase of pluripotency mRNAs and proteins)
leading to de-differentiation (reflected in a decreased level of Müller
cell marker vimentin) and increased level of early retinal protein PAX6
(possibly revealing trans-differentiation of Müller cells into retinal neu-
rons). 2 out of 5 mice that had lost retinal ganglion and amacrine cells
after NMDA damage showed great improvement in the ERGs’ b-wave
amplitude 30 and 60 days after an hESEV injection (which indicated
recovery of retinal function). No effect was observed in the PBS-injected
retinas.
Conclusion: Exposure to hESEVs or MVs induces molecular changes in
human cultured Müller cells leading to their de-differentiation and
trans-differentiation into retinal neurons. In initial studies, hESEVs
injected into NMDA-damaged retinas of 5 mice, possibly acting through
the endogenous Müller cells, rescued retinal function in 2 animals. These
are promising findings for future therapy of retinal degenerations.
PF11.02
Hyperglycemia induced microvesicles control endothelial cell
migration
Anna Elżbieta. Drożdż1, Robert Jach2, Hubert Huras3 and Ewa Stępień1
1Department of Medical Physics, Faculty of Physics, Astronomy and Applied
Computer Science, Jagiellonian University, Krakow, Poland; 2Department of
Gynaecological Endocrinology, Faculty of Medicine, Jagiellonian University
Medical College, Krakow, Poland; 3Department of Obstetrics and Perinatology,
Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland
Introduction: Cell migration is one of the crucial mechanisms for wound
healing and tissue regeneration. It strongly depends on the biochemical
composition of environment and cell vitality. During diabetic diseases
cell migration is impaired, which could be linked to the influence of
microvesicles (MVs), which are involved in this process.
Methods: Studies were performed using human umbilical vein endothe-
lial cells (HUVECs). The scratch assay was used to assess cell migration
in different conditions. A confluence index (CI) was chosen as a para-
meter to assess cell migration. Culture media containing additional
factors: glucose (25 mM/ml or 50 mM/ml) and MVs isolated from
plasma of (a) uncontrolled diabetic patients (UD) or (b) healthy control
(HC), as well as from the (c) hyperglycemic (25 mM/ml) and (d)
normoglycemic HUVEC preconditioned media. Scratch assay was per-
formed, HUVECs were cultured in the density of 42 × 103 cells/cm2 and
recorded immediately and at several time points in the next 14 h. As a
long time assessment to confirm dynamics in cell metabolism and
proliferation, viability tests were performed. MV concentration in cul-
ture medium was flow cytometry tested in the range of 2–4 mln/mL.
This study has permission of the Bioethical Committee of Jagiellonian
University (KBET/206/B/2013 and 122.6120.78.2016)
Results: Preliminary results showed that in normoglycemic conditions
cell migration is higher in presence of MVs from HC compared to the
control without MVs (CI: 94.33 ± 6% vs. 81.52 ± 9.47%, respectively). In
hyperglycemic conditions cell migration was dysregulated, CI:
53.34 ± 12.85% in presence of UD MVs vs. 81.52 ± 12.8% in the control
medium. No differences in cell metabolism and proliferations were
observed in the viability tests.
Summary: Endothelial cell migration appears to be controlled by MVs. If
MV were isolated from hyperglycemic conditions efficiency of migration
was lowered which could be the reason of impaired wound healing
process in patient suffer from diabetics disease.
Funding: This study was supported by the Polish National Science
Centre grant (2012/07/B/NZ5/02510).
PF11.03
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Novel cell wall remodelling functions of extracellular vesicles secreted
by Saccharomyces cerevisiae
Kening Zhao1, Mark Bleackley1, David Chisanga2, Michael Liem1, Hina
Kalra1, Shivakumar Keerthikumar1, Ching-Seng Ang3, Christopher Adda1,
Lahiru Gangoda1, Lanzhou Jiang1, Ivan Poon1, Peter Lock1, Marilyn
Anderson1 and Suresh Mathivanan1
1La Trobe Institute for Molecular Science, Melbourne, Australia; 2La Trobe
University; 3Bio21 Institute, University of Melbourne, Melbourne, Australia
Introduction: Extracellular vesicles (EVs) are membranous vesicles
released into the extracellular environment by cells. EVs contain various
functional cargo that play crucial roles in intercellular communications.
In mammalian studies, it is well established that the endosomal sorting
complex required for transport (ESCRT) machinery is responsible for
the biogenesis of exosomes, an important subtype of EVs with endocytic
origin. The ESCRT machinery was first described for its involvement in
endosome formation using yeast as a model. Mechanisms of yeast EV
biogenesis and release remain unclear, thus further investigations on the
characterisation of yeast EVs are required.
Methods: EVs were isolated by differential centrifugations from model
yeast Saccharomyces cerevisiae upon knockout of selected ESCRT com-
ponents. Protein quantification, electron microscopy, nanoparticle track-
ing analysis and label-free quantitative proteomics analysis were done to
characterise these EVs. EVs from yeast cultures upon specific drug
treatments or gene deletions were also collected for proteomic analysis.
Confocal microscopy and flow cytometry were done to investigate EV
uptake in yeast. Survival assays with functional EV uptake were then
carried out for wild type and cell wall mutant yeast strains upon drug-
induced cell wall stress.
Results: It was revealed that EVs isolated from ESCRT knockout cells
were altered in terms of protein amounts, protein cargo, morphologies
as well as size compared to wild type cells. These differences are espe-
cially prominent in EVs upon knockouts of three Vps proteins.





























Proteomics analysis promoted further characterisations of different types
of yeast EVs and highlighted the enrichment of functional components
related to cell wall remodelling in EVs. The presence of EV uptake in
yeast was observed, and functional uptake analysis confirmed cell wall
remodelling properties of yeast EVs.
Conclusion: This study confirms that yeast EVs can mediate cell wall
remodelling under stressful conditions.
PF11.05
Mesenchymal stem cells from chronic kidney disease patients
produce extracellular vesicles with increased angiogenic potential
Bas W.M. van Balkom, Femke C.C. van Rhijn Brouwer, Hendrik Gremmels,
Vidalmar Briceno and Marianne C. Verhaar
UMC Utrecht
Introduction: Mesenchymal stromal cell (MSC) therapy is used for a
variety of degenerative and immunological diseases. A fundamental
question is whether co-existing disease affects the regenerative properties
of autologous cells. MSCs exert their regenerative properties through
paracrine secretions, with a major role for extracellular vesicles (EV). We
investigated whether chronic kidney disease (CKD) affects the angio-
genic potential of MSC-derived paracrine factors.
Methods: Bone marrow from patients scheduled for living donor kidney
transplant (CKD) and from persons donating a kidney (healthy controls)
was obtained for subsequent MSC isolation and culturing. The study was
approved by the local medical ethical committee and all MSC donors
provided written consent. We determined angiogenic potential of con-
ditioned medium and isolated EVs by in vitro matrigel angiogenesis
analysis. EVs were isolated by sequential centrifugation and presence
and purity were assessed by nanoparticle tracking analysis, sucrose
density gradient centrifugation and immunoblotting.
Results: MSCs from three controls and three CKD patients were cultured
up to passage 8 and conditioned medium was collected for angiogenesis
assays and EV isolation. Isolated EVs had a density of 1.1 g/mL, a
nominal size of 144 nm and contained the typical EV marker Flotillin-
1, and nuclear and mitochondrial proteins were absent, indicating their
purity. MSC-conditioned medium from both controls and patients sti-
mulated angiogenesis. No differences could be observed between the
two. Interestingly, isolated EV from CKD patient MSCs potently stimu-
lated angiogenesis, whereas no vessel formation could be observed after
stimulation with EV from control MSCs.
Conclusion: EV from patient MSCs show a higher angiogenic potential
than those from healthy control MSCs. This effect of disease state on
MSC-derived EV function could be attributed to differences in EV
secretion or EV content.
PF11.06
Exosomes secreted by human adipose-derived stem cells regulate the
expression of collagen synthesis-related genes in human dermal
fibroblasts
Yeo Jin Choi, Kyoung Soo Lee, Seung Ho Yeom and Yong Woo Cho
Hanyang University, Seoul, Republic of Korea
Introduction: Human skin ageing is a complex biological process influ-
enced by intrinsic (e.g., hormone and metabolic processes) or extrinsic
factors (e.g., ultraviolet radiation). In particular, UV-induced ageing
causes significant downregulation of collagen synthesis and induction of
matrix metalloproteinases (MMPs) expression in skin, leading to wrinkle
formation. Human adipose-derived stem cells (HASCs) secrete exosomes
containing nucleic acids (mRNAs and microRNAs) and bioactive pro-
teins, which could act as critical signals of tissue regeneration. Herein, we
hypothesised that HASCs-derived exosomes may have a positive role in
promotion of collagen remodelling in UVB-induced skin damage.
Methods: Exosomes were isolated from conditioned media during HASC
proliferation through pre-filtration in 0.2 μm, followed by tangential
flow filtration (TFF) system (500 kD MWCO). The isolated exosomes
are characterised by transmission electron microscopy (TEM), nanopar-
ticle tracking analysis (NTA) and western blot analysis. Exosomal
miRNA were profiled using miRNA arrays containing probes for 2578
human mature miRNAs and cytokines were analysed using human 80
cytokine array kit. The potency of exosomes was evaluated by a mon-
itoring of the cellular behaviours and expression of collagen synthesis-
associated genes in UVB-exposed dermal fibroblasts.
Results: The exosomes were approximately 50–120 nm in diameter and
expressed exosomal markers such as CD9 and CD81. Exosomal miRNAs
and various cytokines related to skin reconstruction were identified in exo-
somes. We found that exosomes significantly promoted fibroblast migration
in a scratch assay. Interestingly, exosome treatment reduced UVB-induced
MMP-1 gene expression and increased gene expression of tissue inhibitor of
megalloproteinase-1/-3 (TIMP-1/-3) and collagen type I alpha 1 (COL1A1).
Conclusion: Our findings suggest that HASC-derived exosomes act as a
biological cue stimulating dermal fibroblasts and might be used as a
potential agent for skin rejuvenation.
PF11.07
Co-delivery of multiple miRNA cargos to enhance therapeutic
vascularisation bioactivity of extracellular vesicles
Anjana Jeyaram and Steven M. Jay
University of Maryland, College Park, MA, USA
Introduction: Extracellular vesicles (EVs) are promising candidates for
therapeutic miRNA delivery, however challenges related to large scale
production of desired vesicles as well as relatively low and variable levels
of endogenous miRNAs pose obstacles for eventual clinical translation.
Thus, it is desirable to controllably engineer EV content via extrinsic
loading methods. As multiple pathways regulate disease conditions, we
believe that actively loading multiple cargos can effectively enhance the
therapeutic bioactivity of EVs.
Methods: Human embryonic kidney cell (HEK293T)-derived EVs were
used to deliver miRNAs since they are believed to be relatively inert and
do not enrich disease-related pathways. Known inducers of vascularisa-
tion, miR-93 and miR-126, were selected as cargo molecules. EVs were
loaded via sonication, as we previously demonstrated its advantages over
electroporation. After using fluorescent measurements to quantify
miRNA loading after sonication, human umbilical vein endothelial
cells (HUVECs) were used to assess vascularisation potential of EVs in
a wound healing migration assay. Western blots of cell lysates demon-
strate signalling regulation.
Results: A dose-dependent increase in HUVEC migration area was
observed for cells treated with each of the miRNA loaded EVs. While
cells treated with only miR-93 loaded EVs or only miR-126 loaded EVs
showed 50% and 69% closure of the wound area, respectively, cells
treated with EVs with a combination of two miRNAs induced 81%
wound area closure. Treatment of cells with HEK293T-derived EVs
without miRNA cargo showed only 39% wound area closure.
Conclusion: Delivery of pro-vascular miRNAs via EVs can potentially
enable the revascularisation of chronic wounds and ischemic tissues.
Overall, this study points to potential benefits of co-delivery of miRNA
cargos targeting different gene regulation pathways towards vascularisa-
tion. Ongoing work will assess whether loading multiple miRNAs within
the same EV is more effective than using multiple populations of EVs
loaded with different cargos.
PF11.08
NOS1AP coded protein, capon, is required for leucocyte microparticle
production and inflammasome activation in response to
hyperglycemia
Stephen R. Thom1, Veena Bhopale1 and David Margolis2
1University of Maryland School of Medicine, MA, USA; 2University of
Pennsylvania School of Medicine, PA, USA
Introduction: Up to 20% of diabetic patients develop a foot ulcer (DFU)
and most who have a lower extremity amputation (LEA) will have had a





























DFU. We demonstrated in diabetics that Nitric oxide synthase 1 adaptor
protein (NOS1AP) gene variation is associated with LEA. Function of the
NOS1AP coded protein, capon, is unknown outside the nervous system.
We hypothesised that hyperglycemia stimulates leukocytes to produce
microparticles (MPs, 0.1–1 µm diameter, annexin V-positive) and acti-
vates the nucleotide-binding domain-like receptor 3 (NLRP3) inflamma-
some due to oxidative stress, and capon has a role.
Methods: Human and murine leukocytes were incubated ex vivo in
buffer containing 5.5–20 mM glucose, the buffer and cells separated
for flow cytometer MPs analysis and biochemical assays. Capon content
was manipulated using small inhibitory RNA.
Results: Hyperglycemia (>11 mM) increased neutrophil mitochondrial
reactive oxygen species production and activity of NADPH oxidase.
Concomitant activation of type-2 nitric oxide synthase (NOS) occurs with
secondary oxidants resulting in actin S-nitrosylation and enhanced filamen-
tous actin turnover, followed by increased MPs production.
Oligomerisation of inflammasome components including Apoptosis-asso-
ciated Speck protein with CARD domain, NLRP3 and caspase 1 occurs
leading to IL-1β synthesis and packagingwithinMPs. Immunoprecipitation
shows capon is required for NOS linkage to short filamentous actin. Capon
depletion prevents hyperglycemia-induced NOS activation, actin turnover,
MPs formation and NLRP3 activation.
Conclusion: Capon links NOS to the cytoskeleton. It is required for
enhanced reactive species formation and consequent production of MPs
containing IL-1β. MPs are elevated in diabetes and hyperglycemia can
activate the NLRP3 inflammasome, which contributes to development of
diabetic vasculopathy. We hypothesise that gene variations modify capon
causing a gain of NOS function that exacerbates risk for LEA.
PF11.09
Transfer of extracellular vesicles between fibroblasts and
keratinocytes in cellular senescence
Madhusudhan Reddy Bobbili1, Lucia Terlecki Zaniewicz2, Markus
Schosserer1, Vera Pils2, Dietmar Pum3 and Johannes Grillari2
1University of Natural Resources and Life Sciences, Department of
Biotechnology; 2Christian Doppler Laboratory for Biotechnology of Skin
Ageing, Department of Biotechnology, BOKU University Vienna, Austria;
3University of Natural Resources and Life Sciences, Institute of
Nanobiotechnology
Introduction: Extracellular vesicles emerged as an important mode of
cell-to-cell communication in both normal and pathological conditions.
Extracellular vesicles regulate the target cell by releasing their cargo –
RNA, proteins and metabolites, which they carry from the cell they
originate.
Methods: We observed that extravesicular (EV)-miRNAs secreted from
fibroblasts are taken up by keratinocytes. Our main aim, is to identify
senescence-associated extravesicular (SA-EV) small RNAs, especially
EV-miRNAs and their impact on keratinocyte functionality. To achieve
this, stress-induced premature senescence (SIPS) was triggered in human
dermal fibroblasts (HDF) and EVs below 220 nm in diameter were
harvested by differential centrifugation.
Results and Conclusion: Thereby, we have observed that senescent HDFs
secrete more than 4-fold more exosome like vesicles per cell, and that
these EVs show hallmarks of exosome. In addition, to an EV-transfer in
2D, we also observed a miRNA crosstalk in an in vivo mimicking 3D cell
culture model. We further analysed the EV-miRNA signature and iden-
tified highly secreted candidates that might be involved in keratinocyte
differentiation and wound healing.
LBP.27
Placental trophoblast debris mediated feto-maternal signaling via
small RNA delivery: implications for preeclampsia
Jia Wei1, Cherie Blenkiron2, Peter Tsai3, Joanna James3, Qi Chen3, Peter
Stone3 and Lawrence Chamley3
1The University of Auckland, New Zealand; 2Department of Molecular
Medicine and Pathology, University of Auckland, Auckland, New Zealand
and School of Biological Sciences, University of Auckland, Auckland, New
Zealand; 3University of Auckland, New Zealand
Introduction: During pregnancy the outer layer of the placenta, the
trophoblast, sheds large quantities of debris into the maternal circula-
tion. These macrovesicles (MaV) have an important signaling role in
maternal cardiovascular adaptation to pregnancy in part through mod-
ulation of recipient endothelial cells. We hypothesized that the small
RNA cargo of MaV would be involved in this signaling, a process which
may be modified in the hypertensive disease preeclampsia.
Methods: Placenta were collected from term normotensive (n=13) or
preeclamptic (n=10) pregnancies with written consent from the donors
under National Ethics committee project approval NTX/12/06/057. MaV
were collected from placental explant cultures by centrifugation after
transfection with artificial small RNAs and delivery of Cy3-labelled
RNAs was visualized by confocal microscopy or validated by qRT-
PCR. The small RNA content of placenta MaV (n=5 each group) was
determined by small RNA-seq and analysed using the published iSRAP
pipeline.
Results: Explant cultures showed uptake of a control Cy3-labelled small
RNA into the placental tissue, with efficient packaging into deported
MaV and subsequent delivery into MaV treated recipient endothelial
cells. Small RNA-seq identified the contents of MaV differed between
healthy term and preeclamptic placenta with differential abundance of
16 miRNAs (including miR-145), 5 tRNA fragments, 13 snRNA frag-
ments and 85 rRNA fragments. There was also evidence of selective
packaging of selected small RNAs into the MaV from the placenta.
Finally, engineered healthy placental MaV were able to deliver synthetic
miR-145 into endothelial cells which induced transcriptional changes in
endothelial cells similar to those induced by preeclamptic MaV.
Summary/Conclusion: Macrovesicles deported into the maternal circu-
lation might deliver small RNA to maternal cells and contribute to feto-
maternal communication. These small RNAs are dysregulated in pre-
eclamptic MaV and may contribute to the endothelial cell activation, a
hallmark of preeclampsia.
Funding: JW was the recipient of a doctoral scholarship from the China
Scholarship Council. Project funding was received from the University
of Auckland, postgraduate research funds.
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Placenta-specific microRNAs in circulating exosomes showed different
levels in pregnancies complicated by preeclampsia
Virginie Gillet, Larissa Takser and Annie Ouellet
Université de Sherbrooke, Sherbrooke, Montreal, Canada
Introduction: Preeclampsia (PE) is a pregnancy-specific syndrome and
one of the leading causes of maternal and fetal morbidity and mortality.
Even if the pathophysiological mechanisms remain poorly known, pla-
cental dysfunction is involved in pathogenesis and clinical signs (hyper-
tension and proteinuria) appear during 2nd or 3rd trimester. Several
studies revealed differentially expressed microRNAs with either high or
low levels of expression in human placentas from normal versus pre-
eclamptic pregnancies. Recent studies reported that placental-specific
miRNAs belonging to C19 miRNA cluster (C19MC) were released into
maternal circulation through exosomes and could represent new avenue
for biomarker discovery.
Methods: Methods: We performed a case-control study in a cohort of 40
pregnant women enrolled during their third trimester of pregnancy, in
Centre Hospitalier Universitaire, Sherbrooke, Canada. Plasma samples
from 10 women with PE, 10 high-risk women for PE but who did not
develop the disease and 20 women with a normal pregnancy were
analysed. The concentration of placental exosomes was quantified
using a commercial ELISA kit. Circulating exosomes (including placen-
tal exosomes) and microRNAs were purified from maternal blood using
ExoRNeasy method and relative expression of the C19MC microRNAs
was done by qRT-PCR home-made assays.
Results: Results: C19MC placenta specific miRNAs (mir-515-5p, miR-
517-5p, miR-517a, miR-518b, miR-520a, miR-520h and miR-525-5)
were detected in our samples confirming the presence placental-EVs in
maternal blood. Despite a slightly increase level of placental EVs for PE
cases compared to normal pregnancies and high-risk pregnancy, results





























did not reach significance. In PE pregnancies we report over-expression
of miR-525-5p, miR-517a and miR-520a (fold change = 1.3; 1.4 and 7
respectively) compared to both high-risk and normal pregnancies. On
the contrary, miR-515, miR-517-5p, miR-518 and miR-520h levels are
diminished by 2-fold compared to both high-risk and normal pregnan-
cies. No difference was observed between miRNAs levels between high-
risk and normal pregnancies, tending to support a specific miRNA
signature for PE. Summary/Conclusion: Conclusion: Exosomes as well
as miRNAs could represent a new avenue in the area of diagnostic of
pregnancy complications related to placental dysfunction.
LBP.29
Evaluation of a profile of exosomes and MiRs playing roles in the
pathogenesis of human corneal endothelial dysfunctions
Junji Hamuro1, Kazuko Asada2, Morio Ueno2, Chie Sotozono2, Takahiro
Ochiya3 and Shigeru Kinoshita4
1Department of Ophthalmology; 2Dept Ophthalmology; 3Division of
Molecular and Cellular Medicine, National Cancer Center Research
Institute, Japan; 4Department of Frontier Medical Science and Technology
for Ophthalmology
Introduction: Cultured human corneal endothelial cells (cHCECs) serve
as an alternative to donor corneas for the medication of corneal
endothelial dysfunction. However, predisposition of cHCECs into a
senescence phenotype, epithelial-mesenchymal transition (EMT) have
been hampering the practice in clinical settings.
Methods: The variations of cHCECs in their composites of heteroge-
neous SPs were certified in the context of their surface CD markers. The
integrated analysis of miRNA profiles contained in secreted exosomes
were investigated by 3D-gene (Toray). The exosomes were analyzed
either by western blotting, exoscreen or FACS for CD9 CD63 CD81
and EpCAM. The function of detected miRs was validated by transdu-
cing them into heterogeneous SPs of cHCECs.
Results: Secreted exosome profiles among morphologically diverse
CHCEC SPs proved to be useful for their distinction each other. The
CD44 negative SP suitable for injection therapy expressed only CD63,
while the CD44 intermediate Sp expressed CD81 in an inverse correla-
tion with the extent of CD44. The CD44 strongly expressing cHCEC Sp
with cell state transition (CST) secreted CD9CD63 double positive exo-
some. The candidate miRs included in exosomes, able to discriminate
CD44- SPs from those with CD44+++ phenotypes were 1246 and 1273e
(inverse relation with CD44 expression), and 24-3p and 184 (positive
correlation with CD44). Of note, intracellular miR184 only decreased
inversely in parallel with the upregulation of CD44 on cHCECs. CD9
CD63 double positive exosomes secreted far abundantly by cHCEC Sps
with CST were far more incorporated into both of cHCECs with or
without senescence or EMT-like CST, indicating the presence of new
pathway of synchronized cell state conversion into pathogenic pheno-
types, by intracellular export of extracellular vesicles (EVs) into cHCECs
without CST.
Summary/Conclusion: The cHCECs sharing a CD44- phenotype may be
discriminated by the profile of exosomes secreted. Thus miRs in secreted
exosomes may serve as the tool to qualify cultured cHCECs. The precise
analysis of the proposed cell to cell communication through EVs might
open the new aspect for the better understanding of pathogenesis of
bullous keratoplasty.
Funding: This research is supported by the Highway Program for
Realization of Regenerative Medicine from AMED, JSPS KAKENHI
JP26293376 and Core to Core programme, AMED, Japan
LBP.30
Role of tumor-derived exosomes in immunosuppression in malignant
melanoma
Viktor Fleming
German Cancer Research Center, Heidelberg, Germany
Introduction: Malignant melanoma is the most dangerous form of skin
cancer and accounts for almost 80% of all skin cancer deaths. The
accumulation of highly immunosuppressive myeloid-derived suppressor
cells (MDSCs), which arise from immature myeloid cells (IMC) in the
bone marrow, play a significant role in immunosuppression and in the
resistance to immunotherapy of malignant melanoma. It was shown that
melanoma cells can recruit MDSC by secreting exosomes.
Methods: TEX were isolated in vitro from RET-murine melanoma cell
line by serial centrifugation steps and characterized via western blot for
exosomal markers. In addition, we performed nanoparticle tracking
analysis for the size distribution of the isolated vesicles. To investigate
the effects of TEX on IMC, IMC were isolated from the bone marrow of
wildtype C57BL/6 mice via magnetic sorting. Those cells were either
prepared for flow cytometry, Western blot, ELISA or qPCR analysis.
Results: We have previously shown that injection of TEX derived from
the murine RET melanoma cell line induced the accumulation of IMC in
the bone marrow after injecting TEX into wildtype C57BL/6 mice. TEX
induced the activation of STAT3 and NFkB in IMC. Moreover, the
treatment with TEX was sufficient to block the differentiation of IMC
into mature myeloid cells. Instead, the treated IMC were producing
inflammatory cytokines such as IL-1β, IL-6, IL-10, TNF-α and VEGF.
In addition, a strong upregulation of PD-L1 was measured. By studying
myD88 knock-out mice, we found that these alterations were mediated
by the stimulation of the NFkB signaling pathway. TEX-treated IMC
could also inhibit the proliferation of CD8+ T cells and reduce the
production of interferon-γ. Interestingly, the impact of TEX-treated
IMC on T cell functions was not mediated by the NFkB pathway.
Summary/Conclusion: Taken together the results confirm that TEX play
an import role in the tumor progression. Melanoma cells use exosomes
to dampen the immune system by converting myeloid cells into an
immunosuppressive phenotype. Furthermore, increased amounts of
TEX leads to an accumulation of immature myeloid cells in the bone
marrow. The signaling pathways involved in the TEX-mediated conver-
sion of IMC into MDSC-like cells are now under investigation.
LBP.31
The diagnostic potential of sentinel extracellular vesicles in early
inflammation
Revathy Munuswamy1, Sören Kuypers1, Jan D’Haen2, Inge Nelissen3, Joy I.
Irobi1, Baharak Hosseinkhani1 and Luc Michiels1
1Hasselt University, Biomedical research institute, Martelarenlaan 42, 3500
Hasselt, Belgium; 2IMO-IMOMEC, Hasselt University, Wetenschapspark 1,
3590, Diepenbeek, Belgium; 3VITO NV, Boeretang 200, 2400 Mol, Belgium
Introduction: Inflammation is involved in the onset of several diseases such as
Alzheimer, allergies and cardiovascular disease. Recent evidence reveals a
strong association of monomeric C-reactive protein (mCRP) in the early
inflammation process and we demonstrated the presence of mCRP on
Extracellular Vesicles (EV) produced by inflamed cells. EV play a pivotal
role in the process of initiation, propagation and regulation of inflammation.
However, the precise role of mCRP in the physiological and pathological
functions of EV and their potential as biomarkers in inflammatory conditions
is not known yet. Our aim is to address the question whether mCRP carrying
EV can serve as a potential sentinel marker for early inflammation.
Methods: Primary endothelial cells (HUVEC) were cultivated either
unstimulated or triggered for inflammation using TNF-α. EV were
isolated from supernatant of both HUVEC cultures using size exclusion
chromatography (SEC). Different tools such as an immunofluorescence
(IF) assays, western blot (WB), TEM and NTA analysis were performed
to characterize and to confirm successful isolation of EV from both
conditions. mCRP carrying EV were analyzed by binding to a mCRP
specific aptamer using label free, surface plasmon resonance (SPR).
Results: Vesicles having an approximate size range between 100-200 nm
were successfully isolated using SEC. SPR analysis showed a fivefold increase
of mCRP+ EV in TNF-α treated HUVEC cultures as compared to untreated
cells. The observed changes were confirmed using WB, TEM and IF tech-
niques. Moreover the WB analysis also showed the presence of EV classical
markers such as CD9. Using fluorescent labeled aptamer we demonstrated
the ability of inflamed EV to transport mCRP to untreated HUVEC cells
triggering this way a pro-inflammatory status in the recipient cell.
Summary/Conclusion: Our current study confirms that the circulating
EV have a great potential as a sentinel tool in early inflammation. This





























study also opens up the opportunity to develop a reliable, reproducible
and robust tool to detect circulating mCRP EV in diagnostic application.
Funding: This work was financed by Hasselt University and by EFRO
through the Interreg V Grensregio Vlaanderen-Nederland project Trans
Tech Diagnostics and the Marie-Curie Initial Network programme,
r’BIRTH project (grant agreement no. 608346) from the EU.
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Extracellular vesicles derived from monocytic THP-1 and SW480 colon
cancer cells induce pro-inflammatory response in human primary
monocytes
Tonje Bjørnetrø1, Kari Bente Foss Haug2, Beate Vestad2, Lilly Alice Skaaraas2,
Anne-Marie Trøseid2, Hans Christian D Aass2, Alicia Llorente3 and Reidun
Øvstebø2
1Institute of Clinical Medicine, University of Oslo, Norway; 2The Blood Cell
Research Group, Department of Medical Biochemistry, Oslo University
Hospital, Ullevål, Norway; 3Oslo University Hospital-The Norwegian
Radium Hospital, Oslo, Norway
Introduction: Extracellular vesicles (EV) represent an important mode of
intercellular communication by serving as vehicles for molecular transfer
between cells. The specific functions of EV on target cells depend on the
ability of EV to interact with recipient cells, delivery of their specific
contents and initiating downstream signaling. The present study has
investigated if THP1- and SW480-derived microvesicles (MV) and exo-
somes (EXO) are able to enter and activate an inflammatory response in
human primary monocytes.
Methods: Collection and isolation of EV: THP-1 (human leukemia
monocytic) and the SW480 (human colon adenocarcinoma) cells were
cultured at 37°C, 5% CO2 in serum-free RPMI media for 24 hours.
Subpopulations of EV were obtained from sequential centrifugation of
the 4500xg supernatant; in particular MV were pelleted by 17000xg, 30
min and EXO obtained by filtration of the 17000xg supernatant with a
0.22mm filter (Millex GV) and concentrated by a 100kDa Centricon
filter (Amicon ®Ultra-4). Particle size and concentration of EV were
analyzed by NTA.
Functionality of EV in human primary monocytes: Elutriation-purified,
cryopreserved monocytes (1.5 x 105 in150 mL) from healthy donors
were thawed and re-suspended in 10 % (v/v) FCS-RPMI. MV and
EXO (1010-108) (derived from THP-1 and SW480 cells) ± fluorescently
labeled with PKH67 (Sigma Aldrich) were incubated with monocytes for
4 hours at 37°C, 5% CO2. Subsequently, the supernatants were harvested
and stored at -80°C until the secretion of IL1-b, IL6, IL8, TNF-a, MCP-1,
MIP-1b and IP10 proteins (Luminex) were analyzed. The uptake of EV
in monocytes was analyzed by flow cytometry (BD Accuri C6) and
fluorescence microscopy/live imaging (Nikon Eclipse Ti).
Results: THP-1 and SW480 derived MV and EXO were all internalized
by human primary monocytes in a dose-dependent manner. The expo-
sure of EV induced a dose-dependent secretion of IL1-b, IL6, IL8, TNF-
a, MCP-1, MIP-1b and IP10 from the monocytes. Our data show that
MV and EXO derived from different cell lines affect the secretion of
inflammatory molecules to different extents.
Summary/Conclusion: Extracellular vesicles derived from THP-1 and
SW480 cells are internalized and induce inflammatory responses in
human primary monocytes.
Funding: Regional Research Network on Extracellular Vesicles, South-
Eastern Norway Regional Health Authority
LBP.33
Exosomal miRNA in Hep2G cells stimulated by pro-inflammatory
cytokines
Justyna Totoń-Żurańska1, Michał Seweryn1, Katarzyna Poskrubek2, Anna
Wiśniewska2, Rafał Olszanecki2, Pawel Wołkow3 and Ryszard Korbut4
1Jagiellonian University Medical College Center for Medical Genomics -
OMICRON, Krakow, Poland; 2Jagiellonian University Medical College
Department of Pharmacology, Krakow, Poland; 3Jagiellonian University
Medical College Center for Medical Genomics - OMICRON, Jagiellonian
university Medical College Department Of Pharmacology, Krakow, Poland;
4Department of Pharmacology Jagiellonian University Medical College,
Krakow, Poland
Introduction: Mutual interplay between Kupffer cells (KCs) and hepa-
tocytes plays a role in the development of non-alcoholic liver steatosis
and steatohepatitis. Excessively activated by lipid accumulation Kupffer
cells (KCs) release a large amount of pro-inflammatory cytokines, which
are harmful to hepatic cells. Other way around, hepatocytes secrete
multiple factors with potential influence on KCs. The aim of our study
was to assess exosomal miRNA cargo of hepatic cells primed in vitro by
inflammatory stimuli in order to identify miRNA, which potentially
could in response regulate expression of transcripts involved in KCs.
Additionally, in this setting we assessed the action of sylimarin – the
compound with recognized mild hepatoprotective action.
Methods: We have performed sequencing of exosomal miRNA from
Hep2G cells treated with: TNF-alpha, INF-gamma, silimarin. We have
used EdgeR’ to detect transcripts differentially regulated between condi-
tions. We aimed to detect non-linear effects of treatment with silimarin.
We have detected octamer RNA sequences which are over-represented
in the exosomes from stimulated cells and we have used these motifs to
detect mRNAs related to lipid metabolism which are more likely to be
the targets of micro RNAs with these specific motifs. We validated our
predictions using the available databases for miRNA-target interaction
prediction (e.g. PITA, TargetScanS). We have used Renyi Divergence of
order 0.5 to quantify the similarity of expression patterns of all tran-
scripts, to a pre-selected set of miRNAs known to be involved in
inflammatory pathway, across all experimental conditions. We have
performed hierarchical clustering to detect co-regulated micro RNAs.
Results: Among most significantly changed by inflammatory stimuli
exosomal miRNAs were: hsa-let-7b-5p, targeting IRS2, involved in stea-
tohepatitis, hsa-miR-6790-5p and hsa-miR-146b-5p, whereas silimarin
affected exosomal presence of hsa-miR-146b-5p, hsa-miR-542-3p. mir-
146b was reported to directly influence TRAF6 and IRAK1 mRNA and
protein levels in macrophages
Summary/Conclusion: We have identified set of miRNAs, which pre-
sence in Hep2G exosomes is altered by inflammatory stimuli and which
could potentially affect expression of genes involved in lipid metabolism
in KCs. The exact influence of Hep2G-derived miRNA on KCs require
further investigation.
LBP.34
Platelet derived-microparticles as modulator of plasmacytoid
dendritic cell inflammatory response
Adam Ceroi1, Sameh Obeid2, Thomas Cherrier3, Céline Elie-Caille2, Wilfried
Boireau2 and Philippe Saas3
1Ravicahndran’s Lab., University of Virgina, VA, USA; 2Institut FEMTO-ST,
CNRS, Univ. Bourgogne Franche Comte; 3INSERM UMR 1098, ESF-
Bourgogne-Franche Comté, Univ. de Franche-Comte
Introduction: Microparticles (MP) are generated from the plasma mem-
brane of parental cells after activation or cell death. Depending on the
stimulus responsible for MP generation, it was demonstrated that the
quantity, content and biological activities of MP may vary. Previously,
we demonstrated that platelet or endothelial cell-derived MP uptake by
plasmacytoid dendritic cells (PDC) can modulate the Liver X Receptor
(LXR) pathway, and then regulate inflammatory responses. Here, we
used MP from resting- or collagen activated-platelet (rest-PMP or col-
PMP, respectively) to compare their size and protein content, and
investigate their effect on the LXR pathway and the subsequent inflam-
matory response in PDC.
Methods: Platelet from healthy donors were stimulated or not by col-
lagen, and platelet derived-MP (PMP) were isolated by centrifugation.
PMP size and concentration were investigated by flow cytometry and
Surface Plasmon Resonance coupled with Atomic Force Microscopy,
followed by Mass Spectrometry to ask their protein content. Using
PDC from healthy donors, we investigated LXR pathway involvement
(through LXR-target gene expression: LXRA, SREBF1 and ABCA1) and
inflammatory cytokine transcription (TNFA and IL8) in these cells after
culture with PMP.
Results: Rest-PMP showed a significant bigger size associated with a
specific protein content. Culture of PDC with rest-PMP activated





























significantly the LXR pathway and repressed IL-8 and TNFA transcrip-
tion. Interestingly, culture of PDC with col-PMP induced the opposite
effect, with a significant repression of the LXR pathway and an increase
of inflammatory cytokine gene transcription.
Summary/Conclusion: These data demonstrated that collagen stimula-
tion of platelets induced PMP with modified size and protein content,
able to induce a PDC inflammatory response in culture. Since collagen-
stimulated platelets and PDC are involved in rheumatoid arthritis, the
col-PMP-induced PDC inflammatory response might be a new thera-
peutic approach in this context.
Funding: Agence Nationale de la Recherche (LabEx LipSTIC, ANR-11-
LABX-0021), FHU (Grantno.FHUINCREASE2015-03) “INCREASE”
LBP.35
Microvesicles, an anti-inflammatory player, compromised in
asthmatic patients
Adam Ceroi1, Alexandra Bettina1, John Steinke2, Luca Musante3, Uta
Erdbruegger4, Larry Borish5 and Kodi Ravichandran6
1Ravicahndran’s Lab., University of Virgina, VA, USA; 2Department of
Medicine, Allergy and Immunology, University of Virgina, VA, USA;
3Department of Medicine, Nephrology Division, University of Virgina, VA,
USA; 4Department of Medicine/Nephrology Division, University of Virgina,
VA, USA; 5Department of Medicine, Allergy and Immunology;
6Microbiology, Immunology, and Cancer Biology Dpt., University of
Virgina, VA, USA
Introduction: Alveolar macrophage (AM)-derived microvesicles (MV)
reduce inflammatory responses of alveolar epithelial cells in lung
(Bourdonnay et al., JEM, 2015). Soluble factors produced by macro-
phages, such as IGF-1, which promotes the uptake of microvesicles,
dampened airway inflammation in mice (Han et al., nature, 2016).
Here, we tested the inflammatory effects of MV isolated from
broncho-alveolar lavage fluid (BALF) from asthmatic patients, on the
airway epithelial cells.
Methods: MV isolated from BALF from asthmatic patients, and AM-MV
from alveolar macrophages cell line (MH-S) cultures, were isolated after
cell depletion, filtration (0.8 µm), size exclusion chromatography, and
precipitation by differential centrifugation. MV size and concentration
were assessed by tunable resistive pulse sensing. Two alveolar epithelial
cell lines (BEAS-2B and A549) were used to assess MV uptake and
transcriptomic modification within the epithelial cells, in the presence
or absence of BALF or microvesicles-depleted BALF (BALF-MV−).
Results: BALF from asthmatic patients induced inflammatory cytokines
(CSF2, IL-6 and IL-8) in alveolar epithelial cells. Unexpectedly, total
microvesicles from BALF (as well as AM-MV) reduced induction of
inflammatory cytokines, while microvesicles-depleted BALF-MV− did
not reduce pro-inflammatory cytokines. In contrast, the BALF-MV−
reversed the effect of microvesicles in dampening inflammatory CSF2,
IL-6 and IL-8 expression. These effects of the BALF-MV− were corre-
lated with a decrease of microvesicle uptake by epithelial cells.
Summary/Conclusion: These data suggest that MV from BALF from
asthmatic patients have the potential to dampen the inflammatory cyto-
kine production by alveolar epithelial cells. Nevertheless, this anti-inflam-
matory effect is reversed by BALF supernatant (i.e. components other
than microvesicles), which may involve an inhibition of MV uptake by
airway epithelial cells. The identification of the specific BALF components
that are responsible for reversing the inherent anti-inflammatory effect of
microvesicles could serve as potential therapeutic targets.
LBP.37
Rapamycin-loaded Exosomes: A strategy to enhance drug-delivery to
Insulin-producing beta-cells
Miles Brooke1, Marta Garcia-Contreras2 and Camillo Ricordi3
1Diabetes Research Institute; 2University of Miami, Diabetes Research
Institute, FL, USA; 3University of Miami, Diabetes Research Institute,
FL, USA
Introduction: Exosomes are a type of extracellular vesicle that mediate
intercellular communication between cells by transporting molecular
information. Exosomes have emerged as relevant therapeutic tools and
pharmaceutical drug delivery vehicles. The aim of this study was to
investigated the ability of exosomes to act as an effective transporter of
an immunosuppressant drug, rapamycin, and evaluate their in vitro
cytotoxicity to MIN6 cells. Rapamycin (sirolimus) is one of the primary
immuno-suppressants for islet transplantation. MIN6 cells display char-
acteristics of pancreatic beta islet cells, such as the secretion of insulin,
which makes them important in diabetes research.
Methods: We isolated exosomes from the culture medium of MIN6 cells
and Adipose-derived Mesenchymal Stem Cells (MSCs) using Exoquick-
TC (SBI). Exosomes were characterized by transmission electron micro-
scopy, nanoparticle tracking analysis and Western blot. Rapamycin was
loaded into the MIN6 or MSCs-derived exosomes and confirmed by
HPLC, the uptake of exosomes by MIN6 cells was assessed by confocal
microscopy. Cell death was evaluated using Annexin V/Propidium
Iodide with Flow cytometry and an Alamarblue Viability Assay were
conducted to measure the cytotoxicity effectiveness of exosomes as a
delivery system for rapamycin.
Results: Our results point to exosomes being an effective delivery system
for rapamycin into MIN6 cells. The cytotoxic effect of the rapamycin
increased when loaded into exosomes as compared to unloaded delivery.
As the concentration of rapamycin loaded into the exosomes increased,
the percentage of cells that began signaling for cell death increased. The
delivery of rapamycin to the target cells was more efficient in the MIN6
derived exosomes than in those from the MSC cells.
Summary/Conclusion: Exosomes are a viable and effective delivery system
for drug delivery into MIN6 cells. The loaded exosomes lead to rapamycin
having an increased cytotoxic effect than when introduced to MIN6 cells
in an unloaded state. Exosomes can be thought as a potential tool for a
specific delivery of functional drugs to improve islet transplantation.
Funding: This work was supported by the Diabetes Research Institute
Foundation (DRIF).
LBP.38
Exosomes released by Insulin-secreting cells and human islets under
stress conditions reveal an altered microRNA profile: Implications for
Monitoring Islet transplantation
Marta Garcia-Contreras1, Alejandro Tamayo2, Miles Brooke2, Carlo Bosi3,
Luciarita Boccuzzi4, Peter Buchwald5, Paul Robbins6 and Camillo Ricordi7
1University of Miami, Diabetes Research Institute, FL, USA; 2Diabetes
Research Institute; 3University of Milan, Milan, Italy; 4Florida International
Institute, FL, USA; 5Diabetes Research Institute; 6The Scripps Research
Institute, Jupiter, Florida, USA; 7University of Miami, Diabetes Research
Institute, FL, USA
Introduction: There is a need for non-invasive biomarkers for early detec-
tion of beta cell survival, functional integrity, dysfunction and loss after
transplantation and following intervention trials to reverse autoimmunity in
Type 1 Diabetes Mellitus(T1D). Exosomes (EXOs) have been shown to
provide an enriched protective source of miRNAs for biomarker profiling
compared to tissue/cellular and plasma/serum sources. The aim of this study
was to evaluate the impact of stress conditions, that human islets are exposed
in the transplantation period, on the miRNA profile of insulin-producing β-
cells and validate their biomarker potential in the clinical setting.
Methods: MIN6 cells and Human islets were cultured for 48 h under
standard, hypoxic (3% O2), or inflammatory conditions (cytokine cock-
tail of IL-1β, 50 U/mL; IFN-γ, 1,000 U/mL; and TNF-α, 1,000 U/mL).
Plasma samples were collected from T1D patients before and after islet
transplantation (consenting and ethics approved). EXOs were isolated
from conditioned medium using Exoquick-TC (SBI) and from 500 ml of
human plasma were isolated by ultracentrifugation. EXOs were charac-
terized by TEM microscopy, Nanoparticle tracking analysis, flow cyto-
metry and western blot. RNA was isolated (miRVana, Ambion) and
exosomal miRNA profiling was performed using a Nanostring 800
miRNA array (Nanostring) on MIN6 and islet-derived EXOs and
plasma-derived EXOs content was analyzed by RNAseq (SBI).
Results: Insulin-secreting β-cell derived EXOs express a distinct RNA
signature compared to stressed cells. A subset of 2/4 and 14/20 miRNAs
were differentially expressed in MIN6 EXOs/human-islet EXOs under
inflammatory and hypoxic conditions respectively. Preliminary RNASeq





























data analysis revealed that islet-derived EXOs miRNAs were found in
transplanted patients in relation to allograft injury and function.
Summary/Conclusion: Together, our findings provide strong evidence
that exosomes from insulin-secreting cells under stress-induced condi-
tions modify their cargo. Those changes in the exosomes can be detected
in immediate islet post-transplantation period, and could be used as
biomarkers for assessment and monitoring in-vivo beta cell functional
integrity, dysfunction, and loss.
Funding: This work was supported by the NIH-NIDDK
(1UC4DK104208) and Diabetes Research Institute Foundation.
LBP.39
Metabolomic profiling of breast cancer-derived extracellular vesicles:
Metabolic reprograming by interferon-gamma
Hiroko Tadokoro1, Ryuhei Kudo2, Akiyoshi Hirayama2, Yusuke Yoshioka3,
Masahiro Sugimoto2 and Takahiro Ochiya3
1Division of Molecular and Cellular Medicine, National Cancer Center
Research Institute; 2Institute for Advanced Biosciences Keio University,
Tokyo, Japan; 3Division of Molecular and Cellular Medicine, National
Cancer Center Research Institute, Japan
Introduction: Since some studies reveal that immune cells upon activation
show distinct metabolic changes that impact their immune functions, it is
focused to whether immune cells also undergo metabolic reprogramming
in cancer and how this might affect their contribution in cancer progres-
sion. EVs contain various molecular constituents such as proteins, nucleic
acid, and metabolites. However, the functions of metabolites in EVs
remain largely unknown. Indoleamine-2,3-dioxygenase (IDO), trypto-
phan catabolic enzyme, is constitutively expressed in tumor and it is
assumed that it serves as an immune-escape mechanism. In some cancer,
IDO expression appears to be induced by cytokines, such as interferon
(IFN)-gamma. Cancer-derived extracellular vesicles (EVs) also contribute
to the neutralization of the anti-cancer immune response. Therefore, the
purpose of this study is to identify cancer metabolites which are associated
with immunosuppressive functions of the breast cancer cells-derived EVs
in the presence or absence of IFN-gamma.
Methods: Metabolomic analysis of cell and EVs are performed on breast
cancer cell lines, MDA-MB-231-D3H2LN (D3H2LN). D3H2LN cultured
in the presence and absence of IFN-gamma. EVs were purified from cell
supernatant by ultracentrifugation. EV samples were then washed with
PBS twice for metabolomics analysis. Next, methanol containing internal
standard was added to the sample. The metabolomic analysis was per-
formed by CE-TOFMS and IC/LC-QE.
Results: Based on the analysis by CE-TOFMS, we found that cells
contain the 95 metabolites (Positive ionization mode (Pos): 45,
Negative ionization mode (Neg): 50). The 11 metabolites (Pos: 9, Neg:
2) were detected to be a higher amount in D3H2LN cell cultured in the
presence of IFN-gamma and the 7 metabolites (Pos: 4, Neg: 3) were
significantly a higher amount in D3H2LN cells cultured in the absence
of IFN-gamma.
Summary/Conclusion: IFN-gamma induced metabolic changes in the
breast cancer cell. Some metabolites are characteristic in D3H2LN cell
cultured in the presence of IFN-gamma.
LBP.40
Outer membrane vesicles derived from Escherichia coli mediate
neutrophil infiltration into the lungs via IL-8 release from endothelial
cells
Nhung Thi Hong. Dinh1, Yae Jin Yoon2, Ji Hyun Kim2, Hyun Taek Park1,
Gyeongyun Go1, Changjin Lee2 and Yong Song Gho1
1POSTECH; 2Postech
Introduction: Outer membrane vesicles (OMVs) are spherical proteo-
lipid nanostructures that are constitutively secreted by Gram-negative
bacteria including E. coli. Our previous work showed that E. coli
OMVs stimulate strong pulmonary inflammatory response after intra-
peritoneal administration to mice. This immune response led to
significant infiltration of neutrophils into the lungs. Thus, the
mechanisms of neutrophil recruitment by E. coli OMVs need to be
elucidated
Methods: Mice were intraperitoneally administered with E. coli
OMVs, then immunostaining was employed to examine neutrophil
infiltration into the lungs. Lung RNAs were isolated and subjected
to real-time RT-PCR to measure IL-8 expression. The localization
of OMVs in the lungs was identified by immunofluorescence
imaging. Various types of cells were used to find the main sources
of IL-8. Relevant Toll-like receptors (TLRs) and downstream sig-
naling pathways were examined to find the mechanisms of IL-8
release
Results: Intraperitoneal administration of E. coli OMVs resulted in
significant infiltration of neutrophils into the lungs, and IL-8 expres-
sion was significantly increased. In addition, OMVs injected co-loca-
lized with CD31-positive cells (endothelial cells) in the lung. Among
various types of cells, endothelial cells were found to be the main
source of IL-8 in response to OMV treatment. Among TLRs expres-
sing on endothelial cells, TLR4 was shown as the main component in
OMV recognition. IL-8 production was notably observed on HEK293
overexpressing TLR4/MD2 cells upon OMV treatment while this
function was abrogated in TLR4 knock-out mice
Summary/Conclusion: Taken together, our data revealed that E. coli
OMVs recruit neutrophils to the lung via IL-8 release from endothelial
cells in TLR4-dependent manner
LBP.41
Wharton’s Jelly mesenchymal stem-stromal cell suppression of T helper
cell division by exosomes is mediated by membrane bound TGFβ
Sarah Crain1, Kristen Thane2, Airiel Davis2 and Andrew Hoffman2
1Tufts University Cummings School of Veterinary Medicine, MA, USA; 2Tufts
University, MA, USA
Introduction:Mesenchymal stem-stromal cells (MSC) are known to suppress
activation and proliferation of CD4+ T cells, and soluble transforming growth
factor β (TGFβ) plays an important role in that mechanism.
Immunosuppression by membrane bound TGFβ is recognized in dendritic
cell and cancer associated fibroblast extracellular vesicles (EV), but this
mechanism has not been documented for MSC-EV. We hypothesized that
EV membrane bound TGFβ is central to the immunomodulatory mechan-
ism of MSC.
Methods: Serum-free culture media from canine Wharton’s Jelly
mesenchymal stem cells (WJ-MSC: CD44+ CD90+ CD34− CD45−
MHCII−; n=6 cell lines) was collected after 48hr and EV (WJ-EV) isolated
via differential ultracentrifugation. EV output was assessed using NTA.
CFSE-stained peripheral blood mononuclear cells were collected from
healthy dogs (n=8) exposed to concanavalin A (ConA; 5μg/ml), and co-
incubated with WJ-MSC (1:10) across transwell membrane (0.4μm pore
size) or WJ-MSC EV (1:104) +10μM SB431542 (TGFβR1 inhibitor) or
TGFβneutralizing antibody (Ab) for 72hr. Analysis of CFSE fluorescence
using FlowJo (v7.6.5) yielded %CD4+ divided.
Results: An average of 83+2% of the particle count from WJ-MSC condi-
tioned medium were in the exosome size range (30-200nm) based on
NTA. The %CD4+ division in response to ConA alone (60+17%) was
significantly higher than ConA+WJ-MSC (25+11%, P < 0.01), ConA+WJ-
EV (23+13%, P < 0.01), or soluble TGFβ1 alone (21+10%, P < 0.01).
Addition of SB431542 to ConA+WJ-EV increased CD4+ division to 52
+17% (P < 0.01 vs ConA+WJ-EV). Addition of TGFβ Ab to ConA+WJ-
EV at 0.1, 1, or 10μg/ml resulted in CD4+ division of 58+14%, 60+16%,
and 58+10% (P < 0.01 vs ConA+WJ-EV), respectively.
Summary/Conclusion: These data demonstrate that mitogen induced T
cell proliferation, markedly suppressed by WJ-EV, is mediated in part by
membrane bound TGFβ. Further research is necessary to determine the
signaling pathway of EV-derived TGFβ.
Funding: Shipley Foundation
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MTE- Session V: Vesicular and non-vesicular pathways of
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MTE-Session VI: EV-mediated parasite-host interactions
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Symposium Session 19 – EVs in Tumour Immunity and Angiogenesis
Chairs: Carol Parent and Janusz Rak 9:00–10:00 a.m.
OS19.01
Release of endothelial cell-associated VEGFR2 during TGF-beta
modulated angiogenesis in vitro
Alicia M. Viloria-Petit1, Mai Jarad1, Elizabeth Kuczynski1, Jodi Morrison1,
Laura Montermini2, Dong-Sic Choi2, Janusz Rak2 and Brenda Coomber1
1Department of Biomedical Sciences, University of Guelph, Ontario, Canada;
2The Research Institute of the McGill University Health Center, Quebec,
Canada
Introduction: Sprouting angiogenesis is regulated by soluble factors,
principally vascular endothelial growth factor (VEGF), and via bidirec-
tional signalling through the Jagged/Notch system, leading to assign-
ment of tip cell and stalk cell identity. Transforming growth factor beta
(TGFβ) can either stimulate or inhibit angiogenesis via its differential
surface receptor signalling.
Methods: Using immunoblotting and qRT-PCR we evaluated changes in
expression of angiogenic signalling receptors in bovine aortic endothelial
cells exposed to TGFβ1, and correlated these changes to endothelial cord
formation on Matrigel. The extracellular vesicles (EVs) in the condi-
tioned media were assessed via particle tracking and proteomic analysis,
following EV purification by ultracentrifugation at 100,000g.
Results: TGFβ1 induced a dose dependent inhibition of cord formation,
maximal at 5.0 ng/ml. This occurred via ALK5-dependent pathways and
was accompanied by significant upregulation of the TGFβ co-receptor
endoglin, and SMAD2 phosphorylation, but no alteration in SMAD 1/5
activation. TGFβ1 also induced ALK5-dependent downregulation of
Notch1 but not of its ligand delta-like ligand 4 (Dll4). Cell associated
VEGFR2 (but not VEGFR1) was significantly downregulated and accom-
panied by reciprocal upregulation of VEGFR2 in conditioned medium.
qRT-PCR analysis revealed that this soluble VEGFR2 was not generated
by a selective shift in mRNA isoform transcription. This VEGFR2 was
full-length protein and was associated with increased soluble HSP-90,
consistent with shedding of EVs. Particle tracking and proteomic analysis
indicate modulation of EV production and cargo by TGFβ1.
Conclusions: Our results suggest that angiogenesis-associated changes in
endothelial cells exposed to TGFβ1 might be mediated, at least in part,
by the release of key mediators of angiogenic signals, including VEGFR2,
into the extracellular environment. The biological significance of this
remains to be determined.
OS19.02
Mutant p53 cancers reprogram tumour associated macrophages via
exosomal miR-1246
Tomer Cooks1 and Curtis C. Harris2
1National Cancer Institute, NIH; 2Lab of Human Carcinogenesis, NCI
Introduction: TP53 mutants are involved in the pathogenesis of most
solid tumours and are known to gain oncogenic functions distinct from
their original wild-type form. The existence of such gain-of-function
(GOF) activities is supported by ample evidence, however only in a
cell-autonomous fashion. Since tumour-associated macrophages (TAM)
are also a hallmark of solid tumours typically correlated with poor
prognosis, we investigated the link between mutations in the TP53
gene (mutp53) occurring in epithelial tumour cells and the formation
of a surrounding TAM population in situ.
Methods: By designing a co-culture system we incubated human pri-
mary monocytes together with colorectal cancer (CRC) cells differing in
their p53 status. Relevant macrophages markers were evaluated on RNA
level and protein level. In addition, co-cultured macrophages were sub-
jected to various functional assays (phagocytosis, migration, and inva-
sion). In attempt to confirm clinical relevance, samples from a cohort of
human CRC patients were analysed using genomic and immunohisto-
chemical methods. To identify the interaction between the tumour cells
and the macrophages, we isolated exosomes from the CRC cells and
subjected them to a Nanostring analysis to learn about their microRNAs
composition.
Results: In this study, we discovered that mutp53 exerts a non-cell-
autonomous effect over neighbouring macrophages by using specific
microRNAs (miRs) which are shuttled through an exosomal transfer
resulting with a phenotype change of the affected macrophages. Mutp53-
specific exosomes containing cargoes such as miR-1246 were shown to
be used by macrophages at the receiving end, thus promoting the
formation of TAM subset also observed in surgical specimens resected
from cancer patients.
Conclusions: Mutp53-reprogammed TAM favour anti-inflammatory
immunosuppression with increased activity of TGF-β. These findings,
observed also in colon cancer patients, strongly support a microenviron-
mental GOF role for mutp53 in actively engaging the immune system to
promote cancer progression and metastasis.
OS19.03
Determining the role of key regulators of apoptotic cell disassembly
in cell clearance
Rochelle Tixeira1, Christina Nedeva1, Georgia Atkin-Smith1, Thanh Kha
Phan1, Hamsa Puthalakath1, Marco Herold2, Mark Hulett1 and Ivan Poon1
1La Trobe Institute for Molecular Science, Melbourne, Australia; 2The Walter
and Eliza Hall Institute, Parkville, Australia
Introduction: Apoptosis is a key process in maintaining homeostasis.
Efficient clearance of apoptotic cells is necessary, as failure in this
process is linked to various disorders including autoimmune, inflamma-
tion and cancer. In order to achieve timely clearance, apoptotic cells
undergo regulated disassembly into smaller membrane bound vesicles
called apoptotic bodies. Apoptotic cell disassembly (ACD) involves a
series of morphological changes such as membrane blebbing, followed
by string like membrane extensions termed apoptopodia, and cell frag-
mentation to generate apoptotic bodies. Drug based assays have shown
Rho kinase 1 (ROCK1) and P21 activated kinase 2 (PAK2) are involved
in membrane blebbing, while membrane protein Pannexin 1 (PANX1) is
a negative regulator of apoptopodia and apoptotic body formation.
While the need for efficient clearance is necessary, the role of these
key regulators in ACD and their implication to cell clearance is not
well understood. Moreover, understanding the clearance of apoptotic
cells and bodies may provide key insights in linked diseases.
Methods: Using CRISPR gene editing technology in human Jurkat T
cells as a model, gene disruptions were introduced in ROCK1, PAK2 and
PANX1 leading to a loss of protein expression. Clonal populations
showing loss of ROCK1, PAK2 and PANX1 were obtained and subject
to apoptosis using UV radiation and anti-Fas. Apoptotic cells were
characterised for morphology and disassembly by differential interfer-
ence microscopy and flow cytometry. To determine the implications of
ACD on clearance, these knockout cell clones were subject to engulf-
ment assay using professional phagocytes namely macrophages and
immature dendritic cells.
Results: ROCK1 is important for ACD as loss of ROCK1 expression in
Jurkat T cells lead to impairment in both membrane blebbing and
apoptotic body formation while loss of PAK2 did not affect ACD as
compared to control. Cells lacking PANX1 showed marked increase in
apoptotic body formation. Moreover, both macrophages and immature





























dendritic cells show a preference for apoptotic bodies over apoptotic
cells.
Summary: These findings suggest that apoptotic cell disassembly plays a
vital role in cell clearance, whereby the formation of apoptotic bodies
allows for efficient clearance by both dendritic cells and macrophages.
OS19.04
Proteomic analysis of exosomes derived from serum and cells in non–
small cell lung cancer
Si-Hua Qin1, Yong Xu2, Taixue An3, Yue-Ting Tang4, Yiyao Huang1 and Lei
Zheng3
1Department of Laboratory Medicine, Nanfang Hospital, Southern Medical
University, Guangdong, China; 2Southern Medical University Affiliated
Nanfang Hospital, Guangdong, China; 3Department of Laboratory
Medicine, Southern Medical University Affiliated Nanfang Hospital,
Guangdong, China; 4Department of Clinical Laboratory, Zhongnan
Hospital, Wuhan University, Hubei, China
Introduction: Exosomes are small (30–100 nm) membrane vesicles can
mediate intercellular communication via transfer of proteins and other
biological molecules. A number of exosomal proteins are reported as
diagnostic, prognostic, or even therapeutic biomarkers in cancer patients.
Method: We employed a mass spectrometry (LC-MS/MS) quantitative
proteomics strategy to examine the different exosomal proteins expres-
sion in non-small cell lung cancer (NSCLC). Exosomes, isolated from
not only the pooled serum of 8 patients with NSCLC (stages I and II), 8
patients with NSCLC (stages III and IV) and 12 normal volunteers, but
also the cell culture medium of an immortalised normal bronchial
epithelial cell line 16HBE and a NSCLC cell line A549,were separated
by ultracentrifugation. Written informed consents were obtained from
all patients and normal volunteers.
Result: 696 and 1811 exosomal proteins were identified in three pooled
serum and two cell lines. Compared with the SPEs of normal volun-
teers, we found 42 proteins upregulated and 54 proteins downregulated
in the NSCLC patients, and 93 proteins were only detected in the
NSCLC patients. Then 26 proteins were unregulated and 26 proteins
were downregulated in the NSCLC (stages III and IV) patients com-
pared with the SPEs of NSCLC (stages I and II) patients. The differ-
ential proteins proﬁle associated with NSCLC exosomes that suggested
a role these vesicles have in the progression of lung carcinogenesis, as
well as identiﬁed several novel candidates that could be utilised as a
multi-marker protein panel in a diagnostic or prognostic platform for
NSCLC. Next, we found 66 proteins upregulated and 62 proteins
downregulated in exosomes derived from two cell lines, 519 proteins
were only identified in one cell line. Differential proteins were asso-
ciated with signalling pathway, including Wnt, VEGF, PI3K-Ak, mTOR
and ErbB, especially hedgehog signalling pathway were enriched in
NSCLC. It also enriched in pentose phosphate pathway and amino
sugar and nucleotide sugar metabolism which probably play a signifi-
cant role in cancer progression.
Conclusion: The investigation of the NSCLC exosomal proteome has
identiﬁed enriched protein cargo that may contribute to lung cancer
progression, which may have potential clinical implications in biomarker
development for patients with NSCLC.
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OS20.01
Exosomes as a vector for Wnt7a systemic treatment in Duchenne
Muscular Dystrophy
Uxia Gurriaran1,2, Fan Xiao1,2 and Michael A. Rudnicki1,2
1Sprott Centre for Stem Cell Research, Ottawa Hospital Research Institute,
Ottawa, Canada; 2Department of Cellular and Molecular Medicine, Faculty of
Medicine, University of Ottawa, Ottawa, Canada
Introduction: Duchenne muscular dystrophy (DMD) is a genetic myo-
pathy characterised by the lack of dystrophin, evoking skeletal muscle
debilitation and ultimately death. To date, no successful therapies exist
to cure DMD. Our group discovered that Wnt7a, a secreted glycopro-
tein, represents an intrinsic mechanism for skeletal muscle regeneration.
Local muscle injection of Wnt7a into dystrophic mice restores muscle
function by stimulating muscle regeneration. However, given its hydro-
phobic nature, Wnt7a cannot be delivered systemically. Our goal is to
overcome this limitation by testing the suitability of exosomes as a
vector for systemic delivery of Wnt7a.
Methodology: Exosomes were isolated from human transfected cells
using a novel method designed by our laboratory that allows for the
separation of exosomal secreted Wnt7a and secreted non-exosomal
Wnt7a. Muscle regenerative effect of exosomal Wnt7a was tested by
assaying exosome uptake in mice primary myoblasts, expansion of
muscle stem cells cultured ex vivo on cultured myofibers, and induction
of myotube and myofiber hypertrophy.
Results: After transfection of expression plasmids into human cells,
Wnt7a is specifically secreted on the exosomal surface. Unexpectedly,
Wnt7a exosomal secretion is not impaired upon specific mutation of the
pamitoylation sites in Wnt7a. Therefore, unlike other Wnts, pamitoyla-
tion is not required for Wnt7a exosomal secretion. Furthermore, exoso-
mal Wnt7a generated from human cells readily stimulates murine
satellite cell symmetric expansion, motility, and myofiber hypertrophy,
eliciting the full biological response of Wnt7a in muscle.
Conclusions: Our experiments demonstrate that Wnt7a is efficiently
delivered through exosomes into myogenic cells where it elicits the full
regenerative response in skeletal muscle. Moreover, we found that pami-
toylation is not required for secretion of Wnt7a in exosomes. This
finding suggests that different mechanisms are involved in short- versus
long-range Wnt signalling. Taken together, our data indicates that deliv-
ery of Wnt7a via exosomes represents a promising therapeutic avenue
for system delivery for treating DMD.
OS20.02
Angiogenic mechanisms of human CD34+ stem cell exosomes in the
repair of ischemic heart
Yaxuan Liang1, Prabhu Mathiyalagan1, Sol Misener2, Douglas Losordo3 and
Susmita Sahoo1
1Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai,
New York, USA; 2Feinberg Cardiovascular Research Institute, Feinberg School
of Medicine, Northwestern University, NY, USA; 3Caladrius Biosciences
Introduction: Locally transplanted human CD34+ stem cells have been
shown to improve exercise tolerance in patients with myocardial ische-
mia and promote angiogenesis in animal models. In an earlier study,
first of its kind, we have demonstrated that CD34+ cells secrete exosomes
(CD34Exo) that constitute a critical component of the pro-angiogenic
paracrine activity of the cells. Here, we investigated the mechanisms of
CD34Exo-mediated repair of the ischemic myocardium and therapeutic
angiogenesis by studying their miRNA content and uptake.
Methods and Results: Using a murine model of myocardial ischemia we
found that CD34Exo replicated the therapeutic activity of their parent
cells by significantly improving myocardial ischemia (ejection fraction,
42 ± 4 vs. 22 ± 6%, capillary density, 113 ± 7 vs. 66 ± 6/HPF, fibrosis,
27 ± 2 vs. 48 ± 7%, p < 0.05, n = 7–12), compred with PBS control.
Knocking down miR-126 from CD34exo abolished their angiogenic
activity and beneficial function both in vitro and in vivo. Injection of
CD34Exo increased miR-126 levels in mouse ischemic heart, but did not
affect the endogenous synthesis of miR-126 suggesting a direct transfer
of stable and functional exosomal miR-126. miR-126 enhanced angio-
genesis by suppressing the expression of its known target, SPRED1 and
simultaneously modulating the expression of genes involved in angio-
genic pathways such as VEGF, ANG1, ANG2 etc. Interestingly,
CD34Exo, when treated to ischemic hearts, was most efficiently inter-
nalised by endothelial cells relative to smooth muscle cells and fibro-
blasts demonstrating a direct role of stem cell-derived exosomes on
mouse endothelium at the cellular level.
Conclusion: Collectively, our results have demonstrated a novel mechan-
ism by which cell-free CD34Exo mediates ischemic tissue repair via
beneficial angiogenesis. Exosome-shuttled angiomiRs may signify ampli-
fication of stem cell function and may explain the angiogenic and ther-
apeutic benefits associated with CD34+ stem cell therapy.Trafficking
studies using confocal imaging and flow cytometry analyses revealed
that CD34Exo was selectively internalised by endothelial cells and cardi-
omyocytes relative to fibroblasts in the CD34Exo-injected ischemic hearts.
MicroRNA expression profiling and Taqman assays indicated that
CD34Exo are significantly enriched with pro-angiogenic miRNAs such
as miR126. CD34Exo injection induced the expression of miR126 and
several pro-angiogenic mRNAs in mouse ischemic myocardium, suggest-
ing a direct transfer of miR126. CD34Exo lacking in miR126 had
decreased angiogenic and therapeutic activity both in vitro and in vivo
indicating that miR126 was important for CD34Exo function.
OS20.03
Mesenchymal stem cells and their secreted exosomes exert
therapeutic effects in Duchenne muscular dystrophy
Ariel Bier1, Peter Bernstein1, Simona Cazacu2, Amir Dori3 and Chaya Brodie4
1Bar-Ilan University, Israel; 2Henry Ford Health Systems, Detroit, MI, USA;
3Sheba Medical Centre, Israel; 4Faculty of Life Sciences Bar-Ilan University,
Israel and Neurosurgery Department, Henry Ford Health Systems, Detroit,
MI, USA
Duchenne muscular dystrophy (DMD) is a progressive lethal, X-linked
disease of skeletal and cardiac muscles caused by mutation of the
dystrophin gene, which leads to muscle degeneration. Cell therapy
using different cell types has been considered a potential therapeutic
approach for the treatment of DMD. Mesenchymal stromal cells (MSCs)
are obtained from autologous bone marrow and adipose tissues or from
allogeneic placenta and umbilical cord. The safety and therapeutic
impact of MSCs have been demonstrated in pre-clinical and clinical
studies and are attributed to paracrine effects that are partly mediated
by extracellular vesicles. Here, we studied the therapeutic effects of
MSCs and their secreted exosomes using human in vitro disease models
of skeletal muscle cultures derived from healthy and Duchenne patients
and MDX mice. Treatment of satellite cells with conditioned media or
exosomes secreted by MSCs increased the proliferation and generation
of PAX7+/MyoD+ cells and the differentiation of human myoblasts from
both healthy and DMD patients. MSCs from different sources exerted
differential effects on the function of the muscle cells. Secretome and
RNA sequencing analysis of the MSC-derived exosomes revealed specific
cytokines and clusters of miRNAs and long non-coding RNAs that were
associated with anti-inflammatory and pro-regenerative activities in
muscle cells. Using novel quantitative miRNA reporters, we demon-
strated that MSC-derived exosomes delivered both endogenous and





























exogenous miRNAs to satellite cells and myoblasts. Intramuscular
implantation of MSCs to MDX mice resulted in decreased tissue fibrosis
and CK level, increased differentiation of satellite cells, expression of
utrophin and motor function. Imaging analyses using labelled MSCs and
exosomes, demonstrated their localisation in the muscle tissues up to
4 weeks. These results demonstrate that MSCs and their secreted exo-
somes have important clinical applications in cell therapy of DMD partly
via the targeted delivery of therapeutic non-coding RNAs.
OS20.04
Exosomes and microparticles released by mesenchymal stem cells
exert a chondroprotective effect in osteoarthritis
Stella Cosenza1, Karine Toupet1, Claire Bony1, Olivier P. Blanc-brude2,
Christian Jorgensen3 and Daniele Noel4
1Inserm u1183; 2INSERM UMR970 – Paris Cardiovascular Research Centre
(ParCC), Paris, France; 3CHU Montpellier-University of Montpellier, France;
4Inserm
Introduction: Mesenchymal stem cells (MSC) are multipotent cells
that possess regenerative functions that are of interest for in osteoar-
ticular diseases such as osteoarthritis (OA). These functions are
thought to be primarily mediated by mediators released within extra-
cellular vesicles (EVs). EVs consist of exosomes, microparticles and
apoptotic bodies that mirror the effect of parental cells but little is
known about their respective role . The aim of this study was to
compare the immunomodulatory effects of exosomes and micropar-
ticles secreted by MSCs.
Methods: EV subsets were isolated from murine primary MSCs by
ultracentrifugation. Size and structure were evaluated by dynamic
light scattering and electron microscopy. Expression of membrane
and endosomal markers was tested by flow cytometry or western
blot. Proliferation of murine splenocytes was quantified after 72 h of
incubation with EVs after CFSE-labelling. Phenotypic analysis of T
lymphocyte subpopulations was also performed by flow cytometry.
In vivo, EVs were injected in the knee joint in the collagenase-
induced osteoarthritis (CIOA) model and histological score was
performed.
Results: MSC-derived exosomes were less than 120 nm in diameter and
expressed CD9, CD81 and TSG101 while microparticles were around
400 nm in diameter and expressed CD29, CD44 and Sca1 MSC mar-
kers. In vitro functional analysis indicated that addition of microparti-
cles or exosomes in proliferative assays inhibited the proliferation of
total splenocytes in a dose-dependent manner. Analysis of T cell sub-
populations revealed a decrease in CD8+IFNγ+ lymphocytes and an
increase in both CD4+IL10+ Tr1 and CD4+CD25+FOXP3+ Treg cells.
This immunomodulatory function of EVs was also observed in vivo in
the CIOA model with a significantly reduced osteoarthritic score on
histological sections.
Conclusion: Our in vitro data indicated that the immunosuppressive
effect of MSCs is in part mediated by exosomes and microparticles.
These vesicles were shown in vivo to play a major role in MSC-mediated
therapeutic effect by reducing osteoarthritic symptoms.
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Milk exosomes enhance anti-proliferative and anti-cancer activities of
berry anthocyanidins against multiple human cancers
Ramesh C. Gupta1, Jeyaprakash Jeyabalan2, Ashley Mudd3, Ashish Kumar
Agrawal2, Al-Hassan Kyakulaga3, Wendy Spencer4, Manicka V. Vadhanam2,
Farrukh Aqil5 and Radha Munagala5
1Department of Pharmacology and Toxicology and JG Brown Cancer Center,
University of Louisville, KY, USA; 2JG Brown Cancer Center, University of
Louisville, KY, USA; 3Department of Pharmacology and Toxicology,
University of Louisville, KY, USA; 43P Biotechnologies, Inc., Louisville, KY,
USA; 5Department of Medicine and JG Brown Cancer Center, University of
Louisville KY, USA
Introduction: Berries have been reported with beneficial effects against
various diseases including cancer, and anthocyanidins (Anthos) are
considered presumptive active components. However, bioactivities of
Anthos are compromised due to their instability and poor oral bioavail-
ability. Here we report that therapeutic efficacy of Anthos can be
enhanced when used as exosomal formulation (ExoAnthos), and that it
lacks toxicity.
Methods: ExoAnthos was prepared by incubation of bilberry-derived
Anthos with bovine milk exosomes, and harvesting of ExoAnthos by ultra-
centrifugation which was then analysed for particle size by zetasizer and
AFM. Antiproliferative potential of ExoAnthos was determined by MTT
assay against various human cancer cells (lung, breast, prostate, pancreas,
and colon). Anti-cancer activity of ExoAnthos was determined against lung
tumour xenograft in nude mice. Toxicity was determined in wild-type mice
treated orally with the Anthos, Exo and ExoAnthos for 3 weeks.
Results: Significant loading of Anthos was observed in the exosomes
(Exo) presumably due to hydrophobic interactions as revealed by a
substantial quenching of fluorescence inherent of the native Exo pro-
teins. Particle size of ExoAnthos was essentially unchanged vs. Exo (79
vs. 83 nm). HPLC analysis of ExoAnthos stored at −80°C showed no
change in the drug load for up to 4 weeks. ExoAnthos showed 5- to 50-
fold reduction in the IC50values of ExoAnthos vs. Anthos presumably
due to higher cell up take and stability. Anthos (10 mg/kg) given orally
three times a week showed a slight but insignificant inhibition of the
tumour growth. However, ExoAnthos even at a lower dose (5 mg/kg)
showed significant inhibition of lung tumour xenograft (>40% reduc-
tion, p < 0.01). Analysis of blood and the plasma showed no effect on the
liver and kidney function enzymes and hematopoietic parameters fol-
lowing treatment with ExoAnthos, Anthos or Exo indicating these
agents were well tolerated.
Conclusion: Our data demonstrate significantly enhanced antiprolifera-
tive and anticancer activities of the berry Anthos when embedded in the
exosomes, and suggest that milk exosomes may serve as an excellent
nano carrier for plant bioactives that encounter stability and oral bioa-
vailability issues.
Financial support: Duggan Endowment and Helmsley Trust Fund.
OS21.02
Characterisation of extracellular vesicles with milk fat globule
membrane-like properties that carry most microRNAs in commercial
dairy cow milk
Benmoussa Abderrahim1, Ly Sophia2, Shan Si Ting2, Jonathan Laugier2, Eric
Boilard2, Gilbert Caroline2 and Patrick Provost2
1Centre de Recherche du CHU de Québec /Pavillon CHUL – Université
Laval, Quebec, Canada; 2Department of Microbiology-Infectious Disease
and Immunity and Faculty of Medicine, Université Laval, Quebec, Canada
Introduction: MicroRNAs are short (~22 nucleotides), non-coding
RNAs that play an essential role in post-transcriptional gene regulation.
Found in several biological fluids, including milk, they are often asso-
ciated with extracellular vesicles (EVs), like exosomes. In a previous
study, we found that commercial dairy cow milk microRNAs resist
digestion in vitro. Surprisingly, we observed thatmost of them sediment
at low centrifugation speed, thereby challenging their association with
exosomes in commercial milk.
Methods: We used differential ultracentrifugation and iodixanol density
gradient (IDG) to isolate milk EVs, which we analysed for microRNA
enrichment by reverse transcription and quantitative polymerase chain
reaction (RT-qPCR) and for EV-associated proteins by western blot. We
further characterised these EVs by density measurements, fluorescence
RNA labelling, mass spectrometry (LC-MS/MS), dynamic light scatter-
ing (DLS), flow cytometry, transmission electron microscopy (TEM) and
proteinase K assay.
Results: We found no correlation between bta-miR-223 and bta-miR-125b
and exosome-associated proteins found in low speed ultracentrifugation
pellets (i.e. 12,000g and 35,000g), but a positive correlation (p < 0.05)
between bta-miR-125b and xanthine dehydrogenase (XDH). Two IDG
fractions were highly enriched in double stranded RNAs and microRNAs,
contained several exosome-associated proteins and most of the exosome-
like EVs found in these gradients. However, proteinase K assay and
subsequent LC-MS/MS analysis challenged the exosome nature of these
EVs, as all exosome-enriched proteins were digested during the assay and
these digested EVs were found to contain milk fat globule membrane
(MFGM)-enriched proteins, including immunomodulatory XDH, butyr-
ophilin 1A1 (BTN1A1), mucin (MUC-1) and lactadherin (MFG-E8).
Conclusion: Our results suggest the presence of exosome-like EVs with
MFGM-like properties in commercial milk and their association with
the majority of milk microRNAs.
Considering their resistance to proteinase K digestion and bioaccessi-
bility in vitro, these EVs may contribute to interspecies transfer of diet-
ary microRNAs and immune regulation by milk EVs, which require
further investigations.
Financial support: CIHR grants No. 319618 and 327522 (to P.P.).
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Tracing cellular origin of human exosomes using multiplex proximity
extension assay
Pia Larssen1, Lotta Wik2, Paulo Czarnewski1, Maria Eldh1, Liza Löf2, Göran
Ronquist2, Louise Dubois2, Eva Freyhult2, Caroline Gallant2, Johan Oelrich2,
Anders Larsson2, Gunnar Ronquist2, Eduardo Villablanca1, Ulf Landegren2,
Masood Kamali-Moghaddam2 and Susanne Gabrielsson3
1Karolinska Institute, Solna, Sweden; 2Uppsala University, Uppsala, Sweden;
3Immunology and Allergy Unit, Department of Medicine, Karolinska
Institutet, Stockholm, Sweden
Extracellular vesicles (EVs) are membrane-coated objects such as exo-
somes and microvesicles, released by many cell-types. Their presence in
body fluids and the variable surface composition and content render
them attractive potential biomarkers. The ability to determine their
cellular origin could greatly move the field forward. We used multiplex
proximity extension assays (PEA) to identify with high specificity and
sensitivity the protein profiles of exosomes of different origins, including
seven cell lines and two different body fluids. By comparing cells and
exosomes, and after appropriate data filtering, we successfully identified
the cells originating the exosomes. Furthermore, human milk EVs and
prostasomes released from prostate acinar cells clustered with cell lines
from breast and prostate tissue, respectively. Milk exosomes uniquely
expressed CXCL5, MIA and KLK6, while prostasomes carried NKX31,
GSTP1 and SRC, highlighting that EVs originitating from different
origins have different properties. In conclusion, PEA provides a





























powerful protein screening tool in exosome research, for purposes of
identifying the cell source of exosomes, or new biomarkers in diseases
such as cancer and inflammation.
OS21.04
Biological activities of extracellular vesicles and their cargos from
bovine milk in non-bovine species
Sonia Manca, Fang Zhou, Mahrou Sadri, Jiang Shu, Jacob Jarecke, Ana
Aguilar-Lozano, Amy Leiferman, Ryan Grove, Henry Paz, Jiri Adamec,
Samodha Fernando, Juan Cui and Janos Zempleni
University of Nebraska-Lincoln, NE, USA
Background: Extracellular vesicles (EVs), and in particular exosomes,
play important roles in cell-to-cell communication, facilitated by the
transfer of nucleic acids, lipids, and proteins from donor cells to reci-
pient cells. Exosomes in bovine milk are absorbed by endocytosis and
deliver their cargos to circulating cells and tissues in non-bovine species.
The phenotypes of dietary exosome depletion are unknown.
Hypothesis: Bovine milk exosomes and their cargos have biological
activities in non-bovine species.
Objectives: (1) Assess the bioavailability and distribution of bovine milk
exosomes and RNA cargos in mice. (2) Assess whether milk exosome-
defined diets elicit phenotypes in mice. 3) Assess whether milk exosomes
alter the gut microbiome.
Methods: In bioavailability studies, milk exosomes and RNA cargos
were labelled with DiR and Exo-Red, respectively, and the tissue dis-
tribution was assessed using iBox and Licor imagers following oral
exosome administration. In phenotype and microbiome studies,
C57BL/6 mice were fed AIN93G-based, milk exosome-defined diets
for up to 42 weeks, starting at weaning (3 wk). At ages 7, 15 and
45 weeks, phenotypes were assessed using a hypothesis-generating,
unbiased phenotype screen.
Results: While the majority of exosomes accumulated in spleen and liver,
their RNA cargos localised to brain and kidney. A fraction of exosomes
was not absorbed and entered the large intestine. Phenotypes of dietary
milk exosome depletion included an about 50% decrease in litter size, up
to 1900% and 144% increases in liver amino acids and purines, respec-
tively, and 150% and 200% percent impaired spatial memory and kainic
acid survival times. Depending on sex and age, between 200 and 500
“strains” of microorganisms (operational taxonomic units) were differ-
entially expressed in mice fed an exosome-depleted diet compared with
exosome-sufficient controls.
Conclusions: Bovine milk exosomes and their cargos are bioavailable
and accumulate in distinct tissues. Exosome-defined diets elicit strong
phenotypes, and changes in the gut microbiome might contribute
towards these phenotypes.
Support: NIFA 2015-67017-23181, NIFA 2016-67001-25301/NIH
DK107264, NIH 1P20GM104320, the Gerber Foundation, and USDA
Hatch Act and W3002.
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The role of extracellular vesicles (MalaEx) from the commensal yeast
Malassezia sympodialis in atopic eczema
Helen Vallhov1, Henrik Johansson2, Ulf Gehrmann3, Tina Holm3, Janne
Lehtiö2 and Annika Scheynius1
1Department of Clinical Science and Education, Karolinska Institutet, and Sachs’
Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden; 2Science for
Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet,
Stockholm, Sweden; 3Department of Medicine Solna, Translational Immunology
Unit, Karolinska Institutet and University Hospital, Stockholm, Sweden
Introduction:Malassezia is the dominant commensal fungi in the human skin
mycobiome but is also associated with common skin disorders including
atopic eczema (AE). More than 50% of AE-patients have specific IgE and
T-cell reactivity towards Malassezia sympodialis, which is one of the most
frequently isolated species from both AE patients and healthy individuals.
Malassezia releases nanosized exosome-like vesicles, designated MalaEx,
which carry allergens and can induce inflammatory cytokine responses (1).
Recently, we detected several small RNAs in MalaEx and interestingly, bioin-
formatic analyses indicated thatMalaEx have an RNAi-independent route for
biogenesis (2).Wedid not find any significant difference concerning the levels
of these RNAs or the production and the morphology of the MalaEx when
comparingMalaEx, which have been isolated fromM. sympodialis cultured at
normal skin pH versus the higher pH present on the skin of AE patients. Our
aim is now to further understand how MalaEx is involved in host-microbe
interactions, by comparing protein content of MalaEx and the whole yeast
cells, and by investigating interactions of MalaEx with cells in the skin.
Methods: MalaEx are collected from M. sympodialis cultures by serial ultra-
centrifugation and when needed by sucrose gradient. The particle size is
estimated by NanoSight and transmission electron microscopy (TEM). The
protein content of MalaEx ant the whole yeast cells is assessed with quanti-
tative proteomic analysis. Human primary cells are isolated from skin taken
care after cosmetic surgery and cultured together with MalaEx.
Results: We have identified 2714 proteins in whole yeast cells and
approximately 300 in MalaEx. 34 proteins are enriched in MalaEx and
among those two of the major M. sympodialis allergens, Mala s 1 and s 7.
Preliminary functional experiments suggest an active binding of MalaEx
to human keratinocytes using confocal microscopy.
Conclusion: Our results support an active involvement of MalaEx in host-
microbe interactions, by binding to host cells, and by the spreading of
allergens, thereby contributing to the allergic inflammation. By understand-
ing the role of MalaEx in the sensitisation and maintenance phases of AE,
novel prevention strategies and potential therapeutic targets may arise.
References
1. Gehrmann U et al., PLoS One. 2011; 6(7):e21480.
2. Rayner S et al., Sci Rep. 2017; 7:39742.
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Vesicle-mediated cross-species RNA interference between the
gastrointestinal nematode Heligmosomoides polygyrus and its mouse
host
Franklin W.N. Chow1, Cesare Ovando Vazquez2, Georgios Koutsovoulos3,
José Roberto Bermúdez Barrientos2, Tuhin Maity4, Mark Blaxter3, Julie
Claycomb4, Cei Abreu-Goodger2 and Amy H. Buck1
1Institute of Immunology and Infection Research, Centre for Immunity, Infection
and Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh,
United Kingdom; 2Langebio–Cinvestav; 3University of Edinburgh, United
Kingdom; 4University of Toronto, Canada
Introduction: Extracellular RNA has been proposed as a means of cell-to-cell
communication within an organism and a mechanism of cross-species
communication. We previously showed that an Argonaute protein
(HpWAGO) and small RNAs (miRNAs and Y-RNAs) are secreted in extra-
cellular vesicles produced by Heligmosomoides polygyrus, a gastrointestinal
nematode that infects mice. Some of these miRNAs can suppress mouse
immune-related host genes in a reporter assay. Here we describe the bio-
chemical properties of the secreted Argonaute protein including its potential
interaction partners inside the nematode as well as the mouse host.
Methods: Sucrose gradient purification of the ultracentrifuged excreted-
secreted material from H. polygyrus followed by western blot analysis was
used to determine the association of the nematode Argonaute protein with
extracellular vesicles. Associated protein binding partners of the
Argonaute protein were then identified by immunoprecipitation followed
by LC MS/MS in H. polygyrus as well as a C. elegans strain in which it has
been introduced (HpWAGO::GFP). Small RNA sequencing analysis was
used to identify the class of Argonaute-associated RNAs in the secreted
material and modified nucleotide analogues were used to label nematode
RNA to examine uptake into mouse cells using CLICK chemistry.
Results: The H. polygyrus co-fractionates with extracellular vesicles based
on sucrose gradient purification and co-fractionates with a class of
secreted secondary small siRNAs based on size exclusion chromatography.
Consistent with this, immunoprecipitation experiments of the Argonaute
protein suggest it associates with factors involved in secondary siRNA
biogenesis inside of nematodes. Most of these siRNAs come from unan-
notated regions within the H. polygyrus genome, not clearly associated
with protein-coding genes. The nematode RNA can be visualised in the
cytoplasm of mouse cells following incubation in transwell assays.
Conclusion: These results suggest further diversity in extracellular RNA from
a nematode parasite and lay a foundation for understanding the origin of
these exRNAs inside the parasite and the mechanisms by which theymediate
cross-species communication through interaction with mouse genes.
OS22.03
Membrane vesicles from Piscirickettsia salmonis induce protective
immunity and reduced disease development in an adult zebrafish
model
Julia Tandberg1, Leidy Lagos2, Mona Gaarder1, Petter Langlete1, Erik
Ropstad2 and Hanne Winther-Larsen1
1University of Oslo, Norway; 2Norwegian University of Life Sciences, Oslo,
Norway
Introduction: Bacterial membrane vesicles (MVs) are 50–250 nm spherical
structures secreted from the surface of many bacteria. Proteomic and bio-
chemical characterisation has revealed that the vesicles contain a variety of
bacterial components, including proteins, lipopolysaccharides, DNA and
RNA. This makes MVs interesting as potential vaccine candidates, as they
represent several aspects of the bacteria, but in a non-replicative form. MV-
based vaccines have, furthermore, been successfully used for epidemic con-
trol in against serogroup B meningococcal disease, but there are still little
known regarding the use ofMV-based vaccines in other animals.We recently
identified and characterised MVs from the fish pathogen Piscirickettsia
salmonis, which showed that the isolated MVs share several similarities





























with the bacteria. Thus, the present study focused on evacuating the use of
MVs from P. salmonis as a vaccine candidate using an adult zebrafish model.
Methods: Adult zebrafish were immunised with a concentration of 20 µg
MVs or phosphate buffer by i.p. injection. The fish were then challenge by i.
p. injection after an immunisation period of 28 days with a challenge dose of
108 CFU P. salmonis. Serum and organ sampling for immunoblot analysis
and RT-qPCR was performed 1, 14 and 28 days post-immunisation and 1,
3, 5 and 28 days post-challenge. Fish for histology was sampled at 28 days
post-immunisation and 3 and 7 days post-challenge. All zebrafish experi-
ment was approved by The Norwegian Animal Research Authority.
Results: Immunisation with MVs protected zebrafish against a lethal dose
of P. salmonis, and histology showed a reduced formation of granulomas
compared to the control group. Immunised fish also displayed an
increased macrophage response and reduced inflammatory response
after challenge, as well as an increased IgM response after vaccination.
Summary: Our data suggest an immunogenic potential of P. salmonis
MVs and indicate an important immune response associated with P.
salmonis pathogenesis and protection.
OS22.04
Extracellular vesicles released by m. tuberculosis-infected
macrophages contain mycobacterial RNAs and induce Type I
interferon expression in uninfected cells
Yong Cheng and Jeff Schorey
University of Notre Dame, IN, USA
Introduction: Mycobacterium tuberculosis, the causative agent of tuber-
culosis (TB), is an intracellular pathogenic bacterium which primarily
infects pulmonary macrophages. Approximately one third of the world’s
population is infected with M. tuberculosis of which 5–10% develop
active TB at some point in their lives. In 2015 this resulted in an
estimated 10.4 million new active TB cases and 1.8 million deaths. Our
studies aim to better understand how this pathogen intersects with our
immune system with the primary focus being on the release of extra-
cellular vesicles (EVs) and their role during an M. tuberculosis infection.
The current study addresses the presence of mycobacterial RNA in EVs
and their function as modulators of an immune response.
Methods: Next-generation sequencing (NGS) technique (IlluminaMiSeq) and
a subsequent RNA analysis pipeline was used to reveal mycobacterial tran-
script profile in exosomes isolated from the serum of mice infected with M.
tuberculosis. Mycobacterial genetic manipulation, quantitative real-time PCR
and ELISA were performed to determine M. tuberculosis components that
contribute to the trafficking ofmycobacterial transcripts into exosomes. Type I
interferon (IFN-β) was measured by both quantitative RT-PCR and ELISA.
Results: Sixteen potential mycobacterial transcripts were originally identified
from serum exosomes of mice infected with M. tuberculosis using Illumina
MiSeq data. RT-PCR andDNA sequencing further determined the existence
of mycobacterial transcripts in these exosomes that include mce1B, rpoC,
rv0730, rv1629 and rv0453. The abundance of these mycobacterial tran-
scripts was markedly diminished in exosomes released by macrophages
infected with a ΔsecA2 mutant of M. tuberculosis in which the secA2 gene
was inactivated by a transposon insertion. Consistent with RNA viruses,
exosomes isolated from M. tuberculosis-infected macrophages induced a
dose-dependent expression of IFN-β in primary murine macrophages.
Conclusion: M. tuberculosis transcripts are delivered into exosomes of
host cells via a SecA2-dependent pathway, and these mycobacterial
transcripts may induce expression of type I interferon in neighbouring
cells, potentially increasing mycobacterial survival in TB patients.
OS22.05
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Dysregulation of nutritional immunity during respiratory virus
infection enhances Pseudomonas aeruginosa biofilm growth
Matthew Hendricks1, Jeffrey Melvin1, Yingshi Ouyangi2, Donna Stolz1, Yoel
Sadovsky2 and Jennifer Bomberger1
1University of Pittsburgh, PA, USA; 2MageeWomens Research Institute, PA, USA
Clinical observations link respiratory virus infection and chronic
Pseudomonas aeruginosa infection in chronic lung disease patients, including
cystic fibrosis, but the mechanism underlying this interaction is not well
understood. The development of chronic P. aeruginosa infections often
involves the development of highly recalcitrant biofilm communities in the
lung. We have recently shown that respiratory syncytial virus (RSV) co-
infection significantly increasesP. aeruginosabiofilmgrowthon airway epithe-
lial cells (AECs) through a mechanism that is dependent on the induction of
antiviral innate immune response and apical release of the host iron-binding
protein transferrin, suggesting that RSV dysregulates nutritional immunity in
the airway epithelium (1). However, the mechanism by which transferrin is
released from AECs during respiratory viral infection remains undefined.We
hypothesised that respiratory viral infection causes a mislocalisation of trans-
ferrin within AECs and allows its apical secretion, thereby promoting P.
aeruginosa biofilm biogenesis. In the current study, we show that extracellular
vesicles released apically from AECs during RSV co-infection enhanced P.
aeruginosa biofilm growth. The extracellular vesicles had significantly
increased levels of iron and chelation of iron from the extracellular vesicles
reduced their ability to stimulate P. aeruginosa biofilm growth. Interestingly,
RSV infection enhanced transcytosis and apical secretion of transferrin loaded
onto extracellular vesicles. Together these results suggest RSV infection redir-
ects transferrin trafficking in AECs, resulting in the loading of transferrin onto
extracellular vesicles, which are secreted from AECs and can be utilised as an
iron source by P. aeruginosa to form biofilms. Interferon signalling, which is a
key component of antiviral immunity, replicates the enhanced biofilm forma-
tion observed during viral co-infection. We are currently investigating
mechanisms by which interferon signalling induces transferrin packaging
and secretion in extracellular vesicles to stimulate P. aeruginosa biofilm
growth. Our data suggest a novel nutrient acquisition pathway for bacteria
and provide mechanistic insight into nutritional immunity in the lung.
Reference
1. Hendricks et al., PNAS. 2016; ?.
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A novel biochip for capture and characterisation of extracellular
vesicle subgroups in cancer patient plasma
Kwang J. Kwak, Hong Li and L. James Lee
Chemical and Biomolecular Engineering at Ohio State University, OH, USA
Introduction: Extracellular vesicles (EVs) are small membrane-bound
fluid particles comprised of exosomes, microvesicles, apoptotic bodies
and others that are released by different mechanisms from almost all cell
types. The specific surface receptors provide means to sort EVs into
relatively homogeneous subgroups. The most widely used antibody-
driven method for isolating and characterising EVs involves the use of
microfluidics or micron-sized magnetic beads for EV sorting and total
RNA and protein based analysis for characterisation. These methods are
tedious and can only provide average information from all sorted EVs.
We have developed a facile technology termed immuno-tethered lipo-
plex nanoparticle (ILN) biochip.
Methods: Our ILN biochip is based on surface marker specific antibody
to capture EV subgroups and cationic lipoplex nanoparticles (CLNs)
containing RNA-specific molecular beacons (MBs) that can fuse with the
captured EVs and detect specific RNA targets in individual EVs with a
very small sample volume (e.g. 10–20 uL plasma) within 4 hours assay
time. When the specific EVs are captured onto the glass chip surface by
tethered antibody, the fluorescence signal from hybridisation between
the MBs and target RNAs can be detected by total internal reflection
fluorescence microscopy after EV-CLN fusion.
Results: We sorted malignant multiple myeloma (MM) cells (CD38
+CD138+CD19-) and normal B cells (CD38-CD138-CD19+) from per-
ipheral blood of MM patients and used our ILN biochip tethered with
anti-CD38 mAb to capture and characterise the CD38+ EVs from both
the MM cell secreted EVs and circulating EVs in blood plasma. For all
studies, approval and consent was obtained from The Ohio State
University institutional review board and in accordance with the
Declaration of Helsinki. The results showed that the ILN biochip can
clearly distinguish MM patients from healthy donors by upregulated
miR-29b and down-regulated miR-16 expression in captured CD38+
EVs from plasma samples, much better than qRT-PCR or other methods
relying on total EVs in plasma. A similar performance for chronic
lymphocytic leukaemia patients was observed by CD20+ and CD37+
mAb captured EV subgroups.
Conclusion: We are extending this technology application to early detec-
tion of solid tumours such as lung cancer and pancreatic cancer.
OS23.02
Circulating microparticles as predictive biomarkers of severe
complications of radiotherapy for prostate adenocarcinoma
Alexandre Ribault1, Mohamedamine Benadjaoud2, Claire Squiban1, Romaric
Lacroix3, Coralie Judicone4, Laurent Arnaud4, Jean-Marc Simon5, Florence
Sabatier4, Stephane Flamant1, Marc Benderitter2 and Radia Tamarat2
1IRSN/PRP-HOM/SRBE/LR2I; 2IRSN/PRP-HOM/SRBE; 3Aix-Marseille
Université, VRCM, UMR-S1076, INSERM, UFR de Pharmacie, Marseille, France
and Department of Haematology and Vascular Biology, CHU La Conception,
APHM, Marseille, France; 4Département d’Hématologie et de Biologie
Vasculaire, CHU La Conception, Assistance Publique-Hôpitaux de Marseille;
5Hôpital la Pitié Salpétrière, Assistance Publique-Hôpitaux de Paris, France
Introduction: Microparticles (MPs) are membrane fragments with bio-
logical activities shed from activated cells. MPs have been studied as
biomarkers in several inflammatory diseases and as central players in
intercellular communication. In this study we investigated the potential
use of MPs as predicitive biomarkers of normal tissue complication after
radiotherapy for prostate cancer.
Methods: We included 217 patients overexposed during a course of
conformal 3D radiotherapy for a prostate adenocarcinoma between
2000 and 2006 in Jean MONNET hospital, Epinal, France. Their plate-
let-free plasma was obtained after several centrifugations then MPs were
quantified and phenotyped by flow cytometry. The rectal toxicity scores
following the blood sampling were collected during the routine follow-
up and were tested for association with MPs using a logistic regression
adjusted on several clinical confounders. Furthermore, anal canal, ante-
rior prostate and bladder dose volume histograms (DVHs) informations
were extracted for 36 patients to investigate MPs dosimetric correlations.
Results: A significant correlation was found between the number of
platelet-derived MPs (PMPs) and monocyte-derived MPs (MMPs) with
the range of doses up to the median exposure (40 Gy) of bladder/rectum
and anterior prostate respectively. No correlation with the most elevated
doses was found. Furthermore, a high level of MMPs was significantly
associated to an increased risk of grade ≥ 3 rectal bleeding (OR = 1.19
[1.02–1.39] by +10 MMPs/µl, p = 0.02) and to a borderline significant
risk of grade ≥ 2 radiation rectitis (OR = 1.1185 [0.9824–1.2735] by
+10 MMPs/µl, p = 0.07)
Conclusion: Our data demonstrate that the levels of circulating PMPs
and MMPs are correlated to low and moderate radiation doses rather
than to the highest one. These results suggest that these 2 MP subtypes
are released after irradiation, though their number reaches a plateau
beyond a threshold around the median dose. Furthermore, MMPs
appear as predictive of severe rectal complications. These findings sug-
gest that circulating MMPs may be valuable for the prognostic of radio-
therapy late complications.
OS23.03
Using machine learning of extracellular vesicle flow cytometry to
build predictive fingerprints for prostate cancer diagnosis
Robert Paproski, Deborah Sosnowski, Desmond Pink and John Lewis
University of Alberta, Alberta, Canada
Introduction: Extracellular vesicles (EVs) hold great promise for diag-
nostics in cancer. Micro-flow cytometry can enumerate and characterise
EVs in biological fluids although EV heterogeneity in size, abundance,
and marker expression complicates analysis. Our goal was to develop an
algorithm capable of predicting clinical outcomes from EVs in bodily
fluids.
Methods: Pre-diagnosis plasma samples from 215 men which received
prostate biopsies were stained with a variety of markers including
prostate-specific membrane antigen (PSMA) and ghrelin and analysed
with the Apogee A50 flow cytometer. Informed consent was obtained
and the study was approved by the Health Research Ethics Board of
Alberta Cancer Committee. Data was loaded into MATLAB, log trans-
formed and particle abundance was determined using multidimensional
histograms. Bins per parameter were varied from 2 to 128. Particle
abundance within bins was transformed with or without log, z-score,
and t-SNE (dimensionality reduction technique) and analysed with 23
different machine learning algorithms to predict aggressive prostate
cancer (Gleason 4 + 3 or higher). Fivefold cross-validation was used
and repeated 10 times with patient randomisation. Our results were
compared with the established Citrus algorithm. We also created syn-
thetic data sets with “shifting” scatter plots to determine if convolutional
neural networks could solve this issue.
Results: Using at least 8 bins per parameter generated the best predictive
models. The highest AUCs for the LALS-ghrelin, LALS-PSMA, LALS-
PSMA-ghrelin and PSMA-ghrelin data sets were 0.56, 0.58, 0.59 and
0.63, respectively. Log and z-score transformation increased AUCs for
the LALS-ghrelin and PSMA-ghrelin data sets to 0.61 and 0.69,





























respectively. t-SNE transformation increased the PSMA-ghrelin data set
AUC to 0.71. Combining the best predictive scores of all 2 parameter
data sets provided an AUC of 0.76 which was higher than the 0.64 AUC
from Citrus. When analysing shifted synthetic data, convolutional neural
networks provided the most accurate results.
Conclusion: We’ve optimised an advanced algorithm capable of predict-
ing prostate cancer aggressiveness from flow cytometry data. Further
integration of deep learning algorithms should improve model
performance.
OS23.04
TGFβ3 expression level in extracellular vesicles present in the plasma
of patients with head and neck squamous cell carcinoma is a marker
for treatment response
Dorival Mendes Rodrigues1, Soon Sim Tan2, Sai Kiang Lim2, Andre Lopes
Carvalho3, N. Gopalakrishna Yier4 and Andre Luiz Vettore1
1Universidade Federal de São Paulo, Brazil; 2A*STAR; 3Hospital do Câncer de
Barretos, Brazil; 4National Cancer Centre of Singapore, Singapore
Approximately 30% of patients with locally advanced head and neck
squamous cell carcinoma (HNSCC) (stage III–IV) treated with cisplatin-
based chemoradiotherapy (CRT) have incomplete response to the treat-
ment and there is no biomarker able to prospectively segregate these
patients from those who respond to the treatment. It had been shown
that TGFβ is a regulator of radiation therapy and promotes heterogene-
ity and drug resistance in squamous cell carcinoma. Since extracellular
vesicles (EVs) are able to carry proteins in the plasma, Cholera toxin B
chain (CTB) and Annexin V (AV), which respectively binds GM1 gang-
lioside and phosphatidylserine, were used to isolate EVs from cell lines
and total plasma samples. HNSCC cell line HN120, which were inher-
ently sensitive to cisplatin (WT), and their isogenic cisplatin-resistant
(CR) counterpart were evaluated in this study. It was observed that
TGFβ3 expression was higher in the CTB-EVs in HN120 CR when
compared to HN120 WT. TGFβ3 expression was also examined in
plasma samples from 38 HNSCC patients through ELISA sandwich.
This assay revealed that TGFβ3 in CTB and AV EVs was significantly
lower in the patients presenting complete response to CRT compared to
the patients with incomplete response. This study demonstrated that
TGFβ3 expression in CTB-EVs or AV-EVs circulating in plasma could
be used to determine the better treatment choice, improving the clinical
outcome for HNSCC patients, since it would be able to segregate these
patients that may respond or not to CRT approach.
OS23.05
EV-associated MMP9 in high grade serous ovarian cancer is
preferentially localised to Annexin V-binding EVs
Agnes T. Reiner1, Sisareuth Tan2, Stefanie Aust3, Nina Pecha3, Mattias
Mandorfer4, Alain R. Brisson2, Robert Zeillinger3 and Sai Kiang Lim5
1BioSensor Technologies, AIT-Austrian Institute of Technology GmbH;
2UMR-5248 CNRS – University of Bordeaux, France; 3Molecular Oncology
Group, Department of Obstetrics and Gynecology, Medical University of
Vienna, Italy; 4Division of Gastroenterology and Hepatology, Department
of Internal Medicine III, Medical University of Vienna, Italy; 5A*STAR
Among gynaecological cancers high grade serous ovarian cancer
(HGSOC) is the most aggressive type and responsible for most deaths.
Still there is a lack of biomarkers that are sensitive and specific enough
for clinical applications. In order to identify new markers, different
extracellular vesicle (EV) types were isolated from ascites of ovarian
cancer patients according to their affinities for lipid-binding proteins –
annexin V (AV), cholera toxin B chain (CTB) and shiga toxin B chain
(STB) – and their protein cargo was analysed. Low signal-to-noise ratios,
which are typically a problem when working with biological fluids for
biomarker discovery, are circumvented by this approach. Furthermore,
contamination by non-EV complexes, like protein aggregates, which are
often present in EV isolations, is minimised, because of specific binding
to lipids. We’ve isolated and analysed CTB-binding EVs (CTB-EV), AV-
binding EVs (AV-EVs) and STB-binding EVs (STB-EVs) from malig-
nant ascites of patients with ovarian cancer and from non-cancerous
portal-hypertensive ascites of patients with cirrhosis. Each of these three
EV types has different levels of CD9, CD63, CD71 and ALIX, suggesting
that they are unique EV populations. Next we’ve analysed them for
cancer associated proteins and observed that AV-EVs in ascites of
patients with HGSOC, but not patients with cirrhosis have higher levels
of protein matrix metalloproteinase 9 (MMP9). As MMP9 was not
detected in CTB- or STB-EVs, our study validates our approach of
using different EV types for optimal biomarker discovery. Furthermore
MMP9 in AV-binding EVs could be a HGSOC biomarker with
enhanced specificity, because its identification requires detection of
two distinct components, i.e. lipid and protein.
OS23.06
Proteome-wide profiling of viable tissue-derived extracellular vesicles
for development of early diagnostic biomarkers for colorectal cancer
Satoshi Muraoka1, Satoshi Nagayama2 and Koji Ueda1
1Project for Personalised Cancer Medicine, Cancer Precision Medicine
Centre, Japanese Foundation for Cancer Research, Japan; 2Department of
Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation
for Cancer Research, Japan
Introduction: Early detection of colorectal cancer (CRC) is essential for
improvement of prognosis by enabling therapeutic intervention at early
stage. Recently, it has been shown extracellular vesicles (EVs) could have
potential to be served as attractive biomarker carriers in any body fluids.
In this study, to identify novel EV biomarkers for CRC early detection,
we performed comprehensive proteome analysis of viable CRC tissue-
derived EVs, termed as tissue-exudative EVs (Te-EVs).
Methods: Te-EVs were obtained from serum-free culture media of
freshly resected CRC tissues and adjacent normal mucosa using the
sequential ultracentrifugation method (n = 20). A quantitative expres-
sion profile of Te-EV proteins was acquired by LC/MS. Following
protein identification and quantification analysis by MaxQuant software.
Four statistically valid biomarker candidate proteins were further eval-
uated by plasma EV-ELISA assays. Additional clinical and functional
assessments were also performed including IHC staining and EV incor-
poration assays.
Results: Among 6371 identified Te-EV proteins, 616 proteins were sig-
nificantly overexpressed (p < 0.05, fold change >4.0) in EVs from CRC
tissues compared to those from paired normal mucosa. We especially
focused on four EV membrane proteins as potential biomarkers, TMAM
(p = 3.62 × 10–5, fold change = 7.0), STAM (p = 1.88 × 10–3, fold
change = 6.0), GAM (p = 7.46 × 10–3, fold change = 4.4) and CSAM
(detected only in CRC tissue), since their expression levels in plasma
EVs from CRC patients were also significantly higher than those from
healthy donors in EV-ELISA assays using independent validation set.
IHC staining analysis also demonstrated four EV proteins specifically
overexpressed in CRC cells. Interestingly, uptake of STAM++ EVs
enhanced both proliferation and invasion of recipient cells in vitro.
Conclusions:Thus TMAM, STAM, GAM and CSAM on EVs should be
potential diagnostic or prognostic biomarkers for CRC, leading to devel-
opment of precise, non-invasive and low-cost blood liquid biopsy tests
in future.
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Extracellular vesicles from adipose-derived mesenchymal stem cells
promote autophagy in human osteoarthritic chondrocytes
Miguel Tofiño-Vian1, Maria Jose Alcaraz1, Maria Dolores Perez del Caz2,
Miguel Angel Castejon3 and Isabel Guillen4
1IDM, University of Valencia; 2Department of Burn and Plastic Surgery, La
Fe University Hospital; 3Department Orthopaedic Surgery and
Traumatology, La Ribera University Hospital; 4IDM, University of Valencia
and Department of Pharmacy, CEU-Cardenal Herrera, Valencia
Introduction: Adipose tissue-derived mesenchymal stem cells (AD-
MSC) release extracellular vesicles (EV) both under physiological and
pathological conditions. The immunomodulatory and anti-inflammatory
properties of AD-MSC have proven to be beneficial in several diseases.
Osteoarthritis (OA) is a leading cause of disability in the elderly.
Cartilage destruction is mediated by changes in chondrocyte metabolism
and the up-regulation of inflammatory or catabolic genes. In OA chon-
drocytes, the induction of autophagy may be a protective mechanism
against stress. We have investigated the effects of microvesicles (MV)
and exosomes (EX) from AD-MSC on autophagy, measured as LC3B-
positive autophagosome formation, and the production of inflammatory
and catabolic mediators in OA chondrocytes stimulated with IL-1β.
Methods: AD-MSC were isolated from fat of patients who undergone
abdominoplasty. EV were isolated from AD-MSC conditioned medium
by differential centrifugation with size filtration. Tunable resistive pulse
sensing was used to evaluate the concentration and size of Ex and Mv. OA
chondrocytes were stimulated with IL-1β (10 ng/mL) and treated with
MV (3.6 × 107 particles/mL) or EX (7.2 × 107 particles/mL) for 24 h. The
levels of oxidised proteins, IL-6, IL-10 and TNFα were measured by
ELISA, PGE2 by RIA, and MMP activity and NO by fluorometry. The
expression of collagen II and LC3B was evaluated by confocal microscopy.
The data were analysed by ANOVA followed by Dunnett’s test.
Results and Conclusion: EV down-regulated the production of inflam-
matory and degradative mediators induced by IL-1β. Treatment of OA
chondrocytes with MV or EX resulted in a significant reduction of MMP
activity, oxidative stress, IL-6 and TNFα levels. In addition, they
increased the production of the anti-inflammatory cytokine IL-10 and
the expression of collagen II. Both types of EV promoted the liberation
of LC3B-positive autophagosomes, with a higher effect for MV. Our data
indicate that EV exert protective effects on OA chondrocytes and may
have potential pharmacological applications to control autophagy,
inflammatory processes and extracellular matrix degradation.
Funding: SAF2013-48724-R (MINECO, FEDER) and PROMETEOII/
2014/071 (Generalitat Valenciana).
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Therapeutic control of systemic inflammation & atherosclerosis with
apoe-polarised macrophage exosomes
Robert Raffai, Kang Li and David Wong
University of California San Francisco, CA, USA
Introduction: ApoE expression by myeloid cells has been shown to sup-
press and even reverse atherosclerosis. We reported that apoE increases
microRNA-146a levels to suppress NF-kB activation in monocytes and
macrophages and thereby inflammation and atherosclerosis in mice.
What is not known is whether macrophage apoE expression modulates
microRNA levels in their secreted exosomes to suppress systemic and
vascular inflammation via intercellular communication, and whether such
exosomes could serve as treatments for atherosclerosis.
Methods: Bone marrow-derived macrophages were cultured from wild-
type (WT) mice and ApoE deficient (ApoE-/-) mice. Exosomes were
isolated using gradient density ultracentrifugation and assessed by
Nano-particle analysis. Global microRNA content in macrophages and
their exosomes were assessed by unbiased sequencing. Exosomes were
tested for their capacity to alter NF-kB activation in cultured endothelial
cells and macrophages. Exosomes were also tested for their capacity to
control acute and chronic inflammation in vivo by infusing 10E10
particles into WT and ApoE-/- mice every two days for a period of
two weeks. Subsequently, WT mice were challenged with sub-lethal LPS
and were examined for inflammation in peritoneal macrophages, while
levels of Ly6Chi monocytes were detected in the circulation of ApoE-/-
mice.
Results: An absence of ApoE expression in macrophages increased exo-
some secretion and substantially altered their microRNA content.
ApoE-/- exosomes enhanced NF-kB activation in cultured endothelial
cells and macrophages, and infusions of apoE-/- exosomes enhanced
inflammation in peritoneal macrophages of WT mice. In contrast, infu-
sions of WT macrophage exosomes significantly reduced the expression
of TNF-alpha and IL-6 in peritoneal macrophages isolated from mice
stimulated with LPS. Moreover, WT exosomes caused a two-fold reduc-
tion in levels of pro-inflammatory Ly6Chi monocytes in the circulation
of ApoE-/- mice.
Conclusions: ApoE expression by macrophages controls the rate of
exosome production and their microRNA content to suppress acute
and chronic inflammation. Ongoing studies explore whether defined
microRNA are responsible for these protective effects and whether
such exosomes can be used to suppress atherosclerosis in hyperlipidemic
mice.
OS24.03
Apoptotic-cell derived extracellular vesicles are rich in enzymatically-
derived active lipid mediators and can modulate immune responses
Ivana Milic1, Roberta Liccardo1, Parbata Chauhan1, Kesley Attridge1, Helen
R. Griffiths2 and Andrew Devitt1
1School of Life and Health Sciences, Aston University, Birmingham, United
Kingdom; 2Faculty of Health and Medical Sciences, University of Surrey,
Surrey, United Kingdom
Introduction: Apoptosis is a highly orchestrated programme resulting in
an active release of apoptotic cell-derived extracellular vesicles
(ACdEVs) to communicate their presence and enable efferocytosis. We
have shown that ICAM-3 on ACdEVs interacts with macrophages and
promotes chemotaxis. Given the molecular complexity of ACdEVs, it is
highly likely that other functional mediators (eg proteins, lipids, meta-
bolites) that promote efferocytosis and resolution of inflammation
remain unidentified. We aim to address ACdEVs structure-function
relationship using a comprehensive multidisciplinary approach.
Methods: Human primary lymphocytes were negatively isolated from per-
ipheral blood. Apoptosis was monitored using annexin V and propidium
iodide staining. ACdEVs isolated by centrifugation were characterised
using TRPS technology, for EV size and concentration. Presence of EV
markers was confirmed by Western blotting. Using a novel downstream
multi-omics approach we could simultaneously analyse miRNA, small lipid
metabolites and proteins in ACdEVs.Wideband protein and lipid profiling,
metabolipidomics were performed using nLC-HR-Q-TOF-MS/MS and
LC-QqLIT-MRM, respectively. The functional nature of ACdEVs towards
human macrophages was analysed by migration assays.
Results: Apoptosis of primary lymphocytes promotes release of EV that fall
within the exosome size range and are positive for exosomal markers (eg
TSG101). ACdEVs were shown to promote macrophage chemoattraction.
Proteomics of ACdEVs revealedmore than 500 proteins, highly enriched in
exosomal proteins. A systems biology approach revealed that ACdEVs were
enriched in membrane domain proteins involved with cell adhesion,





























regulation of immune responses and cell migration. Metabolipidomics
revealed an assembly of LOX and COX polyunsaturated fatty acid-derived
metabolites, with pro-inflammatory (eg PGD2, PGE2, LtB4), anti-inflam-
matory and pro resolving properties (eg RvD1, LXA4, LXB4, Mar1).
Summary: Our novel data suggest that ACdEVs may act as a pool of
small pro resolving metabolites and their precursors, and adhesion
molecules to effect macrophage recruitment, efferocytosis and subse-
quent immune modulation. Future studies will aim to address the func-
tion of a selected panel of protein and metabolite targets.
OS24.04
Histone flow: from nucleus to extracellular vesicles
Rohini Ravindran Nair, Davide Mazza, Alessandra Agresti and Marco
Bianchi
University of San Raffaele, Milan, Italy
Introduction: Histones play a central role in DNA packaging and epige-
netic regulation. Interestingly, histones are also found as soluble mole-
cules in the blood of sepsis patients (1). Until recently researchers viewed
histone content in each and every cell as fixed. Recent reports indicate
that histone content decreases in senescent cells. Our group had shown
that macrophages treated with LPS decrease their nucleosome content by
approximately 20% in 4 h (2). Our aim was to determine the fate of the
20% “missing” histones in macrophages stimulated with LPS.
Methods and Results: First, we evaluated whether stimulated macrophages
reorganise their chromatin structure, at a global level. Using quantitative
super-resolution microscopy (STORM) we observed that after LPS stimula-
tion of macrophages, nucleosomes clutches (2) reduce both their size and
density, suggesting that histones are evicted from chromatin.
Evicted histones can have two possible fates: they can be degraded or secreted
out of the cells. To test for histone degradation we collected the cells together
with their medium, but we found no difference before and after stimulation.
In contrast, histones amount in the medium increased after stimulation.
These data imply that histones are not degraded but secreted.
The medium of stimulated macrophages was subjected to ultracentrifu-
gation on an Optiprep density gradient. We found more histones both in
extracellular vesicles (EVs) and in the soluble fraction. This result was
confirmed using knock-in mice expressing H2B-GFP macrophages
which were found to secrete microvesicles containing H2B-GFP.
We excluded that EVs originate from membrane blebbing occurring
during apoptosis and necrosis, since there is no significant apoptosis
or necrosis in LPS-stimulated macrophages. However, we observed a
high level of H3K4 trimethylation in the secreted histones, suggesting
that they originate from the nucleus.
We next investigated the localisation of histones in microvesicles: inside
or outside the membrane. Biochemical experiments and STROM images
indicate that histones are mostly on the outer surface of the vesicles.
Conclusion: Our data show that the nuclear histones can be evicted out
of chromatin and be expelled either as soluble protein or microvesicle–
associated proteins.
References
1. Chen R et al., Cell Death Dis. 2014; 5: e1370.
2. De Toma I et al., J Intern Med. 2014; 276: 454–469.
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Chondrocytes derived from mesenchymal stem cells differentiated in
the presence of plasma-derived extracellular vesicles from
osteoarthritic patients express disease-related genes
Bartijn Pieters, Onno Arntz, Peter van der Kraan and Fons van de Loo
Radboudumc
Introduction: Osteoarthritis (OA) is an age-related musculoskeletal dis-
ease and the most common form of arthritis characterised by low grade
synovial inflammation and articular cartilage degeneration. Very little is
known about the pathophysiological role of extracellular vesicles (EVs)
in musculoskeletal diseases, such as OA. In this study, we investigated
the effect of plasma EVs from OA patients during chondrogenic differ-
entiation of mesenchymal stem cells (MSCs).
Methods: Plasma-derived extracellular vesicles (pEVs) were isolated
from plasma of OA patients and age-matched healthy controls using
size-exclusion chromatography. EV containing fractions were charac-
terised according to the ISEV guidelines. Pelleted MSCs were stimulated
with TGF-β and BMP-2 to induce chondrogenic differentiation, either in
the presence of pEVs isolated from OA patients or healthy controls.
After 8 days, RNA was isolated and RT-qPCR was performed to deter-
mine the gene expression profiles.
Results: No significant difference was observed in particle concentration,
size or protein concentration between OA patients and age-matched
controls. In the presence of pEVs from OA patients MSC-derived
chondrocytes showed a significant increase in the expression of MMP-
13 (6.1-fold), RUNX2 (1.9-fold) and RANKL (2.3-fold), compared to
pEVs from healthy controls. A trend towards higher ADAMTS5 expres-
sion (2.5-fold, p = 0.0685) with OA pEVs was also observed.
Additionally, we found a significant higher expression of WISP-1 (24-
fold), suggesting activation of the Wnt-pathway. All other proinflamma-
tory genes tested were not significantly different between the two groups.
Summary: A previous study (1) has shown that EVs released from IL-1β
stimulated synovial fibroblasts can induce osteoarthritic changes in
articular chondrocytes. Here, we show direct evidence that that circulat-
ing pEVs from OA patients can enhance OA-related genes in MSC-
derived chondrocytes. The expression profile found suggest the presence
of Wnt-proteins on pEVs from OA patients, which are known to be
involved in cartilage development and we previously have shown that
WISP-1 expression is a feature of experimental and human OA (2).
References
1. Kato T et al., J Intern Med. 2014; 276: 454–469.
2. Blom AB et al., Arthritis Rheum. 2009; 60: 501–512
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Role of exosomes in the immunopathogenesis of sarcoidosis
Abhay Kumar1, Rinkee Kumari2, Deepshi Thakral3, Samarjit Das4 and
Dipendra K Mitra5
1Department of TII, All India Institute of Medical Sciences, New Delhi, India;
2TII, AIIMS; 3AIIMS; 4Johns Hopkins University, MD, USA; 5Department of
TII, AIIMS
Introduction: Sarcoidosis is a disease of unknown aetiology and involves
formation of non-caseating granuloma in various organs. Exaggerated
immune response is the key feature of the disease; however, the exact
mechanism of this immune dysregulation is unknown. Few attempts have
been made to understand the role of exosomes in immunopathogenesis of
sarcoidosis but with limited success. Here, we investigated the impact of BAL
fluid-derived exosomes on various immune cells from sarcoidosis patients.
Methods: Exosomes were purified from BAL fluid and plasma by differ-
ential centrifugation followed by ultracentrifugation and stored at −80°
C. Further, exosomes were analysed for purity and size (by Nanosight
and Transmission Electron Microscopy) and stained with fluorescently
labelled antibodies (CD81, CD63, CD3, CD14, CD19) for flow cyto-
metric analysis (BD Calibur). Data was analysed using FlowJo software.
Their impact on monocytes, regulatory and effector Tcells was deter-
mined by flow cytometry.
Results: The monocytes and T-cells derived exosomes were significantly
high in BAL fluid of sarcoidosis patients. An increase in the expression
of IL-12 and TNFα was observed by autologous monocytes in presence
of BAL derived exosomes. Moreover, the frequency of T-cells expressing
IFN-γ, TNF-α, IL9 and IL17 were increased, when co-cultured with
exosoms from the BAL. In contrast, we observed exosome-dependent
decrease in expression of IL10 by Tregs and monocytes. Furthermore,
the impact of BAL-derived exosomes was similar but more profound
than plasma-derived exosomes on the above immune parameters.
Conclusion: Our preliminary observations indicate an important role of
exosomes in inflammatory cytokine production by the monocytes and T
cells among sarcoidosis patients. Efforts are underway to decipher the
mechanism employed by exosomes for immune-modulation and to
identify exosome- based biomarker for the disease.
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Circulating tumor-associated microparticles in hepatocellular
carcinoma and cholangiocarcinoma
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Willms2, Krzysztof Jankowski3, Waldemar Patkowski4, Beata Kruk5, Maciej
Krasnodębski4, Joanna Ligocka4, Robert Schwab2, Ines Richardsen2, Sebastian
Schaaf2, Angelina Klein2, Sebastian Gehlert6, Markus Casper7, Jesus Banales8,
Detlef Schuppan9, Piotr Milkiewicz4, Frank Lammert7, Marek Krawczyk4,
Veronika Lukacs-Kornek7 and Miroslaw Kornek1
1Department of Internal Medicine II, Saarland University Medical Center,
Saarland University, Homburg, Germany; 2Department of General, Visceral
and Thoracic Surgery, German Armed Forces Central Hospital, Koblenz,
Germany; 3Department of Internal Medicine and Cardiology, Medical
University of Warsaw, Warsaw, Poland; 4Department of General,
Transplant and Liver Surgery, Medical University of Warsaw, Warsaw,
Poland; 5Laboratory of Metabolic Liver Diseases, Department of General,
Transplant and Liver Surgery, Medical University of Warsaw, Warsaw,
Poland; 6Department of Molecular and Cellular Sport Medicine, Institute of
Cardiovascular Research and Sport Medicine, German Sport University
Cologne, Cologne, Germany; 7Department of Medicine II, Saarland
University Medical Center, Saarland University, Homburg, Germany;
8Department of Liver and Gastrointestinal Diseases, Biodonostia Health
Research Institute – Donostia University Hospital, University of the Basque
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of Translational Immunology and Research Center for Immune Therapy,
University Medical Center, Johannes Gutenberg University, Mainz, Germany
Introduction: Considering the high lethality of liver cancer, new early
detection methods are in urgent need to increase patient survival. Here,
we aim to improve early diagnosis and therapy monitoring possibilities
of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) by
applying a minimally-invasive approach involving tumor-associated
microparticles (taMPs), large extracellular vesicles.
Methods: TaMPs from patients’ sera were isolated by a sequential two-
step ultracentrifugation (2,000 and 20,000 g). Their surface antigen
composition was analyzed by FACS in order to identify subpopulations
associated with the presence of liver tumors or liver cirrhosis, a non-
tumor related disease (EV-TRACK ID: EV170006). In total, 172 liver
cancer patients (CCA or HCC), 54 cirrhosis patients and 202 control
subjects participated in the study. In 27 liver cancer patients a R0
resection was performed.
Results: By identifying AnnexinV+EpCAM+CD147+ taMP populations,
HCC and CCA patients could be detected. Moreover,
AnnexinV+EpCAM+CD133+ and Annexin V+ EpCAM+ASGPR1+
CD133+ taMPs were capable of discriminating liver disorders (HCC,
CCA and cirrhosis) from patients bearing non-liver cancers and from
disease-free individuals. Additionally, AnnexinV+EpCAM+ASGPR1+
taMP levels were elevated in liver cancer patients (HCC and CCA com-
bined) by 3.05-fold (p < 0.0005) as compared to tumor-free cirrhosis
patients. Associated AUROC (0.7), sensitivity (75%) and positive predictive
value (78%) implied a potent diagnostic accuracy. During the course of 10
days AnnexinV+EpCAM+ASGPR1+ taMPs decreased from 26.7 (pre-R0
resection) to 7.7 (p < 0.05) taMPs per 103 Annexin V+ MPs. The smallest
detectable liver tumors were 9 mm (HCC) and 11 mm (CCA) in size.
Summary/Conclusion: Our results demonstrate the potential of
AnnexinV+EpCAM+ASGPR1+ taMPs as a novel biomarker for HCC
and CCA detection. Since their assessment reveals the presence and
possibly the extent of these cancers, they feature a minimally-invasive,
accurate liquid biopsy screening tool that could considerably improve
(early) diagnostics and therapy in patients with primary liver cancer.
Funding: Studies were supported by a German Cancer Foundation grant
(111184) to Miroslaw Kornek and by the Alexander von Humboldt
Foundation -
SKA 2012 award to Veronika Lukacs-Kornek
LBO.13
Pre-metastatic cancer exosomes induce immune surveillance by
patrolling monocytes at the pre-metastatic niche
Michael P. Plebanek1, C. Shad Thaxton1 and Olga Volpert2
1Northwestern University, Chicago USA; 2University of Texas MD Anderson
Cancer Center, Houston, USA
Introduction: Metastatic cancers produce exosomes that condition pre-
metastatic niches in remote microenvironments to favor metastasis. Here
we show that exosomes from poorly metastatic melanoma cells can inhibit
metastasis to the lung. These “non-metastatic” exosomes stimulated an
innate immune response through the expansion of Ly6Clow patrolling
monocytes (PMos), which then caused cancer cells clearance at the pre-
metastatic niche. This is the first demonstration that pre-metastatic tumors
produce exosomes, which elicit a broad range of PMo-reliant innate
immune responses, causing cancer cell clearance at the pre-metastatic niche.
Methods: Exosomes were isolated from A375 or B16F10 melanoma cells
by differential ultracentrifugation and from patient samples using pre-
cipitation followed by CD63/CD81 affinity capture. Mouse models of
melanoma were used to show exosomes effects on metastasis, and flow
cytometry and immunohistochemistry to determine the immune cell
types targeted by exosomes. Additionally, exosomes from the sera of
melanoma patients were collected and ELISA was used to determine
pigment epithelium-derived factor (PEDF) presence in exosomes.
Results: Our data shows that non-metastatic exosomes drive expansion
of PMos as was evident by increased Nr4a1 expression of bone marrow
monocytes after treatment with non-metastatic exosomes compared to
metastatic exosomes or untreated control cells, as well increased pre-
sence of Nr4a1-positive cells in the lungs. Additionally, non-metastatic
exosomes contain PEDF as shown, whereas metastatic exosomes are
devoid of PEDF. Most importantly, ELISA shows significantly higher
amounts of PEDF in the sera exosomes of melanoma patients with a
greater than 5-year survival, as opposed to patients with more rapidly
progressing disease.
Summary/Conclusion: In this study we discovered that early stage, pre-
metastatic melanomas express triggers of immune clearance (PEDF) that
are loaded onto the surface of exosomes, activate the innate immune cells
PMos and could be developed into potential biomarkers. Lack of PEDF on
exosomes is associated with more aggressive disease. Additionally, this
study provides an entirely novel mechanism for the increased presence of
PMos at the pre-metastatic niche where they recruit NK cells to clear
circulating tumor cells from the tumor bearing host.
LBO.14
An extracellular vesicle blood fingerprint distinguishes between
patients with indolent and aggressive prostate cancer at diagnosis
John Lewis1, Robert Paproski1, Desmond Pink1, Catalina Vasquez1, Deborah
Sosnowski1, Bryan Donnelly2, Adrian Fairey1, Ron Moore1, Eric Hyndman2,
Martin Duffy2 and Jun Kawakami2
1University of Alberta, Canada; 2University of Calgary, Canada
Introduction: Prostate cancer is the most commonly diagnosed cancer in
men, and early diagnosis is essential to providing curative intervention
for those with aggressive disease. Blood PSA levels are currently used to
decide whether men will receive an invasive prostate needle biopsy,
which provides a diagnosis but comes with significant discomfort and
risk of infection. Using a highly sensitive micro-flow cytometry assay
and advanced machine learning approaches, we have developed a pros-
tate cancer EV fingerprint that can distinguish between patients with
indolent and aggressive prostate cancer at diagnosis using a few drops of





























blood. Here we present our initial clinical validation and accuracy of the
test in a prospective pre-diagnosis patient cohort.
Methods: Pre-diagnosis plasma samples from 377 Albertan men for
whom a prostate biopsy was ordered were analyzed using the Apogee
A50 micro-flow cytometer. A panel of biomarkers including prostate-
specific membrane antigen (PSMA) and ghrelin was utilized to enumer-
ate specific EV populations from the bulk EVs present in plasma. Using
a customized XGBoost machine learning approach with advanced fea-
ture selection, a prospective training cohort of 289 patients was utilized
to generate an EV fingerprint predictive score (EV-FPS) with a range of
0-100 to distinguish between patients with aggressive prostate cancer
(Grade Groups 3-5) from those with indolent prostate cancer (Grade
Groups 1 and 2). The EV-FPS was then validated in an independent
prospective cohort of 88 patients.
Results: EV-FPS was significantly higher in aggressive (17) vs. indolent
(5.8) prostate cancer (p < 0.0001). At a sensitivity of 95%, clinical
features including PSA provided only 17% specificity for aggressive
prostate cancer with an AUC of 0.72. Combining EV-FPS with clinical
features at sensitivity 95% increased the specificity for aggressive pros-
tate cancer to 56% with an AUC of 0.83.
Summary/Conclusion: The EV-FPS test significantly increases diagnostic
performance for the prediction of aggressive prostate cancer compared to
PSA and clinical features alone. Using a score cut-off that achieves 95%
sensitivity, men with aggressive prostate cancer can be accurately identi-
fied, and up to 56% of men could potentially avoid a biopsy altogether.
Funding: Alberta Cancer Foundation, Prostate Cancer Canada
LBO.15
Molecular subtypes of glioma stem cells as determinants of tumour
vesiculome and extracellular vesicle mediated intercellular
communication
Cristiana Spinelli1, Laura Montermini2, Dong-Sic Choi3, Brian Meehan3,
Delphine Garnier4, Shilpa Chennakrishnaiah5, Esterina D’Asti2, Ichiro
Nakano6 and Janusz Rak7
1McGill University, Montreal, Canada; 2The Research Institute of the McGill
University Health Center, Montreal, Canada; 3The Research Institute of the
McGill University Health Center, Montreal, Canada; 4UMR Inserm 892/
CNRS 629 - CRCNA Nantes; 5Mcgill Center, Montreal, Canada;
6Department of Neurosurgery, University of Alabama at Birmingham, AL,
USA; 7Montreal Children’s Hospital, Research Institute of the McGill
University Health Center, Montreal, QC, Canada
Introduction: One of the emerging mechanisms that govern multicellular
processes in cancer is the direct exchange of bioactive molecules via inter-
cellular trafficking of extracellular vesicles (EVs). These heterogeneous
membrane structures include exosomes, ectosomes, apoptotic bodies and
other EV subsets still poorly defined. We have previously uncovered the
impact of oncogenic and differentiation processes on biogenesis and func-
tion of cancer EVs and wish to extend this to the biology of glioma stem
cells (GSC) responsible for the recurrent and incurable nature of aggressive
brain tumours know as glioblastoma multiforme (GBM).We propose that
biogenesis, properties and biological activity of GBM-related EVs are dic-
tated by oncogenic and epigenetic pathways driving proneural (PN) or
mesenchymal (MES) subtypes of GSC populations.
Methods: We isolated and analyzed EVs from cultured GSCs using
differential centrifugation nanoparticle tracking (NTA) molecular profil-
ing (sequencing, proteomics, western blot, qRT-PCR) electron micro-
scopy and endothelial bioassays.
Results: We observed that human PN and MES GSC lines, exhibit
subtype-specific profiles of EV-related genes (vesiculome) and unique
patters of EV formation. Serum-induced differentiation impacted both
the GSC phenotypes and EV outputs, including the expression of CD133
(PN) and CD44 (MES) GSC markers, markers of astrocytic (GFAP) or
neuronal (TUJ1) lineage commitment. NTA revealed the existence of
exosome sized EVs in the GSC conditioned medium which markedly
increased in upon differentiation. Proteomic characterization of the EV
cargo documented that MES GSCs emit completely different EVs com-
pared to their PN counterparts the latter lacking common exosomal
markers. The respective EVs also exhibited different biological activities
against endothelial cells, as a function of their subtype and differentia-
tion status.
Summary/Conclusion: With these findings we posit that EVs contribute
to and reflect the equilibrium between GBM stem and non-stem cell
populations, and they regulate tumour-vascular interactions in a manner
influenced by their subtype and differentiation state. Moreover, oncogenic
and epigenetic pathways, underlying known trajectories of GBM progres-
sion, control EV biogenesis, bioactive cargo, and intercellular interactions.
Funding: MICRTP Studentship 2016
OS25.01
Insights into the mechanisms of neratinib-resistance: investigating a
possible role for extracellular vesicles in HER2-overexpressing breast
cancer
Michelle C. Lowry1, Susan Breslin1, Sinead Toomey2, Bryan T. Hennessy2 and
Lorraine O’Driscoll3
1Trinity College Dublin, Ireland; 2Royal College of Surgeons, London, United
Kingdom; 3School of Pharmacy and Pharmaceutical Sciences and Trinity
Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
Introduction: Excluding non-melanoma skin cancer, breast cancer is the
most common female cancer and the most common cause of female cancer
deaths worldwide. Amajor issue in the treatment of breast cancer is de novo
and acquired resistance to therapies. Although neratinib is proving effica-
cious in HER2+ metastatic breast cancer clinical trials, neratinib-resistance
(NR) is an evolving issue. This study aims to determine the mechanisms of
NR, discover potential predictive biomarkers and to potentially lead to the
discovery of new therapeutic targets in HER2+ breast cancer.
Methods: NR variants of three HER2+ cell lines (EFM19.2A, HCC1954 and
SKBR3) were developed by exposing these previously drug-sensitive cells to
increasing concentrations of neratinib over a 6 month period. Neratinib IC50
for all variants was determined using acid phosphatase assays. Extracellular
vesicles (EVs) released from each variant were isolated using ultracentrifuga-
tion. To characterise EVs, immunoblotting, nanosight tracking analysis
(NTA) and transmission electron microscopy (TEM) were performed.
Cellular DNA content was investigated using Sequenom MALDI-TOF MS.
Proteomic analysis of cellular and EV content was performed by Olink.
Results: NR variants of the three cell lines were successfully developed, as
EFM19.2A-NR, HCC1954-NR and SKBR3-NR. The neratinib IC50 for
these variants were 6.5-fold, 6.8-fold and 7.4-fold that of their respective
parent cell lines. Immunoblotting, NTA and TEM showed successful
isolation of EVs from each. DNA Sequenom led to the discovery of 3
SNPs in the HCC1954-parent and HCC1954-NR variants i.e. two SNPs
in PIK3CA gene, one SNP in PIK3R1. Of the 181 proteins analysed,
some were found to be enriched in EVs compared to cells, others
displayed opposite trends. Three proteins (CA9, CSF-1 and TLR3)
showed substantial increased quantities in NR variants and their respec-
tive EVs, compared to drug-sensitive counterparts.
Conclusions: Further studies are warranted to validate these findings in
more cell models, to investigate the functional relevance of CA9, CSF-1
and TLR3 in NR and, subsequently, progress our findings to analysis of
specimens from appropriate cohorts of breast cancer patients.
Funding: Irish Cancer Society’s support of Breast-Predict and H2020
support of BM1202 ME-HaD.
OS25.02
The role of extracellular vesicle transfer in the heterogeneity of
glioblastoma
Jakub Godlewski, E. Antonio Chiocca and Agnieszka Bronisz
Brigham and Women’s Hospital, MA, USA, Harvard Medical School,
MA, USA
Introduction: Despite the importance of molecular subtype classification
of glioblastoma multiforme (GBM), the extent of extracellular vesicle
(EV)-driven molecular and phenotypic re-programming remains poorly
understood.
Methods: Using intracranial xenografts of patient-derived GBM stem-like
cells (GSCs), we identified subpopulations with distinct transcriptomes,
displaying either proliferative/nodular or migratory/invasive modes that





























were associated with mesenchymal-like or proneural-like subtype, respec-
tively. To reveal complex subpopulation dynamics within the heteroge-
neous intra-tumoral ecosystem, we characterised protein and microRNA
expression and secretion in these phenotypically diverse subpopulations
of GSC. Bioinformatic analysis followed by functional EV transfer
between GSC in vitro and in vivo was used to analyse their molecular
and phenotype subtype characteristics.
Results The highly heterogeneous profile of microRNAs expression in GBMs
was distinguishable into two unsupervised classes that partially overlapped
with previously determined molecular subtypes, with both subclasses of
GSCs displayed differential cellular and EV microRNA profiles. The analysis
of microRNA/target networks provided evidence that EV/microRNAs are
modifiers of both the molecular landscape and phenotype, acting via cell
type-dependent targeting. Importantly, EV proteome retained the subtype
specificity and EV protein signatures were associated with worse outcome.
The transfer of EVs between subpopulations of GSCs led to increased
tumorigenicity in vitro and in vivo but did not cause a phenotypic switch,
facilitating the formation of inter-dependent tumour organisation.
Conclusions: Our findings demonstrated the existence of previously
underappreciated heterogeneity among cancer EVs that contribute to
the diverse complexity of the brain tumour ecosystem, indicating that
clinical outcome is influenced by the proportion of tumour cells of varying
subtypes which by the exchange of EVs can modify molecular landscape
and phenotype, acting in tumour anatomic sites-dependent fashion.
OS25.03
Adipose tissue endothelial cell derived microparticles are a potential
link between obesity and prostate cancer
Bronson Haynes, Justin Cimring, Ryan Huyck, Lifang Yang, Vanessa L.
Correll, Michael McGeagh, Sucharita Dutta, Oliver J. Semmes and Anca D.
Dobrian
Eastern Virginia Medical School, VA, USA
Introduction: Obesity increases the risk and aggressiveness of multiple
cancers including prostate cancer. Visceral adiposity is a rich source
of inflammatory mediators and endothelial cells (EC) from adipose
tissue are exposed to such a pro-inflammatory milieu in obesity. We
hypothesise that adipose tissue EC exposed to pro-inflammatory
cytokines produce microparticles (MP) that contribute to increased
tumorigenesis and metastasis of prostate cancer cells via deliveryof a
pro-oncogenic mRNA and protein cargo.
Methods: Human adipose tissues EC were treated with TGF-β, IFN-γ
and TNF-α and MPs from conditioned media isolated by ultracentrifu-
gation and characterised by particle track analysis and electron micro-
scopy. DIO-labelled MP were incubated with ARCaP-M cells and
particle uptake, proliferation and migration were quantified by fluores-
cence microscopy, BrdU incorporation and invasion assays, respectively.
MP proteome was analysed by LC/MS/MS and western blot and mRNA
content by RT-PCR.
Results: Cytokine-treated EC produced ~5-fold more MP compared
to untreated EC, their uptake by ARCaP-M cells, but not by EC was
2-fold higher, indicating selective tropism for ARCaP-M cells. mRNA
for Twist-1 and Snail-1 was significantly increased in MP from
cytokine-treated EC. LC/MS/MS revealed protein signatures for
Twist-1 and Snail-1, two oncogenes that induce epithelial to mesench-
ymal transition. In addition, 12-lipoxygenase (ALOX12) mRNA and
protein were found in MP and could account for increased MP
uptake. MP increased proliferation of ARCaP-M cells and matrigel
invasion assay showed a dose-dependent increased migration of MP
treated ARCaP cells vs. controls.
Conclusion: MP produced by adipose tissue EC exposed to a pro-
inflammatory milieu, such as is the case in obesity contain a pro-
oncogenic cargo. ALOX12 and Twist-1 were associated with aggres-
sive prostate tumours in humans. Exposure of human prostate cancer
cells to MP produced by EC in pro-inflammatory conditions led to
increased proliferation and migration of tumour cells and MP-derived
proteins such as Twist-1 and Snail1 may play a key role. This study
reveals a yet unrecognised cross-talk between EC-derived MP from
human visceral fat and tumour cells and proposes a new link between
visceral obesity and prostate cancer.
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On-disc Isolation and Analysis of Extracellular Vesicles from Biological
Samples
Vijaya Sunkara1, Hyun-Kyung Woo2, Juhee Park3, Tae-Hyeong Kim3, Chi-Ju
Kim2, Hyun-Il Choi4, Yoon-Keun Kim5 and Yoon-Kyoung Cho6
1Ulsan National Institute of Science and Technology, Ulsan, Republic of
Korea; 2Ulsan National Institute of Science and Technology; 3Center for
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Science & Technology; Institute of MD Healthcare, Pohang, Republic of
Korea; 6Center for Soft & Living Matter, Institute for Basic Science (IBS);
Ulsan National Institute of Science and Technology, Republic of Korea
Introduction: Extracellular vesicles (EVs) are 40 to 1000 nm-sized, cell-
derived, membranous vesicles that carry nucleic acids and proteins of
the cell of their origin. They are prominent in many body fluids and play
diverse roles in intercellular communications. Despite of the increasing
interest as potential biomarkers, current methods of their isolation and
analysis suffer from the limitations such as requirement of expensive
equipment, long processing time or low yield and purity of the vesicles.
To address some of the issues, we have demonstrated the use of an
Exodisc for isolation and subsequent analysis of the EVs from culture
media and urine. Currently, the ability of the Exodisc for isolation of
EVs from plasma and other biological fluids are being studied.
Methods: The channels and chambers were fabricated on a polycarbo-
nate (PC) disc by CNC micromachining. A pushpin valve was integrated
to control the flow of the fluid. The device consists of two nano-porous
membranes with pore sizes of 600 nm (track-etched PC membrane) and
20 nm (AAO membrane). First, the debris was sediment and then
solution was passed through the two filters sequentially, by spinning
the disc at 3000 rpm. The EVs > 600 nm gets trapped on filter I and
those between 20 to 600 nm on filter II. Finally, EVs on filter II were
washed with PBS and either analyzed by ELISA on the disc or trans-
ferred to a collection chamber for retrieval.
Results: In the Exodisc, starting with raw sample, whole procedure from
sample preparation to EVs detection is achieved within one hour. The
data shows that the on-disc filtration isolates about four times higher
EVs, and analysis of the EV mRNA also shows >100-fold higher con-
centration of mRNA compared to UC. In addition, the device could able
to differentiate the urinary EVs from bladder cancer patients to that of
healthy donors, by performing on-disc ELISA utilizing their CD9 and
CD81 expressions.
Summary/Conclusion: The Exodisc provides rapid isolation, higher
recovery as well as high-sensitive protein detection of EVs compared
to conventional methods. The EVs enriched on 20 nm filter can either be
retrieved as pristine and intact EVs for conventional analyses or detected
on the same device by using specific detection antibodies, promising its
potential utility in the EV field.
Funding: HI12C1845, IBS-R020-D1, and SRC (2010-0028684) funded by
the Korean Government.
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High resolution size exclusion chromatography allows detailed study
of exosome heterogeneity
Eduard Willms1, Pieter Vader2, Matthew J. Wood3, Simonides Immanuel van
de Wakker1, Olivier Gerrit de Jong1, Imre Mäger3, Samir El Andaloussi4 and
Carlos Cabañas5
1Professor Matthew Wood Lab; Department of Physiology, Anatomy and
Genetics; University of Oxford, United Kingdom; 2University Medical
Center Utrecht, The Netherlands; 3Department of Physiology, Anatomy and
Genetics, University of Oxford, Oxford, United Kingdom; 4University of
Oxford, United Kingdom; 5Complutense University of Madrid; Department
of Microbiology; Spain
Introduction: Cells release membrane enclosed vesicles termed extracel-
lular vesicles (EVs) that function as mediators of intercellular commu-
nication. Exosomes, EVs released upon fusion of the multi-vesicular body
and cell membrane, are thought to represent a population of EVs with
homogenous biophysical and functional characteristics. However,
increasing evidence highlights that exosomes are a heterogeneous popula-
tion of EVs (Willms et al. 2016, Collino et al. 2017). Here, we employed a
two-step size exclusion chromatography approach to identify multiple
exosome subpopulations with distinct composition and function.
Methods: Exosomes were isolated from cell culture supernatants using
size exclusion chromatography (SEC). Subsequently, exosomes were
subjected to fractionation by high resolution size exclusion chromato-
graphy (HR-SEC). Dot blot analysis was performed on individual HR-
SEC fractions to determine expression of common exosomal markers.
Based on expression patterns of these markers, individual HR-SEC
fractions were pooled to obtain exosome subpopulations. Western blot
analysis was performed to study the composition of the subpopulations,
and particle size was determined using nanoparticle tracking analysis.
Functional effects on recipient cells were studied using proliferation and
migration assays.
Results: Fractionation of isolated exosomes using HR-SEC revealed that
exosomes represent a heterogeneous population of EVs. Dot blot analy-
sis on individual HR-SEC fractions demonstrated a distinct distribution
of common exosome markers. Exosome subpopulations were identified
based on differential expression of common exosomal proteins and
previously identified exosome subpopulation markers (Willms et al.
2016). Exposure of recipient cells to subpopulations resulted in differ-
ential functional effects.
Conclusion: In conclusion, we demonstrate that exosomes represent a
heterogeneous EV population. HR-SEC allows for in depth-study of
exosome heterogeneity and identification of exosome subpopulations
with distinct biophysical and functional characteristics. Increased under-
standing of exosome heterogeneity will allow for more detailed study of
exosome biology and will facilitate biomarker discovery as well as highly
specific engineering of exosomes.
LBO.18
EVQuant: Combined quantification and phenotypic analysis of
individual extracellular vesicles in experimental and clinical samples
Thomas Hartjes1, Diederick Duijvesz2, Roy van der Meel3, Mirella
Vredenbregt2, Matthijs Bekkers2, Raymond M. Schiffelers4, Adriaan
Houtsmuller1, Guido Jenster2 and Martin van Royen1
1Department of Pathology/Erasmus Optical Imaging Centre, Erasmus
Medical Center, Rotterdam, The Netherlands; 2Department of Urology,
Erasmus Medical Center, Rotterdam, The Netherlands; 3Department of
Biochemistry and Molecular Biology, University of British Columbia,
Vancouver, British Columbia, Canada/Department of Clinical Chemistry
and Haematology, University Medical Center Utrecht, Utrecht, The
Netherlands; 4Department of Clinical Chemistry and Haematology,
University Medical Center Utrecht, Utrecht, The Netherlands
Introduction: Extracellular vesicles (EVs) are an important biomarker
source for a range of diseases. Proteins on the surface of secreted organ-
or disease-specific EVs in body fluids could be used for detection or
monitoring disease. Although various methods exist to quantify EVs, EV
quantification in clinical samples remains challenging and more impor-
tantly, current approaches are often unable to identify EV subpopula-
tions. Here we provide a microscopy based assay (EVQuant) to both
quantify and phenotype individual EVs without the need for EV isola-
tion/purification.





























Methods: In short, EVs are labelled using a fluorescent membrane dye
and/or immunofluorescent antibodies. To enable detection of low inten-
sity signals, EVs are immobilized in a transparent medium and detected
using confocal microscopy or a high-throughput imaging system.
Fluorescent EV signals are quantified using open source software.
Liposomes were used to identify the size limitation for detection. EVs
from 10 different cell lines were quantified and phenotypically analysed
by combining general membrane labelling and specific labelling of the
EV markers CD9 and CD63 using fluorescent antibodies. The CD9 and
CD63 distribution was compared to CD9 and CD63 time-resolved
fluorescence immunoassay (TR-FIA) analysis of the same samples.
Results: Quantification of liposomes showed EVQuant was able to detect
EVs down to 50nm in size. Multicolor imaging of individual EVs allowed
the detection of EV sub-populations and showed a large variation in the
presence of the general markers CD9 and CD63 on EVs between cell lines.
Concentrations of CD9 or CD63 positive EVs were compared to presence
of CD9 or CD63 quantified by TR-FIA and showed no direct correlation
which could be partially explained by differences in the average number
CD9 and CD63 molecules present on EVs between cell lines.
Summary/Conclusion: EVQuant is a rapid, robust, widely accessible
assay with the following benefits; the ability to detect vesicles down to
50 nm in size, no EV isolation/purification needed, and the possibility to
perform multicolor imaging. The ability to detect EV sub-populations
based on specific biomarkers and the possibility to analyse EV samples
in high-throughput, makes EVQuant a suitable candidate for implemen-
tation in a clinical setting.
Funding: This project is funded by Prostate Cancer UK (G2012-36)
LBO.19
High sensitivity, quantitative epitope analysis of plasma EVs by flow
cytometry
Aizea Morales-Kastresana1, Xiaomei Yan2, Shaobin Zhu3, Katherine
McKinnon4, William Telford5, Veena Kapoor5, Jay A. Berzofsky4 and
Jennifer C. Jones4
1National Cancer Institute, National Institutes of Health; 2Xiamen University;
3nanoFCM, Inc., Fujian, Chyina; 4National Cancer Institute, Vaccine Branch;
5National Institutes of Health
Introduction: Most conventional flow cytometers are unable to resolve
individual 30 – 200 nm extracellular vesicles (EVs), which are likely to
carry fewer than 100 copies of any specific epitope. Typically, these EVs
are not only too small, but also too dimly-labeled to be individually
classified as “positive.” Although the limits of scattered light detection
are well described, there are no comprehensive reports that delineate the
molecular limits of resolution of modern flow cytometers, in terms of
how many epitopes or fluorophores are required for detection.
Methods: EVs were isolated size exclusion chromatography and ultrafiltra-
tion. We determined Mean Equivalent Soluble Fluorophore (MESF) limits
of several instruments, and compared these values with a next generation
high sensitivity, avalanche photodiode (APD)-enabled flow cytometer
(nanoFCM). Next, we assayed the plasma EV expression of more than 300
epitopes, using PE-conjugated monoclonal antibodies against human cell
surface markers and isotype controls. Results: Most conventional flow
cytometers cannot detect signals from fewer than 100-1000 fluorophores.
Therefore, many EVs that carry low or intermediate numbers of any specific
surface molecule will be too dim to be detected by fluorescence with those
instruments. However, the nanoFCM demonstrated 10-100-fold higher
sensitivity, and a commensurate ability to detect epitope-positive EVs that
are too dim to be detected with most available flow- or image- cytometers.
Not surprisingly, we found that unbound labels must be removed prior to
running samples on the nanoFCM, to achieve maximal sensitivity.
Summary/Conclusion: Due to the diversity of EV sources and biological
effects, a longstanding goal of the EV research community is to define
relevant EV repertoires and their associated surface epitopes. This is the
first comprehensive, quantitative comparison of limits of detection for
several flow cytometers, with respect to the detection of fluorescently
labeled surface molecules. The nanoFCM enables detection of low- to
intermediate-levels of EV surface markers, and our results provide a
benchmark profile for high-sensitivity plasma EV epitope detection for
more than 300 cell surface epitopes.
Funding: National Institutes of Health, NCI-CCR Vaccine Branch,
Radiation Oncology Branch, & Assistant Clinical Investigator Program.
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Extracellular vesicle and miRNA profiling of the primate
cervicovaginal compartment reveal possible anti-HIV defences
Zezhou Zhao, Dillon Muth, Kathleen Mulka, Bonita Powell, Kelly Metcalf
Pate, Zhaohao Liao and Kenneth Witwer
The Johns Hopkins University School of Medicine, MD, USA
Introduction: We previously observed changes in overall concentration
of extracellular particles including extracellular vesicles (EVs) recovered
from cervicovaginal lavage (CVL) and other fluids in endometriosis and
in HIV/SIV infection. Here, we further characterise EVs released during
the menstrual cycle and retroviral infection and develop a reference
profile of small RNAs of the primate cervicovaginal compartment.
Methods: CVL of rhesus macaques, previously collected over the course
of five weeks, were subjected to differential centrifugation to enrich EVs.
Characterisation was performed by NTA and WB for EV markers. A
medium-throughput qPCR platform was used to profile miRNAs in
CVL, swabbed secretions, enriched EVs and biopsy samples, and results
were validated by individual qPCR. miRNA function in relation to HIV
infection was assessed in monocyte-derived macrophages using HIV-1
BaL or green fluorescent protein-encoding HIV.
Results: EVs with standard EV markers were successfully enriched from
CVL. However, miRNAs were present predominantly in EV-depleted frac-
tions of CVL, not in EV-enriched centrifuge pellets. The most abundant
miRNAs across fractions were miRs-223, -203, -24, -150, -146a, -21, -222,
-92a, -17 and -106a, with only a few miRNAs enriched in EVs. Surprisingly,
few miRNAs profile changes were observed during the menstrual cycle or
during SIV infection, in either CVL or EVs. However, several abundant
CVL miRNAs, including miR-223, may be generally protective against
retroviral infection, as suggested by in vitro infection assays.
Conclusions: We have established a miRNA profile of CVL fractions and
probed the overlap of CVL and EV miRNAs with those found in
secretions and epithelial tissues. Although menstrual cycle and SIV
infection have only minor effects on CVL miRNA profiles, CVL
miRNAs may contribute to antiviral defences. Additional studies are
underway to elucidate the role of EV small RNAs in protecting against
retroviral reproductive tract infection.
OS26.02
Inflammatory glia alter synapse stability via the transfer of
extracellular vesicle-associated miRNAs
Ilaria Prada1, Elena Turola2, Martina Gabrielli3, Giulia D’Arrigo4, Alessia
Iorio1, Giuseppe Legname4, Dan Cojoc5, Marta Fumagalli1, Francesca
Peruzzi6 and Claudia Verderio3
1Università degli Studi di Milano, Milan, Italy; 2Gastroenterology Unit,
Department of Internal Medicine, University of Modena and Reggio Emilia,
Italy; 3CNR-IN Neuroscience Institute, Department of Medicine, Milan, Italy;
4Department of Neuroscience, Scuola Internazionale Superiore di Studi
Avanzati (SISSA), Trieste, Italy; 5CNR-IOM Institute of materials,Trieste,
Italy; 6Department of Medicine, Scott Cancer Center, New Orleans, LA, USA
Introduction: Beyond the classical secretory mechanism through which
glial cells influence brain activity, astrocytes andmicroglia, release circular
membrane fragments, known as extracellular vesicles (EVs). EVs contain
several components of the donor cell (RNAs, proteins, lipids) and can
transfer their cargo to recipient cells. Our aim is to investigate whether glia
can regulate neuron gene-expression through the secretion of EVs.
Methods: Rat primary cell cultures, EV isolation, RealTime-PCR,
Renilla/Luciferase-based assay, transfection, immunocytochemistry, wes-
tern blot, optical manipulation and live imaging.
Results: Using miRNA real-time-PCR panels, we identified a set of
miRNAs differentially expressed in EVs produced by pro-inflamma-
tory compared to pro-regenerative microglia. Among them, we found
miR-146a, a known miRNA involved in inflammatory responses,
which is also altered in brain disorders and targets neuron-specific
genes. To investigate possible glia-to-neuron shuttling of miR-146a,
we performed a Renilla/Luciferase-based assay transfecting rat hippo-
campal neurons with a miR-146a-specific sensor, and exposing them





























to EVs for 24 h. Neuron exposure to glial EVs caused an increase in
neuronal miR-146a levels, with a consequent decrease in protein
expression of validated miR-146a targets, such as the synaptic vesicle
protein synaptotagmin 1 and the postsynaptic adhesion protein neu-
roligin 1. Morover, this effect resulted in decreased dendritic spine
density and reduced number of excitatory synapses in target neurons.
Donor glia transfection with miR-146a inhibitor or blockade of phos-
phatidyl-serine residues on glial EVs, a determinant for EV binding
on neurons, prevented the up-regulation of miR-146a and the con-
sequent down-regulation of its downstream targets in neurons.
Additionally, by visualising single EV-neuron contacts driven by
optical manipulation we observed that EVs form stable interactions
with neurons, ruling out the possibility that EVs undergo rapid
internalisation or full fusion.
Conclusions: Our data indicate that reactive glia may influence neuronal
activity by regulating the translation of crucial components of the
synapse through secretion of miR146a-storing EVs.
OS26.03
Stressing out the neighbours: stressed exosomes (“sexosomes”?)
passage stress phenotypes to recipient cells
Jasmina Redzic1, Tom Anchordoquy1 and Michael W. Graner2
1University of Colorado Denver, Anschutz Medical Campus, Skaggs School
of Pharmacy, CO, USA; 2University of Colorado Denver, Anschutz Medical
Campus, Department of Neurosurgery, CO, USA
Cancer cells undergo a number of stresses, many of them self-inflicted,
but often do not appear to suffer the consequences of those stresses. In
some cases, the stress responses may actually prove beneficial to the
tumour cells, providing them with potent resilience to their less-than-
hospitable environments. One consistent tumour stress is the unfolded
protein response (UPR), an endoplasmic reticulum-based stress-man-
agement system with sensors, transducers, and effectors that result in a
transcriptional and translational landscape rearrangement leading to
resolution of the stress, or cellular apoptosis. However, tumours may
incorporate the UPR into their stress portfolio to survive or even thrive
amidst their environmental insults. We propose that exosomes from
stressed cells (stressed exosomes, or “sexosomes”) are able to induce
stress response phenotypes in recipient, unstressed cells, thus enabling
stress responses without having to experience the actual stress. Our
analysis in this report goes to the molecular level, monitoring proteome
changes in glioma cells when those cells are exposed to exosomes
released from UPR-stressed cells. We find high overlap in the pro-
teomes of stressed cells and unstressed cells that receive “sexosomes”,
suggesting that tumours may unify their overall stress responses
despite their inherent heterogeneity. The implications for general
tumour biology, and in particular, therapeutic resistance, are
highlighted.
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Ghost nanovesicles for targeted delivery of chemotherapeutics
Gyeongyun Go1, Changjin Lee2, Hyun Taek Park1, Nhung Thi Hong. Dinh1,
Dong-Sic Choi3, Su Chul Jang4 and Yong Song Gho1
1POSTECH; 2Postech; 3The Research Institute of the McGill University
Health Centre, Montreal, Canada; 4Krefting Research Centre, Institute of
Medicine, University of Gothenburg, Sweden
Introduction: Extracellular vesicles are endogenous nanocarriers that can
deliver cellular molecules between cells and they are recognized as
alternative targeted drug delivery systems. However, extracellular vesi-
cles are produced in low quantities and the vesicles are filled with
cellular molecules that may interrupt efficient drug loading. Here, we
developed ghost nanovesicles in which molecules entrapped by cell
membrane are released by opening cell membrane under high pH and
the membrane are resealed in neutral condition.
Methodsr: Cell membrane sheets of human monocytic U937 cells were
isolated by sonication and ultracentrifugation of the cells lysed in
sodium carbonate solution. The drug-loaded ghost nanovesicles were
generated by further sonicating the membrane sheets in the presence of
the drug under neutral pH. Characteristics of the ghost nanovesicles in
terms of size, topology, and protein, nucleic acid components were
analyzed. Specific uptake and drug delivery of ghost nanovesicles were
examined on TNF-α stimulated human umbilical vein endothelial cells
(HUVEC) in vitro.
Results: Electron microscopy and dynamic light scattering analyses
revealed that the ghost nanovesicles were intact membrane vesicles
with 120 nm average size. Topology analysis showed that the ghost
nanovesicles preserve the original membrane topology. Western blot
and qPCR results showed that the ghost nanovesicles are de-enriched
with cytosolic proteins, nucleic acids while the nanovesicles enriched
with membrane proteins for targeted delivery. The ghost nanovesicles
retained natural targeting characteristic of source cells and showed
targeted drug delivery on TNF-α stimulated HUVEC.
Summary/Conclusion: These results suggest that the ghost nanovesicles
can serve as a novel drug delivery system to achieve effective loading and
specific delivery of chemotherapeutics to target cells.
LBO.21
Duotype-specific peptides as tool for tumor progression monitoring
via tumor-derived exosomes targeting
Enrico Iaccino1, Selena Mimmi1, Ileana Quinto1 and Giuseppe Scala2
1Department of Experimental and Clinical Medicine University; 2Department
of Experimental and Clinical Medicine University “Magna Graecia” of
Catanzaro
Introduction: In contrast to invasive tissue biopsy, exosomes are effective
biomarkers in the diversified diagnosis of personalized medicine.
Although several methods have been developed to purify exosomes,
none of these can clearly discriminate between normal and tumor-
derived exosomes (TDEs) and to completely avoid contaminations by
other shed membranes. Recently we reported that small peptide ligands
(Id-peptides) targeting the immunoglobulin B-cell receptor are a unique
tool to target both transformed and clonogenic precursors of B-cell
malignancies. As shown in recently published works, MM released
exosomes constitutively express the Ig-BCR making MM secreted exo-
somes a reliable target for id-peptides binding.
Methods: The monoclonal immunoglobulin (Ig-BCR) from the
5T33MM cell line was purified by Protein G affinity chromatography
and utilized as a bait to isolate binders of their antigen-binding site using
a C7C phage-displayed peptide library fused to the M13 minor coat
protein. Synthetic peptides corresponding to the peptide insert of phage
clones were assayed for their antigenic properties out from the phage
context, while their specific binding to the target cells was assayed by
flow cytometer using fluorescein isothiocyanate (FITC)-conjugated Id-
peptides.
Results: The Id-peptides capability to specifically target 5T33MM-
derived exosomes was confirmed both in vitro and ex vivo. Before
these validations, exosomes were first purified using standard proce-
dures and then characterized by scanning electron microscope, nano-
sizer and Western blotting analysis. Streptavidin magnetic beads were
first decorated with biotinylated anti-CD63, incubated with the
serum-derived exosomes and then analyzed for FITC-conjugated Id-
peptides specificity by flow cytometry. The ex vivo experiments were
conducted using the C57BL/KaLwRij strain and their survival rate
was evaluated. Blood samples from 5T33MM injected mice were
collected every seven days post cells inoculation and serum exosomes
were evaluated for Id-peptides targeting in comparison with parapro-
tein concentration.
Summary/Conclusion: According to the above-mentioned results, this
work provides an innovative approach to the early detection and clinical
evaluation of the selected disease opening of new horizons for a more
comprehensive knowledge of exosomes biological functions.
LBO.20
Mesenchymal stem cell-derived exosomes promote neurologic
recovery in experimental autoimmune encephalomyelitis model of
multiple sclerosis
Milad Riazifar1, Egest Pone1, Ashish Yeri2, Cecilia Lässer3, Ganesh Shelke4,
Elizabeth Hutchins2, Erika Calle1, Ashley Hamamoto1, Rossella Crescitelli4,
Wenbin Liao1, Victor Pham1, Aude Segaliny1, Yanan Yin5, Craig Walsh6,
Kendall Jensen7, Jan Lotvall8 and Weian Zhao1
1Department of Pharmaceutical Sciences, University of California, Irvine,
California 92697; 2Neurogenomics Division, Translational Genomics
Research Institute, Phoenix, AZ, USA; 3Krefting Research Centre,
University of Gothenburg, Sweden; 4Krefting Research Centre, Institute of
Medicine, University of Gothenburg; 5The Krefting Research Centre, Institute
of Medicine, The Sahlgrenska Academy, Göteborg University, Sweden;
6Department of Molecular Biology and Biochemistry, Sue and Bill Gross
Stem Cell Center, Multiple Sclerosis Research Center, University of
California, Irvine, CA, USA; 7Neurogenomics, Translational Genomics
Research Institute; 8Codiak BioSciences
Introduction: Multiple sclerosis (MS) is an inflammatory disease of the
central nervous system (CNS) in which T cells attack the CNS, resulting
in demyelination, neuronal injury and death, leading to clinical neuro-
logical deficits. Preclinical studies have revealed immunosuppressive
properties of mesenchymal stem cell (MSC) to treat MS. However,
lung entrapment, maldifferentiation, phenotype change and potentially
tumor formation are current challenges for stem cell therapy. The much
smaller size of MSC-derived exosomes (Exo) allow reduced lung entrap-
ment, achieve superior biocompatibility, and are more stable and expose
fewer risks, which together make them an attractive alternative to MSC.
Methods: Exo were obtained from MSC cultures and were injected I.V.
in EAE model of MS.
Results: Here, using experimental autoimmune encephalomyelitis (EAE)
as MS mouse model (n=30), we show that systemic injection of MSC-
Exo (150 ug) results in sustained recovery and improved motor function
(p< 0.01). This recovery is associated reduced in neuroinflammation and
increased re-myelination (p< 0.05). Biodistribution experiments show
that Exo were mostly found in liver and sple






























Identification of cancer-derived large oncosomes in urine samples of
prostate cancer patients
Tatyana Vagner1, Dolores Di Vizio2, Valentina R Minciacchi3, Mandana
Zandian4, Edwin M. Posadas2 and Andries Zijlstra5
1Department of Surgery, Cedars-Sinai Medical Center, CA, USA; 2Cedars
Sinai Medical Center, CA, USA; 3Georg-Speyer-Haus, Institute for Tumor
Biology and Experimental Therapy, Frankfurt, Germany; 4Division of Cancer
Biology and Therapeutics, Departments of Surgery, Biomedical Sciences and
Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer
Institute, Cedars-Sinai Medical Center, Los Angeles, US; 5Department of
Pathology, Microbiology and Immunology, Vanderbilt University Medical
Center, Nashville, TN, USA
Introduction: Large oncosomes (LO) are atypically large (1-10µm) can-
cer-derived extracellular vesicles (EVs), selectively shed by cancer cells
with highly migratory properties. LO are visible by microscopy in tumor
tissues as they blebb off the plasma membrane of cancer cells during
“amoeboid” migration. LO are emerging as a promising source of
circulating biomarkers because they contain several types of biomole-
cules, which represent molecular signatures of their cells of origin. LO
have been identified in tumor tissue and in plasma of prostate cancer
patients, but their presence in urine has never been examined. The use of
urine in clinical tests has several advantages compared with other bio-
fluids, such as blood, because urine is collected non-invasively and the
procedure is fast and cost-efficient. The aim of this study was to identify
molecular markers that would allow detection of LO in patient urine
samples.
Methods: Tunable Resistive Pulse Sensing (TRPS), differential and den-
sity gradient ultracentrifugation; western blot; mass spectrometry, flow
cytometry.
Results: From mass spectrometry analysis, we found that CK18 was
highly abundant in large EVs, while the tetraspanin CD81 was expressed
at negligible levels. We validated these findings in vitro using EVs
isolated from prostate cancer cell line PC3 and showed that CK18 was
enriched in large EVs. In contrast, CD81 was over-represented in nano-
sized EVs. Similar results were obtained by spiking in PC3 EVs into the
urine of normal subjects, which allowed us to generate urine benchmark
LO and exosome samples. TRPS and flow cytometry both identified
large EVs in urine of prostate cancer patients. These EVs could also be
identified with molecular markers of LO and exosomes, CK18 and CD81
respectively, suggesting that the large EVs detected in urine represent
LO. Finally, to determine if urine LO can provide valid prostate cancer
biomarkers, we correlated enumeration and molecular cargo of LO from
urine and plasma of the same patients.
Summary/Conclusion: Our results indicate that tumor-derived LO can
be identified in urine of prostate cancer patients, thus providing an
alternative, non-invasive access to circulating diagnostic/prognostic
molecular signatures of cancer cells.
Funding: National Institutes of Health NIH UCLA SPORE in Prostate
Cancer award P50 CA092131; DoD PCRP Award PC150836 (to DDV).
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Effect of stem cell-derived extracellular vesicles on tumour
angiogenesis
Benedetta Bussolati1, Tatiana Lopatina2, Cristina Grange2, Marta Tapparo2,
Adriana Pitino3, Ciro Tetta4 and Giovanni Camussi2
1Department of Molecular Biotechnology and Health Sciences, University of
Torino, Italy; 2Department of Medical Sciences, University of Torino, Italy;
3Molecular Biotechnology Centre; 4Unicyte AG
Introduction: Endothelial cells present in tumour are characterised by
increased angiogenic properties that may contribute to tumour develop-
ment, growth and metastatisation. Extracellular vesicles from human
liver stem cells (HLSC-EVs) and mesenchymal stem cells (EV-MSCs)
were reported to display an anti-tumour effect in a number of experi-
mental models. However, the effect of these EVs on tumour angiogenesis
has not been studied yet.
Methods: We here evaluated the anti-angiogenic potential of stem cell
EVs on tumour-derived endothelial cells (TECs) obtained from renal
carcinomas. In particular, we tested the effect on tube formation, pro-
liferation, invasion, motility and apoptosis in vitro. In vivo, we tested the
anti-angiogenic effect SC-EVs on a model of tumour angiogenesis
obtained by TEC subcutaneous implantation in SCID mice.
Biodistribution of intravenously injected EVs was also studied. The
molecular effect of EVs on TECs was investigated using gene array
analysis.
Results: HLSC-EVs inhibited the angiogenic potential of TEC in vitro
and reduced TEC survival and organisation into vascularised structures
in vivo. No effect was observed for MSC-EVs. Injected EVs were loca-
lised into the vascular structures formed by EVs in vivo and showed an
increased presence in respect to adjacent normal skin vessels. Finally,
microarray analysis performed on HLSC-EV-treated TECs identified
down-regulation of several pro-angiogenic genes, including HIF-1,
VEGF, S1PR1, Integrin β3 and TGF-β, as compared to untreated cells.
Conclusion: HLSC-EVs but not MSC-EVs displayed an anti-angiogenic
effect on TECs and inhibited pathways involved in tumour angiogenesis
that may contribute to the anti-tumour effect of HLSC-EVs.
OS27.02
RAB7 and prion protein modulate the secretion of extracellular
vesicles and show a prognostic value in head and neck squamous cell
carcinoma
Fernanda Giudice, Bruna Rodrigues, Tonielle Lacerda, Antuani Baptistella,
Marcos Salles, Luiz Paulo Kowalski and Vilma Regina Martins
A.C. Camargo Cancer Center, Sao Paulo, Brazil
Background: Studies have pointed that Rabs, in particular Rab7, modulate
extracellular vesicles (EVs) secretion. In addition, we have recently demon-
strated that Prion protein (PrPC) induces exosome secretion through acti-
vation of caveolin and impairment of autophagy. The head and neck
squamous cell carcinoma (HNSCC) is one of the six most common malig-
nancies worldwide with a high local invasion and metastasis. The charac-
terisation of biomarkers associated with HNSCC progression is very
important since it may dictate the prognosis and indicate its best treatment.
Material and Methods: EVs secreted from HNSCC cell lines were isolated
by ultracentrifugation and quantified. Rab7 and PrPC were overexpressed
or knockdown in these cells and the secretion of EVs and the cellular
invasion were quantified. Rab7 and PrPC expression were also evaluated
in 223 HNSCC specimens in tissue microarrays using immunohistochem-
istry (approved by the Institutional Ethics Committee-1791/13) and com-
pared to clinical and pathological data. Experiments were compared using
one-way ANOVA and patient data and immunohistochemistry results
were analysed using chi-square, Kaplan Meier and log-rank tests.
Results: In cell lines RAB7 expression decreases the secretion of EVs and
cellular invasion while PrPC expression increases the secretion of EVs
and cellular invasion. Patients with HNSCC presenting higher levels of
RAB7 or lower levels of PrPC show a better prognosis with lower cancer
recurrence or cancer-related death during 5 years of follow-up than
those expressing lower levels of RAB 7 or higher levels of PrPC.
Conclusion: Our data suggest the importance of RAb7 and PrPC expres-
sion as prognostic markers for HNSCC. The correlation of EVs secretion
from HNSCC and tumour recurrence and disease free survival is under
evaluation.
OS27.03
Epigenetic dysregulation of hematopoietic stem cell function by
extracellular vesicle (ev) trafficking in the leukaemia
microenvironment
Sherif Abdelhamed1, Noah Hornick2, Ben Doron1, Young me Yoon1 and
Peter Kurre1
1Pediatric Cancer Biology, Knight Cancer Institute, Oregon Health and
Science University, OR, USA; 2Oregon Health and Science University,
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Acute myeloid leukaemia (AML) is a heterogeneous blood cancer that is
associated with the progressive loss of normal bone marrow function. We
recently reported that extracellular vesicles (EVs) released from AML
cells, but not healthy controls, directly suppress hematopoietic progenitor
function via miR155 and miR150 targeting of cMyb, a highly regulated
transcription factor expressed in differentiating progenitors. To deter-
mine the impact on long-term hematopoietic stem cells (LT-HSC) we
used a combination of in vivo AML xenografting and intrafemoral EV
injections in immunodeficient mice. We observed a significant increase in
the frequency of the LT-HSC with gains in quiescence (G0) an increase in
DNA damage, evidenced by gH2AX foci and transcriptional upregulation
of Rad51 and p21 gene expression. Along with an increase in phosphor-
ylation of the tumour suppressor p53, these changes were reminiscent of
changes seen during HSC ageing. We reasoned that a mechanism other
than the progenitor specific transcription factor c-Myb would have to
account for the deregulation of LT-HSC. In a miRNA survey we identified
miR-1246 as highly abundant in AML-EV and used our recently reported
RISCtrap discovery pipeline and identified a set of targets enriched for
negative cell cycle regulators and epigenetic modifiers, Dnmt1 and Hells
among them. We propose that AML-EV miRNA lead to epigenetic
changes and studies to identify differentially methylated genomic regions
that account for the coincident accumulation of DNA damage in quies-
cent LT-HSC are underway. The epigenetic regulation of hematopoietic
stem cells by EV miRNA presents a novel paradigm and the identification
of differentially methylated targets may help ameliorate morbidity and
mortality from the suppression of hematopoiesis in the AML patients.
OS27.04
Acute myeloid leukaemia transforms the bone marrow niche into a
leukaemia-permissive microenvironment through exosome secretion
Bijender Kumar1, Mayra Garcia1, Lihong Weng1, Xiaoman Jung1, Jodi
Murakami1, Xingbin Hu2, Tinisha Mcdonald1, Allen Lin1, Ashish Kumar3,
David DiGuisto4, Vinod Pullarkat5, Susanta Hui5, Nadia Carlesso1, Ya-Huei
Kuo1, Ravi Bhatia6, Guido Marcucci1 and Ching-Cheng Chen1
1Beckman Research Institute of City of Hope, CA, USA; 2Research Associate;
3Cincinnati Childrens’s Hospital, OH, USA; 4Stanford Hospital and Clinics,
CA, USA; 5City of Hope National Medical Center, CA, USA; 6University of
Alabama Birmingham, AL, USA
Little is known about how leukaemia cells alter the bone marrow (BM)
niche to facilitate their own growth and evade chemotherapy. Here, we
provide evidence that acute myeloid leukaemia (AML) blasts remodel
the BM niche into a leukaemia-growth-permissive and normal-hemato-
poiesis-suppressive microenvironment through exosome secretion.
Either engrafted AML cells or AML-derived exosomes increased
mesenchymal stromal progenitors and blocked osteolineage develop-
ment and bone formation in vivo. Pre-conditioning with AML-derived
exosomes “primed” the animals for accelerated AML growth.
Conversely,disruption of exosome secretion in AML cells through tar-
geting Rab27a, an important regulator involved in exosome release,
significantly delayed leukaemia development. In BM stromal cells,
AML-derived exosomes induced the expression of DKK1, a suppressor
of normal hematopoiesis and osteogenesis, thereby contributing to
osteoblast loss. Conversely, treatment with a DKK1 inhibitor delayed
AML progression and prolonged survival in AML-engrafted mice. In
addition, AML-derived exosomes induced a broad downregulation of
hematopoietic stem cell supporting factors (e.g., CXCL12, KITL, and
IGF1) in BM stromal cells and reduced their ability to support normal
hematopoiesis. Altogether, this study uncovers novel features of AML
pathogenesis and unveils how AML cells create a self-strengthening
leukaemic niche thatpromotes leukaemic cell proliferation and survival,
while suppressing normal hematopoiesis through exosome secretion.
OS27.05
Bio-engineered extracellular microvesicles and cell membrane-
derived nanoghosts as multivalent approach for cancer therapy
Vladimir Mulens-Arias1, Alba Nicolás-Boluda2, Alice Balfourier2, Amanda
Brun2, Claire Wilhelm2, Florent Carn2 and Florence Gazeau2
1Laboratoire Matières et Systèmes Complèxes; 2Laboratoire Matière et
Systèmes Complexes, UMR 7075, CNRS and Université Paris Diderot
Introduction: In physiological and altered conditions, cells shed submi-
cronic extracellular vesicles (EVs) containing a variety of soluble and
membrane-embedded factors. All of them mediate intercellular commu-
nication, thereby allowing cross-regulation. The induction of anti-
tumour immune response is one of the more extended strategies for
cancer treatment. In addition, cell membrane-derived vesicles produced
by physical extrusion, known as nanoghosts, harbour enormous poten-
tial as therapeutic platform. We then intend to use both types of
membrane-based vesicles as drug nanocarriers for cancer theranosis.
Methods: We started the characterisation of empty or SPION-loaded
EVs derived from different cell types as to their immunogenicity and
effects on podosome/invadosome dynamics. We produced cell mem-
brane nanoghosts loaded with 5-fluorouacil and gold nanoparticle and
tested their potential as photothermal and photoacoustic agents.
Results: EVs derived from mouse colon carcinoma CT26, mouse
endothelial cells SVEC, mouse mesenchymal stem cells, and HUVEC
activated macrophages as determined by cytokine secretion and modu-
lated podosome dynamics. Importantly, SPION-loaded EVs appeared to
modulate macrophage behaviour in a different manner as compared to
empty EVs. We loaded nanoghosts with gold nanoparticles and fluor-
ouracil and we proved their plasmonic behaviour for photothermal
therapy and photo-acoustic imaging purposes. This all-in-one bio-
camouflaged platform combines photothermia, drug-loading and
immune-modulation functions to tackle tumour cells by multiple fronts
while enabling imaging follow-up.
Conclusions: Altogether, EVs might potentiate natural or induced
immune response suggesting their use as nanocarriers in combinatorial
therapeutic approaches. Likewise, cell membrane-derived gold nanopar-
ticle-loaded nanoghosts show promising properties for their exploitation
in cancer multivalent therapy.
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PPARα carried by microparticles restores the failed differentiation
and functionality of bone marrow-derived cells induced by high-fat
diet
Luisa Vergori1, Emilie Lauret2, Raffaella Soleti2, Ramaroson
Andriantsitohaina1 and M. Carmen Martinez1
1INSERM U1063; 2INSERM UMR1063 – University of Angers, France
Metabolic pathologies such as diabetes and obesity are associated with
decreased level of circulating and bone marrow (BM)-derived endothe-
lial progenitor cells (EPCs). It is known that activation of peroxisome
proliferator-activated receptor (PPARα) may stimulate cell differentia-
tion. In addition, microparticles (MPs), small membranes vesicles pro-
duced by activated and apoptotic cells, are able to reprogram EPCs.
Here, we evaluated the role of PPARα carried by MPs on both pheno-
type and function of progenitor cells from mice fed with a high-fat diet
(HFD). Male (C57BL/6N, 8 weeks-old) mice received either a standard
or a high-fat diet (HFD) (42% kcal from fat) for 12 weeks. Bone marrow
(BM)-derived cells were obtained from femurs and tibias of mice and
cultured in the absence or in the presence of MPs taken either from
wild-type (PPARα+/+) or PPARα knock out (PPARα-/-) mice for 7 days.
Characterisation of cells was performed by flow cytometry. The effects of
MPs in vivo neovascularisation were studied by Matrigel plug assay. We
observed that HFD induced hyperglycemia and dyslipidemia, and
reduced circulating EPCs. After 7 days of culture, BM-derived EPCs
and monocytic progenitor cells from HFD-fed mice displayed impaired
differentiation. At the same time, we show that MPs bearing PPARα,
MPsPPARα+/+, increased the differentiation of EPCs and monocytic pro-
genitors from HFD-fed mice, whereas MPsPPARα-/- had not effect on the
differentiation of all types of progenitor cells. Furthermore, MPsPPARα+/+
increased the ability of progenitor cells to promote in vivo angiogenesis
in mice fed with HFD. The in vitro and in vivo effects of MPsPPARα+/+
were abolished in presence of PPARα inhibitor, MK886. These data
highlight the ability of PPARα carried by MPs to restore the failed
differentiation and functionality of BM-derived cells induced by HFD.
PS01.02
Divergence of glioblastoma stem cell phenotypes during in vivo
development of resistance to temozolomide is reflected by cargo of
extracellular vesicles
Delphine Garnier1, Brian Meehan2, Laura Montermini2, Thomas Kislinger3,
Ichiro Nakano4 and Janusz Rak3
1UMR Inserm 892/CNRS 629 – CRCNA Nantes; 2The Research Institute of
the McGill University Health Center, Montreal, Canada; 3Princess Margaret
Cancer Center, Toronto, Canada; 4Department of Neurosurgery, University
of Alabama at Birmingham, AL, USA
Introduction: Glioblastoma multiforme (GBM) represents the most fre-
quent and almost uniformly fatal class of grade IV (WHO) primary
astrocytic brain tumours, and is associated with the median survival of
only 12–15 months post diagnosis. Therapy combines surgical resection,
radiation and adjuvant courses of oral temozolomide (TMZ), unfortu-
nately the initial response is followed by acquisition of resistance by
GBM stem cells (GSCs). To better detect, understand and prevent the
occurrence of resistance to TMZ chemotherapy, we investigated the
profile of extracellular vesicles (EVs) secreted by TMZ-sensitive and
-resistant GSCs from the Mesenchymal GBM subtype.
Methods:We generated GBM xenografts through orthotopic implantation of
humanmesenchymal GSCs into NSGmice. While the control group was left
untreated, the other mice were treated with several rounds of TMZ, leading
initially to tumour response but eventually to the acquisition of resistance by
GBM cells, and fatal tumour relapse. EVs were purified from both TMZ-
sensitive and -resistant GSC lines, and analysed by nanoparticle tracking
analysis (NTA) and mRNA expression profiles.
Results: Individual tumours derived from the same isogenic GSC line
expressed divergent profiles of TMZ resistance markers, with a minor repre-
sentation of the O6-methyl guanine DNA methyltransferase (MGMT). The
changes in mRNA profiles, reflective of TMZ resistance and stemness
expressed by chemo-resistant GSCs, were recapitulated in the transcriptome
of exosome-like EVs released by these cells into the culture medium.
Moreover a significant increase in the number of EVs released was observed
in 2 over 3 TMZ-resistant variants compared to TMZ-sensitive GSCs.
Conclusion: Thus, GBM tumour initiating cells harbour multiple alter-
native programmes that translate into chemotherapy resistance in vivo,
and can be monitored by molecular profiling of stem cell-related EVs.
PS01.03
Promising effects of menstrual blood mesenchymal stromal cell
exosomes on inflamation in wound healing process of diabetic mice
Razieh Dalirfardouei, Khadije Jamialhmadi and Elahe Mahdipour
Department of Medical Biotechnology, School of Medicine, Mashhad
University of Medical Sciences, Mashhad, Iran
Introduction: Wound healing is a complicated process that contains some
overlapping and consecutive phases including inflammation, proliferation
and remodelling. Disruption in each phase can cause chronic non-healing
wounds. Most of the chronic wounds do not respond to common ther-
apeutic procedure. Currently, there is a growing interest to use mesench-
ymal stem cells (MSCs) especially their paracrine factors to improve
wound healing process. The focus of the recent researches has been on
exosomes as paracrine factors derived from MSCs. These natural nano-
vehicles contain bioactive macromolecules which affect intracellular sig-
nalling pathways similar to MSCs without their detrimental effects. In the
current study, we investigated the effects of exosomes released from
menstrual blood-derived MSCs on wound healing in diabetic mice.
Methods: MSCs derived from menstrual blood were characterised by
flow cytometry and differentiation potential. The exosomes were isolated
from conditioned media using ultracentrifugation and were charac-
terised by AFM, TEM and western blotting for CD81 and TSG101.
The exosomes were quantified by ELISA. A full thickness excisional
wound was created on the dorsal skin of each STZ-induced diabetic
C57BL/6 male mice. Eighteen mice were divided into three groups as
follows: PBS group, exosomes group (10 μg) and MSC group (1 × 106
cells). The wound tissues were excised on day four to evaluate the
inflammation process through iNOS (as M1 marker) and arginase (as
M2 marker) activity assay and RelA gene expression.
Results: To evaluate the effects of exosomes on macrophages, iNOS and
arginas enzyme activities were measured. In the exosome group, iNOS
activity was significantly decreased compared with MSC group and control
group. However, we did not observe any significant increase in arginase
activity. The expression level of RelA was assessed to evaluate the NFκB as a
well-characterised pro-inflammatory signalling pathway. The RelA gene
expression was remarkably decreased in exosome group(p < 0.05)which
was assessed with real time PCR.
Conclusion: The results showed that the exosomes preferentially lead to
M1/M2 polarisation as well as the decrease in RelA expression compar-
ing to MSCs. Conclusively, exosomes can ameliorate wound healing
through inflammation reduction.
PS01.04
Convective exosome-tracing microfluidics for analysis of cell-non-
autonomous neurogenesis
Do Won Hwang1, Hyun Jeong Oh1, Hyunjong Lee1, Yoojin Shin2, Dong Soo
Lee1 and Seok Chung2





























1Department of Nuclear Medicine, Seoul National University, Seoul, Republic
of Korea; 2School of Mechanical Engineering, Korea University, Seoul,
Republic of Korea
Introduction: The effective role of exosome delivering neurogenic
microRNA (miRNA) enables to induce efficient differentiation process
during neurogenesis. The microfluidic system capable of visualising the
exosomal behaviour such as secretion, migration, and uptake of indivi-
dual exosomes can be used as a robust technique to understand the
exosome-mediated change of cellular behaviour. Here, we developed the
exosome-tracing microfluidic system to visualise exosomal transport
carrying the neurogenic miRNA from leading to neighbouring cells,
and found a new mode of exosome-mediated cell-non-autonomous
neurogenesis.
Methods Exosomes were visualised using GFP-tagged CD63 plasmid
vector. Live-cell imaging was performed by confocal microscopy on
microfluidic device. NE-4C, neural stem cells and F11, neural progenitor
cells were used to monitor exosomal behaviour. To detect miRNA
expression, pRV-effLuc/3xPT_miR-193a vector containing the triplicates
of miRNA binding site in the 3ʹ UTR of effLuc was used.
Results The miR-193a facilitated neurogenesis in F11 cells by blocking
proliferation-related target genes. In addition to time-lapse live-cell
imaging, microfluidics system visualised the convective transport of
exosomes from differentiated to undifferentiated cells. Individual exo-
somes containing miR-193a from differentiated donor cells were taken
up by undifferentiated cells to lead them to neurogenesis. Induction of
anti-miR-193a was sufficient to block neurogenesis in F11 cells.
Inhibition of the exosomal production by manumycin-A and treatment
of anti-miR-193a in the differentiated donor cells failed to induce neu-
rogenesis in undifferentiated recipient cells.
Conclusions These findings indicate that neural progenitors and neuro-
genic miRNA within exosomes propagate cell-non-autonomous differ-
entiation to neighbouring progenitors, and delineate the roles of
exosome mediating neurogenesis of population of homologous neural
progenitor cells
PS01.05
Mechanisms of exosomal secretion of Wnt proteins
Alena Ivanova1, Oksana Voloshanenko1, Jan Winter1 and Michael Boutros1,2
1German Cancer Research Centre (DKFZ), Division Signalling and
Functional Genomics; 2Heidelberg University, Department of Cell and
Molecular Biology, Faculty of Medicine Mannheim, Heidelberg, Germany
The Wnt signalling pathway plays an important role during develop-
ment, carcinogenesis and many other diseases. According to the current
understanding of Wnt secretion, Wnt proteins are palmitoylated by the
membrane-bound O-acyltransferase Porcupine in the endoplasmic reti-
culum (ER) and then transported into the Golgi by p24-mediated sorting
into COPII-vesicles. Subsequently, the cargo receptor Evi/Wls is respon-
sible of the intracellular movement and secretion of Wnt proteins: it
binds Wnt proteins in the ER and transports them to the plasma
membrane. Previously, we have shown that Wnt proteins can be
recycled through the endosomal compartment and secreted on exosomes
(1). However, the mechanisms how Wnt proteins are secreted on exo-
somes as well as general factors required for exosomal release remain
largely unknown.
Here, we established genetic tools to identify genes which are involved in
the secretory pathway of Wnt proteins. We use CRISPR/Cas9 screening
technologies for targeted disruption of genes in combination with Wnt
activity assays to identify genes that are required for the secretion of
functional Wnt proteins. A panel of 50 candidate secretory factors genes
have been we have identified several genes with a potential regulatory
role in Wnts secretory pathway. In summary, the established tool will
contribute towards the understanding of Wnts trafficking and their
secretion routes.
Reference
1. Gross et al., Nat. Cell Biol. 2012; 14, 1036–1045.
PS01.06
Extracellular vesicles from adipose-derived mesenchymal stem cells
increase the phagocytic activity in peritoneal macrophages
Carmen Carceller1, Isabel Guillen1,2, Alba Martinez3, Maria Luisa Gil3, Maria
Luisa Ferrandiz1 and Maria Jose Alcaraz1
1IDM, University of Valencia, Spain; 2Department of Pharmacy, CEU-
Cardenal Herrera, Valencia; 3Department of Microbiology and ERI
BIOTECMED, University of Valencia, Spain
Introduction: The secretome from adipose tissue derived mesenchymal
stem cells (ASC) has been shown anti-inflammatory and immunomo-
dulatory activity in different conditions. However, the contribution of
extracellular vesicles, microvesicles (Mv) and exosomes (Ex) to the
effects of ASC secretome, has not been widely studied.The purpose of
this work was to investigate whether Mv and Ex from ASC can regulate
the phagocytic activity and the production of inflammatory mediators
during the innate immune response in mouse peritoneal macrophages.
Methods: CD1 male mice were used to isolate macrophages from the
peritoneal cavity and ASC from perigonadal fat pads. Isolation of Ex
and Mv from ASC secretome was performed by differential (ultra)
centrifugation combined with size filtration. Tunable resistive pulse
sensing was used to evaluate the concentration and size of Ex and
Mv. After characterisation of macrophages by flow cytometry, they
were seeded and stimulated with lipopolysaccharide (LPS, 1 µg/ml),
and treated with 2 × 107 Ex/ml or 9 × 104 Mv/ml for 20 h. Phagocytosis
assay was performed by flow cytometry and confocal microscopy, IL-
1β, TNFα and KC production was measured by ELISA, PGE2 by RIA
and nitrite levels by fluorometry. The data were analysed by one-way
analysis of variance (ANOVA) followed by Dunnett’s multiple com-
parisons test.
Results: The secretion of inflammatory mediators and the phagocytic
activity of macrophages were significantly increased after LPS stimula-
tion compared with cells in basal conditions. Ex significantly reduced the
levels of TNFα, PGE2 and NO with respect to the LPS control whereas
Mv only diminished TNFα. Regarding the phagocytic activity, both Ex
and Mv raised it significantly. Our data suggest that extracellular vesicles
can regulate macrophage activity in the innate immune response and
contribute to the anti-inflammatory effects of ASC. These findings sup-
port the interest of Ex for the development of potential new approaches
to the treatment of inflammatory diseases.
Funding: SAF2013-48724-R (MINECO, FEDER) and PROMETEOII/
2014/071(Generalitat Valenciana).
PS01.07
Role the central carbon metabolism pathway in tumour stromal
support – a study using extracellular vesicles of mesenchymal stem
cells from normal and osteosarcoma participants
Patrice Penfornis1, K. Sreekumaran Nair2 and Radhika Pochampally1
1University of Mississippi Medical Center, MI, USA; 2Mayo Clinic, Rochester,
MN, USA
Introduction: Previous studies have shown the role of mesenchymal
stem cells (MSCs) from bone marrow in the growth and metastasis of
solid tumours but mechanisms remains unclear in osteosarcoma (OS).
Our recent study have shown the role of MSCs extracellular vesicles
(EVs) in the proliferation and migration of osteosarcoma cells
(PMID27812189). We have previously characterised MSCs-EVs using
genomics, lipidomics and proteomics (PMID25669974). In this study we
focused on difference in the metabolome of EVs from MSCs from
healthy and diagnosed OS participants.
Methods: Biopsies from cancer participants were collected and osteosar-
coma along with bone marrow mesenchymal stem cells were derived in
cell culture. Cell phenotypes were confirmed using specific markers.
Normal MSCs from healthy patient has been used as reference. All
cells were cultured in factories (>108 cells) and serum-free cell super-
natant were collected, concentrated and extracellular vesicles were iso-
lated using serial ultracentrifugation. Purified EVs were analysed at the





























Mayo Clinic Metabolomics Core. In parallel, cells mRNA levels were
analysed by microarray at the UMMC Genomics Core. Data was nor-
malised and analysed by one-way ANOVA and integrated molecular
pathway level analysis.
Results: Preliminary data showed that EVs studied contains at least 250
metabolites with a KEGG ID. Ontology revealed an enrichment of
metabolites involved in arginine and proline degradation pathways.
Compared to their OS-EVs, cancer patient MSCs-EVs are, for example,
enriched in adenine and hexanoylglycine (20–40 fold). Interestingly,
cancer patient MSCs-EVs are notably enriched of succinic acid, lactic
acid, proline, phosphoenol pyruvate, fumaric acid (3–10 fold range)
compared to the healthy patient-derived MSCs-EVs. Correlation
between metabolites and gene expression up-regulation revealed the
involvement of the central carbon metabolism in cancer pathway
(KEGG hsa05230). Moreover, proteomics data showed that 9 glycolysis
pathway enzymes are detected in MSCs-EVs.
Conclusion: This preliminary study reveals that cancer patient MSCs secrete
EVs which are enriched with metabolites that are in demand by OS cancer
cells metabolism, thus promoting tumour growth. These data confirmmulti-
ple supportive roles of stromal cells EVs in cancer progression.
PS01.08
Cardiosphere-derived cell and mesenchymal stem cell extracellular
vesicles contain distinct RNA cargo
Ann-Sophie Walravens, Kiel Peck, Linda Marban and Geoffrey de Couto and
Luis Rodriguez-Borlado
Capricor Therapeutics
Introduction: Cardiosphere-derived cells (CDCs) possess regenerative,
immunomodulatory and cardioprotective characteristics when delivered to
the heart post-myocardial infarction (MI). In contrast to other cell types, this
vast array of therapeutic benefits appears to be a unique trait to CDCs.We’ve
previously demonstrated that human CDC-derived extracellular vesicles
(CDC-EVs) recapitulate the effects of CDCs in acute and chronic in vivo
models of MI. Thus, we believe that the efficacy of CDC therapy is mediated
by CDC-EVs. Here we are testing the hypothesis that a distinct cargo profile
will define the functional efficacy between CDC-EVs and mesenchymal stem
cell-derived EVs (MSC-EVs).
Methods: CDCs or MSCs were cultured in serum-free medium for 15 days
and then the conditioned media was concentrated by ultrafiltration (MWCO
10 kDa) to isolate EVs. The miRNeasy Serum/Plasma kit (QIAGEN) was
used to extract total RNA from EVs followed by small RNA sequencing
(NextSeq 500, Illumina) (CDC-EVs, n = 5, MSC-EVs, n = 2) or nCounter
miRNA expression analysis (Nanostring technologies).
Results: RNA sequencing analysis of CDC-EVs and MSC-EVs revealed a
greater overall abundance of Y-RNA fragments in CDC-EVs. When we
examined the specific Y-RNA classes, we found that MSC-EVs contained
an expression profile with lower Y4 (p < 0.05), but higher Y5 (p < 0.05),
Y-RNA fragments. Interestingly, miR-22 was highly expressed in both CDC-
EVs and MSC-EVs, which suggests that it may serve as a housekeeping
miRNA for EVs derived from different cell sources. Four miRNAs (miR-
146a, miR-151, miR-409, miR-423) were highly enriched in CDC-EVs, while
miR-10a and miR-4792 were more abundant in MSC-EVs. These miRNA
results are being validated by nCounter miRNA expression analysis.
Conclusion: Here, we’ve demonstrated that CDC-EVs contain a unique
RNA cargo set that can differentiate CDC-EVs from MSC-EVs. The
higher presence of Y RNA in CDC-EVs as compared to MSC-EV
could be responsible for the ability of CDCs to regulate stem cell
activation and tissue regeneration. The highly enriched panel of
miRNAs observed in CDC-EVs, in contrast to MSC-EVs, suggest that
they may support some of the functional benefits observed post-MI.
PS01.09
Enhanced cardiomyogenic and angiogenic potential of extracellular
vesicles derived from genetically modified stem cells expressing
selected micro RNAs
Sylwia Bobis-Wozowicz1, Katarzyna Kmiotek1, Malgorzata Sekula2, Dariusz
Boruczkowski3, Jacek Kolcz4, Zbigniew Madeja1 and Ewa K. Zuba-Surma5
1Jagiellonian University, Krakow, Poland; 2Malopolska Centre of
Biotechnology; 3Polish Stem Cell Bank, Poland; 4Polish-American Children’s
Hospital, Poland; 5Department of Cell Biology, Faculty of Biochemistry,
Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
Introduction: Extracellular vesicles (EVs) are small circular structures
composed of a cellular membrane and cytosolic cargo, mainly small
RNAs, proteins and lipids. By transferring their bioactive components
to other cells, EVs may influence cell fate and behaviour. This study
investigated efficacy of EVs isolated from human umbilical cord-derived
mesenchymal stem cells (hUC-MSC) and human induced pluripotent
stem cells (hiPSC) in transferring selected proangiogenic and cardio-
myogenic miRNAs (miR-1, miR-199a and miR-126) to cardiac mesench-
ymal stromal cells (cMSC).
Methods: hUC-MSCs and hiPSCs were genetically engineered to express
selected miRNAs and green fluorescent protein (copGFP) by lentiviral
transduction. EVs were isolated by sequential ultracentrifugation (2000g,
100,000g ×2) from cell conditioned media. Expression of the transgenes
were analysed in EVs, their parental cells and cMSCs by real time qPCR.
cMSC upon EVs transfer were subjected to cardiomyogenic and angio-
genic differentiation.
Results: Genetic modification of hUC-MSC and hiPSC resulted in con-
stitutive and stable expression of selected miRNAs in these cells, which
was confirmed by molecular analyses. EVs isolated from these cells
contained elevated levels of the introduced miRNAs. EVs cargo was
efficiently transferred to the acceptor cells – cMSCs – and enhanced
their differentiation towards cardiac and endothelial lineages.
Conclusion: In this study we have shown that EVs isolated from geneti-
cally modified hiPS and hUC-MSC were enriched in specific miRNAs,
which modulated ability of target cells to differentiate into cardiac and
endothelial lineages. Obtained results indicate usefulness of stem cells-
derived EVs as potential tools in miRNAs transfer, which can be further
exploited in regenerative medicine.
PS01.10
Cell-engineered nanovesicle as a surrogate inducer for contact-
dependent stimuli
Chungmin Han, Junho Kim, Yong Song Gho and Jaesung Park
Pohang University of Science and Technology, Pohang, Republic of Korea
Heterotypic interactions between cells are crucial in various biological
phenomena. Particularly, stimuli that regulate embryonic stem cell
(ESC) fate are often provided from neighbouring cells. However, except
feeder cultures, there have been no practical methods that can provide
ESCs with contact-dependent cell stimuli. To induce contact-dependent
cell stimuli in the absence of living cells, we describe a new method that
uses cell-engineered nanovesicles (CNV) that are made by extruding
living cells through micro-porous membrane. Protein compositions of
CNVs are similar to their originating cells, and freely diffusible and
precisely scalable. Treatment of CNVs produced from three different
stromal cells successfully induced the same effect as feeder cultures. Our
results suggest that the effect of CNVs are mainly mediated by mem-
brane-associated components. The use of CNVs might provide us with a
new and efficient tool for ESC research.
PS01.11
Economics and quality attributes of hMSC production in xeno-free
bioprocessing media
Lye Theng Lock, Timothy Olsen, Keith Dailey and Jon Rowley
RoosterBio
Human mesenchymal stem cells (hMSCs) are key raw materials in
Regenerative Medicine and are widely used for cell or secretome-based
therapeutics, engineered tissues, or medical devices. Yet, achieving an
economical bioprocess for hMSC production remains a significant chal-
lenge in the regenerative medicine industry. Modelling of hMSC man-
ufacturing bioprocess economics identifies culture media as a major cost





























driver in a cell manufacturing process. The availability of efficient and
robust xeno-free bioprocessing media will not only reduce manufactur-
ing cost, but also decrease regulatory burden associated with bovine
serum components found in traditional culture media. Here, we evalu-
ated and compared hMSC quality parameters in bovine serum-contain-
ing and xeno-free bioprocess media formulations and assessed quality
parameters such as cell identity and potency. The hMSCs cultured in
xeno-free media expanded rapidly and achieved confluency within
4–5 days without media exchange in 2D culture. Furthermore, cells in
xeno-free media maintained critical hMSC functional properties includ-
ing angiogenic cytokine (FGF, HGF, IL8, TIMP1, TIMP2 and VEGF)
secretion, trilineage differentiation, and immunomodulatory potential. A
scale-up study using a 3D bioreactor platform with a xeno-free bioreac-
tor feed was conducted and was determined to be a robust scalable
production format for hMSCs. The economics of hMSC expansion in
this xeno-free media system were modelled for both 2D and 3D bior-
eactor culture, and the critical productivity metric of million cells gen-
erated per litre of media demonstrated that the xeno-free media
consistently outperformed traditional hMSC media systems (by yielding
more than 8-fold higher cells/L media used), thus making it the robust
and economic choice for industrial-scale manufacturing of hMSCs for its
secretome or cellular material.
LBP.43
A comparison of exosome isolation methods from conditioned media
of amniotic fluid stem cells
Lina Antounians, Vincenzo Catania, Adrienne Sulistyo, Alison Hock, Bo Li
and Augusto Zani
The Hospital for Sick Children
Introduction: Amniotic fluid stem cells (AFSC) are CD117+ cells that
express markers of pluripotency, and can be directed into all three
primary embryonic cell lineages. AFSC have proved to be effective in
tissue regeneration in various disease models, mainly acting through a
paracrine mechanism. There has been an increasing interest in deter-
mining the potential of AFSC-derived exosomes as an alternative treat-
ment option to cell-based therapy. The aim of our study was to compare
isolation methods of exosome derived from AFSC conditioned media,
that to the best of our knowledge has not yet been established.
Methods: Conditioned media was collected from AFSC grown overnight
in exosome-depleted media. 2mL was used to compare exosome isola-
tion methods via ultracentrifugation, Exo-Prep, Exo-Quick, and Total
Exosome Isolation reagents, following supplier recommended protocols
(at least three replicates per method). Exosome protein was quantified
using the Pierce Bradford assay. Exosomes were visualized under trans-
mission electron microscopy and assessed for vesicle size via NanoSight.
Exosomes were tested for protein expression via Western blot using
markers CD9, CD63, CD81, Hsp70, and negative markers for
Histone H3.
Results: Exosomes isolated from all methods were positive for CD63 and
Hsp70 markers, but did not show detectable levels of CD9, CD81 via
Western blot. Exo-Prep reagent precipitated the highest protein concen-
tration compared to ultracentrifugation and other commercially avail-
able kits. Ultracentrifugation yielded the highest concentration of CD63
and Hsp70 protein. Nanoparticle tracking revealed that Total Exosome
Isolation reagent had the highest yield of nanoparticles within 30-120nm
range.
Summary/Conclusion: Given the low cost and high purity obtained
using ultracentrifugation, this is our preferred method of exosome iso-
lation from AFSC. Further studies are needed to assess the reparative
effects of AFSC derived exosomes isolated from these different methods.
Funding: SickKids Start-Up Fund.
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PS02.01
Evaluation of cellular uptake of exosomes during cancer treatment
with gefitinib
Tomoya Takenaka1, Miku Katayama1, Ikuo Fujii1, Susumu Kobayashi2 and
Ikuhiko Nakase1
1Osaka Prefecture University, Osaka, Japan; 2Beth Israel Deaconess Medical
Center/Harvard Medical School, MA, USA
Introduction: During cell-to-cell communication, extracellular vesicles
(EVs) such as exosomes play crucial roles because they deliver biofunc-
tional molecules (e.g. microRNAs and enzymes) into cells that control
cellular functions. In cancer progression, exosomal communications have
been shown to participate significantly. Therefore, it is important to
understand the effects of cancer treatment on exosomal communications.
Gefitinib (commercial name: Iressa) is a tyrosine kinase inhibitor of
epidermal growth factor receptor (EGFR) and is approved for the ther-
apeutic treatment of non-small cell lung cancers (NSCLCs) with EGFR
mutations. In this study, we demonstrated the influence of gefitinib on
cellular exosome uptake and cancer treatment.
Methods: HCC827 (mutant EGFR) and A549 (wild-type EGFR) cells, which
are gefitinib-sensitive and low-sensitive NSCLCs, respectively, were treated
with FITC-dextran-loaded exosomes (derived from HeLa cells) or fluores-
cein-labelled liposomes in the presence or absence of gefitinib (10 nM), the
concentration of which did not affect cell growth under this experimental
condition. After 24 h incubation, each cellular-uptake efficacy was assessed
using flow cytometry and confocal microscopy. Moreover, the cytotoxicity of
doxorubicin (DOX)-loaded exosomes or liposomes on the cells in the pre-
sence or absence of gefitinib was also assessed using OneCell counter.
Results and Conclusion: In HCC827 cells, the cellular uptake of exosomes
was enhanced, while that of liposomes was suppressed by gefitinib treat-
ment, suggesting that the cellular uptake pathways for exosomes and lipo-
somes are different in gefitinib-sensitive HCC827 cells. On the contrary, no
change was observed in gefitinib-low-sensitive A549 cells. The same trend
was observed in the cytotoxicity study. The gefitinib treatment enhanced
the cytotoxicity of DOX-loaded exosomes, but inhibited the cytotoxicity of
DOX-loaded liposomes. Moreover, DOX-loaded exosomes showed super-
ior anti-cancer efficacy compared to DOX-loaded liposomes based on IC50.
These findings indicate that exosomal cell-to-cell communication is possi-
bly affected by cancer treatment with gefitinib, and exosome-based intra-
cellular delivery is considered to have pharmaceutical advantages.
PS02.02
Enzymatic exosomes with GPI-anchored hyaluronidase for enhanced
tumour penetration and anti-tumour efficacy
Yeon-Sun Hong1, Yoosoo Yang2 and In-San Kim2
1KU-KIST Graduate School of Converging Science and Technology, Korea
University; 2Korea Institute of Science and Technology
Please see OPT01.05
PS02.03
Efficient delivery of glucocerebrosidase lysosomal enzyme via
EXPLOR technology for treatment of Gaucher disease
Hojun Choi1, Kyungsun Choi1, Nambin Choi1, Seung Wook Choi2 and
Chulhee Choi1
1KAIST, Seoul, Republic of Korea; 2Cellex Life Sciences, Inc
Introduction: We have previously developed an opto-genetically
engineered exosome system, named “exosomes for protein loading
via optically reversible protein–protein interaction” (EXPLOR)
that can deliver soluble proteins into the cytosol via controlled,
reversible protein–protein interactions (PPI). Treatment with pro-
tein-loaded EXPLORs was shown to significantly increase intracel-
lular levels of cargo proteins and their function in recipient cells in
both a time- and dose-dependent manner. In the present study, we
tested the feasibility of EXPLOR technology for delivery of beta-
glucocerebrosidase (GBA) as a potential treatment for Gaucher
disease.
Methods: In the present study, we have incorporated GBA enzyme
into the engineered exosomes by fusion with optically controlled
PPI module. GBA-loaded exosomes were then tested for protein
loading efficiency and in vitro enzymatic activity. Patient-derived
fibroblasts were tested for delivery of GBA by GBA-loaded
exosomes.
Results: We were able to load GBA into engineered exosomes by
transiently or stably expressing fusion proteins in exosome producing
cells. We further demonstrated the intracellular delivery of GBA as
functional proteins in the target cells in vitro and target organs in vivo.
Conclusion: These results clearly indicate the potential of EXPLORs for
treatment of Gaucher disease.
PS02.05
Intein mediated enrichment of soluble proteins into exosomes
Justin Hean1, Imre Mäger2, Inna Uliyakina1, Joel Z. Nordin3, Samir EL-
Andaloussi3,2 and Matthew J. Wood2
1University of Oxford, Oxford, UK; 2Department of Physiology, Anatomy
and Genetics, University of Oxford, Oxford, UK; 3Department of Laboratory
Medicine, Karolinska Instiutet, Stockholm, Sweden
Introduction: Exosomes are readily taken up by many cell types, in
what appears to be an energy-dependent, directed process.
Furthermore exosomes have been described to transport a variety of
bioactive molecules such as proteins, lipids and nucleic acids.
Together with their possible non-immunogenic properties, exosomes
facilitate a new paradigm in the delivery of therapeutic agents.
However, owing to their biogenesis mechanisms, exosomes are not
readily enriched with targeted soluble proteins without anchoring to
the exosomal membrane or incurring bulky fusion modifications.
Here we demonstrate that utilising an exosomal co-localisation signal,
and a self-cleaving protein we are able to enrich for specific soluble
proteins within the exosomal lumen.
Methods: DNA constructs were generated by introducing the self-
cleaving intein, ΔIC-TM, downstream of the CD63 ORF. Following
the intein region a reporter ORF of interest was inserted. Exosomes
containing the self-cleaving constructs were generated in HEK293t
cells and characterised by NTA and western blotting. Finally the
reporter enriched exosomes were co-incubated with recipient cell
lines and analysed by confocal microscopy or appropriate readout
assay.
Results: Here we show that exosomes are successfully enriched with
the reporter protein, independent of the co-localisation signal-intein
fusion. NTA and western blot analysis of the vesicles suggests little to
no variation from their wild type counterparts. Finally,
exosomes enriched with the reporter proteins are readily taken up
by recipient cells, and display evidence of cargo protein assimilation
Conclusion: Here we describe a novel method of enriching exosomes
with a soluble protein independent of remnant co-localisation fusions.
These enriched exosome were demonstrated to deliver their cargo to
recipient cells. We envisage this strategy applicable to both basic and
therapeutic biology alike.






























Delivery of membrane-bound CD39/CD73 by extracellular vesicles
(EVs) for treatment of inflammatory disease
Susanne A. Snoek1, Niels Broekstra1, Jan van Ittersum1, Jeroen de Vrij2,
Edwin van der Pol3, Rienk Nieuwland4, Lisa G.M. van Baarsen5, Paul P.
Tak1, Margriet Vervoordeldonk1 and Jonathan Finn1
1Arthrogen BV; 2Department of Neurology, ErasmusMedical Center; 3Biomedical
Engineering & Physics and Vesicles Observation Center, Academic Medical
Center; 4Clinical Chemistry department, Academisch Medisch Centrum;
5Clinical Immunology and Rheumatology, Academic Medical Center
Introduction: Our recent data demonstrated that the balance between
pro-inflammatory extracellular ATP and anti-inflammatory adenosine is
skewed in the synovial compartment of rheumatoid arthritis patients,
likely contributing to ongoing inflammation. CD39 is an ATPase that
converts ATP and ADP into AMP, while CD73 converts AMP into
adenosine. CD39 and CD73 are membrane bound enzymes and previous
studies have shown that removing the transmembrane domain of CD39
reduces its activity by >90%. Thus we assessed the potential of extra-
cellular vesicle (EV)-mediated delivery of these membrane-bound
enzymes as a novel treatment for inflammatory disease.
Methods: We performed a large scale purification (~50 L) of CD39/
CD73-EVs from the supernatant of a stably transfected HEK293 cell line
overexpressing both CD39 and CD73. EVs were concentrated by tan-
gential flow filtration, then precipitated using total exosome isolation
buffer, and subsequently purified by size exclusion chromatography.
Particle concentration was determined using nanoparticle tracking ana-
lysis and total protein levels where measured with a micro BCA protein
kit. CD39 and CD73 activity of EVs was measured using the malachite
green phosphate detection kit, and CD39 or CD73 protein levels were
assessed by Western blot.
Results: Purified EVs were very pure as indicated by a high particle/total
protein (μg) ratio (5.76E10). Specific enzymatic activity (released phos-
phate/min/μg protein) of CD39/CD73-EVs was 20.5-fold (CD39) and
4.5-fold (CD73) higher when compared with their soluble counterparts,
likely due to maintaining the native structure of the enzymes. CD39/
CD73-EVs were ~10-fold more potent in reducing pro-inflammatory
cytokine production in in vitro human cell-based inflammation assays.
Conclusion: Engineered EVs are a promising tool to deliver membrane-
bound, biologically active therapeutic enzymes and may have great potential
for the treatment of inflammatory disease, including rheumatoid arthritis.
PS02.07
Synthetic lipid nanoparticles for combination treatment of prostate
cancer
Roy van der Meel1,2, Sam Chen1,3, Josh Zaifman1,4, Joslyn Quick1, Raymond
M. Schiffelers2, Marco A. Ciufolini1, Yuen Yi C. Tam1,3 and Pieter R. Cullis1
1Department of Biochemistry and Molecular Biology, University of British
Columbia, Vancouver, British Columbia, Canada; 2Department of Clinical
Chemistry and Haematology, University Medical Centre Utrecht, Utrecht,
The Netherlands; 3Integrated Nanotherapeutics, Vancouver, British
Columbia, Canada; 4Department of Chemistry, University of British
Columbia, Vancouver, British Columbia, Canada
Introduction: Current treatment strategies for advanced prostate cancer
include androgen receptor (AR) pathway inhibition and taxane-based
chemotherapy. However, the effectiveness of chemotherapy is hampered
by dose-limiting adverse effects and the vast majority of tumours
develop resistance mechanisms against AR inhibitors and taxane drugs.
Lipid nanoparticles (LNPs) are the most clinically advanced delivery
systems for chemotherapeutics and genetic drugs such as siRNA.
Long-circulating LNPs accumulate in tumours to a higher extent com-
pared to free drugs, resulting in increased therapeutic efficacy and
reduced adverse effects. We have recently developed new technology
that allows the incorporation of virtually any small molecule in LNPs,
raising opportunities to combine chemotherapy and gene silencing.
Methods: LNPs containing both taxane chemotherapeutics and siRNA
against constitutively active AR variants (AR-V) were formulated by
rapid mixing methods. LNPs were characterised by physicochemical
analysis including size and drug content. LNP stability in serum was
determined by UPLC. Gene silencing efficiency of LNPs was determined
by siRNA target knockdown using qPCR. Therapeutic efficacy of LNPs
was determined by cell viability assays in PC cell lines expressing AR
(variants) including 22Rv1, LNCaP and VCaP while the AR-negative cell
line PC3 was used as control.
Results: Physicochemical analysis indicated LNP size of 60 nm and >90%
siRNA encapsulation efficiency. The incorporation of taxane chemother-
apeutics was varied from 1–10 mol% without effecting the stability of the
formulation in serum. LNPs containing siRNA with and without taxane
drug induced >80% knockdown of AR-V in 22Rv1 cells. LNPs contain-
ing both AR-V siRNA and taxane chemotherapeutics induced greater
inhibition of cell viability when compared to control formulations in
22Rv1, LNCaP and VCaP cells while no difference was observed in AR-
negative PC3 cells.
Conclusion: LNPs containing both siRNA and chemotherapeutics for
are an attractive strategy for the development of effective combination
treatments for advanced prostate cancer.
PS02.08
Efficient delivery of super repressor IκB via EXPLOR technology for
treatment of chronic inflammatory diseases
Kyungsun Choi1, Nambin Choi1, Seung Wook Choi2, Amin Choi1, Hojun
Choi1 and Chulhee Choi1
1KAIST, Seoul, Republic of Korea; 2Cellex Life Sciences, Inc
Introduction: We have previously developed an opto-genetically engi-
neered exosome system, named “exosomes for protein loading via opti-
cally reversible protein–protein interaction” (EXPLOR) that can deliver
soluble proteins into the cytosol via controlled, reversible protein–pro-
tein interactions (PPI). Treatment with protein-loaded EXPLORs was
shown to significantly increase intracellular levels of cargo proteins and
their function in recipient cells in both a time- and dose-dependent
manner. In the present study, we tested the feasibility of EXPLOR
technology for delivery of super repressor IκB (SRI), a potent inhibitor
of NF-κB pathway, as a potential treatment for chronic inflammatory
diseases such as rheumatoid arthritis.
Methods: In the present study, we have incorporated SRI into the
engineered exosomes by fusion with optically controlled PPI module.
SRI-loaded exosomes were then tested for protein loading efficiency and
in vitro inhibitory activity on TNF-α-induced NK-κB activation. Anti-
inflammatory effect of SRI-loaded exosomes was tested by systemic
administration in a collagen-induced arthritis model.
Results: We were able to load SRI into engineered exosomes by transi-
ently or stably expressing fusion proteins in exosome producing cells.
We further demonstrated the intracellular delivery of SRI as functional
proteins in the target cells in vitro and target organs in vivo. Finally, we
have observed a beneficial effect of SRI-loaded exosomes in collagen-
induced arthritis model compared to naïve exosomes.
Conclusion: These results clearly indicate the potential of EXPLORs for
treatment of chronic inflammatory diseases.
PS02.09
Withdrawn at author’s request.
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Improving extracellular vesicles-mediated mRNA delivery specifically
to HER2+ve cancer for effective CNOB/hChrR6 gene-delivered
(GDEPT) therapy
Alexis V. Forterre1, Jing-Hung Wang1, Alain Delcayre2, Travis Antes3, Neil
Aronin4, Anastasia Khvorova4, Stefanie Jeffrey1 and A.C. Matin1
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Introduction: We have been using directed c1c2-anti-HER2 scFv anti-
body tacked extracellular vesicles (dirEVs) for the delivery of mRNA,
encoding the enzyme hChrR6 specifically to HER2+ve cells to confer on
them the capacity to activate the prodrug CNOB to generate the cyto-
toxic agent, MCHB. The latter can be quantified by its fluorescence
intensity. Inadequate DNA-mediated gene delivery efficiency and
expression compromise the efficacy of GDEPT. We have therefore
used mRNA for gene delivery and present here measures for its
improved expression.
Methods: We modified the plasmid Xport-MSCV-hChrR6 used pre-
viously, by replacing its MSCV promoter by the CMV promoter. The
hChrR6 mRNA in EVs and in BT474 recipient cells was quantified by
qRT-PCR. EVs functionality was assessed by MCHB fluorescence quan-
tification. Cell viability was assessed by MTT assay.
Results: The use of Xport-MSCV-hChrR6 and CMV-hChrR6 plasmids
resulted in the introduction of 0.001 and 0.005 copy of the mRNA per
EV, respectively, thus, the latter method decreased the number of EVs
required to deliver one copy of the mRNA to the cells from 747 to 196
[73% improvement (p = 0.05)]. MCHB fluorescence in BT474 CNOB-
treated cells receiving the mRNA from dirEVs was visible at 24 h. At
30–72 h incubation, BT474 cells receiving mRNA from CMV-hChrR6
dirEVs were 14% more active in generating MCHB than when MSCV-
hChrR6 dirEVs was used for mRNA delivery. Cell-free medium of
CNOB-treated BT474 cells receiving the mRNA from CMV-hChrR6
dirEVs showed 10 to 20% greater MCHB than cells getting it from
MSCV-hChrR6 dirEVs, thus, the use of the former plasmid also gener-
ated a stronger bystander effect.
Conclusion: We have improved the engineering of dirEVs containing
mRNAs leading to better capacity to activate the prodrug CNOB. Work
is in progress to determine the effect at stabilisation of mRNA expres-
sion by incorporation of the 3ʹ-UTR of the Beta-globin gene in the
upstream region of our mRNA poly (A) tail. Also, we have constructed
self-delivery oligos for incorporation into the hChrR6 mRNA to facil-
itate its passage into the cells and directly into the EVs.
PS02.11
MHC mismatch in exosomal cancer immunotherapy – paving the way
for allogeneic exosome treatment?
Pia Larssen1, Rosanne Veerman2, Stefanie Hiltbrunner2, Mikael Karlsson3
and Susanne Gabrielsson2
1Karolinska Institutet; 2Immunology and Allergy Unit, Department ofMedicine,
Karolinska Institutet, Stockholm, Sweden; 3Department of Microbiology,
Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Exosomes are interesting as potential cancer immunotherapy vehicles
due to their capacity to potentiate immune responses and stimulate
tumour-specific immune activation in mice. However, previous clinical
trials with peptide-loaded autologous exosomes only showed moderate
T cell responses in humans, suggesting that exosome-induced immu-
nity is still not fully understood. We recently demonstrated that anti-
gen-specific CD8+ T cell responses are independent of major
histocompatibility complex (MHC) class I presence on exosomes.
Furthermore, exosomes lacking MHC class I, as well as exosomes
with both MHC class I and II mismatch, are equally efficient in
inducing antigen-specific tumour-infiltrating T cells in a B16 mela-
noma model as autologous exosomes. Still, the effect of multiple injec-
tions of allogeneic exosomes has not yet been investigated. We here
show that repeated injections of OVA loaded exosomes induce more
germinal centre B cells and boost antigen-specific antibody production,
thus providing an adjuvant effect in vivo. In addition, the effect of
repeated injections on tumour clearance in the B16-OVA melanoma
model is currently under investigation. In conclusion, our data show
that booster injections of allogeneic exosomes result in enhanced anti-
gen-specific CD8+ T cell, germinal centre B cell, and follicular T helper
cell responses, as well as increased antigen-specific antibodies.
Importantly, our findings support the application of allogeneic exo-
somes for therapeutic use in humans.
PS02.12
Virus-mimetic fusogenic exosomes for direct delivery of integral
membrane proteins to target cell membranes
Yoosoo Yang and In-San Kim
Korea Institute of Science and Technology, Republic of Korea
A number of major human diseases are related to defects in membrane
proteins. Despite several efforts aimed at delivering membrane proteins to
the defective cell membranes, currently workable approaches to treat such
membrane defects have been elusive. Here, we investigated an unprece-
dented exosome-based nano-platform for delivering membrane proteins
directly into recipient cell membranes. Based on the features of exosomes
that could be engineered by nature, we developed a fusogenic exosome
platform in which expression of the viral fusogen, vascular stomatitis virus
(VSV)-G protein, induces the exosomal membrane to fuse with recipient
cell membranes at acidic pH. Our results revealed that the fusogenic
exosomes could efficiently deliver GFP fused CD63 (CD63-GFP) or
glucose transporter-4 (GLUT4-GFP) to recipient cell membrane.
Fusogenic exosomes mediated transfer of biologically active GLUT4 to
mouse muscle membranes both in vitro and in vivo, allowing the increased
glucose uptake of recipient cells. This highlights the potential of our
fusogenic exosome platform for delivering membrane proteins.
(Advanced Materials, Accepted)
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Extracellular vesicle-encapsulated oncolytic adenoviruses for
enhanced therapeutic effect
Heikki Saari1, Mariangela Garofalo1, Petter Somersalo1, Laura Aksela2, Elisa
Lázaro-Ibáñez1, Matti Jalasvuori3, Tatu Rojalin4, Vincenzo Cerullo5, Lukasz
Kuryk6 and Marjo Yliperttula1
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Pharmacy, University of Helsinki, Finland; 2Orion Corporation; 3Biological and
Enviromental Science, University of Jyväskylä, Finland; 4University of Helsinki,
Finland; 5Laboratory of ImmunoVirothetherapy, Centre for Drug Research,
Faculty of Pharmacy, University of Helsinki, Finland; 6Laboratory of
ImmunoVirotherapy, Centre for Drug Reserach, Division of Pharmaceutical
Biosciences, Faculty of Pharmacy, University of Helsinki, Finland
Introduction: Oncolytic viruses are a promising future treatment option
for cancer, however, their use in therapy is limited due to their immune
reactivity and requirement towards specific receptors on the surface of
the cells to be infected. Here we have studied the possibility of encasing
the virus inside extracellular vesicles (EVs) in order to circumvent these
limitations by both shielding them from any interactions with immune
cells and providing alternative mechanisms for cellular uptake.
Methods: EV-encapsulated oncolytic adenoviruses were prepared by
infecting cancer cells with the virus. Once the cells were observed to
be dead EVs were isolated from the cell culture medium by ultracen-
trifugation followed by overnight gradient centrifugation in a linear
sucrose gradient. 1 mL fractions were collected from the gradient and
analysed by electron microscopy, nanoparticle tracking analysis, blotting
for CD9 and adenoviral hexon protein and for their infectivity towards
cancer cells.
Results: The EV-encased viruses (V-EVs) were found to migrate to a
density characteristic to EVs in the gradient, lower than free viruses. The
V-EV fractions were found to be even more infective than the free
viruses, acting faster to infect significantly more cells. These fractions
were also positive for the viral coat protein but not enriched with CD9,
suggesting an apoptotic origin. Unlike free viruses, the V-EVs were also
found to retain their infectivity even after treatment with NaOH, sug-
gesting that the EV membrane shields the virus from the treatment.
Conclusion: Infection of cancer cells with oncolytic adenoviruses natu-
rally results in membrane-encased particles containing fragments of the
virus. These particles are also more infective and might be effective in
the treatment of cancer due to their protective membrane structure.
However, an alternative strategy for loading of the viruses inside EVs
would be beneficial, since the presented approach applies only to EVs of
cancer cells.






























Extracellular vesicle-mediated delivery of synthetic receptors for
enhanced tumour penetration of targeted agents
Heegon Kim, Chanhee Oh and Ji Ho Park
KAIST, Seoul, Republic of Korea
Introduction: Extracellular vesicles (EV) secreted by cells into extracel-
lular environment mediate intercellular communication by delivering
biological materials to neighbouring cells. Since EVs originate from
plasma membrane of cells, they also have lipid bilayer structure. In
this study, we seek to employ EVs as carriers of synthetic receptors to
achieve deep penetration into tumour tissue. Firstly, membrane fuso-
genic liposomes (MFL) deliver synthetic receptor-lipids (SR-lipid) to
tumour cell membrane via membrane fusion. Becoming building blocks
of plasma membrane, the synthetic receptor-lipids are incorporated into
EVs released by the tumour cells. Hitchhiking the EVs, the synthetic
receptors can be further delivered to other cells nearby, spreading
throughout tumour regions where conventional liposomes have limited
access. Subsequent administration of targeted agents showed tumour-
specifically enhanced accumulation and penetration.
Methods: In vitro, we examined whether SR-lipids could be localised
more selectively onto the plasma membrane of tumour cells than other
cells including macrophages, endothelial cells and fibroblasts. In addi-
tion, EV-mediated transfer of SR-lipids was inviestigated by isolating
EVs from MFL-treated cells and treateing the EVs to other cells. In vivo,
we intravenously injected MFLs carrying SR-lipids mice bearing 4T1
tumours 1 day prior to intravenous administration of targeted agents. At
2 days, the distribution of targeted agents in tumour sections was studied
using a confocal microscope and NIS-elements BR software.
Results: In vitro, we observed that SR-lipids were delivered to tumour
cell membrane by MFLs. We also observed that the SR-lipids on the cell
membrane were further transferred to neighbouring cells by EVs. The
SR-lipids provided binding sites on the cells for targeted agents. In vivo,
we found out that the selective delivery of SR-lipids to tumour cell
membranes using MFLs enhanced accumulation and penetration of
subsequent targeted agents.
Conclusion: By using liposomes to modify tumour cell membrane and
hitchhiking EVs, we successfully delivered synthetic receptors through-
out a tumour and achieved enhanced accumulation and penetration of
targeted agents.
PS02.15
In vitro insertion of ligands to extracellular vesicles for efficient in
vivo cancer targeting and regression with little liver accumulation
Fengmei Pi1, Zhefeng Li1, Daniel Binzel1, Bin Guo2 and Peixuan Guo1,3
1Division of Pharmaceutics and Pharmaceutical Chemistry, College of
Pharmacy; 2Department of Pharmacological and Pharmaceutical Sciences,
School of Pharmacy, Houston, TX, USA; 3Department of Physiology & Cell
Biology, College of Medicine, Dorothy M Davis Heart and Lung Research
Institute, The Ohio State University, Columbus, OH, USA
Utilisation of extracellular vesicles (EVs) for non-viral gene delivery is an
emerging platform in nanotechnology and nanomedicine. Here we
report the combination of the advantages of both EV for membrane
fusion and nanotechnology for ligand displaying, resulting in specific
cancer targeting and cytosol delivery. Using special sedimentation
separation technology, our small exosome showed reduce accumulation
in liver and other normal organs. Delivery of therapeutic RNA molecules
with this new strategy shows significant gene silencing and tumour
regression without obvious toxicity observed in animal trials. The pre-
sentation will include methods for large-scale EVs purification with
reservation of native shape and original function. Size, zeta potential,
and electronic microscopic morphology analysis reveal that this method
eliminated impurity but also avoid of aggregation and particle
disruption.
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Sweating the small stuff: extracellular vesicles from sweat




ExRNA Atlas resource for sharing extracellular RNA data and for
analysing it in the context of exRNA pathway knowledge
William Thistlethwaite1, Sai Subramanian1, Neethu Shah1, Andrew R. Jackson1,
Robert Kitchen2, Joel Rozowsky3, James Diao, Timur Galeev4, Anders Riutta5,
Kristina Hanspers5, Alex Pico5, Roger P. Alexander6, David Galas6, Andrew Su7,
Matthew Roth1, Mark Gerstein8 and Aleksandar Milosavljevic1
1Molecular & Human Genetics, Baylor College of Medicine, TX, USA;
2Exosome Diagnostics; 3Department of Molecular Biophysics &
Biochemistry, Yale University, CT, USA; 4Molecular Biophysics and
Biochemistry, Yale University, CT, USA; 5The Gladstone Institutes;
6Pacific Northwest Research Institute; 7Department of Molecular and
Experimental Medicine, The Scripps Research Institute; 8Molecular
Biophysics and Biochemistry: Genomics, Genetics, and Bioinformatics
Introduction: The Extracellular RNA Communication Consortium
(ERCC) has created the exRNA Atlas, a public web-accessible resource
that includes over 1500 uniformly processed and curated exRNA pro-
files, on-line tools and links to computable knowledge resources. The
exRNA Atlas can be accessed either directly (www.exrna-atlas.org) or via
the Quick Links section in the exRNA Portal (www.exrna.org).
Methods: Datasets stored in the Atlas are derived from either RNA-seq or
qPCR assays. All RNA-seq data are uniformly processed using the extracel-
lular RNA processing toolkit (exceRpt), which generates sample-level quality
control metrics, produces abundance estimates for small RNA species, and
provides detailed alignment information for visualisation and validation. The
Atlas also stores metadata for all samples using the GenboreeKB exRNA
Metadata Tracker, a MongoDB-backed database service.
Results: Users may currently explore the 1567 exRNA profiles from 12
studies that are already present in the Atlas. We have integrated BioGPS
to allow browsing of specific exRNA profiles within individual studies or
across studies that employ similar experimental protocols. We have also
created a census of miRNAs in the Atlas across body fluids and RNA
isolation kits. User-supplied profiles may be compared across other
profiles in the Atlas using an integrated PCA tool. The comparison
may increase rigour and reproducibility by validating biofluid type and
assay performance, it may also reveal novel associations and clustering
patterns due to biological or experimental reasons. Finally, researchers
can leverage our integrated network analysis tools including the Target
Interaction Finder and Pathway Finder to interpret modules of covary-
ing miRNA and other non-coding RNA species in the context of a
growing exRNA pathway section in WikiPathways
Conclusion: The exRNA Atlas resource provides FAIR (Findable,
Accessible, Interoperable, Reusable) exRNA profiling data, relevant
tools, and computable exRNA pathway knowledge, thus catalysing
data-intensive exRNA research.
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How anticoagulation of plasma really affects EV yield and their
properties?
Maarit Takatalo1, Mari Palviainen2, Sami Valkonen3, Saara Laitinen4 and Pia
R-M. Siljander5
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Finland FIMM, University of Helsinki, Finland; 3Division of Biochemistry
and Biotechnology, Department of Biosciences/Division of Pharmaceutical
Biosciences, Centre for Drug Research, Faculty of Pharmacy, University of
Helsinki, Helsinki, Finland, Finnish Red Cross Blood Service, Helsinki,
Finland; 4Finnish Red Cross Blood Service, Helsinki, Finland; 5Division of
Biochemistry and Biotechnology, Department of Biosciences/Division of
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Introduction: Extracellular vesicles (EVs) provide a common source
material for biomarker studies or may in the future be used as biomar-
kers themselves. As a liquid biopsy, plasma or serum are relatively non-
invasive providing a material rich in EVs from a variety of cells/tissues.
Despite EVs’ popularity, the issues of pre-analytical variables regarding
plasma/serum as an EV source have not yet been explored in depth:
several beliefs exist in the EV field, but data is lacking. In this study, we
addressed the effect of anticoagulation to the yield and characteristics of
the obtained EVs.
Methods: Pools of EDTA-, citrate-, acidic citrated dextrose (ACD)-antic-
oagulated plasma or serum were prepared from 10 healthy volunteers
with identical centrifugation parameters and processed within an hour
from blood collection. Plasma/serum was investigated for the presence
(Coulter) and source of remnant cells (LSRII flow cytometer). EVs were
isolated by ultracentrifugation and analysed for total protein and particle
number (NTA) and by flow cytometry (Apogee). Western blotting was
used to detect EV markers and ApoB.
Results: As expected, the largest differences were found between the serum-
derived and the three plasma-derived EVs. Differences in size profiles, the
presence of platelet-derived EVs and lipid labelling were detected. However,
the EV yield from serum was the same as from plasma. In contrast,
differences in the EVs isolated from the three plasma sources showed
only minute differences regarding the presence of platelet-derived EVs
and total protein, but had some clear distinctions in other parameters.
Conclusion: Compared to the EVs from serum, the choice of antic-
oagulation may not be the most crucial factor determining EV-yield or
quality when pre-analytical conditions are considered. However, since
the EVs had some unique characteristics depending on the source
plasma, the choice of anticoagulant may be relevant in regard of some
downstream analyses.
PS03.04
Serum miRNAs level is affected by feeding bovine and porcine milk in
newborn piglets
Delin Lin, Liyuan Yao, Qianyun Xi, Jiajie Sun, Ting Chen and Yong-Liang
Zhang
College of Animal Science, South China Agricultural University, Guangdong,
China
Breast milk is the first and most important nutrient source for mammals
after birth. Studies have indicated that 12 kinds of body fluid contain
miRNAs, and milk has the highest concentration of total RNA. In milk,
miRNA may be encapsulated in exosome, or bind to lipoprotein. In the
present study, we hypothesised that miRNAs in breast milk can be
absorbed by newborn piglets. Firstly, qRT-PCR was used to compare
miRNA level between porcine and bovine milk, and four miRNAs (miR-
2284x, miR-2291, miR-7134 and miR-1343) were identified with signifi-
cant difference. Secondly, in vivo test was conducted to compare miRNA
level in piglet serum after feeding porcine or bovine milk. Twelve piglets





























were randomly selected from four sow’s litters, 4 form each litter, and
fed with bovine milk, while 12 other piglets took milk from their own
mother. Serum samples of each piglet were collected on day 1, 3, 7 and
14, respectively. Total RNA was extracted from serum by Trizol method,
and qRT-PCR was used to detect serum miRNA level quantitively. We
confirmed that four miRNAs, miR-2284x, miR-2291, miR-7134 and
miR-1343, showed significantly different levels in newborn piglets’
serum after taking different kinds of milk. Meanwhile, porcine small
intestinal epithelial cells (IPEC-J2) was co-cultured with bovine and
porcine milk exosome and their exosome-free whey, respectively. The
relative levels of four miRNAs in different experimental groups were
detected to be higher than those in control group. The results indicate
that not only miRNAs in milk exosome but also in exosome-freee whey
can be absorbed by IPEC-J2 cells. Our findings suggest that miRNAs in
breast milk can be absorbed by piglets via digestive tract. More impor-
tantly, different kinds of milk cause differences in miRNA absorption
and levels in infant serum.
PS03.05
Differentially expressed exosome miRNAs induced by blood flow
restricted exercise – possible effectors of endogenous organ
protection and muscle hypertrophy
Jesper Just1, Mette Sloth1, Yan Yan2, Kristian Vissing3, Jørgen Kjems2 and
Kim Ryun Drasbek1
1Department of Clinical Medicine, Centre of Functionally Integrative
Neuroscience, Aarhus University, Aarhus, Denmark; 2Interdisciplinary
Nanoscience Centre, Aarhus University, Aarhus, Denmark; 3Section of
Sport Science, Department of Public Health, Aarhus University, Aarhus,
Denmark
Introduction: Remote ischemic conditioning strategies delivers an
expanded potential as activation of endogenous organ protection dur-
ing prolonged ischemia, and have shown promising results as addi-
tional acute treatment for myocardial infarct and stroke. However, at-
risk subjects or patients with chronic conditions might also benefit
from a prophylactic conditioning regiment. Here, blood flow restricted
exercise (BFRE) is of special interest. BFRE is initiated by applying
external pressure to the proximal part of the lower or upper extremi-
ties, which occludes venous outflow flow but maintains arterial inflow
to the extremity. Combining BFRE with low-intensity training have
demonstrated the ability of this method to increase muscle strength
and hypertrophy. However, BFRE may also activate the endogenous
organ protection seen in acute conditioning strategies, as similar bio-
logical pathways could be involved. A possible effector of ischemic
conditioning is blood-borne micro RNAs (miRNA) carried in small
extracellular vesicles (EVs). These released encapsulated miRNAs have
the potential to change cellular protein expression both locally and
systemically.
Methods: To investigate which known or novel miRNAs were up- or
downregulated during BFRE, small EV RNAs (<50 bp) were isolated
from plasma of five healthy human subjects pre and post BFRE. The
isolated RNAs were sequenced by NGS and differential expression
analysis was carried out using the Deseq2 software package in R.
Results: We show that several known miRNAs were up- and down-
regulated following BFRE. These miRNAs were compared to the existing
literature and some of them showed interesting associations, suggesting
a protective effect in ischemic disease.
Conclusion: Further investigations of these miRNAs might help to
rebuild the beneficial underlying molecular mechanisms of ischemic
conditioning and BFRE, and could offer new therapeutic targets in
pathologies involving damaging hypoxia.
PS03.06
Minimal volume of urine for microvesicles detection
Luca Musante1, Sai Vineela Bontha2, Christine Rudy1, Joanne Lannigan3,
Valeria Mas4 and Uta Erdbruegger1
1Department of Medicine/Nephrology Division, University of Virginia, VA,
USA; 2Translational Genomics Transplant Laboratory, Division of
Transplant, Department of Surgery, University of Virginia, VA, USA;
3School of Medicine, Flow Cytometry Core, University of Virginia, VA,
USA; 4Translational Genomics Transplant Laboratory, Division of
Transplant, Department of Surgery, University of Virginia, VA, USA
Introduction: Urinary extracellular vesicles (UEVs) provide a relative
novel source of valuable biomarkers for kidney and urogenital diseases.
As a matter of fact, so far the bulk of the research has focused mainly on
exosomes as the primary source of extracellular vesicles (EVs). Only
recently, have urinary microvesicles/microparticles been regarded as an
additional important fraction of EVs carrying biomarkers. The number
of MVs released by podocyte has shown to be higher in the urine of
patient with diabetes mellitus type 1 without any kidney complications
for instance. This study aims to investigate what is the minimal amount
of urine which enables the detection and characterisation of MVs.
Methods: First morning void urine was centrifuged at relative centrifu-
gation force RCF of 3200g. The supernatant was split in 0.5, 1.0, 1.5, 3.0,
4.5, 9.0 and 13.5 ml fractions to enrich MVs by centrifugation at RCF of
20,000g. Tunable resistive pulse sensing, imaging flow cytometry, cryo-
transmission electron microscopy (TEM) and extraction of RNA were
the techniques adopted to establish the minimal volume of urine to
provide material for analysis. RNA was isolated from the MV pellet of
0.5 ml urine fraction for miRNA analysis.
Results: MVs could be detected by TRSP, and imaging flow cytometry
and, it was possible to extract RNA and identify miRNA (that are
previously identified in cell free healthy urine) using qPCR, already
starting from 0.5 ml of urine with an estimated 1.5 × 108 particles in
TRSP. Cryo-TEM provided adequately good images starting from a
minimal volume of 1.5 ml of urine with MVs of the size which corre-
sponded to the particle size distribution established in TRSP. However
smaller vesicles with a diameter ≤100 nm were also detectable.
Conclusion: Depending on the sensitivity of the technique in use, a
minimal volume of 0.5 ml urine can be useful for particle enumeration,
MVs surface phenotyping and RNA analysis.
PS03.07
The phenotypical changes of plasma EVs over time in healthy donors
Rikke Baek1, Morten Hjuler Nielsen2, Jaco Botha2, Lotte H. Pugholm1, Evo K.
L. Soendergaard1, Kim Varming1, Aase Handberg2 and Malene M. Jorgensen1
1Department of Clinical Immunology, Aalborg University Hospital, Aalborg,
Denmark; 2Department of Clinical Biochemistry, Aalborg University
Hospital, Aalborg, Denmark
Introduction: Extracellular vesicles (EVs) in plasma have a great diag-
nostic potential as biomarkers for several diseases. In order to use EVs in
a clinical setting, it is of great importance to know whether the protein
phenotypes of EVs in a healthy cohort changes over time. In this study,
we collected blood from 10 apparently healthy donors over a period of
6 weeks to determine the long-term (week-to-week) as well as the short-
term (day-to-day) variance of EV concentration and composition.
Furthermore, blood cell counts were determined.
Methods: Venous peripheral blood (EDTA and CPDA) was obtained
from 10 healthy donors once a week over a period of 6 weeks.
Furthermore, blood samples were drawn from five of the donors daily
during one week. Blood cell counts were measured by a Sysmex XN-
1000. Small EV concentration and composition were analysed by the EV
Array (1) using 29 selected surface-markers. The antibodies used to
capture the EVs included antibodies against EVs in general (CD9,
CD63, CD81, Alix, Flotilin-1 etc.), and immunological and inflamma-
tory markers (CD4, CD8, CD80, HLA ABC, HLA DR/DP/DQ, TNF RI
and RII etc.). Flow cytometry was used to analyse the larger vesicles
(0.1–1.0 µm) for their content of phosphatidylserine, CD41 and CD36.
Results: In total, 80 plasma samples were collected and analysed. Large
inter-individual variation was found in both cells and EVs. The long-
term intra-individual variation in blood cells varied for some of the cell
types significantly over time, which was not seen in the contents of small
EVs. Smaller short-term and intra-individual variation (day-to-day)
variation were observed in the cellular composition, but this was not
reflected in the obtained phenotypes of EVs.
Conclusion: A few of the selected surface markers of the EVs showed
minor changes over time, although this did not reflect the significant





























changes identified on the cellular level. Hence, EVs tend to be a stable
diagnostic biomarker source.
Reference
1. Jorgensen M et al., J Extracell Vesicles. 2013; 2: 3402/jev.v2i0.20920
2013.
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Purification, molecular characterisation and initial functional
characterisation of the EVs derived from renal cell carcinoma (RCC)
and human sweat
Geneviève Bart, Anatoliy Samoylenko, Khem Giri, Fabienne Wagner, Hanna
Thoma, Prateek Singh and Seppo Vainio
University of Oulu, Finland
Introduction: The extracellular vesicles (EVs) secreted by cells into the
body fluids serve to remove cellular waste products but they also act as
molecular transport vehicles to nearby or distant cells. While the detailed
in vivo function of secreted EVs remains still poorly characterised
identification of their cargo content may serve to provide valuable
information about the status of cells with putatively great value as
novel diagnostic markers besides other important medical potentials.
Methods: Two types of EVs were used in this study: EVs secreted by
mouse renal carcinoma cells in normal or hypoxic conditions were
collected from conditioned media and body fluid EVs were purified
from human sweat. Purified RNA was sequenced with Iontorrent PGM
(small RNA) and RNA annotation was done using Genboree
Workbench. EV DNA was sequenced with NextSeq550 (Illumina)
using whole genome approach. We also studied the effect of such EVs
on mobility and proliferation of the recipient cells. To functionally test
the EVs we applied them to mouse, dog and human derived cells lines
and studied putative changes in gene expression based on the most
abundant miRNA identified in our EVs.
Results: The sequencing data revealed that a large number of the RNA species
that associated with EVs, were non-coding RNAs such as rRNA, tRNA,
miRNA, lncRNa but also anti-sense ones. Fragments of mRNAwere detected
as well. Interestingly the EV associated DNA sequences depicted relatively
widely distributed but chromosomally restricted “hot spot” segments includ-
ing the mitochondria. In the functional assays the EVs had a notable impact
on cell proliferation, cell motility and cell survival and lead to changes in
mRNA expression in line with the presence of miRNAs in the EVs.
Conclusion: Characterisation of nucleic acid cargo of the EVs secreted by the
twomodel systems, renal cell carcinoma (RCC) and sweat identifies a wealth
of RNA and DNA sequences with diagnostic potential. We can conclude
that detailed functional tests need to be carried out to classify the regulatory
roles of the EVs, preferably eventually at the single EV and cell level.
PS03.09
Characterisation of extracellular vesicles released from adult mouse
retina
Jason Mighty1, Jing Zhou1, Alberto Benito-Martin2 and Stephen Redenti1
1CUNY Lehman College, NY, USA; 2Weill Cornell Medical College, NY, USA
Extracellular vesicles (EVs), are lipid enclosed cell fragments with diameters
ranging from 50 nM to 2 mM and released from most cell types including
embryonic stem cells, hematopoietic stem cells and neurons. EVs have been
shown to be involved in cell-cell communication via transfer of protein,
mRNA and miRNA. EVs encapsulate factors representative of cell of origin
genotype and phenotype. Currently there is limited research on EVs
released from retinal tissue. In this study, we analysed the release rate,
concentration and content of EVs released from adult mouse retina in
vitro. EV release rate and ultrastructure were analysed using SEM and
Nanosight analysis. Under standard culture conditionsmouse retinal tissues
were shown to release 1041.67 vesicles/hour with an average diameter of
196 nm.Using immulogold TEMandwestern blottingmouse retina derived
EVs were shown to incorporate the tetraspanin proteins, Tsg101 and CD63.
Genetic analysis revealed the presence of mRNA species within EVs
comparable to those present in adult retinal tissue. These findings demon-
strate that the adult mouse retina releases EVs and Future work will reveal
potential influence of EVs in adult retinal function.
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The exRNA virtual biorepository: a biospecimen catalogue service for
sharing biofluid and tissue samples
Aleksandar Milosavljevic1, Sai Subramanian1, William Thistlethwaite1,
Andrew R. Jackson1, Neethu Shah1, Sameer Paithankar1, Matthew Roth1,
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4Neurogenomics Division, Translational Genomics Research Institute;
5Neurosurgery, Barrow Neurological Institute; 6Department of Neurosurgery,
University of Utah School of Medicine, UT, USA; 7Anesthesiology and
Perioperative Medicine, Oregon Health and Science University, OR, USA;
8Computational Biology, Oregon Health and Science University, OR, USA;
9Neurology, OHSU School of Medicine; 10The Scintillon Institute, CA, USA
Introduction: The exRNA virtual biorepository (EVB) is a cloud-hos-
ted“virtual” repository of biospecimens developed by the Extracellular
RNA Communication Consortium (ERCC) for sample tracking, discov-
ery, and sharing within the scientific community. The EVB supports the
sharing of information about both biofluid- and tissue-derived samples
that reside at participating laboratories and institutions. There are cur-
rently 4800+ biofluid samples in the EVB.
Methods: The EVB follows a spoke-hub model, where the hub functions as
a central entity that receives updates regarding available biosamples at
participating institutions and provides access to the combined information
to researchers. All data and services are exposed via a FAIR REST API.
Results: The EVB Hub’s portal page allows faceted filtering of samples by
various data elements such as biofluid type, diagnosis at the time of
sampling, and donor demographics. Searches can be saved for future
use. When viewing search results, users can review additional details
about the samples, decide whether to include them in an order cart, and
then place the order. The hub breaks the cart into sub-orders for each
participating institution, and aids in back-and-forth mediation between
sample providers and sample requesters, so that requests are processed
in a trackable, seamless, and timely manner. Participating institutions
that provide samples and researchers requesting samples can be rated by
the respective counter-party at the end of the transaction, similar to
popular online marketplaces, and rating information is available as part
of an institution’s or user’s profile to aid decision-making. We have
implemented a model extension mechanism to support various research
efforts – for example, the cerebrospinal fluid (CSF) consortium includes
additional metadata about extracellular vesicle and RNA extraction
methods, as well as vesicle quantification information from techniques
such as NTA, TRPS, and vesicle flow cytometry.
Conclusion: The EVB Hub portal will be made accessible for public use
in the coming months. In the meantime, the consortium anticipates
adding several thousand samples to the current collection, thus catalys-
ing exRNA research via sample sharing.
PS03.11
Yield, physicochemical properties and pharmacokinetics of exosomes
derived from mouse cell lines
Chonlada Charoenviriyakul1, Yuki Takahashi2, Masaki Morishita2, Akihiro
Matsumoto2, Makiya Nishikawa2 and Yoshinobu Takakura2
1Kyoto University, Kyoto, Japan; 2Graduate School of Pharmaceutical
Sciences, Kyoto University, Kyoto, Japan
Exosomes are small membrane vesicles secreted from cells and are
expected to be used as drug delivery systems. Characteristics of
exosomes, such as yield, physicochemical properties, and





























pharmacokinetics, are important for the purpose and may be differ-
ent among different cell types. However, there is limited information
about the effect of cell type on these characteristics. In the current
study, we evaluated these characteristics of exosomes derived from five
different types of mouse cell lines: B16BL6 murine melanoma cells,
C2C12 murine myoblast cells, NIH3T3 murine fibroblast cells, MAEC
murine aortic endothelial cells, and RAW264.7 murine macrophage-like
cells. A differential ultracentrifugation method was used to collect exo-
somes. The exosomes collected from all the cell types were negatively
charged globular vesicles with a diameter of approximately 100 nm, and
not statistically different. C2C12 and RAW264.7 cells produced more
exosomes than the other types of cells. To evaluate the pharmacokinetics
of the exosomes, they were labelled with a fusion protein of Gaussia
luciferase (gLuc) and lactadherin (LA) by transfection of cells with gLuc-
LA-expressing plasmid vectors. After intravenous injection into mice, all
the gLuc-LA-labelled exosomes rapidly disappeared from the systemic
circulation and mainly distributed to the liver. Fluorescent immunostain-
ing revealed that the exosomes administered by intravenous injection
were mainly taken up by F4/80+ macrophage sin the liver irrespective of
the types of exosome-producing cells. In conclusion, these results indi-
cate that the exosome yield was significantly different among the cell
types, whereas the physicochemical properties and pharmacokinetics
were comparable among all the exosomes examined.
PS03.12
Phospholipid influence prompts the need for an anti-TF antibody to
specifically measure tissue factor activity on microvesicles
Loris Vallier1, Tarik Bouriche2, Amandine Bonifay1, Jeremie Bez2, Françoise
Dignat-George3, Romaric Lacroix3 and Philippe Poncelet2
1Aix-Marseille Université, VRCM, UMR-S1076, INSERM, UFR de Pharmacie,
Marseille, France; 2Research and Technology Department, BioCytex, Marseille,
France; 3Aix-Marseille Université, VRCM, UMR-S1076, INSERM, UFR de
Pharmacie, Marseille, France and Department of Haematology and Vascular
Biology, CHU La Conception, APHM, Marseille, France
Introduction: Tumours and inflammatory blood cells express tissue
factor (TF) and release TF-positive microvesicles (MV-TF) which
activate blood coagulation. Many studies suggest that elevated MV-
TF number or activity levels correlate with high risk of thrombosis.
Several versions of a functional test measuring MP-TF activity via
FXa generation have been described but their TF specificity and the
influence of the phospholipid environment remain unclear. Our work
aims to evaluate the influence of phospholipids on the TF activity
of MVs.
Methods: Factor Xa generation assay was performed onTF+MVs fromHAP-
1 myeloïd cell line and vesicular phospholipids as TF-free MVs including (i)
MVs from knocked-out TF (KO-TF) HAP-1, (ii) erythrocyte-derived MVs
(ery-MVs) and (iii) platelet-derived MVs (PMVs). To measure TF-specific
activity, the measure was carried out in parallel with an irrelevant antibody
and a fully blocking anti-TF antibody (SBTF1, BioCytex).
Results: Factor Xa generation assay carried with various amounts of TF-
free MVs showed a dose-related non-specific activity which is detectable
from 2,5.105 KO-TF HAP-1 or Ery-MVs or 2.106 PMVs. For exemple,
KO-TF HAP-1 MVs induce 220 ± 120 relative fluorescence units per
minute (RFU/min) with 2.106 MVs. Similarly, a residual activity
(390 ± 40 RFU) which is not inhibited by a specific anti-TF antibody
was measured using the same amount of TF+ HAP-1 MVs. Moreover,
when excess amounts of KO-TF HAP-1 MVs, ery-MVs or PMVs were
incubated with a fixed amount of TF+MVs, a significant increase in factor
Xa generation was observed which is not inhibited in presence of an anti-
TF inhibitory antibody (respectively 149 ± 15%, 127 ± 20% and 134 ± 17%
of initial activity with addition of 2.5 × 105 TF-free MPs).
Conclusion: This study shows that the presence of vesicular phospholipids
in the surrounding environnement significantly impact on the measure-
ment of the MV-dependent FXa activity. This artefact requires the man-
datory use of an inhibitory anti-TF antibody in the assay to measure only
TF-specific FXa generation. Results from commercial assays not using
such specific inhibition should be interpreted with caution.
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PS04.01
Easy extracellular vesicle detection on a surface-functionalised
power-free microchip
Ryo Ishihara1, Tadaaki Nakajima2, Asuka Katagiri1, Yoshitaka Uchino1,
Kazuo Hosokawa3, Mizuo Maeda3, Yasuhiro Tomooka2 and Akihiko
Kikuchi1
1Department of Materials Science and Technology, Tokyo University of Science,
Tokyo, Japan; 2Department of Biological Science and Technology, Tokyo
University of Science, Tokyo, Japan; 3Bioengineering Laboratory, RIKEN
Please see OPT03.02
PS04.02
Methodological considerations for nanoparticle tracking analysis
(NTA) of neat biofluids obtained from cardiac surgery
Andrew I.U. Shearn1, Costanza Emanueli2 and Giovanni Biglino1
1University of Bristol, United Kingdom; 2Bristol Heart Institute, University of
Bristol, United Kingdom
Introduction: Exosomes are potential biomarkers in the cardiac surgery
setting. The use of NTA technology with neat biological samples and the
way different parameters affect NTA results in this context have not
been fully explored, particularly with the latest technology/software. This
study sought to determine important parameters that need to be con-
sidered when analysing neat human biofluids with NTA.
Methods: Human plasma and pericardial fluid, collected from cardiac
surgery patients under ethical approval, were analysed on an NS300
(Malvern, Malvern, UK) using NTA software v3.2 with a syringe
pump. Calibration of the machine was performed using artificial exo-
somes (HansaBioMed, Tallin, Estonia).
Results: Calibration was performed successfully and recording reprodu-
cibility verified. Video length has a substantial impact on total particle
concentration, the total number of particles counted in the 30–120 nm
(exosomal) range being 42% higher when 150 s videos are used compared
to 90 s. More videos reduce the variability of absolute particle count (SD
2.68 × 108 30–120 nm particles/mL for 2 videos vs. 2.02 × 108 for 4 videos).
Unfiltered samples showed substantial underestimation of particles in the
exosomal range due to reflections, whilst filtration of samples with a
0.22 µm filter prevented large aggregates interfering with the measure-
ments. Reasonable variations in the max jump settings and small neces-
sary focus adjustments do not substantially affect quantification of
nanoparticles compared to default settings. Camera levels and detection
thresholds should be kept consistent between different patients.
Conclusion: NTA can analyse nanovesicles in whole biofluids. Certain
settings must be optimised prior to acquisition, particularly video length
and the number of videos. In addition to optimising focusing of the
instrument and ensuring thorough cleaning between samples, sample
filtration eliminates larger particles that can interfere with processing
and mask smaller particles.
PS04.03
An affinity-based method for efficient recovery of tumour-derived evs
from conditioned media and human plasma that can be used for
detection of actionable mutations in liquid biopsy applications
Catherine Taylor1, Sheena Fry1, Anirban Ghosh2, Jeremy Roy1, Nicolas
Crapoulet3, Simi Chacko1, Annie-pier Beauregard1, Sebastien Fournier1, Biji
Anish1, Ian C. Chute1, Remi Richard1, Stephen M. Lewis2 and Rodney J.
Ouellette2
1Atlantic Cancer Research Institute, New Brunswick, Canada; 2Department of
Chemistry and Biochemistry, Université de Moncton, New Brunswick,
Canada; 3Department of Chemistry and Biochemistry, Faculty of Medicine,
Université de Sherbrooke, New Brunswick, Canada
Introduction: Circulating DNA in blood is becoming an increasingly
important resource for detection of “actionable”mutations that are impor-
tant for determining therapeutic strategies in the treatment of cancer
patients. In addition to cell-free DNA (cfDNA) and circulating tumour
cell DNA, extracellular vesicles (EVs) are gaining recognition as an impor-
tant source of tumour-derived DNA in liquid biopsy applications. Vn96 is a
synthetic peptide with an affinity for heat-shock proteins that has been
developed into a fast and efficient method for EV isolation from a variety of
biofluids. In this study, Vn96 peptide was used to isolate tumour EV-
derived DNA in order to assess the detection of actionable mutations
from both EV-spiked plasma and breast cancer patient plasma samples.
Methods: Nanoparticle tracking analysis (NTA) was used to quantify the
number of EVs isolated using increasing concentrations of Vn96 from
conditioned cell culture media and from normal human plasma spiked
with purified PANC10.05 (KRAS G12D heterozygous pancreatic cell
line) EVs. Recovery of PANC10.05 EV DNA from spiked plasma was
assessed by digital drop PCR analysis of KRAS (WT and G12D). DNA
was isolated using Vn96 from 1 mL samples of breast cancer patient
plasma and actionable mutations were detected by next-generation
sequencing. A comparison to cfDNA isolated from the same plasma
samples was made. Since the number of EVs in blood may be an
important diagnostic marker of disease in its own right, NTA was used
to explore correlations between the number particles per mL in breast
cancer patient plasma (isolated using Vn96) and disease stage.
Results: A good correlation (r = 0.95) was observed between Vn96
binding studies using conditioned media from two different cell lines,
with an average isolation of 5.7 × 108 particles per µg Vn96. Vn96 was
also found to be able to efficiently recover EVs from plasma, with >80%
recovery of EV-derived DNA from spiked plasma samples. Sufficient
DNA for next-generation sequencing was obtained from only 1 mL of
plasma from patients with advanced breast cancer.
Conclusion: Affinity purification of EVs using Vn96 peptide provides a
simple, scalable technique that can be used for EV research and which
has the potential to be useful in the development of liquid biopsy
technologies for clinical diagnostics.
PS04.04
Evaluation of individual exosomes down to 10 nm in microfluidic
devices
Takanori Ichiki and Takanori Akagi
University of Tokyo, Japan
Currently, one can use various methods for characterising a heterogeneous
population of extracellular vesicles (EVs), e.g. transmission electron micro-
scopy (TEM), atomic force microscopy (AFM), nanoparticle tracking analy-
sis (NTA), flow cytometry and so forth. Besides them, authors have recently
developed a microfluidic-based analytical platform that enables the multi-
parametric characterisation of nanovesicles by concentration, diameter, zeta
potential, and surface antigenicity (1). Unfortunately, however, most of the
above methods are suffering from difficulty in detecting small vesicles below
50 nm with the exception of TEM, and there is a strong demand for
extending the detection size limit to clarify the whole picture of EVs including
exosomes. In this presentation, we will report the successful improvement of
detecting individual EVs down to 10 nm on our analytical platform.
As a demonstration of the improved performance, size measurement of
EVs was conducted as follows. After cultivation with a serum-free medium
for 48 h, culture supernatants of human breast cancer SkBr3 and leukaemia
HL60 cells were centrifuged at 300g for 10 min, at 2000g for 20 min and at
10,000g for 100 min. The clarified supernatant, used as a feed sample, was
further centrifuged at 100,000g for 200 min. Vesicles in resulting super-
natant (100ksup) and pellet (100kpt) were evaluated. Size ranges of SkBr3’s





























EV in the feed, 100ksup and 100kpt were 18.7–204, 21.5–136 and 5.1–
104 nm, respectively, while those of HL60’s EV in the feed, 100ksup and
100kpt were 34.1–287, 8.7–271 and 8.6–152 nm, respectively. In the case of
SkBr3, ratios of vesicles of 50 nm or less to the whole were 5.6%, 19.0% and
59.4% for the feed, 100ksup and 100kpt, respectively. And, in the case of
HL60, ratios of vesicles of 50 nm or less to the whole in the feed, 100ksup
and 100kpt were 39.6%, 60.0% and 92.2%, respectively. Thus the improve-
ment in detection limit down to 10 nm can shine a spotlight on innegligible
amount of subjects that could not be measured until now.
Reference
1. Akagi T et al., PLoS One. 2015; 10: e0123603.
PS04.05
High throughput qualitative and quantitative analysis of plasma-
bound microvesicles
Wei Zhang1, Neva Kandzija1, Vuyane Mhlomi2, Ana-Sofia Cerdeira3, Gavin
Collett1, Alexandra Burdujan1, Ian Sargent1, Christopher Redman1, David
Ferguson1 and Manu Vatish1
1Oxford University, Oxford, United Kingdom; 2Oxford, United Kingdom; 3NHS
The current go-to technique for microvesicle analysis utilises flow cyt-
ometers capable of single-event multi-parameter analysis. Using a conven-
tional LSR-II and placental derived microvesicles as a model, we report a
detailed method to (1) optimise flow cytometer scatter resolution and
determine size limitation for microvesicle detection in an antigen and
machine specific context; (2) incorporate a “dump channel” (used in rare
event analysis) to enhance microvesicle detection specificity in complex
biological fluids. Blood samples from women with normal term pregnancy
were collected with informed consent.We found significant decreases in the
number of circulating trophoblast extracellular vesicles (event positive for
placental alkaline phosphate) in 100ul of the same donor’s platelet-free
plasma compared to platelet-poor plasma for both uterine vein
(670.8 ± 371 vs. 2781 ± 1534, n = 6, p = 0.03) and peripheral samples
(281.3 ± 113.3 vs. 522.5 ± 145.9, n = 8, p = 0.008). The natural gradient of
trophoblast extracellular vesicles seen in uterine vein compared to paired
peripheral blood was only visible when using platelet-poor plasma
(p = 0.002) and was not visible when using platelet-free plasma (the gen-
erally recommended material for plasma microvesicle analysis). Our data
presents an optimised technique for microvesicle detection and also cau-
tions against use of platelet-free plasma since significant signals may be lost.
PS04.06
Nanoarray platform for high-throughput single exosome proteomic
characterisation
Philippe DeCorwin-Martin, Eun Hae Oh, Rosalie Martel and David Juncker
McGill University and Genome Quebec Innovation Centre, Montreal, Canada
Introduction: Extracellular vesicles (EVs) are highly heterogeneous in
their composition, and there is a need to characterise subpopulations of
EVs that may be key in understanding the effects and mechanisms by
which they shape cellular processes. Whereas electron microscopy iden-
tifies single EV, the throughput is too low, yet most other methods only
provide averaged data. Recently significant progress has been achieved
by flow cytometry for high throughput analysis of single EVs. Here, we
propose a nanoarray platform to characterise single exosomes immobi-
lised on a surface in a high-throughput manner and help differentiate
exosome subpopulations.
Methods: A nanoarray of anti-mouse IgG was printed onto a glass slide
using lift-off nanocontact printing, and the surface was passivated before
incubating with mouse monoclonal capture antibodies. The nanoarray
consists of 100 nm spots that capture single exosomes by size exclusion.
They are separated by a 2 mm pitch such that adjacent captured vesicles
can be easily distinguished. Exosome samples, purified from cell super-
natant using ultracentrifugation or size exclusion columns, are incubated
on the nanoarray overnight and detected using a fluorescently tagged
detection antibody. The slide is then imaged on a fluorescent micro-
scope, allowing for up to four fluorescent channels.
Results: Single vesicle capture was demonstrated on the nanoarray in proof-
of-principle experiments using fluorescently labelled liposomes. Vesicles con-
taining down to a few fluorophores could be detected over the background.
Conclusion: The heterogeneity of extracellular vesicles calls for methods
that can measure single vesicles to allow for an accurate description of
vesicle composition. With the nanoarray’s ability to capture single exo-
somes in a high-throughput method and detect up to four different co-
expressed proteins, vesicle subpopulations can now be studied for their
distinct effects in cell processes.
PS04.07
Improved resolution in extracellular vesicle populations using 405 nm
instead of 488 nm wavelength side scatter
Mark John McVey1, Chris Spring2, Vera A. Tang3, Marc-Andre Langlois3 and
Wolfgang Kuebler4
1University of Toronto, Canada; 2Keenan Research Centre (St-Michael’s
Hospital) Toronto, Canada; 3University of Ottawa, Canada; 4Charite
University, University of Toronto, Canada
Introduction: Improvements in identification and functional assessments
of extracellular vesicles (EVs) has led to a recent surge in EV publications
investigating their roles as biomarkers and effectors of disease and repair.
As this area of research evolves, a common limitation to allow meaningful
comparisons is accurate and reproducible enumeration and characterisa-
tion of EVs in biological fluids. High sensitivity flow cytometry (FCM) is a
popular strategy to assess EVs, however an impediment in using FCM is
differing and often limited ability to resolve smaller EVs.
Methods: To address this limitation we propose the use of lasers with
405 nm (violet) in place of 488 nm (blue) side scatter (SSC) detection to
obtain greater resolution of smaller EVs using high sensitivity FCM. To
test this hypothesis we resolved latex and silicone reference beads as well
as biological EVs from plasma and bronchoalveolar lavage fluid (BAL)
using either violet or blue wavelength SSC EV detection and quantified
the change in particle resolution.
Results: Mie scatter modelling reveals violet SSC improves resolution of
small (100–500 nm) spherical particles with refractive indices (1.34–1.46)
similar to EVs by approximately 2 fold in terms of light intensity and a
nearly 20% increase in side scatter signal quantum efficiency. Reference
beads showed improved resolution when detected by violet instead of blue
SSC with nearly twofold decreases in coefficients of variation for
300–500 nm particles, and fivefold for 180–240 nm particles. Similar effects
were seen when resolving EVs from plasma and BAL using both SSC
wavelengths. Specifically, violet SSC detection allowed for greater sampling
of smaller EVs, which is of particular relevance considering nanotracker
analysis revealed in both plasma and BAL that most EVs were <300 nm.
Conclusion: Violet instead of blue SSC detection for high sensitivity FCM
allows significantly greater resolution of EVs in plasma and BAL. The
advantages of violet detection were exaggerated for smaller particles,
hence these insights may prove especially helpful in detection of smaller
EVs. Notably, this simple strategy is readily accessible and inexpensive for
machines equipped with 405 nm SSC or the ability to accommodate appro-
priately positioned 405/10 nm bandpass filters in their detection arrays.
PS04.08
Best before – lyophilisation as novel storage alternative for
extracellular vesicles
Julia Frank and Gregor Fuhrmann
Helmholtz-Institute for Pharmaceutical Research
Introduction: Extracellular vesicles (EVs) are increasingly studied for
biosignalling, pathogenesis and biomedical applications (1). Currently,
the international consensus supports their storage at −80°C (2).
Lyophilisation (freeze-dry) of EV would allow easy handling at room
temperature (RT) and thus significantly boost their expanded investiga-
tion. However, EV behaviour upon lyophilisation remains largely
unknown. We comprehensively evaluated for the first time the freeze-





























drying impact on various EV’s stability and functionality upon model
enzyme loading, and we assessed the effect of cryoprotectants.
Methods: EVs were isolated from 48 h conditioned culture medium by
ultracentrifugation (120,000g, 2 h), loaded with glucuronidase via sapo-
nin treatment (3) and purified by gel filtration (Sepharose CL-2B). EVs
were stored at RT, 4 or −80°C, and lyophilised with/without addition of
mannitol or trehalose, and analysed by nanoparticle tracking analysis
and electron microscopy (TEM, phosphotungstic acid stain). Residual
enzyme activity was assessed with fluorescein glucuronide (37°C) and
compared to liposomes (phosphocholine/cholesterol 60:40 mol%).
Results: After 14 d EV from A549 lung cancer, MSC stem or HUVEC
endothelial cells and liposomes showed average sizes of ~190 nm for all
storage conditions. A 60% decrease in particle number was observed for
A549 EV during freeze-drying compared to storage at −80°C but was
less pronounced for MSC (30%) and HUVEC EV (20%). Addition of
1 wt% mannitol caused cryoprotection and inverted this effect, with EV
morphology not altered as imaged by TEM. The glucuronidase activity
of loaded MSC EV was lost after 14 d of storage but addition of 4 wt%
trehalose induced 80% recovery of enzymatic cleavage comparable to
activity levels of liposomes (70% recovery), indicating that low sugar
concentrations preserve the EV’s functionality.
Conclusion: For the first time, we show that EV have natural stability
during freeze-drying, further optimised by the addition of cryoprotect-
ing sugars. Our findings provide new insight and a firm basis for
exploring lyophilisation as novel EV storage modality.
References
1. Fuhrmann et al., Nano Today 2015; 10: 397.
2. Witwer et al., J. Extracell. Vesicles 2013; 2: 20360.
3. Fuhrmann et al., J Control Release 2015; 205: 35.
PS04.09
EV core – the world’s first technology platform dedicated to
extracellular vesicle isolation and analytics
Maija Puhka1, Mari Palviainen2 and Pia R-M. Siljander3
1Institute for Molecular Medicine Finland FIMM, University of Helsinki,
Finland; 2EV-core, Division of Biochemistry and Biotechnology,
Department of Biosciences/Division of Pharmaceutical Biosciences, Centre
for Drug Research, Faculty of Pharmacy and Institute of Molecular Medicine
Finland FIMM, University of Helsinki, Finland; 3Division of Biochemistry
and Biotechnology, Department of Biosciences/Division of Pharmaceutical
Biosciences, Centre for Drug Research, Faculty of Pharmacy, University of
Helsinki, Helsinki, Finland
Introduction: Extracellular vesicles (EVs) are rich in blood and other
biofluids and as cross-kingdom signalosomes they present both a novel
research target but also ample possibilities for utilisation. Particularly
due to their biomarker potential and the non-invasive availability, EVs
are investigated for diagnostic and therapeutic applications. However,
currently the unmet need for specific analysis instruments, lacking
standardisation and the need for better optimisation in the purification
and basic characterisation of EVs hinders the progress.
Methods: As a novel infrastructure, we have set up an academic, non-
profit EV technology core facility in the University of Helsinki. We offer
an easier access to the state-of-the-art and emerging technologies for
research groups, hospitals and authorities interested in EVs. The exper-
tise of the EV core encompasses: (1) sample handling and storage,
material requirements (plasma, urine, culture media, etc.); (2) EV isola-
tion with ultracentrifugation, chromatography and kits; (3) low-amount
methods: particle size and number, protein, nucleic acid, lipid, metabo-
lite and EM analyses; (4) EV flow cytometry; (5) EV-specific data
analysis/normalisation.
Results: During this first year, we have produced several SOPs for EV
analyses and two new methodologies to improve EV isolation (patent
investigation ongoing) and one method for purity analysis. We have
participated in the development of biological EV reference materials.
Through our clients, we are involved in research projects to which we
contribute various analytical services. We are also addressing several
basic questions from kit comparisons to pre-analytical considerations
for EV isolation (see abstract on plasma vs serum EVs).
Conclusion: While the interest and applications for EV use are exponen-
tially increasing, there is an unmet need to improve and standardise the
basic isolation and characterisation methods and to develop reference
materials to enable intra- and inter-laboratory comparison of results.
Based on our experience so far, there is also an unmet need for such a
core facility helping both newcomers to EV field and the more experi-
enced in need of the specialised EV analyses. An academic EV core
dedicated to these issues can significantly facilitate these important goals.
PS04.10
Large extracellular vesicles dominate the results of immunosorbent
assays
Elmar Gool1, Rienk Nieuwland2 and Frank A. W. Coumans1
1Biomedical Engineering & Physics, Academisch Medisch Centrum; 2Clinical
Chemistry Department, Academisch Medisch Centrum
Introduction: Immunosorbent assays (ISA), such as the enzyme linked
immunosorbent assay (ELISA), are widely used to phenotype extracel-
lular vesicles (EVs). However, EV samples are heterogeneous and it is
unknown to which extent ISA results reflect the antigen exposure of all
EV present in a sample or of a subpopulation. Here we determine the
effect of the EV diameter on the contribution to ISA results.
Methods: A diffusion model was developed to determine the diameter
and amount of EV that are captured by an antibody-coated surface. The
initial EV size distribution for the model was obtained from a condi-
tioned cell culture supernatant, and the EV transport towards the surface
was modelled with 1D particle diffusion described by the Stokes-Einstein
relation. Subsequently, the contribution of the captured EV to the total
number of epitopes was determined by assuming equal antigen surface
density irrespective of the EV diameter.
Results: Small EV, arbitrarily defined as 50–200 nm, outnumbered large
EV (400–1000 nm) by 10-fold in the initial sample. The model deter-
mined that this ratio will increase to 26-fold for captured EV on the
antibody-coated surface. Since small EV diffuse faster than larger EV,
small EV will travel longer distances to the surface. Consequently,
relatively more small EV are captured than larger EV. However, because
large EV have a larger surface area and contain up to 400-fold more
epitopes, our model predicts that large and small EV will contribute to
~48% and ~28% of the total epitopes, respectively. The ratio of epitopes
provided by small and large EV, that contribute to the ISA result, is
thus 0.6.
Conclusion: This theoretical approach demonstrates that ISA results are
influenced by the diameter of EV and mainly reflect the antigen expo-
sure of an EV subpopulation. To validate this finding, we are currently
performing verification experiments. In daily practice, our study indi-
cates that ELISA signals are dominated by epitopes on large EV, whereas
signals from label-free ISA methods will contain an askew contribution
of small EV.
PS04.11
Characterisation of mycobacterial membrane vesicles
Vanessa Chang1, Priscila Dauros-Singorenko2, James Dalton1, Cherie
Blenkiron1,2, Siouxsie Wiles1, Simon Swift1 and Anthony Phillips2,3
1Department of Molecular Medicine and Pathology, University of Auckland,
Auckland, NZ; 2School of Biological Sciences, University of Auckland,
Auckland, NZ; 3Department of Surgery, University of Auckland,
Auckland, NZ
Introduction: Tuberculous and non-tuberculous Mycobacteria release mem-
brane vesicles (MMVs), reported to range from 60 to 300 nm in diameter,
predominantly contain lipoproteins and polar lipids. It is hypothesised that
MVs facilitate delivery of virulence factors and function as “immune decoys”
modulating host immune responses contributing to severe disease.
To better understand MMV biology we undertook the analysis of three
species: Mycobacterium smegmatis (non-pathogenic, fast-grower), M.
abscessus (human pathogen, fast-grower) and M. marinum (fish and
opportunistic human pathogen, slow-grower). The M. marinum-





























zebrafish model has been proposed to be one of the best models to study
human tuberculosis.
Methods and Results: Different MMV parameters including composition,
size, concentration and release with respect to cell growth and viability
were studied. Nanoparticle tracking analysis and electron microscopy
techniques were used to determine MMV concentration and size.
We isolated MMVs with mean diameters between 80–200 nm. SDS-
PAGE protein profiles were similar for three isolations for each species
with interspecies differences. DNA and RNA concentrations between
2–85 and 3–45 µg/ml of original culture respectively were obtained.
Conclusion: MMVs were produced throughout growth, with most
produced at the transition between exponential and stationary
phase. Stationary phase MMVs from M. abscessus were the largest
(~200 nm) and contained more DNA than RNA (~20×) suggesting
the existence of a selective packaging mechanism. MMVs from M.
smegmatis and M. marinum contained equal levels of DNA and
RNA. MMV production was correlated with cell viability using
live/dead staining, showing that MMVs were produced by live cells
suggesting vesicle production could be an active biological process.
Purification of MMVs by density gradient centrifugation showed
distinct MMV rich fractions in all species investigated, with differ-
ent DNA and RNA patterns across the density layers suggesting
heterogeneity among species. In vitro experiments challenging
THP-1 cells with M. marinum vesicles showed that MMVs had a
dose dependent effect on THP-1 cell viability. Further investigation
is required to identify the active MMV components, the mechanism
of killing and to characterise the effects of sub-lethal MMV
challenges.
PS04.12
The use of fluorescent metabolites for the detection of exosomes
from cancer cells
Alan M. Ezrin1, Michael W. Graner2 and Steven G. Griffiths3
1NX Development Corporation; 2University of Colorado Denver, Anschutz
Medical Campus, Dept of Neurosurgery, CO, USA; 3X0S0ME
Introduction: Despite the labyrinthine paths taken to reach malig-
nancy and the multiphenotypic character of individual cancers, all
are affected by dysregulated metabolism. Initially glycolysis and
anaplerotic pathways sustain biosynthetic requirements, mitochon-
drial activity innate or coopted are prequisites for tissue invasion
and metastasis. Ergo beacons of altered metabolism are useful in
cancer detection, location and treatment; a prime example is
FDG PET.
Of particular importance in the tumorigenic metabolic landscape is the
heme pathway: it promulgates carbon fixation, biosynthetic precursors,
redox control and removal of toxic by-products. Glioblastoma manage-
ment has been assisted by water soluble heme precursor 5-ALA
(Gliolan): the drug is converted rapidly in cancer to a fluorescent bottle-
neck metabolite PPIX. The fluorescence enables complete surgical
removal of brain cancer tissue since the metabolite binds to affected
cell membranes. We wondered whether 5-ALA could be used to reveal
evidence of hyperkinetic pathways from source cells or restored in EVs
as markers for cancer detection and treatment.
Methods: EVs were harvested from oncosphere cultures of normal
human astrocytoma and the glioblastoma F3-8, incubated with or with-
out water soluble 5-ALA, by differential centrifugation. EVs were ana-
lysed for canonical proteins by western blot; PPIX presence was
determined by NanoSight LM10 with a cut off filter at 565 nm to exclude
non-specific particles.
Results: EVs were validated through the presence of CD63 and heat
shock proteins among others. Analysis of a suspension of EVs by
Nanosight enabled the identification of aggregates of brightly fluorescent
particles using the 565 nM filter, indicative of origin or that 5-ALA
metabolism can reflect dysregulated metabolism from source cells or via
pathway(s) reestablished extracellularly.
Conclusion: The detection and management of cancer will depend on
identification of key metabolic features by minimally invasive collec-
tion from blood or urine. In this study we demonstrate that it is
possible to detect EVs from cancer cells with accelerated heme meta-
bolism. Thus detection may be realised through administration of
Gliolan to the patient prior to sample collection or mixture of pur-
ified EVs after collection.
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Identification of a novel population of lipid-rich extracellular vesicles
Alanna Sedgwick1, M. Olivia Balmert1 and Crislyn D’Souza-Schorey2
1University of Notre Dame, IL, USA; 2Department of Biological Sciences,
University of Notre Dame, IL, USA
Extracellular vesicles (EVs) comprise a heterogeneous group of cargo-
loaded vesicles, which are released from cells to mediate extracellular
communication in normal physiology and disease. Such diversity in shed
vesicles endows the cell with the ability to react to disparate physiologi-
cal signals via the mobilisation of specific types of vesicles. The two best-
characterised classes of EVs at present are exosomes and microvesicles,
distinguished largely on the basis of size, but each identified with a
unique set of cargo, size profile and mechanism of biogenesis. More
recently, a relatively homogenous population of nanovesicles has also
been described. Using a variety of fluorescence microscopy approaches
and biochemical characterisation we have identified a novel population
of large extracellular vesicles, which are largely devoid of classical mar-
kers used to distinguish the currently characterised EV populations. This
new class of EVs encompasses lipid-rich extracellular vesicles (LEVs),
and is formed at the cell surface in a wide range of cell types and
requires the integrity of the microtubule cytoskeleton. LEVs exhibit
unique morphological features and appear to function in lipid efflux.
These vesicles represent an exciting avenue for future research particu-
larly in diseases whose pathology may be responsive to lipid alterations.
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Bioavailability of bovine milk-derived EVs for drug delivery
application
Masaharu Somiya1, Yusuke Yoshioka2 and Takahiro Ochiya2
1Division of Molecular and Cellular Medicine, National Cancer Center
Research Institute; 2Division of Molecular and Cellular Medicine, National
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Introduction: EVs deliver their cargo to recipient cells and this
ability can be utilized for the delivery system of therapeutic mole-
cules. Some reports revealed that bovine milk is ideal raw material
for the drug delivery application of EVs, since bovine milk is rich in
EVs and widely available. However, toxicity and immunogenicity of
bovine milk-derived EVs (mEVs) are not fully evaluated. In this
study, we isolated mEVs and characterized its protein components.
Furthermore, we determined the bioavailability of mEVs upon sys-
temic administration into mice.
Methods: For the purification of mEVs, defatted bovine milk was treated
with acetic acid to precipitate non-EV proteins, followed by ultracentri-
fugation. Protein components in mEV fraction were determined by
western blotting, proteomic analysis, and ExoScreen method. Cellular
uptake and cytotoxicity of mEVs were evaluated using mouse macro-
phage cell line Raw264.7. After the several intravenous administrations
of mEVs into mice, toxicity, immunogenicity, and anaphylactic reaction
were examined.
Results: Approximately 10 mg of EVs was isolated from one litter of
bovine milk and mEV fraction contains typical EV marker proteins,
such as tetraspanins and Rab family proteins. mEVs showed 120 nm
in diameters and spherical shape. mEVs were efficiently taken up by
Raw264.7 cells in vitro without affecting cell proliferation, suggesting
that mEVs could be used for the delivery of therapeutic molecules. In the
animal experiments, we did not observe any systemic toxicity upon
intravenous administration. Some types of cytokines and chemokines
in blood were slightly increased, however, anaphylactic reaction was not
observed.
Summary/Conclusion: Taken together, mEVs are well-tolerated in the
systemic administration and can be used as safe and cost-effective drug
delivery system.






























Recipient cell organelle separation for EV uptake studies: Tracking of
extracellular vesicles
Ganesh Shelke1 and Jan Lötvall2
1Krefting Research Centre, Institute of Medicine, University of Gothenburg,
Sweden; 2Krefting Research Centre, University of Gothenburg, Sweden
Background: Extracellular vesicles (EVs) such as exosomes and micro-
vesicle are known to delivery cargo like proteins, lipids, RNA, and DNA
to the recipient cells. Transfer of EVs to recipient cells to deliver these
cargos is essential to induce cellular phenotypic changes. Current meth-
ods to localize EVs in recipient cells are restricted to imaging of cells
using co-localization of fluorescent probes. We propose a physical
method that provides high-resolution separation of organelles that can
be associated with EVs recipient cell trafficking.
Methods: EVs were isolated from mast cell line (HMC1.2) by differential
centrifugation (16,500´g 20 min and 120,000´g 3 hr) followed by flota-
tion on iodixanol gradient (182,300´g for 16 hours; SW40-Ti rotor). EVs
were biotinylated by incubating it with EZ-Link Sulfo-NHS-Biotin
(Thermo Scientific) and free biotin was removed by dialysis (3.5 kDa
filter) as per the manufacturer recommendations. Biotinylated-EVs were
later incubated with HEK-293T cells for 60 min, after which cells were
lysed (High salt, high pH buffer and sonication) to obtain crude orga-
nelles. Crude organelles carrying biotinylated EVs were further separated
on iodixanol density gradient with two consecutive ultracentrifugation
steps. Various iodixanol fractions were analyzed using immunoblotting
for lysosomal (LAMP1) and endosomal protein (EEA1), as well as
streptavidin-HRP based detection of EVs-biotin.
Results: High resolution separation of endosomal and lysosomal orga-
nelles fraction was obtained using this method. We found that biotiny-
lated EV proteins were enriched in the endosomal fraction. A small
quantity of biotinylated-EV proteins were also present in lysosomal
enriched fraction.
Summary/Conclusion: Endosomal and lysosomal localization of EVs can
be performed in recipient cell by iodixanol density gradient centrifuga-
tion. EVs were primarily enriched in the endosomal compartment, and
only traces were detected in the endo-lysosomal compartment at the
time point studied.
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Proteomic profiling reveal Src as a novel microvesicle-associated
biomarker for myocardial infarction
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Quantification of the circulating vesicle-bound pools of
adipocytokines reveals that MFG-E8 and MIF are conveyed by
plasmatic EVs
Maeva Durcin1, Marine Malloci2, Luisa Vergori2, Severine Dubois3, Gilles
Simard3, Olivier Hue4, M. Carmen Martinez2, Ramaroson Andriantsitohaina2
and Soazig Le Lay5
1INSERM U1063/University of the French West Indies; 2INSERM U1063;
3INSERM U1063/Angers University Hospital; 4University of the French West
Indies; 5INSERM
Introduction: Obesity-associated metabolic diseases are linked to dysre-
gulated production of many factors secreted by adipose tissue, known as
adipocytokines. Accumulating evidences suggest a role for circulating
extracellular vesicles (EVs), significantly increased in obesity, in obesity-
associated metabolic dysfunctions. Since EVs may convey hormones and
metabolites, we aimed to evaluate their contribution in the secretion of
adipocytokines.
Methods: EV subsets, including microvesicles (MV) and exosomes
(EXO), were isolated from plasma samples collected from patients suf-
fering of metabolic syndrome (MS) and quantified by NTA and flow
cytometry. Patients were classified according to their body mass index
(BMI): control (BMI < 27), overweight (27 < BMI < 30) and obese (BMI
> 30). 22 adipocytokines circulating concentrations were successively
measured on total, MV- and EV-depleted plasma samples by multiplex
immunoassays.
We first showed that circulating MV and EXO populations were sig-
nificantly increased with BMI supporting a role of these vesicles as
metabolic relays in the context of obesity. Multiplex analysis of plasmatic
adipocytokines confirms dysregulated production of these factors with
increased BMI. Sequential depletion of MV and EXO from all plasma
patients did not modify adipocytokine circulating levels, at the exception
of MFG-E8 (Milk Fat Globule-EGF-Factor VIII) and MIF (macrophage
migration inhibitory factor), which were decreased. Of interest, 37.3% of
circulating MFG-E8 and 57.3% of circulating MIF were associated to
EVs. Notably, MFGE-E8 preferentially associated with EXO (24%)
whereas MV carried more than half of circulating MIF (50.6%).
Nonetheless, EV-associated proportions of these two adipokines were
unchanged with obesity suggesting that MFG-E8 and MIF constitutively
used EVs as secretory pathways.
Results: Our results highlight that a significant proportion of MFG-E8
and MIF associate with EXO and MV, respectively, in plasma. Thus, this
study emphasises the importance to consider EV secretory pathways in
the metabolic actions of adipocytokines.
This study was approved by Angers University hospital ethical commit-
tee (NCT: 00997165) and received written consent from patients.
Funding: This work was funded by a research national grant (ANR
MilkChEST n°ANR-12-BSV6-0013-04), by GIS APIS-GENE and the
French Society of Diabetes.
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Adipocyte extracellular vesicles increase leucocyte attachment to
vascular endothelial cells
Rebecca M. Wadey1, Katherine D. Connolly1, Aled Rees2 and Philip James1
1Cardiff Metropolitan University, Cardiff, United Kingdom; 2Cardiff
University, Cardiff, United Kingdom
Introduction: The hypoxic and chronic low grade inflammatory state of
adipose tissue in obesity is associated with an overall increased risk of
cardiovascular disease. The aim of this study was to determine if extra-
cellular vesicles (EVs) derived from adipocytes cultured in a manner that
mimics that of obese adipose tissue, play a functional role in the pro-
gression of cardiovascular disease, by promoting leucocyte attachment to
vascular endothelial cells.
Methods: Differentiated 3T3-L1 adipocytes were incubated for 24 h in
one of four conditions: “control” (serum-free medium (SFM), 95% air/
5% CO2), “TNFα” (SFM plus 30 ng/ml TNFα, 95% air/5% CO2),
“hypoxia” (SFM, 1% O2) or “TNFα & hypoxia” (SFM plus 30 ng/ml
TNFα, 1% O2). EV were isolated from media by ultracentrifugation.
Freshly isolated primary human umbilical vein endothelial cells
(HUVEC) were treated with (and without) EV for 6 h before either
being lysed for western blotting, or used in leucocyte attachment assays.
Results: EV from “TNFα” and “TNFα & hypoxia” treated 3T3-L1 cells,
increased vascular cell adhesion molecule (VCAM) protein expression in
HUVEC, an effect that could be blocked in a dose-dependent fashion
using an anti-TNFα neutralising antibody. No changes in the expression
of other HUVEC adhesion molecules (E-selectin, P-selectin, platelet
endothelial cell adhesion molecule (PECAM) and VE-Cadherin) were
observed in any treatment group. Pre-incubation of HUVEC with
“TNFα” EV and “TNFα & hypoxia” EV increased the subsequent attach-
ment of freshly isolated leukocytes.
Conclusion: EV derived from adipocytes cultured in conditions mimicking
that of obese adipose tissue, induce VCAM expression in vascular endothe-
lial cells in a TNFα-dependantmanner. This predisposes endothelial cells to
the subsequent attachment of leukocytes. Preventing the adipocyte EV-
induced upregulation of endothelial VCAM may offer a novel therapeutic
window for minimising vascular disease in obese patients.
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Diabetes affects extracellular vesicle content and function
Makon-Sébastien Njock1, Mark Chandy2, Shawn C. Veitch2, Dakota
Gustafson2, Zhiqi Chen2, Kim Connelly3, Mansoor Husain2 and Jason E.
Fish2
1Laboratory of Molecular Angiogenesis, GIGA Centre, University of Liège,
Belgium; 2Toronto General Hospital Research Institute, University Health
Network, Toronto, Canada; 3Keenan Research Centre for Biomedical Science,
St. Michael’s Hospital
Introduction: The role of circulating extracellular vesicles in cardiovascular
diseases remains incompletely understood. We previously demonstrated that
extracellular vesicles circulating in plasma of healthy mice can suppress
monocyte activation through transfer of anti-inflammatory microRNAs.
Here we set out to determine the effect of diabetes on the function of plasma
extracellular vesicles since diabetes is known to negatively affect vascular
function, playing a contributory role in cardiovascular diseases.
Methods: Circulating plasma extracellular vesicles were isolated from
mouse and rat models of type 2 diabetes. Extracellular vesicles were
characterised with nanoparticle tracking analysis. Furthermore, qPCR
and RNA-sequencing approaches were used to characterise vesicle con-
tent and function.





























Results: We found that vesicle abundance and size were increased in mouse
and rat models of type 2 diabetes. MicroRNAs in plasma extracellular vesicles
were dysregulated during the progression of diabetes in thesemodels. Finally,
we demonstrate that vesicles isolated from diabetic plasma can activate
inflammatory pathways in endothelial cells. Current studies are seeking to
determine the contribution ofmicroRNA transfer to endothelial dysfunction.
Conclusions: These studies suggest that the microRNA content and
function of extracellular vesicles are dysregulated during diabetes.
Advancements in this area could facilitate the development of more
effective non-invasive diagnostics, prognostics, and therapeutics.
Funding: Supported by funding from the Canadian Vascular Network
and the Canadian Institutes of Health Research.
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Intra-cardiac release of extracellular vesicles governs infiltrating
monocyte activation following myocardial infarction
Xavier Loyer1, Ivana Zlatanova1, Min Yin1, Kiave-Yune HoWangYin1, Cecile
Devue1, Phatchanat Klaihmon1, Coralie L Guerin2, Marouane Kheloufi1, Jose
Vilar1, Bernd Fleischmann3, Philippe Menasché4, Jean-Sebastien Silvestre1
and Chantal M Boulanger1
1InsermUMR970 – Paris Cardiovascular Research Centre (PARCC); 2National
Cytometry Platform, Department of Infection and Immunity, Luxembourg
Institute of Health; 3Institute of Physiology, University of Bonn, Life and
Brain Centre, Medical Faculty, Germany; 4Inserm UMR970 – Paris
Cardiovascular Research Centre (PARCC), Department of Cardiovascular
Surgery, Hôpital Européen Georges Pompidou, APHP, Paris, France
Introduction: A rapid and massive influx of inflammatory cells occurs
into ischemic areas following myocardial infarction (MI). This results in
the local release of cytokines and growth factors, but the mechanisms
regulating their production are not fully explored in the ischemic myo-
cardium. Extracellular vesicle (EV) release in the interstitial space curbs
important biological functions, including inflammation. So far, there is
no evidence of EVs in situ release in the heart following MI. The present
study tested the hypothesis that local generation of EVs in the infarcted
heart coordinates cardiac inflammation following MI.
Methods: MI was induced by permanent left anterior descending artery
ligation in C57BL/6 mice. Sham-operated mice were used as controls.
Sham and MI mice were sacrificed between 0 and 3 days after the onset
of ischemia. EVs from ischemic and sham left ventricles were isolated by
sequential centrifugations, and separated into microvesicle-enriched
(MVs) and exosome-enriched (Exos) fractions. Both fractions were
analysed by TRPS (qNANO). In addition, MVs cellular origin and
phosphatidylserine exposure were determined by flow cytometry.
FACS-sorted Ly6 C+ monocytes were isolated from ischemic myocar-
dium 24 h post-ligation and were exposed in vitro for 24 hours to either
MVs or Exos isolated from MI hearts 24 h post ligation. ELISA assessed
subsequent cytokine release from cardiac-derived monocytes.
Results: Coronary artery ligation in mice transiently increases EV levels
in the left ventricle when compared to sham animals. EVs from infarcted
hearts were characterised as MVs and Exos based on their size (Exos
mean diameter 118 ± 4 nm vs MVs 252 ± 18 nm). Exos fraction was
enriched in the exosomal markers CD63 and CD9. MVs were transiently
release at 15 and 24 h post ischemia and then returned to shams levels.
Exosomes follow similar time-dependent pattern. MVs mostly originated
from cardiomyocytes and increased the release of IL-6, chemokines
CCL2, CCL7 and interleukin-10 from FACS-sorted Ly6C+ cardiac
monocytes. Exos stimulated the release of anti-inflammatory IL-10 only.
Conclusion: These results highlight the paracrine crosstalk between
cardiac inflammatory cells and endogenously released extracellular vesi-
cles following myocardial infarction.
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Acoustic trapping of microparticles and its application in measuring
the effect of bilberry powder consumption on plasma microparticles
in patients with myocardial infarction
Paulina Bryl-Gorecka1, Ramasri Sathanoori1, Rikard Landberg2, Mikael
Evander3, Björn Olde1, Thomas Laurell4, Ole Fröbert5, David Erlinge1 and
Lilith Arevström5
1Department of Cardiology, Clinical Sciences, Lund University, Sweden;
2Swedish University of Agricultural Sciences, Uppsala, Sweden;
3Department of Biomedical Engineering, Lund University, Sweden; 4Lund
University; 5Faculty of Health, Department of Cardiology, Örebro University,
Sweden
Introduction: Microparticles (MPs) are submicron particles released
under several physiological and pathological states. Isolation, enumera-
tion and characterisation of MPs from human plasma are promising
approaches to understand their role in pathophysiology of cardiovascu-
lar diseases (CVD). Current methods are time consuming, and require
large sample volumes, which is a limitation when analysing clinical
samples. Here we have developed an alternative method based on a
microscale acoustic standing wave technology to retain particles in a
microfluidic channel. Bilberries (Vaccinium myrtillum) are known to
improve endothelial function and the antioxidant status. In order to
understand the effect of bilberry powder consumption on circulating
MPs, we analysed plasma samples from myocardial infarction (MI)
patients before and 8 weeks after bilberry powder consumption.
Methods: All participants provided informed consent and the study was
approved by the regional ethics review committee in Uppsala, Sweden.
MPs were isolated from diluted cell free plasma using acoustic trapping.
Briefly, exciting a capillary with a piezoelectric transducer creates a
standing wave that traps MPs together with 12 mm polystyrene seed
particles through acoustic radiation forces. We used an internal control
of pooled frozen plasma from healthy volunteers to validate device
performance. MPs originating from endothelial cells (EMPs) and plate-
lets (PMPs) were enumerated using flow cytometry.
Results: The acoustic trapping method achieved ±52% recovery of
CD42a+ MPs using the internal control. Isolation and enumeration of
EMPs and PMPs in the patient samples showed that bilberry powder
consumption for 8 weeks decreased the levels of both types of MPs.
Summary: The acoustic trapping is a fast and efficient method for
plasma MP isolation. It uses small sample volumes, making it a promis-
ing solution in clinical practice. Bilberry extract consumption decreases
EMP and PMP levels in patients with myocardial infarction.
Financial support: This work was supported by Swedish Foundation for
Strategic Research, Knut and Alice Wallenberg Foundation and Örebro
University Hospital Research Foundation.
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The signature of apoptotic endothelial cell-derived microparticles in
patients with different phenotypes of chronic heart failure
Alexander E. Berezin1, Alexander Kremzer2, Tatyana Samura2 and Tatyana
Berezina3
1Internal Medicine Department, Medical University, Zaporozhye, Ukraine;
2Clinical Pharmacology Department, Medical University, Zaporozhye,
Ukraine; 3Private Hospital VitaCenter, Zaporozhye, Ukraine
Introduction: Chronic heart failure (HF) remains a leading cause of
cardiovascular (CV) mortality and morbidity worldwide. The aim of
the study was to investigate whether the pattern of endothelial progeni-
tor cells (EPCs) with angiogenic capacity and apoptotic endothelial cell-
derived microparticles (EMPs) would be able to differentiate HF with
reduced (HFrEF) and preserved (HFpEF) ejection fraction.
Methods: One hundred and sixty-four chronic HF subjects met inclu-
sion criteria. Patients with global left ventricular ejection fraction
50–59% were categorised as the HFpEF group (n = 79) and those with
≤45% as the HFrEF group (n = 85). The flow cytometric technique was
used for predictably distinguishing circulating cell subsets depending on
expression of CD45, CD34, CD14, Tie-2 and CD309 antigens and
determining endothelial cell-derived microparticles. CD31+/annexin V
+ was defined as apoptotic endothelial cell-derived MPs, MPs labelled
for CD105+ or CD62E+ were determined as MPs produced due to
activation of endothelial cells.
Results: In multivariate logistic regression model T2DM (R2 = 0.26,
p = 0.001), obesity (R2 = 0.22, p = 0.001), previous MI (R2 = 0.17,
p = 0.012), galectin-3 (R2 = 0.67, p = 0.012), CD31+/annexin V+
EMPs to CD14+CD309+ cells ratio (R2 = 0.16, p = 0.001), CD31+/
annexin V+ EMPs (R2 = 0.11, p = 0.001), NT-proBNP (R2 = 0.11,
p = 0.046), CD31+/annexin V+ EMPs to CD14+CD309+Tie-2+ cells





























ratio (R2 = 0.102, p = 0.001), CD14+CD309+ cells (R2 = 0.058, p = 0.001)
and CD14+СD309+ Tie-2+ cells (R2 = 0.044, p = 0.028) were found as
independent predictors of HFpEF. Using multivariate Cox-regression
analysis adjusted aetiology (previous myocardial infarction), cardiovas-
cular risk factors (obesity, type 2 diabetes mellitus) we found that NT-
proBNP (OR 1.08, 95% CI = 1.03–1.12 p = 0.001) and CD31+/annexin V
+ EMPs to CD14+CD309+ cells ratio (OR 1.06, 95% CI = 1.02–1.11,
p = 0.02) remained independent predictors for HFpEF.
Conclusion: We found that CD31+/annexin V+ EMPs to CD14+CD309
+ cells ratio added to NT-proBNP, clinical data, and cardiovascular risk
factors has exhibited the best discriminate value and higher reliability to
predict HFpEF compared with NT-proBNP and clinical data /cardiovas-
cular risk factors alone.
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Identification and characterisation of exosomes derived from blood
outgrowth endothelial cells in oxidative stress conditions
Arief Wibowo and Stefan Janssens
KU Leuven
Introduction: Blood outgrowth endothelial cells (BOECs) mediate ther-
apeutic neovascularisation in experimental models. We hypothesised
that BOECs promote angiogenesis and protect against oxidative stress
via secretion of exosomes.
Methods: BOECs were isolated from the peripheral blood of patients
with severe ischemic heart disease and were exposed to hypoxia (1% O2)
or normoxia (21% O2) for 12 h. Exosomes were isolated from the
medium by differential ultracentrifugation. Size and the number of
exosomes were determined by nano tracking analysis (NTA) and immo-
noblot analysis of the surface markers, TSG101 and Flotilin-1. Matrigel
2D tube formation assay was performed to explore angiogenic potential
of HUVECs in the presence or absence of BOECs-derived exosomes.
qPCR analysis was performed to investigate transcript level of angio-
genic factors both in BOECs and exosomes. In addition, H9C2 rat
cardiomyoblast cells were incubated with PKH67 labelled BOEC-derived
exosomes for 4, 8 and 12 h to assess exosomes uptake. Exosomes
mediated protection against H2O2-induced oxidative stress in H9C2
cells was determined by ROS formation and LDH release.
Results: Quantification of exosomes by NTA showed more exosomes in
the medium after hypoxia compared to normoxia (14.01 ± 0.23 × 108 vs.
12.51 ± 0.23 × 108 particles/ml). Western blot showed exosome markers
TSG101 and Flotilin-1. 2D-Tube formation assay indicated an increased
mature vascular network after 4 h exposure to BOECs-derived exosomes
from both normoxic and hypoxic conditions compared to negative
control (p < 0.001). qPCR analysis demonstrates an expression levels
of 40–60% for angiogenic factors VEGFA, PLGF, MCP-1 and ANG2 in
exosomes compared to BOECs. In addition, exosomes uptake studies
showed that PKH67-labelled exosomes were taken up by H9C2 cells as
early as 4 h. H2O2-induced ROS formation (DCF-DA) and LDH release
were greatly attenuated in exosomes pre-treated (4 h) group demonstrat-
ing exosomes-mediated protection against oxidative stress.
Conclusion: Our results suggest that BOECs-derived exosomes are taken up
by neighbouring cells, induce vascular network formation, and protect
against oxidative stress. Further research is needed to investigate the under-
lying mechanism and potential therapeutic applications of exosomes.
PS05.09
Paracrine effect of GATA-4-modified mesenchymal stem cells on the
angiogenesis is mediated by the transfer of miRs via exosomes
Min Gong1, Bin Yu1, Yigang Wang1, Muhammad Ashraf2 and Meifeng Xu1
1University of Cincinnati, OH, USA; 2University of Illnois in Chicago, OH, USA
Introduction: We previously reported that GATA-4-overexpressing
mesenchymal stem cells (MSCGATA-4) increased angiogenesis in
ischemic myocardium via paracrine effect. Here, we investigated
whether the paracrine effect of MSCGATA-4 is mediated by the transfer
of miRs via exosomes (EXO).
Methods: MSCs were transduced with GATA-4 using the murine stem cell
virus retroviral expression and the conditioned mediumwas collected from
MSCGATA-4 (CdMGATA-4) and its control counterpart MSCnull (CdMnull).
Results:
(1) The total length of capillary-like tubes in human umbilical vein
endothelial cells (HUVEC) and the cumulative sprout length per
HUVEC spheroid treated with CdMGATA-4 were significantly
longer than in those treated with CdMnull. However, the tube-
like formation was reduced significantly in the CdM obtained
from MSCGATA-4 which treated with GW4869 (10μM), an EXO
release inhibitor.
(2) The tube formation was significantly increased in HUVECs treated
with EXO isolated from CdMGATA-4 (ExoGATA-4) than in those
treated with EXO derived from CdMnull (Exonull). The cumulative
sprout length per spheroid was also greater in ExoGATA-4-treated
HUVECs than Exonull-treated cells. Subcutaneous transplantation
of Matrigel plug into mice showed that blood flow and the expres-
sion of endothelial cell marker CD31 was significantly increased in
the plugs containing ExoGATA-4 (100 μg/plug) than in plugs con-
taining Exonull or BSA control.
(3) Real-time PCR indicated that let-7 family is significantly upregu-
lated in ExoGATA-4 compared to that in Exonull. EXO pre-labelled
with PKH26 to track their fate indicated that EXO could be inter-
nalised by HUVECs. The expression of let-7 was significantly
upregulated in HUVECs treated with ExoGATA-4.
(4) Gain-and-loss function studies indicated that the tube-like struc-
ture formation following different EXO treatment was positively
related to the expression of let-7f in HUVECs. Moreover,
thrombospondin 1 (THBS1), an anti-angiogenic gene, was
down-regulated in HUVEC treated with ExoGATA-4 compared
with that treated with Exonull.
Conclusion: These results suggested that the increased pro-angiogenic
capacity of MSCGATA-4 is associated with angiogenetic miRs transfer via
exosomes, which results in regulating the expression of angiogenetic
biomolecules in endothelial cells.
PS05.10
Extracellular vesicles-associated and plasma fatty acid binding
protein 4 (FABP4) fluctuations following bariatric surgery
Justyna K. Witczak1, Thinzar Min2, Sarah Prior2, Jeffrey Stephens2, Philip
James3 and Aled Rees1
1Cardiff University, Cardiff, UnitedKingdom; 2Diabetes ResearchGroup, Swansea
University, Swansea, United Kingdom; 3Cardiff Metropolitan University, Cardiff,
United Kingdom
Introduction: Bariatric surgery markedly reduces fat mass which results
in various cardiometabolic benefits but the effect of weight loss on
circulating extracellular vesicles (EVs) remains unclear. We sought to
characterise changes in circulating EVs in patients undergoing bariatric
surgery with particular focus on changes in adipokine content of
plasma EVs.
Methods: Plasma EVs were isolated by differential ultracentrifugation
from individuals undergoing bariatric surgery (n = 20,
BMI = 54.1 ± 12.6 kg/m2) at baseline, 1- and 6-months postoperatively.
EV concentration was established using Nanoparticle Tracking Analysis.
EV origin (CD9: exosome, CD41: platelet, CD235a: erythrocyte, CD11b:
leucocyte, CD144: endothelial), cytokine (interferon γ, interleukin-6,
TNFα) and adipocyte marker (adiponectin, FABP4, PPARγ) expression
was measured by 96-well plate immunophenotyping assay, and com-
pared with plasma adipocytokine levels.
Results: EV concentration and distribution of the principal EV cell-of-
origin markers (CD41, CD235a, CD11b, CD144) did not alter in
response to surgery, however a significant reduction in EVs measuring
between 100 and 200 nm in diameter at 6 months compared to baseline
was observed (p < 0.001). EV-derived Fatty Acid Binding Protein 4
(FABP4) increased at 1 month (by 49%) before returning to baseline
by 6 months (−51.2%, p < 0.05), corresponding to similar changes in
circulating plasma FABP4 (+21.9% and −24.1% at 1 and 6 months,
respectively, p < 0.001). Plasma FABP4 also correlated with plasma
free fatty acids (FFA’s) at 1 month (p < 0.05). There were no differences
in EV-expressed interferon ϒ, interleukin-6, TNFα, adiponectin, PPARϒ





























or CD9. Plasma concentration of IL-6 and adiponectin did not differ
either (p = ns). CD9 expression correlated with EV-expressed FABP4
(r = 0.5, p < 0.001), adiponectin (r = 0.59, p < 0.0001), TNFα (r = 0.53,
p < 0.0001) and interferon ϒ (r = 0.41, p < 0.005) suggesting an EV
population of exosomal rather than microvesicle origin transports these
proteins predominantly.
Conclusion: Transient rise in EV-associated and plasma FABP4 secre-
tion following bariatric surgery reflects postoperative changes in adipose
tissue homeostasis which are most likely triggered by increased lipolysis.
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Small EVs related to T-cell-mediated inflammation and vascular
function are increased in familial hypercholesterolemia
Morten Hjuler Nielsen1, Rikke Baek2, Malene M. Jorgensen2 and Aase
Handberg1
1Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg,
Denmark; 2Department of Clinical Immunology, Aalborg University
Hospital, Aalborg, Denmark
Introduction: Low-grade inflammation and endothelial dysfunction
predisposes to atherosclerosis in familial hypercholesterolemia (FH),
especially when associated with high levels of oxLDL cholesterol.
Activation of both innate and adaptive immune responses against
oxLDL is the major cause of inflammation, and extracellular vesicles
(EVs) released from both non-immune and immune cells may have
important roles in the pathogenesis. The aim of our study was to
investigate small EVs derived from endothelial cells and cells involved
in the adaptive immune response in subjects with subclinical
atherosclerosis.
Methods: Thirty FH patients and 23 controls were included. Intima-
media thickness (IMT), a marker of subclinical atherosclerosis,
plasma levels of oxLDL and two inflammatory markers (CRP and
IL-6) were determined. The EV Array was used to phenotype small
EVs. The array containing antibodies targeting proteins expressed on
both B- and T-cells, as well as endothelial cells, captured small EVs/
exosomes, which were visualised by a cocktail of biotin-conjugated
CD9, CD63 and CD81 antibodies. The study was approved by the
local ethical committee and informed consent was obtained before
inclusion.
Results: FH patients had significantly higher IMT, and higher
levels of oxLDL and IL-6. In addition, FH patients had significantly
higher level of EVs expressing exosome specific markers CD9, CD63
and CD81, but not TSG101, Alix or Flotilin-1. The T-cell-specific
markers CD28, CD4 and CTLA-4 were increased in FH, whereas
B-cell-specific markers CD19 and CD80 were unaltered. The
endothelial cell-specific markers E-selectin, VE-Cadherin, tPA and
THBS1 were increased in FH, whereas VCAM-1 and MCAM were
unaltered.
Conclusion: Our findings support increased activity of cells involved in
adaptive immunity and endothelial dysfunction in subclinical athero-
sclerosis. Further studies may improve our understanding of pathophy-
siology and holds the potential to provide better risk assessment in the
future.
PS05.12
Exosomal miRNA profiles in patients with coronary artery disease
Melanie Maerte1, Dominik Buschmann2, Marlene Reithmair3, Florian
Brandes1, Benedikt Kirchner2, Alexander Chouker1, Michael Pfaffl2 and
Gustav Schelling1
1Department of Anaesthesiology, University Hospital, Ludwig-Maximilians-
University, Munich, Germany; 2Division of Animal Physiology and
Immunology, TUM School of Life Sciences Weihenstephan, Technical
University Munich, Germany; 3Institute of Human Genetics, University
Hospital of Ludwig-Maximilians-University Munich, Munich, Germany
Introduction: Cardiovascular diseases (CVDs) are the number 1 cause of
death globally. People with CVDs or who are at high cardiovascular risk
need early detection and concise management. Liquid biopsies assessing
exosomal microRNA (exmiRNA) profiles could represent a useful tool
for diagnosis and monitoring of patients with CVDs. We aimed at
identifying differentially regulated exmiRNAs between patients with
coronary artery disease (CAD, n = 6) and age and gender matched
healthy controls (HCs, n = 7), and detecting previously unknown
CAD-associated exmiRNAs.
Methods: Exosomes were isolated from serum samples. The presence of
exosomes was confirmed by electron microscopy, nanotracking analysis
and western blot. ExmiRNAs were profiled by next-generation sequen-
cing. Informed consent was obtained from all study subjects and the
investigation was approved by the local IRB.
Results: In CAD patients, a total of 5 and 11, respectively, distinct
exmiRNAs were down- and upregulated compared to HCs. With the
exception of miR-320a, a known key regulator of multiple aspects of
atherogenesis, these differentially regulated exmiRNAs had not been
previously associated with CAD. In silico analysis demonstrated
target genes of the identified exmiRNAs with critical regulatory
functions in CVDs. These included serum response factor (SRF),
hypoxia-dependent regulators of myocardial cell differentiation
(MYOCARDIN), risk factors for atherosclerotic vascular disease
(TGBR2) and IGF1R signalling, an important predictor of myocar-
dial stem cell growth potency and outcome of cardiac revascularisa-
tion surgery.
Conclusion: This study identified miRNA expression profiles from
blood-derived exosomes in CAD suggesting novel approaches to diag-
nosis and monitoring of patients with CVDs.
PS05.13
Preconditioning affects the miRNA composition of cardiac cell-
derived EVs
Sebastian Borosch1, Eva Dahmen1, Christian Stoppe2, Eva Buhl3, Christian
Beckers1, Bernd Denecke4, Andreas Goetzenich1, Rüdiger Autschbach1 and
Sandra Kraemer1
1Department of Thoracic and Cardiovascular Surgery, University Hospital
RWTH Aachen, Aachen, Germany; 2Department of Intensive Care Medicine,
University Hospital RWTH Aachen, Aachen, Germany; 3Electron
Microscopy Facility, University Hospital RWTH Aachen, Aachen, Germany;
4Interdisciplinary Centre for Clinical Research, University Hospital RWTH
Aachen, Aachen, Germany
Introduction: To protect the heart from ischemia reperfusion injury,
preconditioning with brief cycles of hypoxia or volatile anaesthetics
like isoflurane is a promising technique. In this context, communication
between different cardiac cells and their exchange of proteins, lipids and
especially miRNA by EVs has come into focus of our research. miRNAs
have been shown to facilitate cardioprotective properties by inducing
cardiomyocyte proliferation or regulating neovascularisation. However,
it still remains elusive whether specific preconditioning stimuli trigger
the release of EVs with cardioprotective properties.
Methods: Primary rat cardiac fibroblasts were preconditioned with
either isoflurane (1.5 Vol%, 4 h) or hypoxia (<1% O2, 1 h).
Supernatants were collected after 48 h and EVs were isolated by size-
exclusion chromatography. Particles were characterised by tunable resis-
tive pulse sensing (TRPS) and electron microscopy. miRNA was isolated
from EVs and an affymetrix miRNA microchip array was performed.
Results: Preconditioning triggered the release of EVs with an altered
miRNA composition compared to untreated cardiac fibroblasts even
though vesicle number was not affected. Microarray analysis revealed
that preconditioning with isoflurane significantly regulated 14 miRNAs.
Out of these, 9 (e.g. miR-351 (p = 0.008), miR-384-3p (p = 0.04) and
miR-352 (p = 0.01)) have been described in the context of cardioprotec-
tion. Hypoxic stimulation affected 11 miRNAs in total and out of these
7, for example miR-761 (p = 0.04), with cardioprotective properties.
Additionally, several miRNAs from the let 7 family like let-7a-1-3p
(p = 0.01) were significantly regulated by both treatments.
Conclusion: The miRNA cargo released after a preconditioning stimulus
is strongly dependent on the applied stimulus indicating different sort-
ing and loading mechanisms. Preconditioning probably influences the
loading of cardioprotective miRNAs in EVs which in turn might indicate
a role in cardioprotection.






























Characterisation of inside-out erythrocyte microvesicles in sickle cell
blood
Rachel A. Smith1, Tosti Mankelow2, Rebecca Griffiths2, Sara Trompeter3 and
David Anstee2
1University of Bristol, United Kingdom; 2NHSBT; 3University College
Hospitals London, United Kingdom
Introduction: Elevated levels of circulating red cell microvesicles (RMVs)
have been observed in sickle cell disease (SCD) patients. These RMVs
express phosphatidylserine (PS) which is thought to contribute to the
pro-inflammatory state associated with SCD. The majority of studies on
SCD RMVs have only measured Glycophorin A (GPA) expression but
did not examine other membrane proteins. Recently, “inside-out” micro-
vesicles were observed to be present in SCD erythrocytes (1). To exam-
ine whether “inside-out” microvesicles can be detected in SCD plasma,
this study examines the expression of intracellular (IC) domains of red
cell membrane proteins on the surface of RMVs.
Methods: Blood was collected from SCD patients receiving regular transfu-
sion therapy. RMVs attached to red cells were analysed by confocal micro-
scopy and RMVs in plasma were analysed by flow cytometry using Annexin
V and fluorescent labelled antibodies against IC domains of GPA and C,
Anion exchanger-1 (Band 3), and Glucose transporter-1 (GLUT-1). Size
distribution of RMVs was assessed by flow cytometry using commercial
standards.
Results: In agreement with published results (1), SCD patients had elevated
numbers of red cells with an attached RMV which stained positive for IC
protein domains, compared to healthy donors. This indicates that these
RMVs have an inside-out orientation. RMVs in SCD plasma were found to
exist in two distinct populations. Both populations expressed PS alongside
extracellular GPA and Band 3 and were shown to be >0.5 μm to <1 μm in
size. However, one population also stained positively for IC domains of GPA
and C, Band 3, and GLUT-1. This sub-population is present in negligible
amounts in plasma from healthy donors.
Conclusion: This study is the first to examine the presence of IC mem-
brane proteins on RMVs in plasma from SCD patients. A subset of plasma
RMVs were found to stain positively for IC domains of red cell proteins.
However, these RMVs also expressed extracellular protein domains so it is
unclear whether the RMV membranes are inside-out or these microvesi-
cles, once released from reticulocytes, become permeable to antibodies.
The RMVs in plasma are smaller than inside-out vesicles emerging from
reticulocytes suggesting membrane instability in the circulation.
Reference
1. Mankelow TJ et al., Blood 2015; 126: 1831–1834.
LBP.46
miR-193 is released by cardiomyocytes in response to stress and
inhibit fibroblast proliferation and activation
Mun Chun Chan1, Olivia Ziegler2, Rodosthenis Rodosthenous3, Kirsty
Danielson4, Ravi Shah3 and Saumya Das2
1Georgetown University, DC, USA; 2Mass General Hospital, MA, USA;
3MGH; 4University of Dunedin, New Zealand
Introduction: Plasma microRNA-193 appears to be increased in
human patients with cardiomyopathies and after cardiac injury.
However, its functional role in modulating cardiac remodeling has
not been studied. Previous studies have shown intercellular commu-
nication between cardiac myocytes and fibroblasts. Here we describe
the regulation of miR-193a primary cardiomyocytes and define its
role in mediating signaling between cardiac myocytes and
fibroblasts.
Methods: Experiments were conducted with isolated neonatal rat
ventricular myocytes (NRVMs) and neonatal rat cardiac fibroblasts
(CFs). The regulation of miR-193 in NRVMs in response to
hypoxia/re-oxygenation and its effects on CF phenotype was studied.
LNA-miR193a mimic (gain-of-function) and LNA-anti-miR193a
(loss-of-function) were used to further analyze the role of
miR-193a in mediating intercellular signaling between NRVMs
and CFs.
Results: 1. NRVM expression and secretion of miR-193a in EVs
increases in response to hypoxia/re-oxygenation. 2. CFs treated with
hypoxia-treated NRVM conditioned-media show an increase in miR-
193a levels (but not pre-miR-193a), and this is abrogated by pre-
treatment of NRVM-derived EVs with RNAse in combination with
detergent. 3. Treatment of CFs with CM-conditioned medium and
EVs leads to inhibition of CF proliferation and activation in response
to TGF-beta and angiotensin II. This phenotype is recapitulated with
direct transfection of miR-193a mimic, but abrogated by silencing of
miR-193a in NRVMs. 4. Bioinformatics analysis identified several
targets of miR-193a and qRT-PCR confirmed a marked decrease in
ERBB4 and ARHGAP19 at the mRNA and protein level suggesting
novel regulatory pathways in fibroblast biology in the context of
cardiac remodeling.
Summary/Conclusion: Extracellular miR-193a is altered in human
cardiovascular diseases and appears to be dynamically regulated by
the stress of hypoxia/re-oxygenation in cardiac myocytes. miR-193a
appears to be secreted in EVs and may mediate intercellular commu-
nication between myocytes and fibroblasts to regulate fibrosis, a
critical process in cardiac remodeling.
Funding: NIH NCATS UH3TR000901 to SD.
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Significant increase of blood exosomes in pulmonary vein as
potential prognostic biomarker for lung cancer patients
Byeonghyeon Choi1, Yu Hua Quan2, Jiyun Rho2, Xu Rong2, Kook Nam Han2,
Sunghoi Hong3, Yeonho Choi4, Yong Park5, Ji Ho Park6, Young Ho Choi2
and Hyun Koo Kim2
1Korea University; 2Department of Thoracic and Cardiovascular Surgery, Korea
University GuroHospital, Korea University College ofMedicine, Seoul, Republic
of Korea; 3School of Biosystem and Biomedical Science, Korea University,
Republic of Korea; 4Department of Bioconvergence Engineering, Korea
University, Republic of Korea; 5Division of Haematology-Oncology,
Department of Internal medicine, Korea University Anam Hospital, Korea
University College of Medicine, Republic of Korea; 6KAIST, Republic of Korea
Introduction: Previous researches have demonstrated that the level of
exosomes is increased in cancer patients than healthy controls. This
study was conducted to evaluate the variation of exosome-count in the
proximal tumour-drainage vessel and peripheral vessels during surgery
for VX2 rabbit lung cancer model and primary lung cancer patients.
Methods: A total of 6 rabbits were used in this study (3 in normal group,
3 in lung cancer group). Rabbit VX2 lung cancer model was made by
computed tomographic (CT) guided injection of VX2 cancer. Blood was
sampled from rabbit ear vein (peripheral vein) and pulmonary vein
(proximal tumour-drainage vein). A total of 3 controls and 6 patients
with primary lung cancer who had pT2aN0 and underwent lobectomy
were selected. For each patient, 3 ml of blood was sampled from the
radial artery before surgery and from pulmonary vein during surgery.
Normal blood was collected from peripheral vessels. Exosomes were
isolated by serial centrifugation followed by ExoQuick and quantitative
analysis was performed by NTA and western blot.
Results: Exosome-count was not different in normal rabbits according to
blood sampling sites (peripheral: 2.78 × 108 particles/ml, pulmonary:
2.64 ×v108 particles/ml, p = 0.104). But, in VX2 rabbit lung cancer
model, exosomes were increased by 623.5% in peripheral vein
(1.73 × 109 particles/ml, p = 0.003) and 787.9% in pulmonary vein
(2.08 × 109 particles/ml, p = 0.001) comparing to those of normal.
And, we confirmed that exosomes in VX2 lung cancer model was
increased by 120.0% (p = 0.05) on the proximal tumour-drainage vein
than peripheral vessel. In human blood, peripheral blood exosomes were
increased by 216.7% in cancer patient in comparison with controls
(2.44 × 108 particles/ml in control, 5.3 × 108 particles/ml in patients,
p = 0.04). And, exosomes were significantly increased by 542.1% in
pulmonary vein (3.0 × 109 particles/ml, p = 0.01) comparing to periph-
eral vessels in cancer patients.
Summary: We firstly demonstrated that the increase of exosome was
more prominent in tumour-drainage veins than peripheral vein in
animal cancer models and lung cancer patients. We suggest that increase
of exosomes from tumour-drainage veins may provide more relevant
prognostic information of the lung cancer patients comparing to those
from peripheral vein after surgery.
PS06.02
The effect of erythrocyte-derived microvesicles on the malignant
potential of gastric and colorectal cancer
Daiki Matsubara, Tomohiro Arita, Daisuke Ichikawa, Hirotaka Konishi,
Katsutoshi Shoda, Shuhei Komatsu, Atsushi Shiozaki, Shinpei Ogino, Yuji
Fujita, Toshiyuki Kosuga, Hitoshi Fujiwara, Kazuma Okamoto and Eigo Otsuji
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural
University of Medicine, Kyoto, Japan
Introduction: Exosomes are small membrane vesicles of endocytic origin
secreted by most cell types. They play important roles in intercellular
communications and also influence cancer survival or outgrowth in
malignancies. Besides, several studies suggest that bone-mallow-derived
cell, such as many types of blood cells, contribute to cancer develop-
ment. In this study, the effects of erythrocyte-derived microvesicles
(EDMs) on the progression of gastric and colorectal cancer cells were
investigated.
Methods: Peripheral blood samples of gastric and colorectal cancer
patients were collected before surgical resection. After centrifugation of
whole blood, erythrocytes were cultured in exosome-free medium for
24 h. The culture medium was filtered through 0.22 μm filter and
ultracentrifuged. An obtained pellet was washed with PBS, and ultra-
centrifuged again. The Pellet was resuspended in PBS and stored at −80°
C. Presence and deliveries into various cells of EDMs were confirmed by
immunofluorescence staining. The effects of EDMs on the malignant
potential of gastric and colorectal cancer cells were investigated in
invasion, migration and wound healing assays.
Results: EDMs were labelled with PKH67 and the delivered EDMs were
detected in the cellular cytoplasm using fluorescence microscopy. EDMs
obtained from colon cancer patients enhanced the motility of colon
cancer cells in wound healing assays. Invasion and migration assays
were also performed for gastric cancer cells with gastric cancer
patients-derived EDMs. These assays revealed that EDMs obtained
from gastric cancer patients enhanced the migration ability of gastric
cancer cells.
Conclusion: Microvesicles secreted from erythrocytes of gastric and
colorectal cancer patients may promote the malignant potential.
Further studies are in progress to fully elucidate the role of EDMs in
cancer survival or outgrowth.
PS06.03
Isolation and characterisation of extracellular vesicles from patient-
derived primary high-grade serous ovarian cancer cells
Laura Lehtinen1, Parvez Syed2, Rainer Lehtonen3, Sampsa Hautaniemi3, Aled
Clayton4 and Olli Carpèn5
1Department of Pathology, University of Turku and Turku University
Hospital, Turku, Finland, 2Department of Biochemistry/Biotechnology,
University of Turku, Finland, 3Research Programmes Unit, Genome-Scale
Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland,
4Division of Cancer and Genetics, School of Medicine, Cardiff University
and Velindre Cancer Centre, Cardiff, United Kingdom, 5Department of
Pathology, University of Helsinki and Helsinki University Hospital,
Helsinki, Finland
Introduction: Ovarian cancer is prime example of a disease, in which
increased molecular knowledge has not yet translated to outcome improve-
ment: therefore novel approaches are needed. Most studies on high-grade
serous ovarian cancer (HGS-OvCa) concentrate on the genetic background
and characterisation of cell subpopulations inside the tumours, while a
critically important step in disease progression, the discussion between
tumour cells and surrounding stroma, has gained less attention.
According to current knowledge, extracellular vesicles (EV) provide inter-
cellular communication between tumour and stromal cells. The content of
EVs shed by cancer cells differ from normal cells, but the correlation with
tumour characteristics and clinical data remains unknown.
Methods: Primary ovarian cancer cell lines were established from fresh
HGS-OvCa tumours and ascites fluids. The study protocol and use of all
material was approved by local ethical committees and comply with the
Declaration of Helsinki. For isolation of EVs, primary cells were cultured in
Integra bioreactor flasks, conditioned culture media was collected and
subjected to sequential centrifugations and filtering followed by ultracen-
trifugation with sucrose cushion. The isolated EVs were analysed with
nanoparticle tracking analysis and transmission electron microscopy, and
characterised for the presence of protein markers with western blotting and
ELISA assays. For further characterisation, RNA was extracted from the
EVs and the cargo composition explored with Next-generation sequencing.
RNAseq data was also obtained from the cell lines and original tumours.





























Bioinformatic analyses are currently performed to compare the EV RNA
profile to the original cells and tumour samples.
Results: We have successfully isolated significant amounts of highly pure
EV samples from primary ovarian cancer cells. Preliminary results
indicate variance in EV shedding between different primary cell lines.
In addition, analysis of surface protein markers showed differences in
the expression of Epcam and ITGA3, both with previous implications in
malignant tumours.
Conclusion: This study indicates differences in EV composition between
HGS-OvCa primary cell lines. Comprehensive results of these analyses
will be presented in the meeting.
PS06.04
Extracellular vesicles have a functional role in the aggressive
behaviour of young women’s and postpartum breast cancer
Troy B. Schedin1, Kimberly R. Jordan1, Jessica Hall1, Kirk Hansen1, Pepper
Schedin2 and Virginia F. Borges1
1University of Colorado, CO, USA; 2Oregon Health & Science University,
OR, USA
Introduction: Young women’s breast cancer (YWBC) affects 27,000 US
women under age 45 annually. Half of these cancers occur within 5 years
of childbirth, termed postpartum breast cancer (PPBC), which is associated
with a 3-fold increased risk of metastasis and death. Extracellular vesicles
(EVs) released by cancer cells are found in the peripheral blood of cancer
patients and alter both the local tumour microenvironment and establish
distant metastatic niches. EVs isolated from aggressive breast cancer cell
lines increase proliferation and invasion of less invasive breast cancer cells
in vitro. However, the impact of EVs isolated from breast cancer patients is
largely unknown. We hypothesised that EVs from YWBC/PPBC patients
contain pro-metastatic cargo, influence breast cancer cell behaviour and
induce genetic changes in recipient cancer cells.
Methods: EVs were isolated using size-exclusion chromatography (SEC)
from plasma of 10 healthy young women and 20 YWBC patients
balanced for parity, age, subtype and stage. EV proteins from various
clinical groups were compared using a basic proteomics approach and
the functional impact of these EVs was determined using tumour cell
motility, proliferation, and gene expression assays.
Results: We identified 22 proteins that were significantly increased in the
EVs of YWBC compared to the healthy donor group. Eight proteins
were significantly increased in PPBC EVs, providing novel breast cancer
biomarkers in a clinically high-risk patient cohort. YWBC EVs are
engulfed by BC cells in vitro and increased the proliferation and inva-
siveness of ductal carcinoma in situ, DCIS, cells in both 2D scratch
wound and 3D organoid assays. Furthermore, gene expression was
altered in DCIS cells after exposure to YWBC EVs, demonstrating the
functional capability of EVs produced by breast cancer cells.
Conclusion: EVs isolated from YWBC & PPBC cases have unique
protein content and increase breast cancer invasiveness. EV’s isolated
from YWBC & PPBC cases alter gene expression in non-invasive DCIS
cells, thereby promoting tumour cell proliferation and invasion. These
results suggest potential mechanistic roles for EVs in the increased
metastatic risk groups of YWBC and PPBC and provide potential
novel candidate targets for intervention.
PS06.05
Analysis of biodistribution and cellular uptake of B16BL6-derived
exosomes in relation to their biological effects on tumour progression
Akihiro Matsumoto1, Yuki Takahashi1, Makiya Nishikawa1, Kohei Sano1,
Masaki Morishita1, Chonlada Charoenviriyakul2, Hideo Saji1 and
Yoshinobu Takakura1
1Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto,
Japan; 2Kyoto University, Kyoto, Japan
Introduction: A growing body of evidences has revealed that cancer cell-
derived exosomes play important pathophysiological roles in tumour
progression. However, in vivo behaviour of cancer cell-derived exosomes
are scarcely investigated so far although it is one of the most important
factors in understanding their roles. In the present study, we focused on
the biodistribution of exogenously administered exosomes derived from
murine melanoma B16BL6 cells in relation to their biological effects on
tumour progression.
Methods and Results: Addition of B16BL6-derived exosomes to B16BL6
cells increased proliferation and inhibited apoptosis, which was corre-
lated with the changes in the intracellular amounts of proliferation- and
apoptosis-related proteins. Addition of GW4869, an inhibitor of exo-
some secretion, reduced the proliferation of B16BL6 cells, which was
restored by the addition of B16BL6-derived exosomes to cells. After
intratumoral injection of radiolabeled B16BL6-derived exosomes to
mice, most radioactivity was detected in the tumour tissue.
Fractionation of the cells in the tumour tissue revealed that exosomes
were mainly taken up by B16BL6 cells. Moreover, intratumoral injection
of B16BL6-derived exosomes promoted tumour growth while that of
GW4869 suppressed the tumour growth.
Conclusion: These results indicate that cancer cells efficiently take up
their own exosomes to induce tumour progression.
PS06.06
Characterisation of DNA from cancer cell-derived extracellular
vesicles
Yumi Kawamura1,2, Yusuke Yamamoto1, Taka-Aki Sato2 and Takahiro
Ochiya1
1Division of Molecular and Cellular Medicine, National Cancer Centre
Research Institute, Japan; 2Ph.D. Programme in Human Biology, School of
Integrative and Global Majors, University of Tsukuba, Japan
Introduction: The composition of genetic material in extracellular vesi-
cles (EVs) has sparked interest particularly in the potential for horizontal
gene transfer by EVs. Several reports have demonstrated the presence of
mitochondrial DNA, single-stranded DNA and double-stranded DNA in
EVs. However, the localisation of DNA in EVs has been unclear, in
addition to their functionality in EV-recipient cells. The aim of this
study was to examine the DNA content of cancer cell-derived EVs
(termed EV-DNA) in order to understand their physiological signifi-
cance in the cancer microenvironment.
Methods: EVs were isolated from human cancer cell lines HCT116 and
MDA-MB-231 by ultracentrifugation, and characterised by western blot
and nanoparticle tracking analysis. EVs were untreated or pretreated
with Exonuclease III or DNase I prior to DNA extraction. DNA con-
centration and size distribution was compared between untreated and
pretreated EV groups. EV-DNA was assessed for specific sequences
by PCR.
Results: Cancer cell-derived EVs purified by ultracentrifugation were
abundant in DNA. For instance, KRAS mutations were present in EV-
DNA, reflective of the parental cell lines HCT116 and MDA-MB-231. In
addition to this, it was found that high copies of retrotransposon DNA
sequences were found in EV-DNA. However, the pretreatment of EVs
with Exonuclease III and DNase I before DNA extraction significantly
decreased the concentration and size distribution of EV-DNA, indicat-
ing that DNA is mostly present on the outer surface of EVs.
Interestingly, retrotransposon sequences were detected in EVs after
DNase I treatment.
Conclusion: Here we show that DNA is abundant on the outer surface of
cancer cell-derived EVs. Although it is still unknown whether EV-DNA
can be integrated into the genome of the recipient cell, it is likely that
EV-DNA may cause phenotypic changes that promote tumour growth in
neighbouring cells. Further investigation into the functionality of genetic
material in EVs will help to better define their roles in disease progres-
sion and their potential use as circulating biomarkers.
PS06.07
Investigating the involvement of macroautophagy in exosome
production
Jing Xu1, Shane Colborne1, Elham Hosseini-Beheshti2, Emma Guns3, Gregg
Morin1 and Sharon Gorski1
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Research, NSW, Australia; 3Vancouver Prostate Centre, Vancouver, Canada
Introduction: Macroautophagy (hereafter autophagy) is a cellular cata-
bolic process wherein a portion of cytoplasm containing proteins and
organelles is digested via engulfment in double-membrane autophago-
somes and subsequent fusion with lysosomes. This degradative role of
autophagy can support cell survival under stress by recycling cellular
content for energy and building blocks. Autophagy also contributes to
many other processes and interacts with other cellular pathways.
Autophagosomes are known to fuse with multivesicular bodies
(MVBs), sites of exosome biogenesis, to form amphisomes. However,
the relationship between autophagy and exosome production remains
poorly understood. In triple-negative breast cancers (TNBCs), a subtype
of breast cancer lacking oestrogen, progesterone and HER2 receptors,
both autophagy flux and exosome production were shown to increase in
response to stress. Therefore we investigate the interrelationship between
autophagy and exosome release using TNBC as a model.
Methods: TNBC cell line MDA-MB-231 was used for initial character-
isation of exosomes and autophagy levels. Conditioned media from 48 h
of serum-free incubation was pre-cleared using differential centrifuga-
tion and concentrated using centrifugal filtration. ExoQuick reagent was
used to precipitate exosomes. Western blotting of known markers,
NanoSight and transmission electron microscopy were used to charac-
terise the exosomes isolated. Mass spectrometry was used to identify
exosomal proteins.
Results: We observed increased autophagy flux in TNBC cell line MDA-
MB-231 after 48 h of serum starvation. Treatment with lysosomal
inhibitor chloroquine blocked autophagy and altered exosomal protein
cargo. Autophagosome-associated proteins were identified in MDA-MB-
231 derived exosomes, suggesting that the autophagy process and exo-
some release might be interconnected.
Conclusion: Macroautophagy is closely related to the endocytic pathway
via the multivesicular body, and may contribute to exosome cargo.
Further studies are underway to investigate the exosomal protein con-
tent from TNBC cells with both early and late-stage autophagy blockade.
Funding: This work is supported by CIHR in partnership with Avon
Foundation for Women.
PS06.08
Packaging of specific mRNA into extracellular vesicles using human
endogenous retroviral elements
Kristina P. Friis1, Romy Verschoor1, Leonora Balaj1, Rafael Contreras-
Galindo2, David M. Markovitz2 and Xandra O. Breakefield1
1Department of Neurology and Radiology and Program in Neuroscience,
Massachusetts General Hospital and Harvard Medical School, Boston, MA,
USA; 2Department of Internal Medicine, University of Michigan, Ann Arbor,
MI, USA
Introduction: Human endogenous retroviruses (HERVs) belong to the
group of LTR retrotransposons. These highly mobile elements are scat-
tered throughout our genome and are remnants of ancient viral infec-
tions. Today HERVs constitute 8% of our genome and help maintain the
genetic heterogeneity. Being unable to create replication-competent ret-
roviruses, they are still capable of forming viral-like particles (VLPs).
Interesting, these HERVs have been found to be highly enriched in the
tumour extracellular vesicles (EVs) compared to their cells of origin.
Previous reports have shown that these mobile elements can be trans-
ferred in vitro from medulloblastoma cells to normal human umbilical
vein endothelial cells (1). Hence, we are now investigating the potential
use of these HERV elements to increase the packaging specificity and
transfer of mRNA through EVs.
Methods: The assay is based on the packaging and transfer of a neomycin
reporter gene (neo) using the BOGOTA construct (2). BOGOTA includes
parts of the HERV-K packaging signal and has previously been shown to
increase the amount of neo transferred and hence expressed in VLPs.
Results: Several cell lines have been screened for high HERV expression,
and when combined with the expression of BOGOTA preliminary
studies indicate that BOGOTA increases the selective packaging of the
reporter mRNA into EVs. The selective packaging and transfer is further
improved when co-expressing the HERV proteins known to be involved
in VLP organisation and packaging, and especially when focusing on the
HERV Env-expressing subpopulation of EVs.
Conclusion: The selective packaging of specific mRNA into EVs using
BOGOTA in cell lines with a high expression of HERVs supports future
studies to determine the role of retrotransposon transfer in tumorigen-
esis, and as a potential means of generating therapeutic vehicles utilising
viral packaging signals.
References
1. Balaj L et al. Nat Commun. 2011; 2: 180.
2. Contreras-Galindo R et al. J Virol. 2015; 89: 7187–7201.
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Extracellular vesicle treatment of cholangiocarcinoma cells affects
genes of epithelial-mesenchymal transition and cell survival
Ahmet Canbazoglu1, Ozlem Kucukoglu1, Verena Boerger2, Jan-Peter Sowa1,
Guido Gerken1, Bernd Giebel2,3 and Ali Canbay1,4
1Department of Gastroenterology and Hepatology, University Hospital
Essen, University Duisburg-Essen, Essen, Germany; 2Institute for
Transfusion Medicine, University Hospital Essen, University of Duisburg-
Essen, Essen, Germany; 3Department of Laboratory Medicine, Karolinska
Institutet, Stockholm, Sweden; 4Department of Gastroenterology,
Hepatology and Infectious Diseases, Otto-von-Guericke University,
Magdeburg, Germany
Introduction: Cholangiocarcinoma (CCC) is a malignancy of epithelial
biliary cells with a survival rate of less than 5% at 5-years. The cause for
CCC remains mostly unclear.Extracellular vesicles (EVs) produced by
healthy or tumour cells are known to affect their cellular environment.
In the present study influence of EVs from cholangiocyte cell types on
tumorigenesis or metastasis formation via an epithelial-mesenchymal
transition (EMT) was analysed.
Methods: EVs released from the H69 cell line, mimicking healthy human
cholangiocytes,and from TFK-1 cholangiocarcinoma cells were isolated
by ultracentrifugation and characterised by nanoparticle tracking analy-
sis (NTA). H69 and TFK-1 cells each were treated with EVs released
from both cell lines separately. Intake of EVs by cells was visualised with
PKH67 and PKH26 under a confocal super-resolution microscope
(Zeiss, LSM710). Cell proliferation was assessed with MTT assay and
gene expression levels of EMT markers (E-cadherin, N-cadherin,
S100A4), genes of sonic Hedgehog signalling(PTCH1, Gli), and cell
death receptors (DR4, Trail) were analysed by qrtPCR.
Results: EVs secretion of TFK-1 cells was 2.5 fold higher than from H69
cells. Treatment of TFK-1 cells with H69-EVs resulted in a significant
reduction of EV release (p = 0.02). In parallel TFK-1 cell proliferation
was repressed by H69-EVs (MTT). Conversely, TFK-1-EVstreated H69
cells released 1.5 fold more EVs than without treatment. In TFK-1 cells
treated with H69-Evs expressions of EMT markers were slightly shifted
towards a more epithelial phenotype (n.s.). DR4 (p = 0.03) and TRAIL
(p = 0.09) expressions increased in H69-Evs treated TFK-1 cells.
Expression of Gli was reduced (p = 0.07). In contrast H69 cells treated
withTFK-1 derived EVs exhibited reduced E-cadherin (p = 0.04) and
elevated N-cadherin (p = 0.001) and S100A4 (p = 0.01)expressions.
Expression of DR4 was decreased in TFK-1-Evs treated H69 cells
(p = 0.03). The necrosis marker HMGB1 was reduced in H69 cells
treated with TFK-1 EVs (p = 0.002).
Conclusion: EVs from cholangiocarcinoma cells alter gene expression of
cholangiocytes towards apoptosis resistance and an EMT-like gene
expression. Conversely, EVs from healthy cholangiocytes increase
death receptor expression in cholangiocarcinoma cells.
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The role of extracellular vesicles in advanced prostate cancer
progression
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Introduction: Androgen deprivation therapy (ADT) remains the current
palliative treatment of choice for patients with prostate cancer, despite
its ass ociation with multiple negative side effects. While ADT is initially
effective in treating prostate cancer and metastatic prostate cancer, these
cells are able to adapt such that the androgen receptor (AR) signalling
axis remains active. This AR signalling continues to control cell prolif-
eration and survival, leading to the development of castrate resistant
prostate cancer (CRPC).
Methods: We first discovered that hormonal stimuli of AR expressing
cells alter the protein and miRNA content of small EV. This occurs
through upregulation of CD9 positive (CD9+) EV secretion, influencing
the AR signalling axis. We have shown that CD9+ EV were able to drive
cellular proliferation in charcoal stripped serum (CSS), indicating that
EV can drive cellular proliferation and survival irrespective of the pre-
sence of androgens (1–3). Our most recent studies show that cells
undergoing inhibition of AR signalling using Enzalutamide display a
unique protein and miRNA profile in small EV subpopulations, which
differs to that seen in CSS grown cells. Proteomic analysis of EV from
Enzalutamide treated cells also does not detect multidrug resistant
associated proteins, implicating unique pathways driven by EV towards
CRPC progression. Assessment of CD9+ EV is relevant to advanced
prostate cancer progression as our recent clinical data has found that the
CD9+ EV level is significantly higher in plasma from patients with
advanced metastatic prostate cancer who have detectable circulating
tumour cells than in those who do not. We propose that CD9+ EV
contribute towards the progression of CRPC, allowing prostate cancer
cells to grow despite AR targeted therapy.
Results and Conclusion: Further targeted studies will provide a biologi-
cal understanding on the role of EV in the AR signalling axis, enabling
the design of novel EV based therapeutics to target CRPC.
Grant support: The US DoD PCRP Postdoctoral Training Award
[W81XWH-12-1-0047] and Idea Development New Investigator
Award (W81XWH-15-PCRP-IDA) for CS, the Movember Global
Action Plan (GAP1) for PJR, CCN, CS.
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Introduction: Extracellular vesicles (EVs) are important mediators of cellular
signalling, affecting processes such as cancer development. Internalisation of
EVs can prompt functional changes in the recipient cells depending on the EV
composition and origin. We hypothesised that the EVs derived from
metastatic cancer cells could induce malignant properties in the recipient
cells. To address this question, internalisation (uptake kinetics, effect of cell
cycle) and functional effects (proliferation and migration) of EVs derived
from metastatic and primary prostate cancer (PCa) cells and benign prostate
cells were analysed.
Methods: EVs were isolated from LNCaP, PC-3, RC92a/hTERT and
PNT2 cells by differential centrifugation at 20,000g for microvesicles
and 110,000g for exosomes. Size and morphology of EVs were charac-
terised by transmission electron microscopy and nanoparticle tracking
analysis, and the presence of CD9, CD63, and HSP70 was analysed by
western blotting. EVs were labelled with fixable lipophilic dyes. EV
uptake was determined by high content microscopy, flow cytometry,
and confocal microscopy. Cell cycle, proliferation and migration were
analysed to evaluate the functional effects of the different EVs on
recipient cells.
Results: EVs derived from LNCaP and PC-3 cells of metastatic origin were
internalised by the recipient cells (PCa and benign) more efficiently than
the EVs derived from primary cancer RC92a/hTERT cells or benign PNT2
prostate cells, as shown by flow cytometry and high content microscopy. No
differences were detected in the internalisation rate of microvesicles and
exosomes. Further analysis of EV uptake and cell cycle revealed higher EV
numbers in the G2/M cells than in the G0/G1 or S cells, indicating that the
cell cycle may play a role in active EV uptake. Metastatic cell-derived EVs
from PC-3 and LNCaP cells prompted more proliferative and migratory
behaviour in the recipient cells (PCa and benign) compared to the EVs
derived from primary cancer or benign cells.
Conclusion: These results show that the uptake and functional capacity
of EVs depends on the metastatic state of the parent cells, encouraging
more research into the EV-mediated mechanisms that promote tumour
spread and metastasis in the tumour microenvironment.
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Introduction: We previously developed a new extracellular vesicle (EVs)
isolation method, which in turn yields what we term tissue-exudative
EVs (Te-EVs) from surgically resected viable clear cell renal cell carci-
noma (ccRCC) tissues and adjacent normal renal tissues. LC/MS analysis
revealed that azurocidin (AZU1) was enriched in ccRCC Te-EVs com-
pared to normal renal Te-EVs (p = 2.85 × 10–3, fold-change = 31.59).
Importantly, AZU1 was specifically detected in serum EVs from ccRCC
patients but not from healthy control serum. In this study, we examined
whether EV-AZU1 detected in ccRCC patient serum and ccRCC Te-EVs
were derived from ccRCC cells. In addition, we searched the AZU1
sorting mechanism into EVs focused on AZU1 glycosylation.
Methods: We attempted to detect ccRCC cell-derived EV-AZU1 from
AZU1-FLAG-xenografted mouse serum. PNGaseF was used for an EV
deglycosylation assay. Furthermore, tunicamycin-treated ccRCC cells
were analysed for western blot analysis and immunocytochemistry.
Results: AZU1 was detected in serum EVs and tumour Te-EVs obtained
from AZU1-FLAG-xenografted mice. To identify the ccRCC cell-specific
sorting mechanism of AZU1 into EVs, we focused on glycosylation
status of EV-AZU1. An EV deglycosylation assay revealed that EV-
AZU1 from ccRCC cells was enriched for N-linked oligosaccharides.
Moreover, inhibition of N-linked glycosylation using tunicamycin sig-
nificantly inhibited AZU1 amount on EVs in a dose dependent manner
while the total particle number was not affected. Immunocytochemistry
analysis revealed that tunicamycin changed AZU1 cellular localisation
from golgi apparatus to throughout the cell.
Conclusion: In this study, we successfully detected EV-AZU1 from
AZU1-FLAG-xenografted mouse serum, suggesting that EV-AZU1 was
secreted by ccRCC cells and thus could be a potential biomarker for
ccRCC. Moreover, we found that glycosylation of AZU1 is a key reg-
ulator, which in turn promotes sorting AZU1 into ccRCC-specific EVs.
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Matrix stiffness and extracellular vesicle release
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Introduction: Substrate stiffness dictate cellular function. In-vivo, cells
proliferate in varying tissue mechanics, from bone hard stiffness to
ultrasoft lung mucosa. Traditional biologists tend to ignore these differ-
ences. To our knowledge, this is the first study to investigate extracel-
lular release dependence on cells cultured at varying substrate stiffness.
Methods: Mouse renal adenocarcinoma cells (RENCA) were used in this
study. Cells were cultured on polydimethylsiloxane (PDMS) coated
dishes. Rigidity of the culture surface was varied by using varying
proportions of PDMS to catalyst ratios.
Cell viability and DNA damage were measured by Real-time GLO MT
and SyTox Green cytotoxicity assay respectively. CD63 ELISA was
performed using a CD63 TRIFic exosome assay. BCA assay was used
to measure protein concentrations. Vesicles were separated by sequential
ultracentrifugation. Briefly, cell debris was removed at 1000g, microve-
sicles were separated at 10,000g and extracellular vesicles were collected
at 100,000g centrifugation steps.
Results: The prepared PDMSmatrices represented 4 different stiffness values.
The matrix stiffness for the substrates ranged from 3 gigaPascals (for poly-
styrene dish) to 200 kiloPascals (PDMS 40). Cell viability was highest for the
stiffest substrate, polystyrene, and reduced with softer substrates. However,
microvesicle yield varied less than 10% between the different substrates. Total
extracellular release from the cells was within 5% variation for all but the
softest, 200 kiloPascals (PDMS 40) substrate. The exosome assay however,
revealed that the CD63 positive population of the extracellular vesicles, was
released increasingly from more complaint matrices.
Summary/Conclusion: Our results show that cell attachment to matrix,
which depends highly on the matrix rigidity, reflect the extracellular-
vesicle release from the cells. This is important when comparing vesicle
release from cell types originating from different tissue types, having
intrinsic matrix attachment needs.
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Introduction: Oral leukoplakia (OLK) is the most common premalignant
disorder of the oral mucosa. Although histopathological analysis of biopsies
showed that OLK-associated epithelial dysplasia is an important predictive
factor of malignant transformation, saliva biomarkers to predict oral cancer
development are lacking. Exosomes are nano-sized vesicles that are shed by
producer cells and released into body fluids including saliva. Exosomes con-
tain a complex mixture of microRNAs, mRNAs and proteins from the cell of
origin, making them an ideal source for biomarker discovery and diagnostic
development. Our goal was to characterize saliva exosomes and profile their
microRNAs from patients with OLK, epithelial dysplasia and oral cancer.
Methods: Diagnosis of OLK, epithelial dysplasia or oral cancer was made
on oral mucosal biopsies. Two ml whole-saliva from patients or normal
individuals was collected, and exosomes were isolated. The concentra-
tion of exosomes was measured with Nanosight LM10 Instrument. Saliva
exosomes carried cancer associated microRNAs were assessed using
quantitative PCR. The expression of miR-185 was further evaluated by
in situ hybridization (ISH) in oral mucosal specimens resected from
patients with OLK, dysplasia or cancer.
Results: The patients with epithelial dysplasia has significantly higher con-
centration of saliva exosomes compared to OLK or normal control (mean
1.74 folds), while saliva exosome concentration in oral cancer patients was
significantly decreased (mean 4.21 folds). The changes of exosomal
microRNA levels in epithelial dysplasia or oral cancer include upregulation
of miR-185, miR-200b, miR-29b, miR-409 and down regulation of miR-21,
miR-320, and miR-486, with miR-185 demonstrating highest relative fold-
changes in epithelial dysplasia and oral cancer compared to oral leukopla-
kia. ISH analysis confirmed remarkably increased expression of miR-185 in
epithelial dysplasia and oral cancer patients compared to OLK patients.
Summary/Conclusion: Dynamic changes occur in saliva exosome con-
centration and exosomal microRNA content from epithelial dysplasia
and oral cancer patients. Quantification of saliva exosome or their
carried microRNAs may serve as ideal biomarkers in cancer risk assess-
ment in oral leukoplakia patients.
Funding: Supported by NSFC
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Introduction: Glioblastomas (GBMs) are the most common forms of
malignant tumors of the central nervous system with a poor prognosis.
Currently GBMs are diagnosed using magnetic resonance imaging (MRI)
and validated by an invasive intracranial biopsy. The incidence of tumor
recurrence and response to cancer treatment are also tracked by MRI,
however, this imaging modality has numerous limitations. There remains
an urgent need to develop non-invasive biomarkers for diagnostics and
theranostics. GBMs release large amounts of EVs into the blood repre-
senting a rich source of biological information for biomarker discovery.
The proteomic and mRNA profiles of EVs from GBMs have been studied,
the metabolic profile of GBM-derived EVs is lacking, although cellular
metabolomics analysis has shown distinct subtypes of GBMs.
Methods: In this study we used 3 different human GBM cell lines (U118, LN-
18 andA172), isolated EVs and analyzed theirmetabolite content usingNMR
spectroscopy. GBM cells were cultured in serum-free medium for 72 h and
exosomes were isolated by differential centrifugation followed by filtration.
The clarified conditionedmediumwas concentrated and the supernatant was
ultracentrifugated to pellet exosomes. GBM exosomes expressed the pan-
exosomemarkers, CD9, CD63 and TGS101.Metabolites were extracted from
parental cells, media and exosomes. 1D and 2D NMR spectra were analyzed
qualitatively and quantitatively.
Results: NMR metabolomics has shown distinct profiles for cells, exosomes
and media in all three cell lines. Qualitative, PCA and OPLS investigation
showed over all differences in the three groups of sample sources and sample
types and suggested possiblemetabolites of interest.Metabolite quantification
using multivariate linear regression method developed in our group allowed
determination of specific metabolic differences and suggested possible mar-
kers of exosomes originating from different GBM cell lines.
Summary/Conclusion: Metabolomics analysis of exosomes provides
interesting markers of GBM cellular subtypes. Analysis in patients’
samples is in planning stage.
Funding: National Research Council of Canada
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Introduction: EVs are attractive sources of biomarkers, because EVs that are
produced fromdisease cells, such as cancers, can havemolecular signatures of
the producing cells. However, most EV-based biomarker candidates that
have been identified until now are from cell culture-derived EVs and might
not be valid markers for actual human disease. Here, we have isolated EVs
directly from tumor tissues and analyzed the EV membrane proteome to
describe biomarkers.
Methods: EVs were isolated frommelanoma metastatic tissues and three cell
lines, by differential centrifugation and density gradient. Membrane proteins
of isolated EVs were analyzed by mass spectrometry. Through the bioinfor-
matics analysis, biomarker candidates were selected. Selected candidates were
validated both in isolated EVs and in plasma ofmelanoma patients by ELISA.
Results: Enrichment of mitochondrial membrane proteins was revealed
in melanoma metastatic tissue-derived EVs, compared to non-mela-
noma-derived EVs. Further, we discovered that patients with metastatic
malignant melanoma have increased concentrations of mitochondrial
membrane protein containing EVs in plasma.
Summary/Conclusion: Our results show the ability of cells to release
extracellular vesicles that carry multiple mitochondrial components,
including several mitochondrial membrane proteins, and this rare sub-
population of EVs may be used as a novel biomarker for melanoma.
Funding: This work was funded by the Swedish Research Council (K2014-
85X-22504-01-3), VBG Group Herman Krefting Foundation for Asthma
and Allergy Research, the Swedish Heart and Lung Foundation (20120528),
the Swedish Cancer Foundation (CAN2014/844), and Basic Science
Research Program through the National Research Foundation of Korea
(NRF) funded by the Ministry of Education (2016R1A6A3A03007377)
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Introduction: EVs are known to act as endogenous carriers of a wide
range of proteins and nucleic acids, subsequently delivered to recipient
cells. Hence, EVs hold great potential as being exploited as delivery
vehicles of therapeutic agents. In the current study, we have investigated
the EV-mediated delivery of oncolytic adenovirus and paclitaxel.
Methods: The A549 lung cancer cell line was used to produce EVs contain-
ing oncolytic adenovirus (EV-Vs) as well as control EVs. EV-Vs and EVs
were incubated in 10 µM paclitaxel (PTX) solution to produce correspond-
ing PTX complexes (EV-V-PTXs and EV-PTXs respectively). Test prepara-
tions produced were characterized using nanoparticle tracking analysis
(NTA) and electron microscopy. In vitro virus transduction efficiency and
cytotoxicity in A549 cells was assessed. Furthermore, an in vivo efficacy
study using a lung cancer xenograft in BALB/c nude mice, was performed.
Results: A significant increase in virus transduction efficiency was
observed in cells when treated with EV-Vs or EV-V-PTXs. Indeed, the
viability of cells treated with EV-Vs or EV-V-PTXs was shown to be
significantly lower than that observed in virus treated cells. In vivo, EV-
V treatment was shown to control tumor growth better than virus alone.
Summary/Conclusion: In conclusion, the EV-mediated delivery of onco-
lytic adenovirus and paclitaxel could be a promising novel strategy for
cancer targeted drug delivery.
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Introduction: Phosphorylation and dephosphorylation are important
processes related to post-translational modifications which influence
cell signaling pathways, and when deregulated are related to diseases.
Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP) is
upregulated in several cancers, including colorectal cancer (CRC), and
it has been correlated with aggressiveness, chemoresistance and poor
prognostic. Extracellular vesicles (EVs) have gained attention in cancer
research due to their role in cell-to-cell communication and tumorigen-
esis. This study aimed to examine whether the LMWPTP could take part
in EVs biogenesis and/or secretion in CRC cell lines.
Methods: HCT116 and HT29cells were purchased from BCRJ (Brazil)
and then routinely grown in McCoy5A media. Western Blot (WB) was
performed to analyze LMWPTP and EVs biogenesis proteins expression.
For EVs isolation, cells were cultured in filtered-serum-free McCoy5A
media for 12 hours. After, the EVs were isolated by ultracentrifugation
(UC) and Total Exosome Isolation Reagent kit (TEI, Invitrogen).
Nanoparticle tracking analysis (NTA) was performed to achieve concen-
tration and size.
Results: WB analysis showed that LMWPTP is overexpressed in HT29
compared to HCT116 as well as EVs biogenesis related proteins LAMP-
1, LAMP-2, HRS, STAM-2, Flotillin-1, Rab5, Rab7, Rab11 and Rab35
were highly expressed in HT29 vs HCT116; while TSG101 and ALIX
were lower expressed in HT29. EVs isolated by UC and TEI methods
showed that the culture media from HT29 displayed higher concentra-
tion of EVs than HCT116.
Summary/Conclusion: This study show, for the first time, that the LMWPTP
might be associated to EVs biogenesis or trafficking mechanisms, once its
higher expression is related to high amount of EVs from HT29 cells.
Furthermore, it was observed higher expression of proteins involved in
biogenesis and trafficking in HT29 compared with HCT116. These findings
indicate an application potential of this enzyme in the EVs research.
Funding: Grant 2016/02770-6, São Paulo Research Foundation
(FAPESP).
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Introduction: Colorectal cancer (CRC) is the third most frequent cause
of cancer-related death in Western countries. Interestingly, the expres-
sion level of a fibroblast-specific gene set shows strong correlation with
patient survival in CRC. Furthermore, the activation of fibroblasts is
generally considered a major factor in their tumor growth-promoting
function. Here we studied whether fibroblast activating factors lead to an
increased EV production and whether increased fibroblast-derived EV
release may have an impact on CRC survival.





























Methods: We analyzed publicly available gene expression data, normal
colon- and CRC patient-derived fibroblasts. Our studies were approved
by an ethics committee and informed consent was obtained. We mea-
sured the EV production of the fibroblasts by qNano as well as by bead-
based methods using low and high resolution flow cytometry.
Results: Both normal colon-derived (NCF) and CRC patient-derived (CAF)
fibroblasts were CD63high/CD81high/CD9low. While NCFs and CAFs
secreted CD63+ and CD81+ small EVs, large Annexin V+ EVs were hardly
detectable. Interestingly, major fibroblast activating molecules such as TNF
alpha or TGF beta, did not increase the EV production of either NCFs or
CAFs. Furthermore, bioinformatics analysis of publicly available gene
expression data did not reveal a significant correlation between the expres-
sion level of genes involved in EV biogenesis and the risk of disease relapse
in CRC patients. These genes also showed unchanged or decreased expres-
sion levels in CRC patients compared to normal colon samples.
Summary/Conclusion: Our data suggest that the amount of fibroblast-
derived EVs may not be critical in patient survival in CRC. However,
changes in their molecular content require further detailed analysis.
Funding: This work was funded by the Semmelweis University Faculty
of Medicine Starting Grant and the OTKA-NN (118018) by the National
Research, Development and Innovation Office (Hungary). Z.W. is sup-
ported by the János Bolyai Fellowship (Hungarian Academy of Sciences).
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possible causative agent of prostate cancer via over-expression of
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Introduction: Prostate cancer (PCa) is the most common non-cutaneous
cancer, which is a main cause of morbidity and mortality in men in
western countries. In various PCa cases, PCa patients were reported to
be related with Propionibacterium acnes (P. acnes), which was human
normal flora found throughout gastrointestinal tract and skin tissues.
Methods: In this study, we targeted P. acnes-derived extracellular vesicle
(PaEV) that might cause over-proliferation of prostate cells thereby,
cause prostate cancer. The PaEVs were isolated by the ultracentrifuga-
tion of P. acnes culture media and characterized as previously described.
Results: Through in vitro and in vivo studies, we confirmed immunogenicity
of PaEV, and we showed that it induced the over-expression of androgen
receptor (AR) which caused persistent proliferation of prostate cells. The
PaEV increased the production of pro-inflammatory mediators (IL-1β, IL-6,
TNF-α) by raw264.7 as dose dependent manner. After intraperitoneal injec-
tion, the PaEVs induced strong expression of AR in the prostate tissue of
mice but peptidoglycan (PGN) and lipoteichoic acid (LTA) did not.
Summary/Conclusion: In conclusion, these results show the possibility that
PaEVs are a novel causative agent being able to induce prostate
carcinogenesis.
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Introduction: Tumor invasion and metastasis can be mediated by the
distribution of tumor-derived extracellular vesicles, which carry oncogenic
material. Tumor cells can also undergo non-apoptotic membrane blebbing
to form large extracellular vesicles (EVs) known as large oncosomes (LOs)
that are between 1 to 10 µm in diameter. Amoeboid phenotype associated
with LO formation can be induced with Epidermal Growth Factor (EGF)
treatment and knockdown of DIAPH3, an actin-nucleating protein. LO
formation has not yet been described in thyroid cancer.
Methods: Anaplastic thyroid cancer (ATC) and papillary thyroid cancer
(PTC) cell lines (TPC-1, BCPAP, C643, SW1736) were used to study LO
formation. PTC and ATC lines were cultured with no treatment, treated
with epidermal growth factor (EGF), or subjected to DIAPH3 knockdown
using siRNA. Cells and LOs were stained with Cholera Toxin subunit B to
visualize the membrane using fluorescence microscopy. LOs were also
measured by flow cytometry (LSR Fortessa). LOs were separated from
supernatant components by low-speed centrifugation or by a centrifugation
and filtration strategy, and RNAwas isolated fromLOs and cells for miRNA
profiling using custom TaqMan low density arrays.
Results: LO formation was detected in four thyroid cancer cell lines
using both fluorescence microscopy and flow cytometry. Treatment of
EGF caused an increase in the amoeboid phenotype and LO production
in all four cell lines, with a more striking change in phenotype occurring
in the PTC lines. Moreover, knockdown of DIAPH3 increased LO
formation in all lines.
Summary/Conclusion: LO production in thyroid cancer cell lines can be
detected using microscopy and flow cytometry. Treatment of EGF and
DIAPH3 knockdown both resulted in an increased amoeboid phenotype,
implying that thyroid cancer LOs form in a manner similar to previously
studied LOs in prostate cancer. Future directions include identifying
quantitative differences of LO production between the different thyroid
cancer cell lines as well as characterizing the protein and RNA content
within the LOs.
LBP.56
A potential exosome biomarker for non-small cell lung cancer by
proteomics analysis
Hyesun Jeong1, Byeonghyeon Choi2, Jik Han Jung3, Jaena Park4, Yong Park5,
Ji Ho Park3, Yeonho Choi6, Hyun Koo Kim7 and Sunghoi Hong8
1Korea University Department of public health, Korea University, Seoul 136-701,
Republic of Korea; 2Korea University, Seoul, Republic of Korea; 3KAIST, Seoul,
Republic of Korea; 4Korea University, Seoul, Republic of Korea; 5Division of
Hematology-Oncology, Department of Internal medicine, Korea University
Anam Hospital, Korea University College of Medicina, Seoul, Republic of Korea;
6Department of Bioconvergence Engineering, Korea University, Seoul, Republic of
Korea; 7Department of Thoracic and Cardiovascular Surgery, Korea University
Guro Hospital, Korea University College of Medicine, Republic of Korea; 8School
of Biosystem and Biomedical Science, Korea University, Seoul, Republic of Korea
Introduction: Exosomes are cell-derived vesicles, which are ranged from 50 to
150 nm size, that are secreted in perhaps all eukaryotic fluids, such as blood,
urine and cell culturemedium. Since they have specialized functions and play
a role in many biological processes such as intercellular signaling, there is a
growing interest in the clinical applications of exosomes such as diagnostic
biomarkers for cancer.
Methods: Exosomes from Non-small cell lung cancer (NSCLC) cells and
Human Pulmonary Artery Endothelial Cell (HPAEC) were isolated by
column liquid chromatography and analyzed by Dynamic Light
Scattering (DLS), Nanoparticle Tracking Analysis (NTA) and western-
blotting (CD63). The exosomes were lysed and applied to proteomic
analysis.
Results: Five proteins were identified in NSCLC exosomes but not
HPAEC. One of them was dramatically increased in NSCLC cell
lines- and NSCLC patients-derived exosomes but not normal
HPAEC by our quantitative RT-PCR and western blot. The protein
was named as lung cancer exosome-specific protein 1 (LESP1),
which is involved in endosome-to-Golgi transport. Summary/
Conclusion: The protein, LESP1, may be a potential biomarker for
NSCLC diagnosis. Funding: This research was supported by a grant
of the Korea Health Technology R&D Project through the Korea
Health Industry Development Institute (KHIDI), funded by the
Ministry of Health & Welfare, Republic of Korea (grant number:
HR14C0007).






























Comparative analysis of EV gene products to subcellular fractions in a
K-562 human lymphoblast cell model
Fabio Alexis Lefebvre1, Juan-Carlos A. Padilla2, Neal Cody3, Louis Philip
Benoit Bouvrette1, Janusz Rak4 and Eric Lécuyer5
1Institut de Recherche Clinique de Montréal (IRCM), Montréal, QC, Canada;
Département de Biochimie, Université de Montréal, Montréal, QC, Canada;
2Institut de Recherches Clinique de Montréal (IRCM), Montréal, QC,
Canada; Division of Experimental Medicine, McGill University, Montréal,
QC, Canada; 3Icahn School of Medicine, Mount Sinai, New York, NY, USA;
4Montreal Children’s Hospital, Research Institute of the McGill University
Health Center, Montreal, QC, Canada; 5Institut de Recherches Clinique de
Montréal (IRCM), Montréal, QC, Canada; Département de Biochimie,
Université de Montréal, Montréal, QC, Canada; Division of Experimental
Medicine, McGill University, Montréal, QC, Canada
Background: Efforts in the study of extracellular vesicles (EVs) have
revealed diverse species of gene products being shuttled out of many
cell models. Although much effort has been placed in the characteriza-
tion of EVs contents, less attention has been given to investigating the
subcellular targeting of gene products to EVs. Here, we report a large-
scale comparative analysis of protein and RNA contents in different
subcellular fractions versus those found in EVs.
Methods: EVs were isolated from human K-562 lymphoblast cells by
differential centrifugation of cell culture media at 110,000 × g for 60
minutes. Subcellular fractions were isolated from pelleted cells using a
validated biochemical approach with the use of a sucrose cushion tech-
nique to isolated nuclear and cytosolic fractions, and Titron-X to sepa-
rate membrane and insoluble fractions. The isolated fractions and EVs
were subject to proteomic profiling using liquid chromatography-tan-
dem mass spectrometry (LC-MS/MS), while RNA distribution was ana-
lysed through deep sequencing of long and short RNAs.
Results: Out of 3355 identified proteins, only 31 were ubiquitous across
all studied fractions, suggesting that there is a strong spatial asymmetry
in the distribution of these proteins. On the other hand, pairwise corre-
lative analysis of Exponentially Modified Protein Abundance Index (%
emPAI) values revealed linear and ordinal associations among the pro-
teomic signatures of EVs and the cytosolic fraction. RNA distribution
analysis showed that transcripts found in EVs were poorly expressed in
total cell extracts (Kruskal-Wallis test; P≤10−4), while exhibiting distinc-
tive functional signatures. Analysis of the cytotopic distribution of small
regulatory RNAs revealed that read length distributions were distinctive
and reproducible across fractions, and similarities in the content of EVs
and the cytosolic fraction were observed.
Summary/Conclusion: Our comparative analysis point to a semi-selec-
tive model of targeting and incorporation of gene products into EVs,
which is highlighted by the spatial asymmetry of protein distribution
among subcellular fractions, and the association of proteomic and RNA
signatures between EVs and the cytosolic fraction.
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LBP.58
Characterization of extracellular vesicle (EV) concentration and size
distribution following pathogen inactivation treatment of platelet
components
Paula Saá1, Tracey Díaz2, Felicia Santa María2, Anoop Pal3, Gary Holley1,
David Krysztof1, Adonis Stassinopoulos2 and Susan Stramer1
1American Red Cross; 2Cerus Corporation; 3Izon Science
Introduction: New strategies have been developed to inactivate infectious
agents in blood. Cerus’ INTERCEPT™ Blood System for platelet components
combines amotosalen with Ultraviolet (UVA) illumination to specifically
target nucleic acids and irreversibly cross-link or form adducts on these
molecules, thereby blocking pathogen replication. The efficacy and safety of
amotosalen/UVA treated platelet and plasma components has been broadly
investigated, the effects on EVs and their biological activity have not been
extensively explored.
Methods: Apheresis platelet concentrates (PCs) in 100% plasma were col-
lected from healthy donors and pathogen inactivated following standard
procedures. To evaluate changes in EV size and concentration, a control
sample aliquot was removed from the PCs after amotosalen addition, but
before UVA illumination. PCs were then illuminated and a post-treatment
aliquot collected. EVs were isolated from pre- and post-illumination samples
by centrifugation and size exclusion chromatography (SEC) and their pre-
sence was assessed by biochemical and biophysical methods.
Results: EVs were detected by electron microscopy imaging in all sam-
ples regardless of treatment. The size and morphology of these vesicles
(30-50 nm) was consistent with literature reports. No substantial quali-
tative changes were observed between pre- and post-illumination sam-
ples. Comprehensive analyses of pooled SEC fractions 9-11 by tunable
resistive pulse sensing confirmed the absence of statistically significant
differences in EV concentration (3.39E^10 vs. 3.81E^10) and size (157
vs. 158 nm) between pre- and post-illumination samples, respectively.
Likewise, protein analysis of EV lysates by quantitative and qualitative
assays did not find major phenotypic changes.
Summary/Conclusion: These results suggest that INTERCEPT does not
induce significant changes in EV size, concentration and phenotype.
Additional studies will evaluate their biological properties and clinical
applications.
Funding: Cerus Corporation and American Red Cross.
LBP.59
Exosome involvement in JC Polyomavirus Infection
Aisling S. Dugan1, Bethany O’Hara2, Gretchen Gee2, Benedetta Assetta2,
Jenna Morris-Love3 and Sheila Haley2
1Assumption College, MA, USA; 2Brown University, RI, USA; 3Pathobiology
Graduate Program, Brown University, RI, USA
Introduction: Human JC polyomavirus (JCPyV) causes the fatal demyelinat-
ing disease progressive multifocal leukoencephalopathy (PML) in AIDS
patients. JCPyV utilizes the sialyated glucan, LSTc, and the serotonin 2
subgroup of receptors to gain entry into the human glial cell line, SVG
cells. Paradoxically, patient isolates of JCPyV from PML patients have muta-
tions in the major viral capsid protein, VP1, that prevent binding to the
serotonin receptor and infection of SVG cells. Moreover, some primary cells
without the LSTc receptor can be infected with JCPyV. These observations
suggest that there may be an alternative route for JCPyV infection in humans
that does not involve the canonical receptors. Exosomes are small (30-100
nm) vesicles released by cells shown to be critical for cell-cell communication
and important in the spread of some viruses.
Methods: Exosomes were isolated from JCpyV infected SVG cells and
examined for exosome number, infectivity, and visualized using trans-
mission electron microscopy.
Results: Our data showed that exosomes isolated and purified from the
supernatant of JCPyV infected SVG cells contain VP1 and are infectious.
JCPyV infection increased the number of exosomes released in media com-
pared to uninfected cells. Exosome inhibitors block JCPyV spread.
Transmission electron microscopy revealed that exosomes isolated from
JCPyV infected cells were found within vesicle-like sacs consistent with
exosomes.
Summary/Conclusion: Together, these data suggest a role for exosomes
in the spread of infectious JCPyV.
Funding: NIH funded: 2R01NS043097-15A1.
LBP.60
Extracellular vesicles in the immune response to Hepatitis-Virus
infections
Stephanie Jung1, Yuchen Xia1, Michaela Gack2 and Ulrike Protzer1
1Helmholtz Center Munich, Munich, Germany; 2University of Chicago, IL, USA
Introduction: Hepatitis B Virus (HBV) infection is a global health issue with
240 million chronical carriers and a major driver of liver cirrhosis and
hepatocellular carcinoma. Coinfection of HBV-positive patients with
Hepatitis D Virus (HDV) enhances the risk of severe fulminante hepatitis
with liver failure and high mortality rates. Current therapies against HBV
prevent the progression of the disease but are ineffective in mediating viral
clearance. We aim to understand the immunomodulatory role of EVs in
HBV and HDV infection. HBV is considered a stealth virus, fundamentally
blocking cytokine production in the infected cell by extensive immune
evasive mechanisms. HDV is a satellite virus that requires HBV for virus
production and propagation.
Methods: We hypothesize that HBV/HDV infected cells shuttle exosomes
to non-infected cells, herewith modulating the innate immune response. To
test this hypothesis, we purify and transfer exosomes produced by virus-
infected cells to non-infected immune cells and quantify cytokine produc-
tion by both qRT-PCR and ELISA.
Results: Preliminary results indicate an immuno-modulatory effect of exo-
somes released by HDV-infected cells. Additionally, we observe that both
intracellular HBV-DNA and HBV transcription levels are diminished in
response to transfer of supernatant derived from IFN-α pretreated cells. It
can be shown that not interferon itself but heparin-binding particles of high
molecular weight released by pretreated cells are responsible for this effect.
These very particles inhibit virus entry into hepatoma cells and interact with
the HBV receptor heparan glycosaminoglycan.
Summary/Conclusion: Resulting data shall elucidate mechanisms of HBV
and/or HDV pattern recognition by the immune response. Not only the
mode of signal transmission, but also detected pathogen-associated molecu-
lar patterns and their corresponding receptors can be identified. These results
might give insight into additional HBV-detecting pattern recognition
receptors.
Funding: SJ is funded by the Helmholtz Association’s Initiative and
Networking Fund, YX is partly sponsored by The International Liver
Cancer Association and MG is funded by NIH.
LBP.61
How much exosomes will mimic physiological response in in vitro
experiment? Learning from Extracellular vesicles mediate signaling in
ocular system
Elie Beit-Yannai, Sofia Schreiber-Avissar and Natalie Lener
Ben-Gurion University, Israel
Introduction: Extracellular vesicles (EVs) mediated signaling attract
researcher in many biological disciplines, and many research are conducted
in-vitro. Howmuch EVs are required to mimic the physiological condition is
unclear. EVs calibrated according to their protein content were used in the
range of 1µg to 50µg per couple of millions targeted cells. In most of the cases





























EVs dose response was not addressed. In the present research we examine the
effects of different concentrations of EVs derived from the aqueous humor
producing cells (NPCE) on the trabecular meshwork (TM) cells.
Communication between these tissues in-vivo is considered important for
maintaining the intra ocular pressure and have an important role in glau-
coma disease. Changes in gene, protein expression and activity of the Wnt
signaling pathway members, known to be involved in the pathology of
glaucoma disease, were examined according the tested EVs doses.
Methods: Human NPCE cell line was grown in exosome depleted medium
and EVs were extracted using the PEG precipitation method followed by
ultra-centrifugation. The exosomes were incubated for 8h, at three different
concentrations (6.8*109 (X1), 13.6*109 (X2) or 60.8*109 (X10) with 0.5*106
TM cells. EVs were determined using Bradford and FRAP methods. Retinal
pigment epithelium cells derived EVs were used as control and incubated at
the same concentrations with 0.5*106 TM cells. Quantitative PCR, Western
Blot analysis and Zymography were used.
Results: Exposure of confluent TM cells for 8h to various concentrations
of EVs, lead to significant changes in the expression of the measured
proteins. Exposure to low exosome concentration was associated with
decreased expression of β-Catenin, GSK-3β, as compared to exposure to
high exosomal concentrations (p < 0.01). When exosomes were incu-
bated with TM cells for 2h, a tendency of decrease was found in β-
catenin, Axin2 and LEF1 mRNA levels in low concentrations of exo-
somes compared to high ones.
Summary/Conclusion: Cross talk between the ocular drainage tissues via
EVs exist . NPCE derived EVs specifically target the TM cells resulting in
changes in the TM ECM
Our findings suggest that EVs concentration plays a major role in the
NPCE-TM communication in-vitro. Furthermore, a bimodal TM
response to exosome concentration exposure was found.
LBP.62
Blood neuron-derived exosomes as biomarkers of cognitive
impairment in HIV infection
Lynn Pulliam1, Bing Sun2 and Pranjali Dalvi3
1University of California, San Francisco, CA, USA; 2Veterans Affairs Medical
Center, USA; 3Veterans Affairs Medical Center, USA
Introduction: A subset of HIV-infected subjects continues to have cog-
nitive impairment in spite of effective therapy suppressing viral load.
This may be due to the high probability of a persistent viral reservoir
and ongoing injury. Finding an inexpensive, noninvasive, peripheral
biomarker for cognitive impairment has been a high priority.
Exosomes (exos) are shed from most cells including neural cells. We
isolated neuron-derived exosomes (NDE) in plasma from controls and
HIV-infected subjects with varying degrees of cognitive impairment.
We examined these NDE for markers of neuronal damage.
Methods: Total exos were isolated from plasma of 12 healthy control
subjects and 23 HIV-infected subjects using Exoquick. Institutional
informed consent was obtained from all subjects. All HIV positive subjects
were on antiretroviral therapy with none to varying degrees of cognitive
impairment; most had controlled viral load. Further isolation to NDE was
performed by immunoadsorption using antibody to the neuron specific cell
marker L1CAM.NDEwere characterized byNSE, NF-L and synaptophysin
(SYP). We looked at exo numbers, CD81 and protein content by ELISA for
2 targets associated with neurodegeneration, Aβ and HMGB1.
Results: HIV-infected subjects had significantly fewer total plasma exos
compared to controls but there was no difference in NDE numbers; NF-L
and SYP were elevated in NDE. Neuropsychologically impaired (NPI)
subjects had significantly fewer NDE. HMGB1, Aβ and NF-L were
increased in NDE from impaired compared to normal subjects.
Summary/Conclusion: We demonstrate for the first time that the number
of total exos in the plasma of individuals with HIV infection is decreased.
Subjects with cognitive impairment had decreased NDE suggesting fewer
neurons. However, within NDE, there is a significant increase in several
targets including an alarmin, HMGB1, from impaired subjects. NDE cargo
reflects neuronal damage and may predict a cognitive impairment profile.
Funding: National Institutes of Health, MH085538 and MH112483 (to
L.P.).
LBP.63
Withdrawn at author’s request.
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Fish MVs: A diagnostic tool?
Leidy Lagos1, Sabina Leanti La Rosa2, Julia Tandberg3, Hanne Winther-
Larsen3 and Margareth Øverland2
1Norwegian University of Life Sciences, Oslo, Norway; 2University of Life
Sciences, Oslo, Norway; 3University of Oslo, Oslo, Norway
Introduction: Extracellular vesicles (EVs) with lipid bilayers consist of
apoptotic bodies, ectosomes, microparticles, microvesicles and exo-
somes. Exosomes represent endosome-originated small membrane vesi-
cles, about 30–100 nm in diameter that are secreted by cells and contain
several molecules, including proteins and nucleic acids. The secretion of
MVs is a common feature of most cells, including eukaryotic cells and
bacteria. Piscirickettisa salmonis is a facultative intracellular pathogen
that affects farmed salmonids around the world. This Gram-negative
fastidious bacteria produces a systemic infection characterized by colo-
nization of several organs in the fish and is able to infect, survive, and
replicate inside macrophages, however little is known about its mechan-
isms of pathogenesis. Recently, we have proven that P. salmonis is able to
secrete MVs as strategies to deliver virulence factors to the eukaryotic
host cells.
Methods: MVs were isolated from salmon (Atlantic salmon) plasma that
were infected with the fish pathogen P. salmonis using a commercial kit
and their presence was confirmed by transmission electron microscopy,
Nanosizer, flow cytometry and its protein content was analyze by mass
spectrometry.
Results: The proteomics results shown 113 protein present in both,
healthy and infected fish. However, 106 proteins were present just in
the group infected with P. salmonis. Among these proteins are heat
shock protein 90, proteasomes subunit, complement protein, autophagy
and major histocompatibility class (MHCI), which are key to overcome
intracellular infection. Interestingly, we were able to identify bacterial
proteins, such as phenylalanine–tRNA ligase, porin and diguanylate
cyclase in the plasma of infected animals. Our results suggest that the
protein present in MVs depend of the health status of the animal, as well
as confirming the ability of P. salmonis to secrete MVs in vivo.
Summary/Conclusion: Our results suggest that the protein present in
MVs depend of the health status of the animal, as well as confirming the
ability of P. salmonis to secrete MVs in vivo.
LBP.65
Extracellular vesicle-associated miR-155 may contribute to HIV-1
pathogenesis
Audrey Hubert1, Caroline Subra2, Julien Vitry1, Myriam Vaillancourt1, Anne
Bergeron1, Frédéric Barabé1, Mohammad-Ali Jenabian3, Cecile Tremblay4,
Jean-Pierre Routy5, Provost Patrick6, Sylvie Trottier1 and Gilbert Caroline6
1Université Laval, Quebec, Canada; 2U.S. Military HIV Research Program;
3UQAM; 4CHUM; 5McGill University, Montreal, Canada; 6Department of
Microbiology-Infectious Disease and Immunity and Faculty of Medicine,
Université Laval, Quebec, Canada
Introduction: Extracellular vesicles (EVs) mediate cellular communica-
tions and transformation, and contain genetic materials. The abundance
of EVs in plasma (pEVs), and their microRNA content may thus be used
as biomarkers of inflammatory diseases such as HIV infection. We
reported that pEVs isolated from antiretroviral-therapy-naïve HIV-1
patients are enriched in miR-155. However, the type of microRNA-
containing EVs and their relevance to HIV-1 pathogenesis remains
unknown.





























Methods: pEVs were precipitated from plasma ART-treated and
untreated patients, elite controllers and healthy individuals (n=8/
group) by using ExoQuickTM and separated by velocity gradients.
Selected microRNAs were detected by qPCR, and the impacts of EVs
enriched in miR-155 were tested in vitro and in vivo by using relevant
HIV-1 infection models.
Results: We observed an increased abundance of acetylcholinester-
ase-positive pEV (exosomes) in first fractions, and concentrations of
EV-borne miR-155 in mischaracterized denser fractions in the case
of ART-naïve subjects. Peripheral blood mononuclear cells or NOD/
Scid/IL2rγnull (NSG) humanized mice responded to miR-155-bear-
ing vesicles with a marked decrease in the CD4+/CD8+ T lympho-
cyte ratio resulting from an increase in CD8 T cells, and with the
expression of exhaustion marker PD-1 and increased viral
production.
Summary/Conclusion: This study confirms that the pEV population
increases in heterogeneity during infection with HIV-1 and those
ART-naïve patients appear to have uncharacterized pEVs that are
larger than exosomes and enriched in miR-155. This study showed
that velocity gradient remains the most effective method of resolving
the pEV population. More importantly, we provide evidence that
miR-155-enriched EVs affect HIV-1-associated pathogenesis by pro-
moting activation of CD8 T cells and possibly exhaustion on the long
term.
Funding: This study was funded through grants MOP-267056 (HIV/
AIDS initiative) to C.G., a FRQ-S AIDS and infectious Diseases Network
grant to C.G. and S.T, grant MOP-03230 to J.P.R. and C.T. (for cohort
establishment) and by the FRQ-S AIDS and infectious Diseases
Network. This work was supported in part from a grant awarded to
Drs Barabé and Gilbert through a donation of Merck Sharpe & Dohme
Corp. to the Faculty of Medicine via the Fondation de l’Université Laval.
LBP.66
Role of Nedd4-family members in assembly and release of quasi-
enveloped hepatitis A virus (eHAV)
Olga González-López1, Kevin L. McKnight1 and Stanley M. Lemon2
1University of North Carolina, NC, USA; 2University of North Carolina at
Chapel Hill, NC, USA
Hepatitis A virus (HAV) is an important cause of enterically transmitted
hepatitis in humans and a unique picornavirus that is released from cells
non-lytically enclosed in 50-110 nm membranous vesicles. These infec-
tious, quasi-enveloped virions (eHAV) are the only form of virus found
in blood from infected humans. Release of eHAV from infected Huh-7.5
hepatoma cells is ablated by siRNA knockdown of ALIX or VPS4B,
ESCRT-associated proteins required for exosome biogenesis via the
multi-vesicular body (MVB) pathway. Consistent with this, a proteomics
analysis of gradient-purified eHAV identified numerous host proteins
normally localizing to endolysosomes. Among these, NDFIP2 (Nedd4-
family interacting protein 2) is an adaptor protein that binds and
activates HECT domain Nedd4 family E3 ubiquitin ligases and that
has been implicated in sorting of cargo for delivery to MVBs.
LBP.67
Blueberry fruit nano vesicles
Ryan Yu and Benjamin D. Zeitlin
University of the Pacific Arthur A. Dugoni School of Dentistry, CA, USA
Introduction: Nanovesicles have been identified in preparations of edible
plants and certain fruit although the exact cellular origin of these vesicles
remains unclear. Cross-kingdom biological effects have been demonstrated
for nanovesicles isolated from certain fruit - notably lemons and grapes -
that are absent fromnormal, dietary intake of the whole fruit, this suggests a
therapeutic potential for isolated fruit vesicles. Anthocyanins and other
polyphenolic anti-oxidant compounds are known to accumulate in plant
vesicles as are specific proteins, lipids and microRNAs species. Here we
investigate the presence of nanovesicles in antioxidant-rich blueberry fruit.
Methods: Fresh blueberries were manually crushed and the pulp passed
through a course sieve. Pulp was diluted with phosphate buffered saline
and subject to differential centrifugation and ultracentrifugation. The
resulting pellet was insoluble and highly resistant to disruption. A jelly-
like consistency of the pellet suggested precipitation of soluble structural
polysaccharide such as pectin common to soft fruits. To examine the
pellet, a sample was fixed in formaldehyde/glutaraldehyde, dehydrated in
acetone and embedded in resin. The sample was sectioned and subject to
transmission electron microscopy (TEM).
Results: We observed sections with numerous vesicle-like structures -
approximately 30-100 nm - in addition to highly fibrous areas but
generally not in the same field.
Summary/Conclusion: In summary we report we believe for the first time
the presence of nanovesicle-like structures in extracts from fresh blueber-
ries. We also highlight a previously unreported challenge to vesicle isolation
from berry fruit in the form of a fibrous matrix.
Funding: University of the Pacific Dugoni School of Dentistry intra-
mural funds.
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Characterization of extracellular vesicles released from parasitic
nematodes with different host adaptation
Eline Palm Hansen1, Kasper Lind Andersen1, Antonio Marcilla2, Aaron Jex3,
Robin Gasser3, Neil David Young3, Ross Stephen Hall3, Merete Fredholm1,
Stig Milan Thamsborg1 and Peter Nejsum4
1University of Copenhagen, Denmark; 2Universitat de Valencia, Valencia, Spain;
3University of Melbourne, Melbourne, Australia; 4Aarhus University, Denmark
Introduction: Parasitic worms have developed an amazing ability to
evade or modulate the host immune response and recent studies indicate
that extracellular vesicles (EVs) are crucial for host-parasite interactions.
In this study, we examined EVs released from three gastrointestinal
nematodes of pigs, Ascaris suum, Trichuris suis and Oesophagostomum
dentatum. These parasites have different patterns of migration and
location in the host, as well as the immunological response they evoke.
They could therefore represent suitable candidates to explore unique as
well as common modes of host adaptation and immune modulation.
Methods: Adult worms were incubated in RPMI under sterile conditions
and EVs were purified by differential centrifugations, including two
ultracentrifugations at 110,000 x g, and identified by transmission elec-
tron microscopy. EV RNA was isolated and sequenced, and the miRNAs
for each of the three species were identified using miRDeep2. Predicting
miRNA targets and potential functions is part of an on-going analysis,
but preliminary results indicate immune-related properties of highly
expressed miRNAs. In order to visualize the uptake of EVs and the
subsequent transfer of EV RNA into host cells, EVs were treated with
RNase, labelled with EV membrane stain as well as RNA stain, trans-
ferred to intestinal epithelial cells (Caco-2) and examined by confocal
microscopy at 37°C.
Results: We found that EVs of all three species were taken up by
intestinal epithelial cells followed by a release of RNA, which had a
tendency to accumulate in the cell nuclei. We are currently undertaking
in vitro studies to functionally test the role of EVs on immune cells.
Summary/Conclusion: The findings of this study contribute to unravel-
ing the complex interplay between parasites and their hosts, which may
provide new targets for diagnostic tests and novel ways for intervention
and disease control in the future.
Funding: The University of Copenhagen, Denmark; Direktør Ejnar
Jonasson kaldet Johnsen og hustrus mindelegat: Danish Council for
Independent Research (DFF-6111-00521)






























Heligmosomoides polygyrus vesicle-derived small RNAs inside mouse
cells: detection and targets
Jose Roberto. Bermúdez1, Franklin W.N. Chow2, Amy H. Buck3 and Cei
Abreu-Goodger4
1LANGEBIO, CINVESTAV, IRAPUATO MX; 2Institute of Immunology and
Infection Research, Centre for Immunity, Infection and Evolution, School of
Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom;
3Institute of Immunology and Infection Research, Centre for Immunity,
Infection and Evolution, School of Biological Sciences, University of
Edinburgh, United Kingdom; 4Langebio–Cinvestav
Introduction: Evidence for a cell-to-cell communication system
mediated by vesicles loaded with small RNAs (sRNAs) is accumulating.
However, we still ignore if sRNA-loaded vesicles could be used for
communication between different species. Heligmosomoides polygyrus
is a nematode that infects mice and is a valuable model to study the
immune response to chronic infections. During its adult phase, H.
polygyrus secretes vesicles while residing in the mouse intestine. We
have already shown that these vesicles have immune-modulation capa-
city, and that they contain proteins as well as small RNAs. We ultimately
aim to determine if these H. polygyrus small RNAs (Hp-sRNAs) have a
role during interaction with the host. Nematode vesicles have the capa-
city to enter MODE-K epithelial intestine mouse cells in vitro, as
revealed by fluorescently labelling the nematode vesicles.
Methods: To explore in an unbiased manner the capacity of Hp-sRNAs
to enter mouse cells we cultured mouse cells together with H. polygyrus
vesicles or total secretion and performed Small RNA sequencing (sRNA-
Seq). To determine if there is specificity in Hp-sRNAs internalization,
we used two different cell types: MODE-K and bone marrow derived
macrophages. To assess the stability of Hp-sRNAs inside mouse cells we
applied two incubation times (4 and 24 hours), prior to sequencing.
Results: We can use bioinformatics to disentangle nematode and mouse
sRNAs with mapping strategies and differential expression analyses. We
identify 75 high confidence Hp-sRNAs inside MODE-K cells after treat-
ment. These sRNAs are found in vesicles and tend to belong to the 22G
siRNA class (nematode specific). We are currently exploring the target-
ing capacity for these Hp-sRNAs in mouse, and looking for over-repre-
sented functions among putative targets.
Summary/Conclusion: Our project explores the possibility of sRNA-
loaded vesicles being used as a means for inter-species communication.































Direct from sample surface marker based single exosome counting
and characterization
George Daaboul1, David Freedman2, Mani Sadredini3, Steven Scherr4, Paola
Gagni5, Marcella Chiari5, John Connor6 and Selim Unlu7
1nanoView Diagnostics Inc.; 2nanoView Diagnostics; 3Oslo University Oslo,
Norway; 4Boston University College of Mechanical Engineering, MA, USA;
5Consiglio Nazionale delle Ricerche, Istituto di Chimica del Riconoscimento
Molecolare; 6Boston University School of Medicine, MA, USA; Department of
Microbiology; 7Boston University College of Electrical and Computer
Engineering, MA, USA
Introduction: Exosomes are currently characterized by running non-
specific nanoparticle analysis followed by proteomic analysis to confirm
the existence of exosome markers. This approach usually requires exo-
somes to be isolated through ultracentrifugation (UC) to separate inter-
ference from soluble markers in the biological fluid. Recently, flow
cytometers have been adapted to combine light scatter measurements
from nanoparticles with fluorescent detection of exosome markers. The
combination of the light scatter with specific markers improves the
reliability and specificity of exosome detection. However, the small-size
of exosomes makes specific detection above background levels difficult
because these diameters (50-200 nm) are too small for traditional visua-
lization technologies.
Methods: We have applied a label-free microarray imaging technique for
enumeration, sizing and phenotyping of exosomes. The technique is
termed Single Particle Interferometric Reflectance Imaging Sensor
(SPIRIS) that allows visualization of individual nanovesicles captured
on the sensor surface, which is functionalized with a non-fouling poly-
mer arrayed with antibodies against surface markers. The sensor is
comprised of a silicon substrate with a thin silicon dioxide layer forming
a common path interferometer. The spectrally reflected light from the
sensor surface interferes with the scattered light from captured nano-
particles enhancing their visibility.
Results: We have verified the sizing sensitivity of the sensor using viral
particles from cell culture media spanning diameters from 40 nm (Zika
Virus) to 360 nm (Vaccinia Virus). We have also demonstrated direct-
from-sample extracellular vesicle phenotyping from cell culture media
and human plasma. To validate specificity of direct-from-sample detec-
tion, results were compared to detection post-isolation using UC.
Summary/Conclusion: A detection limit of 5 x 105 particles/ml or 0.5
zepto moles when using 5 µl of sample was demonstrated. Direct detec-
tion of exosomes from cell culture and human plasma is shown without
the need for isolation. SPIRIS direct-from-sample high-throughput tech-
nique could improve standardization of exosome preparations and facil-
itate translation of exosome-based liquid biopsies.
IP.02 (Gold Sponsor Abstract)
Development of an integrated methodology for extracellular vesicle
purification, characterization and linking biophysical properties to
biological function
Anoop Pal, Robert Vogel, Julien Muzard and Murray Broom
Izon Science
Introduction: Extracellular Vesicles (EVs) are heterogeneous in size,
number, membrane composition and contents. A thorough understand-
ing of this diversity and the linkage of biophysical properties to EV
biological role and function is necessary. Real, validated, repeatable
measurement data are required for the biomedical adoption of EV
based diagnostics and therapeutic developments. These have not always
been prominent in EV research. We also believe that normalization of
any biochemical analyses back to the EV particle properties will become
a standard requirement.
Methods: An integrated, standardizable and very practical methodology
for EV purification and measurement has been developed. SEC columns
provide clean EVs from biological fluids and cell culture, 99% free of
non-vesicular proteins. TRPS provides detailed, calibrated measurement
of EV particle number, size, concentration of each size fraction, and
individual particle surface charge. Continual improvements by users in
the usability and reproducibility of TRPS have reduced the time required
while improving quality.
Results: In the first case study, EVs purified from BAL fluid were
quantified and analyzed for difference in size, concentration over a
defined size range and surface charge post lung exposure to nanoparti-
cles. In second case study tissue factor bearing microparticles from two
different cell lines were separated, characterized, and functionally eval-
uated by tissue factor activity assay. The assay responses were normal-
ized to the TRPS data to assess the impact of particle size, surface area
and volume on tissue factor activity. Further, quantification of EV sur-
face markers (CD63 and CD142) and phenotyping of specific EVs
captured via antibody conjugated to magnetic beads was achieved. Our
results showed a proportional increase in size, volume and surface
charge of the EV-Magnetic bead complex (immunoprecipitated) over a
defined dose-range. Secondary measurements confirmed these findings
as well.
Summary/Conclusion: Thus, the proposed integrated methodology pro-
vides a simple, rapid, reliable, and cost efficient approach for EV pur-
ification and biophysical characterization amenable for diagnostic and
therapeutic proposes.
IP.03
Particle Size and refractive index derived from three-dimensional
light scatter data
Oliver Kenyon
Apogee Flow Systems Ltd
Introduction: The complex relationship between particle size and the
amount of light scattered at different collection angles makes it difficult
to infer particle size from a flow cytometer’s light scatter data. A
population may be described as scattering an amount of light equal to
a reference particle (e.g. a latex or silica bead of known size) but same
sized particles of different refractive index give different signal strengths.
When comparing data between flow cytometers the difficulties are
compounded by differences in light scatter illumination and collection
angles
Methods: A particle suspension containing a continuum of particle sizes
of well-defined and known refractive index may be used to characterize
the light scatter optics of any flow cytometer. Once the light scatter
optics have been characterized in this way, data from biological samples
(e.g. virions, extracellular vesicles) can be transformed from light scatter
space (e.g. small, medium and large angle dimensions) to size and
refractive index dimensions.
Results: It is possible to convert light scatter data into particle size and
refractive index information. This may be thought of as a conversion
from three (or more) dimensional light scatter space to 2-dimensional
space with dimensions ‘size’ and ‘refractive index’.
Summary/Conclusion: Size and refractive index parameters allow com-
parison of data among flow cytometers and other particle analyzers in a
way not possible with light scatter data. For this reason it is well suited to
studies of submicron particles such as bacteria, virus and extracellular
vesicles. The new size and refractive index parameters can be stored in
FCS format, compatible with widely available software.
Funding: Apogee Flow Systems Ltd
IP.04
Application of liposomes for study of biological microvesicles
Oleg Guryev1, Tatyana Chernenko1, Majid Mehrpouyan1, Gulam Shaikh1,
Pam Canaday2, Claudia Lopez3, Terry K. Morgan4 and Marybeth Sharkey1





























1BD Biosciences; 2Department of Pathology, OHSU; 3Multiscale Microscopy
Core, Center for Spatial Systems Biomedicine, OHSU; 4OHSU
Introduction: Liposomes are nano/micro-size sphere-shaped lipid vesi-
cles of single or multiple lipid bilayers. They are often used as a model
objects in study of biological microvesicles (MVs). However, there is no
standardized method for preparation of liposomes of different sizes. The
goal of our project was to develop reliable and reproducible procedure
for on-site liposome preparation when researcher can make liposomes
and use them immediately in their experiments. Using liposomes as
reference standards, we propose a technique based on side-scattered
light analysis on a flow cytometer to characterize MVs from human
serum.
Methods: Liposomes where prepared via new centrifugation technology.
They were analyzed by dynamic light scattering (DLS), transmission
electron microscopy (TEM) and flow cytometry.
Results: Flow cytometry was used to study fluorescein labeled or blank
liposomes of defined dimensions. Their size and structure was con-
firmed by dynamic light scattering (DLS) and transmission electron
microscopy (TEM). Linear dependence of side scattering (SSC) from
liposome size was established in the range from 200 nm to 700 nm.
However, it was found that liposome light scatter depends on their lipid
composition. We use liposomes and polystyrene microparticles for flow
cytometry instrument calibration and MV size determination.
Summary/Conclusion: 1. A new technology was utilized to produce a set
of liposomes of different sizes ranging from 100 to 700 nm. 2.
Dependence of SSC from liposome dimensions has a linear correlation.
3. This set of liposomes can be used for size determination of MVs from
human serum.
IP.05
Rapid isolation and miRNA profiling of intact exosomes in colorectal-
cancer patients
Jonathan Shaffer1, Martin Schlumpberger2, Karolin Spitzer2, Verena
Schramm2 and Markus Sprenger-Haussels2
1QIAGEN Sciences; 2QIAGEN GmbH
Introduction: Fast and reproducible isolation of exosomes and other
extracellular vesicles presents a major challenge in exosome research
and further hinders downstream analysis. Here, we demonstrate a com-
plete and reproducible workflow from rapid isolation of vesicular-spe-
cific RNA, including miRNA and other small RNAs, using a membrane
affinity-based procedure in spin column format [1] to efficient profiling
and analysis of vesicular miRNA content by next-generation sequencing.
This workflow was applied to colorectal cancer (CRC) patients.
[1] Enderle D, Spiel A, Coticchia CM, Berghoff E, Mueller R,
Schlumpberger M, et al. (2015) Characterization of RNA from
Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin
Column-Based Method. PLoS ONE 10(8): e0136133.
Methods: Vesicular RNA from plasma of CRC patients was isolated using a
spin column-based approach. Libraries for miRNA-Seq were prepared
using a novel ligation-mediated approach for library prep which assigns
uniquemolecular indices (UMIs) to eachmiRNA. Next-generation sequen-
cing was then performed using a benchtop sequencer. Reads were mapped
tomiRbase and identical reads were collapsed based on the UMI sequences.
Results: Using the novel workflow, EV-specific miRNA content from
serum, plasma and other biofluids can be profiled efficiently with total
hands-on time of less than four hours for the complete workflow from
isolation of vesicular RNA to miRNA-seq libraries. 35-40% of all reads
consistently map to known miRNAs annotated in miRbase. This high
percentage of mapped reads results from efficient removal of Y-RNAs
and other small RNAs during the library preparation. We find EV-
specific miRNAs to be highly abundant among all sequenced miRNAs
proving the isolation of EV-specific RNA content.
Summary/Conclusion:We conclude that the combination of a spin-column
based EV-specific RNA isolation and miRNA-seq library preparation opti-
mized to remove Y-RNAs is highly suited to accurately profile miRNAs
from CRC patients. This approach maximizes the amount of interpretable
data to specifically profile miRNAs inside of EVs without background from
miRNAs outside of EVs.
Funding: This research was funded by QIAGEN GmbH, Hilden, Germany.
CRC patient samples were provided by our collaborator Prof. Dockhorn at
Zentrum für Pathologie, Kempten, Germany
IP.06
EXÖBead: A glycan recognition method of isolating exosomes from
small sample volumes without ultracentrifugation
Dapi Chiang1, Dominik Buschmann2, Benedikt Kirchner2 and Michael Pfaffl2
1Biovesicle Inc.; 2Division of Animal Physiology and Immunology, TUM
School of Life Sciences Weihenstephan, Technical University Munich
Introduction: Exosomes are small vesicles (30-150 nm) secreted from
different cell types and found in various biofluids, such as blood, urine,
saliva and CSF. Exosomes contribute to cell-cell communication, antigen
presentation or tumor progression by carrying cellular proteins, RNA/
DNA, glycans and lipids. Differential ultracentrifugation (UC) is still
regarded the ‘Gold Standard’ for exosome isolation. However, UC is a
laborious and time-consuming method that requires specialized equipment
and operational expertise. Several alternative methods such as antibody-
conjugated beads were developed to isolate exosomes without UC. Isolation
based on antibody-conjugated beads, however may damage exosomes by
using acidic or alkaline reagent to break antigen-antibody interactions.
Methods: To solve these issues, we create a “non-antibody” coated bead,
called EXÖBead, that is able to isolate exosomes. We incubated
EXÖBead with pre-cleared cell culture medium (CCMs) or serum and
analyzed the pulled-down fraction by FACS, western blot, Bioanalyzer
2100 capillary electrophoresis, Transmission Electron Microscopy
(TEM) and Nanoparticle Tracking Analysis (NTA).
Results: Our result showed that CD63 can be detected by FACS in exo-
some-bead complexes from 100 µl to 1 ml human serum (MFI: 40.7% to
76.2%). Additionally, the expression of Alix and Rab5 was substantiated
by western blot using the exosome-EXÖBead complex from 200 µl mouse
serum or 200 µl B16F10 CCMs. The pattern of vesicular RNA and its
cDNA was found to be similar for exosomes isolated by EXÖBead and
differential UC (120,000 g pellet). For the RT-qPCR study, U6 (28.9
cycles) and miR-33 (34.7 cycles) can be detected in exosomes isolated
from 10ml THP-1 derived macrophage CCMs. Furthermore, we designed
an exosome elution buffer without using any acidic or alkaline reagents.
To test its ability to release exosomes from beads, we performed NTA and
TEM to assess vesicle size and morphology. The size of exosomes from
NTA (mode of diameter: 154.3 +/- 4.9 nm) and TEM (diameter: 50 nm to
110 nm) eluted from beads is similar to exosomes isolated by UC.
Summary/Conclusion: In conclusion, EXÖBead can capture exosomes
from biofluid samples without ultracentrifugation and exosomes can be
successfully eluted from the beads.
IP.07
Activity assays for evaluation of clinical grade MSC-EV anti-
inflammatory properties for use in treatment of drug-resistant
epilepsy in children
Alessandra Fierabracci1, Valeria La Marca1, Kelly Van Wemmel2, Sally
Snyman2, Silvia Balosso3, Laura Papetti4, Maurizio Muraca5, Annamaria
Vezzani6, Federico Vigevano7 and Marcin Jurga2
1Children’s Hospital Bambino Gesù, Infectivology and Clinical Trials Area,
Type 1 Diabetes Centre; 2Esperite Cell Factory; 3Dept of Neuroscience,
IRCCS Ist. Ricerche Farmacologiche Mario Negri; 4Dept of Neurosciences,
Children’s Hospital Bambino Gesu’; 5Department of Women’s and Children’s
Health, University of Padua, Padua, Italy; 6Dept of Neuroscience, IRCCS Ist
Ricerche Farmacologiche Mario Negri; 7Children’s Hospital Bambino Gesù,
Dept of Neuroscience
Introduction: MSCs exert their biological effects through secretion of
extracellular vesicles (EV). We previously showed that MSC-EV have
significant immunomodulatory properties. MSC-EV inhibit B cells pro-
liferation/differentiation upon PBMC CpG stimulation, similarly to par-
ent MSCs. Furthermore, MSC-EV induce Treg proliferation/apoptosis
and IL-10 secretion, following antiCD3/CD28 PBMC stimulus. In this
study we show that clinical grade (CG) EV exert similar





























immunomodulation to research grade (RG) counterparts. CG EV could
be produced with higher efficiency if compared to RG EV and MSCs
manufacturing. Currently our group is preparing MSC-derived EV for
clinical tests in treatment of epilepsy, a disorder resistant to anti-epilep-
tic drugs in 40% of children due to neuroinflammation. A novel anti-
inflammatory strategy, based on CG EV, is proposed.
Methods: Amethod of CG EV production is based on human umbilical cord
derived (UC) MSCs cultured in a closed, scalable stirred-tank bioreactor
system in fully defined GMP culture media. EVs are purified by sequential
filtration/sterilization. The final product is analyzed by NTA to evaluate size
and quantity, and EVs are characterized byMACSPlex immunophenotyping
(FACS), to identify specific CDmarkers. The immuno-modulatory activity of
the CG product is evaluated in comparison with RG EVs and MSCs by
specific in vitro B and T cells assays.
Results: The CG EV isolation method, has been optimized to obtain at
least 1.5 * 10^9 EV/mL in 24 h from 0.1 * 10^6 MSCs. EV diameter cut
off is 300 nm. MACSPlex exosome assay revealed that EV are CD9,
CD63 and CD81 positive, but HLA-ABC and HLA-DRPQ negative. T
and B potency assays, performed on PBMC, indicate immunosuppres-
sion by CG EV, similarly to the RG EV obtained from the same MSCs.
This effect is revealed by Treg increase, counteracting T eff, upon T cells
activation, and by reduction of B cells proliferation and plasma cell
differentiation, following B cells activation.
Summary/Conclusion:We have developed and standardized a reproducible
method for the production, quantification and immunophenotyping of CG
EV, starting from human UC MSCs, with similar immunomodulation if
compared to RG EV counterparts. Our data indicate that the use of CG EV
could be effective in the treatment of a wide range of immunological
diseases, and provide a more accessible alternative for allogenic MSCs.
Funding: Esperite (B)
IP.08
Clinical scale production and wound healing activity of human
adipose derived mesenchymal stem cell extracellular vesicles from a
hollow fiber bioreactor
John J. Cadwell1, John Ludlow2 and Tony Rutt3
1FiberCell Systems Inc.; 2Zen Bio; 3KD Bio
Introduction: Current methods for collecting EVs from conditioned med-
ium use large numbers of tissue culture flasks. EVs are secreted in small
quantities and a standard preparation can entail a final stage of 200 T225
flasks or more. This method is wasteful, time consuming, space consuming
and the cells are growing in a non-physiologic environment. Hollow fiber
bioreactors have been used to produce large quantities of exosomes from
human adipose derived MSCs in culture for over two months with no
change in phenotype. The harvest volume is 40mls and harvests can be
performed 2-3 times a week. Functional assays have shown the bioreactor
exosomes were at least as active as the ones obtained from flasks.
Methods: Cryopreserved ASCs (1 x 109) were used to seed a 20Kd
MWCO PS cartridge (C2011, FiberCell® Systems Inc.) After 48 hours
the non-adhered cells were removed from the system. Circulating PM-1
medium was changed when the starting glucose level of 0.45mg/mL was
depleted by 50%. A time course of monitoring revealed medium changes
need to occur every 3-5 days, which coincided with harvesting the
conditioned serum-free medium from the bioreactor cartridge for EV
isolation. Cultures were maintained in this manner for three months. In
vivo biological activity was determined using a model whereby 2cm
diameter wounds were made in the back skin of rats and then treated
with vehicle control or EVs (25 x106 particles). The wounds received a
single treatment by topical application onto the surface of the wound
and allowing to air-dry for 10 min before covering with a bandage.
Results: A total of 8.60 X 1011 EVs were harvested in a total volume of 120 ml
over the course of 6weeks. 130 T225 flasks yielded a total of 1.6 X 109 EVs in a
volume of 4000 ml. The hollow fiber bioreactor produced the equivalent of
nearly 7,000T225 flasks but in amuch smaller volume. The ratwoundhealing
model demonstrated a significant acceleration of the wound healing process.
Summary/Conclusion: Hollow fiber bioreactors represent a more in vivo
like way to produce exosomes of both the quality and quantity required
for clinical relevance in a closed, single use system. MSC phenotype
remains unchanged over the course of culture and can produce EVs in a
continuous process at a high concentration. EVs produced in this man-
ner demonstrate significant wound healing and biological activity.
IP.09
Urine exosome proteins CXCL9 and CXCL10 are predictors of kidney
transplant rejection
Christine M. Coticchia1, James Hurley1, Anand Srivastava2, Esilida Karecci2,
Vasisht Tadigotla1, Mia Sher1, Siawosh Eskandari2, Albana Mihali2, Jamil
Azzi2 and Johan Skog1
1Exosome Diagnostics; 2Transplant Research Center, Brigham and Women’s
Hospital and Harvard Medical School, MA, USA
Introduction: Approximately 15% of patients with end stage renal disease
(ESRD) who undergo kidney transplant will suffer from acute rejection,
negatively impacting long-term graft survival and function. Current
methods for monitoring rejection, such as serum creatinine and urine
protein secretion are not specific and cannot detect subclinical rejection.
Kidney biopsy is therefore routinely used to assess acute rejection,
increasing both risk to the patient and cost. An accurate, non-invasive
method to determine the presence of early, acute kidney rejection would
minimize the amount of immunosuppression needed to manage these
patients. Exosomal mRNA (exoRNA) and proteins are an ideal source for
such biomarker studies. In the transplanted kidney, exosomes originate
from glomerular podocytes, renal tubular cells and from immune cells,
generated during rejection. Using these exosomes we previously reported
the discovery and validation of a 23-gene urinary exoRNA signature for
the diagnosis of human kidney transplant rejection. Here we asked if urine
exosomal proteins could increase the accuracy, and reduce the number of
genes required for the detection of kidney transplant rejection.
Methods: Urine samples were collected from patients undergoing a
transplant kidney biopsy for clinical indications. A total of 21 urine
samples (10 rejections, 11 non-rejections) were collected from 21 indi-
vidual patients. Total exosomes were isolated from 10 mL of patient
urine and the presence of 92 exosome proteins was determined by
Proseek® Multiplex Inflammation, an immunoassay using Olink
Proteomics proximity extension assay (PEA).
Results: Among the 92 proteins examined, CXCL9 and CXCL10 were
identified to be differentially expressed in both rejection versus non-
rejection urine exosome protein and urine exoRNA. Receiver-operating-
characteristic (ROC) area under the curve (AUC) analysis determined
that urine exosome-associated proteins CXCL9 and CXCL10 could dis-
tinguish patients with kidney transplant rejection from those without
rejection with an accuracy of 0.827, (P ≤ 0.01).
Summary/Conclusion: We additionally identified 3 independent exo-
some proteins that are differentially expressed in patients with and
without kidney transplant rejection, demonstrating that urine exosome
proteins are a promising source of biomarkers for organ rejection.
IP.10
Many standard urine extracellular vesicle preparations contain
significant cellular biomolecule contamination
Anna Markowska, R. Scott Pendergrast, J. Stephen Pendergrast and
P. Shannon Pendergrast
Ymir Genomics LLC
Introduction: Urine offers many advantages over blood as a source of the
diagnostic and prognostic biomarkers contained in extracellular vesicles
(EVs). Its collection is easy and less invasive. It is itself less of a biohazard
and does not generate biohazards such as used needles and specimen vials.
These advantages suggest the potential for At-Home donation of urine
samples for clinical studies via mail. At-home donation would dramatically
increase the convenience and thus compliance from patients and decrease
costs for clinicians. However, although urine contains far less cells than
blood, the number contaminating white blood cells, red blood cells, epithelial
cells and podocytes is not negligible and is also highly variable from sample to
sample. Delivery of urine samples to a clinical and/or research laboratory via
the mail introduces the possibility of cellular rupture and contamination of
the extracellular fraction with cellular biomolecules.
Methods: Here we investigate the degree of cellular contamination of EV
preparations from “natural” urine samples and from samples spiked with
red and white blood cells. We look at both protein and RNA





























contamination under a variety of shipping, storage, and experimental
conditions. Storage/transport temperatures investigated include Room
Temperature, Refrigeration, and Freezing for 0-3 days. Experimental
conditions include filtration, cell preservatives, and different low speed
spins.
Results: We find that natural samples can contain very significant con-
tamination from proteins and RNA that are highly expressed in blood
cells. For instance, the red blood cell miRNA mir-451a can increase >50-
fold in samples from women during menstruation. Also, no storage or
shipping condition completely protects samples from cellular contam-
ination, including commercial preparations advertised to protect bio-
fluids from cellular degradation. Furthermore, some standard methods
for removing cells can actually introduce cellular contamination.
Summary/Conclusion: These findings strongly encourage researchers work-
ing with urine samples to take precautions towards preparing truly cell free
fractions of vesicles. Possible solutions to this problem will be discussed.
Funding: This study was funded entirely by Ymir Genomics LLC
IP.12
Identification of a one-step scalable method for isolation of
extracellular vesicles
Nikki Heath1, Lois Grant2, Xabier Osteikoetxea1, Niek Dekker1, Lorenz
Mayr2 and Ross Overman2
1Astrazeneca; 2AstraZeneca
Introduction: Extracellular vesicles (EVs) have a unique and natural
ability to deliver functional cargoes to recipient cells. Exploitation of
EVs to deliver therapeutic cargoes such as nucleic acids, small mole-
cules or proteins, to diseased cells is becoming an increasingly inter-
esting and feasible notion. For this to become a reality and enter the
clinic, a rapid, scalable and reproducible method of EV isolation will
need to be developed. There are some caveats surrounding the current
methods for EV isolation. For example the gold standard protocol of
differential centrifugation is not readily scalable, and cross flow filtra-
tion requires additional subsequent clean-up procedures to isolate EVs
in a pure form.
Methods: Here we develop a method by which we use column-based
chromatography to isolate EVs in a single step protocol. EVs were
isolated by ultracentrifugation, cross flow filtration and ion exchange
chromatography from HEK293T cells. Collected EVs were analysed by
Western blotting for EV markers, nanoparticle tracking analysis and
cryoelectron microscopy.
Results: We have demonstrated that ion exchange chromatography can
reproducibly isolate CD63, CD81, ALIX and TSG101 containing EVs
from conditioned media. The size distribution of EVs isolated by ion
exchange chromatography (mean 179 nm) was similar to that of EVs
isolated by ultracentrifugation (mean 160 nm) but not EVs isolated by
filtration (mean 123 nm). Although the yield from ion exchange isola-
tion was lower than achieved by filtration (IEX 183 EVs/cell vs. filtration
748 EVs/cell), it was higher than for ultracentrifugation-derived EVs
(125 EVs/cell). In addition, unlike cross flow filtration, the isolated
EVs did not require further downstream processing to purify the vesicles
away from contaminating proteins such as BSA.
Summary/Conclusion: Ion exchange chromatography provides an ideal
compromise as an efficient and scalable method for the isolation of clean
preparations of EVs in a single step. Further analysis of EVs isolated by
ion exchange at a larger scale, together with a better understanding of
their in vivo characteristics, will be beneficial to determine the extent to
which this isolation method could be used within a clinical setting.
Funding: Postdoctoral research scientist AstraZeneca
IP.13
Size Exclusion Chromatography applications: EV isolation from large
sample volume
Julia Gavrilova1, Jekaterina Muhhina2, Triin Oja2, Davide Zocco3, Giorgia
Radano3, Natasha Zarovni4 and Paolo Guazzi2
1HansaBioMed Life-Sciences; 2HansaBioMed Life Sciences; 3Exosomics Siena;
4Exosomics Siena SpA
Introduction: Size Exclusion Chromatography (SEC) is emerging as
one the most promising methods for isolating and purifying extra-
cellular vesicles (EVs) from different matrices. SEC technique is very
efficient for separating EVs from the circulating proteins and does
not affect the original shape and functionality of the vesicles, but its
use is applicable only to small sample volume (maximum 2 ml, due
to the volume capacity of the columns commercially available) limit-
ing negatively the EV recovery from diluted matrices as urine or cell
media. HBM-LS has developed a new SEC column for isolating EVs
from a large volume of sample and adapted it to different matrices.
Additionally, the column separated efficiently the different EV sizes
from a single sample.
Methods: EVs isolation was performed from 20 ml of bodily fluids
(urine) and cell medium, using ultracentrifugation or SEC. Isolation
efficiency, EV size and shape have been assayed with different com-
mon techniques (NTA, TEM, ELISA quantification).
Results: SEC had several advantages over ultracentrifugation, includ-
ing reduced hands-on time and cost, improved ease of use, and
higher yield from the same sample volume. Remarkably, the SEC
column allowed the separation of EVs of different sizes from the
same sample, subsequently characterized by nanotracking analysis
and electron microscopy
Summary/Conclusion: The novel SEC column allows EVs isolation from
large volume of diluted matrices with higher yield than ultracentrifuga-
tion. The protocol enables the separation of EVs of different size suitable
for phenotyping or molecular analysis.
IP.14
Nanoparticle tracking (NTA) quantification of fluorescent
nanoparticles
Clemens Helmbrecht and Hanno Wachernig
PARTICLE METRIX GmbH
Introduction: Nanoparticle Tracking Analysis (NTA) measures size
and concentration in the size range from 10 nm to 1 µm. Physical
techniques such as NTA detect particles, however, cannot discrimi-
nate whether the detected particles are biological or inorganic parti-
cles such as e.g. dust, nano-bubble, metal-oxide particles or
precipitates from buffer. To overcome this limitation, NTA is
equipped with fluorescence detection capabilities combining the
advantages of fluorescence detection and nanoparticle characteriza-
tion to form fluorescence NTA (F-NTA). Quantification of fluores-
cent nanoparticles by F-NTA has proven to be challenging, but
recently credible results have been obtained as researchers examine
what is required to obtain reliable results with exosome samples.
Particle Metrix GmbH (PMX) expanded the options available by
proper choice of photo-stable dyes as well as instrument design to
limit photo bleaching.
Methods: Rapid, reliable and fast acquisition has been performed by
short acquisition at several positions by scanning-NTA to avoid photo
bleaching of standard fluorophores such as Alexa 488. By scanning
through the sample volume, significant statistics can be achieved in a
short acquisition time.
Results: Performance of NTA fluorescence detection was verified by
means of fluorescent nanoparticle size standards < 40 nm. With
quantum nano-dots (Q-dots), lower sizes are achievable. The dynamic
range of detection was expanded to the detection of ONE fluorescent
PS particle (100 nm) in the presence of 10000 unlabeled particles.
Evaluation of methods using membrane dyes such as PKH67, DiO,
DiL and CMO are shown on EVs and Liposomes. Quantification of
EVs selectively tagged by means of specific antibody labelled with
Alexa-Fluor dyes is also shown.
Summary/Conclusion: Although F-NTA was first introduced 6-8
years ago, it has been slow to develop due to challenges tagging
with quantum dots, and photo bleaching of standard fluorophores.
PMX GmbH has designed an F-NTA instrument that in large part
negates the issue of photo bleaching with many fluorophores by
quickly scanning through the sample volume with 1-2 second acqui-
sition times.






























Evaluating limit of detection for fluorescence NTA measurements:
experiments with model systems and fluorophores
Agnieszka Siupa, Clayton Deighan, Sonja Capracotta and Duncan Griffiths
Malvern Instruments
Introduction: As interest in extracellular vesicles (EV) continues to grow,
the Nanoparticle Tracking Analysis (NTA) technique has proven to be a
valuable and effective tool for EV characterization, commonly used for
the detection and measurement (size and concentration) of EV’s after
isolation. By introducing a fluorescence label and using fluorescence
mode NTA (fNTA), researchers are able to confirm that the isolated
particles are vesicles or identify a particular biomarker to expand upon
the current EV characterization methods. To date, fNTA experiments
have met with varying degrees of success.
Methods: This paper discusses a critical variable for successful fNTA
measurements, the minimum number of fluorophore molecules needed
per particle for detection and example experiments to show how to
ascertain this value for different fluorophores. Detection of a fluores-
cently labeled particle is a multifaceted problem related to the intrinsic
properties of the dye molecule, the optical arrangement of the instru-
ment, and method of sample preparation. To quantify in specific terms
the number of fluorophores required for detection in different systems
three model experiment results are presented.
Results: Three separate model systems were evaluated:
● Liposomes (~120 nm) loaded with Atto 550 incorporated at
different concentrations.
● Cationic lipoplex nanoparticles (~60 nm) formed with various
loadings of Cy3 labeled short RNAs.
● Titration of biotinylated 80 nm gold nanoparticles labeled with
streptavidin labelled with NorthernLights™ 557 dye
These model systems provide easily quantifiable approaches to deter-
mining number of fluorophores per particle and give results of 160, 35,
and 20 fluorophores/particle respectively.
Summary/Conclusion: We discuss these results in the context of exo-
some labeling experiments, providing the reader with important con-
siderations and experimental design points.
Funding
These experiments were funded as regular work duties of the authors in
developing new applications.
IP.16
To the standardization of exosome isolation and characterization
Julia Luciano-Chadee
Beckman Coulter Inc.
Introduction: Research involving exosomes is rapidly expanding with a
vast increase in the quality and quantity of publications. An improved
and more efficient isolation protocol for exosomes is critical to advan-
cing this exciting filed.
Methods: Challenges to researchers working with exosomes include
setting up density gradients by hand, because it is tedious, time con-
suming and subject to user, lab, and method analysis. At the same time,
experts in the field have called for the establishment of standard proto-
cols. This poster focuses on solutions to those challenges through cost-
effective, large-scale purification and fast analysis of exosomes.
Results: Specifically, the Beckman Coulter product portfolio helps to
overcome human variables and cost while maintaining reliability, repro-
ducibility, and high-throughput.
Summary/Conclusion: Beckman Coulter is a complete exosomes work-
flow solution that combines methods of centrifugation, automation, flow
cytometry, and particle analysis.
Funding: Beckman Coulter, the stylized logo, and the Beckman Coulter
product and service marks mentioned herein are trademarks or registered
trademarks of Beckman Coulter, Inc. in the United States and other
countries. All other trademarks are the property of their respective owners.
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Synthetic stem cell microparticles for heart repair
Ke Cheng
UNC-Chapel Hill & NC State University, NC, USA
Introduction: Stem cell therapy faces a number of challenges. It is
difficult to expand, store, and transport stem cells before they are
administered to the patient. Synthetic analogs for stem cells and acellular
approaches are promising to overcome these hurdles and hold the
potential to revolutionize regenerative medicine. We sought to fabricate
synthetic analogs of stem cells and test their therapeutic potential for
treatment of acute myocardial infarction in mice.
Methods: We packaged secreted factors from human stem cells into Poly
(lactic-co-glycolic acid) PLGA microparticles and then coated them with
stem cell membranes. We named these therapeutic particles “synthetic
stem cells”.
Results: Synthetic stem cells exhibited a factor release profile and surface
antigens similar to those of genuine cells. They promoted cardiomyocyte
functions and displayed cryopreservation and lyophilization stability in
vitro and in vivo. In a mouse model of acute myocardial infarction,
direct injection of synthetic stem cells promoted angiogenesis and miti-
gated left ventricle remodeling.
Summary/Conclusion: The synthetic stem cell strategy may provide
novel insight into tissue engineering for treating multiple diseases. In
my talk I will cover the results recently published (Circ Res 2017; Nature
Commun 2017) as well as some unpublished data regarding the vascular
delivery and targeting aspect of microparticles and stem cells.
Funding: NIH of USA.
LBO.25
Calpain carried by platelet-derived microparticles cleaves the
protease-activated receptor 1 on endothelial cells and initiates
vascular inflammation during diabetes
Anastasia Kyselova1, Ingrid Fleming1 and Voahanginirina Randriamboavonjy2
1Institute for Vascular Signaling, Goethe University, Frankfurt, Germany;
2Institute for Vascular Signaling, Goethe University, Frankfurt, Germany
Introduction: The morbidity and mortality associated with diabetes is
related to micro-and macro-vascular complications. The Ca2+-activated
proteases or calpains have been implicated in the platelet hyperactivation
associated with diabetes. Since calpains are known to be carried by
platelet-derived microparticles (PMPs), the aim of the present study
was to determine the effect of platelet-derived calpain on the vascular
wall.
Methods: Mass spectrometry and ELISA were used to analyse proteins in
the culture medium from calpain-treated endothelial cells. Protein levels
on the surface of endothelial cells were measured by FACS and en-face
immunostaining was used to assess protein expression levels on intact
aorta while Western-blot was used to investigate intracellular signaling.
Results: In vitro treatment of endothelial cells with PMPs or recombi-
nant calpain 1(CAPN1) led to a decrease in endothelial protein C
receptor (EPCR) levels on the cell surface and an increase in its levels
in the culture medium. EPCR levels were also increased in plasma from
diabetic patients and correlated with plasma calpain activity. Diabetes
induction in mice led to increased EPCR levels in the plasma which was
prevented by the treatment of the mice with the calpain inhibitor A-
705253. Mechanistically, calpain cleaved the protease-activated receptor
1 (PAR-1) on endothelial cells leading to the activation of an intracel-
lular signaling i.e. protein kinase C and extracellular signaling-regulated
kinase (ERK) phosphorylation causing on one hand the activation of the
Tumor necrosis factor-α converting enzyme and EPCR shedding and on
the other hand the increase in the expression levels of Intercellular cell
adhesion molecule-1 and leukocytes adhesion as well as cell permeabil-
ity. All of the calpain effects could be mimicked by PMPs from wild-type
but not from CAPN1−/- mice and were abolished in PAR-1−/- endothelial
cells.
Summary/Conclusion: These data demonstrate that platelet-derived cal-
pains contribute to diabetes-associated vascular inflammation by target-
ing the PAR-1 receptor and suggest calpain as a therapeutic target for
the prevention of cardiovascular complication of diabetes.
Funding: Deutsche Forschungsgemeinschaft-RA 2435/3-1.
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Role of RBC-derived EVs in mediating intercellular communication in
murine cardiovascular disease models
Avash Das1, Olivia Ziegler2, Shulin Lu3, John Tigges3, Vasilis Toxavidis3,
Kirsty Danielson4, Saumya Das2 and Ionita C. Ghiran5
1Massachusetts General Hospital, MA, USA; 2Mass General Hospital, MA,
USA; 3Beth Israel Deaconess Medical Hospital, MA, USA; 4University of
Otago, Dunedin, New Zealand; 5Beth Israel Deaconess Medical Center;
Harvard Medical Hospital, MA, USA
Introduction: Extracellular vesicles (EVs) function as novel mediators of
intercellular communication. Here, we describe a fluorescence switch-
based, experimental model to study EV-mediated communication
between RBCs and the heart as well as other organs that permits
characterization of cross-talk between RBCs and cardiomyocytes at
homeostasis and after myocardial infarction.
Methods: Mice with RBC-specific expression of Cre (Erythropoietin
Receptor (EpoR) Cre) were crossed with reporter mTmG Rosa26 mice
to yield EpoRCre/mTmG off-springs with membrane GFP expression in
RBCs and RBC-derived EVs. Cultured dermal fibroblasts from mTmG
mice and a mT/floxed/mGFP HEK 293 reporter cell line were used to
assess transfer of functional Cre in RBC-derived EVs. To determine
targets of RBC-EVs, organs from i) EpoRCre/mTmG (n=3), ii) mTmG
(n=3) or iii) mTmG mice transfused with RBC-EVs from EpoR-Cre
mice and targets of RBC-EVs (determined by mGFP expression due to
Cre-recombination) were assessed by confocal microscopy. Finally,
ischemia-reperfusion-infarction (30 min. LAD ligation) was done in
EpoRCre/mGmT mice (n=3) and their blood and organs harvested
after a span of 4 weeks to analyze changes in quality and quantity of
RBC-EV targets following MI.
Results: 1. RBC-EVs (mGFP positive) in plasma accounted for about 9%
of total fluorescent EVs as detected by nano-flow cytometry and micro-
scopy. 2. In vitro dermal fibroblasts from mTmG mice or mT/floxed/
mGFP HEK 293 reporter cells showed mGFP expression with EpoRCre
RBC-EVs, suggesting EV-mediated transfer of functional Cre. 3. Cre-
mediated recombination was noted in diverse organs in EpoRCre/
mTmG mice and mTmTG mice transfused with EpoRCre- EVs with
the bone marrow, heart, lungs, kidney and spleen showing the largest
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degree of recombined cells. 4. Target profile of RBC-EVs demonstrates a
distinct pattern of EV-mediated communication among the organs at
baseline that was altered following MI, with increased recombination
events in the brain, spleen and peri-infarcted heart.
Summary/Conclusion: We show proof-of-concept for a novel model to
study origin and targets of EV-mediated intercellular communication with
significant EV-mediated communication between RBCs and cardiomyo-
cytes under homeostatic conditions and following myocardial infarction.
Funding: NIH (NHLBI R01 HL122547 to Saumya Das).
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Extracellular vesicles released by induced pluripotent stem cells
induce cardiac repair in a model of myocardial infarction/reperfusion
Marta Adamiak1, Guangming Cheng2, Sylwia Bobis-Wozowicz1, Elżbieta
Karnas3, Robert Vincent2, Michał Sarna4, Zbigniew Madeja1, Buddhadeb
Dawn2 and Ewa K. Zuba-Surma1
1Department of Cell Biology, Faculty of Biochemistry, Biophysics and
Biotechnology, Jagiellonian University, Krakow, Poland; 2Division of
Cardiovascular Diseases, Cardiovascular Research Institute, University of
Kansas Medical Center, KS, USA; 3Department of Cell Biology, Faculty of
Biochemistry, Biophysics and Biotechnology, Jagiellonian University,
Krakow, Poland; Malopolska Centre of Biotechnology, Krakow, Poland;
4Department of Biophysics, Faculty of Biochemistry, Biophysics and
Biotechnology, Jagiellonian University, Krakow, Poland; Malopolska Centre
of Biotechnology, Jagiellonian University, Krakow, Poland
Introduction: Extracellular vesicles (EVs) from different kinds of stem
cells have been effectively used to promote cardiac function under
pathological conditions. One of the most fascinating characteristics of
EVs is their ability to carry cell-type specific mRNAs, miRNAs and
proteins. Thus, EVs derived from induced pluripotent stem cells
(iPSCs) may provide an interesting alternative to harness the salutary
effects of iPSCs and circumvent concerns associated with iPSC research.
Here, we aimed to determine the effect of murine iPSC - derived EVs
(miPSC-EVs) on the repair of ischemic myocardium in vivo.
Methods: EVs were purified by sequential centrifugation of conditioned
media collected from the serum- and feeder-free culture of miPSCs. EV
morphology, molecular content as well as the influence of EVs on target
cell function in vitro were carefully characterized. In the in vivo study,
C57BL/6 mice underwent a 30-minute coronary occlusion followed by
reperfusion, and 48 hours later, received intramyocardial injection of
vehicle (PBS, n=14), miPSCs (n=15) or miPSC-EVs (n=13).
Echocardiography was performed 4 days prior to coronary occlusion/
reperfusion and at 48 hours and 30 days after injection. Mice were
euthanized at 30 days post injection, heart tissue was harvested and
histological analyses were performed.
Results: Cardiac endothelial cells treated with miPSC-EVs exhibited
greater angiogenic activity in vitro and were more resistant to apop-
tosis. At day 32 after coronary occlusion/reperfusion, mice injected
with iPSC-EVs exhibited significantly improved left ventricular ejec-
tion fraction and end-systolic volume compared with vehicle-treated
mice (P < 0.05). Although iPSC-injected hearts showed improved
function and structure, several mice in this group grew teratomas at
myocardial injection sites.
Summary/Conclusion: Our data show that intramyocardial injection of
miPSC-EVs after myocardial infarction/reperfusion produced similar
improvement in cardiac structure and function compared with
miPSCs. Thus, we conclude that miPSC-EVs may represent a safer
therapeutic alternative to whole cell-based therapy for cardiovascular
repair.






























Exosomes as key regulators of signal relay during chemotaxis
Carole Parent1, Ritankar Majumdar2 and Paul Kriebel1
1Lab Cellular & Molecular Biology, CCR, NCI, NIH; 2Lab Cellular &
Molecular Biology, CCR, NCI. NIH
Introduction: The property of sensing and initiating directional migra-
tion in response to external cues or chemotaxis is a fundamental prop-
erty of biological systems. How cells detect and respond to external
chemotactic signals and, in particular, how the spatial and temporal
relay of chemotactic signals between cells impact single and group cell
migration are key questions in the chemotaxis field.
Methods: Using the social amoebae Dictyostelium discoideum, where
cAMP acts as a chemoattractant, we have shown that the relay of
chemotactic signals between cells is mediated through the release of
extracellular vesicles that contain the enzyme responsible for synthesiz-
ing cAMP, the adenylyl cyclase ACA. We purified the extracellular
vesicles from chemotactic cells and showed that they are exosomal,
contain and release cAMP and attract cells in an ACA-dependent fash-
ion. Indeed, mass spectrometry analyses identified many canonical exo-
somal proteins as well as upstream regulators of ACA. We further show
that cAMP is released through specific ABC transporters expressed in
exosomes.
Results: We extended our studies to neutrophils and show that LTB4, a
key secondary chemoattractant in neutrophils, and its synthesizing
enzymes localize to intracellular multi-vesicular bodies that, upon sti-
mulation, release their content as exosomes. Our findings establish that
the exosomal pool of LTB4 acts in an autocrine fashion to sensitize
neutrophils towards the primary chemoattractant, and in a paracrine
fashion to mediate the recruitment of neighboring neutrophils in trans.
We also investigated the mechanism by which LTB4 synthesizing
enzymes, which are primarily localized on the nuclear envelope, are
repackaged in exosomes and provide evidence that lipid homeostasis is
involved in LTB4 vesicular packaging.
Summary/Conclusion: We envision that the packaging of chemoattrac-
tants in exosomes provides a means of maintaining highly diffusible
signals available for long-range cell-cell communication. We foresee
that this newly uncovered mechanism is used by other signals to foster
communication between cells in harsh extracellular environments.
Funding: This research was supported by the Intramural Research
Program of the Center for Cancer Research, NCI, NIH.
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Anti-tumor effect of bacterial outer membrane vesicles mediated by
interferon-γ
Hyun Taek Park, Kim Oh Youn, Nhung Thi Hong. Dinh, Gyeongyun Go,
Lee Changjin and Yong Song Gho
POSTECH
Introduction: Outer membrane vesicles (OMVs) secreted by Gram-
negative bacteria is spherical nano-scale membrane vesicles filled
with periplasmic contents and currently shed new light on possibility
of non-living complex vaccines or delivery vehicles. However, there
was no attempt to treat cancer using OMVs. In this study, we
investigated bacterial OMVs as a therapeutic agent for treating
cancer.
Methods: CT26 (murine colon adenocarcinoma) were grafted subcuta-
neously to wild type and interferon-γ knockout mice. Following intra-
venous administration of bacterial OMVs derived from ΔmsbB E. coli to
those mice, tumor volume was measured every 3 days. Tumor tissues
obtained are subsequently examined. IVIS analyses are used to monitor
targeting of OMVs to tumor tissue. Cytokine levels in blood and tumor
tissue lysates are measured by ELISA.
Results: Treatment of âˆ†msbB E. coliOMVs reduced tumor volume in dose-
dependent manner and completely eradicated the tumor tissue when 5 μg of
âˆ†msbB OMVs are injected (P < 0.001, versus no-treated mice; total n = 14
mice per group, two independent experiments). Interestingly, IVIS imaging
analyses showed that OMVs were highly enriched in tumor tissue rather than
spreading out the other organs. Cytokine analyses have revealed that IL-
12p40, IFN-γ and CXCL10 cytokines increased in blood and tumor tissue
upon OMVs treatment. In addition, OMV treatments of mice with IFN-γ
deficiency failed to induce such anti-tumor effect (P < 0.001, versus wild type
mice; n = 6 mice per group).
Summary/Conclusion: We here demonstrated that administration of bacter-
ial extracellular vesicles, especially Gram-negative bacterial OMVs, resulted
in a remarkable anti-tumor effect without noticeable side effects. Moreover,
we found that anti-tumor effect of OMVs is mediated by interferon-γ
dependent manner since tumor in IFN-γ deficient mice were not affected
by OMV treatment. Therefore, we here suggest that bacterial OMVs are
promise immunotherapeutic agent to treat various cancers and these could
bring a new insight in the development of novel immunotherapy in the
future.
LBO.30
The particular pathology of systemic lupus erythematosus
Ole Østergaard1, Julia T. Tanassi2, Christoffer T. Nielsen3, Jesper V. Olsen4
and Niels H. H. Heegaard5
1Department of Autoimmunology and Biomarkers, Statens Serum Institute
+ The Novo Nordisk Foundation Center for Protein Research, University
of Copenhagen, Denmark; 2Department of Autoimmunology and
Biomarkers, Statens Serum Institut; 3Copenhagen Lupus & Vasculitis
Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitale,
Copenhagen, Denmark; 4The Novo Nordisk Foundation Center for
Protein Research, University of Copenhagen, Denmark; 5Department of
Autoimmunology and Biomarkers, Statens Serum Institute + Department
of Clinical Biochemistry and Pharmacology, Odense University Hospital,
Copenhagen, Denmark
Introduction: The pathogenesis of the autoimmune disease systemic lupus
erythematosus (SLE) may be linked to aberrant microparticle (MP) genera-
tion and removal leading to inflammatory signaling and subsequent auto-
immune reactions and tissue damage. While the removal of normal MPs
appears to work efficiently in SLE we previously found increased numbers of
Annexin V (AnxV) non-binding MPs in the plasma of SLE patients com-
pared to healthy controls (HC) and other autoimmune diseases. We here
characterize the proteomes of MPs and AnxV non-binding MPs from SLE
and HC to get insights to the origin and uniqueness of SLE associated MPs
(luposomes).
Methods: MPs were isolated from HC (n=4) and SLE (n=4) citrate plasma
by repeated centrifugation at 18,890 x g. AnxV non-binding MPs were
enriched by negative selection using AnxV-coupled microMACS beads.
The total MPs and the AnxV non-binding MPs were then subjected to
tryptic digestion and resulting peptides were analyzed by LC-MSMS to
identify and quantitate proteins by label free quantitation using
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MaxQuant. MP groups were compared after normalization using β-actin
levels and results were analysed further in Perseus and Excel.
Results: In the total MPs samples 2,500-3,500 unique proteins were
identified while the AnxV non-binding MPs yielded 1,700-3,000 pro-
teins. Hierarchical clustering showed separation between HC and SLE
MPs and between HC and SLE AnxV non-binding MPs. Overall, col-
lagen-derived peptides were increased in the AnxV non-binding MPs.
Specifically for the SLE AnxV non-binding MP there were increased
amounts of complement factors, immunoglobulins, galectin-3 binding
protein and other proteins. Conversely, platelet integrins and mitochon-
drial proteins were increased in total MPs compared to the AnxV non-
binding MPs.
Summary/Conclusion: Deep proteome profiling of MPs from SLE patients
and HC confirm the presence of a sub-fraction of abnormal MPs in SLE.
Furthermore, for the first time we here characterize the extremely different
proteome profile of AnxV non-binding MPs from SLE patients that seems to
be responsible for the differences in the total MP profiles that are unique for
SLE. The characterization of these MPs (luposomes) is of importance for
understanding the pathogenesis of SLE, for development of new diagnostic
tools, and also provide avenues for the development of new therapeutic
concepts.
LBO.31
Presence of diabetes autoantigens in extracellular vesicles derived
from human islets
Craig P. Hasilo1, Sarita Negi2, Isabelle Allaeys3, Nathalie Cloutier3, Alissa K.
Rutman4, Marco Gasparrini2, Eric Bonneil5, Pierre Thibault5, Eric Boilard6
and Steven Paraskevas2
1McGill University, Montreal, Canada; 2McGill University Health Centre,
Research Institute of the MUHC, Montreal, Canada; 3Centre de Recherche
du CHU de Québec, CHUL; 4Research Institute of the McGill University
Health Centre, McGill University, Montreal, Canada; 5Institute for Research,
Immunology and Cancer, Université de Montreal, Canada; 6Department of
Microbiology-Infectious Disease and Immunity and Faculty of Medicine,
Université Laval, Quebec, Canada
Introduction: The role of extracellular vesicles (EV) in the etiology of
type 1 diabetes is poorly understood. We set out to determine if human
islets, isolated using clinical transplant protocols, produce EV in culture
and if they contain diabetes autoantigens (DAA).
Methods: Islet conditioned media (ICM) was collected from human islets
(≥80% purity; cultured up to 72hrs) isolated from non-diabetic donors
(n=10) under research consent. Nanoparticle tracking analysis (NTA) and
flow cytometry (FC) were used to determine particle concentration and size
distribution. ICM (n=10) were labeled with CellTracker Deep Red (CT),
annexin V, DAA GAD65, IA-2, and ZnT8, βcell markers Glut2 and Hsc70,
EVmarkers CD9 and CD14 on a FACS Canto II with small particle analyzer.
Serial centrifugation at 50 000 g and 200 000 g generated ICM-50K and ICM-
200K fractions, respectively. Double-labeled immunogold TEM was per-
formed for AnnV plus GAD65, ZnT8 or Glut2. Proteomic analyses were
performed bymass spectrometry on ICM-50K and ICM-200K (n=5 donors),
and islet cell lysate (ICL) on a LTQ-Orbitrap Elite. Values obtained in lot-
matched unconditioned media were subtracted from experimental values.
Results: Varying levels of EV between donor ICM were detected with a
consistent size distribution, and varying antigen levels. Proteomics of ICM-
50K and ICM-200K revealed over 56% homology with ICL, but not with an
endothelial cell line. Enrichment analyses identified proteins of exosome
lineage, associated with diabetes pathways, and capable of eliciting an
immune response. GAD65, ZnT8 and Glut2 presence on EV was confirmed
with immunogold-EM.
Summary/Conclusion: Morphologically diverse ICM EV, containing varying
levels of DAAGAD65, ZnT8, and Glut2, were detected with a consistent size
profile between non-diabetic donors. Proteomic evaluation reflected an islet-
specific protein signature capable of promoting an immune response. These
biomarkers may be strong targets for early diagnostic markers of β-cell injury
and interventional strategies in diabetes and islet transplantation.
Funding: Canadian National Transplant Research Program (CNTRP) and
the McGill University Health Centre Foundation. C.P.H. is the recipient of
the Astellas CNRTP Training Award, and E.B. is the recipient of a new
investigator salary award from the Canadian Institutes of Health Research.






























Neutral sphingomyelinases control Extracellular Vesicles budding
from the plasma membrane
Julia C. Gross1, Kerstin Menck2, Can Sönmezer3, Thomas Worst4, Matthias
Schulz3, Gry Dihazi3, Frank Streit3, Gerrit Erdmann5, Simon Kling6, Michael
Boutros7 and Claudia Binder3
1University Medical Center Gottingen, Germany; 2INSERM, U1068, Centre
de Recherche et Cancérologie de Marseille, France; 3University Medical
Center Gottingen, Germany; 4Mannheim Medical Center, University of
Heidelberg, Germany; 5NMI TT Pharmaservices; 6NMI Natural and
Medical Sciences Institute at the University of Tubingen, Germany;
7German Cancer Research Center (DKFZ), Division Signaling and
Functional Genomics and Heidelberg University, Heidelberg, Germany,
Department of Cell and Molecular Biology, Faculty of Medicine Mannheim,
Im Neuenheimer Feld 580, 69120 Heidelberg, Germany; German Cancer Con
Introduction: Extracellular vesicles (EVs) are membrane particles
secreted from cells into all body fluids. Several EV populations exist
differing in size and cellular origin.
Methods: Using differential centrifugation EVs pelleting at 14,000 g
(“microvesicles” (MV)) and 100,000 g (“exosomes”) are distinguishable
by protein markers. Neutral sphingomyelinase (nSMase) inhibition has
been shown to inhibit exosome release from cells and has since been
used to study their functional implications.
Results: How nSMases (also known as SMPD2 and SMPD3) affect the
secretion of MVs is unknown. Here we investigated how SMPD2/3
impact both EV populations. SMPD2/3 inhibition by GW4869 or
RNAi decreases secretion of exosomes, but also increases secretion of
MVs from the
plasma membrane. Both populations differ significantly in metabolite
composition and Wnt proteins are specifically shifted onto MVs under
these conditions.
Summary/Conclusion: Taken together, our data reveal a novel regulatory
function of SMPD2/3 in vesicle budding from the plasma membrane and
clearly suggests that - despite the different vesicle biogenesis - the routes
of vesicular export are adaptable.
LBO.33
Live-cell imaging for neural stem cells-derived exosomes during
neurogenesis by exosomal microRNA using a microfluidic device
Hyun Jeong Oh1, Seok Chung2, Do Won Hwang1 and Dong Soo Lee1
1Department of Nuclear Medicine, Seoul National University, Seoul, Republic
of Korea; 2School of Mechanical Engineering, Korea University, Seoul,
Republic of Korea
Introduction: Exosomes are cell-derived vesicles that shuttle miRNAs
involved in regulation of cellular process including cell proliferation and
differentiation. Neurogenic microRNA (miRNA) such as miR-124 or
miR-9 can be transferred and plays essential roles in differentiation of
neural stem cells (NSCs) and neural progenitor cells (NPs) to neuronal
cells. In this study, we proposed a mode of exosomal miRNA-mediated
cell-non-autonomous neurogenesis and visualized the migration of exo-
somes to neighboring cells using a customized microfluidic assay.
Methods: Real-time imaging of exosomal transport was performed using
the GFP-tagged CD63 plasmid vector and GFP-tagged exosomes were
monitored by confocal microscopy on microfluidic device. NE-4C,
neural stem cells and F11, neural progenitor cells were used to examine
exosomes. The pRV-effLuc/3xPT_miR-193a vector was used to detect
miR-193a expression which luciferase signal could be turned off by
binding of miR-193a to the triplicates of miRNA binding site in the 3’
UTR of effLuc.
Results: The miR-193a was highly expressed in differentiated cells and
exosomes secreted from those cells after neurogenesis. The miR-193a
facilitated neurogenesis in neural progenitor cells and neural stem cells
by blocking proliferation-related target genes. Luciferase activity of
undifferentiated (UD) recipient F11 cells/effLuc/3×PT_miR-193a was
decreased only co-culture with differentiated (D) donor cells after neu-
rogenesis using a microfluidic device. Time-lapse live-cell imaging using
microfluidics clearly visualized the convective transport of exosomes
from D-donor to UD-recipient cells. Exosomes containing miR-193a
from D-donor cells were taken up by UD-recipient cells and lead them
to neurogenesis.
Summary/Conclusion: In this study, we established exosome-tracing
microfluidic platform to visualize convective exosomal transport from
differentiated to undifferentiated cells and validated that exosomes and
neurogenic miRNA within these exosomes propagate cell-non-autono-
mous neurogenesis to neighboring progenitors.
LBO.34
Importance of choroid plexus-mediated extracellular vesicle secretion
in the propagation of Alzheimer’s disease
Sriram Balusu1, Charysse Vandendriessche1, Caroline Van Cauwenberghe1,
Marjana Brkic1, Bart De Strooper2, Claude Libert1 and Roosmarijn
Vandenbroucke1
1VIB-UGent; 2VIB-KULeuven
Introduction: Increasing evidence indicates that extracellular vesicles
(EVs), including exosomes, play an important role in Alzheimer’s
disease (AD) pathology. We recently reported that the choroid plexus
epithelial cells, present at the interface between blood and cerebrosp-
inal fluid (CSF), show increased EV secretion into the CSF upon
peripheral inflammation. Moreover, these EVs were able to enter
the brain parenchyma thereby spreading a pro-inflammatory message.
Here, we studied the importance of choroid plexus-derived EVs in
AD pathology.
Methods: We made use of two mouse models of Alzheimer’s disease:
transgenic APP/PS1 mice and intracerebroventricular (icv) injection of
Aβ oligomers (AβO) in wild type mice. EVs were analyzed using
NanoSight, electron microscopy and western blot analysis. Several
immunostainings with EV markers were performed on brain sections.
To assess cognition, we made use of the novel object recognition test.
Results: Analysis of CSF of transgenic APP/PS1 mice revealed that early
on in disease progression, there was an increase in amount of EVs
compared to age-matched controls. In contrast, no difference in amount
of EVs could be observed later on during disease progression.
Interestingly, this correlated with an early increase in CSF Aβ. Next,
we studied the effect of icv AβO injection and this revealed a significant
increase in amount of EVs in CSF. Moreover, we observed that the
choroid plexus epithelial cells are an important source of CSF EVs
based on in vitro analysis of AβO stimulated primary choroid plexus
cells and in vivo immunostainings and transmission electron microscopy
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analysis of choroid plexus tissue. Importantly, we could link the choroid
plexus-mediated EV secretion with AβO-induced cognitive decline.
Summary/Conclusion: In conclusion, our results show that AβO induces
EV secretion by the choroid plexus and that these EVs play a role in
disease spreading and loss of cognition. These data suggest that inhibi-
tion of EV production by the choroid plexus might be an interesting
therapeutic approach to prevent or treat AD.
Funding: SAO-FRA (Stichting Alzheimer Onderzoek), Research
Foundation - Flanders (FWO) and MouseAge COST action.
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Rapid isolation of extracellular vesicles using lipid nanoprobes for
cancer diagnosis in NSCLC patients
Siyang Zheng1, Yuan Wan2, Gong Cheng2, Xin Liu3, Si-Jie Hao2, Merisa
Nisic4, Chuan-Dong Zhu5, Yi-Qiu Xia2, Wen-Qing Li2, Zhi-Gang Wang2,
Wen-Long Zhang2, Shawn J. Rice3, Aswathy Sebastian6, Istvan Albert7 and
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(MINIBIO) Laboratory; Dept of Biochemistry and Molecular Biology,
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Biomedical Engineering, Micro & Nano Integrated Biosystem (MINIBIO)
Laboratory, University Park, PA; Penn State Materials Research Institute,
University Park, PA, USA; 3Penn State Milton S. Hershey Medical Center,
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Institute, The Pennsylvania State University, Hershey, PA, USA; 4Department
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Molecular Biology, University Park, PA, USA; 7The Huck Institutes of the
Life Sciences, University Park, PA; Department of Biochemistry and
Molecular Biology, University Park, PA, USA
Introduction: Extracellular vesicles (EVs) released by various cells are lipid
bilayer-enclosed entities that can mediate intercellular communication by
transferring cargo proteins and nucleic acids. Recently, the pathophysiolo-
gical roles and clinical values for EVs are under intense investigation.
However, most studies are limited by technical challenges in isolating EVs.
Methods: We report a new method for EV isolation that uses a nanop-
robe system for spontaneous membrane labeling and magnetic enrich-
ment of EVs in 15 minutes. We use EVs derived from cancer cell line as
a model system and compare the isolation performance between the
nanoprobe system and ultracentrifugation. Furthermore, we isolate EVs
from plasma samples of 19 non-small lung cancer (NSCLC) patients and
perform DNA mutation detection.
Results:
A comparison study demonstrates the nanoprobe system offers compar-
able isolation efficiency, similar cargo composition compared with ultra-
centrifugation. In addition, it can be readily modified to meet the
requirements for various EV and cargo analyses such as EV amount,
morphology, cargo contents (DNA, RNA and protein). Further, aided
with this system we isolated nEVs in blood plasma from NSCLC patients
and successfully identified EGFR and KRAS mutations.
Summary/Conclusion: The efficiency and versatility make this nanop-
robe system a new method for EV isolation. Analyses based on this
method are conducive to future cancer diagnostics.

































Milk-derived extracellular vesicles from non-allergic and allergic
mothers differ in T cell modulatory capacity and have a distinct
protein composition
Martijn J.C. van Herwijnen1, Marijke I. Zonneveld2, Soenita Goerdayal3,
Arianne van Bruggen – de Haan4, Esther N.M. Nolte-’t-Hoen1, Johan
Garssen5, Maarten A.F. Altelaar3, Gerbrich N. van der Meulen4, Ruurd M.
van Elburg6, Frank A. Redegeld7 and Marca H.M. Wauben1
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3Biomolecular Mass Spectrometry and Proteomics Group, Bijvoet Centre for
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4Department of Paediatric Allergy, Martini Hospital, Groningen, The
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Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands
and Nutricia Research Centre for Specialised Nutrition, Utrecht, The
Netherlands; 6Department of Pediatrics, Emma Children’s Hospital/
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Introduction: Breast milk is nature’s first functional food which contains
various bioactive components that modulate the infant’s immune system.
Early life nutrition is vital for health later in life and breastfeeding may aid in
the prevention of allergies. Nevertheless, it has been suggested that the breast
milk from allergic mothers can negatively influence the infant’s immunity,
possibly caused by an alteredmilk composition. However, due to the complex
structure of milk, the molecular mechanism underlying this effect has not
been solved. Recently, we and others have identified milk-derived extracel-
lular vesicles (EVs) as an immune modulatory component in milk. In this
study, we compared the protein composition and functional T cell modula-
tory capacity of milk-EV derived from allergic and non-allergic mothers.
Methods: Milk-derived EVs were isolated via differential centrifugation
followed by density gradient-based separation of human milk from
allergic or non-allergic mothers. Functionality was tested in vitro by
co-culturing EVs with αCD3/αCD28-stimulated CD4+ T cells.
Additionally, LC-MS/MS proteomic analysis was performed to compare
the milk-EV proteomes, followed by pathway analysis of proteins that
were differentially expressed using MetaCore and ImmuNet.
Results: T cell proliferation, upregulation of activation markers and overall
cytokine production were inhibited in the presence of milk-derived EVs, in
contrast to T cells that were cultured withmilk supernatant depleted of EVs.
Remarkably, milk-derived EV from allergic mothers inhibited T cell activa-
tion to a lesser extent than EVs from non-allergic mothers. By comparing
the proteomes of milk-derived EVs from allergic and non-allergic mothers
we found quantitative differences in key proteins between these two groups.
These individual proteins linked specifically to the Rac1 and CDC42 signal-
ling pathways, affecting cell proliferation pathways.
Conclusion: These data show that milk-derived EVs differ in their T cell
modulatory capacity depending on the allergic status of the mother. The
reduced T cell inhibition by EVs from allergic mothers might be due to
the relative abundance of key proteins in these EVs.
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Characterising extracellular RNA inside and outside of vesicles
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Introduction: Exosomes contain a variety of RNAs, including both
protein-coding messenger RNAs (mRNAs) and non-coding RNAs.
Previous reports have found that for extracellular microRNAs, some
exist inside vesicles whereas others are contained outside of vesicles in
protein complexes. It is unclear what proportion of extracellular RNA
resides inside vs. outside of vesicles.
Methods: We have used differential ultracentrifugation to isolate exo-
somes from the K562 leukaemia cell line. We then developed a proto-
col to get rid of RNA not protected by intact lipid membranes by
sequential Proteinase and RNAse treatment, resulting in only the RNA
inside of the vesicles. We have also verified that this method does not
break vesicles. To characterise the resulting RNA inside of vesicles, we
have used various techniques such as Bioanalyzer, qRT-PCR and
RNA-Seq.
Results: We have found that the majority of RNA (particularly the small
RNA fraction) in an exosome pellet isolated by differential ultracentri-
fugation is not inside vesicles when comparing Bioanalyzer traces of the
untreated pellet to the proteinase/RNase treated one. However, our qRT-
PCR and RNA-Seq analysis demonstrates that the mRNAs in the exo-
some pellet are inside the vesicles.
Conclusion: The exosome pellet isolated by differential ultracentrifuga-
tion contains RNA that is both inside and outside vesicles. We have
developed a protocol to distinguish RNA that is inside of vesicles from
that which is outside. We have found that the mRNAs are inside vesicles
whereas a considerable portion of the small RNAs are outside of vesicles
(presumably in free protein complexes). Identifying RNAs that are truly
inside vesicle has important implications for studying the role of exo-
some cargo in intercellular communication.
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Live tracking of endogenous exosome communication in vivo
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Introduction: Exosomes are a nano-sized subclass of Extracellular
Vesicles (EVs), released by a wide variety of cell types, that have been
implicated in many important physiological and pathological processes.
Due to the lack of suitable in vivo models, however, the in vivo dynamics
and physiology of exosomes are poorly understood.
Methods: We developed an animal model to study endogenous exo-
somes in vivo by (site-specific) expression of a hCD63-based fluor-
escent reporter for exosome secretion in zebrafish and used various
light- and electron microscopy (LM and EM) techniques for our
analysis.
Results: A combination of light- and electron microscopy (LM and EM)
techniques allowed us to observe exosome release in vivo and track a
massive pool of endogenous exosomes in the blood flow of zebrafish
embryos. Site specific expression confirmed that these exosomes origi-
nated from the Yolk Syncytial Layer (YSL), a multinucleate cell layer in-
between the yolk and the developing embryo with essential nutrient
transport functions, sharing functional homologies with the mammalian
placenta. By Electron Microscopy we observed massive release of EVs
from the apical side of the YSL into the blood flow, further confirming





























the YSL as major source of (CD63+ve) exosomes in the developing
embryo. Next, we used live imaging to track endogenous EVs in the
blood flow to identify their main targets. CD63+ EVs where preferen-
tially interacting with endothelial cells in the caudal vein and plexus
compared to the caudal artery. EM revealed endocytosis of these EVs in
endosomal compartments of endothelial cells. We detected another
major fraction of exosomes in the interstitial fluid, suggesting extravasa-
tion outside of the vasculature of YSL derived EVs. We finally observed
active and specific endocytosis and storage of CD63+ EVs by scavenging
macrophages of the caudal plexus.
Summary/Conclusion: Functionally, our data could support a role for
YSL derived EVs in nutrient delivery during development, which is
our current focus. Altogether, these data reveal for the first time the
release, journey and target of endogenous exosomes in vivo. We
propose the zebrafish embryo as a new model to study endogenous
EVs in vivo that will open new avenues to unravel fundamental
aspects in EV biology.
Funding: EMBO ALTF 1383-2014; ARC PDF20160604167â€¨; Labex
CelTisPhyBio post-doc & project grants; FRM AJE20160635884
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